
<html lang="en"     class="pb-page"  data-request-id="31777927-762e-4b2a-a88b-cb64776f980e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2012.55.issue-8;article:article:10.1021/jm201271b;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors" /></meta><meta name="dc.Creator" content="Rajinder  Singh" /></meta><meta name="dc.Creator" content="Esteban S.  Masuda" /></meta><meta name="dc.Creator" content="Donald G.  Payan" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 14, 2012" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201271b" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201271b" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201271b" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201271b" /></link>
        
    
    

<title>Discovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201271b" /></meta><meta property="og:title" content="Discovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201271b"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201271b">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201271b&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201271b&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201271b&amp;href=/doi/10.1021/jm201271b" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3614-3643</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200990c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm2010964" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajinder++Singh">Rajinder Singh</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Esteban+S.++Masuda">Esteban S. Masuda</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+G.++Payan">Donald G. Payan</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Rigel, Inc., 1180 Veterans Boulevard, South San Francisco, California 94080, United States</span></div><div class="corresp-info"><strong>*</strong>Telephone: (650) 624-1167. E-mail: <a href="/cdn-cgi/l/email-protection#3644455f58515e76445f51535a1855595b"><span class="__cf_email__" data-cfemail="7e0c0d171019163e0c17191b12501d1113">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201271b&amp;href=/doi/10.1021%2Fjm201271b" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3614–3643</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 18, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 September 2011</li><li><span class="item_label"><b>Published</b> online</span>14 February 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 April 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201271b" title="DOI URL">https://doi.org/10.1021/jm201271b</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3614%26pageCount%3D30%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRajinder%2BSingh%252C%2BEsteban%2BS.%2BMasuda%252C%2BDonald%2BG.%2BPayan%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D8%26contentID%3Djm201271b%26title%3DDiscovery%2Band%2BDevelopment%2Bof%2BSpleen%2BTyrosine%2BKinase%2B%2528SYK%2529%2BInhibitors%26numPages%3D30%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3643%26publicationDate%3DApril%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201271b"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4725</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">55</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201271b" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Development of Spleen Tyrosine Kinase (SYK) Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Rajinder&quot;,&quot;last_name&quot;:&quot;Singh&quot;},{&quot;first_name&quot;:&quot;Esteban&quot;,&quot;last_name&quot;:&quot;S. Masuda&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;G. Payan&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;3614-3643&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201271b&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201271b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201271b" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201271b&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201271b" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201271b&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201271b" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201271b&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201271b&amp;href=/doi/10.1021/jm201271b" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201271b" /></input><a href="/doi/pdf/10.1021/jm201271b" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201271b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201271b%26sid%3Dliteratum%253Aachs%26pmid%3D22257213%26genre%3Darticle%26aulast%3DSingh%26date%3D2012%26atitle%3DDiscovery%2Band%2BDevelopment%2Bof%2BSpleen%2BTyrosine%2BKinase%2B%2528SYK%2529%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D8%26spage%3D3614%26epage%3D3643%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jmcmar.2012.55.issue-8/production/jmcmar.2012.55.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Allergic and autoimmune disorders share significant functional overlap in the biologic pathways responsible for the activation of signal transduction events leading to production of numerous proinflammatory factors involved in disease initiation and progression. Given the reciprocal connections in these mechanistic pathways, it would be advantageous to target strategic master regulators with novel therapeutics to treat allergic and autoimmune diseases. One such crucial regulator is spleen tyrosine kinase (SYK), a member of the cytoplasmic protein tyrosine kinase (PTK) family. Geahlen et al. initially reported SYK as a proteolytically derived fragment (p40) from a parent p72 protein extracted from bovine thymus.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The isolated p40 protein was found to be catalytically active, possessing an adenosine 5′-triphosphate (ATP) binding site, and capable of intramolecular autophosphorylation of tyrosine residues.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Further studies have led to the observation that antibodies to p40 concomitantly showed cross-reactivity with a 72 kDa protein-tyrosine kinase from the spleen and thymus.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Yamamura et al. corroborated the earlier work, employing immunoblot analysis using anticytosolic protein-tyrosine kinase-40 antibody made for the N-terminal portion of the 40 kDa kinase, and identified a 72 kDa protein, which is now known as the SYK protein.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Application of a partial sequence oligonucleotide probe for the 40 kDa kinase led to a clone comprising the complete coding sequence for the 40 kDa kinase; the clone was made up of 628 amino acids with a molecular weight of 71 618 Da and corresponded to acidophilic SYK kinase.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> Subsequent to its initial discovery, SYK has garnered substantial attention because of its importance as a key signal transduction regulator through antigen and Fc receptors in hematopoietic cells.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> The validity of SYK as a target for therapeutic intervention has progressed over the past 15 years, and SYK has recently entered the mainstream of potential pharmaceutical targets with a number of inhibitor classes being reported in the literature.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17">(12-17)</a> The true potential as a validated target for inhibition by small molecules has also been investigated in the past few years, with advanced clinical trial data only emerging during this period of time (vide infra).</div><div class="NLM_p">Expression of SYK is found extensively in hematopoietic cells, such as mast cells, basophils, B-cells, T-cells, neutrophils, dendritic cells (DC), macrophages, monocytes, erythrocytes, and platelets, as well as nonhematopoietic cells, such as osteoclasts, epithelial cells, fibroblasts, hepatocytes, and neuronal and vascular endothelial cells.<a onclick="showRef(event, 'ref6 ref9 ref10 ref11 ref16 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref6 ref9 ref10 ref11 ref16 ref18 ref19 ref20 ref21">(6, 9-11, 16, 18-21)</a> Another member of the nonreceptor tyrosine family is ζ-chain-associated protein kinase 70 of 70 kDa (ZAP-70), which is present in the cytoplasm and is closely related to SYK in both homology and function.<a onclick="showRef(event, 'ref9 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref9 ref22 ref23 ref24 ref25">(9, 22-25)</a> However, ZAP-70 expression is limited to T lymphocytes and natural killer (NK) cells.<a onclick="showRef(event, 'ref9 ref19 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref9 ref19 ref22 ref23 ref24 ref25">(9, 19, 22-25)</a></div><div class="NLM_p">SYK and ZAP-70 constitute the cytoplasmic PTK family, possessing tandem N-terminal Src homology-2 domains (SH2) referred to as N-SH2 and C-SH2 domains. These are separated by interdomain A, and the C-SH2 domain is followed by interdomain B which precedes the C-terminal kinase domain (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref11 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref11 ref25 ref26 ref27 ref28 ref29">(11, 25-29)</a> The SH2 domains bind phosphorylated tyrosines, and the tandem SH2 domains of the SYK family neatly dock into a conserved peptide motif containing two phosphorylated tyrosines separated by 9–11 amino acids.<a onclick="showRef(event, 'ref25 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref25 ref30 ref31 ref32 ref33 ref34">(25, 30-34)</a> These motifs are found in signaling chains of multimeric receptors that respond to foreign and self-antigens in immune cells. Such motifs are referred to as immunoreceptor tyrosine-based activation motifs (ITAMs).<a onclick="showRef(event, 'ref25 ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref25 ref30 ref31 ref32 ref33 ref34">(25, 30-34)</a> Importantly, the tandem SH2 domains also help to maintain SYK family kinases in an inactivated state via intramolecular interactions in resting immune cells.<a onclick="showRef(event, 'ref11 ref24 ref26 ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref11 ref24 ref26 ref27 ref29">(11, 24, 26, 27, 29)</a> Consequently, the binding of the two SH2 domains to ITAMs of receptors plays a critical role in SYK activation and frees the activated kinase domain for substrate interaction.<a onclick="showRef(event, 'ref11 ref21 ref25'); return false;" href="javascript:void(0);" class="ref ref11 ref21 ref25">(11, 21, 25)</a></div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structural sequence of SYK kinase. SYK is composed of tandem N-SH2 and C-SH2 domains, separated by interdomain-A and interdomain-B (activation loop) leads to kinase catalytic domain. The sites on SYK involved in phosphorylation through trans- and autophosphorylation, leading to activation and substrate docking and regulation of kinase activity, are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This mode of activation also serves as a guiding principle to recognize the receptors that activate SYK family kinases. Essentially, the activation of these kinases is mediated by ITAM-containing receptors.<a onclick="showRef(event, 'ref9 ref10 ref11 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref25 ref26">(9-11, 25, 26)</a> SYK, for example, transduces signals from antigen receptors such as the B-cell antigen receptor (BCR) and Fc receptors (FcR) that bind the Fc portion of immunoglobulins, which in turn bind antigens (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref9 ref10 ref11 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref25 ref26">(9-11, 25, 26)</a> ZAP-70, consistent with its narrow expression profile, transduces signals from the T cell receptor (TCR) and ITAM-bearing NK cell receptors.<a onclick="showRef(event, 'ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24 ref25">(22-25)</a> These multimeric receptors invariably contain one or more subunits possessing ITAM motifs.<a onclick="showRef(event, 'ref9 ref10 ref11 ref26'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref26">(9-11, 26)</a></div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SYK in ITAM receptor signaling in multiple hematopoietic cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It has been recognized that ITAM-bearing subunits are shared with other receptors. For example, specific leukocyte integrins, receptor activator of nuclear factor-κB ligand (RANKL), and C-type lectin receptors (CLR), such as Dectin-2 or Mincle, have been shown to co-opt FcRγ and DNAX-activated protein (DAP12), which contain ITAMs, and when engaged they activate SYK.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a></div><div class="NLM_p">SYK PTK intrinsic activity has been reported to be up to 100-fold more active than ZAP-70,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and this difference probably reflects that SYK is easier to activate than ZAP-70. SYK, for example, is not as reliant on phosphorylated ITAM architecture for enzymatic activation as ZAP-70.<a onclick="showRef(event, 'ref19 ref25'); return false;" href="javascript:void(0);" class="ref ref19 ref25">(19, 25)</a> Interestingly, it has become clear in recent years that incomplete ITAMs, referred to as hemITAMs, are capable of interacting with and mediating SYK activation.<a onclick="showRef(event, 'ref11 ref34'); return false;" href="javascript:void(0);" class="ref ref11 ref34">(11, 34)</a> In this way, a number of C-type lectin receptors, such as Dectin-1, CLEC2, and CLEC9A, possess hemITAMs and transduce signals through SYK.<a onclick="showRef(event, 'ref11 ref13 ref34'); return false;" href="javascript:void(0);" class="ref ref11 ref13 ref34">(11, 13, 34)</a>Altogether, SYK is activated through ITAMs present in BCRs and FcRs that respond to antigen, in C-type lectin receptors that respond to pathogen- and damage-associated molecular patterns (PAMPs and DAMPs), and in receptors that have co-opted ITAM-bearing signaling chains (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Most, if not all, of the triggering ligands, in one way or another, have been associated with the inflammatory process in response to pathogens, antigens, and/or cellular damage.</div><div class="NLM_p">SYK possesses multiple phosphorylation sites<a onclick="showRef(event, 'ref11 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref11 ref25 ref26 ref27 ref28 ref29">(11, 25-29)</a> that are fundamental structural prerequisites to the diverse functional activity of SYK (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). These phosphorylation sites contribute to maintaining the kinase in an inactivated state and are implicated in events leading to primary activation of the kinase catalytic domain, amplification of this activity, and the orchestrated phosphorylation of multiple substrates.<a onclick="showRef(event, 'ref11 ref25 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref11 ref25 ref27 ref28">(11, 25, 27, 28)</a> Regarding this last point, in particular, several of the phosphorylated SYK residues serve as docking sites for downstream-signaling proteins that orchestrate overall cellular responses together.<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26-29)</a> Despite considerable overlap, each specific cell type possesses a distinct set of effector molecules that respond to signals generated from SYK. In this way, activation of SYK can lead to varied cellular end points depending on the cell type, such as B cell survival, degranulation in mast cells, oxidative burst in neutrophils, antigen presentation in denditric cells, proinflammatory cytokine production by macrophages, and so on (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref9 ref10 ref11 ref25'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref25">(9-11, 25)</a> In other words, utilization of the numerous sites of phosphorylation on SYK leads to the activation of a multitude of signaling networks relevant to immune and autoimmune maladies.<a onclick="showRef(event, 'ref9 ref10 ref11 ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref25 ref26 ref27 ref28 ref29">(9-11, 25-29)</a> SYK, therefore, serves as a master regulator of inflammatory responses by a multitude of immune cells, and as a result, inhibiting SYK activity dampens inflammation broadly and comprehensively.</div><div class="NLM_p">In addition to SYK and ZAP-70, there is an additional spliced variant known as SYKB<a onclick="showRef(event, 'ref15 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref15 ref19 ref20">(15, 19, 20)</a> that lacks a 23-amino acid sequence in interdomain-B preceding the kinase domain. ZAP-70 also lacks this 23-amino acid sequence in interdomain-B. This similarity between SYKB and ZAP-70 implies functional overlap between the two kinases. SYKB is broadly expressed in numerous tissue types, such as spleen, lung, and bone marrow.<a onclick="showRef(event, 'ref15 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref15 ref19 ref20">(15, 19, 20)</a> This makes SYKB the third family member with tandem SH2 domains, although with reduced proficiency in binding to ITAM.<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref34">(30-34)</a> Intriguingly, SYKB is more stable to protease degradation in lysates of RBL-2H3 basophil cells than SYK,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which may influence functional outcomes and provide further differentiation between SYK and SYKB.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Little else is known about the function of SYKB in diverse tissue types, and it has not been reported whether small molecule inhibitors differentiate between SYK and SYKB in cell-based assays.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17">(12-17)</a>Biochemical SYK assays are typically conducted with the kinase domain, which is the same for both SYK and SYKB. It is important to note that successful small molecule optimization has relied heavily on the application of functional cell-based assays (vide infra), and this will discussed throughout this review.</div><div class="NLM_p">The murine genetic knockout of SYK has led to perinatal lethality caused by lymphatic vascular developmental abnormalities.<a onclick="showRef(event, 'ref10 ref27 ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref10 ref27 ref35 ref36 ref37">(10, 27, 35-37)</a> A recent study of SYK knockout mice avoided this difficulty by the use of bone marrow chimeras with SYK<sup>–/–</sup> hematopoietic cells, which established that SYK is necessary in the hematopoietic compartment for the development of autoimmune arthritis.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> SYK<sup>–/–</sup> fetal liver cells were transplanted to wild-type mice that were lethally irradiated, producing SYK<sup>–/–</sup> bone marrow chimeras possessing a SYK-deficient hematopoietic system. Treatment of lethally irradiated wild-type mice with a single intraperitoneal injection of arthritogenic (K/BxN) serum induced arthritis, as assessed by both macroscopic and microscopic observation. No evidence or signs of arthritis were detected in these genetically modified mice lacking SYK.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Small-molecule inhibitors targeting SYK have shown preliminary efficacy in both animal models of arthritis and early phase rheumatoid arthritis (RA) clinical trials in humans, and recent genetic evidence in animals has validated this approach.<a onclick="showRef(event, 'ref12 ref13 ref14 ref16 ref38'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref16 ref38">(12-14, 16, 38)</a></div><div class="NLM_p">The lethal hemorrhaging phenotype of the SYK-deficient mice led to initial concerns for SYK as a therapeutic target.<a onclick="showRef(event, 'ref9 ref10 ref11 ref37'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref37">(9-11, 37)</a> However, as mentioned, it was later shown that the perinatal lethality was due to a developmental defect and unlikely to occur in adults. Furthermore, mice reconstituted with SYK-deficient platelets exhibited normal bleeding times. This is likely due to redundant pathways impinging in platelet aggregation.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> That is, SYK inhibition may block a specific platelet response, such as CLEC2 activation, but it is unable to stop aggregation resulting from the collection of inducers that control hemostasis.<a onclick="showRef(event, 'ref10 ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref13">(10, 11, 13)</a></div><div class="NLM_p">Another interesting genetic knockdown study of SYK was conducted in macrophages. Macrophages are a key player in both the innate and adaptive immune function and play an important role in inflammatory diseases through phagocytosis.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a>In a murine model, genetically modified SYK-deficient macrophages were unable to participate in phagocytosis and activation of downstream secondary messenger generation. However, these same macrophages were shown to have normal behavior upon stimulation by lipopolysaccharides (LPS).<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a> Indeed, the SYK-deficient macrophages only had FcγR-mediated phagocytosis defects (no effects were seen on phagocytosis incurred by microorganisms or synthetic particles in innate immune functioning), thereby avoiding broad on-target immune deficiency.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a></div><div class="NLM_p">As mentioned above, SYK plays a role in mediating immunoreceptor-induced signals for cell growth and cell survival. In particular, SYK has been shown to activate PI3K, Akt, and mitogen-activated protein kinase (MAPK) signaling pathways in B cells, mast cells, monocytes, and NK cells.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref41'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref41">(10-16, 41)</a> The potential use of SYK inhibitors in hematological malignancies and virus-induced tumors has been reviewed elsewhere.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref16 ref41'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref16 ref41">(10-14, 16, 41)</a> Conversely, it has been proposed that SYK, via an undefined mechanism, may suppress the growth and spread of certain solid tumors.<a onclick="showRef(event, 'ref10 ref11 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref42 ref43">(10, 11, 42, 43)</a> The original premise stemmed from the observation that SYK expression was inversely correlated with the invasiveness of breast cancer cell lines. However, in retrospect, it is now clear that breast cancer cell lines have well-defined gene signatures that correlate with their cell origin (luminal cells versus basal cells) and their invasiveness.<a onclick="showRef(event, 'ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref44 ref45 ref46">(44-46)</a> Consequently, hundreds of genes define the expression profile of these cell lines, and thus, the inverse correlation of invasiveness to SYK expression is not necessarily causal and is possibly coincidental.<a onclick="showRef(event, 'ref10 ref46'); return false;" href="javascript:void(0);" class="ref ref10 ref46">(10, 46)</a> Moreover, in the clinical setting, variation of SYK expression has not been associated with any of the molecular prognostic signatures that have been established in multiple gene-expression profiling studies in breast cancer.<a onclick="showRef(event, 'ref47 ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50 ref51">(47-51)</a> Follow-up cell signaling experiments have been convoluted with forced SYK overexpression in cell lines that do not normally express SYK, and the results have been inconsistent and the effects unimpressive.<a onclick="showRef(event, 'ref10 ref44 ref46'); return false;" href="javascript:void(0);" class="ref ref10 ref44 ref46">(10, 44, 46)</a> Thus, the data indicate that the association of SYK suppression with adverse prognosis of breast cancer is superficial, simplistic, and possibly completely wrong.</div><div class="NLM_p last">Several publications have described cell-based and biochemical assays for SYK activity inhibition.<a onclick="showRef(event, 'ref52 ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54 ref55">(52-55)</a> Cell-based assays for functional evaluation of SYK inhibitory activity have included the use of basophils, cultured human mast cells (CHMC), B-cells, macrophages, neutrophils, and the monocytic cell line THP-1 using anti-immunoglobulin E (IgE), anti-IgG, and anti-IgM stimulation to assess activity on FcεR1, FcγR, and BCR, respectively.<a onclick="showRef(event, 'ref52 ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref52 ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64">(52, 56-64)</a> For example, SYK-dependent inhibition of CHMC degranulation, as measured by reduction in tryptase release, is a classic readout of IgE<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> receptor-dependent activation. In parallel, evaluation of ionomycin-induced degranulation, through calcium mobilization, provides useful counterscreen data to ensure that inhibition of readout is not due to targets downstream of SYK.<a onclick="showRef(event, 'ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64">(56-64)</a> Mast cells can also be used to ascertain inhibition of lipid mediators such as PGE<sub>2</sub> and LTC<sub>4</sub> and cytokines, such as TNFα, interleukin-8 (IL-8), granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-10, and IL-13. Inhibitors aimed at autoimmune disease need to show activity on key cell types involved with disease propagation to block multiple hubs of the underlying processes, which, if not inhibited, could lead to redundant pathways exploiting missed opportunities for inhibition.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">SYK Activation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">SYK possesses multiple phosphorylation sites that participate in regulation and activation through trans- and autophosphorylation (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref11 ref25 ref26 ref27 ref28 ref29 ref65 ref66 ref67 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref11 ref25 ref26 ref27 ref28 ref29 ref65 ref66 ref67 ref68 ref69 ref70">(11, 25-29, 65-70)</a> In addition, these sites are involved in amplification of enzymatic activity, resulting from conformational changes, and serve as docking sites for multiple interactive signaling proteins, thus promoting phosphorylation of numerous substrates responsible for downstream signal transmission (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>–<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref11 ref60 ref65 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref11 ref60 ref65 ref68 ref69 ref70">(11, 60, 65, 68-70)</a></div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) SYK kinase is maintained in an inactive conformation, which entails the N-SH2 and C-SH2, along with C-terminus blocking access to the kinase ATP pocket. (b) Activation can be initiated through ITAM binding to the dual SH2 domains of SYK, resulting in conformational change and access to the kinase ATP pocket opening. Release from ITAM following phosphorylation of tyrosine residues (not shown) on SYK leaves the kinase in fully activated form.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recent work, including the elucidation of the three-dimensional crystal structure of the complete ZAP-70 kinase, has shed light on the molecular basis of the regulation of SYK PTK family activity.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> A key step in the activation of most eukaryotic protein kinases is the correct positioning of a flexible C-helix in the kinase domain so that it forms a salt bridge with a catalytic lysine, which coordinates with the phosphate group of ATP.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> In ZAP-70, this C-helix is kept away in an “inactive” position by the concerted interaction of several residues from interdomain-A and -B and from the kinase domain, as well as from the carboxy terminus.<a onclick="showRef(event, 'ref69 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref71">(69, 71)</a> This structure has been termed the “linker–kinase sandwich”, and the disruption of this “sandwich” is essential for enzymatic activation of ZAP-70.<a onclick="showRef(event, 'ref69 ref71'); return false;" href="javascript:void(0);" class="ref ref69 ref71">(69, 71)</a></div><div class="NLM_p">On the basis of the structural details defined for ZAP-70, all evidence points to SYK being regulated in an analogous mode.<a onclick="showRef(event, 'ref66 ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref66 ref69 ref70 ref71">(66, 69-71)</a> Most residues involved in the regulation of their activity are conserved. A low-resolution, 24 Å, three-dimensional structure of full-length SYK using single-particle electron microscopy (EM) indicates that SYK acquires a closed autoinhibited conformation similar to that of ZAP-70 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref73 ref74">(73, 74)</a> In addition, mutational studies of SYK interdomain-B residues (Y348 and Y352 in human SYK) substantiate the existence of autoinhibition, involving a mechanism corresponding to the “linker–kinase sandwich” region of ZAP-70.<a onclick="showRef(event, 'ref69 ref75'); return false;" href="javascript:void(0);" class="ref ref69 ref75">(69, 75)</a> Likewise, mutations in the C-terminal tail of SYK corroborate that residues in this region, including Y630 on SYK, play similar roles to those in ZAP-70.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p">Classical activation of SYK occurs through interaction of its two SH2 domains with single dual phosphorylated tyrosine residues on ITAM subunits in the intracellular space. Tyrosine residues on the ITAM are separated by 12 amino acids. The entire length of the ITAM is composed of 18 amino acid residues with the consensus motif composed of D/ExxYxxL/Ix<sub>6–8</sub>YxxL/I,, and the two conserved tyrosines are separated by a 9–11 amino acid sequence.<a onclick="showRef(event, 'ref11 ref26 ref30 ref31 ref32 ref33 ref34 ref65 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref11 ref26 ref30 ref31 ref32 ref33 ref34 ref65 ref69 ref70">(11, 26, 30-34, 65, 69, 70)</a></div><div class="NLM_p">Although details remain to be elucidated in any one system, the prototypical activation of SYK can be envisioned to result from the following sequence.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> First, the engagement and cross-linking of receptors by antigen or ligand result in the unmasking of ITAM tyrosine residues that can be phosphorylated by Src kinases such as Lyn (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>–<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> The dual-phosphorylated ITAM then recruits SYK by binding its SH2 domains in a head-to-tail fashion (where the N-terminal phosphorylated tyrosine of the ITAM binds the C-SH2 and the C-terminal one binds the N-SH2).<a onclick="showRef(event, 'ref11 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref11 ref69 ref70">(11, 69, 70)</a> This binding strains the conformation of the interdomain-A region, disrupting the autoinhibitory “linker–kinase sandwich”, which in turn allows the repositioning of the C-helix into an “active” conformation (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Subsequent phosphorylation of tyrosine residues Y348 and Y352 on interdomain-B further disrupts the linker–kinase interaction, making the reversion to autoinhibition unachievable.<a onclick="showRef(event, 'ref11 ref69 ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref11 ref69 ref70 ref71">(11, 69-71)</a> As mentioned above, in support of this mechanism, the mutation of tyrosine residues Y348 and Y352 into phenylalanine residues locks the enzyme in a “closed state”, resulting in marked reduction in ability to signal downstream.<a onclick="showRef(event, 'ref69 ref76'); return false;" href="javascript:void(0);" class="ref ref69 ref76">(69, 76)</a></div><div class="NLM_p">The phosphorylation of residues Y348 and Y352 has been associated with the action of Src kinases, such as Lyn, and can occur on catalytically inactive SYK.<a onclick="showRef(event, 'ref11 ref26 ref27 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref11 ref26 ref27 ref69 ref70">(11, 26, 27, 69, 70)</a> The significance of trans- and autophosphorylation on these sites has also been assessed using small-molecule inhibitors.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Compound <b>1</b> (BIRA766, structure not disclosed), a Src kinase inhibitor, completely blocks phosphorylation of Y352 (Y346 in murine), implicating this as a major site for transphosphorylation by Lyn.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> In addition, compound <b>1</b> shows no biochemical inhibition of SYK and potently inhibits Src kinase members Lyn, Fyn, Src, Fgr, and Yes.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> SYK inhibitor, compound <b>2</b> (BAY61-3606, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), on the other hand, causes no reduction in phosphorylation of Y352, ratifying this site as not being susceptible to autophosphorylation.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Both compounds <b>1</b> and <b>2</b> abrogate the phosphorylation of Y348 (Y342 in murine) by an equivalent magnitude.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Compound <b>3</b> (R406, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) shows no inhibition of phosphorylation of Y352 but inhibits the phosphorylation on Y191 of human linker for activation of T-cells (LAT), a substrate for SYK, confirming that compound <b>3</b> works directly through SYK in primary cell lines.<a onclick="showRef(event, 'ref12 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref12 ref77 ref78">(12, 77, 78)</a></div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of SYK kinase inhibitors <b>2</b>–<b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For activation of SYK, the phosphorylation of carboxy-terminus residues Y630 and Y631 has been extensively investigated.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79, 80)</a> These two residues probably interact with a proline residue from interdomain-A and also form part of the “linker–kinase sandwich” structure that autoinhibits the kinase.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Subsequent phosphorylation of Y630 prevents its interaction with interdomain-A, helping to disrupt the “sandwich” and keeping SYK in the active conformation.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79, 80)</a> Finally, the activation of SYK activity allows the autophosphorylation of Y525 and Y526 in the activation loop of the SYK kinase domain supporting an extended conformation of the loop, driving it out of the active site, and making space for substrate phosphorylation (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). In this way, the binding of the tandem SH2 domains to phosphorylated ITAM, followed by multiple tyrosine phosphorylations, results in the activation of SYK.<a onclick="showRef(event, 'ref70 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref70 ref79 ref80">(70, 79, 80)</a> Mast cell degranulation, as measured by β-hexosaminidase release or activation of nuclear factor of activated T-cells (NFAT) and nuclear factor κ-light-chain-enhancer of activated B-cells (NF-κB) following antigen-mediated stimulation, was used to assess the functional cell-based impact of these mutations on SYK activity.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79, 80)</a></div><div class="NLM_p">The conformational changes involved in SYK activation from the resting state are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. Appreciable conformational changes in the N-SH2 and C-SH2 domains, interdomain-A and -B, and kinase domain occur in transition from inactive to active form,<a onclick="showRef(event, 'ref66 ref69 ref70 ref71 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref66 ref69 ref70 ref71 ref79 ref80">(66, 69-71, 79, 80)</a> resulting in a significant reduction in the interaction of peripheral residues with the kinase domain, thus exposing the ATP binding pocket. The inactive SYK model is based on the homology model developed from the crystal structure of inactive ZAP-70 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OZO">2OZO</a>). The active SYK kinase model is based on the overlay of the crystal structure of the SYK kinase domain (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XBC">1XBC</a>) and the SH2 domain of SYK (<a href="https://" class="ext-link">1A81</a>) on the crystal structure of inactive ZAP-70 (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OZO">2OZO</a>).<a onclick="showRef(event, 'ref71 ref81 ref82 ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref71 ref81 ref82 ref83 ref84">(71, 81-84)</a></div><div class="NLM_p">Notably, this mode of activation does not explain how hemITAMs are able to activate SYK.<a onclick="showRef(event, 'ref11 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref11 ref85 ref86">(11, 85, 86)</a> Remarkably, in these cases, both SYK SH2 domains are still required for SYK activation. This requirement became more understandable with the demonstration that phosphorylated hemITAMs interact with SYK with a 2:1 stoichiometry<a onclick="showRef(event, 'ref11 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref11 ref85 ref86">(11, 85, 86)</a> (i.e., two hemITAMs, each contributing one pITAM, bind to the SH2 domains of one SYK protein). However, whether extracellular ligand interactions cross-linking hemITAM-containing receptors transmit signals that result in disruption of the SYK “linker–kinase sandwich” and whether this leads to SYK activation remain unknown.</div><div class="NLM_p last">In summary, a delicate balance exists in the amount of activated and autoinhibited SYK.<a onclick="showRef(event, 'ref68 ref86'); return false;" href="javascript:void(0);" class="ref ref68 ref86">(68, 86)</a> The numerous sites of phosphorylation on the SYK sequence contribute to both activation and regulation of its enzymatic activity.<a onclick="showRef(event, 'ref11 ref26 ref27 ref28 ref66 ref67 ref68 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref11 ref26 ref27 ref28 ref66 ref67 ref68 ref69 ref70">(11, 26-28, 66-70)</a> The regulation of SYK will be discussed in the next section.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">SYK Regulation</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72168" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72168" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">SYK plays a pivotal role in the signal transduction of ITAM-dependent receptor activation. In fact, it has been argued that SYK acts as “signaling switch” while Src kinases act as “rheostats” that can be dialed in or out in a graded manner.<a onclick="showRef(event, 'ref66 ref67 ref86'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref86">(66, 67, 86)</a> This is likely due to SYK kinase’s unique positive autoregulation where, once activated, SYK can autophosphorylate residues in its linker domains that disrupt the autoinhibition and perpetuate an open conformation.<a onclick="showRef(event, 'ref66 ref67 ref69 ref70 ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref69 ref70 ref79 ref80">(66, 67, 69, 70, 79, 80)</a></div><div class="NLM_p">Furthermore, the phosphorylation of tyrosine residues in SYK produces additional regulatory roles, as they serve as docking sites for proteins interacting with SYK.<a onclick="showRef(event, 'ref11 ref27 ref60'); return false;" href="javascript:void(0);" class="ref ref11 ref27 ref60">(11, 27, 60)</a> This binding not only ensures proximity of substrates for downstream signaling but also protects the phosphorylated tyrosines from phosphatases. The various direct binding partners of SYK, including other signaling intermediates forming various signaling complexes in different hematopoietic cells, have been described extensively in recent excellent reviews.<a onclick="showRef(event, 'ref6 ref9 ref10 ref11 ref26 ref27 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref6 ref9 ref10 ref11 ref26 ref27 ref69 ref70">(6, 9-11, 26, 27, 69, 70)</a> For example, phosphorylated interdomain-B residues Y348 (pY348) and pY352 are important for binding and activating Vav and phospholipase C-γ (PLCγ) proteins.<a onclick="showRef(event, 'ref11 ref79'); return false;" href="javascript:void(0);" class="ref ref11 ref79">(11, 79)</a> These are necessary events for coupling to NFAT pathways by way of calcium mobilization and to NF-κB pathways through the CARD (caspase-recruitment domain)-MALT1-BCL10 complexes.<a onclick="showRef(event, 'ref11 ref86'); return false;" href="javascript:void(0);" class="ref ref11 ref86">(11, 86)</a> These activations result in the production and release of inflammatory cytokines. The sustained activation of SYK is significant, as it has been shown that SYK activity is required throughout the process of cytokine production and release, and SYK inhibitors are able to block ongoing cytokine production.<a onclick="showRef(event, 'ref16 ref78'); return false;" href="javascript:void(0);" class="ref ref16 ref78">(16, 78)</a></div><div class="NLM_p">Phosphorylated Y352 has also been shown to bind growth factor receptor-bound protein 2 that couples to extracellular signal-regulated kinase (ERK) signaling, as well as the p85 subunit of PI3K, leading to Akt activity.<a onclick="showRef(event, 'ref10 ref11 ref41 ref69'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref41 ref69">(10, 11, 41, 69)</a> The engagement of these two pathways leads to cellular survival and proliferation. Thus, it appears that SYK activation can lead to different outcomes (cytokine release or cell proliferation) in part by the differential docking of signaling molecules to pY352, directed by divergent intracellular circumstances.<a onclick="showRef(event, 'ref41 ref69'); return false;" href="javascript:void(0);" class="ref ref41 ref69">(41, 69)</a> The formation of these differential complexes can also make use of multipartite mutual interactions for multiple reasons. The phosphorylation of SYK Y630, for instance, generates a docking site for the SH2 domain containing leukocyte protein (SLP) family.<a onclick="showRef(event, 'ref11 ref69 ref79'); return false;" href="javascript:void(0);" class="ref ref11 ref69 ref79">(11, 69, 79)</a> In B-cells, pY630 binds SLP-65, a membrane protein that itself binds PLCγ and the Tec family kinase Btk.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Interestingly, this interaction allows for the maintenance of active SYK close to the cell membrane, even after BCR internalization. It is also noteworthy that phosphorylation of Y130 of interdomain-A in SYK results in reduced affinity of the SH2 domains for pY of ITAMs, at the same time disrupting the autoinhibitory “linker–kinase sandwich”.<a onclick="showRef(event, 'ref25 ref87'); return false;" href="javascript:void(0);" class="ref ref25 ref87">(25, 87)</a> This mechanism possibly accounts for the release of SYK from membrane-bound ITAMs while maintaining an active conformation for subsequent interactions in different intracellular compartments.<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87, 88)</a></div><div class="NLM_p">Alternatively, the disengagement of SYK from ITAMs may be part of its eventual deactivation.<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87, 88)</a> In this regard, much remains to be elucidated of how SYK returns to its basal state. However, it does appear that differential interactions play a role in turning off SYK. pY323 in interdomain-B has been shown to be a docking site for either PLCγ or the E3 ubiquitin ligase Casitas B-lineage lymphoma (Cbl) family of proteins.<a onclick="showRef(event, 'ref64 ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref64 ref89 ref90 ref91">(64, 89-91)</a> The interaction of pY323 with Cbl proteins is important in the ubiquitination and degradation of SYK. Mutation of Y323 results in enhanced SYK-dependent signaling as shown in mast cells and basophils, as well as in B-cells.<a onclick="showRef(event, 'ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91">(89-91)</a></div><div class="NLM_p">Consistent with SYK acting as a “signaling switch”, the major regulatory step for its activity is during the initial steps of its activation.<a onclick="showRef(event, 'ref66 ref67'); return false;" href="javascript:void(0);" class="ref ref66 ref67">(66, 67)</a> It appears that SYK responds to a threshold of pITAMs set by the collective work of activating and inhibitory signals. As mentioned, ITAMs are initially phosphorylated by the Src family of kinases, which can be dialed in or out in a gradual fashion. Counteracting ITAM signaling are membrane- bound receptors that signal through conserved immunoreceptor tyrosine-based inhibitory motifs (ITIMs) of sequence I/V/L/SxYxxL/V.<a onclick="showRef(event, 'ref62 ref63 ref86 ref92 ref93 ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref62 ref63 ref86 ref92 ref93 ref94 ref95">(62, 63, 86, 92-95)</a> Fittingly, ITIMs are also phosphorylated by Src family kinases, but instead of recruiting SYK, pITIMs recruit phosphatases such as SH2 domain-containing tyrosine phosphatase or SH2-containing inositol phosphatase, which dephosphorylate signaling molecules, resulting in the down-regulation of signaling responses.<a onclick="showRef(event, 'ref62 ref86 ref95'); return false;" href="javascript:void(0);" class="ref ref62 ref86 ref95">(62, 86, 95)</a> Thus, the nature of the immunoreceptors engaged on the surface of the cells determines the balance between pITIMs and pITAMs that determine whether SYK is activated or not. Curiously, depending on the quality of ligation of some immunoreceptors, pITAMs have been occasionally reported to also mediate inhibitory signals; however, the pITAMs appear to recruit phosphatases rather than SYK. SYK activity is invariably associated with activating ITAM-dependent signaling, and thus, SYK inhibitors do not affect inhibitory signaling.<a onclick="showRef(event, 'ref62 ref64 ref86 ref96'); return false;" href="javascript:void(0);" class="ref ref62 ref64 ref86 ref96">(62, 64, 86, 96)</a></div><div class="NLM_p">Recently, the phosphorylation of S291 (as opposed to tyrosine), found on the 23-amino acid sequence of interdomain-B in SYK, was reported to be catalyzed by the action of protein kinase C (PKC).<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Upon BCR activation, PKC is activated as a direct consequence of the upstream activation of SYK. Combined, the mutual interplay by these two kinases provides the framework for a positive regulatory loop, where SYK activity leads to the activation of PKC, which in turn phosphorylates the solvent-exposed S291 on the flexible 23-amino acid sequence of SYK. This phosphorylation appears to promote interaction with prohibitin, a chaperone protein, thereby enhancing the ability of SYK to induce NFAT and Elk-dependent transcription.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div><div class="NLM_p last">In summary, SYK can be inhibited following receptor activation conformational change to the fully active form and also in its inactive state.<a onclick="showRef(event, 'ref64 ref65 ref79 ref80 ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref64 ref65 ref79 ref80 ref89 ref90 ref91">(64, 65, 79, 80, 89-91)</a> Subsequent to activation of SYK through BCR signaling, interaction of residue Y323 with Cbl attenuates SYK activity.<a onclick="showRef(event, 'ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91">(89-91)</a> Independent of any association with BCR through phosphorylation of S291 by PKC, SYK can be additionally regulated. In BCR activation, PKC is inherently linked to downstream signaling through SYK. Signal amplification is controlled through auto- and transphosphorylation of SYK, and therefore, SYK is continually available to activate PKC. The activated PKC is then available to participate in phosphorylation of S291 on interdomain-B of SYK and to contribute to SYK regulation to function as a signaling switch.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">SYK Structure</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36287" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36287" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The high-resolution crystal structure of full-length SYK has not been reported; however, the solution structure of SYK C-terminal SH2 (SYK-C) domain of the human kinase interacting with a pentapeptide, mimicking the ITAM, has been determined.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> For high-affinity binding to ITAM of Fc receptors, both the C- and N-SH2 domains of SYK need to participate in binding. However, in in vitro experiments, SYK-C possesses the capacity to bind to phosphorylated ITAM autonomously. Only SYK-C domain is able, through affinity purification to pull down the IgE-receptor complex adequately.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> During mast-cell activation, SYK principally binds through sequential interaction of C- and N-SH2 domains to the γ-subunit of FcεR1 receptor ITAM domain.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98, 99)</a> FcεR1 has no enzymatic activity by itself and is reliant on Src and PTK for activation.<a onclick="showRef(event, 'ref26 ref62 ref79'); return false;" href="javascript:void(0);" class="ref ref26 ref62 ref79">(26, 62, 79)</a> The C-terminal SH2 domain can bind in vitro unilaterally to tyrosine phosphorylated ITAM of FcεR1. In combination with SYK, containing only the C-SH2 domain, solution-based structural studies using phosphotyrosine peptide designed to mimic the γ-subunit of FcεR1 have been carried out to understand this interaction.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> The most potent peptide Ac-Thr-pTyr-Glu-Thr-Leu-NH<sub>2</sub>, based on the pY76 SH2-binding motif, was found to bind with IC<sub>50</sub> = 20 μM, as determined by ligand concentration necessary to inhibit 50% of the binding of SYK-C to bound ITAM peptide covalently.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> This study was the first attempt at elucidating the structure of SH2 and ITAM binding, suggesting that SYK-C can bind independently to ITAM. However, for strong in vivo binding, both SYK-C and SYK-N are obligatory.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> For this peptide-based approach to be useful in inhibitor discovery, acceptable potency for SYK-C inhibition must translate to inhibition of full-length SYK found in the intracellular milieu. Full-length SYK adopts a more complex conformation in vivo compared to artificial constructs.<a onclick="showRef(event, 'ref66 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref66 ref73 ref74">(66, 73, 74)</a> Additionally, for such a peptide approach to be pursued successfully, rapid metabolic clearance would have to be overcome for meaningful therapeutic application.</div><div class="NLM_p">In contrast to its family homologue ZAP-70,<a onclick="showRef(event, 'ref71 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref71 ref81 ref82">(71, 81, 82)</a> SYK displays more conformational elasticity, accounting for its role in functional binding to multiple substrates.<a onclick="showRef(event, 'ref11 ref69'); return false;" href="javascript:void(0);" class="ref ref11 ref69">(11, 69)</a> The ability of the C- and N-SH2 domains in SYK to work in an independent and highly flexible manner has been investigated using X-ray crystallography.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> The C- and N-SH2 domain sequence, from residues 7 to 269, was prepared and isolated for cocomplex formation with the CD3ε-chain diphosphorylated ITAM 20mer peptide sequence PDpYEPIRKGQRDLpYSGLNQR.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> By use of the tandem SH2 domain as the docking site and phosphorylated ITAM peptide as ligand, the X-ray crystal structure was determined to a resolution of 3 Å.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Inhibitors blocking binding of the tandem SH2 domain of SYK with ITAM subunit could give more selective inhibition than small molecules targeting the kinase ATP pocket.</div><div class="NLM_p">Several research groups have independently reported the crystal structure of the SYK catalytic domain, cocrystallized and ligand soaked with small molecule inhibitors (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref78 ref83 ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref78 ref83 ref100 ref101">(78, 83, 100, 101)</a>The Roche group obtained the cocrystal structures of SYK kinase domain with three inhibitors <b>4</b> (YM193306),<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a><b>5</b>(7-azaindole),<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> and <b>3</b><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> to a resolution of 2.5, 2.25, and 2.1 Å,<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a). SYK inhibition varies considerably for the three inhibitors. Compound <b>4</b> inhibits SYK with <i>K</i><sub>i</sub> = 0.005–0.02 μM. <b>5</b> has IC<sub>50</sub> = 0.57 μM, and <b>3</b> shows IC<sub>50</sub> = 0.041 μM.<a onclick="showRef(event, 'ref78 ref101'); return false;" href="javascript:void(0);" class="ref ref78 ref101">(78, 101)</a> The biochemical potency of compound <b>3</b> is rationalized by interaction of the pyrimidine nitrogen at the 1-position and the N–H linker from the trimethoxyphenyl at the 2-position participating in hydrogen bonding with hinge residue A451, and the trinitrogen assembly from the dimethylpyridoxazinone bicyclic system interacting with two water molecules and its participation in hydrophobic interactions. The solution side of the catalytic pocket has some flexibility, accounting for the subtle differences from a previously determined cocrystal structure with compound <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b).<a onclick="showRef(event, 'ref78 ref101'); return false;" href="javascript:void(0);" class="ref ref78 ref101">(78, 101)</a> Inhibition of SYK by <i>cis</i>-cyclohexyldiamine containing pyrimidine compound <b>4</b><a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> can be explained by combination of hydrogen bond-donating interactions with residues R498, N499, and D512 from the primary amine and pyrimidine linking secondary amine. Furthermore, the salt bridge resulting from primary amine hydrogen bond interaction to the D512 carboxyl moiety aids in potency.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> The weakly active SYK inhibitor <b>5</b> has the crucial interaction with hinge A451 but does not penetrate the ATP pocket significantly, in contrast to compounds <b>3</b> and <b>4</b>.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Cocrystal image of compounds <b>3</b> (green), <b>4</b> (orange), and <b>5</b> (purple). (b) Cocrystal image of compound <b>3</b>. (c) Cocrystal image of compounds <b>6</b> (orange) and <b>7</b> (green) and overlap with docked compound <b>8</b> (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structures of compounds <b>6</b> (staurosporine)<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> and <b>7</b> (imatinib) with SYK kinase catalytic domain have also been reported (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>c).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Compound <b>7</b> adopts a structure similar to the promiscuous kinase inhibitor <b>6</b>.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The reported crystal structures of compounds <b>6</b> and <b>7</b> indicate that the ligands bind the activated form of SYK. Thus, the SYK binding modes of ligands <b>6</b> and <b>7</b> resemble the cocrystal structure elucidated with compounds <b>3</b>, <b>4</b>, and <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The <i>o</i>-methyl group on compound <b>7</b> reduces the effectiveness for SYK binding (displaying <i>K</i><sub>i</sub> = 5 μM) because of steric hindrance blocking the formation of a U-shaped cis-conformation required for hydrogen bonding of the N–H from the ligand and SYK hinge residue A451.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Indeed, an analogue lacking this <i>o</i>-methyl group, compound <b>8</b> (demethylimatinib), is more potent for SYK inhibition with a <i>K</i><sub>i</sub> of 0.16 μM.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> An analogous effect was observed in the cocrystal structure with potent inhibitor <i>N</i>-phenyl-4-(thiazol-2-yl)pyrimidin-2-amine compound <b>9</b>, which has <i>K</i><sub>i</sub> = 0.009 μM for SYK inhibition.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Introduction of an <i>o</i>-methyl on the 3,4-dimethylaniline linked at the 2-position of the pyrimidine, compound <b>10</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), substantially reduces SYK inhibition with <i>K</i><sub>i</sub> = 1.817 μM, but also it must be taken into account that the methyl substituent and alanol side chain are not present in this analogue. The coplanarity of the pyrimidine ring and the 3,5-dimethylaniline substituent at the 2-position is critical to avoid a steric clash with hinge residue A451 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> All the structures obtained with the SYK kinase domain show the ligands binding through distinguished U-shaped conformations because the pocket is unable to bind these ligands in alternative forms (Figures <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref78 ref83 ref101 ref104'); return false;" href="javascript:void(0);" class="ref ref78 ref83 ref101 ref104">(78, 83, 101, 104)</a> Ligands capable of inducing conformational changes in the ATP-binding pocket would allow alternative binding modes, thus potentially improving selectivity for SYK over other protein kinases. All the current inhibitors reported bind to SYK in the active form, but SYK in vitro activity does not necessitate phosphorylation of tyrosine residues.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Future efforts directed at binding to the inactive form to derive better selectivity should be investigated, with continued use of cell-based functional assays to investigate in vivo selectivity.<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a></div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cocrystal image of compound <b>9</b> (green) and overlap with docked compound <b>10</b> (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">SYK Kinase and Disease</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">SYK plays an indispensable role in acute and chronic inflammation.<a onclick="showRef(event, 'ref10 ref11 ref56 ref105 ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref56 ref105 ref106 ref107">(10, 11, 56, 105-107)</a> As outlined previously, activation of SYK occurs through preliminary extracellular antigen-induced cross-linking of FcεR1 and FcγRs I, IIA, and IIIA.<a onclick="showRef(event, 'ref10 ref11 ref59'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref59">(10, 11, 59)</a> Upon activation, SYK, a master upstream regulator of signal transduction, propagates downstream signaling molecules, resulting in initiation of disease.<a onclick="showRef(event, 'ref10 ref11 ref105 ref106 ref107 ref108'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref105 ref106 ref107 ref108">(10, 11, 105-108)</a></div><div class="NLM_p">Inflammation is a fundamental response to challenges on the body, instigated by injury sustained through physical tissue damage, exposure to chemicals, and pathogens. The immediate acute response is to eradicate the initial offense and launch repair mechanisms directed at damaged tissue through a complex series of steps. Exacerbated reaction to the primary insult leads to the development of chronic inflammatory processes, which remain less well understood and, if unrestrained, lead to stepwise pathogenesis of a plethora of ailments. Chronic inflammation with persistent efforts at repair may produce structural and dysfunctional tissue damage. Maladies resulting from chronic inflammation include asthma, RA, Crohn’s disease, systemic lupus erythematosus (SLE), idiopathic thrombocytopenic purpura (ITP), and multiple sclerosis.<a onclick="showRef(event, 'ref10 ref56 ref59 ref62 ref105 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref113 ref114 ref115 ref116 ref117 ref118 ref119 ref120 ref121 ref122 ref123 ref124 ref125 ref126'); return false;" href="javascript:void(0);" class="ref ref10 ref56 ref59 ref62 ref105 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref113 ref114 ref115 ref116 ref117 ref118 ref119 ref120 ref121 ref122 ref123 ref124 ref125 ref126">(10, 56, 59, 62, 105-126)</a> Control of inflammation has become a mainstay in the management of these chronic inflammatory conditions.<a onclick="showRef(event, 'ref62 ref106 ref107 ref108 ref109 ref110 ref111 ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref62 ref106 ref107 ref108 ref109 ref110 ref111 ref117 ref118">(62, 106-111, 117, 118)</a></div><div class="NLM_p">Through the action of pathogens, chemicals, or physical injury, inflammatory responses are implemented by the coordinated action of leukocytes residing close to or within the distressed tissue. These immune cells have the ability to differentiate between harmful and harmless mediators and crucially between self- and nonself-molecular constituents of the body. PAMPs, DAMPs, and virulence factors (products of damaged cells) initiate innate immune responses leading to inflammation (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref10 ref11 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref85 ref86">(10, 11, 85, 86)</a> The innate immune response, however, does not provide long-lasting immunologic memory and is complemented by the specificity of the adaptive immune system. This involves recognition of both intact pathogenic antigens by antibodies and fragment antigens presented on major histocompatibility (MHC) molecules. The inflammatory response by adaptive immunity is generated through BCRs and TCRs, and the respective interaction with the Fc portion of antibodies is denoted as activating FcR.</div><div class="NLM_p last">Controlling these important activation events in immune cells can be used as a broad mechanism for the treatment of autoimmune and inflammatory diseases at pivotal stages of disease development. An attractive avenue to pursue is the upstream mitigation of key targets such as SYK.<a onclick="showRef(event, 'ref10 ref11 ref105 ref106 ref107 ref108 ref110 ref111 ref112 ref114'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref105 ref106 ref107 ref108 ref110 ref111 ref112 ref114">(10, 11, 105-108, 110-112, 114)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div id="ac_i6" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i6"> </h2><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Allergic Rhinitis, Asthma, and Atopic Dermatitis</h3><div class="NLM_p">Up to 25% of the population in the developed world is stricken by anaphylaxis, allergic rhinitis (or hay fever), atopic dermatitis (or eczema), and allergic (or atopic) asthma.<a onclick="showRef(event, 'ref116 ref117 ref118 ref119 ref127 ref128 ref129'); return false;" href="javascript:void(0);" class="ref ref116 ref117 ref118 ref119 ref127 ref128 ref129">(116-119, 127-129)</a> These conditions are generally recognized as allergic disorders. At a basic level, these maladies have a significant impact on quality of life, and at their worst they can culminate in possibly fatal systemic allergic reaction, usually referred to as anaphylaxis.<a onclick="showRef(event, 'ref116 ref129'); return false;" href="javascript:void(0);" class="ref ref116 ref129">(116, 129)</a> On a molecular level, these disorders are driven by allergen-specific IgE and T helper 2 (T<sub>H</sub>2) cell responses that recognize allergen-derived antigens.<a onclick="showRef(event, 'ref116 ref130'); return false;" href="javascript:void(0);" class="ref ref116 ref130">(116, 130)</a> Single exposure of a sensitized subject to a specific allergen leads to the manifestation of early phase reaction or a type I immediate hypersensitivity reaction (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> This is the result of allergen cross-linking IgE-bound FcεR1 on mast cells and basophils, leading to degranulation.<a onclick="showRef(event, 'ref94 ref95 ref99 ref116 ref117 ref118 ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref94 ref95 ref99 ref116 ref117 ref118 ref127 ref128">(94, 95, 99, 116-118, 127, 128)</a> Degranulation of mast cells and basophils leads to secretion of preformed mediators such as histamine, tryptase, 5-hydroxytryptamine (5-HT), and heparin, which is followed minutes later with the production and release of eicosanoids, lipid mediators such as leukotrienes (LTs) and prostaglandins, then hours later with the production of chemokines and inflammatory cytokines (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Collectively, these mediators stimulate recruitment and activation of leukocytes for late-phase allergic reactions, which encompass recruitment and activation of T<sub>H</sub>2 cells, eosinophils, basophils, and other leukocytes in conjunction with prolonged mediator release by mast-cell degranulation.<a onclick="showRef(event, 'ref94 ref95 ref99 ref116'); return false;" href="javascript:void(0);" class="ref ref94 ref95 ref99 ref116">(94, 95, 99, 116)</a> Unrelenting exposure to specific allergens leads to chronic allergic inflammation through both innate and adaptive immune cells, leading to tissue remodeling.<a onclick="showRef(event, 'ref116 ref131'); return false;" href="javascript:void(0);" class="ref ref116 ref131">(116, 131)</a></div><div class="NLM_p">Current treatments of asthma, allergic rhinitis, and atopic dermatitis include limiting exposure to the offending allergen(s) and use of antihistamines, decongestants, LT inhibitors, topical chromones, and corticosteroids.<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117, 118)</a> Notwithstanding this success with existing therapies, symptoms still persist in some patients and there is ample opportunity for the development of further novel therapies.<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117, 118)</a> Targets for inhibition include mediator inhibitors, mast-cell stabilizers, neural pathway inhibitors, allergen-specific peptide-based and deoxyribonucleic acid (DNA) based immunotherapies, blocking of IgE cross-linking of FcεR1 receptor, cytokine and chemokine inhibition, enhancement of T<sub>H</sub>1 responses, blocking adhesion molecules, and phosphodiesterase inhibitors.<a onclick="showRef(event, 'ref10 ref11 ref117'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref117">(10, 11, 117)</a></div><div class="NLM_p">Mast cell overactivation and degranulation leading to release of multiple proinflammatory mediators are key components of allergic diseases.<a onclick="showRef(event, 'ref94 ref95 ref127 ref128 ref129 ref130 ref131 ref132 ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref94 ref95 ref127 ref128 ref129 ref130 ref131 ref132 ref133 ref134">(94, 95, 127-134)</a> Thus, inhibitors of these processes represent a potential route to developing novel therapies.<a onclick="showRef(event, 'ref127 ref128 ref129 ref130 ref131 ref132 ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref127 ref128 ref129 ref130 ref131 ref132 ref133 ref134">(127-134)</a> In this endeavor, SYK inhibitors have been developed that show efficacy in animal models of allergic disease and in clinical studies of allergic rhinitis and asthma (vide infra).<a onclick="showRef(event, 'ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref127 ref128">(127, 128)</a></div><div class="NLM_p">A humanized monoclonal antibody to IgE, better known as omalizumab, administered through the intravenous route has been shown to be effective in treating the early- and late-phase response in asthma, initiated through inhalation of allergen.<a onclick="showRef(event, 'ref130 ref135'); return false;" href="javascript:void(0);" class="ref ref130 ref135">(130, 135)</a> Interestingly, omalizumab was ineffective through the aerosolized route, speculated to result from lack of exposure, but the study did indicate a greater chance of adverse immunogenic reaction.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> The relatively high cost of treatment and reported adverse events of anaphylaxis in a limited number of treated patients has meant the drug has to be administered in an office setting under physician monitoring.<a onclick="showRef(event, 'ref117 ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref117 ref135 ref136">(117, 135, 136)</a></div><div class="NLM_p last">More recently, application of tyrosine kinase inhibitors for the treatment of allergic disorders has steadily gained momentum and represents a therapeutic intervention strategy for the future.<a onclick="showRef(event, 'ref127 ref128 ref129'); return false;" href="javascript:void(0);" class="ref ref127 ref128 ref129">(127-129)</a></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Autoimmune Disorders: ITP, RA, SLE, and Type 1 Diabetes (T1D)</h3><div class="NLM_p">In autoimmune disorders, components of adaptive immunity mistakenly recognize self-antigens as foreign and initiate a program for the elimination of agents containing such antigens.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> ITP and autoimmune hemolytic anemia (AIHA) are diseases characterized by destruction of platelets and red blood cells, directed by autoantibodies recognizing cell-specific components that lead to mucocutaneous bleeding and anemia, respectively.<a onclick="showRef(event, 'ref107 ref137'); return false;" href="javascript:void(0);" class="ref ref107 ref137">(107, 137)</a> This antibody-targeted destruction is mediated by FcR-signaling and, by extension, SYK, which induces phagocytosis by macrophages of the reticuloendothelial systems. Indeed, SYK inhibition has been shown to be protective in murine models of ITP and AIHA using autoantibodies that recognize antigens in platelets and erythrocytes.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><div class="NLM_p">In another set of autoimmune disorders, autoantibodies recognize self-antigens in anatomical structures too large to be engulfed by phagocytes, namely, macrophages and neutrophils.<a onclick="showRef(event, 'ref9 ref10 ref11 ref39 ref40 ref59'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref39 ref40 ref59">(9-11, 39, 40, 59)</a> In these cases, the follow-up defensive action by the “frustrated” phagocytes is to release toxic agents such as reactive oxygen species (ROS), proteases, and phospholipases into the environment, causing local destruction of cells and tissues, with the intent to neutralize “injurious” agents at the expense of some collateral damage. This is eventually followed by the production and release of lipid mediators, such as LTs and prostaglandins, to signal pain.<a onclick="showRef(event, 'ref95 ref106 ref110 ref115 ref116 ref123 ref131'); return false;" href="javascript:void(0);" class="ref ref95 ref106 ref110 ref115 ref116 ref123 ref131">(95, 106, 110, 115, 116, 123, 131)</a> The production of chemokines and cytokines that recruit additional immune cells to the site of injury establishes a concerted and sustained inflammatory response, which intensifies tissue destruction. Subsequent steps include efforts of containment to ward off the “foreign” agents, followed by tissue repair. These measures include scar tissue formation, which can result in the remodeling of tissues, resulting in more permanent structural impairments.<a onclick="showRef(event, 'ref10 ref62 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref113 ref114 ref115'); return false;" href="javascript:void(0);" class="ref ref10 ref62 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref113 ref114 ref115">(10, 62, 106-115)</a></div><div class="NLM_p">Several of these inflammatory conditions are partially reproduced in animal models using antibodies specific for particular tissue components. The intradermal injection of immune complexes in the Arthus reaction, for example, leads to the typical signals of acute inflammation, including swelling, induration, edema, hemorrhage, and pain.<a onclick="showRef(event, 'ref78 ref138'); return false;" href="javascript:void(0);" class="ref ref78 ref138">(78, 138)</a> Similarly, in rodent models of RA, injections of joint-specific antibodies elicit arthritic pathology in rodent paws, as evidenced by inflammation of joint synovial lining, pannus formation, and infiltration of inflammatory cells. These responses are also mediated by FcR signaling, implicating SYK as playing a pivotal role in the induction of inflammation.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Consistent with this suggestion, joint inflammation is observed in these antibody-directed arthritis models whether the antibody recognizes collagen in the collagen-antibody induced arthritis (CAIA) model or glucose 6-phosphate isomerase in the passive K/BxN model. Importantly, treatment with SYK inhibitor compound <b>3</b> (which has been shown to potently block FcR-dependent ROS production by neutrophils and cytokine production by mast cells and macrophages) ameliorates all inflammatory responses in the Arthus reaction, CAIA and K/BxN models.<a onclick="showRef(event, 'ref78 ref138'); return false;" href="javascript:void(0);" class="ref ref78 ref138">(78, 138)</a> Moreover, as mentioned above, SYK deficiency in the hematopoietic compartment in chimeric mice prevented arthritis in the K/BxN serum transfer model, providing genetic evidence for SYK’s crucial involvement in the elicitation of joint pathology by autoantibodies.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Compound <b>3</b> and its methylene phosphate prodrug <b>11</b> (R788-fostamatinib) (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) are also able to inhibit disease progression and severity of the more complex model induced by collagen immunization (as opposed to passive injection of antibodies) in the collagen-induced arthritis model.<a onclick="showRef(event, 'ref12 ref13 ref14 ref16 ref78 ref138'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref16 ref78 ref138">(12-14, 16, 78, 138)</a> Treatment with compounds <b>3</b> and <b>11</b> not only blocked joint inflammation but also showed protection from bone destruction as determined by radiography and micro-CT (computed tomography) scans.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> The suppression of joint pathology was complemented by reduction of serum of chemokine and cytokine levels, as well as cartilage degradation products.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> However, there was little effect on anticollagen antibody levels.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Conversion of methylene phosphate prodrug <b>11</b> to biologically active parent compound <b>3</b>. The conversion is catalyzed by the action of alkaline phosphatases present on the apical brush-border of the membranes of the intestinal enterocytes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An important aspect of SYK is its role in osteoimmunology. This refers to the coordinated relationship of the immune system and bone compartments,<a onclick="showRef(event, 'ref139 ref140 ref141 ref142 ref143 ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141 ref142 ref143 ref144 ref145">(139-145)</a> which share common signal transduction pathways and precursor cells in bone marrow. Pathology of RA leads to irreversible bone erosion, carried out through the process of osteoclastogenesis, and culminates in increased propensity for bone fracture.<a onclick="showRef(event, 'ref139 ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141">(139-141)</a> One mechanistic pathway leading to bone erosion is directly correlated to SYK activity.<a onclick="showRef(event, 'ref139 ref140 ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141 ref142">(139-142)</a> Macrophage colony-stimulating factor binds to the c-Fms receptor on osteoclasts, resulting in proliferation and survival of osteoclast precursor cells.<a onclick="showRef(event, 'ref139 ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141">(139-141)</a> The interaction of osteoblasts (responsible for bone formation) with osteoclasts (responsible for bone resorption) occurs through RANKL or tumor necrosis factor (TNF) related activation-induced cytokine on the former cell binding to receptor activator nuclear factor-κB (RANK) on the latter cell type.<a onclick="showRef(event, 'ref139 ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141">(139-141)</a> This RANKL/RANK interaction recruits TNF receptor-associated factor 6.<a onclick="showRef(event, 'ref139 ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141">(139-141)</a> An unknown ligand on osteoblasts binds with ITAM subunits on DAP12/FcRγ<a onclick="showRef(event, 'ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref142 ref143">(142, 143)</a> in the intracellular region, leading to enzymatic activation of SYK. This precedes the phosphorylated activation of PLCγ,<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> in conjunction with RANK, leading to calcium mobilization and interaction with calcium/calmodulin-dependent protein kinase type IV and calcineurin.<a onclick="showRef(event, 'ref139 ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141">(139-141)</a> Several pathways are involved in osteoclast differentiation and osteoclastogenesis through NFAT, cytoplasmic 1 (NFATc1).<a onclick="showRef(event, 'ref139 ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141">(139-141)</a> The ITAM-signaling events involved in osteoclastogenesis have been referred to as costimulatory to the RANK/RANKL pathway because both are necessary for the process to occur successfully.<a onclick="showRef(event, 'ref139 ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141">(139-141)</a> The role of SYK in osteoclastic bone resorption has been examined using SYK<sup>–/–</sup> bone marrow macrophages (BMM) in both in vitro and in vivo studies.<a onclick="showRef(event, 'ref142 ref143 ref145'); return false;" href="javascript:void(0);" class="ref ref142 ref143 ref145">(142, 143, 145)</a> The conclusions from these studies are that SYK<sup>–/–</sup> osteoclasts have diminished bone resorption ability of osteoclasts but display no effects on osteoclast differentiation.<a onclick="showRef(event, 'ref142 ref143 ref145'); return false;" href="javascript:void(0);" class="ref ref142 ref143 ref145">(142, 143, 145)</a> Thus, inhibition of SYK could have utility in preventing bone damage in RA. Overall, the case for the importance of SYK in the development of RA is very strong, based on mechanism of action studies, informative genetic knockout investigations, and indications from early clinical trial data.<a onclick="showRef(event, 'ref38 ref105 ref106 ref107 ref108 ref109 ref110 ref142 ref143 ref144 ref145'); return false;" href="javascript:void(0);" class="ref ref38 ref105 ref106 ref107 ref108 ref109 ref110 ref142 ref143 ref144 ref145">(38, 105-110, 142-145)</a></div><div class="NLM_p">Chronic autoimmune diseases, such as RA, are multifaceted, and their etiology is complex and, for the most part, ambiguous. It is generally believed that RA is genetically determined but that environmental factors play a role in the outcome of this disorder.<a onclick="showRef(event, 'ref106 ref115'); return false;" href="javascript:void(0);" class="ref ref106 ref115">(106, 115)</a> Some of the factors, which can serve as environmental triggers and misdirect immune response, could be infectious agents (e.g., viruses, bacteria, and fungi) or harmful chemicals (e.g., pollutants and tobacco smoke).<a onclick="showRef(event, 'ref11 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref11 ref85 ref86">(11, 85, 86)</a> An interesting rodent model highlighting this aspect is the Sakaguchi (SKG) mouse, which is genetically prone to develop autoimmune arthritis.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Interestingly, these mice do not develop disease in a clean environment, but a single injection of β-glucan, a substitute for fungal antigens, can elicit severe chronic arthritis. It turns out that blocking Dectin-1, a major receptor for β-glucan, prevents disease induction.<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146, 147)</a> Dectin-1, as mentioned above, is a CLR that signals through SYK, employing hemITAM motifs.<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146, 147)</a> Whether SYK inhibition blocks SKG arthritis induced by fungal membrane components remains to be examined. However, it is tempting to speculate that, like in the SKG mice, PAMPs may also influence the course of autoimmune disorders and that SYK inhibition can be beneficial in preventing the establishment and re-establishment of some of these chronic inflammatory conditions.<a onclick="showRef(event, 'ref11 ref78 ref138 ref146'); return false;" href="javascript:void(0);" class="ref ref11 ref78 ref138 ref146">(11, 78, 138, 146)</a></div><div class="NLM_p">Antibody-mediated glomerulonephritis is another chronic disorder with far reaching clinical implications. Antibodies and/or immune complexes (ICs) under certain unfavorable conditions can initiate and sustain an inflammatory response in the glomeruli of the kidney, leading to its dysfunction characterized by protein in the urine (proteinuria).<a onclick="showRef(event, 'ref148 ref149 ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref148 ref149 ref150 ref151">(148-151)</a> In murine models, this ailment is dependent on Fc receptors, as shown by the reduction of disease severity in FcR deficient mice. These results also implicate SYK activity in the pathogenesis of the disorder, and indeed, treatment with SYK inhibitor compound <b>11</b> prevented crescentic glomerulonephritis in the nephrotoxic nephritis (NTN) model in Wistar–Kyoto rats.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> This well-characterized model is elicited by the injection of nephrotoxic serum containing antibodies directed at kidney components. Notably, compound <b>11</b> treatment averted disease without blocking deposition of the ICs in the glomeruli;<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> i.e., SYK inhibition limited inflammation induced by ICs but not the deposition of ICs in the kidney. Additionally, treatment with compound <b>11</b> was able to reverse already established severe proteinuria even after the onset of disease.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Furthermore, compound <b>11</b> reduced the number of macrophages that had already infiltrated the glomeruli and ameliorated tissue injury as observed by the reduction of serum creatinine and the number of glomerular crescents.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a></div><div class="NLM_p">Glomerulonephritis is one of the most serious manifestations of SLE, a major chronic inflammatory disease affecting multiple tissues and organs including skin, joints, kidneys, small blood vessels, and the brain.<a onclick="showRef(event, 'ref120 ref148 ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref120 ref148 ref149 ref150">(120, 148-150)</a> SLE is characterized by the presence of high-affinity autoantibodies against a plethora of intracellular and cell surface targets. Such targets include tissue-specific proteins and ubiquitously expressed cellular components (e.g., anti-DNA, anti-Ro, anticardiolipin, anti-NMDA receptor antibodies) and have all been implicated in the clinical manifestations of SLE. In the murine model of SLE NZB/W F1 mice, FcRγ-deficiency protected animals from disease without affecting the generation and deposition of ICs. This implicates autoantibodies, FcR signaling, and SYK in the downstream inflammatory events, and as expected, administration of compound <b>11</b> prior to or after onset of disease reduces renal pathology, delays the onset of proteinuria, and significantly prolongs survival of lupus-prone NZB/W F1 mice.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Similarly, SYK inhibition with <b>11</b> also suppressed established skin and kidney disease in the MRL/lpr and BAX/BAK murine models of SLE.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div><div class="NLM_p">A complex autoimmune disease like SLE is multifactorial and the autoantibody-FcR-SYK axis need not be the only path to tissue damage and pathology.<a onclick="showRef(event, 'ref120 ref148 ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref120 ref148 ref149 ref150">(120, 148-150)</a> In fact, T-cells in SLE patients have been reported to have an overactive phenotype, and this hyperactive state is claimed to be due, in part, to a “rewiring” of the T-cell receptor (TCR) signaling complex, where the ITAM-bearing ζ chain of the TCR associated with ZAP-70 is replaced by the “trigger-happy” FcRγ-SYK.<a onclick="showRef(event, 'ref120 ref148 ref149 ref150'); return false;" href="javascript:void(0);" class="ref ref120 ref148 ref149 ref150">(120, 148-150)</a> Interestingly, SYK inhibition selectively reduced TCR-induced calcium responses in SLE T-cells and may represent an avenue to repress their hyperactive state. Furthermore, consistent with the prevalence in SLE of antibodies against intracellular and nuclear components, incomplete clearance of dying cells is thought to play an inflammatory role and to be a major source of autoantigens. Recently, another cellular response to DAMPs has been recognized. Mincle (also known as CLEC4E), for example, is a C-type lectin receptor on macrophages that senses necrotic cells by recognizing spliceosome-associated protein 130 in the extracellular compartment. CLEC4E associates with FcRγ, and its engagement results in ITAM-dependent activation of proinflammatory cytokines IL-1β and IL-18 by caspase-1 via a SYK-CARD9 pathway.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85, 86)</a> Similarly, C-type lectin receptor CLEC9A (also known as DNGR-1) on DCs is capable of sensing a necrotic signal that becomes exposed upon disruption of membrane integrity of the cells. Notably, CLEC9A possesses a hemITAM motif and signals through SYK to present antigens associated with cell death to activate CD8 cytotoxic T-cells.<a onclick="showRef(event, 'ref11 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref11 ref85 ref86">(11, 85, 86)</a> Significantly, blocking CLEC9A in DCs reduced this cross-antigen presentation but without affecting the uptake of necrotic material. Thus, the emerging paradigm is that SYK-coupled CLRs are able to initiate inflammatory responses by both PAMPs and DAMPs. In the case of SLE, SYK inhibition may be beneficial by dampening responses to DAMPs and to self-antigen autoantibody ICs, as well as by suppressing hyperactive T-cells.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p">T1D is a chronic autoimmune disease that targets and destroys pancreatic β-cells, resulting in severe insulin deficiency.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> This disease is characterized by the early expression of anti-islet autoantibodies, where the presence of these autoantibodies allows prediction of T1D disease development and progression.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> This association is mirrored in the nonobese diabetic (NOD) mouse, which also displays anti-insulin autoantibodies prior to overt diabetes. Moreover, NOD mice deficient in activating FcR receptors were protected from disease despite comparable production of autoantibodies. Correspondingly, administration of SYK inhibitor <b>11</b> to NOD mice delayed onset of spontaneous disease and progression of established early diabetes.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> This salutary effect is likely due to suppression of diabetogenic T cell priming. Interestingly, treatment with compound <b>11</b> in this NOD model was found to increase the relative numbers of IL-10-expressing B-cells, a subset population capable of modulating down immune responses.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><div class="NLM_p">In a set of insightful experiments, Clynes and colleagues demonstrated that genetic SYK deficiency in DCs resulted in impaired cross-priming of diabetogenic CD8 T-cells in the RIP-mOVA mouse model of diabetes, a process that was phenocopied by treatment with SYK inhibitor compound <b>11</b>.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> In this model, which is dependent on FcRγ signaling, autoantibodies enhance antigen uptake and presentation to pathogenic T-cells to cause insulitis and diabetes development.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Interestingly, SYK inhibition with compound <b>11</b> impaired peptide loading into MHC when antigen was provided in the context of ICs but had no effect when provided as free peptides.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> SYK inhibition did not disrupt the binding or internalization of ICs, suggesting a block in antigen processing. Treatment with compound <b>11</b> also blocked BCR-dependent antigen presentation by B-cells, a process known to be dependent on ITAMs present in the BCR.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><div class="NLM_p last">In summary, SYK inhibition has great potential for the treatment of allergic inflammatory disorders, as it blocks IgE-mediated activation of mast cells and basophils, a hallmark of atopic diseases that include asthma, allergic rhinitis, and atopic dermatitis.<a onclick="showRef(event, 'ref127 ref128 ref129'); return false;" href="javascript:void(0);" class="ref ref127 ref128 ref129">(127-129)</a> Rather than inhibiting a single class of mediators such as histamine and LT, as most current therapies entail,<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117, 118)</a> SYK inhibition blocks the generation of all preformed granule contents, including lipid metabolites and cytokines, potentially imparting broadly beneficial anti-inflammatory effects.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16">(10-16)</a> Inhibition of SYK is a logical strategy to prevent autoantibody-mediated disease given its pivotal role in FcR signaling in leukocytes, like macrophages and neutrophils.<a onclick="showRef(event, 'ref77 ref78 ref105 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref114 ref137 ref138 ref150 ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref105 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref114 ref137 ref138 ref150 ref151 ref152">(77, 78, 105-112, 114, 137, 138, 150-152)</a> These indications include autoantibody-mediated elimination of cells (e.g., ITP and AIHA), tissue-specific autoantibody-directed disorders (e.g., pemphigus in skin, glomerulonephritis in kidney), antineutrophil cytoplasmic autoantibodies-associated vasculitides in blood vessels, and systemic inflammatory diseases associated with autoantibodies (e.g., RA and SLE).<a onclick="showRef(event, 'ref77 ref78 ref105 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref114 ref137 ref138 ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref77 ref78 ref105 ref106 ref107 ref108 ref109 ref110 ref111 ref112 ref114 ref137 ref138 ref150 ref151">(77, 78, 105-112, 114, 137, 138, 150, 151)</a>In myeloid cells, SYK also mediates ITAM-dependent CLR inflammatory responses to pathogens and cellular damage through PAMPs and DAMPs, respectively.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> Thus, inhibiting SYK activity may prevent, delay, and diminish the intensity of the inflammation initiation, as well as relapse, awakened by infections and dying cells in autoimmune disease-prone individuals. SYK in fact plays a key role in the ITAM-mediated antigen presentation by B-cells to helper T-cells that amplify and perpetuate adaptive immune responses (in the autoimmune context, responses to self) and in the cross-presentation of antigens to CD8 cytotoxic T-cells that proceed to destroy invaded or supposedly invaded cells. Likewise, SYK plays pivotal roles in other harmful effector mechanisms including oxidative burst by neutrophils and bone resorption by osteoclasts.<a onclick="showRef(event, 'ref139 ref140 ref141 ref142 ref145'); return false;" href="javascript:void(0);" class="ref ref139 ref140 ref141 ref142 ref145">(139-142, 145)</a> Given the broad anti-inflammatory effects, SYK inhibition is likely to be efficacious in other varied indications associated with inflammation and detrimental antibodies.<a onclick="showRef(event, 'ref150 ref151 ref152'); return false;" href="javascript:void(0);" class="ref ref150 ref151 ref152">(150-152)</a> Recent examples include ischemia–reperfusion, atherosclerosis, type 2 diabetes, and antibody-mediated cancer progression.<a onclick="showRef(event, 'ref153 ref154 ref155 ref156 ref157 ref158 ref159 ref160 ref161 ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref153 ref154 ref155 ref156 ref157 ref158 ref159 ref160 ref161 ref162 ref163">(153-163)</a></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> B-Cell Lymphomas: Non-Hodgkin Lymphomas (NHL)</h3><div class="NLM_p last">SYK is necessary to transduce constitutive BCR signals<a onclick="showRef(event, 'ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref158 ref159">(158, 159)</a>and participates in the survival and growth of B-cells in response to BCR stimulation (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). In specific contexts, BCR signaling via SYK is activated in an uncontrolled manner leading to lymphomas and leukemia. Indeed, murine studies have shown that SYK expression is required for the survival of NHL-like tumors in vitro.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Furthermore, pharmacologic inhibition of SYK-induced apoptosis in murine B-cell lymphomas in vitro and resulted in regression of NHL-like B-cell lymphomas.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> Taken together, these results suggest that SYK expression and function are necessary for the survival of NHL cell lines<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> and highlight the potential use of SYK inhibition in the treatment of B-cell lymphomas. The use of SYK inhibitors in these indications has been recently summarized in detail and is discussed in the clinical section of this article.<a onclick="showRef(event, 'ref161 ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref161 ref162 ref163">(161-163)</a></div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Discovery of SYK Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Structure–activity relationship (SAR) work directed toward inhibition of SYK has lagged behind the elegant insights gained into its biology, mechanism of action, and potential therapeutic utility.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17">(9-17)</a> This section will provide, in chronological order, the discovery of SYK inhibitors. Early inhibitors were employed as probe compounds for the study of biologic mechanism of action. Interestingly, optimization programs directed toward SYK inhibitors have gained great value from reliance on cell-based functional assays for both on-target and off-target activity assessment. Initial assessment of SYK as a target for therapeutic intervention relied on the application of RBL-2H3 rat tumor basophils and CHMC cell lines.<a onclick="showRef(event, 'ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58 ref59 ref60 ref61 ref62 ref63 ref64">(56-64)</a> Selectivity determination employed the use of CHMC, primary human T-cells, Jurkat T-cells, Ramos B-cells, and A549 epithelial, H1299 lung cancer, and HeLa cell lines.<a onclick="showRef(event, 'ref9 ref10 ref11 ref78'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref78">(9-11, 78)</a></div><div class="NLM_p last">Over the past decade, diverse biologic activities of SYK in disease have been complemented by maturation in SAR programs and generation of pharmacologically relevant agents.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17">(12-17)</a> These agents have paved the path toward efficacy in animal models mimicking human disease. More recently, SYK inhibitors have advanced into clinical trials for the treatment of human maladies.<a onclick="showRef(event, 'ref16 ref105 ref107 ref108 ref109 ref110 ref112 ref114'); return false;" href="javascript:void(0);" class="ref ref16 ref105 ref107 ref108 ref109 ref110 ref112 ref114">(16, 105, 107-110, 112, 114)</a></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">First Generation of SYK Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55143" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55143" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>12</b> (piceatannol, 3,4,3′,5′-tetrahydroxy-<i>trans</i>-stilbene; Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) isolated as a plant secondary natural product inhibits antigen-induced activation of SYK in RBL-2H3 rat tumor basophils, allowing mechanistic elucidation into the involvement of SYK in mast cell and basophil degranulation.<a onclick="showRef(event, 'ref95 ref164'); return false;" href="javascript:void(0);" class="ref ref95 ref164">(95, 164)</a> The compound showed less effect on Lyn kinase activity, as measured by autophosphorylation in antikinase ICs and additionally by phosphorylation of peptide substrate angiotensin I.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a></div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of SYK inhibitors <b>12</b>, <b>28</b>, <b>83</b> and compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Assessment of SYK inhibition was evaluated through effects on antigen-induced FcεR1 cross-linking leading to mast cell degranulation and release of 5-HT.<a onclick="showRef(event, 'ref60 ref95 ref127'); return false;" href="javascript:void(0);" class="ref ref60 ref95 ref127">(60, 95, 127)</a> Compound <b>12</b> only partially blocked the corresponding, non-SYK mediated, ionomycin-induced degranulation.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> However, it showed discrepancy in concentrations necessary to effect anti-IgE mediated histamine release in human basophils, EC<sub>50</sub> = 5 μM, versus human lung mast cells, EC<sub>50</sub> = 25 μM.<a onclick="showRef(event, 'ref164 ref165'); return false;" href="javascript:void(0);" class="ref ref164 ref165">(164, 165)</a> Mechanistically, this disagreement suggests that the compound is inhibiting different molecular targets. Further variability was found, with compound <b>12</b> inhibiting SYK independent phorbol myristate acetate induced histamine release in human basophils but not in RBL-2H3 cells.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> The phosphorylation of SYK is not inhibited in human basophils at 30 μM, which is effective for completely blocking IgE-mediated degranulation in the RBL-2H3 cell line.<a onclick="showRef(event, 'ref164 ref165 ref166'); return false;" href="javascript:void(0);" class="ref ref164 ref165 ref166">(164-166)</a> The weak margin of potency observed with <b>12</b> for SYK inhibition has led to selective application as a chemical reagent for the study of RBL-2H3, human mast cells, and basophil function and not for therapeutic intervention.</div><div class="NLM_p">Another first-generation inhibitor, compound <b>13</b> (ER-27319, 10-(3-aminopropyl)-3,4-dimethylacridin-9(10<i>H</i>)-one; Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), has been reported as an inhibitor of antigen or anti-IgE-mediated degranulation of rodent and human mast cells.<a onclick="showRef(event, 'ref95 ref167'); return false;" href="javascript:void(0);" class="ref ref95 ref167">(95, 167)</a> Human mast cells were generated using methodology developed by the Saito group.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Inhibition of SYK activity by compound <b>13</b> was assessed by effects on 5-HT, inositol phosphate, arachidonic acid, and TNFα release, with IC<sub>50</sub> of 10 μM, in RBL-2H3 cells stimulated by 4-dinitrophenylated bovine serum albumin (DNP-BSA).<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Given the high concentration of compound <b>13</b> required to cause half-maximal inhibition of degranulation, targets other than SYK may also be inhibited. Inhibition of SYK by compound <b>13</b> was examined in RBL-2H3 and human mast cells through its effects on tyrosine phosphorylation of SYK using immunoprecipitation at an IC<sub>50</sub> of 10 μM.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Measurement of tyrosine phosphorylation in Jurkat T-cells showed selectivity of compound <b>13</b> for SYK over family member ZAP-70.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> By use of anti-CD3 stimulation, no inhibition of PLCγ phosphorylation by compound <b>13</b> was observed up to 100 μM. In contrast, phosphorylation of PLCγ in RBL-2H3 cells was inhibited. Antigen-induced cross-linking of FcεR1 leads to Lyn activation, which is a prerequisite for the phosphorylation of β and γ ITAM subunits of FcεR1. In RBL-2H3 cells, compound <b>13</b> did not abrogate the activity of Lyn, as phosphorylation of PKCδ was still detected up to 30 μM compound <b>13</b>.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></div><div class="NLM_p">The action of compound <b>13</b> appears to be specific to mast cells, as inhibition of tyrosine phosphorylation of SYK in B-cells induced with anti-IgM was not blocked.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> High concentrations of compound <b>13</b> are essential for antagonistic effects through SYK activation in mast cells and basophils.<a onclick="showRef(event, 'ref166 ref167'); return false;" href="javascript:void(0);" class="ref ref166 ref167">(166, 167)</a> However, the potential for inhibition of and/or binding to other targets, contributing to the observed phenotype, must not be overlooked.<a onclick="showRef(event, 'ref166 ref167'); return false;" href="javascript:void(0);" class="ref ref166 ref167">(166, 167)</a></div><div class="NLM_p">Following the natural product trend, flavonoids were screened as inhibitors of SYK activity in both biochemical and CHMC assays.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> The activity of flavones <b>14</b> (luteolin) and <b>15</b> (apigenin) in a biochemical SYK assay is weak, with IC<sub>50</sub> of 12.0 and 4.2 μM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Compounds <b>14</b> and <b>15</b> were both more potent in the inhibition of mast cell degranulation, as determined by tryptase release, with EC<sub>50</sub> of 4.5 and 3.0 μM.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> A group of flavonols, <b>16</b> (quercetin), <b>17</b> (fisetin), <b>18</b> (myricetin), and <b>19</b> (morin), were also tested and showed weak inhibition for both SYK and mast cell degranulation (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Activity correlated with CLogP values, which can contribute to permeability, but given the weak activity in biochemical SYK assays, the lack of translation to high potency in the mast cell assay is not surprising (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Isolated Flavones and Flavonols, Showing SYK and CHMC Activity</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0012.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">SYK, IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">CHMC, EC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">CLogP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b> (luteolin)</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12.0</td><td class="colsep0 rowsep0" align="left">4.5</td><td class="colsep0 rowsep0" align="left">1.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b> (apigenin)</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">2.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b> (quercetin)</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">20.0</td><td class="colsep0 rowsep0" align="left">35.0</td><td class="colsep0 rowsep0" align="left">0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b> (fisetin)</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">15.0</td><td class="colsep0 rowsep0" align="left">19.0</td><td class="colsep0 rowsep0" align="left">1.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b> (myricetin)</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">54.0</td><td class="colsep0 rowsep0" align="left">–0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b> (morin)</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">28.0</td><td class="colsep0 rowsep0" align="left">>300</td><td class="colsep0 rowsep0" align="left">1.73</td></tr></tbody></table></div></div><div class="NLM_p last">These initial forays into SYK inhibitors relied on the application of cell-based functional assays with sporadic confirmation through biochemical assays. Structures <b>12</b>–<b>19</b> do not fit pharmacophores associated with kinase inhibition through ATP pocket binding. Compound <b>13</b> targets the activation of SYK mediated through FcεR1γ ITAM, suggesting there is no direct interaction with the SYK ATP pocket. Additionally it lacks the ability to cause inhibition of activated SYK following immunoprecipation of SYK from activated cells.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Second Generation of SYK Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Optimization of second-generation SYK inhibitors appeared to be more dependent on the application of biochemical assays. This may have been driven by the availability of diverse biochemical kinase screening panels. As such, structural features indicative of binding to the ATP pocket of SYK became more apparent, following the screening of in-house libraries leading to the identification of diverse scaffold classes.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17 ref77 ref78 ref83 ref101 ref102 ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17 ref77 ref78 ref83 ref101 ref102 ref103 ref104">(12-17, 77, 78, 83, 101-104)</a></div><div class="NLM_p">A series of oxindoles were examined employing a homogeneous time-resolved fluorescence assay, and analogue <b>20</b>, with the sulfonamide side chain, proved to be the most potent derivative reported from this SAR.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> The functional activity of compound <b>20</b> was ascertained using RBL-2H3 rat basophil cell IgE/FcεR1-mediated degranulation inhibition, measured as 5-HT release (EC<sub>50</sub> = 0.11 μM).<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Similarly, the SYK biochemical activity for compound <b>21</b> also translated to the cell-based assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Oxindole SAR for SYK and RBL-2H3 Activities</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0013.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0014.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">From ref <a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">170</a>.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Calculated using ref <a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">171</a>.</p></div></div><div></div></div><div class="NLM_p">Oxindole derivatives showed good potency in the biochemical SYK assay. However, because of high polar surface area (PSA)<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> values, low solubility correlation with activity in functional RBL-2H3 cells did not consistently translate, as exemplified by compounds <b>22</b> and <b>23</b>.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> The most potent compounds, displaying both SYK biochemical and functional RBL-2H3 activity, have PSA values ranging between 70 and 108 Å<sup>2</sup>. Analogues with improved solubility also introduced additional polar moieties, with increase in heteroatom count, leading to an increase in PSA and ultimately decreased cell permeability.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> The geometry at the 3-position of the oxindole is important for maintaining activity, with the <i>Z</i>-analogue <b>24</b> showing significant loss of activity. Reduction of the double bond in analogue <b>25</b> also shows loss in potency.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> The sulfonamide functional group adds considerably to the total PSA. Bioisosteric acid (<b>26</b>) and amide (<b>27</b>) functionalities were used to circumvent this increase, and these analogues showed a wide range in cell-based activity, EC<sub>50</sub> of 3.5 and 0.10 μM, respectively.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a></div><div class="NLM_p">The cell-based potency is rationalized through PSA but can be attributed to lack of selectivity. Control experiments to detect non-SYK dependent downstream ionomycin-induced degranulation were not reported, and thus, the degranulation phenotype could in fact be a result of promiscuous kinase inhibition. The oxindole scaffold, along with other SYK inhibitors, has been employed in pharmacophore model studies to identify novel scaffold classes and thus represents a useful class to lead-hop to other chemotypes.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a></div><div class="NLM_p">Compound <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) has a bicyclic imidazo[1,2-<i>c</i>]pyrimidine core, with nitrogen-linked nicotinamide and C–C linked 3,4-dimethoxyphenyl side chains at the 5- and 7-positions, respectively, and has been one of the most extensively profiled, potent SYK inhibitors in both biochemical and cell-based assays.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Compound <b>2</b> showed potent biochemical inhibition of SYK with <i>K</i><sub>i</sub> = 0.0075 ± 0.0025 μM and selectivity over a limited panel of Lyn, Fyn, Src, Itk, Btk, PKCα, and PKCθ kinases.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> In human-cultured mast cells compound <b>2</b> inhibited FcεR1-mediated release of histamine, tryptase, prostaglandin D2, LT C<sub>4</sub>/D<sub>4</sub>/E<sub>4</sub>, and de novo synthesis of cytokine GM-CSF.<a onclick="showRef(event, 'ref168 ref173'); return false;" href="javascript:void(0);" class="ref ref168 ref173">(168, 173)</a></div><div class="NLM_p">For an inhibitor to be broadly relevant as an anti-inflammatory agent, inhibition of both FcεR1 and Fcγ receptors is highly desirable.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Compound <b>2</b> effectively inhibited FcγR-mediated production of superoxide in a human monocytic cell line (U937) and freshly isolated monocytes from peripheral blood, with EC<sub>50</sub> of 0.052 and 0.012 μM, respectively.<a onclick="showRef(event, 'ref52 ref173'); return false;" href="javascript:void(0);" class="ref ref52 ref173">(52, 173)</a> Furthermore, B-cell receptor function is extremely important in the development of disease resulting from overactivity in the immune system, and in human Ramos B-cells and mouse splenic B-cells, <b>2</b> inhibited [Ca<sup>2+</sup>] release and proliferation with EC<sub>50</sub> of 0.081 and 0.058 μM, respectively.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div><div class="NLM_p">Compound <b>2</b> inhibited the passive cutaneous anaphylaxis (PCA) reaction in rats in a dose-dependent manner and had ED<sub>50</sub> = 8 mg/kg.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> In addition, this compound showed efficacy in the DNP-BSA-induced acute asthma bronchoconstriction and bronchial edema model in male Wistar rats at 3 mg/kg.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> In Brown Norway rats at 30 mg/kg, eosinophil buildup of bronchoalveolar lavage (BAL) fluid was largely mitigated in ovalbumin (OVA) induced chronic airway inflammation model. The substantial discrepancy between the dosing level in the acute and chronic models can be accounted for by the pharmacokinetic profile of compound <b>2</b>, maximum exposure of 0.167 mg/L being reached 2 h after administration of a single 10 mg/kg po dose and short half-life of 1.78 h.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div><div class="NLM_p">Compound <b>2</b> affects both IgG- and IgE-mediated pathways, implying application for both allergic and autoimmune diseases. At the time compound <b>2</b> was being investigated, the literature suggested that inhibiting SYK could lead to serious on-target side effects, such as tumor causation<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42, 43)</a> and severe systemic hemorrhaging.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> To date, however, there have been no reports of such on-target liabilities caused by compound <b>2</b> or other SYK inhibitors, and this may, in part, be due to the fact that such side effects, including platelet activation and thrombus development, are controlled by a number of pathways.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref17 ref41 ref46 ref78 ref173'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref17 ref41 ref46 ref78 ref173">(12-17, 41, 46, 78, 173)</a> As SYK has been shown to play a pivotal role in platelet activation through collagen receptor (glycoprotein VI) and some specific integrins (αIIββ3),<a onclick="showRef(event, 'ref153 ref175 ref176 ref177'); return false;" href="javascript:void(0);" class="ref ref153 ref175 ref176 ref177">(153, 175-177)</a> it is, however, imperative to assess the activity of any SYK inhibitor on platelet function. This can be accomplished by measuring hemostasis in vivo, as assessed by effects on bleeding times following tail-tip amputation in mice, as demonstrated by compound <b>3</b>.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Indeed, no increase in bleeding time of mice is observed, following treatment with compound <b>3</b>, compared to control groups dosed with aspirin, which causes a substantial increase in bleeding time, thus confirming that SYK inhibition by compound <b>3</b> is not likely to cause severe systemic hemorrhaging.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a></div><div class="NLM_p">Compound <b>28</b> (Compound-D, Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), is from the same class as compound <b>2</b>, with the introduction of a 1<i>H</i>-indazol-6-amine side chain in place of the 2-aminonicotinamide group at the 5-position of the core imidazo[1,2-<i>c</i>]pyrimidine scaffold.<a onclick="showRef(event, 'ref173 ref178'); return false;" href="javascript:void(0);" class="ref ref173 ref178">(173, 178)</a> The compound was utilized to probe the relationship of SYK inhibition to antigen presentation in mouse bone marrow DCs. Internalization of IC plays an important role in linking innate and adaptive immunity.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Upon internalization the antigen undergoes degradation by lysosomes, then loaded onto MHC and presented to T-cells as a MHC-peptide complex. This initiates the immune reaction to the internalized antigen. The activation of IgG Fcγ receptors in macrophages, monocytes, neutrophils, and DCs mirrors the activation of IgE FcεR1 in mast cells and basophils.<a onclick="showRef(event, 'ref39 ref40 ref59'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref59">(39, 40, 59)</a> Both involve upstream intracellular events mediated by interaction of SYK with phosphorylated ITAM.</div><div class="NLM_p">Compound <b>28</b> inhibits SYK with <i>K</i><sub>i</sub> = 0.01 μM and less potently inhibits Lyn, Fyn, Src, Itk, Btk, PKCα, and PKCθ.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> Inhibition of IL-4 production (EC<sub>50</sub> = 1.08 μM) was measured to establish inhibition of antigen presentation of IC by DCs to T-cells.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> To prove that the effect of <b>28</b> on IL-4 production was not through either direct impairment of T-cells or non-IgG-mediated internalization, compound <b>28</b> was screened using a high concentration of conalbumin (10 μg/mL) or conalbumin peptide and showed no inhibition under these respective conditions.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> Studies with compound <b>28</b> confirm and complement previous knockdown studies in Fcγ-receptor-mediated presentation and internalization of IC in DCs.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39, 40)</a></div><div class="NLM_p">A set of 5,7-disubstituted[1,6]naphthyridines with promising SYK biochemical activity have been reported.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Initial analogues <b>29</b> and <b>30</b> showed SYK activity with IC<sub>50</sub> of 1.5 and 0.49 μM, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Replacement of the [1,6]naphthyridine ring system by pyrido[2,3-<i>d</i>]pyrimidine (compound <b>31</b>), isoquinoline (compound <b>32</b>), and quinazoline (compound <b>33</b>) led to greatly diminished SYK activity. Going from the ethylenediamine (compound <b>29</b>) to a propylenediamine (compound <b>34</b>) substituent at the 5-position of the [1,6]naphthyridine enhanced potency by 10-fold, with SYK IC<sub>50</sub> = 0.14 μM.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Replacement of the 4-methoxyphenyl ring on compound <b>29</b> at the 7-position of the central heterocyclic core with a 4-dimethylaminophenyl group (compound <b>35</b>) is tolerated and improves SYK activity to 0.19 μM.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Introduction of a hydroxyl (compound <b>36</b>) or trifluoromethyl (compound <b>37</b>)group at the 2-postion of the [1,6]naphthyridine led to complete loss of activity. Electron-withdrawing groups such as fluoro and chloro on the 7-phenyl ring decreased potency.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a>The 4-halogen analogues <b>38</b> (SYK IC<sub>50</sub> = 1.1 μM) and <b>39</b> (SYK IC<sub>50</sub> = 1.2 μM) showed activity similar to that of 3-substituted analogues <b>40</b> (SYK IC<sub>50</sub> = 0.85 μM) and <b>41</b> (SYK IC<sub>50</sub> = 0.26 μM), with <b>41</b> showing the best activity in this subset.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> In fact, the 7-phenyl ring could be substituted with a larger 4-morpholino group with enhanced potency, <b>42</b> (SYK IC<sub>50</sub> = 0.008 μM).<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> This position is relatively open to diverse substitution, possibly because substituents sit on the solution side of the ATP-binding pocket. Not all moieties maintained potency, as shown by compounds <b>43</b> and <b>44</b>. Compounds <b>45</b>, <b>46</b>, <b>47</b>, and <b>48</b> confirmed the preference for terminal basic nitrogen-containing propylenediamine and butylenediamine side chains at the R<sub>5</sub> position, with the presence of a dimethylaminophenyl group at the R<sub>7</sub> position.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> In combination, with a propylenediamine group at the 5-position, the 7-position tolerates a hydrophobic isopropyl group on the phenyl ring (compound <b>49</b>). Replacement of the nitrogen connection to the [1,6]naphthyridine ring system with oxygen, as in compound <b>50</b>, showed significantly less activity compared to compound <b>46</b>. Likewise, substitution of the terminal amine with a hydroxy (compound <b>51</b>) moiety led to loss in activity. The R<sub>5</sub> position is limited to acyclic side chains with basic amines being preferred and aromatic containing side chains not tolerated.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR for 5,7-Disubstituted[1,6]naphthyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0015.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">R<sub>7</sub></th><th class="colsep0 rowsep0" align="center">SYK, IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>OC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>OC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>OC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">>30 μg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>OC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">>30 μg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>OC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>OC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-(CH<sub>3</sub>)<sub>2</sub>NC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>OC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">>30 μg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>OC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">>30 μg/mL</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-F-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-Cl-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3-F-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3-Cl-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-(<i>N</i>-morpholinyl)C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.008</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-(N(CH<sub>3</sub>)(CH<sub>2</sub>)<sub>3</sub>N(CH<sub>3</sub>)<sub>2</sub>)C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-BrC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-(CH<sub>3</sub>)<sub>2</sub>NC<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.034</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>4</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-(CH<sub>3</sub>)<sub>2</sub>N-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.019</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-(CH<sub>3</sub>)<sub>2</sub>N-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.072</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-(CH<sub>3</sub>)<sub>2</sub>N-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.078</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>3</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-CH(CH<sub>3</sub>)<sub>2</sub>-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.090</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">O(CH<sub>2</sub>)<sub>4</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-(CH<sub>3</sub>)<sub>2</sub>N-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">N</td><td class="colsep0 rowsep0" align="left">C</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>4</sub>OH</td><td class="colsep0 rowsep0" align="left">4-(CH<sub>3</sub>)<sub>2</sub>N-C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">0.20</td></tr></tbody></table></div></div><div class="NLM_p">The [1,6]naphthyridine compounds have shown potent on-target biochemical SYK inhibition.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Unfortunately, no data-profiling selectivity over other kinase families in biochemical or cell-based functional assays and in pharmacokinetic, metabolism evaluation, efficacy, or toxicity studies have been reported. Interest has picked up again on this scaffold class with the generation of updated patents.<a onclick="showRef(event, 'ref180 ref181'); return false;" href="javascript:void(0);" class="ref ref180 ref181">(180, 181)</a></div><div class="NLM_p">Pyrimidine-5-carboxamide compound <b>52</b> was discovered by employing a SYK biochemical high-throughput screening (HTS) assay. The molecule displayed potent SYK inhibition, with IC<sub>50</sub> = 0.041 μM and 273-fold selectivity over ZAP-70 (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).<a onclick="showRef(event, 'ref182 ref183'); return false;" href="javascript:void(0);" class="ref ref182 ref183">(182, 183)</a> Replacement of the 2-ethylenediamino side chain at the 2-position of the pyrimidine with hydrogen, 2-methyl, and 2-phenyl led to complete loss of activity, as shown by compounds <b>53</b>, <b>54</b>, and <b>55</b>, respectively. Increased chain length from 2-ethylenediamino (compound <b>52</b>) to the 2-butylenediamino (<b>56</b>) analogue maintained activity. However, going to a secondary amine (compound <b>57</b>) diminished activity.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Introduction of a piperazine ring at the 2-position of the pyrimidine in analogue <b>58</b>, with secondary terminal basic nitrogen, completely abolishes activity, confirming the importance of a primary amine at the terminus. As exemplified by 2-ethylenehydroxy analogue <b>59</b>, an alcohol functional group is not tolerated.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Substitution on the phenyl ring and aromatic character of the side chain at the 4-position of the pyrimidine play valuable roles in maintaining activity, as proven by analogues <b>60</b>, <b>61</b>, <b>62</b>, and <b>63</b>; however, the cyclohexyl compound <b>64</b> loses significant activity.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Just as important is the role of the carboxamide, with the secondary amide (<b>65</b>) and carboxylic acid (<b>66</b>) analogues losing activity.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> The SAR was rationalized employing a published cocrystal structure of compound <b>7</b> with SYK<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> and also the crystal structure of Lck, because of the high degree of similarity of the respective ATP pockets.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of Pyrimidine-5-carboxamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0016.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">SYK</th><th class="colsep0 rowsep0" align="center">ZAP70</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.041</td><td class="colsep0 rowsep0" align="left">11.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>4</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.047</td><td class="colsep0 rowsep0" align="left">10.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.21</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">piperazin-1-yl</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.35</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">C<sub>6</sub>H<sub>5</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">13.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">2-CH<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.23</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3-CH<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">4-CH<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">6.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">cyclohexyl</td><td class="colsep0 rowsep0" align="left">CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CONHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>C<sub>6</sub>H<sub>4</sub></td><td class="colsep0 rowsep0" align="left">CO<sub>2</sub>H</td><td class="colsep0 rowsep0" align="left">>5</td><td class="colsep0 rowsep0" align="left">>5</td></tr></tbody></table></div></div><div class="NLM_p">Potent analogues <b>52</b>, <b>56</b>, <b>62</b>, <b>67</b>, and <b>68</b> were screened for selectivity using a limited panel of six biochemical kinase assays and also an on-target functional assay assessing the inhibition of 5-HT release in RBL-2H3 cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> The initial HTS hit <b>52</b> proved to be the most potent compound in the RBL-2H3 cell-based assay. The in vitro on-target potency translated to an animal model, with analogue <b>52</b> showing efficacy in the PCA reaction with ED<sub>50</sub> = 13.2 mg/kg.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Selectivity Profiling of Pyrimidine-5-carboxamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0017.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">SYK</th><th class="colsep0 rowsep0" align="center">Itk</th><th class="colsep0 rowsep0" align="center">Btk</th><th class="colsep0 rowsep0" align="center">PKCα</th><th class="colsep0 rowsep0" align="center">PKCβ2</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)<br /></br>5-HT release</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.041</td><td class="colsep0 rowsep0" align="left">22.6</td><td class="colsep0 rowsep0" align="left">15.5</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">0.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>4</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.047</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">1.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="left">29.3</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">0.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.066</td><td class="colsep0 rowsep0" align="left">28.0</td><td class="colsep0 rowsep0" align="left">8.7</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">NH(CH<sub>2</sub>)<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">0.081</td><td class="colsep0 rowsep0" align="left">23.1</td><td class="colsep0 rowsep0" align="left">10.7</td><td class="colsep0 rowsep0" align="left">8.5</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">0.93</td></tr></tbody></table></div></div><div class="NLM_p">HTS screening led to the identification of potent <i>N</i>-phenyl-4-(thiazol-2-yl)pyrimidin-2-amine SYK inhibitors (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Compound <b>69</b> inhibits SYK with <i>K</i><sub>i</sub> = 0.63 μM.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> SAR produced a set of potent analogues with biochemical activity, corroborated in cell-based mast cell degranulation assays. Selectivity was assessed by counterassays targeting ZAP-70, cyclin-dependent kinase 2, Rho-associated serine/threonine kinase, and Src kinases. A range of substituents on the <i>N</i>-phenyl group at the 2-position of the pyrimidine were made, leading to noticeable improvements in SYK biochemical and mast cell degranulation potency.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. SAR of <i>N</i>-Phenyl-4-(thiazol-2-yl)pyrimidin-2-amine Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0018.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0019.gif" alt="" id="fx8" /></img><div></div></div><div class="NLM_p">Interestingly, chirality influences activity, as shown by dissimilarities between (<i>S</i>)- and (<i>R</i>)-alanol derivatives <b>9</b> and <b>70</b>, showing SYK <i>K</i><sub>i</sub> of 0.009 and 0.21 μM, respectively.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a>A cocrystal structure of the SYK ATP pocket with potent analogue <b>9</b> aided in rationalizing this difference in potency (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The pyrimidine ring nitrogen at the 1-position provides a hydrogen bond acceptor interaction with SYK hinge residue A451, and the NH linker at the 2-position has hydrogen bond donor interaction with the carbonyl group of A451.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Also, the (<i>S</i>)-alanol side chain sits in the vicinity of the salt bridge formed between K402 and D512, and the geometry of two enantiomers <b>9</b> and <b>70</b> is slightly different resulting in a change in interaction and accounting for the difference in activity (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). The crystal structure indicates the importance of the hydrophobic binding interactions of 3,5-disubstituted phenyl ring in the ATP pocket and accounts for the loss of potency of the much simpler compound <b>10</b>, where an <i>o</i>-methyl group disrupts the coplanarity of the pyrimidine and phenyl rings (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Solubility and permeability of compounds may also account for differences in the activity observed in the cell-based assay.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cocrystal image of compound <b>9</b> (green) and docked compound <b>70</b> (purple) in SYK. In contrast to enantiomer <b>9</b>, hydroxyl group on enantiomer <b>70</b> is facing away from ASP512.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A homology model for ZAP-70<a onclick="showRef(event, 'ref24 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref24 ref81 ref82">(24, 81, 82)</a> based on a reported crystal structure of activated Lck kinase domain was employed for docking pyrimidine-5-carboxamide inhibitors and to lead-hop to other scaffold classes (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> This work led to the initial optimization of 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine and 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine scaffolds directed at SYK and ZAP-70 inhibition.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> In general, compounds from these scaffold classes possessed greater potency for SYK. Given the close homology of SYK and ZAP-70<a onclick="showRef(event, 'ref24 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref24 ref81 ref82">(24, 81, 82)</a> (vide supra), structure <b>52</b> was used as the initial scaffold for docking, along with the promiscuous kinase inhibitor <b>6</b>.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Docking studies of compound <b>52</b> in the ZAP-70 homology model point to a cavity where a ring could be constructed between the 1- and 6-positions of the pyrimidine ring (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). This proposal was initially explored through screening of the 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine central bicyclic scaffold and subsequently extended to the 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine class (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). The 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine chemotype can be converted to the 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine by a Dimroth rearrangement (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Dimroth Rearrangement for Conversion of 1,2,4-Triazolo[4,3-<i>c</i>]pyrimidine to 1,2,4-Triazolo[1,5-<i>c</i>]pyrimidine Scaffold and SYK and ZAP-70 SAR Summary of 1,2,4-Triazolo[4,3-<i>c</i>]pyrimidine and 1,2,4-Triazolo[1,5-<i>c</i>]pyrimidine Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0020.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0021.gif" alt="" id="fx10" /></img><div></div></div><div class="NLM_p">The 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine scaffold compound <b>71</b> shows improved SYK activity compared to pyrimidine compound <b>52</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), although the ZAP-70 activities remain similar (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>).<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Replacement of 2-ethylenediamino by a <i>cis</i>-cyclohexyldiamino group (compound <b>72</b>) retains SYK potency, but selectivity over ZAP-70 is decreased. Dimroth rearrangement of 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine (compound <b>72</b>)generated 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine compound <b>73</b>, which maintains similar SYK potency and activity for ZAP-70.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Aromatic substitution at the 3-position on the 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine ring (compound <b>74</b>) leads to loss of both SYK and ZAP-70 activity. However, introduction of an aromatic ring at the 2-position of the 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine ring system (compound <b>75</b>) leads to a 10-fold reduction in SYK activity but with an improvement in ZAP-70 potency.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Further reduction in SYK activity is observed by introducing a 3-methoxyphenyl ring (compound <b>76</b>) at the 2-position of the triazole ring. The most potent ZAP-70 compound is produced by introduction of a 2-chlorophenyl ring (compound <b>77</b>) on the triazole ring. Cell-based activity of analogues was assessed by measurement of the inhibition of IL-2 production in peripheral blood mononuclear cells (PBMCs) and whole blood (WB) cells. The most potent compounds in these functional assays were <b>72</b> and <b>73</b>, with PBMC inhibition of 0.046 and 0.076 μM and WB inhibition of 0.44 and 0.48 μM, respectively.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Interestingly, compound <b>77</b>, a potent SYK and ZAP-70 inhibitor, shows activity of 1.76 μM in IL-2 production inhibition. Lack of solubility and cell permeability may account for the weaker IL2 inhibition exhibited by compound <b>77</b>. Taken together, these data suggest that these compounds show good potency for SYK and consistent selectivity over ZAP-70 and that many kinases upstream and downstream are involved in the IL-2 pathway leading to IL-2 production. However, more extensive selectivity assessment of these potent SYK inhibitors in both biochemical and cell-based assays is warranted.</div><div class="NLM_p">The imidazo[1,2-<i>c</i>]pyrimidine scaffold class followed from the previously reported 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine and from 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine modulators of SYK and ZAP-70 activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>).<a onclick="showRef(event, 'ref185 ref186'); return false;" href="javascript:void(0);" class="ref ref185 ref186">(185, 186)</a> Both 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine and 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine have high PSA values and low Caco-2 permeability,<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> ultimately leading to low oral bioavailability and limiting the chances of success in animal efficacy models. The 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine compound <b>72</b> and 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine analogue <b>73</b> have low Caco-permeability, 0.01 × 10<sup>–6</sup> and 0.33 × 10<sup>–6</sup> cm/s, respectively.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> The imidazo[1,2-<i>c</i>]pyrimidine scaffold has one fewer nitrogen atom, leading to a lower PSA and improved Caco-2 permeability.<a onclick="showRef(event, 'ref171 ref185'); return false;" href="javascript:void(0);" class="ref ref171 ref185">(171, 185)</a></div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. SAR of Imidazo[1,2-<i>c</i>]pyrimidine Scaffold</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0022.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0023.gif" alt="" id="fx12" /></img><div></div></div><div class="NLM_p">The initial compound <b>78</b> with a 2-ethylenediamino moiety did not potently inhibit SYK (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). Introduction of the <i>cis</i>-cyclohexyldiamine side chain, as in compound <b>79</b>, significantly improved activity. The <i>trans</i>-cyclohexyldiamine compound <b>80</b> shows loss in activity. In addition, isomers (1<i>R</i>,2<i>S</i>)-<b>81</b> and (1<i>S</i>,2<i>R</i>)-<b>82</b> show a significant difference in activity for both SYK and ZAP-70 but with little separation between SYK and ZAP-70 activities.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> Compounds <b>79</b> and <b>82</b> were active, with EC<sub>50</sub> of 0.058 and 0.20 μM in the PBMC and 0.28 and 2.0 μM in the WB assays.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> In contrast to 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine and 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine compounds, imidazo[1,2-<i>c</i>]pyrimidine <b>79</b> shows improved aqueous solubility of 930 μg/mL and Caco-2 permeability of 3.33 × 10<sup>–6</sup> cm/s. Oral dosing of compound <b>79</b> shows a dose-dependent increase in exposure with 3, 10, 30, 100 mg/kg providing exposures of 40, 191, 770, and 4031 ng/mL, respectively.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> Furthermore, compound <b>79</b> shows efficacy in the PCA reaction at doses of 3, 10, 30, and 100 mg/kg, with ED<sub>50</sub> between 3 and 10 mg/kg.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> In addition, concanavalin A induced IL-2 production suppression was only significant at doses higher than 10 mg/kg. This class of compound provides another validation of the translation of SYK inhibition to animal model efficacy.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a></div><div class="NLM_p">The pyrimidine-5-carboxamide<a onclick="showRef(event, 'ref182 ref183'); return false;" href="javascript:void(0);" class="ref ref182 ref183">(182, 183)</a> SYK inhibitors originated from the Yamanouchi group and were in-licensed by Portola.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> Detailed SAR on this scaffold class led to optimization in potency and selectivity and produced a number of analogues, including compound <b>83</b> (PRT060318; Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> Animal efficacy data for the prevention of heparin-induced thrombocytopenia (HIT) and thrombosis in a transgenic mouse model have recently been reported for compound <b>83</b>.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> Compound <b>83</b> inhibited SYK with an IC<sub>50</sub> of 0.004 μM and displayed functional selectivity over Src family kinase Lyn.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> This was confirmed by showing no inhibition of Lyn mediated phosphorylation of Y352 on human SYK in WB, up to 10 μM. The compound showed biochemical selectivity as determined through screening in a panel of 138 kinases.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> On-target convulxin-induced aggregation of human platelet-rich plasma (PRP) activation through GPVI/FcRγ was inhibited with EC<sub>50</sub> = 2.5 ± 0.2 μM, and non-ITAM based platelet activation through adenosine diphosphate was not effected at concentrations up to 50 μM.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> To gain additional insight for on-target mode of action through the FcγRIIA–ITAM–SYK pathway, compound <b>83</b> inhibited platelet activation by HIT IC at concentrations ranging between 0.3 and 3 μM in vitro and PRP from HIT mice treated with anti-CD9 antibody mimicking HIT IC acting through FcγRIIA was completely ablated ex vivo at inhibitor concentrations of ≥0.75 μM.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> In animal efficacy studies, compound <b>83</b> at 30 mg/kg b.i.d. showed improvement in HIT IC induced thrombocytopenia, in treated animals (89.7 ± 3.7% of baseline) versus control (47 ± 10.1% of baseline) as determined by nadir platelet count. Finally, the compound also showed preventative activity on HIT IC-induced thrombosis in mouse lung, as determined by near-infrared imaging.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a></div><div class="NLM_p">The biochemical selectivity of compound <b>83</b> translated to cell-based activity, and the in vitro SYK activity has manifested itself in in vivo animal model studies.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> More detailed cell-based profiling, efficacy, and toxicity evaluation is continuing with this class of compound, along with efficacy studies in man.</div><div class="NLM_p">Rigel SYK inhibitors (compounds <b>84</b> [R112], <b>85</b> [R343], and <b>3</b> and its prodrug compound <b>11</b>) have been the most thoroughly investigated SYK inhibitors to date (Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, and <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref12 ref13 ref14 ref16 ref78 ref137 ref138 ref150 ref151 ref152 ref153 ref154 ref155 ref157 ref158 ref159 ref160 ref161 ref162 ref163 ref188 ref189 ref190 ref191 ref192 ref193 ref194 ref195 ref196 ref197 ref198 ref199 ref200 ref201'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref16 ref78 ref137 ref138 ref150 ref151 ref152 ref153 ref154 ref155 ref157 ref158 ref159 ref160 ref161 ref162 ref163 ref188 ref189 ref190 ref191 ref192 ref193 ref194 ref195 ref196 ref197 ref198 ref199 ref200 ref201">(12-14, 16, 78, 137, 138, 150-155, 157-163, 188-201)</a> Extensive evaluation of the effects of these compounds on the abrogation of FcR and BCR signaling has been undertaken. Also, preliminary signs of efficacy in the treatment of allergic rhinitis, asthma, RA, ITP, lupus, T1D, and B-cell lymphoma have been reported.<a onclick="showRef(event, 'ref78 ref137 ref138 ref150 ref151 ref152 ref153 ref154 ref155 ref157 ref158 ref159 ref160 ref161 ref162 ref163 ref188 ref189 ref190 ref191 ref192 ref193 ref194 ref195 ref196 ref197 ref198 ref199 ref200 ref201'); return false;" href="javascript:void(0);" class="ref ref78 ref137 ref138 ref150 ref151 ref152 ref153 ref154 ref155 ref157 ref158 ref159 ref160 ref161 ref162 ref163 ref188 ref189 ref190 ref191 ref192 ref193 ref194 ref195 ref196 ref197 ref198 ref199 ref200 ref201">(78, 137, 138, 150-155, 157-163, 188-201)</a> Compound <b>3</b> has been investigated as a prodrug <b>11</b> to improve its solubility. Prodrug derivative <b>11</b> rapidly converts to parent drug <b>3</b> through the action of alkaline phosphatase on the apical brush-border of the membranes of intestinal enterocytes when dosed orally (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref194 ref195'); return false;" href="javascript:void(0);" class="ref ref194 ref195">(194, 195)</a></div><figure id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of SYK inhibitors <b>84</b> and <b>85</b> and HTS hit <b>86</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Previously, the use of cell-based assays such as RBL-2H3 and human mast cells has been reported for the investigation of SYK function.<a onclick="showRef(event, 'ref164 ref202'); return false;" href="javascript:void(0);" class="ref ref164 ref202">(164, 202)</a> HTS screening campaigns with CHMCs led to the identification of hit structure <b>86</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), which inhibited anti-IgE-mediated tryptase release with EC<sub>50</sub> = 1.67 μM, and this compound was optimized using CHMC assays.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> The CHMC screens, combined with biochemical and Western blot assays, proved to be extremely useful in mechanism of action studies.<a onclick="showRef(event, 'ref78 ref188 ref189'); return false;" href="javascript:void(0);" class="ref ref78 ref188 ref189">(78, 188, 189)</a> The generation of large numbers of primary human mast cells has been challenging,<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> but the Saito group has reported methodology that was further optimized.<a onclick="showRef(event, 'ref168 ref188'); return false;" href="javascript:void(0);" class="ref ref168 ref188">(168, 188)</a> Improvement relied on expanding cord blood CD34<sup>+</sup> progenitor cells with recombinant human FMS-like tyrosine kinase 3 (Flt3), recombinant human stem-cell factor, and human IL-6.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Primary human mast cells could be differentiated, resulting in the production of 1 × 10<sup>9</sup> cells through this methodology.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Discovery of compound <b>84</b> relied on the optimization of HTS hit <b>86</b>, identified from CHMC functional screens. In CHMCs, compound <b>84</b> inhibited anti-IgE-mediated tryptase release, which is a reliable measure of upstream activation of degranulation, with EC<sub>50</sub> = 0.353 ± 0.117 μmol/L.<a onclick="showRef(event, 'ref188 ref189'); return false;" href="javascript:void(0);" class="ref ref188 ref189">(188, 189)</a> In contrast, compound <b>84</b> showed no inhibition of downstream degranulation mediated through ionomycin-induced mobilization of calcium. Inhibition of anti-IgE-mediated histamine release from human basophils by treatment with compound <b>84</b> occurs with EC<sub>50</sub> = 0.28 μmol/L. Also, compound <b>84</b> inhibits dust-mite stimulation of histamine release with EC<sub>50</sub> = 0.49 μmol/L, which more realistically reflects disease in humans.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Additionally, compound <b>84</b> inhibited multiple downstream biomarkers of SYK activities, such as LTC<sub>4</sub> (EC<sub>50</sub> = 0.115 ± 0.021 μmol/L) secretion and TNFα (EC<sub>50</sub> = 2.01 ± 0.97 μmol/L), GM-CSF (EC<sub>50</sub> = 1.58 ± 0.87 μmol/L), and IL-8 (EC<sub>50</sub> = 1.75 ± 0.88 μmol/L) production.<a onclick="showRef(event, 'ref188 ref189'); return false;" href="javascript:void(0);" class="ref ref188 ref189">(188, 189)</a> Notably, compound <b>84</b> inhibits SYK with <i>K</i><sub>i</sub> = 0.096 μM. The variation in concentration required for the inhibition of downstream markers in cell-based assays may be attributable to augmentation of different signals, variability in expression level of molecules, time required during incubation for inhibitor effect, positive feedback loops, and autoinhibitory effects on SYK. These factors also apply to the biologic effects of other compounds inhibiting SYK such as <b>2</b>, <b>3</b>, and <b>83</b>.<a onclick="showRef(event, 'ref78 ref173 ref187'); return false;" href="javascript:void(0);" class="ref ref78 ref173 ref187">(78, 173, 187)</a> Biochemical screening of <b>84</b> in a panel of 25 kinases showed that SYK and Src kinases were most potently inhibited.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> The mechanism of action of compound <b>84</b> was narrowed down by in vitro analysis of the events upon Lyn phosphorylation at Y352 on interdomain-B of SYK and subsequent SYK phosphorylation of Y191 on LAT and Y783 on PLCγ. Phosphorylation of LAT and PLCγ, both mediated by SYK, is inhibited with EC<sub>50</sub> = 0.4 μmol/L. Compound <b>84</b> did not inhibit the phosphorylation of Y352 on SYK by Lyn in phosphoblot assays, thus showing selective inhibition of SYK over Lyn.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a></div><div class="NLM_p">Onset of action for compound <b>84</b> is rapid, as shown by in vitro inhibition of tryptase release from mast cells stimulated with anti-IgE antibody, following introduction of compound <b>84</b> in parallel or in 30 and 60 min increments.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Given the aim of treating allergic rhinitis and prophylactic application, rapid onset of action represents an improvement from existing therapies.<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117, 118)</a></div><div class="NLM_p">Extensive optimization of compound <b>84</b> led to more potent analogues suitable for inhaled and oral administration.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16 ref78 ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16 ref78 ref190 ref191">(12-16, 78, 190, 191)</a> Thus, compound <b>85</b> has been developed for inhaled treatment of asthma, and compounds <b>3</b> and <b>11</b> have been developed for oral treatment of autoimmune and inflammatory diseases.<a onclick="showRef(event, 'ref13 ref78 ref137 ref197 ref198 ref199 ref200 ref201'); return false;" href="javascript:void(0);" class="ref ref13 ref78 ref137 ref197 ref198 ref199 ref200 ref201">(13, 78, 137, 197-201)</a> Compound <b>85</b><a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> inhibits SYK with <i>K</i><sub>i</sub> = 1.8 nM in the biochemical assay and SYK-dependent tryptase release in CHMC (EC<sub>50</sub> = 27 nM). Other kinases most potently inhibited by compound <b>85</b> include Lyn, EGFR, Lck, Jak2, and FGFR4 with <i>K</i><sub>i</sub> of 30, 35, 116, 130, and 217 nM, respectively. In functional assays compound <b>85</b> is 100-fold more selective for SYK over Lyn kinase. This is demonstrated by <b>85</b><a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> not inhibiting phosphorylation of SYK Y352 mediated by Lyn but inhibiting the phosphorylation on Y191 of LAT in CHMC,<a onclick="showRef(event, 'ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref77 ref78">(77, 78)</a> a substrate for SYK, confirming that compound <b>85</b> works directly through SYK.</div><div class="NLM_p">Autoimmune diseases, such as RA, are inherently heterogeneous in character, involving numerous cell types such as macrophages, mast cells, DCs, B-cells, neutrophils, fibroblasts, and osteoclasts.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> The association of SYK as an upstream regulator of signal transduction in these diverse cell types has been substantiated, and its role in autoimmune diseases has gained considerable attention.<a onclick="showRef(event, 'ref10 ref11 ref78 ref138 ref150 ref151 ref152 ref153 ref154 ref155 ref156 ref187 ref193 ref197 ref198 ref199 ref200'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref78 ref138 ref150 ref151 ref152 ref153 ref154 ref155 ref156 ref187 ref193 ref197 ref198 ref199 ref200">(10, 11, 78, 138, 150-156, 187, 193, 197-200)</a></div><div class="NLM_p">Compound <b>3</b> inhibits SYK, with <i>K</i><sub>i</sub> = 30 nM, and SYK-dependent FcεR1 and FcγR signaling in various cell types: CHMC (EC<sub>50</sub> = 56 nM), macrophages derived from human monocytes (EC<sub>50</sub> = 111 nM), monocytic THP-1 (EC<sub>50</sub> = 171 nM), neutrophils (EC<sub>50</sub> = 33 nM), and B-cells (EC<sub>50</sub> = 48 nM).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Thus, cross-linking induced through anti-IgE, anti-IgG, and anti-IgM stimulation of FcεR1, FcγR, and BCR, respectively, is potently abolished following treatment with compound <b>3</b>.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Selectivity data for compound <b>3</b> were generated through screening in a panel of over 90 biochemical kinase assays employing a fixed ATP concentration (10 μM) and in over 15 on-target and 20 off-target cell-based assays.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Other kinases inhibited potently in biochemical assays include Ret, Flt 3, Jak, and Lck.<a onclick="showRef(event, 'ref38 ref78 ref203'); return false;" href="javascript:void(0);" class="ref ref38 ref78 ref203">(38, 78, 203)</a> The resulting profile indicated that in cells, compound <b>3</b> generally inhibited other kinases at 5- to 100-fold less potency than SYK as judged by phosphorylation of target proteins and functional readouts.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> After SYK, compound <b>3</b> inhibited Flt3, Jak, and c-kit most potently at about 4- to 5-fold less potency in cell-based functional assays.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> In a separate study, compound <b>3</b> was also shown to potently inhibit Ret in biochemical (IC<sub>50</sub> = 5 nM) and in SK-N-SH cells with EC<sub>50</sub> = 80 nM) and in in vivo animal toxicity studies.<a onclick="showRef(event, 'ref38 ref163 ref203'); return false;" href="javascript:void(0);" class="ref ref38 ref163 ref203">(38, 163, 203)</a> At the clinical doses of 100 mg in RA trials (vide infra), where the SYK activity in blood biomarker assays is inhibited by 50%, it is possible that inhibition to these other minor targets contributes to the overall pharmacological effect of compound <b>3</b>.<a onclick="showRef(event, 'ref38 ref78 ref138 ref197 ref198 ref199'); return false;" href="javascript:void(0);" class="ref ref38 ref78 ref138 ref197 ref198 ref199">(38, 78, 138, 197-199)</a></div><div class="NLM_p">Assessment of SYK-independent signaling through a variety of off-target cell-based assays relying on stimulation that are not dependent on SYK has been carried out. Compound <b>3</b> is at least 10-fold less potent in inhibiting LPS-mediated release of TNFα production through the toll-like receptor 4 (TLR-4).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Because of the involvement of macrophages and neutrophils in innate immune reaction, it is a prerequisite that an inhibitor of SYK does not affect phagocytosis, oxidative burst, chemotaxis, or microbicidal activity.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> These defensive mechanisms not only are reliant on FcR signaling through SYK but also are activated through TLRs and complement those that are not regulated by SYK.<a onclick="showRef(event, 'ref78 ref204 ref205'); return false;" href="javascript:void(0);" class="ref ref78 ref204 ref205">(78, 204, 205)</a> Preferably, inhibition of SYK should provide a sufficient window over these necessary immune responses. Indeed, compound <b>3</b> up to 50 μM had no significant activity on monocyte and granulocyte induced phagocytosis of fluorescein-labeled opsonized <i>Escherichia coli</i> bacteria or the oxidative burst of human leukocytes.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Compound <b>3</b> at 10 μM shows no effect on granulocyte migration toward the chemotactic peptide <i>N</i>-formyl-Met-Leu-Phe or the microbicidal clearance of <i>Staphylococcus aureus</i> by purified primary neutrophils up to 20 μM.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Overall, treatment with compound <b>3</b> shows no interference with the important innate function of pathogen clearance or with the ability to mount a response to infection.<a onclick="showRef(event, 'ref78 ref192'); return false;" href="javascript:void(0);" class="ref ref78 ref192">(78, 192)</a></div><div class="NLM_p">Compound <b>3</b>, a potent SYK inhibitor, has been evaluated in animal models reflecting human disease. Compound <b>3</b> in IC-mediated disease models such as the Arthus reaction, CAIA, and K/xBN models has shown significant efficacy.<a onclick="showRef(event, 'ref78 ref138'); return false;" href="javascript:void(0);" class="ref ref78 ref138">(78, 138)</a> The presence of phosphorylated SYK has been identified in the synovial intimal lining of RA synovial tissue.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> Activation of SYK in fibroblast-like synoviocytes is initiated by proinflammatory cytokines, such as TNFα, and leads to downstream activation of MAPK member c-Jun N-terminal kinase (JNK).<a onclick="showRef(event, 'ref78 ref138 ref193'); return false;" href="javascript:void(0);" class="ref ref78 ref138 ref193">(78, 138, 193)</a> Compound <b>3</b> reduced the cutaneous reverse passive Arthus reaction by 72% and 86% at doses of 1 and 5 mg/kg, respectively.<a onclick="showRef(event, 'ref78 ref138'); return false;" href="javascript:void(0);" class="ref ref78 ref138">(78, 138)</a> In the IC-mediated clinical arthritis CAIA mouse model (induced with passive immunization with arthrogenic anticollagen antibodies), administration of compound <b>3</b> at 5 and 10 mg/kg b.i.d. led to a significant reduction in hind paw clinical scores in comparison to vehicle, naive, and IgG-treated animals.<a onclick="showRef(event, 'ref78 ref138'); return false;" href="javascript:void(0);" class="ref ref78 ref138">(78, 138)</a> Histologic appraisal of the ankle joints of drug treated mice at the end of the study (day 14) confirmed complete absence of chronic synovitis, joint thickening, synovial hyperplasia, pannus formation, and infiltration of neutrophils, lymphocytes, and macrophages.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> No improvement in vehicle-treated control animals was observed. These results were the first validation of SYK inhibition in ablating IC-mediated arthritis. The application of arthritogenic (K/BxN) serum has been reported in SYK<sup>–/–</sup> mouse chimeras to validate the critical importance of this kinase in the development of clinically relevant autoimmune arthritis.<a onclick="showRef(event, 'ref38 ref138'); return false;" href="javascript:void(0);" class="ref ref38 ref138">(38, 138)</a> Induction of arthritis in C57BL/6 mice through use of K/BxN serum followed by treatment with 10 mg/kg compound <b>3</b> b.i.d. delayed arthritis onset and reduced hind limb clinical scores by 50%.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><div class="NLM_p">RA transitions from disease initiation (afferent phase) to propagation (effector phase) and culminates in bone and cartilage tissue damage.<a onclick="showRef(event, 'ref10 ref62'); return false;" href="javascript:void(0);" class="ref ref10 ref62">(10, 62)</a> In RA patients, the presence of cartilage oligomeric matrix protein (COMP) in serum correlates with the degradation of bone. In the collagen-induced arthritis (CIA) rat arthritic model both parent drug <b>3</b> and prodrug <b>11</b> reduced COMP levels following b.i.d. treatment and this level of reduction was consistent with complete reduction in bone degradation, as confirmed by radiography and micro-CT imaging of hind joints in rats.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><div class="NLM_p">In animal studies, compounds <b>3</b> and <b>11</b> blocked the physical signs of arthritis: tissue swelling, joint space narrowing, inflammatory cell infiltration into the synovial fluid and tissue, and bone destruction.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Importantly, these improvements in clinical arthritis also correlated with a decrease in serum biomarkers such as IL-6, matrix metalloproteinase 3 (MMP3), and TNFα, relevant to human clinical studies.<a onclick="showRef(event, 'ref138 ref193 ref197'); return false;" href="javascript:void(0);" class="ref ref138 ref193 ref197">(138, 193, 197)</a></div><div class="NLM_p">As discussed earlier, SLE occurs as result of overactivation of inflammatory conduits through IC presentation and complement. Clinical indicators in human disease include glomerulonephritis, ITP, hemolytic anemia, polyserositis, and vasculitis.<a onclick="showRef(event, 'ref137 ref150'); return false;" href="javascript:void(0);" class="ref ref137 ref150">(137, 150)</a> Compound <b>11</b> was evaluated, at doses of 10, 20, and 40 mg/kg b.i.d., in a lupus NZB/NZW murine model for assessment of efficacy in a model reflective of human SLE.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> This model is characterized by glomerular sclerosis and tubular damage, proteinuria, and elevated blood urea nitrogen levels (BUN).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Treatment of lupus-prone NZB/NZW mice with compound <b>11</b> prevents the development of renal disease and also treats established murine lupus. Overall, compound <b>11</b> shows diminution of renal disease as shown by reduction in glomerular sclerosis and tubular damage and proteinuria and BUN levels.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div><div class="NLM_p">Current therapy for glomerulonephritis is inadequate and relies on the use of broadly active immunosuppressive drugs; however, such treatment regimens result in serious side effects.<a onclick="showRef(event, 'ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref150 ref151">(150, 151)</a> The pathogenesis of glomerulonephritis is an example of a disease mediated through the interaction of antibody or ICs with Fc receptors and represents a potential application of SYK inhibitors for disease amelioration. In the NTN model of antibody mediated glomerulonephritis in Wistar–Kyoto rats, compound <b>11</b> reduces proteinuria and tissue damage as measured by reductions in glomerular macrophage and CD8+ cell numbers and renal monocyte chemoattractant protein-1 (MCP-1) and IL-1β.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Interestingly, compound <b>11</b> demonstrates efficacy when used both prophylactically and during active glomerulonephritis, resulting in histological reversal of disease.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Doses of compound <b>11</b> required for efficacy in glomerulonephritis are in the range of 15–40 mg/kg b.i.d. and overlap with those applicable to RA and SLE animal studies.<a onclick="showRef(event, 'ref78 ref137 ref138 ref150 ref151'); return false;" href="javascript:void(0);" class="ref ref78 ref137 ref138 ref150 ref151">(78, 137, 138, 150, 151)</a></div><div class="NLM_p">T1D is an autoimmune disease characterized by the presence of anti-islet antibodies before pathologic signs of disease activity.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Initial stages of T1D are referred to as the effector phase, primarily mediated by T-cells through ZAP-70, and are not reliant on SYK. Experimentally, this has been deciphered through the failure of prodrug <b>11</b> of SYK inhibitor <b>3</b> to protect NOD/SCID mice that had received diabetogenic splenocytes.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> However, mice that received <b>11</b>-treated splenocytes were protected from diabetes.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Compound <b>11</b> has been tested in T1D RIP-mOVA and NOD spontaneous T1D animal models.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Treatment of NOD mice with compound <b>11</b> delayed the development of diabetes as confirmed by diminished appearance of invasive insulitis through histopathology analysis and by extended survival.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Indeed, compound <b>11</b> does not obstruct the diabetogenic effector phase but rather exerts efficacy through inhibition of islet-reactive T cell priming.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><div class="NLM_p">Compound <b>11</b> was tested in a murine ITP model that can be used to assess effects on cytopenia.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Upon treatment of mice with an antibody targeting integrin αIIb, thrombocytopenia development was confirmed by the changes in platelet count after 24 h. Efficacy was examined by pretreatment of mice with 25 or 40 mg/kg compound <b>11</b>.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Animals showed significant improvement in thrombocytopenia development following treatment with compound <b>11</b>. In contrast, the vehicle treated group showed intense thrombocytopenia. The parent compound of <b>11</b> prevents engulfment of platelets and, hence, their destruction.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div><div class="NLM_p">SYK is the upstream regulator of mast cell and IgE-mediated airway hyperresponsiveness (AHR) in asthma and additionally regulates T<sub>H</sub>2 cells and eosinophil response.<a onclick="showRef(event, 'ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref190 ref191">(190, 191)</a> These cells are responsible for the release of cytokines and chemokines, resulting in airway inflammation with changes in airway function. Thus, SYK inhibitors could be effective agents in treating bronchial asthma.<a onclick="showRef(event, 'ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref190 ref191">(190, 191)</a> This has been evaluated in animal models, such as allergen-induced airway inflammation, leading to AHR in BALB/cmice. As in in vitro screens, compound <b>3</b> inhibited downstream events transpiring as a result of mast cell activation. Thus, in OVA-challenged IgE-sensitized cells, compound <b>3</b> inhibited the release of IL-2, IL-6, IL-13, and TNFα in addition to MAPK-ERK1/2, JNK1/2, and p38 with EC<sub>50</sub> = 0.01–0.1 μM.<a onclick="showRef(event, 'ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref190 ref191">(190, 191)</a> Importantly, compound <b>3</b> inhibited AHR induced by OVA exposure in doses between 3 and 30 mg/kg.<a onclick="showRef(event, 'ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref190 ref191">(190, 191)</a> The importance of SYK in other cell lineages relevant to AHR cannot be overlooked, and the potent inhibition in vivo could be attributable to B-cells, DCs, and eosinophils, which rely on SYK for key signal transduction leading to proinflammatory factor production and release.<a onclick="showRef(event, 'ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref190 ref191">(190, 191)</a></div><div class="NLM_p">The relative SYK activities of compounds <b>3</b>, <b>84</b>, and <b>85</b> for SYK can be rationalized through cocrystal structural data (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) obtained with SYK kinase catalytic domain.<a onclick="showRef(event, 'ref78 ref206'); return false;" href="javascript:void(0);" class="ref ref78 ref206">(78, 206)</a> Compound <b>84</b> shows hydrogen bond interactions with hinge residue ALA451 and GLU452 but no hydrogen bonds with ASP512 and LYS458. In contrast, compound <b>3</b> has hydrogen bonds with hinge ALA451, GLU452 and ASP512, LYS458 residues with the hydrophobic dimethylpyridoxazinone and trimethoxyphenyl rings, respectively.<a onclick="showRef(event, 'ref78 ref101'); return false;" href="javascript:void(0);" class="ref ref78 ref101">(78, 101)</a> The pyrimidine nitrogen at the 1-position and the N–H linker from the phenoxyacetamide at the 2-position of <b>85</b> form hydrogen bonds with hinge ALA451 and adjacent residue GLU452. The 4-position pyrimidine substituent, the difluorobenzoxazinone ring, forms hydrogen bonds with ASP512, and the carbonyl groupfrom the phenoxyacetamide moiety interacts with LYS458. The 5-fluoropyrimidine substituent is generally required to maintain selectivity over other kinases and also translation to cell-based functional assays.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> The tighter binding manifested by numerous interactions with residues in SYK with inhibitors <b>3</b>and <b>85</b> accounts for the potency difference versus compound <b>84</b>.<a onclick="showRef(event, 'ref78 ref188 ref206'); return false;" href="javascript:void(0);" class="ref ref78 ref188 ref206">(78, 188, 206)</a></div><figure id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cocrystal image of compounds <b>3</b> (green), <b>84</b> (purple), and <b>85</b> (yellow). Compound <b>84</b> shows hydrogen bonds with hinge residues ALA451 and GLU452 but no hydrogen bonds with ASP512 and LYS458. In contrast to compound <b>84</b>, compound <b>3</b> has hydrogen bonds with hinge ALA451, GLU452 and ASP512, LYS458 residues. Compound <b>85</b> forms hydrogen bonds with hinge ALA451, GLU452. Difluorobenzoxazinone ring also forms a hydrogen bond with ASP512, and the carbonyl moiety from the phenoxyacetamide side chain interacts with LYS458.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The discovery of compounds <b>3</b>, <b>84</b>, <b>85</b> and other reported inhibitors has been achieved through reliance on primary functional cell-based assays. In addition, data obtained from biochemical assays need to be confirmed with functional cell-based assays, as the former can produce misleading results when relying on screening paradigms using just the kinase catalytic domain. In addition, treatment of complex diseases may need obligatory inhibition of several targets best examined in parallel through functional assays and animal models with appropriate biomarker benchmarks.</div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Clinical Development of SYK Kinase Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02851" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02851" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>3</b>, <b>11</b>, and <b>84</b> are the first SYK inhibitors to transition from research to clinical development. Compound <b>85</b> has been evaluated in asthma patients through the inhalation route in phase 1 studies; however, clinical efficacy has not yet been published for this compound.</div><div class="NLM_p">Compound <b>84</b> has shown preliminary signs of efficacy in a study involving the treatment of symptoms of seasonal allergic rhinitis in a park environment.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> A double-blind, placebo-controlled study was conducted with patients randomized to receive intranasal 3 mg/nostril b.i.d. of compound <b>84</b> or vehicle control.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> The patients were assessed for symptoms of allergic rhinitis (sneezes, runny nose/sniffles, and itchy/stuffy nose), with a global symptom complex (GSC) of 32 as the highest possible score.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> Assessments were made by comparison of GSC over a period of 8 h from baseline of <b>84</b> treatment and placebo groups. Following treatment with compound <b>84</b>, there was a statistically significant (<i>p</i> = 0.005) reduction in GSC compared with placebo (7 units versus 5.4 units, respectively).<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> The GSC prior to start of treatment was ∼18/32 in both groups. This was the first study conducted providing clinical proof that inhibition of SYK could lead to amelioration of a disease functionally related to SYK. Furthermore, the onset of action of compound <b>84</b> was rapid, with considerable improvements in symptoms occurring within 45 min subsequent to dosing, and lasting over a period of 4 h.<a onclick="showRef(event, 'ref188 ref196'); return false;" href="javascript:void(0);" class="ref ref188 ref196">(188, 196)</a> In clinical trials, compound <b>84</b> showed good tolerability, with adverse events similar between treatment and placebo groups.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a> As suggested, this study formed a proof of concept for the clinical use of SYK kinase inhibitors; however, given the potency of compound <b>84</b>, optimization was continued to acquire more potent compounds to advance to clinic and to recognize the full utility of SYK as a target.<a onclick="showRef(event, 'ref188 ref196'); return false;" href="javascript:void(0);" class="ref ref188 ref196">(188, 196)</a></div><div class="NLM_p">The second generation of analogues, related to compound <b>84</b>, is more potent and orally bioavailable. In the first human study with compound <b>3</b> designed to assess biomarker and pharmacodynamic (PD) effects linked to basophil degranulation induced upon ex vivo stimulation with IgE, CD63 cell-surface up-regulation was inhibited with EC<sub>50</sub> = 500 ng/mL.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Phase 1 studies with compound <b>3</b> employed a suspension formulation, but a solid dosage form was more desirable for longer-term studies. Thus, compound <b>3</b> was converted to methylene phosphate prodrug <b>11</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) to allow the delivery of the material in solid dosage form.<a onclick="showRef(event, 'ref12 ref13 ref14 ref16 ref194 ref195'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref16 ref194 ref195">(12-14, 16, 194, 195)</a></div><div class="NLM_p">Inhibition of SYK has gained greatest clinical prominence for the treatment of active RA, with the completion of three phase 2 trials with compound <b>11</b>.<a onclick="showRef(event, 'ref197 ref198 ref199'); return false;" href="javascript:void(0);" class="ref ref197 ref198 ref199">(197-199)</a> Compound <b>11</b> has been examined in patients with active RA who have had incomplete clinical response to methotrexate (MTX) or disease modifiers. The primary efficacy end point in all three studies was American College of Rheumatology 20% improvement criteria (ACR20) response rates after 3 and 6 months of treatment.<a onclick="showRef(event, 'ref197 ref198 ref199'); return false;" href="javascript:void(0);" class="ref ref197 ref198 ref199">(197-199)</a> ACR20 represents ≥20% improvement in swollen and tender joint counts and ≥20% improvements in three of the remaining five core measures (pain, C-reactive protein [CRP] level, modified health assessment questionnaire score, and patient and physician global assessment at week 12).<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> In addition, secondary end points are improvements in ACR50, ACR70, and disease activity score in 28 joints (DAS28). In the initial double-blinded randomized phase 2 dose-ranging study (TASKi1), patients with active RA who were unresponsive to MTX were randomized to receive 50, 100, or 150 mg b.i.d. of compound <b>11</b> or placebo for 3 months. Significant efficacy was observed in both 100 and 150 mg patient groups as determined by ACR20, ACR50, and ACR70 response rates (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>).<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> The 50 mg treatment group showed a response similar to that of the placebo arm. Thus, the preferred dose for future studies was determined to be between 100 and 150 mg. Statistically significant improvements in clinical signs were also noticeable after just 1 week of treatment. This was verified with biomarker measurements, with reduction in serum IL-6 and MMP3 at doses of 100 and 150 mg in 1 week, and these were sustained through the duration of the study.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> Adverse events from this study were manageable, with gastrointestinal effects and transient neutropenia (<1500/mm<sup>3</sup>) occurring in a dose-dependent manner.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> Hypertension was also observed in some patients.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a></div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Phase 2 Data for Compound <b>11</b> in Three RA Clinical Trials</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="5" align="center">TASKi1, Response Rate at Week 12<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">ACR20</th><th class="colsep0 rowsep0" align="center">ACR50</th><th class="colsep0 rowsep0" align="center">ACR70</th><th class="colsep0 rowsep0" align="center">DAS28 < 2.6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">placebo</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>, 50 mg, b.i.d.</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>, 100 mg, b.i.d.</td><td class="colsep0 rowsep0" align="left">65<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">49<a class="ref internalNav" href="#t9fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">33<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">26<a class="ref internalNav" href="#t9fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>, 150 mg, b.i.d.</td><td class="colsep0 rowsep0" align="left">72<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">57<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">40<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">49<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="5" align="center">TASKi2, Response Rate at Month 6<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">ACR20</th><th class="colsep0 rowsep0" align="center">ACR50</th><th class="colsep0 rowsep0" align="center">ACR70</th><th class="colsep0 rowsep0" align="center">DAS28 < 2.6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">placebo</td><td class="colsep0 rowsep0" align="left">35</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>, 100 mg, b.i.d.</td><td class="colsep0 rowsep0" align="left">67<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">43<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">28<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">31<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>, 150 mg, q.d.</td><td class="colsep0 rowsep0" align="left">57<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">32<a class="ref internalNav" href="#t9fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">14<a class="ref internalNav" href="#t9fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">21<a class="ref internalNav" href="#t9fn8" aria-label="h">h</a></td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="5" align="center">TASKi3, Response Rate at Month 3<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">treatment</th><th class="colsep0 rowsep0" align="center">ACR20</th><th class="colsep0 rowsep0" align="center">ACR50</th><th class="colsep0 rowsep0" align="center">ACR70</th><th class="colsep0 rowsep0" align="center">DAS28 < 2.6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">placebo</td><td class="colsep0 rowsep0" align="left">37</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b>, 100 mg, b.i.d.</td><td class="colsep0 rowsep0" align="left">38<a class="ref internalNav" href="#t9fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">22<a class="ref internalNav" href="#t9fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left">9<a class="ref internalNav" href="#t9fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="left">12</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Values are the number percent of patients who met the criteria. ACR20 = American College of Rheumatology 20% improvement criteria. DAS28 = disease activity score in 28 joints. b.i.d. = twice-daily dosing. q.d. = once-daily dosing.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last"><i>p</i> = 0.008.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last"><i>p</i> < 0.001.</p></div><div class="footnote" id="t9fn4"><sup>d</sup><p class="last"><i>p</i> = 0.002.</p></div><div class="footnote" id="t9fn5"><sup>e</sup><p class="last"><i>p</i> = 0.036.</p></div><div class="footnote" id="t9fn6"><sup>f</sup><p class="last"><i>p</i> = 0.007.</p></div><div class="footnote" id="t9fn7"><sup>g</sup><p class="last"><i>p</i> = 0.34.</p></div><div class="footnote" id="t9fn8"><sup>h</sup><p class="last"><i>p</i> = 0.003.</p></div><div class="footnote" id="t9fn9"><sup>i</sup><p class="last"><i>p</i> = 0.84.</p></div><div class="footnote" id="t9fn10"><sup>j</sup><p class="last"><i>p</i> = 0.09.</p></div><div class="footnote" id="t9fn11"><sup>k</sup><p class="last"><i>p</i> = 0.37.</p></div></div></div><div class="NLM_p">In a second double-blinded randomized phase 2 study (TASKi2), patients with active RA, despite treatment with MTX, were randomized to receive 150 mg q.d. or 100 mg b.i.d. of compound <b>11</b> or placebo for 6 months (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>).<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a>A clinical response, as measured by ACR20, was observed in both active groups within 1 week following commencement of treatment. In this study, clinically significant efficacy compared to placebo was seen at 6 months in primary end point of ACR20 response rates, along with secondary assessments of ACR50, ACR70, and remission, as evaluated by DAS28. A greater response rate was seen in patients dosed with compound <b>11</b> at 100 mg b.i.d. in comparison to 150 mg q.d. The adverse events registered during this study were similar to what had been observed during the first phase 2 study.<a onclick="showRef(event, 'ref197 ref198'); return false;" href="javascript:void(0);" class="ref ref197 ref198">(197, 198)</a> In the second phase 2 study, of the 15% of patients recruited who had previously not responded to treatment with biologics, 43% of this group showed significant response in the 100 mg of compound <b>11</b> b.i.d., in contrast to 14% in the placebo arm.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a></div><div class="NLM_p">A parallel, a double-blinded randomized phase 2 (TASKi3) study in patients with active RA who had failed treatment with a biologic agent (including anakinra, abatacept, and/or rituximab) was conducted.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> Patients were randomized to receive 100 mg b.i.d. of compound <b>11</b> or placebo for 3 months.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> The primary end point (ACR20 response rate at month 3) was not met (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>), and this may in part be explained by baseline differences in the compound <b>11</b> and placebo treatment groups in terms of steroid use, prior biologic use, and synovitis score on magnetic resonance imagery (MRI).<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> A high ACR20 response rate was also observed in the placebo group (37%), which may have affected the ability to achieve the study’s primary end point (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>).<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> However, secondary end point improvements in CRP and ESR were observed, along with a reduction in inflammation of the synovium membrane (synovitis) and bone (osteitis) as determined by RA MRI.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> Improvements in these end points are of potential benefit, given that these measurements suggest remission within a very short treatment period.</div><div class="NLM_p">The B-cell receptor has been an important drug target for autoimmune and inflammatory diseases.<a onclick="showRef(event, 'ref6 ref10 ref11 ref57 ref70'); return false;" href="javascript:void(0);" class="ref ref6 ref10 ref11 ref57 ref70">(6, 10, 11, 57, 70)</a> Overactivation of BCR-mediated survival signals can lead to the development of B-cell lymphoma, and SYK is an upstream protein tyrosine kinase involved in this pathway.<a onclick="showRef(event, 'ref161 ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref161 ref162 ref163">(161-163)</a> The SYK inhibitor compound <b>3</b> has been evaluated in in vitro diffuse large B-cell lymphoma (DLBCL) cell lines, which demonstrate both tonic- and ligand-induced BCR signaling, as shown by basal phosphorylation of SYK348/352 and the SYK-dependent linker protein (BLNK).<a onclick="showRef(event, 'ref41 ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref41 ref162 ref163">(41, 162, 163)</a> Compound <b>3</b> causes apoptosis in DLBCL cell lines in concentrations between 1 and 4 μM.<a onclick="showRef(event, 'ref162 ref163'); return false;" href="javascript:void(0);" class="ref ref162 ref163">(162, 163)</a> Thus, SYK inhibitor <b>3</b>, as its prodrug <b>11</b>, was evaluated in patients with B-cell NHL and chronic lymphocytic leukemia (CLL).<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> The phase 1/2 clinical study included patient cohorts afflicted with B-NHL, DLBCL, follicular lymphoma (FL), and other NHL, including mantle cell lymphoma (MCL), marginal zone lymphoma, mucosa-associated lymphoid tissue lymphoma, lymphoplasmacytic lymphoma, and small lymphocytic leukemia/chronic lymphocyte leukemia (SLL/CLL).<a onclick="showRef(event, 'ref41 ref163'); return false;" href="javascript:void(0);" class="ref ref41 ref163">(41, 163)</a> In phase I of the clinical study, 13 patients with refractory DLBCL, FL, MCL, CLL/SLL were treated at doses of 200 mg or 250 mg b.i.d.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Objective response rates were 22% (5 of 23) for DLBCL, 10% (2 of 21) for FL, 55% (6 of 11) for SLL/CLL, and 11% (1 of 9) for MCL.<a onclick="showRef(event, 'ref41 ref163'); return false;" href="javascript:void(0);" class="ref ref41 ref163">(41, 163)</a> The 200 mg b.i.d. dosage was deemed the optimal dose and employed in the phase 2 portion of the study.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Adverse events from this phase 1/2 study were in line with observations from several RA trials and were consistent with the patient population of highly refractory/relapsed patients with cancer.<a onclick="showRef(event, 'ref163 ref197 ref198 ref199'); return false;" href="javascript:void(0);" class="ref ref163 ref197 ref198 ref199">(163, 197-199)</a></div><div class="NLM_p">Compound <b>11</b> has also been evaluated in an open-label dose-escalation phase 2 study in patients with chronic ITP who were refractory to conventional therapy, including corticosteroids, intravenous γ-globulin, monoclonal anti-CD20 antibodies, and thrombopoeitin agonists.<a onclick="showRef(event, 'ref121 ref122 ref137 ref200'); return false;" href="javascript:void(0);" class="ref ref121 ref122 ref137 ref200">(121, 122, 137, 200)</a> In summary, 8 of 16 patients attained continued responses with platelet counts exceeding 50 000 mm<sup>3</sup> on more than 67% of follow-up visits.<a onclick="showRef(event, 'ref137 ref200'); return false;" href="javascript:void(0);" class="ref ref137 ref200">(137, 200)</a> A total of three patients who showed a sustained increase in platelet counts had been refractory to thrombopoietic agonists. Adverse events were similar to what has been observed in other clinical trials with compound <b>11</b>.<a onclick="showRef(event, 'ref137 ref163 ref197 ref198 ref199'); return false;" href="javascript:void(0);" class="ref ref137 ref163 ref197 ref198 ref199">(137, 163, 197-199)</a></div><div class="NLM_p last">On the basis of the results of the RA early phase clinical studies, compound <b>3</b> and its prodrug <b>11</b> have demonstrated preliminary signs of improved outcomes in a dose-dependent manner, with manageable side effects. Compound <b>11</b> is currently in phase 3 RA studies to validate further the premise that autoimmune and inflammatory diseases are amenable to treatment through SYK inhibition.</div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Conclusions and Future Directions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The validation of SYK as an effective target for therapeutic intervention in autoimmune and inflammatory disorders has picked up pace over the past decade. In particular, this has been attributable to the recognition of key biologic findings, coupled with successful small-molecule inhibitors of SYK that have shown early indications of clinical efficacy in diverse autoimmune and inflammatory diseases. Thus, compounds <b>3</b>, <b>11</b>, <b>84</b>, and <b>85</b> have been examined in the clinic for RA, ITP, B-cell lymphoma, allergic rhinitis, and asthma, with compound <b>11</b> currently in phase 3 studies for RA. Kinase programs initially had broad appeal as attractive targets for treatment of oncologic diseases. However, this has matured further with applications encompassing chronic autoimmune and inflammatory diseases. Selectivity has been cited as a major concern in developing drugs targeting ubiquitously expressed kinases. The debate about the specificity of kinase inhibitors has been a major point of discussion and has still not reached a suitable resolution since the first kinase inhibitors entered into medicinal chemistry optimization.<a onclick="showRef(event, 'ref207 ref208'); return false;" href="javascript:void(0);" class="ref ref207 ref208">(207, 208)</a> The question that needs to be asked is how specificity is determined and in what biologic context. In the circumstance of complex diseases like RA and other autoimmune diseases discussed in this review, with multiple pathways operating in concert as the disease progresses, specificity may be a relative attribute. A suitable treatment may need to target multiple biologic pathways, initiated by an upstream enzyme receptor complex. SYK is such a target, and because of the complexity of its intracellular function, diverse appropriate functional assays must be employed in parallel with biochemical assays in inhibitor optimization.</div><div class="NLM_p">Currently, broadly exploited kinase biochemical assays use isolated catalytic domains in combination with peptide substrates during in vitro primary screening in drug discovery efforts. These formats suffer from the inability to address intracellular intricacies and inter- and intramolecular interactions seen in complex signaling cascades. Only by using cell-based assays in primary cells with disease-specific stimuli can the biochemical complexity of these systems be simulated. The latter can account for the dynamic regulation of kinase activity, influence of local environment such as localization, pH, ionic strength, protein–protein interactions, posttranslational modifications, various conformational states, and enzyme isoforms. When inhibitors for enzymes such as SYK kinase are discovered and optimized, biochemical assays may not account for the latent inactivated state present in the cellular environment and prerequisite activation required by ITAM binding, as well as auto- and transphosphorylation steps leading to intensified enzymatic activity. Dissection of these intricate steps for activation is best examined through functional cell-based assays supplemented with measurement of the activation of kinases using antibodies against functionally unique phosphorylated sites of specific substrates through phosphoblot analysis. More stringent methodology applies cell-based functional assays to assess SYK functional phenotype output and employs complementary biochemical assays to get more refinement for the application of structure-based drug design techniques during SAR. Compounds identified through biochemical screens necessitate optimization for translation of potency to the intracellular environment, improvement in poor membrane penetrability, and/or low metabolic stability.</div><div class="NLM_p">The application of functional assays is becoming more widely recognized, with the ability to measure complex interactions in signal transduction pathways and importantly improved assay reliability.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> SYK inhibition has relied on the application of functional assays since its initial discovery, and only now is this approach being validated from discovery to development.<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> The discovery of SYK inhibitors (compounds <b>2</b>, <b>3</b>, <b>28</b>, <b>83</b>, <b>84</b>, and <b>85</b>) has been inherently possible because of the reliance on a functional phenotype based screening paradigm.</div><div class="NLM_p last">Recently, SYK has been described as a “switch” kinase as opposed to Src family kinases, which are akin to “rheostat” kinases.<a onclick="showRef(event, 'ref66 ref67 ref86'); return false;" href="javascript:void(0);" class="ref ref66 ref67 ref86">(66, 67, 86)</a> Translation of this to drug discovery and development relays the point that ameliorating SYK activity will have a defined outcome. This principle has gained reinforcement with the successful completion of several phase 2 clinical studies in RA, ITP, and B-cell lymphoma. Additional translational studies, using PD biomarkers that interrogate compound activity at SYK and kinase targets for which cellular activity has been reported, are part of clinical studies underway that may further emphasize the position of SYK as a therapeutically relevant target.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm201271b" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60254" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60254" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajinder Singh</span> - <span class="hlFld-Affiliation affiliation">Rigel, Inc., 1180 Veterans Boulevard,
South San Francisco, California 94080, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#addfdec4c3cac5eddfc4cac8c183cec2c0"><span class="__cf_email__" data-cfemail="dcaeafb5b2bbb49caeb5bbb9b0f2bfb3b1">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Esteban S. Masuda</span> - <span class="hlFld-Affiliation affiliation">Rigel, Inc., 1180 Veterans Boulevard,
South San Francisco, California 94080, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald G. Payan</span> - <span class="hlFld-Affiliation affiliation">Rigel, Inc., 1180 Veterans Boulevard,
South San Francisco, California 94080, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48557" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48557" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Rajinder Singh</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=bio1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Rajinder Singh</b> earned his B.Sc. in Chemistry from Cardiff University, U.K., in 1988 and completed his D.Phil. studies in Organic Chemistry at University of Oxford, U.K., in 1991, under the guidance of Professor Sir Jack Baldwin. This was followed by an industrial postdoctoral fellowship position at Eli Lilly & Co., until 1994. From 1994 he worked at Chiron Corporation in combinatorial and medicinal chemistry. Joining Rigel in 1998 as Head of Chemistry, he currently holds the position of Vice President of Chemistry. He has led and worked in a number of therapeutic areas, including autoimmune and inflammatory diseases, infectious diseases, oncology, metabolism, and muscle wasting. His interests are in advancing medicinal chemistry targeting novel biological targets, and he has published and holds numerous patents.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Esteban S. Masuda</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=bio2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Esteban S. Masuda</b> earned his B.S. degree in Biochemistry from the University of California, Riverside, U.S., and his Ph.D. in Molecular Genetics from Hiroshima University, Japan, in 1990 under the guidance of Professor Y. Kobayashi. He carried out his postdoctoral work and continued his research on cytokine biology and gene regulation with Dr. Naoko Arai at DNAX Research Institute of Molecular and Cellular Biology in Palo Alto, CA, U.S. In 1998, he began his industrial career with Rigel Pharmaceuticals, where he currently holds the position of Vice President of Immunology. During his time at Rigel, he has led a number of drug and target discovery projects in inflammatory and allergic diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Donald G. Payan</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=bio3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Donald G. Payan</b> earned his B.Sc. in Physics and M.D. at Stanford University, CA, U.S., and his M.Sc. in Physics at the Massachusetts Institute of Technology, MA, U.S. He received his postgraduate medical training in Medicine and Infectious Diseases at the Massachusetts General Hospital and in Immunology at Harvard Medical School, Boston, MA, U.S. He is a former faculty member in the Departments of Medicine and Immunology of the University of California, San Francisco, U.S., and a member of the Howard Hughes Medical Institute, U.S. He is the CSO and a founder of Rigel Pharmaceuticals. He is the author and coauthor of over 180 scientific papers and holder of 30 issued patents.</p></figure></div><div class="ack" id="ACK-d1873e6750-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50662" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50662" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Shelley Lindley, Ph.D., and Caroline Neville from PAREXEL MMS, who provided editorial support funded by AstraZeneca. In addition the authors thank Nan Lin, Ph.D., for help with the figures, and Martin Braddock, Ph.D., Jim Diehl, Ph.D., Dane Goff, Ph.D., Travis Young, Ph.D., and Daniel Magilavy, M.D. for critical review of this manuscript.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i28" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i28"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i29" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i29"> Abbreviations Used</h2><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine</p></td></tr><tr><td class="NLM_term">ACR20</td><td class="NLM_def"><p class="first last">American College of Rheumatology 20% improvement criteria</p></td></tr><tr><td class="NLM_term">AHR</td><td class="NLM_def"><p class="first last">airway hyperresponsiveness</p></td></tr><tr><td class="NLM_term">AIHA</td><td class="NLM_def"><p class="first last">autoimmune hemolytic anemia</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine 5′-triphosphate</p></td></tr><tr><td class="NLM_term">BAL</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage</p></td></tr><tr><td class="NLM_term">BCR</td><td class="NLM_def"><p class="first last">B-cell antigen receptor</p></td></tr><tr><td class="NLM_term">BMM</td><td class="NLM_def"><p class="first last">bone marrow macrophage</p></td></tr><tr><td class="NLM_term">BUN</td><td class="NLM_def"><p class="first last">blood urea nitrogen level</p></td></tr><tr><td class="NLM_term">CAIA</td><td class="NLM_def"><p class="first last">collagen-antibody induced arthritis</p></td></tr><tr><td class="NLM_term">CARD</td><td class="NLM_def"><p class="first last">caspase-recruitment domain</p></td></tr><tr><td class="NLM_term">Cbl</td><td class="NLM_def"><p class="first last">Casitas B-lineage lymphoma</p></td></tr><tr><td class="NLM_term">CHMC</td><td class="NLM_def"><p class="first last">cultured human mast cells</p></td></tr><tr><td class="NLM_term">CIA</td><td class="NLM_def"><p class="first last">collagen-induced arthritis</p></td></tr><tr><td class="NLM_term">CLR</td><td class="NLM_def"><p class="first last">C-type lectin receptors</p></td></tr><tr><td class="NLM_term">CRP</td><td class="NLM_def"><p class="first last">C-reactive protein</p></td></tr><tr><td class="NLM_term">CT</td><td class="NLM_def"><p class="first last">computed tomography</p></td></tr><tr><td class="NLM_term">DAMP</td><td class="NLM_def"><p class="first last">damage-associated molecular pattern</p></td></tr><tr><td class="NLM_term">DAP12</td><td class="NLM_def"><p class="first last">DNAX-activated protein</p></td></tr><tr><td class="NLM_term">DAS28</td><td class="NLM_def"><p class="first last">disease activity score in 28 joints</p></td></tr><tr><td class="NLM_term">DC</td><td class="NLM_def"><p class="first last">dendritic cell</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">deoxyribonucleic acid</p></td></tr><tr><td class="NLM_term">DNP-BSA</td><td class="NLM_def"><p class="first last">dinitrophenylated bovine serum albumin</p></td></tr><tr><td class="NLM_term">EM</td><td class="NLM_def"><p class="first last">electron microscopy</p></td></tr><tr><td class="NLM_term">FcR</td><td class="NLM_def"><p class="first last">Fc receptor</p></td></tr><tr><td class="NLM_term">GM-CSF</td><td class="NLM_def"><p class="first last">granulocyte-macrophage colony-stimulating factor</p></td></tr><tr><td class="NLM_term">GSC</td><td class="NLM_def"><p class="first last">global symptom complex</p></td></tr><tr><td class="NLM_term">HIT</td><td class="NLM_def"><p class="first last">heparin-induced thrombocytopenia</p></td></tr><tr><td class="NLM_term">IC</td><td class="NLM_def"><p class="first last">immune complex</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">ITAM</td><td class="NLM_def"><p class="first last">immunoreceptor tyrosine-based activation motif</p></td></tr><tr><td class="NLM_term">ITIM</td><td class="NLM_def"><p class="first last">immunoreceptor tyrosine-based inhibitory motif</p></td></tr><tr><td class="NLM_term">ITP</td><td class="NLM_def"><p class="first last">idiopathic thrombocytopenia purpura</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">kDa</td><td class="NLM_def"><p class="first last">kilodalton</p></td></tr><tr><td class="NLM_term">LAT</td><td class="NLM_def"><p class="first last">linker for activation of T-cells</p></td></tr><tr><td class="NLM_term">LT</td><td class="NLM_def"><p class="first last">leukotriene</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MCP-1</td><td class="NLM_def"><p class="first last">monocyte chemoattractant protein-1</p></td></tr><tr><td class="NLM_term">MHC</td><td class="NLM_def"><p class="first last">major histocompatibility</p></td></tr><tr><td class="NLM_term">MMP3</td><td class="NLM_def"><p class="first last">matrix metalloproteinase 3</p></td></tr><tr><td class="NLM_term">MTX</td><td class="NLM_def"><p class="first last">methotrexate</p></td></tr><tr><td class="NLM_term">NFAT</td><td class="NLM_def"><p class="first last">nuclear factor of activated T-cells</p></td></tr><tr><td class="NLM_term">NF-κB</td><td class="NLM_def"><p class="first last">nuclear factor κ-light-chain-enhancer of activated B-cells</p></td></tr><tr><td class="NLM_term">NHL</td><td class="NLM_def"><p class="first last">non-Hodgkin lymphoma</p></td></tr><tr><td class="NLM_term">NK</td><td class="NLM_def"><p class="first last">natural killer</p></td></tr><tr><td class="NLM_term">NOD</td><td class="NLM_def"><p class="first last">nonobese diabetic</p></td></tr><tr><td class="NLM_term">NTN</td><td class="NLM_def"><p class="first last">nephrotoxic nephritis</p></td></tr><tr><td class="NLM_term">OVA</td><td class="NLM_def"><p class="first last">ovalbumin</p></td></tr><tr><td class="NLM_term">PAMP</td><td class="NLM_def"><p class="first last">pathogen-associated molecular pattern</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cell</p></td></tr><tr><td class="NLM_term">PCA</td><td class="NLM_def"><p class="first last">passive cutaneous anaphylaxis</p></td></tr><tr><td class="NLM_term">PKC</td><td class="NLM_def"><p class="first last">protein kinase C</p></td></tr><tr><td class="NLM_term">PRP</td><td class="NLM_def"><p class="first last">platelet-rich plasma</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">PTK</td><td class="NLM_def"><p class="first last">protein tyrosine kinase</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">RANK</td><td class="NLM_def"><p class="first last">receptor activator nuclear factor-κB</p></td></tr><tr><td class="NLM_term">RANKL</td><td class="NLM_def"><p class="first last">receptor activator of nuclear factor-κB ligand</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SH2</td><td class="NLM_def"><p class="first last">Src homology-2 domains</p></td></tr><tr><td class="NLM_term">SKG</td><td class="NLM_def"><p class="first last">Sakaguchi</p></td></tr><tr><td class="NLM_term">SLE</td><td class="NLM_def"><p class="first last">systemic lupus erythematosus</p></td></tr><tr><td class="NLM_term">SLP</td><td class="NLM_def"><p class="first last">SH2 domain containing leukocyte protein</p></td></tr><tr><td class="NLM_term">SYK</td><td class="NLM_def"><p class="first last">spleen tyrosine kinase</p></td></tr><tr><td class="NLM_term">T1D</td><td class="NLM_def"><p class="first last">type 1 diabetes</p></td></tr><tr><td class="NLM_term">TCR</td><td class="NLM_def"><p class="first last">T cell receptor</p></td></tr><tr><td class="NLM_term">T<sub>H</sub>2</td><td class="NLM_def"><p class="first last">T helper 2</p></td></tr><tr><td class="NLM_term">TLR-4</td><td class="NLM_def"><p class="first last">toll-like receptor 4</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">WB</td><td class="NLM_def"><p class="first last">whole blood</p></td></tr><tr><td class="NLM_term">ZAP-70</td><td class="NLM_def"><p class="first last">ζ-chain-associated protein kinase 70 of 70 kDa</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 209 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Zioncheck, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Purification and characterization of a protein-tyrosine kinase from bovine thymus</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">261</span><span class="NLM_x">, </span> <span class="NLM_fpage">15637</span><span class="NLM_x">–</span> <span class="NLM_lpage">15643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=15637-15643&author=T.+F.+Zioncheckauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Purification+and+characterization+of+a+protein-tyrosine+kinase+from+bovine+thymus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZioncheck%26aufirst%3DT.%2BF.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DPurification%2520and%2520characterization%2520of%2520a%2520protein-tyrosine%2520kinase%2520from%2520bovine%2520thymus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D15637%26epage%3D15643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Zioncheck, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Generation of an active protein-tyrosine kinase from lymphocytes by proteolysis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">19195</span><span class="NLM_x">–</span> <span class="NLM_lpage">19202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1988&pages=19195-19202&author=T.+F.+Zioncheckauthor=M.+L.+Harrisonauthor=C.+C.+Isaacsonauthor=R.+L.+Geahlen&title=Generation+of+an+active+protein-tyrosine+kinase+from+lymphocytes+by+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZioncheck%26aufirst%3DT.%2BF.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DIsaacson%26aufirst%3DC.%2BC.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DGeneration%2520of%2520an%2520active%2520protein-tyrosine%2520kinase%2520from%2520lymphocytes%2520by%2520proteolysis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1988%26volume%3D263%26spage%3D19195%26epage%3D19202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Sakai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Characterization of partially purified cytosolic protein-tyrosine kinase from porcine spleen</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1988&pages=1123-1130&author=K.+Sakaiauthor=S.+Nakamuraauthor=K.+Sadaauthor=T.+Kobayashiauthor=H.+Unoauthor=H.+Yamamura&title=Characterization+of+partially+purified+cytosolic+protein-tyrosine+kinase+from+porcine+spleen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DSada%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DUno%26aufirst%3DH.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520partially%2520purified%2520cytosolic%2520protein-tyrosine%2520kinase%2520from%2520porcine%2520spleen%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1988%26volume%3D152%26spage%3D1123%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Purification and characterization of a cytosolic protein-tyrosine kinase from porcine spleen</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1432-1033.1990.tb15433.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=2331984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK3cXhslCmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=1990&pages=535-540&author=T.+Kobayashiauthor=S.+Nakamuraauthor=T.+Taniguchiauthor=H.+Yamamura&title=Purification+and+characterization+of+a+cytosolic+protein-tyrosine+kinase+from+porcine+spleen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of a cytosolic protein-tyrosine kinase from porcine spleen</span></div><div class="casAuthors">Kobayashi, Tomoko; Nakamura, Shunichi; Taniguchi, Takanobu; Yamamura, Hirohei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-40</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">A cytosolic protein-tyrosine kinase was highly purified from porcine spleen using [Val5]angiotensin II as a substrate.  The purifn. procedure involves sequential column chromatogs. on phosphocellulose, Sephacryl S-200, casein-Sepharose 4B, heparin-Sepharose CL-6B, and anti-(4-aminobenzyl phosphonic acid)-Sepharose 4B.  Anal. of the most highly purified prepn. by SDS/PAGE revealed a major Ag-stained band of mol. mass 40 kDa.  The 40-kDa cytosolic protein-tyrosine kinase was purified ∼10,000-fold with an overall yield of ∼7%.  It had autophosphorylation activity which was carried out by intramol. catalysis.  The stoichiometry of phosphate incorporation was ∼1 mol phosphate/mol enzyme.  In the autophosphorylation reaction, the apparent Km for ATP was relatively low, 0.35 μM; Mn2+ was slightly preferred to Mg2+ as divalent cation.  [Val5]angiotensin II phosphorylation activity of the 40-kDa kinase increased with the amt. of phosphate incorporated into the enzyme.  A phosphate exchange reaction was obsd. during the autophosphorylation.  Apparently, the 40-kDa kinase described here is a different type of protein-tyrosine kinase than the enzymes so far reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLxkMWu0JEy7Vg90H21EOLACvtfcHk0ljaslLwpE6W3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhslCmsbg%253D&md5=d469bff4aea3dbe07f6c29d7a3ecc4b4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1990.tb15433.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1990.tb15433.x%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DPurification%2520and%2520characterization%2520of%2520a%2520cytosolic%2520protein-tyrosine%2520kinase%2520from%2520porcine%2520spleen%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1990%26volume%3D188%26spage%3D535%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Molecular cloning of a porcine gene <i>SYK</i> that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">15790</span><span class="NLM_x">–</span> <span class="NLM_lpage">15796</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=15790-15796&author=T.+Taniguchiauthor=T.+Kobayashiauthor=J.+Kondoauthor=K.+Takahashiauthor=H.+Nakamuraauthor=J.+Suzukiauthor=K+Nagaiauthor=T.+Yamadaauthor=S.+Nakamuraauthor=H.+Yamamura&title=Molecular+cloning+of+a+porcine+gene+SYK+that+encodes+a+72-kDa+protein-tyrosine+kinase+showing+high+susceptibility+to+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DKondo%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DJ.%26aulast%3DNagai%26aufirst%3DK%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520porcine%2520gene%2520SYK%2520that%2520encodes%2520a%252072-kDa%2520protein-tyrosine%2520kinase%2520showing%2520high%2520susceptibility%2520to%2520proteolysis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D15790%26epage%3D15796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Geahlen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burg, D. L.</span><span> </span><span class="NLM_article-title">The role of SYK in cell signaling</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1994&pages=103-109&author=R.+L.+Geahlenauthor=D.+L.+Burg&title=The+role+of+SYK+in+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26aulast%3DBurg%26aufirst%3DD.%2BL.%26atitle%3DThe%2520role%2520of%2520SYK%2520in%2520cell%2520signaling%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1994%26volume%3D365%26spage%3D103%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Brunati, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donella-Deana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Site specificity of p72<sup><i>syk</i></sup> protein tyrosine kinase: efficient phosphorylation of motifs recognized by Src homology 2 domains of the Src family</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1995&pages=149-152&author=A.+M.+Brunatiauthor=A.+Donella-Deanaauthor=M.+Ruzzeneauthor=O.+Marinauthor=L.+A.+Pinna&title=Site+specificity+of+p72syk+protein+tyrosine+kinase%3A+efficient+phosphorylation+of+motifs+recognized+by+Src+homology+2+domains+of+the+Src+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunati%26aufirst%3DA.%2BM.%26aulast%3DDonella-Deana%26aufirst%3DA.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DSite%2520specificity%2520of%2520p72syk%2520protein%2520tyrosine%2520kinase%253A%2520efficient%2520phosphorylation%2520of%2520motifs%2520recognized%2520by%2520Src%2520homology%25202%2520domains%2520of%2520the%2520Src%2520family%26jtitle%3DFEBS%2520Lett.%26date%3D1995%26volume%3D367%26spage%3D149%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Purification and characterization of a protein-tyrosine kinase p72<sup><i>syk</i></sup> from porcine spleen</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1432-1033.1994.tb18813.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=8181480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK2cXkt12lurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1994&pages=973-978&author=C.+Yangauthor=S.+Yanagiauthor=X.+Wangauthor=K.+Sakaiauthor=T.+Taniguchiauthor=H.+Yamamura&title=Purification+and+characterization+of+a+protein-tyrosine+kinase+p72syk+from+porcine+spleen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of a protein-tyrosine kinase p72syk from porcine spleen</span></div><div class="casAuthors">Yang, Cheng; Yanagi, Shigeru; Wang, Xiaoying; Sakai, Keiko; Taniguchi, Takanobu; Yamamura, Hirohei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">973-8</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The authors have succeeded in purifying p72syk, a non-receptor-type protein-tyrosine kinase carrying high susceptibility to proteolysis [Taniguchi, T., Kobayashi, T., Kondo, J., Takahashi, K., Nakamura, H., Suzuki, J., Nagai, K., Yamada, T., Nakamura, S. and Yamamura, H. (1991) J. Biol. Chem. 266, 15790-15796] from porcine spleen.  The purifn. procedure involves a sequential column chromatog., following extn. with 0.5 M NaCl from spleen homogenate, on phosphocellulose, Sephacryl S-200, heparin-Sepharose CL-6B, Mono Q and Mono S.  SDS/PAGE of the final purified sample revealed a 72-Da protein band with about 95% purity and immunodepletion anal. showed immunol. cross-reactivity with anti-p72syk antibody which does not recognize ZAP-70.  It was purified approx. 3000-fold with an overall yield of 0.54% according to [Val5]angiotensin II phosphorylation activity and the specific activity of the final sample (30nmol phosphate min-1·mg protein-1) was relatively lower than that of the 40-kDa kinase, catalytic fragment f p72syk which lacks two src homol. regions 2 domains.  The p72syk had an autophosphorylation activity that was performed by intramol. catalysis accompanied by a phosphate exchange reaction, and could efficiently phosphorylate tubulin, myelin basic protein and H2B histone.  Employing [Val5]angiotensin II as a substrate, the apparent Km value for the peptide was 0.91 mM and that for ATP was 0.48 μM.  Mn2+, Mg2+ and Co2+ were effective divalent cations and optimum pH was around 8.0-8.5 for the expression of the activity.  These results suggest that the purified p 72syk may exist as a less active form compared with the 40-kDa kinase and that the part of p72syk contg. two src homol. region 2 domains may participate in the regulation of its activity through the enzyme character is quite similar to that of the 40-kDa kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjL-MWyEbC7rVg90H21EOLACvtfcHk0liW8beFeEDxMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt12lurg%253D&md5=9fb487a7a11c3a43eeab24541141dd7d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1994.tb18813.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1994.tb18813.x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DYanagi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DPurification%2520and%2520characterization%2520of%2520a%2520protein-tyrosine%2520kinase%2520p72syk%2520from%2520porcine%2520spleen%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1994%26volume%3D221%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L.</span><span> </span><span class="NLM_article-title">Tyrosine kinase SYK: essential functions for immunoreceptor signalling</span> <span class="citation_source-journal">Immunol. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0167-5699%2899%2901574-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10689303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFOju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=148-154&author=M.+Turnerauthor=E.+Schweighofferauthor=F.+Colucciauthor=J.+P.+Di+Santoauthor=V.+L.+Tybulewicz&title=Tyrosine+kinase+SYK%3A+essential+functions+for+immunoreceptor+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase SYK: essential functions for immunoreceptor signaling</span></div><div class="casAuthors">Turner, M.; Schweighoffer, E.; Colucci, F.; Di Santo, J. P.; Tybulewicz, V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-154</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 54 refs.  The tyrosine kinase SYK plays crit. roles in signaling through immune receptors.  Gene-targeting studies have identified the cell types that require SYK for development and function, and the receptors that use SYK as well as their downstream signaling effectors.  There is also evidence of a role for SYK in non-immune cells and in the maintenance of vascular integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZlinILlIox7Vg90H21EOLACvtfcHk0liW8beFeEDxMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFOju7g%253D&md5=8eebc20afd9de9e2bae1894f9c90b40f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0167-5699%2899%2901574-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-5699%252899%252901574-1%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DSchweighoffer%26aufirst%3DE.%26aulast%3DColucci%26aufirst%3DF.%26aulast%3DDi%2BSanto%26aufirst%3DJ.%2BP.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%26atitle%3DTyrosine%2520kinase%2520SYK%253A%2520essential%2520functions%2520for%2520immunoreceptor%2520signalling%26jtitle%3DImmunol.%2520Today%26date%3D2000%26volume%3D21%26spage%3D148%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Wong, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">Targeting Syk as a treatment for allergic and autoimmune disorders</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=743-762&author=B.+R.+Wongauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+S.+Masuda&title=Targeting+Syk+as+a+treatment+for+allergic+and+autoimmune+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DB.%2BR.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DTargeting%2520Syk%2520as%2520a%2520treatment%2520for%2520allergic%2520and%2520autoimmune%2520disorders%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D743%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Mócsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J.</span><span> </span><span class="NLM_article-title">The SYK tyrosine kinase: a crucial player in diverse biological functions</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20467426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFOkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=387-402&author=A.+M%C3%B3csaiauthor=J.+Rulandauthor=V.+L.+J.+Tybulewicz&title=The+SYK+tyrosine+kinase%3A+a+crucial+player+in+diverse+biological+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The SYK tyrosine kinase: a crucial player in diverse biological functions</span></div><div class="casAuthors">Mocsai, Attila; Ruland, Jurgen; Tybulewicz, Victor L. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">387-402</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (SYK) is known to have a crucial role in adaptive immune receptor signalling.  However, recent reports indicate that SYK also mediates other, unexpectedly diverse biol. functions, including cellular adhesion, innate immune recognition, osteoclast maturation, platelet activation and vascular development.  SYK is activated by C-type lectins and integrins, and activates new targets, including the CARD9-BCL-10-MALT1 pathway and the NLRP3 inflammasome.  Studies using Drosophila melanogaster suggest that there is an evolutionarily ancient origin of SYK-mediated signalling.  Moreover, SYK has a crucial role in autoimmune diseases and haematol. malignancies.  This Review summarizes our current understanding of the diverse functions of SYK and how this is being translated for therapeutic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3YO5BcMqrf7Vg90H21EOLACvtfcHk0liW8beFeEDxMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFOkurk%253D&md5=85857a2b9beb84e0fe74263a90fa8a53</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnri2765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2765%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ.%26atitle%3DThe%2520SYK%2520tyrosine%2520kinase%253A%2520a%2520crucial%2520player%2520in%2520diverse%2520biological%2520functions%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D387%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase (Syk) biology, inhibitors and therapeutic applications</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=379-391&author=R.+Singhauthor=E.+S.+Masuda&title=Spleen+tyrosine+kinase+%28Syk%29+biology%2C+inhibitors+and+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DSpleen%2520tyrosine%2520kinase%2520%2528Syk%2529%2520biology%252C%2520inhibitors%2520and%2520therapeutic%2520applications%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D379%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Riccaboni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, P.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinases: biology, therapeutic targets and drugs</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.drudis.2010.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20553955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVKjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=517-530&author=M.+Riccaboniauthor=I.+Bianchiauthor=P.+Petrillo&title=Spleen+tyrosine+kinases%3A+biology%2C+therapeutic+targets+and+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Spleen tyrosine kinases: biology, therapeutic targets and drugs</span></div><div class="casAuthors">Riccaboni, Mauro; Bianchi, Ivana; Petrillo, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">13/14</span>),
    <span class="NLM_cas:pages">517-530</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (Syk) is an intriguing protein tyrosine kinase involved in signal transduction in a variety of cell types, and its aberrant regulation is assocd. with different allergic disorders and antibody-mediated autoimmune diseases such as rheumatoid arthritis, asthma and allergic rhinitis.  Syk also plays an important part in the uncontrolled growth of tumor cells, particularly B cells.  For these reasons, Syk is considered one of the most interesting biol. targets of the last decade, as proved by the great no. of papers and patents published, and the possibility of treating these pathologies by means of Syk kinase inhibitors has led to a great interest from the pharmaceutical and biotech industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqimmbpqDWfbVg90H21EOLACvtfcHk0lincrNVG06yOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVKjurg%253D&md5=77def570415a150b4ea728ec12144710</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DRiccaboni%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DI.%26aulast%3DPetrillo%26aufirst%3DP.%26atitle%3DSpleen%2520tyrosine%2520kinases%253A%2520biology%252C%2520therapeutic%2520targets%2520and%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D517%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Ruzza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderan, A.</span><span> </span><span class="NLM_article-title">Therapeutic prospect of Syk inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1517%2F13543770903207039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19670961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFyhtLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1361-1376&author=P.+Ruzzaauthor=B.+Biondiauthor=A.+Calderan&title=Therapeutic+prospect+of+Syk+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic prospect of Syk inhibitors</span></div><div class="casAuthors">Ruzza, Paolo; Biondi, Barbara; Calderan, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1361-1376</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The non-receptor spleen tyrosine kinase (Syk; EC 2.7.10.2) is involved in signal transduction in a variety of cell types.  In particular, it is a key mediator of immune receptors signaling in host inflammatory cells (B cells, mast cells, macrophages and neutrophils), important for both allergic and antibody-mediated autoimmune diseases.  Deregulated Syk kinase activity also allows growth factor-independent proliferation and transforms bone marrow-derived pre-B cells that are able to induce leukemia.  Consequently, the development of Syk kinase inhibitors could conceivably treat these disorders and so they have became a major focus in the pharmaceutical and biotech industry.  Objective: In this review, we analyze the structure and role of Syk kinase, the use of small mols., interacting with ATP-binding site, as inhibitors of kinase activity and finally the potential of using inhibitors of Syk kinase expression to attenuate pathol. conditions.  Conclusion: Syk kinase inhibition is suggested as a powerful tool for the therapy of different pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq5SKC7HVACbVg90H21EOLACvtfcHk0lincrNVG06yOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFyhtLfJ&md5=19295f5d8164e52ccfe8d79bd10175d9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543770903207039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903207039%26sid%3Dliteratum%253Aachs%26aulast%3DRuzza%26aufirst%3DP.%26aulast%3DBiondi%26aufirst%3DB.%26aulast%3DCalderan%26aufirst%3DA.%26atitle%3DTherapeutic%2520prospect%2520of%2520Syk%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D1361%26epage%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Denyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span> </span><span class="NLM_article-title">Syk kinase inhibitors in allergic diseases</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1358%2Fdnp.2009.22.3.1354124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19440557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvVOmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=146-150&author=J.+Denyerauthor=V.+Patel&title=Syk+kinase+inhibitors+in+allergic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sky kinase inhibitors in allergic diseases</span></div><div class="casAuthors">Denyer, Jane; Patel, Vipul</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">146-150</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of allergic mechanisms have highlighted the role of IgE signaling in the mast cell.  One of the most important kinases in the IgE signaling pathway is spleen tyrosine kinase (Syk) which has a crit. function early in the signaling cascade following binding of allergen to receptor bound IgE on the mast cell.  A no. of Syk inhibitors have now been developed which have been shown to effectively inhibit IgE-driven mast cell degranulation and release of inflammatory cytokines in vitro and inhibit allergic responses in a variety of in vivo models.  In humans, allergen-driven symptoms were reduced in allergic rhinitis patients exposed to tree pollen in an outdoor environment following intranasal dosing of the Syk inhibitor R-112.  Syk therefore represents a promising target for therapeutic intervention in allergic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4432yAMdRCbVg90H21EOLACvtfcHk0lincrNVG06yOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvVOmt7k%253D&md5=dd088a5051c3b3db64eee4ce8d963541</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2009.22.3.1354124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2009.22.3.1354124%26sid%3Dliteratum%253Aachs%26aulast%3DDenyer%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26atitle%3DSyk%2520kinase%2520inhibitors%2520in%2520allergic%2520diseases%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2009%26volume%3D22%26spage%3D146%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bajpai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastidar, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=641-659&author=M.+Bajpaiauthor=P.+Chopraauthor=S.+G.+Dastidarauthor=A.+Ray&title=Spleen+tyrosine+kinase%3A+a+novel+target+for+therapeutic+intervention+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBajpai%26aufirst%3DM.%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DDastidar%26aufirst%3DS.%2BG.%26aulast%3DRay%26aufirst%3DA.%26atitle%3DSpleen%2520tyrosine%2520kinase%253A%2520a%2520novel%2520target%2520for%2520therapeutic%2520intervention%2520of%2520rheumatoid%2520arthritis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D641%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Moore, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span> </span><span class="NLM_article-title">An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1517%2F13543776.2010.534459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21073366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1703-1722&author=W.+J.+Mooreauthor=D.+Richardauthor=A.+Thorarensen&title=An+analysis+of+the+diaminopyrimidine+patent+estates+describing+spleen+tyrosine+kinase+inhibitors+by+Rigel+and+Portola"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola</span></div><div class="casAuthors">Moore, William J.; Richard, David; Thorarensen, Atli</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1703-1722</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Discovery of small mol. inhibitors for treatment of rheumatoid arthritis is a major ongoing effort within the pharmaceutical industry.  Spleen tyrosine kinase (SYK) is one of the leading small mol. targets with regard to clin. developments due to the efforts of Rigel and Portola.Areas covered in this review: Diaminopyrimidines are one of the most prominent structural elements incorporated into the design of kinase inhibitors.  This review provides an extensive overview of the patent estates for the leading discovery programs at Portola and Rigel on diaminopyrimidines and how their patent estates are in relationship with the competition and prior art.What the reader will gain: An overview of the patent landscape for diaminopyrimidines.  In addn., the reader will be updated on what modifications in these scaffolds lead to very potent SYK inhibitors as judged by the applications.  Finally, the authors will provide their best guess on what the structure is of Portola's recently announced clin. candidate.Take home message: The Rigel and the Portola research organizations have filed a series of patent applications on diaminopyrimidines as inhibitors of SYK.  The scope of these applications is broad in a crowded chem. space.  These applications contain very broad claims and the future will tell how much of the generic space claimed will be allowed in granted patents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7wp-QGiNYmrVg90H21EOLACvtfcHk0ljMJ8xTlzyOZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bJ&md5=a594fee4a53660d83042531aaf569eaf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.534459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.534459%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DRichard%26aufirst%3DD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520diaminopyrimidine%2520patent%2520estates%2520describing%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520by%2520Rigel%2520and%2520Portola%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1703%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Duta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulanova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttagunta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musat-Marcu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrod, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhoff, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Befus, A. D.</span><span> </span><span class="NLM_article-title">Differential expression of spleen tyrosine kinase Syk isoforms in tissues: effects of the microbial flora</span> <span class="citation_source-journal">Histochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1007%2Fs00418-006-0188-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16708245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVart78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=495-505&author=F.+Dutaauthor=M.+Ulanovaauthor=D.+Seidelauthor=L.+Puttaguntaauthor=S.+Musat-Marcuauthor=K.+S.+Harrodauthor=A.+D.+Schreiberauthor=U.+Steinhoffauthor=A.+D.+Befus&title=Differential+expression+of+spleen+tyrosine+kinase+Syk+isoforms+in+tissues%3A+effects+of+the+microbial+flora"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora</span></div><div class="casAuthors">Duta, Florentina; Ulanova, Marina; Seidel, Daniel; Puttagunta, Lakshmi; Musat-Marcu, Sorin; Harrod, Kevin S.; Schreiber, Alan D.; Steinhoff, Ulrich; Befus, A. Dean</div><div class="citationInfo"><span class="NLM_cas:title">Histochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">495-505</span>CODEN:
                <span class="NLM_cas:coden">HCBIFP</span>;
        ISSN:<span class="NLM_cas:issn">0948-6143</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is expressed widely in hematopoietic and non-hematopoietic cells.  The widespread distribution of Syk and its involvement in host defense and allergic reactions, prompted us analyze the influence of microbial exposure on Syk expression.  We compared the distribution of Syk in various tissues of germ-free and conventional mice using immunohistochem., Western blot anal. and real time RT-PCR.  Total Syk expression was similar between germ-free and conventional mice.  Since it was claimed that Syk isoforms are differentially expressed, we studied the distribution and abundance of Syk (L) and Syk (S) isoforms in tissues from these mice.  In contrast to previous reports, we found broad tissue expression of Syk (S).  Interestingly, in germ-free mice the amt. of Syk (S) but not Syk L protein was selectively increased in lung and spleen.  In summary, our study reveals new and broad tissue expression of both Syk isoforms and demonstrates that lack of microbial flora results in selectively increased expression of Syk (S) isoform in lung and spleen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8ojD6rYkMlrVg90H21EOLACvtfcHk0ljMJ8xTlzyOZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVart78%253D&md5=f9d0539d1cc1aed5f9456b42c47a42c4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00418-006-0188-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00418-006-0188-z%26sid%3Dliteratum%253Aachs%26aulast%3DDuta%26aufirst%3DF.%26aulast%3DUlanova%26aufirst%3DM.%26aulast%3DSeidel%26aufirst%3DD.%26aulast%3DPuttagunta%26aufirst%3DL.%26aulast%3DMusat-Marcu%26aufirst%3DS.%26aulast%3DHarrod%26aufirst%3DK.%2BS.%26aulast%3DSchreiber%26aufirst%3DA.%2BD.%26aulast%3DSteinhoff%26aufirst%3DU.%26aulast%3DBefus%26aufirst%3DA.%2BD.%26atitle%3DDifferential%2520expression%2520of%2520spleen%2520tyrosine%2520kinase%2520Syk%2520isoforms%2520in%2520tissues%253A%2520effects%2520of%2520the%2520microbial%2520flora%26jtitle%3DHistochem.%2520Cell%2520Biol.%26date%3D2006%26volume%3D126%26spage%3D495%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Latour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, L. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span> </span><span class="NLM_article-title">Differential intrinsic enzymatic activity of Syk and ZAP-70 protein-tyrosine kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">22782</span><span class="NLM_x">–</span> <span class="NLM_lpage">22790</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22782-22790&author=S.+Latourauthor=L.+M.+L.+Chowauthor=A.+Veillette&title=Differential+intrinsic+enzymatic+activity+of+Syk+and+ZAP-70+protein-tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLatour%26aufirst%3DS.%26aulast%3DChow%26aufirst%3DL.%2BM.%2BL.%26aulast%3DVeillette%26aufirst%3DA.%26atitle%3DDifferential%2520intrinsic%2520enzymatic%2520activity%2520of%2520Syk%2520and%2520ZAP-70%2520protein-tyrosine%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D22782%26epage%3D22790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Latour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siraganian, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span> </span><span class="NLM_article-title">A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signaling</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=2584-2595&author=S.+Latourauthor=J.+Zhangauthor=R.+P.+Siraganianauthor=A.+Veillette&title=A+unique+insert+in+the+linker+domain+of+Syk+is+necessary+for+its+function+in+immunoreceptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLatour%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26aulast%3DVeillette%26aufirst%3DA.%26atitle%3DA%2520unique%2520insert%2520in%2520the%2520linker%2520domain%2520of%2520Syk%2520is%2520necessary%2520for%2520its%2520function%2520in%2520immunoreceptor%2520signaling%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D2584%26epage%3D2595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burg, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Phosphorylation of human erythrocyte band 3 by endogenous p72<sup><i>syk</i></sup></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=955-959&author=M.+L.+Harrisonauthor=C.+C.+Isaacsonauthor=D.+L.+Burgauthor=R.+L.+Geahlenauthor=P.+S.+Low&title=Phosphorylation+of+human+erythrocyte+band+3+by+endogenous+p72syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DIsaacson%26aufirst%3DC.%2BC.%26aulast%3DBurg%26aufirst%3DD.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DPhosphorylation%2520of%2520human%2520erythrocyte%2520band%25203%2520by%2520endogenous%2520p72syk%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D955%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Chan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turck, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCRζ chain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1992&pages=649-662&author=A.+C.+Chanauthor=M.+Iwashimaauthor=C.+W.+Turckauthor=A.+Weiss&title=ZAP-70%3A+a+70+kd+protein-tyrosine+kinase+that+associates+with+the+TCR%CE%B6+chain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DA.%2BC.%26aulast%3DIwashima%26aufirst%3DM.%26aulast%3DTurck%26aufirst%3DC.%2BW.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DZAP-70%253A%2520a%252070%2520kd%2520protein-tyrosine%2520kinase%2520that%2520associates%2520with%2520the%2520TCR%25CE%25B6%2520chain%26jtitle%3DCell%26date%3D1992%26volume%3D71%26spage%3D649%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">van Oers, N. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes</span> <span class="citation_source-journal">Semin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1006%2Fsmim.1995.0027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=8520027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK2MXotFegsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=227-236&author=N.+S.+C.+van+Oersauthor=A.+Weiss&title=The+Syk%2FZAP-70+protein+tyrosine+kinase+connection+to+antigen+receptor+signalling+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signaling processes</span></div><div class="casAuthors">van Oers, Nicolai S.C.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">227-36</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review, with 71 refs.  The T- and B-cell receptor (TCR and BCR) signal transduction processes involve a coordinated interplay between two classes of non-receptor protein tyrosine kinases (PTKs), the Src-family and the Syk/ZAP-70 family of PTKs.  Following antigen-receptor stimulation, the Src-family of PTKs mediate the phosphorylation of tyrosine residues contained in a signaling motif localized in the TCR and BCR subunits.  The phosphorylation of this signaling motif recruits the Syk/ZAP-70 family of PTKs into the antigen receptor complex.  This mechanism requires the tandem SH2 domains in ZAP-70 complexing to two critically spaced phosphotyrosine residues within the signaling motif.  The clustering of Syk/ZAP-70 and cross-talk between this family and the Src-PTKs regulates subsequent signaling events that lead to a variety of cellular responses, such as antibody secretion, lymphokine prodn., cytolytic activity, proliferation, differentiation and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHEeGg6TFm7Vg90H21EOLACvtfcHk0lgPqAaQlijz7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotFegsbs%253D&md5=90b0d29f8cc03e7aaf489025fbe2709f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1006%2Fsmim.1995.0027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fsmim.1995.0027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BOers%26aufirst%3DN.%2BS.%2BC.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DThe%2520Syk%252FZAP-70%2520protein%2520tyrosine%2520kinase%2520connection%2520to%2520antigen%2520receptor%2520signalling%2520processes%26jtitle%3DSemin.%2520Immunol.%26date%3D1995%26volume%3D7%26spage%3D227%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Au-Yeung, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deindl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">The structure, regulation, and function of ZAP-70</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.2008.00753.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19290920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=41-57&author=B.+B.+Au-Yeungauthor=S.+Deindlauthor=L.+Y.+Hsuauthor=E.+H.+Palaciosauthor=S.+E.+Levinauthor=J.+Kuriyanauthor=A.+Weiss&title=The+structure%2C+regulation%2C+and+function+of+ZAP-70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The structure, regulation, and function of ZAP-70</span></div><div class="casAuthors">Au-Yeung, Byron B.; Deindl, Sebastian; Hsu, Lih-Yun; Palacios, Emil H.; Levin, Susan E.; Kuriyan, John; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-57</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The tyrosine ZAP-70 (ζ-assocd. protein of 70 kDa) kinase plays a crit. role in activating many downstream signal transduction pathways in T cells following T-cell receptor (TCR) engagement.  The importance of ZAP-70 is evidenced by the severe combined immunodeficiency that occurs in ZAP-70-deficient mice and humans.  In this review, we describe recent analyses of the ZAP-70 crystal structure, revealing a complex regulatory mechanism of ZAP-70 activity, the differential requirements for ZAP-70 and spleen tyrosine kinase (SyK) in early T-cell development, as well as the role of ZAP-70 in chronic lymphocytic leukemia and autoimmunity.  Thus, the crit. importance of ZAP-70 in TCR signaling and its predominantly T-cell-restricted expression pattern make.  ZAP-70 an attractive drug target for the inhibition of pathol. T-cell responses in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpELG5-oWT4XbVg90H21EOLACvtfcHk0lgPqAaQlijz7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7rN&md5=84d19a10fcda9dc5dd7305679b11cc22</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00753.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00753.x%26sid%3Dliteratum%253Aachs%26aulast%3DAu-Yeung%26aufirst%3DB.%2BB.%26aulast%3DDeindl%26aufirst%3DS.%26aulast%3DHsu%26aufirst%3DL.%2BY.%26aulast%3DPalacios%26aufirst%3DE.%2BH.%26aulast%3DLevin%26aufirst%3DS.%2BE.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DThe%2520structure%252C%2520regulation%252C%2520and%2520function%2520of%2520ZAP-70%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D41%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Chu, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">The Syk family protein tyrosine kinases in T-cell activation and development</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.1998.tb01238.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9850860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1cXotVKhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=1998&pages=167-180&author=D.+H.+Chuauthor=C.+T.+Moritaauthor=A.+Weiss&title=The+Syk+family+protein+tyrosine+kinases+in+T-cell+activation+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Syk family of protein tyrosine kinases in T-cell activation and development</span></div><div class="casAuthors">Chu, David H.; Morita, Craig T.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">167-180</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 79 refs.  The processes of T-cell development and activation employ similar immature and mature receptors as well as similar signal transduction pathways to achieve different outcomes.  Many signaling mols. are shared between the receptor signaling pathways, including two families of cytoplasmic protein tyrosine kinases, the Src family and the Syk family.  The two Syk family members expressed in T cells, Syk and ZAP-70, are structurally similar but are expressed at different times during thymic development and during T-cell activation.  These two kinases, although they share many phys. features, differ in terms of biochem. activity and regulation.  We discuss the overlapping and distinct characteristics of Syk and ZAP-70 in T-cell signaling and the potential biol. importance of their differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojpRLoUNBms7Vg90H21EOLACvtfcHk0lgPqAaQlijz7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVKhtL4%253D&md5=bd8970d0540dc33a5197e5283f31e2ca</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.1998.tb01238.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.1998.tb01238.x%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DD.%2BH.%26aulast%3DMorita%26aufirst%3DC.%2BT.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DThe%2520Syk%2520family%2520protein%2520tyrosine%2520kinases%2520in%2520T-cell%2520activation%2520and%2520development%26jtitle%3DImmunol.%2520Rev.%26date%3D1998%26volume%3D165%26spage%3D167%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Bolen, J. B.</span><span> </span><span class="NLM_article-title">Protein tyrosine kinases in the initiation of antigen receptor signaling</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2F0952-7915%2895%2980103-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=7546393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK2MXntFalt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=306-311&author=J.+B.+Bolen&title=Protein+tyrosine+kinases+in+the+initiation+of+antigen+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine kinases in the initiation of antigen receptor signaling</span></div><div class="casAuthors">Bolen, Joseph B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-11</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review, with 54 refs.  Intracellular responses to antigen receptor engagement involve the activation of protein tyrosine kinases and the tyrosine phosphorylation of cellular proteins, including components of the antigen receptor.  Phosphorylation of two tyrosine residues within an 18 amino acid segment of the cytoplasmic domain of antigen receptor subunits, and the subsequent assocn. of either the Syk or Zap protein tyrosine kinase, has recently been shown to be required for successful antigen receptor signal propagation.  The recent finding that distinct primary human immunodeficiencies result from mutations in genes encoding two non-transmembrane protein tyrosine kinases underscores the importance of this class of enzyme in antigen receptor signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa2fXgX99g67Vg90H21EOLACvtfcHk0lhimGcdJsSe5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFalt7w%253D&md5=b76e01e636e09bbc538e8a87b25c3985</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0952-7915%2895%2980103-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0952-7915%252895%252980103-0%26sid%3Dliteratum%253Aachs%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26atitle%3DProtein%2520tyrosine%2520kinases%2520in%2520the%2520initiation%2520of%2520antigen%2520receptor%2520signaling%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1995%26volume%3D7%26spage%3D306%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Sada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Structure and function of Syk protein-tyrosine kinase</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1093%2Foxfordjournals.jbchem.a002970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11481033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFCrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2001&pages=177-186&author=K.+Sadaauthor=T.+Takanoauthor=S.+Yanagiauthor=H.+Yamamura&title=Structure+and+function+of+Syk+protein-tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of Syk protein-tyrosine kinase</span></div><div class="casAuthors">Sada, Kiyonao; Takano, Tomoko; Yanagi, Shigeru; Yamamura, Hirohei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-186</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review with refs.  Non-receptor type of protein-tyrosine kinase Syk contains 2 Src homol. 2 (SH2) domains in tandem and multiple autophosphorylation sites.  Syk is activated upon binding of tandem SH2 domains to immunoreceptor tyrosine-based activating motif (ITAM) and plays an essential role in lymphocyte development and activation of immune cells.  Syk is crit. for tyrosine phosphorylation of multiple proteins which regulate important pathways leading from the receptor, such as Ca2+ mobilization and mitogen-activated protein kinase (MAPK) cascades.  Recent findings reveal that expression of Syk appears to be involved in a wide variety of cellular functions and pathogenesis of malignant cancer.  These observations have demonstrated that Syk is a key mol. that controls multiple physiol. functions in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEMQjZtBs-1LVg90H21EOLACvtfcHk0lhimGcdJsSe5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFCrtbk%253D&md5=3c25c4b262ce61fd8d45fd137b2c7e97</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a002970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a002970%26sid%3Dliteratum%253Aachs%26aulast%3DSada%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DT.%26aulast%3DYanagi%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DStructure%2520and%2520function%2520of%2520Syk%2520protein-tyrosine%2520kinase%26jtitle%3DJ.%2520Biochem.%26date%3D2001%26volume%3D130%26spage%3D177%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Furlong, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahrenholz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashendel, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1355</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1355&publication_year=1997&pages=177-190&author=M.+T.+Furlongauthor=A.+M.+Mahrenholzauthor=K.+H.+Kimauthor=C.+L.+Ashendelauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Identification+of+the+major+sites+of+autophosphorylation+of+the+murine+protein-tyrosine+kinase+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFurlong%26aufirst%3DM.%2BT.%26aulast%3DMahrenholz%26aufirst%3DA.%2BM.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DAshendel%26aufirst%3DC.%2BL.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DIdentification%2520of%2520the%2520major%2520sites%2520of%2520autophosphorylation%2520of%2520the%2520murine%2520protein-tyrosine%2520kinase%2520Syk%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1997%26volume%3D1355%26spage%3D177%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Chan, A. C.</span><span> </span><span class="NLM_article-title">Syk Family of Protein Tyrosine Kinases</span>. In  <span class="citation_source-book">Encyclopedia of Biological Chemistry</span>; <span class="NLM_contrib-group">Lennarz, W. J.; Lane, M. D.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Boston, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">4</span>, pp  <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FB0-12-443710-9%2F00650-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=139-145&author=A.+C.+Chanauthor=W.+J.+Lennarz&author=M.+D.+Lane&title=Encyclopedia+of+Biological+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FB0-12-443710-9%2F00650-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB0-12-443710-9%252F00650-5%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DA.%2BC.%26atitle%3DSyk%2520Family%2520of%2520Protein%2520Tyrosine%2520Kinases%26btitle%3DEncyclopedia%2520of%2520Biological%2520Chemistry%26aulast%3DLennarz%26aufirst%3DW.%2BJ.%26pub%3DAcademic%2520Press%26date%3D2004%26volume%3D4%26spage%3D139%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Reth, M.</span><span> </span><span class="NLM_article-title">Antigen receptor tail clue</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1989&pages=383-384&author=M.+Reth&title=Antigen+receptor+tail+clue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReth%26aufirst%3DM.%26atitle%3DAntigen%2520receptor%2520tail%2520clue%26jtitle%3DNature%26date%3D1989%26volume%3D338%26spage%3D383%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Cambier, J. C.</span><span> </span><span class="NLM_article-title">Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM)</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">3281</span><span class="NLM_x">–</span> <span class="NLM_lpage">3285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1995&pages=3281-3285&author=J.+C.+Cambier&title=Antigen+and+Fc+receptor+signaling.+The+awesome+power+of+the+immunoreceptor+tyrosine-based+activation+motif+%28ITAM%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCambier%26aufirst%3DJ.%2BC.%26atitle%3DAntigen%2520and%2520Fc%2520receptor%2520signaling.%2520The%2520awesome%2520power%2520of%2520the%2520immunoreceptor%2520tyrosine-based%2520activation%2520motif%2520%2528ITAM%2529%26jtitle%3DJ.%2520Immunol.%26date%3D1995%26volume%3D155%26spage%3D3281%26epage%3D3285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Johnson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneringer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hippen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambier, J. C.</span><span> </span><span class="NLM_article-title">Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">4596</span><span class="NLM_x">–</span> <span class="NLM_lpage">4603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1995&pages=4596-4603&author=S.+A.+Johnsonauthor=C.+M.+Pleimanauthor=L.+Paoauthor=J.+Schneringerauthor=K.+Hippenauthor=J.+C.+Cambier&title=Phosphorylated+immunoreceptor+signaling+motifs+%28ITAMs%29+exhibit+unique+abilities+to+bind+and+activate+Lyn+and+Syk+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BA.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DPao%26aufirst%3DL.%26aulast%3DSchneringer%26aufirst%3DJ.%26aulast%3DHippen%26aufirst%3DK.%26aulast%3DCambier%26aufirst%3DJ.%2BC.%26atitle%3DPhosphorylated%2520immunoreceptor%2520signaling%2520motifs%2520%2528ITAMs%2529%2520exhibit%2520unique%2520abilities%2520to%2520bind%2520and%2520activate%2520Lyn%2520and%2520Syk%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Immunol.%26date%3D1995%26volume%3D155%26spage%3D4596%26epage%3D4603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Underhill, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodridge, H. S.</span><span> </span><span class="NLM_article-title">The many faces of ITAMs</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.it.2006.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17197236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=66-73&author=D.+M.+Underhillauthor=H.+S.+Goodridge&title=The+many+faces+of+ITAMs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces of ITAMs</span></div><div class="casAuthors">Underhill, David M.; Goodridge, Helen S.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">66-73</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Innate and adaptive immune responses are regulated by receptors that signal through immunoreceptor tyrosine-based activation motifs (ITAMs).  The mol. basis of ITAM signaling has been extensively characterized and serves as a model for receptor-mediated signal transduction.  Src family kinases typically phosphorylate ITAMs on dual tyrosines, which enable recruitment and activation of Syk family kinases through binding to dual SH2 domains on these kinases.  Examples of ITAM-based signaling that do not conform precisely to the std. model are becoming increasingly common.  ITAMs that suppress signaling under specific conditions and activate under others have been described, as have ITAM-like signaling mechanisms using nonstandard sequence motifs.  Elucidating the diversity of ITAM-based signaling mechanisms will clarify how activating signals generated by ITAMs are tightly regulated and will open opportunities for specific therapeutic manipulation of ITAM-based signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEtzsSmJyxRrVg90H21EOLACvtfcHk0lhjZXDA0UXLdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSgurw%253D&md5=d246311b91627915e89601206be35e7f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2006.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2006.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DUnderhill%26aufirst%3DD.%2BM.%26aulast%3DGoodridge%26aufirst%3DH.%2BS.%26atitle%3DThe%2520many%2520faces%2520of%2520ITAMs%26jtitle%3DTrends%2520Immunol.%26date%3D2007%26volume%3D28%26spage%3D66%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Abram, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C. A.</span><span> </span><span class="NLM_article-title">The expanding role for ITAM-based signaling pathways in immune cells</span> <span class="citation_source-journal">Sci. STKE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span><span class="NLM_issue">377</span><span class="NLM_x">) </span> <span class="NLM_fpage">re2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1126%2Fstke.3772007re2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17356173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ls1WrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=re2&issue=377&author=C.+L.+Abramauthor=C.+A.+Lowell&title=The+expanding+role+for+ITAM-based+signaling+pathways+in+immune+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The expanding role for ITAM-based signaling pathways in immune cells</span></div><div class="casAuthors">Abram Clare L; Lowell Clifford A</div><div class="citationInfo"><span class="NLM_cas:title">Science's STKE : signal transduction knowledge environment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2007</span>
        (<span class="NLM_cas:issue">377</span>),
    <span class="NLM_cas:pages">re2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The immunoreceptor tyrosine-based activation motif (ITAM) is the primary signaling domain used by classical immunoreceptors, such as the antigen receptors on B and T lymphocytes and the Fc receptors (FcRs) on myeloid cells.  The ITAM is contained in the intracellular region of subunits associated with these receptors, often in pairs, or is part of the cytoplasmic domain of the receptors themselves.  Data from many investigators have demonstrated that ITAMs are both necessary and sufficient for initiation of signaling downstream of all immunoreceptors.  More recent reports indicate that ITAM signaling is used by additional receptors beyond the classical immunoreceptors: Cell adhesion molecules (integrins and PSGL-1), chemokine receptors (CXCR4), plexins, and lectin receptors all mediate immune cell function through ITAM-like signaling pathways.  This convergence of intracellular signaling pathways in leukocytes illuminates the importance of tyrosine-based activation motifs in the immune system and suggests that inhibitors of ITAM signaling may have broader effects than originally envisioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-n2lEL3UQYuRS7coPn-RtfW6udTcc2eYRILYUzHIBULntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ls1WrsA%253D%253D&md5=b9dbc541e2de9ba313c84245281c3e48</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1126%2Fstke.3772007re2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fstke.3772007re2%26sid%3Dliteratum%253Aachs%26aulast%3DAbram%26aufirst%3DC.%2BL.%26aulast%3DLowell%26aufirst%3DC.%2BA.%26atitle%3DThe%2520expanding%2520role%2520for%2520ITAM-based%2520signaling%2520pathways%2520in%2520immune%2520cells%26jtitle%3DSci.%2520STKE%26date%3D2007%26issue%3D377%26spage%3Dre2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Cheng, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayday, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span> </span><span class="NLM_article-title">Syk tyrosine kinase required for mouse viability and B-cell development</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=303-306&author=A.+M.+Chengauthor=B.+Rowleyauthor=W.+Paoauthor=A.+Haydayauthor=J.+B.+Bolenauthor=T.+Pawson&title=Syk+tyrosine+kinase+required+for+mouse+viability+and+B-cell+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DA.%2BM.%26aulast%3DRowley%26aufirst%3DB.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DHayday%26aufirst%3DA.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DPawson%26aufirst%3DT.%26atitle%3DSyk%2520tyrosine%2520kinase%2520required%2520for%2520mouse%2520viability%2520and%2520B-cell%2520development%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D303%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duddy, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furlong, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J.</span><span> </span><span class="NLM_article-title">Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=298-302&author=M.+Turnerauthor=P.+J.+Meeauthor=P.+S.+Costelloauthor=O.+Williamsauthor=A.+A.+Priceauthor=L.+P.+Duddyauthor=M.+T.+Furlongauthor=R.+L.+Geahlenauthor=V.+L.+J.+Tybulewicz&title=Perinatal+lethality+and+blocked+B-cell+development+in+mice+lacking+the+tyrosine+kinase+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DMee%26aufirst%3DP.%2BJ.%26aulast%3DCostello%26aufirst%3DP.%2BS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DPrice%26aufirst%3DA.%2BA.%26aulast%3DDuddy%26aufirst%3DL.%2BP.%26aulast%3DFurlong%26aufirst%3DM.%2BT.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ.%26atitle%3DPerinatal%2520lethality%2520and%2520blocked%2520B-cell%2520development%2520in%2520mice%2520lacking%2520the%2520tyrosine%2520kinase%2520Syk%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D298%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Abtahian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerriero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebzda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mócsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepore, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koretzky, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M. L.</span><span> </span><span class="NLM_article-title">Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2003&pages=247-251&author=F.+Abtahianauthor=A.+Guerrieroauthor=E.+Sebzdaauthor=M.+M.+Luauthor=R.+Zhouauthor=A.+M%C3%B3csaiauthor=E.+E.+Myersauthor=B.+Huangauthor=D.+G.+Jacksonauthor=V.+A.+Ferrariauthor=V.+Tybulewiczauthor=C.+A.+Lowellauthor=J.+J.+Leporeauthor=G.+A.+Koretzkyauthor=M.+L.+Kahn&title=Regulation+of+blood+and+lymphatic+vascular+separation+by+signaling+proteins+SLP-76+and+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbtahian%26aufirst%3DF.%26aulast%3DGuerriero%26aufirst%3DA.%26aulast%3DSebzda%26aufirst%3DE.%26aulast%3DLu%26aufirst%3DM.%2BM.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26aulast%3DMyers%26aufirst%3DE.%2BE.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DJackson%26aufirst%3DD.%2BG.%26aulast%3DFerrari%26aufirst%3DV.%2BA.%26aulast%3DTybulewicz%26aufirst%3DV.%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DLepore%26aufirst%3DJ.%2BJ.%26aulast%3DKoretzky%26aufirst%3DG.%2BA.%26aulast%3DKahn%26aufirst%3DM.%2BL.%26atitle%3DRegulation%2520of%2520blood%2520and%2520lymphatic%2520vascular%2520separation%2520by%2520signaling%2520proteins%2520SLP-76%2520and%2520Syk%26jtitle%3DScience%26date%3D2003%26volume%3D299%26spage%3D247%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Jakus, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balàzs, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mócsai, A.</span><span> </span><span class="NLM_article-title">Genetic deficiency of Syk protects mice from autoantibody-induced arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1899</span><span class="NLM_x">–</span> <span class="NLM_lpage">1910</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20201079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1899-1910&author=Z.+Jakusauthor=E.+Simonauthor=B.+Bal%C3%A0zsauthor=A.+M%C3%B3csai&title=Genetic+deficiency+of+Syk+protects+mice+from+autoantibody-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic deficiency of Syk protects mice from autoantibody-induced arthritis</span></div><div class="casAuthors">Jakus, Zoltan; Simon, Edina; Balazs, Balint; Mocsai, Attila</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1899-1910</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: The Syk tyrosine kinase plays an important role in diverse functions in hematopoietic lineage cells.  Although previous in vitro and pharmacol. analyses suggested Syk to be a possible player in the development of autoimmune arthritis, no in vivo genetic studies addressing that issue have yet been reported.  The aim of the present study was to test whether genetic deficiency of Syk affects autoantibody-induced exptl. arthritis in the K/BxN serumtransfer model.  Methods: Syk-/- bone marrow chimeras carrying a Syk-deficient hematopoietic system were generated by transplanting Syk-/- fetal liver cells into lethally irradiated wild-type recipients.  After complete repopulation of the hematopoietic compartment, autoantibody-mediated arthritis was induced by injection of arthritogenic K/BxN serum.  Arthritis development was monitored by macroscopic and microscopic observation of the ankle joints, micro-computed tomog. of bone morphol., as well as joint function assay.  Results: Genetic deficiency of Syk in the hematopoietic compartment completely blocked the development of all macroscopic and microscopic signs of arthritis.  The Syk-/- mutation also prevented the appearance of periarticular bone erosions.  Finally, Syk-/- bone marrow chimeras were completely protected from arthritis-induced loss of articular function.  Conclusion: Our results indicate that Syk is critically involved in the development of all clin. relevant aspects of autoantibody-mediated K/BxN serumtransfer arthritis in exptl. mice.  These results provide the first in vivo genetic evidence of the role of Syk in the development of autoimmune arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMg3hF7NyGgrVg90H21EOLACvtfcHk0ljoKwd7kD95JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqsL%252FO&md5=0dfab55caa648c3c556fcc8a63ba9a4f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakus%26aufirst%3DZ.%26aulast%3DSimon%26aufirst%3DE.%26aulast%3DBal%25C3%25A0zs%26aufirst%3DB.%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26atitle%3DGenetic%2520deficiency%2520of%2520Syk%2520protects%2520mice%2520from%2520autoantibody-induced%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D1899%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Sedlik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamberale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioan-Facsinay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricciardi-Castagnoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnerot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amigorena, S.</span><span> </span><span class="NLM_article-title">A critical role for SYK protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">846</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=846-852&author=C.+Sedlikauthor=D.+Orbachauthor=P.+Veronauthor=E.+Schweighofferauthor=F.+Colucciauthor=R.+Gamberaleauthor=A.+Ioan-Facsinayauthor=S.+Verbeekauthor=P.+Ricciardi-Castagnoliauthor=C.+Bonnerotauthor=V.+L.+Tybulewiczauthor=J.+Di+Santoauthor=S.+Amigorena&title=A+critical+role+for+SYK+protein+tyrosine+kinase+in+Fc+receptor-mediated+antigen+presentation+and+induction+of+dendritic+cell+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSedlik%26aufirst%3DC.%26aulast%3DOrbach%26aufirst%3DD.%26aulast%3DVeron%26aufirst%3DP.%26aulast%3DSchweighoffer%26aufirst%3DE.%26aulast%3DColucci%26aufirst%3DF.%26aulast%3DGamberale%26aufirst%3DR.%26aulast%3DIoan-Facsinay%26aufirst%3DA.%26aulast%3DVerbeek%26aufirst%3DS.%26aulast%3DRicciardi-Castagnoli%26aufirst%3DP.%26aulast%3DBonnerot%26aufirst%3DC.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%26aulast%3DDi%2BSanto%26aufirst%3DJ.%26aulast%3DAmigorena%26aufirst%3DS.%26atitle%3DA%2520critical%2520role%2520for%2520SYK%2520protein%2520tyrosine%2520kinase%2520in%2520Fc%2520receptor-mediated%2520antigen%2520presentation%2520and%2520induction%2520of%2520dendritic%2520cell%2520maturation%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D846%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Crowley, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzer-Attas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFranco, A. L.</span><span> </span><span class="NLM_article-title">A critical role for Syk in signal transduction and phagocytosis mediated by Fcγ receptors on macrophages</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=1997&pages=1027-1039&author=M.+T.+Crowleyauthor=P.+S.+Costelloauthor=C.+J.+Fitzer-Attasauthor=M.+Turnerauthor=F.+Mengauthor=C.+Lowellauthor=V.+L.+J.+Tybulewiczauthor=A.+L.+DeFranco&title=A+critical+role+for+Syk+in+signal+transduction+and+phagocytosis+mediated+by+Fc%CE%B3+receptors+on+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DM.%2BT.%26aulast%3DCostello%26aufirst%3DP.%2BS.%26aulast%3DFitzer-Attas%26aufirst%3DC.%2BJ.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DLowell%26aufirst%3DC.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ.%26aulast%3DDeFranco%26aufirst%3DA.%2BL.%26atitle%3DA%2520critical%2520role%2520for%2520Syk%2520in%2520signal%2520transduction%2520and%2520phagocytosis%2520mediated%2520by%2520Fc%25CE%25B3%2520receptors%2520on%2520macrophages%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1997%26volume%3D186%26spage%3D1027%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Efremov, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurenti, L.</span><span> </span><span class="NLM_article-title">The Syk kinase as a therapeutic target in leukemia and lymphoma</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=623-636&author=D.+G.+Efremovauthor=L.+Laurenti&title=The+Syk+kinase+as+a+therapeutic+target+in+leukemia+and+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEfremov%26aufirst%3DD.%2BG.%26aulast%3DLaurenti%26aufirst%3DL.%26atitle%3DThe%2520Syk%2520kinase%2520as%2520a%2520therapeutic%2520target%2520in%2520leukemia%2520and%2520lymphoma%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D623%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Coopman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowden, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basyuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blancato, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezza, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeskey, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangeat, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S. C.</span><span> </span><span class="NLM_article-title">The SYK tyrosine kinase suppresses malignant growth of human breast cancer cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">406</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=742-747&author=P.+J.+Coopmanauthor=M.+T.+Doauthor=M.+Barthauthor=E.+T.+Bowdenauthor=A.+J.+Hayesauthor=E.+Basyukauthor=J.+K.+Blancatoauthor=P.+R.+Vezzaauthor=S.+W.+McLeskeyauthor=P.+H.+Mangeatauthor=S.+C.+Mueller&title=The+SYK+tyrosine+kinase+suppresses+malignant+growth+of+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoopman%26aufirst%3DP.%2BJ.%26aulast%3DDo%26aufirst%3DM.%2BT.%26aulast%3DBarth%26aufirst%3DM.%26aulast%3DBowden%26aufirst%3DE.%2BT.%26aulast%3DHayes%26aufirst%3DA.%2BJ.%26aulast%3DBasyuk%26aufirst%3DE.%26aulast%3DBlancato%26aufirst%3DJ.%2BK.%26aulast%3DVezza%26aufirst%3DP.%2BR.%26aulast%3DMcLeskey%26aufirst%3DS.%2BW.%26aulast%3DMangeat%26aufirst%3DP.%2BH.%26aulast%3DMueller%26aufirst%3DS.%2BC.%26atitle%3DThe%2520SYK%2520tyrosine%2520kinase%2520suppresses%2520malignant%2520growth%2520of%2520human%2520breast%2520cancer%2520cells%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D742%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Coopman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S. C.</span><span> </span><span class="NLM_article-title">The SYK tyrosine kinase: a new negative regulator in tumor growth and progression</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.canlet.2005.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16442709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2ms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2006&pages=159-173&author=P.+J.+Coopmanauthor=S.+C.+Mueller&title=The+SYK+tyrosine+kinase%3A+a+new+negative+regulator+in+tumor+growth+and+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Syk tyrosine kinase: A new negative regulator in tumor growth and progression</span></div><div class="casAuthors">Coopman, Peter J.; Mueller, Susette C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-173</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The spleen tyrosine kinase Syk was long thought to be a hematopoietic cell-specific signaling mol.  Recent evidence demonstrated that it is also expressed by many non-hematopoietic cell types and that it plays a neg. role in cancer.  A significant drop in its expression was first obsd. during breast cancer progression, but an anomalous Syk expression has now also been evidenced in many other tumor types.  Mechanistic studies using Syk re-expression demonstrated its suppressive function in tumorigenesis and metastasis formation, which is surprising for a tyrosine kinase.  Loss of Syk expression is regulated, albeit not exclusively, by its promoter hypermethylation.  The mol. mechanism of its tumor-suppressive function remains largely unknown; the identification of its activators and effectors in non-hematopoietic cells will be a challenge for the years to come.  An increasing no. of clin. studies reveal a correlation between reduced Syk expression and an increased risk for metastasis formation, and assign Syk as a potential new prognostic marker in different tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsb5arUIVnUbVg90H21EOLACvtfcHk0ljoKwd7kD95JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2ms7Y%253D&md5=8b02c95328d67f3b9fb2626c86f2dd64</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DCoopman%26aufirst%3DP.%2BJ.%26aulast%3DMueller%26aufirst%3DS.%2BC.%26atitle%3DThe%2520SYK%2520tyrosine%2520kinase%253A%2520a%2520new%2520negative%2520regulator%2520in%2520tumor%2520growth%2520and%2520progression%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D241%26spage%3D159%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Ross, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Rijin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergamenschikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashkari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span> </span><span class="NLM_article-title">Systematic variation in gene expression patterns in human cancer cell lines</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2F73432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10700174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=227-235&author=D.+T.+Rossauthor=U.+Scherfauthor=M.+B.+Eisenauthor=C.+M.+Perouauthor=C.+Reesauthor=P.+Spellmanauthor=V.+Iyerauthor=S.+S.+Jeffreyauthor=M.+Van+de+Rijinauthor=M.+Walthamauthor=A.+Pergamenschikovauthor=J.+C.+F.+Leeauthor=D.+Lashkariauthor=D.+Shalonauthor=T.+G.+Myersauthor=J.+N.+Weinsteinauthor=D.+Botsteinauthor=P.+O.+Brown&title=Systematic+variation+in+gene+expression+patterns+in+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic variation in gene expression patterns in human cancer cell lines</span></div><div class="casAuthors">Ross, Douglas T.; Scherf, Uwe; Eisen, Michael B.; Perou, Charles M.; Rees, Christian; Spellman, Paul; Iyer, Vishwanath; Jeffrey, Stefanie S.; Van de Rijn, Matt; Waltham, Mark; Pergamenschikov, Alexander; Lee, Jeffrey C. F.; Lashkari, Deval; Shalon, Dari; Myers, Timothy G.; Weinstein, John N.; Botstein, David; Brown, Patrick O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-235</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">We used cDNA microarrays to explore the variation in expression of approx. 8,000 unique genes among the 60 cell lines used in the National Cancer Institute's screen for anti-cancer drugs.  Classification of the cell lines based solely on the obsd. patterns of gene expression revealed a correspondence to the ostensible origins of the tumors from which the cell lines were derived.  The consistent relationship between the gene expression patterns and the tissue of origin allowed us to recognize outliers whose previous classification appeared incorrect.  Specific features of the gene expression patterns appeared to be related to physiol. properties of the cell lines, such as their doubling time in culture, drug metab. or the interferon response.  Comparison of gene expression patterns in the cell lines to those obsd. in normal breast tissue or in breast tumor specimens revealed features of the expression patterns in the tumors that had recognizable counterparts in specific cell lines, reflecting the tumor, stromal and inflammatory components of the tumor tissue.  These results provided a novel mol. characterization of this important group of human cell lines and their relationships to tumors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZhocezjCTNbVg90H21EOLACvtfcHk0li6ZUmQW2EgHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrg%253D&md5=248ffa9428fa078fff0bdf45fddaecf4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2F73432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F73432%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DScherf%26aufirst%3DU.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DRees%26aufirst%3DC.%26aulast%3DSpellman%26aufirst%3DP.%26aulast%3DIyer%26aufirst%3DV.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DVan%2Bde%2BRijin%26aufirst%3DM.%26aulast%3DWaltham%26aufirst%3DM.%26aulast%3DPergamenschikov%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DJ.%2BC.%2BF.%26aulast%3DLashkari%26aufirst%3DD.%26aulast%3DShalon%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DBotstein%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26atitle%3DSystematic%2520variation%2520in%2520gene%2520expression%2520patterns%2520in%2520human%2520cancer%2520cell%2520lines%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D24%26spage%3D227%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Neve, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridlyand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baehner, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fevr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppe, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilwell, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.ccr.2006.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17157791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCnsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=515-527&author=R.+M.+Neveauthor=K.+Chinauthor=J.+Fridlyandauthor=J.+Yehauthor=F.+L.+Baehnerauthor=T.+Fevrauthor=L.+Clarkauthor=N.+Bayaniauthor=J.-P.+Coppeauthor=F.+Tongauthor=T.+Speedauthor=P.+T.+Spellmanauthor=S.+De+Vriesauthor=A.+Lapukauthor=N.+J.+Wangauthor=W.-L.+Kuoauthor=J.+L.+Stilwellauthor=D.+Pinkelauthor=D.+G.+Albertsonauthor=F.+M.+Waldmanauthor=F.+McCormickauthor=R.+B.+Dicksonauthor=M.+D.+Johnsonauthor=M.+Lippmanauthor=S.+Ethierauthor=A.+Gazdarauthor=J.+W.+Gray&title=A+collection+of+breast+cancer+cell+lines+for+the+study+of+functionally+distinct+cancer+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes</span></div><div class="casAuthors">Neve, Richard M.; Chin, Koei; Fridlyand, Jane; Yeh, Jennifer; Baehner, Frederick L.; Fevr, Tea; Clark, Laura; Bayani, Nora; Coppe, Jean-Philippe; Tong, Frances; Speed, Terry; Spellman, Paul T.; DeVries, Sandy; Lapuk, Anna; Wang, Nick J.; Kuo, Wen-Lin; Stilwell, Jackie L.; Pinkel, Daniel; Albertson, Donna G.; Waldman, Frederic M.; McCormick, Frank; Dickson, Robert B.; Johnson, Michael D.; Lippman, Marc; Ethier, Stephen; Gazdar, Adi; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">515-527</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recent studies suggest that thousands of genes may contribute to breast cancer pathophysiologies when deregulated by genomic or epigenomic events.  Here, we describe a model "system" to appraise the functional contributions of these genes to breast cancer subsets.  In general, the recurrent genomic and transcriptional characteristics of 51 breast cancer cell lines mirror those of 145 primary breast tumors, although some significant differences are documented.  The cell lines that comprise the system also exhibit the substantial genomic, transcriptional, and biol. heterogeneity found in primary tumors.  We show, using Trastuzumab (Herceptin) monotherapy as an example, that the system can be used to identify mol. features that predict or indicate response to targeted therapies or other physiol. perturbations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprHlT0rEcwBrVg90H21EOLACvtfcHk0li6ZUmQW2EgHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCnsrbE&md5=218682c6f7ffebff329208d476ab35ad</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DNeve%26aufirst%3DR.%2BM.%26aulast%3DChin%26aufirst%3DK.%26aulast%3DFridlyand%26aufirst%3DJ.%26aulast%3DYeh%26aufirst%3DJ.%26aulast%3DBaehner%26aufirst%3DF.%2BL.%26aulast%3DFevr%26aufirst%3DT.%26aulast%3DClark%26aufirst%3DL.%26aulast%3DBayani%26aufirst%3DN.%26aulast%3DCoppe%26aufirst%3DJ.-P.%26aulast%3DTong%26aufirst%3DF.%26aulast%3DSpeed%26aufirst%3DT.%26aulast%3DSpellman%26aufirst%3DP.%2BT.%26aulast%3DDe%2BVries%26aufirst%3DS.%26aulast%3DLapuk%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%2BJ.%26aulast%3DKuo%26aufirst%3DW.-L.%26aulast%3DStilwell%26aufirst%3DJ.%2BL.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DAlbertson%26aufirst%3DD.%2BG.%26aulast%3DWaldman%26aufirst%3DF.%2BM.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DDickson%26aufirst%3DR.%2BB.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26aulast%3DLippman%26aufirst%3DM.%26aulast%3DEthier%26aufirst%3DS.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DA%2520collection%2520of%2520breast%2520cancer%2520cell%2520lines%2520for%2520the%2520study%2520of%2520functionally%2520distinct%2520cancer%2520subtypes%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D515%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span> </span><span class="NLM_article-title">Reply</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.jaci.2006.12.667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17321574" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2007&pages=1277-1279&author=E.+S.+Masudaauthor=E.+B.+Grossbardauthor=D.+G.+Payan&title=Reply"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2006.12.667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2006.12.667%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26atitle%3DReply%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2007%26volume%3D119%26spage%3D1277%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sørlie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Rijn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akslen, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluge, Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergamenschikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lønning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Børresen-Dale, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botstein, D.</span><span> </span><span class="NLM_article-title">Molecular portraits of human breast tumours</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">406</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2F35021093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10963602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1CnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=747-752&author=C.+M.+Perouauthor=T.+S%C3%B8rlieauthor=M.+B.+Eisenauthor=M.+van+de+Rijnauthor=S.+S.+Jeffreyauthor=C.+A.+Reesauthor=J.+R.+Pollackauthor=D.+T.+Rossauthor=H.+Johnsenauthor=L.+A.+Akslenauthor=%C3%98.+Flugeauthor=A.+Pergamenschikovauthor=C.+Williamsauthor=S.+X.+Zhuauthor=P.+E.+L%C3%B8nningauthor=A.-L.+B%C3%B8rresen-Daleauthor=P.+O.+Brownauthor=D.+Botstein&title=Molecular+portraits+of+human+breast+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular portraits of human breast tumors</span></div><div class="casAuthors">Perou, Charles M.; Serlie, Therese; Eisen, Michael B.; Van De Rijn, Matt; Jeffrey, Stefanie S.; Rees, Christian A.; Pollack, Jonathan R.; Rossi, Douglas T.; Johnsen, Hilde; Akslen, Lars A.; Fluge, Oystein; Pergamenschikov, Alexander; Williams, Cheryl; Zhu, Shirley X.; Lenning, Per E.; Berresen-Dale, Anne-Use; Brown, Patrick O.; Botstein, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6797</span>),
    <span class="NLM_cas:pages">747-752</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human breast tumors are diverse in their natural history and in their responsiveness to treatments.  Variation in transcriptional programs accounts for much of the biol. diversity of human cells and tumors.  In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome.  Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumors from 42 different individuals, using cDNA microarrays representing 8102 human genes.  These patterns provided a distinctive mol. portrait of each tumor.  Twenty of the tumors were sampled twice, before and after a 16-wk course of doxorubicin chemotherapy, and two tumors were paired with a lymph node metastasis from the same patient.  Gene expression patterns in two tumor samples from the same individual were almost always more similar to each other than either was to any other sample.  Sets of co-expressed genes were identified for which variation in mRNA levels could be related to specific features of physiol. variation.  The tumors could be classified into subtypes distinguished by pervasive differences in their gene expression patterns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorYsVvqq_EyLVg90H21EOLACvtfcHk0ljECypoM2mGPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1CnsLw%253D&md5=f81e9b3e3d5e339ea463428b1c973f8d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2F35021093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35021093%26sid%3Dliteratum%253Aachs%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DS%25C3%25B8rlie%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DRees%26aufirst%3DC.%2BA.%26aulast%3DPollack%26aufirst%3DJ.%2BR.%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DJohnsen%26aufirst%3DH.%26aulast%3DAkslen%26aufirst%3DL.%2BA.%26aulast%3DFluge%26aufirst%3D%25C3%2598.%26aulast%3DPergamenschikov%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DS.%2BX.%26aulast%3DL%25C3%25B8nning%26aufirst%3DP.%2BE.%26aulast%3DB%25C3%25B8rresen-Dale%26aufirst%3DA.-L.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DBotstein%26aufirst%3DD.%26atitle%3DMolecular%2520portraits%2520of%2520human%2520breast%2520tumours%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D747%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">van’t Veer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Vijver, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterse, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kooy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witteveen, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkhoven, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsley, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span> </span><span class="NLM_article-title">Gene expression profiling predicts clinical outcome of breast cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=530-536&author=L.+J.+van%E2%80%99t+Veerauthor=H.+Daiauthor=M.+J.+van+de+Vijverauthor=Y.+D.+Heauthor=A.+A.+M.+Hartauthor=M.+Maoauthor=H.+L.+Peterseauthor=K.+van+der+Kooyauthor=M.+J.+Martonauthor=A.+T.+Witteveenauthor=G.+J.+Schreiberauthor=R.+M.+Kerkhovenauthor=C.+Robertsauthor=P.+S.+Linsleyauthor=R.+Bernardsauthor=S.+H.+Friend&title=Gene+expression+profiling+predicts+clinical+outcome+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%25E2%2580%2599t%2BVeer%26aufirst%3DL.%2BJ.%26aulast%3DDai%26aufirst%3DH.%26aulast%3Dvan%2Bde%2BVijver%26aufirst%3DM.%2BJ.%26aulast%3DHe%26aufirst%3DY.%2BD.%26aulast%3DHart%26aufirst%3DA.%2BA.%2BM.%26aulast%3DMao%26aufirst%3DM.%26aulast%3DPeterse%26aufirst%3DH.%2BL.%26aulast%3Dvan%2Bder%2BKooy%26aufirst%3DK.%26aulast%3DMarton%26aufirst%3DM.%2BJ.%26aulast%3DWitteveen%26aufirst%3DA.%2BT.%26aulast%3DSchreiber%26aufirst%3DG.%2BJ.%26aulast%3DKerkhoven%26aufirst%3DR.%2BM.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DLinsley%26aufirst%3DP.%2BS.%26aulast%3DBernards%26aufirst%3DR.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26atitle%3DGene%2520expression%2520profiling%2520predicts%2520clinical%2520outcome%2520of%2520breast%2520cancer%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D530%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuyten, D. S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobel, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van’t Veer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span> </span><span class="NLM_article-title">Concordance among gene-expression-based predictors for breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1056%2FNEJMoa052933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16899776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVKnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=560-569&author=C.+Fanauthor=D.+S.+Ohauthor=L.+Wesselsauthor=B.+Weigeltauthor=D.+S.+A.+Nuytenauthor=A.+B.+Nobelauthor=L.+J.+van%E2%80%99t+Veerauthor=C.+M.+Perou&title=Concordance+among+gene-expression-based+predictors+for+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Concordance among gene-expression-based predictors for breast cancer</span></div><div class="casAuthors">Fan, Cheng; Oh, Daniel S.; Wessels, Lodewyk; Weigelt, Britta; Nuyten, Dimitry S. A.; Nobel, Andrew B.; van't Veer, Laura J.; Perou, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">560-569</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Gene-expression-profiling studies of primary breast tumors performed by different labs. have resulted in the identification of a no. of distinct prognostic profiles, or gene sets, with little overlap in terms of gene identity.  METHODS: To compare the predictions derived from these gene sets for individual samples, we obtained a single data set of 295 samples and applied five gene-expression-based models: intrinsic subtypes, 70-gene profile, wound response, recurrence score, and the two-gene ratio (for patients who had been treated with tamoxifen).  RESULTS: We found that most models had high rates of concordance in their outcome predictions for the individual samples.  In particular, almost all tumors identified as having an intrinsic subtype of basal-like, HER2-pos. and estrogen-receptor-neg., or luminal B (assocd. with a poor prognosis) were also classified as having a poor 70-gene profile, activated wound response, and high recurrence score.  The 70-gene and recurrence-score models, which are beginning to be used in the clin. setting, showed 77 to 81 % agreement in outcome classification.  CONCLUSIONS: Even though different gene sets were used for prognostication in patients with breast cancer, four of the five tested showed significant agreement in the outcome predictions for individual patients and are probably tracking a common set of biol. phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ2DPq9UVqQ7Vg90H21EOLACvtfcHk0ljECypoM2mGPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVKnur4%253D&md5=8ed145dc04309fda37bfa779927a87cb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052933%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DC.%26aulast%3DOh%26aufirst%3DD.%2BS.%26aulast%3DWessels%26aufirst%3DL.%26aulast%3DWeigelt%26aufirst%3DB.%26aulast%3DNuyten%26aufirst%3DD.%2BS.%2BA.%26aulast%3DNobel%26aufirst%3DA.%2BB.%26aulast%3Dvan%25E2%2580%2599t%2BVeer%26aufirst%3DL.%2BJ.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26atitle%3DConcordance%2520among%2520gene-expression-based%2520predictors%2520for%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D560%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Chin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teschendorff, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marioni, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa-Morais, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinder, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Wiel, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavaré, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ylstra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, C.</span><span> </span><span class="NLM_article-title">High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer</span> <span class="citation_source-journal">Genome Biol. [Online]</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">R215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=R215&author=S.+F.+Chinauthor=A.+E.+Teschendorffauthor=J.+C.+Marioniauthor=Y.+Wangauthor=N.+L.+Barbosa-Moraisauthor=N.+P.+Thorneauthor=J.+L.+Costaauthor=S.+E.+Pinderauthor=M.+A.+van+de+Wielauthor=A.+R.+Greenauthor=I.+O.+Ellisauthor=P.+L.+Porterauthor=S.+Tavar%C3%A9author=J.+D.+Brentonauthor=B.+Ylstraauthor=C.+Caldas&title=High-resolution+aCGH+and+expression+profiling+identifies+a+novel+genomic+subtype+of+ER+negative+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DS.%2BF.%26aulast%3DTeschendorff%26aufirst%3DA.%2BE.%26aulast%3DMarioni%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBarbosa-Morais%26aufirst%3DN.%2BL.%26aulast%3DThorne%26aufirst%3DN.%2BP.%26aulast%3DCosta%26aufirst%3DJ.%2BL.%26aulast%3DPinder%26aufirst%3DS.%2BE.%26aulast%3Dvan%2Bde%2BWiel%26aufirst%3DM.%2BA.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DEllis%26aufirst%3DI.%2BO.%26aulast%3DPorter%26aufirst%3DP.%2BL.%26aulast%3DTavar%25C3%25A9%26aufirst%3DS.%26aulast%3DBrenton%26aufirst%3DJ.%2BD.%26aulast%3DYlstra%26aufirst%3DB.%26aulast%3DCaldas%26aufirst%3DC.%26atitle%3DHigh-resolution%2520aCGH%2520and%2520expression%2520profiling%2520identifies%2520a%2520novel%2520genomic%2520subtype%2520of%2520ER%2520negative%2520breast%2520cancer%26jtitle%3DGenome%2520Biol.%2520%255BOnline%255D%26date%3D2007%26volume%3D8%26spage%3DR215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Bertucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rougemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charafe-Jauffret, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervera, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarpin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xerri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houlgatte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span> </span><span class="NLM_article-title">Gene expression profiling identifies molecular subtypes of inflammatory breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">2170</span><span class="NLM_x">–</span> <span class="NLM_lpage">2178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2170-2178&author=F.+Bertucciauthor=P.+Finettiauthor=J.+Rougemontauthor=E.+Charafe-Jauffretauthor=N.+Cerveraauthor=C.+Tarpinauthor=C.+Nguyenauthor=L.+Xerriauthor=R.+Houlgatteauthor=J.+Jacquemierauthor=P.+Viensauthor=D.+Birnbaum&title=Gene+expression+profiling+identifies+molecular+subtypes+of+inflammatory+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertucci%26aufirst%3DF.%26aulast%3DFinetti%26aufirst%3DP.%26aulast%3DRougemont%26aufirst%3DJ.%26aulast%3DCharafe-Jauffret%26aufirst%3DE.%26aulast%3DCervera%26aufirst%3DN.%26aulast%3DTarpin%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DXerri%26aufirst%3DL.%26aulast%3DHoulgatte%26aufirst%3DR.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DViens%26aufirst%3DP.%26aulast%3DBirnbaum%26aufirst%3DD.%26atitle%3DGene%2520expression%2520profiling%2520identifies%2520molecular%2520subtypes%2520of%2520inflammatory%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D2170%26epage%3D2178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, T.</span><span> </span><span class="NLM_article-title">Establishment of the superoxide production assay with human monocytic cell line, U937, for the evaluation of Syk kinase inhibitors</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0022-1759%2802%2900188-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12215380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2002&pages=123-130&author=N.+Yamamotoauthor=M.+Shichijoauthor=T.+Kokubo&title=Establishment+of+the+superoxide+production+assay+with+human+monocytic+cell+line%2C+U937%2C+for+the+evaluation+of+Syk+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Establishment of the superoxide production assay with human monocytic cell line, U937, for the evaluation of Syk kinase inhibitors</span></div><div class="casAuthors">Yamamoto, Noriyuki; Shichijo, Michitaka; Kokubo, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-130</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Protein tyrosine kinase Syk is known to play crit. roles in the signal transduction from receptors for Fc portion of Igs (FcRs) and B cell receptor complex (BCR).  Its importance was well studied in FcεRI-induced activation of mast cells; therefore, Syk inhibitors are expected to have anti-allergic effects and to be novel therapy for allergic diseases, such as asthma, allergic rhinitis and atopic dermatitis.  We previously developed an enzyme assay of recombinant human Syk kinase for the high throughput screening.  In order to evaluate the Syk kinase inhibitors in a human cell system, we have developed an assay with human monocytic cell line, U937, to monitor FcγRI-mediated superoxide prodn.  We treated cells with IFN-γ to enhance the expression of FcγRI and to obtain enough prodn. of superoxide.  Engagement of FcγRI stimulated superoxide prodn., which was accompanied with Syk phosphorylation.  PMA, an activator of protein kinase C, also evoked superoxide prodn., but Syk was not phosphorylated.  Moreover, the treatment of cells with antisense oligonucleotide against syk attenuated Syk protein expression and suppressed superoxide prodn. induced by FcγRI-engagement, but not by PMA.  These results confirm that Syk is involved in the signal transduction from FcγRI upstream of PKC in U937 cells and we can evaluate the efficacy and the selectivity of Syk inhibitors with this assay system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRSzIv0lq517Vg90H21EOLACvtfcHk0ljlANLldcXtng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yitrs%253D&md5=fa214d24c90f1d9d966ea30c3cc277d5</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0022-1759%2802%2900188-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1759%252802%252900188-6%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DKokubo%26aufirst%3DT.%26atitle%3DEstablishment%2520of%2520the%2520superoxide%2520production%2520assay%2520with%2520human%2520monocytic%2520cell%2520line%252C%2520U937%252C%2520for%2520the%2520evaluation%2520of%2520Syk%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D2002%26volume%3D268%26spage%3D123%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegelbauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, T.</span><span> </span><span class="NLM_article-title">Development of a high-throughput fluoroimmunoasassy for Syk kinase and Syk kinase inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2003&pages=256-261&author=N.+Yamamotoauthor=H.+Hasegawaauthor=H.+Sekiauthor=K.+Ziegelbauerauthor=T.+Yasuda&title=Development+of+a+high-throughput+fluoroimmunoasassy+for+Syk+kinase+and+Syk+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DHasegawa%26aufirst%3DH.%26aulast%3DSeki%26aufirst%3DH.%26aulast%3DZiegelbauer%26aufirst%3DK.%26aulast%3DYasuda%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520a%2520high-throughput%2520fluoroimmunoasassy%2520for%2520Syk%2520kinase%2520and%2520Syk%2520kinase%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D315%26spage%3D256%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luraghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deakin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E. M.</span><span> </span><span class="NLM_article-title">Kinetic assay for characterization of spleen tyrosine kinase activity and inhibition with recombinant kinase and crude cell lysates</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2009&pages=56-67&author=M.+Liauthor=P.+Luraghiauthor=A.+Amourauthor=X.+D.+Qianauthor=P.+S.+Carterauthor=C.+J.+Clarkauthor=A.+Deakinauthor=J.+Denyerauthor=C.+I.+Hobbsauthor=M.+Surbyauthor=V.+K.+Patelauthor=E.+M.+Schaefer&title=Kinetic+assay+for+characterization+of+spleen+tyrosine+kinase+activity+and+inhibition+with+recombinant+kinase+and+crude+cell+lysates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLuraghi%26aufirst%3DP.%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DQian%26aufirst%3DX.%2BD.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DClark%26aufirst%3DC.%2BJ.%26aulast%3DDeakin%26aufirst%3DA.%26aulast%3DDenyer%26aufirst%3DJ.%26aulast%3DHobbs%26aufirst%3DC.%2BI.%26aulast%3DSurby%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSchaefer%26aufirst%3DE.%2BM.%26atitle%3DKinetic%2520assay%2520for%2520characterization%2520of%2520spleen%2520tyrosine%2520kinase%2520activity%2520and%2520inhibition%2520with%2520recombinant%2520kinase%2520and%2520crude%2520cell%2520lysates%26jtitle%3DAnal.%2520Biochem.%26date%3D2009%26volume%3D384%26spage%3D56%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Singh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saini, K. S.</span><span> </span><span class="NLM_article-title">Human spleen tyrosine kinase (Syk) recombinant expression systems for high-throughput assays</span> <span class="citation_source-journal">Biotechnol. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fbiot.200900139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20013945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVaqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=201-212&author=D.+Singhauthor=R.+Raniauthor=R.+Rajendranauthor=N.+J.+Kaurauthor=A.+Pandeyauthor=P.+Chopraauthor=T.+Jainauthor=M.+K.+Jainauthor=S.+Groverauthor=R.+Aryaauthor=K.+S.+Saini&title=Human+spleen+tyrosine+kinase+%28Syk%29+recombinant+expression+systems+for+high-throughput+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Human spleen tyrosine kinase (Syk) recombinant expression systems for high-throughput assays</span></div><div class="casAuthors">Singh, Deepika; Rani, Reema; Rajendran, Resmi; Kaur, Namrata Jit; Pandey, Abhinav; Chopra, Puneet; Jain, Tarun; Jain, Manish Kumar; Grover, Sonam; Arya, Ranjana; Saini, Kulvinder Singh</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-212</span>CODEN:
                <span class="NLM_cas:coden">BJIOAM</span>;
        ISSN:<span class="NLM_cas:issn">1860-6768</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is an important non-receptor tyrosine kinase and its aberrant regulation is assocd. with a variety of allergic disorders and autoimmune diseases.  To identify small mol. inhibitors of Syk in high-throughput assays, recombinant Syk protein is needed in bulk quantity.  The expression of recombinant human Syk in was studied in three heterologous systems: Escherichia coli, baculovirus expression vector system (BEVS), and the cellular slime mold Dictyostelium discoideum (Dd).  Syk activity was higher in the BEVS as compared to the Dd expression host, whereas in E. coli, no activity was obsd. under the assay conditions.  Purified Syk kinase domain protein from BEVS showed concn. dependent inhibition with OXSI-2, a known Syk inhibitor.  Mol. modeling and docking studies were performed to understand the binding mode and crit. interactions of the inhibitor with catalytic domain of Syk.  The BEVS generated Syk kinase domain showed stability upon multiple freeze-thaw cycles and exhibited significantly higher levels of tyrosine phosphorylation at pTyr525/Tyr526 in the Syk activation loop.  Based on the data, it is concluded that BEVS is the ideal host to produce an active and stable enzyme, which can be successfully employed for screening of Syk inhibitors in a high-throughput system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptM6jBePXyW7Vg90H21EOLACvtfcHk0ljlANLldcXtng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVaqtLs%253D&md5=a08a7142e2ce0126376c3322881d782f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fbiot.200900139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbiot.200900139%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DD.%26aulast%3DRani%26aufirst%3DR.%26aulast%3DRajendran%26aufirst%3DR.%26aulast%3DKaur%26aufirst%3DN.%2BJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DT.%26aulast%3DJain%26aufirst%3DM.%2BK.%26aulast%3DGrover%26aufirst%3DS.%26aulast%3DArya%26aufirst%3DR.%26aulast%3DSaini%26aufirst%3DK.%2BS.%26atitle%3DHuman%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%2520recombinant%2520expression%2520systems%2520for%2520high-throughput%2520assays%26jtitle%3DBiotechnol.%2520J.%26date%3D2010%26volume%3D5%26spage%3D201%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Kinet, J. P.</span><span> </span><span class="NLM_article-title">The high-affinity IgE receptor (FcεRI): from physiology to pathology</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1146%2Fannurev.immunol.17.1.931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10358778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVWls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=931-972&author=J.+P.+Kinet&title=The+high-affinity+IgE+receptor+%28Fc%CE%B5RI%29%3A+from+physiology+to+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The high-affinity IgE receptor (FcεRI): From physiology to pathology</span></div><div class="casAuthors">Kinet, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">931-972</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 249 refs.  The high affinity receptor for IgE (designated Fc.vepsiln.RI) is the member of the antigen (Ag) receptor superfamily responsible for linking pathogen-or allergen-specific IgEs with cellular immunol. effector functions.  This review provides background information on Fc.vepsiln.RI function combined with more detailed summaries of recent progress in understanding specific aspects of Fc.vepsiln.RI biol. and biochem.  Topics covered include the coordination and function of the large multiprotein signaling complexes that are assembled when Fc.vepsiln.RI and other Ag receptors are engaged, new information on human receptor structures and tissue distribution, and the role of the FcRβ chain in signaling and its potential contribution to atopic phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCuAC1T5JlBLVg90H21EOLACvtfcHk0lgbWX7ZrwxvZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVWls7g%253D&md5=d37fa09083728c0f9edce06ae492741d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.17.1.931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.17.1.931%26sid%3Dliteratum%253Aachs%26aulast%3DKinet%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520high-affinity%2520IgE%2520receptor%2520%2528Fc%25CE%25B5RI%2529%253A%2520from%2520physiology%2520to%2520pathology%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1999%26volume%3D17%26spage%3D931%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Kurosaki, T.</span><span> </span><span class="NLM_article-title">Regulation of B cell fates by BCR signaling components</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0952-7915%2802%2900344-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11973132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVeit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=341-347&author=T.+Kurosaki&title=Regulation+of+B+cell+fates+by+BCR+signaling+components"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of B cell fates by BCR signaling components</span></div><div class="casAuthors">Kurosaki, Tomohiro</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-347</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent results obtained in mice harboring cytoplasmic mutations of Igα and/or Igβ have reinforced the concept that the strength of BCR signaling is important for ensuring appropriate developmental outcomes as well as antigen-specific responses.  To establish the optimal signaling intensity and duration, the BCR utilizes pos. and neg. regulatory mols.  Studies are beginning to reveal how these mols. maintain immunol. homeostasis and tolerance.  Each B cell developmental checkpoint requires the distinct signaling intensity through BCR and its surrogates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-895L9tokD7Vg90H21EOLACvtfcHk0lgbWX7ZrwxvZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVeit7c%253D&md5=44fc24782a60417313c4319b03b42dd7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2802%2900344-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252802%252900344-8%26sid%3Dliteratum%253Aachs%26aulast%3DKurosaki%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520B%2520cell%2520fates%2520by%2520BCR%2520signaling%2520components%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2002%26volume%3D14%26spage%3D341%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Daëron, M.</span><span> </span><span class="NLM_article-title">Structural bases of FcγR functions</span> <span class="citation_source-journal">Int. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.3109%2F08830189709045701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9651784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1cXitFensb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=1-27&author=M.+Da%C3%ABron&title=Structural+bases+of+Fc%CE%B3R+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structural bases of FcγR functions</span></div><div class="casAuthors">Daeron, Marc</div><div class="citationInfo"><span class="NLM_cas:title">International Reviews of Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-27</span>CODEN:
                <span class="NLM_cas:coden">IRIMEH</span>;
        ISSN:<span class="NLM_cas:issn">0883-0185</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">A review with 158 refs.  This review describes structures which det. the biol. activities triggered by FcγR and account for the cell-mediated functions of IgG antibodies in physiol. and pathol.  The binding specificity and affinity of FcγR depend primarily on IgG-binding structures, in their Ig-like extracellular domains.  Binding is however also influenced by subunits that assoc. to multichain FcγR.  Effector and regulatory intracytoplasmic sequences that are unique to mols. of the FcγRIIB family det. the internalization properties of these receptors.  Immunoreceptor Tyrosine-based Activation Motifs (ITAMs) are intracytoplasmic effector sequences shared by FcγR and other receptors involved in the recognition of antigen, which trigger cell activation and internalization.  Immunoreceptor Tyrosine-based Inhibition Motifs (ITIMs) are intracytoplasmic sequences, shared by FcγRIIB and a growing no. of neg. coreceptors which neg. regulate cell activation via ITAM-bearing receptors.  Altogether, these structures enable IgG antibodies to exert a variety of finely tuned biol. effects during the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO2A5g5vnVnbVg90H21EOLACvtfcHk0lgbWX7ZrwxvZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFensb4%253D&md5=b17717545468d24c6b0ef9de85dfb94d</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3109%2F08830189709045701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08830189709045701%26sid%3Dliteratum%253Aachs%26aulast%3DDa%25C3%25ABron%26aufirst%3DM.%26atitle%3DStructural%2520bases%2520of%2520Fc%25CE%25B3R%2520functions%26jtitle%3DInt.%2520Rev.%2520Immunol.%26date%3D1997%26volume%3D16%26spage%3D1%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Nimmerjahn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravetch, J. V.</span><span> </span><span class="NLM_article-title">Fcγ receptors as regulators of immune responses</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18064051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKrsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=34-47&author=F.+Nimmerjahnauthor=J.+V.+Ravetch&title=Fc%CE%B3+receptors+as+regulators+of+immune+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Fcγ receptors as regulators of immune responses</span></div><div class="casAuthors">Nimmerjahn, Falk; Ravetch, Jeffrey V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-47</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In addn. to their role in binding antigen, antibodies can regulate immune responses via interaction with Fc receptors (FcRs).  In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo.  Here, the authors discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcγRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBbBMzHXrMsrVg90H21EOLACvtfcHk0lgbWX7ZrwxvZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKrsLnK&md5=dae5144e17b125fe8665944be2486783</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnri2206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2206%26sid%3Dliteratum%253Aachs%26aulast%3DNimmerjahn%26aufirst%3DF.%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26atitle%3DFc%25CE%25B3%2520receptors%2520as%2520regulators%2520of%2520immune%2520responses%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D34%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Siraganian, R. P.</span><span> </span><span class="NLM_article-title">Mast cell signal transduction from the high-affinity IgE receptor</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.coi.2003.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=14630197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVeqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=639-646&author=R.+P.+Siraganian&title=Mast+cell+signal+transduction+from+the+high-affinity+IgE+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cell signal transduction from the high-affinity IgE receptor</span></div><div class="casAuthors">Siraganian, Reuben P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">639-646</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Antigen-mediated aggregation of IgE bound to its high-affinity receptor on mast cells or basophils initiates a complex series of biochem. events, resulting in the release of mediators that cause allergic inflammation and anaphylactic reactions.  Recent progress has defined the mol. pathways that are involved in stimulating these cells and has shown the importance of protein tyrosine kinases in the subsequent reactions.  The activation pathways are regulated both pos. and neg. by the interactions of numerous signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnT2393blBILVg90H21EOLACvtfcHk0li5ls9TssJR_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVeqsLk%253D&md5=0170c139fa1b8a003d87f939cbd260f5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2003.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2003.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DMast%2520cell%2520signal%2520transduction%2520from%2520the%2520high-affinity%2520IgE%2520receptor%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2003%26volume%3D15%26spage%3D639%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Metzger, H.</span><span> </span><span class="NLM_article-title">The receptor with high affinity for IgE</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.1992.tb00624.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=1532373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1CgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1992&pages=37-48&author=H.+Metzger&title=The+receptor+with+high+affinity+for+IgE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The receptor with high affinity for IgE</span></div><div class="casAuthors">Metzger, Henry</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-48</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    </div><div class="casAbstract">A review, with 60 refs., of the current knowledge on the function and structure of the high-affinity IgE receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCkUgLEHd20LVg90H21EOLACvtfcHk0li5ls9TssJR_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1CgsLk%253D&md5=33735404aff1dce0b59153501a9e74d3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.1992.tb00624.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.1992.tb00624.x%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DH.%26atitle%3DThe%2520receptor%2520with%2520high%2520affinity%2520for%2520IgE%26jtitle%3DImmunol.%2520Rev.%26date%3D1992%26volume%3D125%26spage%3D37%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Ravetch, J. V.</span><span> </span><span class="NLM_article-title">Fc Receptors</span>. In  <span class="citation_source-book">Fundamental Immunology</span>, <span class="NLM_edition">5</span>th ed.; <span class="NLM_contrib-group">Paul, W. E.</span>, Ed.; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=685-700&author=J.+V.+Ravetchauthor=W.+E.+Paul&title=Fundamental+Immunology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26atitle%3DFc%2520Receptors%26btitle%3DFundamental%2520Immunology%26aulast%3DPaul%26aufirst%3DW.%2BE.%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2003%26spage%3D685%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Ravetch, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolland, S.</span><span> </span><span class="NLM_article-title">IgG Fc Receptors</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1146%2Fannurev.immunol.19.1.275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11244038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFKgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=275-290&author=J.+V.+Ravetchauthor=S.+Bolland&title=IgG+Fc+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">IgG Fc receptors</span></div><div class="casAuthors">Ravetch, Jeffrey V.; Bolland, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">275-290</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 98 refs.  Since the description of the first mouse knockout for an IgG Fc receptor seven years ago, considerable progress has been made in defining the in vivo functions of these receptors in diverse biol. systems.  The role of activating FcγRs in providing a crit. link between ligands and effector cells in type II and type III inflammation is now well established and has led to a fundamental revision of the significance of these receptors in initiating cellular responses in host defense, in detg. the efficacy of therapeutic antibodies, and in pathol. autoimmune conditions.  Considerable progress has been made in the last two years on the in vivo regulation of these responses, through the appreciation of the importance of balancing activation responses with inhibitory signaling.  The inhibitory FcR functions in the maintenance of peripheral tolerance, in regulating the threshold of activation responses, and ultimately in terminating IgG mediated effector stimulation.  The consequences of deleting the inhibitory arm of this system are thus manifested in both the afferent and efferent immune responses.  The hyperresponsive state that results leads to greatly magnified effector responses by cytotoxic antibodies and immune complexes and can culminate in autoimmunity and autoimmune disease when modified by environmental or genetic factors.  FcγRs offer a paradigm for the biol. significance of balancing activation and inhibitory signaling in the expanding family of activation/inhibitory receptor pairs found in the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLaA63gbW8-LVg90H21EOLACvtfcHk0li5ls9TssJR_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFKgur4%253D&md5=238ba74f178d0db9d1d16734153cfe8f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.19.1.275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.19.1.275%26sid%3Dliteratum%253Aachs%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26aulast%3DBolland%26aufirst%3DS.%26atitle%3DIgG%2520Fc%2520Receptors%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2001%26volume%3D19%26spage%3D275%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Siraganian, R. P.; Zhang, J.; Kimura, T.</span><span> </span><span class="NLM_article-title">Regulation and Function of Protein Tyrosine Kinase Syk in FcεR1-Mediated Signaling</span>. In  <span class="citation_source-book">Signal Transduction in Mast Cells and Basophils</span>; <span class="NLM_contrib-group">Razin, E.; Rivera, J.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1007%2F978-1-4612-2154-8_10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=115-133&author=R.+P.+Siraganian&author=J.+Zhang&author=T.+Kimuraauthor=E.+Razin&author=J.+Rivera&title=Signal+Transduction+in+Mast+Cells+and+Basophils"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1007%2F978-1-4612-2154-8_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4612-2154-8_10%26sid%3Dliteratum%253Aachs%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DRegulation%2520and%2520Function%2520of%2520Protein%2520Tyrosine%2520Kinase%2520Syk%2520in%2520Fc%25CE%25B5R1-Mediated%2520Signaling%26btitle%3DSignal%2520Transduction%2520in%2520Mast%2520Cells%2520and%2520Basophils%26aulast%3DRazin%26aufirst%3DE.%26pub%3DSpringer%26date%3D1999%26spage%3D115%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appella, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siraganian, R. P.</span><span> </span><span class="NLM_article-title">Conformational changes induced in the protein tyrosine kinase p72<sup><i>syk</i></sup> by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1128%2FMCB.16.4.1471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=8657120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK28XhvVahurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=1471-1478&author=T.+Kimuraauthor=H.+Sakamotoauthor=E.+Appellaauthor=R.+P.+Siraganian&title=Conformational+changes+induced+in+the+protein+tyrosine+kinase+p72syk+by+tyrosine+phosphorylation+or+by+binding+of+phosphorylated+immunoreceptor+tyrosine-based+activation+motif+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides</span></div><div class="casAuthors">Kimura, Teruaki; Sakamoto, Hiroshi; Appella, Ettore; Siraganian, Reuben P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1471-8</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A crit. event in signaling in immune cells is the interaction of Syk or ZAP-70 protein tyrosine kinases with multisubunit receptors that contain an ∼18-amino-acid domain called the immunoreceptor tyrosine-based activation motif (ITAM).  Tyrosine-phosphorylated Syk from activated cells was in a conformation different from that in nonstimulated cells as demonstrated by changes in immunoreactivity.  The addn. of tyrosine-diphosphorylated ITAM peptides resulted in a similar conformational change in Syk from nonactivated cells.  The peptides based on FcεRIγ were more active than those based on FcεRIβ.  In vitro autophosphorylation of Syk was dramatically enhanced by the addn. of the diphosphorylated ITAM peptides.  The conformational change and the enhanced autophosphorylation required the presence of both phosphorylated tyrosines on the same mol.  These conformational changes in Syk by tyrosine phosphorylation or binding to diphosphorylated ITAM could be crit. for Syk activation and downstream propagation of intracellular signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3gCIMEi8-HbVg90H21EOLACvtfcHk0liFAghY6K8-Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVahurg%253D&md5=312f8e16881619d114c7810d562fce36</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.4.1471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.4.1471%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DAppella%26aufirst%3DE.%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DConformational%2520changes%2520induced%2520in%2520the%2520protein%2520tyrosine%2520kinase%2520p72syk%2520by%2520tyrosine%2520phosphorylation%2520or%2520by%2520binding%2520of%2520phosphorylated%2520immunoreceptor%2520tyrosine-based%2520activation%2520motif%2520peptides%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D1471%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Tsang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannetti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, J. K. Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span> </span><span class="NLM_article-title">Molecular mechanism of the Syk activation switch</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32650</span><span class="NLM_x">–</span> <span class="NLM_lpage">32659</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32650-32659&author=E.+Tsangauthor=A.+M.+Giannettiauthor=D.+Shawauthor=M.+Dinhauthor=J.+K.+Y+Tseauthor=S.+Gandhiauthor=H.+Hoauthor=S.+Wangauthor=E.+Pappauthor=J.+M.+Bradshaw&title=Molecular+mechanism+of+the+Syk+activation+switch"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DE.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DDinh%26aufirst%3DM.%26aulast%3DTse%26aufirst%3DJ.%2BK.%2BY%26aulast%3DGandhi%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26atitle%3DMolecular%2520mechanism%2520of%2520the%2520Syk%2520activation%2520switch%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32650%26epage%3D32659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span> </span><span class="NLM_article-title">The Src, Syk, and Tec family kinases: distinct types of molecular switches</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.cellsig.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20206686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlyntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=1175-1184&author=J.+M.+Bradshaw&title=The+Src%2C+Syk%2C+and+Tec+family+kinases%3A+distinct+types+of+molecular+switches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The Src, Syk, and Tec family kinases: Distinct types of molecular switches</span></div><div class="casAuthors">Bradshaw, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1175-1184</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The Src, Syk, and Tec family kinases are three of the most well characterized tyrosine kinase families found in the human genome.  Members of these kinase families function downstream of antigen and Fc receptors in hematopoietic cells and transduce signals leading to calcium mobilization, altered gene expression, cytokine prodn., and cell proliferation.  Over the last several years, structural and biochem. studies have begun to uncover the mol. mechanisms regulating activation of these kinases.  It appears that each kinase family functions as a distinct type of mol. switch.  This review discusses the activation of the Src, Syk, and Tec kinases from the perspective of structure, phosphorylation, allosteric regulation, and kinetics.  The multiple factors that regulate the Src, Syk, and Tec families illustrate the important role played by each of these kinases in immune cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PA9QDCCGPLVg90H21EOLACvtfcHk0liFAghY6K8-Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlyntbw%253D&md5=7f562f792a04682d05aa32dc09a7cb6e</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Src%252C%2520Syk%252C%2520and%2520Tec%2520family%2520kinases%253A%2520distinct%2520types%2520of%2520molecular%2520switches%26jtitle%3DCell.%2520Signalling%26date%3D2010%26volume%3D22%26spage%3D1175%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">El-Hillal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, A. M.</span><span> </span><span class="NLM_article-title">syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1919</span><span class="NLM_x">–</span> <span class="NLM_lpage">1924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=1919-1924&author=O.+El-Hillalauthor=T.+Kurosakiauthor=H.+Yamamuraauthor=J.+P.+Kinetauthor=A.+M.+Scharenberg&title=syk+kinase+activation+by+a+src+kinase-initiated+activation+loop+phosphorylation+chain+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Hillal%26aufirst%3DO.%26aulast%3DKurosaki%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DH.%26aulast%3DKinet%26aufirst%3DJ.%2BP.%26aulast%3DScharenberg%26aufirst%3DA.%2BM.%26atitle%3Dsyk%2520kinase%2520activation%2520by%2520a%2520src%2520kinase-initiated%2520activation%2520loop%2520phosphorylation%2520chain%2520reaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D1919%26epage%3D1924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Kulathu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grothe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reth, M.</span><span> </span><span class="NLM_article-title">Autoinhibition and adapter function of Syk</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.2009.00837.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19909371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGlsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2009&pages=286-299&author=Y.+Kulathuauthor=G.+Grotheauthor=M.+Reth&title=Autoinhibition+and+adapter+function+of+Syk"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Autoinhibition and adapter function of Syk</span></div><div class="casAuthors">Kulathu, Yogesh; Grothe, Gesina; Reth, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">286-299</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Development, survival, and activation of B lymphocytes are controlled by signals emanating from the B-cell antigen receptor (BCR).  The BCR has an autonomous signaling function also known as tonic signaling that allows for long-term survival of B cells in the immune system.  Upon binding of antigen to the BCR, the tonic signal is amplified and diversified, leading to alteration in gene expression and B-cell activation.  The spleen tyrosine kinase (Syk) intimately cooperates with the signaling subunits of the BCR and plays a central role in the amplification and diversification of BCR signals.  In this review, we discuss the mol. mechanisms by which Syk activity is inhibited and activated at the BCR.  Importantly, Syk acts not only as a kinase that phosphorylates downstream substrates but also as an adapter that can bind to a diverse set of signaling proteins.  Depending on its interactions and localization, Syk can signal opposing cell fate decisions such as proliferation or differentiation of B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr38HEBsyF34bVg90H21EOLACvtfcHk0lgMy5PLF7XMBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGlsL3E&md5=94fda0d96894c3ccbe0771b0ef438d72</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2009.00837.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2009.00837.x%26sid%3Dliteratum%253Aachs%26aulast%3DKulathu%26aufirst%3DY.%26aulast%3DGrothe%26aufirst%3DG.%26aulast%3DReth%26aufirst%3DM.%26atitle%3DAutoinhibition%2520and%2520adapter%2520function%2520of%2520Syk%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D232%26spage%3D286%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Syk and pTyr’d: signaling through the B cell antigen receptor</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1793</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1793&publication_year=2009&pages=1115-1127&author=R.+L.+Geahlen&title=Syk+and+pTyr%E2%80%99d%3A+signaling+through+the+B+cell+antigen+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DSyk%2520and%2520pTyr%25E2%2580%2599d%253A%2520signaling%2520through%2520the%2520B%2520cell%2520antigen%2520receptor%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D1793%26spage%3D1115%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Deindl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadlecek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brdicka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structural basis for the inhibition of tyrosine kinase activity of ZAP-70</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=735-746&author=S.+Deindlauthor=T.+A.+Kadlecekauthor=T.+Brdickaauthor=X.+Caoauthor=A.+Weissauthor=J.+Kuriyan&title=Structural+basis+for+the+inhibition+of+tyrosine+kinase+activity+of+ZAP-70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeindl%26aufirst%3DS.%26aulast%3DKadlecek%26aufirst%3DT.%2BA.%26aulast%3DBrdicka%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520tyrosine%2520kinase%2520activity%2520of%2520ZAP-70%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D735%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Kannan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuwald, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Analogous regulatory sites within the αC-β4 loop regions of ZAP-70 tyrosine kinase and AGC kinases</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2008&pages=27-32&author=N.+Kannanauthor=A.+F.+Neuwaldauthor=S.+S.+Taylor&title=Analogous+regulatory+sites+within+the+%CE%B1C-%CE%B24+loop+regions+of+ZAP-70+tyrosine+kinase+and+AGC+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKannan%26aufirst%3DN.%26aulast%3DNeuwald%26aufirst%3DA.%2BF.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DAnalogous%2520regulatory%2520sites%2520within%2520the%2520%25CE%25B1C-%25CE%25B24%2520loop%2520regions%2520of%2520ZAP-70%2520tyrosine%2520kinase%2520and%2520AGC%2520kinases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1784%26spage%3D27%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Arias-Palomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recuero-Checa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustelo, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorca, O.</span><span> </span><span class="NLM_article-title">3D structure of Syk kinase determined by single particle electron microscopy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1774</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1774&publication_year=2007&pages=1493-1499&author=E.+Arias-Palomoauthor=M.+A.+Recuero-Checaauthor=X.+R.+Busteloauthor=O.+Llorca&title=3D+structure+of+Syk+kinase+determined+by+single+particle+electron+microscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArias-Palomo%26aufirst%3DE.%26aulast%3DRecuero-Checa%26aufirst%3DM.%2BA.%26aulast%3DBustelo%26aufirst%3DX.%2BR.%26aulast%3DLlorca%26aufirst%3DO.%26atitle%3D3D%2520structure%2520of%2520Syk%2520kinase%2520determined%2520by%2520single%2520particle%2520electron%2520microscopy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2007%26volume%3D1774%26spage%3D1493%26epage%3D1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Arias-Palomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recuero-Checa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustelo, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorca, O.</span><span> </span><span class="NLM_article-title">Conformational rearrangements upon Syk auto-phosphorylation</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1794</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1794&publication_year=2009&pages=1211-1217&author=E.+Arias-Palomoauthor=M.+A.+Recuero-Checaauthor=X.+R.+Busteloauthor=O.+Llorca&title=Conformational+rearrangements+upon+Syk+auto-phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArias-Palomo%26aufirst%3DE.%26aulast%3DRecuero-Checa%26aufirst%3DM.%2BA.%26aulast%3DBustelo%26aufirst%3DX.%2BR.%26aulast%3DLlorca%26aufirst%3DO.%26atitle%3DConformational%2520rearrangements%2520upon%2520Syk%2520auto-phosphorylation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D1794%26spage%3D1211%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Brdicka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadlecek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roose, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastuszak, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4924</span><span class="NLM_x">–</span> <span class="NLM_lpage">4933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1128%2FMCB.25.12.4924-4933.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15923611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1OrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4924-4933&author=T.+Brdickaauthor=T.+A.+Kadlecekauthor=J.+P.+Rooseauthor=A.+W.+Pastuszakauthor=A.+Weiss&title=Intramolecular+regulatory+switch+in+ZAP-70%3A+analogy+with+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular regulatory switch in ZAP-70: Analogy with receptor tyrosine kinases</span></div><div class="casAuthors">Brdicka, Tomas; Kadlecek, Theresa A.; Roose, Jeroen P.; Pastuszak, Alexander W.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4924-4933</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">ZAP-70, a Syk family cytoplasmic protein tyrosine kinase (PTK), is required to couple the activated T-cell antigen receptor (TCR) to downstream signaling pathways.  It contains two tandem SH2 domains that bind to phosphorylated TCR subunits and a C-terminal catalytic domain.  The region connecting the SH2 domains with the kinase domain, termed interdomain B, has previously been shown to have striking regulatory effects on ZAP-70 function, presumed to be due to the recruitment of key substrates.  Paradoxically, deletion of interdomain B preserves ZAP-70 function.  Recent structural studies of several receptor tyrosine kinases (RTKs) revealed that their juxtamembrane regions neg. regulate their catalytic activities.  In EphB2 and several other RTKs, this autoinhibition depends upon interaction between the kinase domain and tyrosine residues within the juxtamembrane region.  Autoinhibition is released when these tyrosines become phosphorylated following receptor stimulation.  Sequence homol. suggested analogous regulation for ZAP-70.  Based on mutagenesis anal. of ZAP-70 interdomain B, we find that this region downregulates ZAP-70 catalytic activity in a similar manner as the juxtamembrane region of EphB2.  Similar regulation was also noted for the related Syk kinase.  These findings suggest that a general autoinhibitory mechanism employed by RTKs is also used by some cytoplasmic tyrosine kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeROLSubXLtLVg90H21EOLACvtfcHk0ljNV8Tmifurkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1OrtLg%253D&md5=e45310dd79c4f16b4579d9d211b9f0f8</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.12.4924-4933.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.12.4924-4933.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBrdicka%26aufirst%3DT.%26aulast%3DKadlecek%26aufirst%3DT.%2BA.%26aulast%3DRoose%26aufirst%3DJ.%2BP.%26aulast%3DPastuszak%26aufirst%3DA.%2BW.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DIntramolecular%2520regulatory%2520switch%2520in%2520ZAP-70%253A%2520analogy%2520with%2520receptor%2520tyrosine%2520kinases%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D4924%26epage%3D4933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenstein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siraganian, R. P.</span><span> </span><span class="NLM_article-title">Phosphorylation of Tyr342 in the linker region of Syk is critical for FcεR1 signaling in mast cells</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">8144</span><span class="NLM_x">–</span> <span class="NLM_lpage">8154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1128%2FMCB.22.23.8144-8154.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12417718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1yhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=8144-8154&author=J.+Zhangauthor=E.+Berensteinauthor=R.+P.+Siraganian&title=Phosphorylation+of+Tyr342+in+the+linker+region+of+Syk+is+critical+for+Fc%CE%B5R1+signaling+in+mast+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of Tyr342 in the linker region of Syk is critical for FcεRI signaling in mast cells</span></div><div class="casAuthors">Zhang, Juan; Berenstein, Elsa; Siraganian, Reuben P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8144-8154</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The linker region of Syk and ZAP70 tyrosine kinases plays an important role in regulating their function.  There are three conserved tyrosines in this linker region; Tyr317 of Syk and its equiv. residue in ZAP70 were previously shown to neg. regulate the function of Syk and ZAP70.  Here we studied the roles of the other two tyrosines, Tyr342 and Tyr346 of Syk, in FcεRI-mediated signaling.  Antigen stimulation resulted in Tyr342 phosphorylation in mast cells.  Syk with Y342F mutation failed to reconstitute FcεRI-initiated histamine release.  In the Syk Y342F-expressing cells there was dramatically impaired receptor-induced phosphorylation of multiple signaling mols., including LAT, SLP-76, phospholipase C-γ2, but not Vav.  Compared to wild-type Syk, Y342F Syk had decreased binding to phosphorylated immunoreceptor tyrosine-based activation motifs and reduced kinase activity.  Surprisingly, mutation of Tyr346 had much less effect on FcεRI-dependent mast cell degranulation.  An anti-Syk-phospho-346 tyrosine antibody indicated that antigen stimulation induced only a very minor increase in the phosphorylation of this tyrosine.  Therefore, Tyr342, but not Tyr346, is crit. for regulating Syk in mast cells and the function of these tyrosines in immune receptor signaling appears to be different from what has been previously reported for the equiv. residues of ZAP70.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrymOpJkP_O-bVg90H21EOLACvtfcHk0ljNV8Tmifurkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1yhs7o%253D&md5=db0afe64aa9c959b72c28f6c50584742</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.23.8144-8154.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.23.8144-8154.2002%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBerenstein%26aufirst%3DE.%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DPhosphorylation%2520of%2520Tyr342%2520in%2520the%2520linker%2520region%2520of%2520Syk%2520is%2520critical%2520for%2520Fc%25CE%25B5R1%2520signaling%2520in%2520mast%2520cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D8144%26epage%3D8154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Sanderson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wex, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnapp, A.</span><span> </span><span class="NLM_article-title">Syk and Lyn mediate distinct Syk phosphorylation events in FcεRI-signal transduction: implications for regulation of IgE-mediated degranulation</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.molimm.2010.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20828828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOnsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=171-178&author=M.+P.+Sandersonauthor=E.+Wexauthor=T.+Konoauthor=K.+Utoauthor=A.+Schnapp&title=Syk+and+Lyn+mediate+distinct+Syk+phosphorylation+events+in+Fc%CE%B5RI-signal+transduction%3A+implications+for+regulation+of+IgE-mediated+degranulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Syk and Lyn mediate distinct Syk phosphorylation events in FcεRI-signal transduction: Implications for regulation of IgE-mediated degranulation</span></div><div class="casAuthors">Sanderson, Michael P.; Wex, Eva; Kono, Takeshi; Uto, Katsuhiro; Schnapp, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">171-178</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a key regulatory factor in the IgE-mediated allergic signal transduction pathway in mast cells and basophils.  Syk is phosphorylated on a no. of tyrosines following the binding of IgE/allergen complexes to FcεRI receptors leading to initiation of inflammatory signaling via downstream enzymes and scaffolding proteins.  We examd. the kinases responsible for the phosphorylation of key Syk tyrosines in rat RBL-2H3 basophilic cells and bone marrow-derived mast cells (BMMCs).  The phosphorylation of Syk tyrosine 346 was completely blocked by the novel Src family kinase inhibitor BIRA766, suggesting this tyrosine is a pure substrate for Src family kinases.  This was supported by the findings that kinase-dead (KD) Syk was efficiently phosphorylated on this tyrosine and that a specific Syk inhibitor BAY61-3606 was without effect.  The phosphorylation of other Syk tyrosines 317, 342, 519 and 520 was reduced by Syk and Src family inhibitors, suggesting a role for auto- and trans-phosphorylation.  Lyn was the predominant Src family kinase expressed and activated in RBL-2H3 cells, meanwhile Lyn knockdown with a specific siRNA interfered with the phosphorylation of all Syk tyrosines and the Syk substrates SLP-76 and LAT.  Pharmacol. inhibition of Syk completely blocked the degranulation of RBL-2H3 and BMMCs.  However, Lyn knockdown sensitized RBL-2H3 cells to FcεRI-induced degranulation.  We showed that while interference with Lyn expression disrupts FcεRI proximal signaling via Syk and its direct substrates including SLP-76 and LAT, distal activation of downstream proteins including Erk is enhanced.  This study identifies the responsible kinases for the phosphorylation of key Syk tyrosines and the propagation of FcεRI receptor mediated signal transduction in allergic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogo10wbe3ZX7Vg90H21EOLACvtfcHk0ljNV8Tmifurkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOnsr7I&md5=e5760b1776ab667759d7af5af7fbc6dd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2010.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2010.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DM.%2BP.%26aulast%3DWex%26aufirst%3DE.%26aulast%3DKono%26aufirst%3DT.%26aulast%3DUto%26aufirst%3DK.%26aulast%3DSchnapp%26aufirst%3DA.%26atitle%3DSyk%2520and%2520Lyn%2520mediate%2520distinct%2520Syk%2520phosphorylation%2520events%2520in%2520Fc%25CE%25B5RI-signal%2520transduction%253A%2520implications%2520for%2520regulation%2520of%2520IgE-mediated%2520degranulation%26jtitle%3DMol.%2520Immunol.%26date%3D2010%26volume%3D48%26spage%3D171%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Braselmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurcevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1124%2Fjpet.106.109058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16946104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yltL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=998-1008&author=S.+Braselmannauthor=V.+Taylorauthor=H.+Zhaoauthor=S.+Wangauthor=C.+Sylvainauthor=M.+Baluomauthor=K.+Quauthor=E.+Herlaarauthor=A.+Lauauthor=C.+Youngauthor=B.+R.+Wongauthor=S+Lovellauthor=T.+Sunauthor=G+Parkauthor=A.+Argadeauthor=S.+Jurcevicauthor=P.+Pineauthor=R.+Singhauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+S.+Masuda&title=R406%2C+an+orally+available+spleen+tyrosine+kinase+inhibitor+blocks+Fc+receptor+signaling+and+reduces+immune+complex-mediated+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation</span></div><div class="casAuthors">Braselmann, Sylvia; Taylor, Vanessa; Zhao, Haoran; Wang, Su; Sylvain, Catherine; Baluom, Muhammad; Qu, Kunbin; Herlaar, Ellen; Lau, Angela; Young, Chi; Wong, Brian R.; Lovell, Scott; Sun, Thomas; Park, Gary; Argade, Ankush; Jurcevic, Stipo; Pine, Polly; Singh, Rajinder; Grossbard, Elliott B.; Payan, Donald G.; Masuda, Esteban S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">998-1008</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent compelling evidence has lead to renewed interest in the role of antibodies and immune complexes in the pathogenesis of several autoimmune disorders, such as rheumatoid arthritis.  These immune complexes, consisting of autoantibodies to self-antigens, can mediate inflammatory responses largely through binding and activating the Ig Fc receptors (FcRs).  Using cell-based structure activity relationships with cultured human mast cells, we have identified the small mol. R406 [N4-(2,2-dimethyl-3-oxo-4H-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2- (3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine] as a potent inhibitor of IgE (IgE)- and IgG-mediated activation of Fc receptor signaling (EC50 for degranulation = 56-64 nM).  Here we show that the primary target for R406 is the spleen tyrosine kinase (Syk), which plays a key role in the signaling of activating Fc receptors and the B-cell receptor (BCR).  R406 inhibited phosphorylation of Syk substrate linker for activation of T cells in mast cells and B-cell linker protein/SLP65 in B cells.  R406 bound to the ATP binding pocket of Syk and inhibited its kinase activity as an ATP-competitive inhibitor (Ki = 30 nM).  Furthermore, R406 blocked Syk-dependent FcR-mediated activation of monocytes/macrophages and neutrophils and BCR-mediated activation of B lymphocytes.  R406 was selective as assessed using a large panel of Syk-independent cell-based assays representing both specific and general signaling pathways.  Consistent with Syk inhibition, oral administration of R406 to mice reduced immune complex-mediated inflammation in a reverse-passive Arthus reaction and two antibody-induced arthritis models.  Finally, we report a first-in-human study showing that R406 is orally bioavailable, achieving exposures capable of inhibiting Syk-dependent IgE-mediated basophil activation.  Collectively, the results show R406 potential for modulating Syk activity in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohoeT9BJQAyLVg90H21EOLACvtfcHk0ljCUd-Mn6HrXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yltL7P&md5=18fea516041ea075d2123158f321a186</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.109058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.109058%26sid%3Dliteratum%253Aachs%26aulast%3DBraselmann%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DK.%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DB.%2BR.%26aulast%3DLovell%26aufirst%3DS%26aulast%3DSun%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DG%26aulast%3DArgade%26aufirst%3DA.%26aulast%3DJurcevic%26aufirst%3DS.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DR406%252C%2520an%2520orally%2520available%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520Fc%2520receptor%2520signaling%2520and%2520reduces%2520immune%2520complex-mediated%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D998%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">de Castro, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamur, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siraganian, R. P.</span><span> </span><span class="NLM_article-title">Tyrosines in the carboxyl terminus regulate Syk kinase activity and function</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26674</span><span class="NLM_x">–</span> <span class="NLM_lpage">26684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=26674-26684&author=R.+O.+de+Castroauthor=J.+Zhangauthor=M.+C.+Jamurauthor=C.+Oliverauthor=R.+P.+Siraganian&title=Tyrosines+in+the+carboxyl+terminus+regulate+Syk+kinase+activity+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCastro%26aufirst%3DR.%2BO.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJamur%26aufirst%3DM.%2BC.%26aulast%3DOliver%26aufirst%3DC.%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DTyrosines%2520in%2520the%2520carboxyl%2520terminus%2520regulate%2520Syk%2520kinase%2520activity%2520and%2520function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D26674%26epage%3D26684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">de Castro, R. O.</span><span> </span><span class="NLM_article-title">Regulation and function of Syk tyrosine kinase in mast cell signaling and beyond</span> <span class="citation_source-journal">J. Signal Transduct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">507291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21776385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BC3MnpvVKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=507291&author=R.+O.+de+Castro&title=Regulation+and+function+of+Syk+tyrosine+kinase+in+mast+cell+signaling+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and function of syk tyrosine kinase in mast cell signaling and beyond</span></div><div class="casAuthors">de Castro Rodrigo Orlandini</div><div class="citationInfo"><span class="NLM_cas:title">Journal of signal transduction</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">507291</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The protein tyrosine kinase Syk plays a critical role in FcεRI signaling in mast cells.  Binding of Syk to phosphorylated immunoreceptor tyrosine-based activation motifs (p-ITAM) of the receptor subunits results in conformational changes and tyrosine phosphorylation at multiple sites that leads to activation of Syk.  The phosphorylated tyrosines throughout the molecule play an important role in the regulation of Syk-mediated signaling.  Reconstitution of receptor-mediated signaling in Syk(-/-) cells by wild-type Syk or mutants which have substitution of these tyrosines with phenylalanine together with in vitro assays has been useful strategies to understand the regulation and function of Syk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCfOL0q4nTvJggzHGM8X5CfW6udTcc2ealA8nn3eLlQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnpvVKksg%253D%253D&md5=23b545f22faa5756e178e86dc180baaf</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCastro%26aufirst%3DR.%2BO.%26atitle%3DRegulation%2520and%2520function%2520of%2520Syk%2520tyrosine%2520kinase%2520in%2520mast%2520cell%2520signaling%2520and%2520beyond%26jtitle%3DJ.%2520Signal%2520Transduct.%26date%3D2011%26spage%3D507291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Deindl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadlecek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Stability of an autoinhibitory interface in the structure of the tyrosine kinase ZAP-70 impacts T cell receptor response</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">20699</span><span class="NLM_x">–</span> <span class="NLM_lpage">20704</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=20699-20704&author=S.+Deindlauthor=T.+A.+Kadlecekauthor=X.+Caoauthor=J.+Kuriyanauthor=A.+Weiss&title=Stability+of+an+autoinhibitory+interface+in+the+structure+of+the+tyrosine+kinase+ZAP-70+impacts+T+cell+receptor+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeindl%26aufirst%3DS.%26aulast%3DKadlecek%26aufirst%3DT.%2BA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DStability%2520of%2520an%2520autoinhibitory%2520interface%2520in%2520the%2520structure%2520of%2520the%2520tyrosine%2520kinase%2520ZAP-70%2520impacts%2520T%2520cell%2520receptor%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D20699%26epage%3D20704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Isakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wange, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samelson, L. E.</span><span> </span><span class="NLM_article-title">ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">181</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=1995&pages=375-380&author=N.+Isakovauthor=R.+L.+Wangeauthor=W.+H.+Burgessauthor=J.+D.+Wattsauthor=R.+Aebersoldauthor=L.+E.+Samelson&title=ZAP-70+binding+specificity+to+T+cell+receptor+tyrosine-based+activation+motifs%3A+the+tandem+SH2+domains+of+ZAP-70+bind+distinct+tyrosine-based+activation+motifs+with+varying+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsakov%26aufirst%3DN.%26aulast%3DWange%26aufirst%3DR.%2BL.%26aulast%3DBurgess%26aufirst%3DW.%2BH.%26aulast%3DWatts%26aufirst%3DJ.%2BD.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26atitle%3DZAP-70%2520binding%2520specificity%2520to%2520T%2520cell%2520receptor%2520tyrosine-based%2520activation%2520motifs%253A%2520the%2520tandem%2520SH2%2520domains%2520of%2520ZAP-70%2520bind%2520distinct%2520tyrosine-based%2520activation%2520motifs%2520with%2520varying%2520affinity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1995%26volume%3D181%26spage%3D375%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Atwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feil, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froning, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Dieckmann, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nienaber, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noland, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajashankar, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burley, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, S. G.</span><span> </span><span class="NLM_article-title">A novel mode of gleevec binding is revealed by the structure of spleen tyrosine kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">55827</span><span class="NLM_x">–</span> <span class="NLM_lpage">55832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1074%2Fjbc.M409792200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15507431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeisL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=55827-55832&author=S.+Atwellauthor=J.+M.+Adamsauthor=J.+Badgerauthor=M.+D.+Buchananauthor=I.+K.+Feilauthor=K.+J.+Froningauthor=X.+Gaoauthor=J.+Hendleauthor=K.+Keeganauthor=B.+C.+Leonauthor=H.+J.+M%C3%BCller-Dieckmannauthor=V.+L.+Nienaberauthor=B.+W.+Nolandauthor=K.+Postauthor=K.+R.+Rajashankarauthor=A.+Ramosauthor=M.+Russellauthor=S.+K.+Burleyauthor=S.+G.+Buchanan&title=A+novel+mode+of+gleevec+binding+is+revealed+by+the+structure+of+spleen+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase</span></div><div class="casAuthors">Atwell, Shane; Adams, Jason M.; Badger, John; Buchanan, Michelle D.; Feil, Ingeborg K.; Froning, Karen J.; Gao, Xia; Hendle, Joerg; Keegan, Kevin; Leon, Barbara C.; Mueller-Dieckmann, Hans J.; Nienaber, Vicki L.; Noland, Brian W.; Post, Kai; Rajashankar, K. R.; Ramos, Aurora; Russell, Marijane; Burley, Stephen K.; Buchanan, Sean G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">55827-55832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a non-receptor tyrosine kinase required for signaling from immunoreceptors in various hematopoietic cells.  Phosphorylation of two tyrosine residues in the activation loop of the Syk kinase catalytic domain is necessary for signaling, a phenomenon typical of tyrosine kinase family members.  Syk in vitro enzyme activity, however, does not depend on phosphorylation (activation loop tyrosine phenylalanine mutants retain catalytic activity).  We have detd. the x-ray structure of the unphosphorylated form of the kinase catalytic domain of Syk.  The enzyme adopts a conformation of the activation loop typically seen only in activated, phosphorylated tyrosine kinases, explaining why Syk does not require phosphorylation for activation.  We also demonstrate that Gleevec (STI-571, Imatinib) inhibits the isolated kinase domains of both unphosphorylated Syk and phosphorylated Abl with comparable potency.  Gleevec binds Syk in a novel, compact cis-conformation that differs dramatically from the binding mode obsd. with unphosphorylated Abl, the more Gleevec-sensitive form of Abl.  This finding suggests the existence of two distinct Gleevec binding modes: an extended, trans-conformation characteristic of tight binding to the inactive conformation of a protein kinase and a second compact, cis-conformation characteristic of weaker binding to the active conformation.  Finally, the Syk-bound cis-conformation of Gleevec bears a striking resemblance to the rigid structure of the nonspecific, natural product kinase inhibitor staurosporine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7D3dM-QQRHLVg90H21EOLACvtfcHk0lh07lRcbP_xuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeisL7N&md5=b55eefe8790607cb5c8ae7be8795a83b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409792200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409792200%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBadger%26aufirst%3DJ.%26aulast%3DBuchanan%26aufirst%3DM.%2BD.%26aulast%3DFeil%26aufirst%3DI.%2BK.%26aulast%3DFroning%26aufirst%3DK.%2BJ.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHendle%26aufirst%3DJ.%26aulast%3DKeegan%26aufirst%3DK.%26aulast%3DLeon%26aufirst%3DB.%2BC.%26aulast%3DM%25C3%25BCller-Dieckmann%26aufirst%3DH.%2BJ.%26aulast%3DNienaber%26aufirst%3DV.%2BL.%26aulast%3DNoland%26aufirst%3DB.%2BW.%26aulast%3DPost%26aufirst%3DK.%26aulast%3DRajashankar%26aufirst%3DK.%2BR.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26atitle%3DA%2520novel%2520mode%2520of%2520gleevec%2520binding%2520is%2520revealed%2520by%2520the%2520structure%2520of%2520spleen%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D55827%26epage%3D55832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Fütterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grucza, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waksman, G.</span><span> </span><span class="NLM_article-title">Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=523-537&author=K.+F%C3%BCttererauthor=J.+Wongauthor=R.+A.+Gruczaauthor=A.+C.+Chanauthor=G.+Waksman&title=Structural+basis+for+Syk+tyrosine+kinase+ubiquity+in+signal+transduction+pathways+revealed+by+the+crystal+structure+of+its+regulatory+SH2+domains+bound+to+a+dually+phosphorylated+ITAM+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DGrucza%26aufirst%3DR.%2BA.%26aulast%3DChan%26aufirst%3DA.%2BC.%26aulast%3DWaksman%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520Syk%2520tyrosine%2520kinase%2520ubiquity%2520in%2520signal%2520transduction%2520pathways%2520revealed%2520by%2520the%2520crystal%2520structure%2520of%2520its%2520regulatory%2520SH2%2520domains%2520bound%2520to%2520a%2520dually%2520phosphorylated%2520ITAM%2520peptide%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D281%26spage%3D523%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Geijtenbeek, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gringhuis, S. I.</span><span> </span><span class="NLM_article-title">Signalling through C-type lectin receptors: shaping immune responses</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19521399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFCgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=465-479&author=T.+B.+Geijtenbeekauthor=S.+I.+Gringhuis&title=Signalling+through+C-type+lectin+receptors%3A+shaping+immune+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling through C-type lectin receptors: shaping immune responses</span></div><div class="casAuthors">Geijtenbeek, Teunis B. H.; Gringhuis, Sonja I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-479</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  C-type lectin receptors (CLRs) expressed by dendritic cells are crucial for tailoring immune responses to pathogens.  Following pathogen binding, CLRs trigger distinct signalling pathways that induce the expression of specific cytokines which det. T cell polarization fates.  Some CLRs can induce signalling pathways that directly activate nuclear factor-κB, whereas other CLRs affect signalling by Toll-like receptors.  Dissecting these signalling pathways and their effects on host immune cells is essential to understand the mol. mechanisms involved in the induction of adaptive immune responses.  In this Review we describe the role of CLR signalling in regulating adaptive immunity and immunopathogenesis and discuss how this knowledge can be harnessed for the development of innovative vaccination approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHSCoghEUNSLVg90H21EOLACvtfcHk0lh07lRcbP_xuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFCgurc%253D&md5=91f3810595e1bb4794efa63a97321ecf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fnri2569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2569%26sid%3Dliteratum%253Aachs%26aulast%3DGeijtenbeek%26aufirst%3DT.%2BB.%26aulast%3DGringhuis%26aufirst%3DS.%2BI.%26atitle%3DSignalling%2520through%2520C-type%2520lectin%2520receptors%253A%2520shaping%2520immune%2520responses%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D465%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Lowell, C. A.</span><span> </span><span class="NLM_article-title">Src-family and SYK kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">a002352</span><div class="note"><p class="first last"> (DOI: 10.1101/cshperspect.a002352)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=a002352&author=C.+A.+Lowell&title=Src-family+and+SYK+kinases+in+activating+and+inhibitory+pathways+in+innate+immune+cells%3A+signaling+cross+talk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLowell%26aufirst%3DC.%2BA.%26atitle%3DSrc-family%2520and%2520SYK%2520kinases%2520in%2520activating%2520and%2520inhibitory%2520pathways%2520in%2520innate%2520immune%2520cells%253A%2520signaling%2520cross%2520talk%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2011%26volume%3D3%26spage%3Da002352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C. B.</span><span> </span><span class="NLM_article-title">Tyr130 phosphorylation triggers Syk release from antigen receptor by long-distance conformational uncoupling</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">11760</span><span class="NLM_x">–</span> <span class="NLM_lpage">11765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=11760-11765&author=Y.+Zhangauthor=H.+Ohauthor=R.+A.+Burtonauthor=J.+W.+Burgnerauthor=R.+L.+Geahlenauthor=C.+B.+Post&title=Tyr130+phosphorylation+triggers+Syk+release+from+antigen+receptor+by+long-distance+conformational+uncoupling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DH.%26aulast%3DBurton%26aufirst%3DR.%2BA.%26aulast%3DBurgner%26aufirst%3DJ.%2BW.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26aulast%3DPost%26aufirst%3DC.%2BB.%26atitle%3DTyr130%2520phosphorylation%2520triggers%2520Syk%2520release%2520from%2520antigen%2520receptor%2520by%2520long-distance%2520conformational%2520uncoupling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D11760%26epage%3D11765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Keshvara, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Syk activation and dissociation from the B-cell antigen receptor is mediated by phosphorylation of tyrosine 130</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">10377</span><span class="NLM_x">–</span> <span class="NLM_lpage">10381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=10377-10381&author=L.+M.+Keshvaraauthor=C.+Isaacsonauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Syk+activation+and+dissociation+from+the+B-cell+antigen+receptor+is+mediated+by+phosphorylation+of+tyrosine+130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeshvara%26aufirst%3DL.%2BM.%26aulast%3DIsaacson%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DSyk%2520activation%2520and%2520dissociation%2520from%2520the%2520B-cell%2520antigen%2520receptor%2520is%2520mediated%2520by%2520phosphorylation%2520of%2520tyrosine%2520130%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D10377%26epage%3D10381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Yankee, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshvara, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawasdikosol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen., R. L.</span><span> </span><span class="NLM_article-title">Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tryrosine 317 and the c-Cbl phosphotyrosine-binding domain</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">5827</span><span class="NLM_x">–</span> <span class="NLM_lpage">5835</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=5827-5835&author=T.+M.+Yankeeauthor=L.+M.+Keshvaraauthor=S.+Sawasdikosolauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen.&title=Inhibition+of+signaling+through+the+B+cell+antigen+receptor+by+the+protooncogene+product%2C+c-Cbl%2C+requires+Syk+tryrosine+317+and+the+c-Cbl+phosphotyrosine-binding+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYankee%26aufirst%3DT.%2BM.%26aulast%3DKeshvara%26aufirst%3DL.%2BM.%26aulast%3DSawasdikosol%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen.%26aufirst%3DR.%2BL.%26atitle%3DInhibition%2520of%2520signaling%2520through%2520the%2520B%2520cell%2520antigen%2520receptor%2520by%2520the%2520protooncogene%2520product%252C%2520c-Cbl%252C%2520requires%2520Syk%2520tryrosine%2520317%2520and%2520the%2520c-Cbl%2520phosphotyrosine-binding%2520domain%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D5827%26epage%3D5835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samelson, L. E.</span><span> </span><span class="NLM_article-title">The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=418-420&author=Y.+Otaauthor=L.+E.+Samelson&title=The+product+of+the+proto-oncogene+c-cbl%3A+a+negative+regulator+of+the+Syk+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOta%26aufirst%3DY.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26atitle%3DThe%2520product%2520of%2520the%2520proto-oncogene%2520c-cbl%253A%2520a%2520negative%2520regulator%2520of%2520the%2520Syk%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D1997%26volume%3D276%26spage%3D418%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Keshvara, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yankee, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarac, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">5276</span><span class="NLM_x">–</span> <span class="NLM_lpage">5283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=1998&pages=5276-5283&author=L.+M.+Keshvaraauthor=C.+C.+Isaacsonauthor=T.+M.+Yankeeauthor=R.+Saracauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Syk-+and+Lyn-dependent+phosphorylation+of+Syk+on+multiple+tyrosines+following+B+cell+activation+includes+a+site+that+negatively+regulates+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeshvara%26aufirst%3DL.%2BM.%26aulast%3DIsaacson%26aufirst%3DC.%2BC.%26aulast%3DYankee%26aufirst%3DT.%2BM.%26aulast%3DSarac%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DSyk-%2520and%2520Lyn-dependent%2520phosphorylation%2520of%2520Syk%2520on%2520multiple%2520tyrosines%2520following%2520B%2520cell%2520activation%2520includes%2520a%2520site%2520that%2520negatively%2520regulates%2520signaling%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D161%26spage%3D5276%26epage%3D5283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Scharenberg, A. M.</span><span> </span><span class="NLM_article-title">The inhibitory receptor superfamily: potential relevance to atopy</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0952-7915%2899%2900027-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10631545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFKmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=621-625&author=A.+M.+Scharenberg&title=The+inhibitory+receptor+superfamily%3A+potential+relevance+to+atopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitory receptor superfamily: potential relevance to atopy</span></div><div class="casAuthors">Scharenberg, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-625</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">A review with 42 refs.  The role of inhibitory receptor superfamily (IRS) members in the pathophysiol. of atopy is still largely unexplored but the past year or so has brought at least three important advances in the understanding of IRS member function: first, several targets of an inositol-phosphatase-dependent inhibitory signaling pathway utilized by some IRS members were identified; second, there is accumulating evidence from murine models supporting the importance of inhibitory Fcγ receptors in modulating immune-complex-mediated inflammation; third, the inhibitory signaling capability of several previously identified candidate IRS members, including several expressed on cell types implicated in atopy and allergic reactions, has been demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpysnpvzXEECrVg90H21EOLACvtfcHk0lhBdxh0A2ufaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFKmtrg%253D&md5=83e956a143f9385cc5340a07dd382fda</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2899%2900027-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252899%252900027-8%26sid%3Dliteratum%253Aachs%26aulast%3DScharenberg%26aufirst%3DA.%2BM.%26atitle%3DThe%2520inhibitory%2520receptor%2520superfamily%253A%2520potential%2520relevance%2520to%2520atopy%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1999%26volume%3D11%26spage%3D621%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Gergely, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecht, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sármay, G.</span><span> </span><span class="NLM_article-title">Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1999&pages=3-15&author=J.+Gergelyauthor=I.+Pechtauthor=G.+S%C3%A1rmay&title=Immunoreceptor+tyrosine-based+inhibition+motif-bearing+receptors+regulate+the+immunoreceptor+tyrosine-based+activation+motif-induced+activation+of+immune+competent+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DJ.%26aulast%3DPecht%26aufirst%3DI.%26aulast%3DS%25C3%25A1rmay%26aufirst%3DG.%26atitle%3DImmunoreceptor%2520tyrosine-based%2520inhibition%2520motif-bearing%2520receptors%2520regulate%2520the%2520immunoreceptor%2520tyrosine-based%2520activation%2520motif-induced%2520activation%2520of%2520immune%2520competent%2520cells%26jtitle%3DImmunol.%2520Lett.%26date%3D1999%26volume%3D68%26spage%3D3%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Ravetch, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, L. L.</span><span> </span><span class="NLM_article-title">Immune inhibitory receptors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=84-89&author=J.+V.+Ravetchauthor=L.+L.+Lanier&title=Immune+inhibitory+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26aulast%3DLanier%26aufirst%3DL.%2BL.%26atitle%3DImmune%2520inhibitory%2520receptors%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D84%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Galli, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalesnikoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimbaldeston, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piliponsky, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M.</span><span> </span><span class="NLM_article-title">Mast cells as “tunable” effector and immunoregulatory cells: recent advances</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1146%2Fannurev.immunol.21.120601.141025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15771585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFOju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=749-786&author=S.+J.+Galliauthor=J.+Kalesnikoffauthor=M.+A.+Grimbaldestonauthor=A.+M.+Piliponskyauthor=C.+M.+M.+Williamsauthor=M.+Tsai&title=Mast+cells+as+%E2%80%9Ctunable%E2%80%9D+effector+and+immunoregulatory+cells%3A+recent+advances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cells as "Tunable" effector and immunoregulatory cells: Recent advances</span></div><div class="casAuthors">Galli, Stephen J.; Kalesnikoff, Janet; Grimbaldeston, Michele A.; Piliponsky, Adrian M.; Williams, Cara M. M.; Tsai, Mindy</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">749-786</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">This review focuses on recent progress in our understanding of how mast cells can contribute to the initiation, development, expression, and regulation of acquired immune responses, both those assocd. with IgE and those that are apparently expressed independently of this class of Ig.  We emphasize findings derived from in vivo studies in mice, particularly those employing genetic approaches to influence mast cell nos. and/or to alter or delete components of pathways that can regulate mast cell development, signaling, or function.  We advance the hypothesis that mast cells not only can function as proinflammatory effector cells and drivers of tissue remodeling in established acquired immune responses, but also may contribute to the initiation and regulation of such responses.  That is, we propose that mast cells can also function as immunoregulatory cells.  Finally, we show that the notion that mast cells have primarily two functional configurations, off (or resting) or on (or activated for extensive mediator release), markedly oversimplifies reality.  Instead, we propose that mast cells are "tunable," by both genetic and environmental factors, such that, depending on the circumstances, the cell can be positioned phenotypically to express a wide spectrum of variation in the types, kinetics, and/or magnitude of its secretory functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSZ9BB0Ws8j7Vg90H21EOLACvtfcHk0ljRwN19Ua_pPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFOju70%253D&md5=4b97d1fd03f2cb9a13db0cf69552b4a4</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.21.120601.141025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.21.120601.141025%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DKalesnikoff%26aufirst%3DJ.%26aulast%3DGrimbaldeston%26aufirst%3DM.%2BA.%26aulast%3DPiliponsky%26aufirst%3DA.%2BM.%26aulast%3DWilliams%26aufirst%3DC.%2BM.%2BM.%26aulast%3DTsai%26aufirst%3DM.%26atitle%3DMast%2520cells%2520as%2520%25E2%2580%259Ctunable%25E2%2580%259D%2520effector%2520and%2520immunoregulatory%2520cells%253A%2520recent%2520advances%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D23%26spage%3D749%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Liang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonna, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignali, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clynes, R.</span><span> </span><span class="NLM_article-title">Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">5916</span><span class="NLM_x">–</span> <span class="NLM_lpage">5926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=5916-5926&author=B.+Liangauthor=C.+Workmanauthor=J.+Leeauthor=C.+Chewauthor=B.+M.+Daleauthor=L.+Colonnaauthor=M.+Floresauthor=N.+Liauthor=E.+Schweighofferauthor=S.+Greenbergauthor=V.+Tybulewiczauthor=D.+Vignaliauthor=R.+Clynes&title=Regulatory+T+cells+inhibit+dendritic+cells+by+lymphocyte+activation+gene-3+engagement+of+MHC+class+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DWorkman%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChew%26aufirst%3DC.%26aulast%3DDale%26aufirst%3DB.%2BM.%26aulast%3DColonna%26aufirst%3DL.%26aulast%3DFlores%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DSchweighoffer%26aufirst%3DE.%26aulast%3DGreenberg%26aufirst%3DS.%26aulast%3DTybulewicz%26aufirst%3DV.%26aulast%3DVignali%26aufirst%3DD.%26aulast%3DClynes%26aufirst%3DR.%26atitle%3DRegulatory%2520T%2520cells%2520inhibit%2520dendritic%2520cells%2520by%2520lymphocyte%2520activation%2520gene-3%2520engagement%2520of%2520MHC%2520class%2520II%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D5916%26epage%3D5926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Paris, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Regulation of Syk by phosphorylation on serine in the linker insert</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">39844</span><span class="NLM_x">–</span> <span class="NLM_lpage">39854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=39844-39854&author=L.+L.+Parisauthor=J.+Huauthor=J.+Galanauthor=S.+S.+Ongauthor=V.+A.+Martinauthor=H.+Maauthor=W.+A.+Taoauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Regulation+of+Syk+by+phosphorylation+on+serine+in+the+linker+insert"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParis%26aufirst%3DL.%2BL.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGalan%26aufirst%3DJ.%26aulast%3DOng%26aufirst%3DS.%2BS.%26aulast%3DMartin%26aufirst%3DV.%2BA.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DTao%26aufirst%3DW.%2BA.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DRegulation%2520of%2520Syk%2520by%2520phosphorylation%2520on%2520serine%2520in%2520the%2520linker%2520insert%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D39844%26epage%3D39854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Narula, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zydowsky, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botfield, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karas, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span> </span><span class="NLM_article-title">Solution structure of the C-terminal SH2 domain of the human tyrosine kinase SYK complexed with a phosphotyrosine pentapeptide</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=1061-1073&author=S.+S.+Narulaauthor=R.+W.+Yuanauthor=S.+E.+Adamsauthor=O.+M.+Greenauthor=J.+Greenauthor=T.+B.+Philipsauthor=L.+D.+Zydowskyauthor=M.+C.+Botfieldauthor=M.+Hatadaauthor=E.+R.+Lairdauthor=M.+J.+Zollerauthor=J.+L.+Karasauthor=D.+C.+Dalgarno&title=Solution+structure+of+the+C-terminal+SH2+domain+of+the+human+tyrosine+kinase+SYK+complexed+with+a+phosphotyrosine+pentapeptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNarula%26aufirst%3DS.%2BS.%26aulast%3DYuan%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DS.%2BE.%26aulast%3DGreen%26aufirst%3DO.%2BM.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DPhilips%26aufirst%3DT.%2BB.%26aulast%3DZydowsky%26aufirst%3DL.%2BD.%26aulast%3DBotfield%26aufirst%3DM.%2BC.%26aulast%3DHatada%26aufirst%3DM.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DZoller%26aufirst%3DM.%2BJ.%26aulast%3DKaras%26aufirst%3DJ.%2BL.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26atitle%3DSolution%2520structure%2520of%2520the%2520C-terminal%2520SH2%2520domain%2520of%2520the%2520human%2520tyrosine%2520kinase%2520SYK%2520complexed%2520with%2520a%2520phosphotyrosine%2520pentapeptide%26jtitle%3DStructure%26date%3D1995%26volume%3D3%26spage%3D1061%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Gilfillan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, J.</span><span> </span><span class="NLM_article-title">The tyrosine kinase network regulating mast cell activation</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.2008.00742.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19290926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=149-169&author=A.+M.+Gilfillanauthor=J.+Rivera&title=The+tyrosine+kinase+network+regulating+mast+cell+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine kinase network regulating mast cell activation</span></div><div class="casAuthors">Gilfillan, Alasdair M.; Rivera, Juan</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-169</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Mast cell mediator release represents a pivotal event in the initiation of inflammatory reactions assocd. with allergic disorders.  These responses follow antigen-mediated aggregation of IgE-occupied high-affinity receptors for IgE (FcεRI) on the mast cell surface, a response which can be further enhanced following stem cell factor-induced ligation of the mast cell growth factor receptor KIT (CD117).  Activation of tyrosine kinases is central to the ability of both FcεRI and KIT to transmit downstream signaling events required for the regulation of mast cell activation.  Whereas KIT possesses inherent tyrosine kinase activity, FcεRI requires the recruitment of Src family tyrosine kinases and Syk to control the early receptor-proximal signaling events.  The signaling pathways propagated by these tyrosine kinases can be further upregulated by the Tec kinase Bruton's tyrosine kinase and downregulated by the actions of the tyrosine Src homol. 1 domain-contg. phosphatase 1 (SHP-1) and SHP-2.  In this review, we discuss the regulation and role of specific members of this tyrosine kinase network in KIT and FcεRI-mediated mast cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy56joV_npvbVg90H21EOLACvtfcHk0ljRwN19Ua_pPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7rL&md5=64230109d9dc900672ae0e605bee57db</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00742.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00742.x%26sid%3Dliteratum%253Aachs%26aulast%3DGilfillan%26aufirst%3DA.%2BM.%26aulast%3DRivera%26aufirst%3DJ.%26atitle%3DThe%2520tyrosine%2520kinase%2520network%2520regulating%2520mast%2520cell%2520activation%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D149%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Williams, D. H.; Lamers, M. B. A. C.; Smith, S.; Cherry, M.</span><span> </span><span class="NLM_article-title">Spleen Tyrosine Kinase Catalytic Domain: Crystal Structure and Binding Pockets Thereof</span>. WO2004035604,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=D.+H.+Williams&author=M.+B.+A.+C.+Lamers&author=S.+Smith&author=M.+Cherry&title=Spleen+Tyrosine+Kinase+Catalytic+Domain%3A+Crystal+Structure+and+Binding+Pockets+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DSpleen%2520Tyrosine%2520Kinase%2520Catalytic%2520Domain%253A%2520Crystal%2520Structure%2520and%2520Binding%2520Pockets%2520Thereof%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Villaseñor, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span> </span><span class="NLM_article-title">Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1747-0285.2009.00785.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19220318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVWhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2009&pages=466-470&author=A.+G.+Villase%C3%B1orauthor=R.+Kondruauthor=H.+Hoauthor=S.+Wangauthor=E.+Pappauthor=D.+Shawauthor=J.+W.+Barnettauthor=M.+F.+Brownerauthor=A.+Kuglstatter&title=Structural+insights+for+design+of+potent+spleen+tyrosine+kinase+inhibitors+from+crystallographic+analysis+of+three+inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes</span></div><div class="casAuthors">Villasenor, Armando G.; Kondru, Rama; Ho, Hoangdung; Wang, Sandra; Papp, Eva; Shaw, David; Barnett, Jim W.; Browner, Michelle F.; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466-470</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase is considered an attractive drug target for the treatment of allergic and anti-body mediated autoimmune diseases.  We have detd. the co-crystal structures of spleen tyrosine kinase complexed with three known inhibitors: YM193306, a 7-azaindole deriv. and R406.  The cis-cyclohexyldiamino moiety of YM193306 is forming four hydrophobically shielded polar interactions with the spleen tyrosine kinase protein and is therefore crucial for the high potency of this inhibitor.  Its primary amino group is inducing a conformational change of the spleen tyrosine kinase DFG Asp side chain.  The crystal structure of the 7-azaindole deriv. bound to spleen tyrosine kinase is the first demonstration of a 2-substituted 7-azaindole bound to a protein kinase.  Its indole-amide substituent is tightly packed between the N- and C-terminal kinase lobes.  The co-crystal structure of the spleen tyrosine kinase-R406 complex shows two main differences to the previously reported structure of spleen tyrosine kinase soaked with R406: (i) the side chain of the highly conserved Lys is disordered and not forming a hydrogen bond to R406 and (ii) the DFG Asp side chain is pointing away from and not towards R406.  The novel protein-ligand interactions and protein conformational changes revealed in these structures guide the rational design and structure-based optimization of second-generation spleen tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4ofv25cSrSbVg90H21EOLACvtfcHk0li_Keax5mtHCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVWhsrY%253D&md5=1646c908ca57dc3b1d612769f9a53c02</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00785.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00785.x%26sid%3Dliteratum%253Aachs%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DBarnett%26aufirst%3DJ.%2BW.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DStructural%2520insights%2520for%2520design%2520of%2520potent%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520from%2520crystallographic%2520analysis%2520of%2520three%2520inhibitor%2520complexes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D73%26spage%3D466%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Hisamichi, H.; Naito, R.; Kawazoe, S.; Toyoshima, A.; Tanabe, K.; Nakai, E.; Ichikawa, A.; Orita, A.; Takeuchi, M.</span><span> </span><span class="NLM_article-title">Preparation of Novel Pyrimidine-5-carboxamide Derivatives as Tyrosinase Inhibitors</span>. WO199931073,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=H.+Hisamichi&author=R.+Naito&author=S.+Kawazoe&author=A.+Toyoshima&author=K.+Tanabe&author=E.+Nakai&author=A.+Ichikawa&author=A.+Orita&author=M.+Takeuchi&title=Preparation+of+Novel+Pyrimidine-5-carboxamide+Derivatives+as+Tyrosinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHisamichi%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520Novel%2520Pyrimidine-5-carboxamide%2520Derivatives%2520as%2520Tyrosinase%2520Inhibitors%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Cox, P. J.; Majid, T. N.; Lai, J. Y. Q.; Morley, A. D.; Amendola, S.; Deprets, S.; Edlin, C.</span><span> </span><span class="NLM_article-title">Preparation of Azaindoles as Protein Kinase Inhibitors</span>. WO200147922,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=P.+J.+Cox&author=T.+N.+Majid&author=J.+Y.+Q.+Lai&author=A.+D.+Morley&author=S.+Amendola&author=S.+Deprets&author=C.+Edlin&title=Preparation+of+Azaindoles+as+Protein+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DP.%2BJ.%26atitle%3DPreparation%2520of%2520Azaindoles%2520as%2520Protein%2520Kinase%2520Inhibitors%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Farmer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britt, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markland, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanthakumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taslimi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhaveri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, F. G.</span><span> </span><span class="NLM_article-title">Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6231</span><span class="NLM_x">–</span> <span class="NLM_lpage">6235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6231-6235&author=L.+J.+Farmerauthor=G.+Bemisauthor=S.+D.+Brittauthor=J.+Cochranauthor=M.+Connorsauthor=E.+M.+Harringtonauthor=T.+Hoockauthor=W.+Marklandauthor=S.+Nanthakumarauthor=P.+Taslimiauthor=E.+Ter+Haarauthor=J.+Wangauthor=D.+Zhaveriauthor=F.+G.+Salituro&title=Discovery+and+SAR+of+novel+4-thiazolyl-2-phenylaminopyrimidines+as+potent+inhibitors+of+spleen+tyrosine+kinase+%28SYK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarmer%26aufirst%3DL.%2BJ.%26aulast%3DBemis%26aufirst%3DG.%26aulast%3DBritt%26aufirst%3DS.%2BD.%26aulast%3DCochran%26aufirst%3DJ.%26aulast%3DConnors%26aufirst%3DM.%26aulast%3DHarrington%26aufirst%3DE.%2BM.%26aulast%3DHoock%26aufirst%3DT.%26aulast%3DMarkland%26aufirst%3DW.%26aulast%3DNanthakumar%26aufirst%3DS.%26aulast%3DTaslimi%26aufirst%3DP.%26aulast%3DTer%2BHaar%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhaveri%26aufirst%3DD.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520novel%25204-thiazolyl-2-phenylaminopyrimidines%2520as%2520potent%2520inhibitors%2520of%2520spleen%2520tyrosine%2520kinase%2520%2528SYK%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6231%26epage%3D6235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Hammaker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">“Go upstream, young man”: lessons learned from the p38 saga</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">i77</span><span class="NLM_x">–</span> <span class="NLM_lpage">i82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=i77-i82&issue=Suppl.+1&author=D.+Hammakerauthor=G.+S.+Firestein&title=%E2%80%9CGo+upstream%2C+young+man%E2%80%9D%3A+lessons+learned+from+the+p38+saga"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHammaker%26aufirst%3DD.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3D%25E2%2580%259CGo%2520upstream%252C%2520young%2520man%25E2%2580%259D%253A%2520lessons%2520learned%2520from%2520the%2520p38%2520saga%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2010%26volume%3D69%26issue%3DSuppl.%25201%26spage%3Di77%26epage%3Di82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Smolen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, G.</span><span> </span><span class="NLM_article-title">Therapeutic strategies for rheumatoid arthritis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=473-488&author=J.+S.+Smolenauthor=G.+Steiner&title=Therapeutic+strategies+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmolen%26aufirst%3DJ.%2BS.%26aulast%3DSteiner%26aufirst%3DG.%26atitle%3DTherapeutic%2520strategies%2520for%2520rheumatoid%2520arthritis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D473%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Pamuk, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1186%2Far3198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21211067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=222&author=O.+N.+Pamukauthor=G.+C.+Tsokos&title=Spleen+tyrosine+kinase+inhibition+in+the+treatment+of+autoimmune%2C+allergic+and+autoinflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases</span></div><div class="casAuthors">Pamuk, Omer N.; Tsokos, George C.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">222</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (Syk) is involved in the development of the adaptive immune system and has been recognized as being important in the function of addnl. cell types, including platelets, phagocytes, fibroblasts, and osteoclasts, and in the generation of the inflammasome.  Preclin. studies presented compelling evidence that Syk inhibition may have therapeutic value in the treatment of rheumatoid arthritis and other forms of arthritis, systemic lupus erythematosus, autoimmune cytopenias, and allergic and autoinflammatory diseases.  In addn., Syk inhibition may have a place in limiting tissue injury assocd. with organ transplant and revascularization procedures.  Clin. trials have documented exciting success in the treatment of patients with rheumatoid arthritis, autoimmune cytopenias, and allergic rhinitis.  While the extent and severity of side effects appear to be limited so far, larger studies will unravel the risk involved with the clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjha8mMit0ELVg90H21EOLACvtfcHk0lhPYtzwx8GnPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSjtLk%253D&md5=2dd62b67d775892137304f8e8514620e</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1186%2Far3198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far3198%26sid%3Dliteratum%253Aachs%26aulast%3DPamuk%26aufirst%3DO.%2BN.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DSpleen%2520tyrosine%2520kinase%2520inhibition%2520in%2520the%2520treatment%2520of%2520autoimmune%252C%2520allergic%2520and%2520autoinflammatory%2520diseases%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2010%26volume%3D12%26spage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases</span> <span class="citation_source-journal">Autoimmunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2010&pages=48-55&author=D.+Ghoshauthor=G.+C.+Tsokos&title=Spleen+tyrosine+kinase%3A+an+Src+family+of+non-receptor+kinase+has+multiple+functions+and+represents+a+valuable+therapeutic+target+in+the+treatment+of+autoimmune+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DSpleen%2520tyrosine%2520kinase%253A%2520an%2520Src%2520family%2520of%2520non-receptor%2520kinase%2520has%2520multiple%2520functions%2520and%2520represents%2520a%2520valuable%2520therapeutic%2520target%2520in%2520the%2520treatment%2520of%2520autoimmune%2520and%2520inflammatory%2520diseases%26jtitle%3DAutoimmunity%26date%3D2010%26volume%3D43%26spage%3D48%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Šenolt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vencovský, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavelka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ospelt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, S.</span><span> </span><span class="NLM_article-title">Prospective new biological therapies for rheumatoid arthritis</span> <span class="citation_source-journal">Autoimmun. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.autrev.2009.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19328245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SjtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=102-107&author=L.+%C5%A0enoltauthor=J.+Vencovsk%C3%BDauthor=K.+Pavelkaauthor=C.+Ospeltauthor=S.+Gay&title=Prospective+new+biological+therapies+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective new biological therapies for rheumatoid arthritis</span></div><div class="casAuthors">Senolt, Ladislav; Vencovsky, Jiri; Pavelka, Karel; Ospelt, Caroline; Gay, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Autoimmunity Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-107</span>CODEN:
                <span class="NLM_cas:coden">ARUEBU</span>;
        ISSN:<span class="NLM_cas:issn">1568-9972</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Advances in the current knowledge of pathogenetic mechanisms of rheumatoid arthritis have contributed to the development of biol. therapy, and translated research findings into clin. practice.  TNF-α (infliximab, etanercept, adalimumab), IL-1 (anakinra) and IL-6 (tocilizumab) inhibitors, a B-cell depleting agent (rituximab) and a drug blocking T-cell costimulation (abatacept) have been approved for rheumatoid arthritis.  The progress in manufg. biotechnol. has contributed to the development of several other prospective agents that may form the basis for the therapy of rheumatoid arthritis in the near future.  New or modified TNF-α inhibitors (golimumab, certolizumab pegol), new monoclonal antibodies against other cytokines (e.g. IL-1, IL-6, IL-12, IL-15, 1L-17, IL-23), and other agents targeting B-cell depletion (e.g. ocrelizumab, ofatumumab) are in various stages of development.  Many pharmaceutical companies have focused on developing small mol. inhibitors with possible peroral administration, which are considered promising drugs for rheumatoid arthritis.  In most cases, these small mols. inhibit cellular kinases (e.g. p38, JAK or Syk) that mediate the signaling and transcription of proinflammatory genes.  In this review, we describe the cytokine inhibitors and modulators of the immune response currently in ongoing clin. trials, the results of which may further expand the spectrum of efficient therapies for chronic autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpssxuz675AqbVg90H21EOLACvtfcHk0lhPYtzwx8GnPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SjtL7M&md5=2a6638a933c1b6be91b2a4c5eb068a07</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.autrev.2009.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autrev.2009.03.010%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0enolt%26aufirst%3DL.%26aulast%3DVencovsk%25C3%25BD%26aufirst%3DJ.%26aulast%3DPavelka%26aufirst%3DK.%26aulast%3DOspelt%26aufirst%3DC.%26aulast%3DGay%26aufirst%3DS.%26atitle%3DProspective%2520new%2520biological%2520therapies%2520for%2520rheumatoid%2520arthritis%26jtitle%3DAutoimmun.%2520Rev.%26date%3D2009%26volume%3D9%26spage%3D102%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischmann, R.</span><span> </span><span class="NLM_article-title">Kinase inhibitors: a new approach to rheumatoid arthritis treatment</span> <span class="citation_source-journal">Curr. Opin. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1097%2FBOR.0b013e3283378e6f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20164774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFClurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=330-335&author=S.+Cohenauthor=R.+Fleischmann&title=Kinase+inhibitors%3A+a+new+approach+to+rheumatoid+arthritis+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase inhibitors: a new approach to rheumatoid arthritis treatment</span></div><div class="casAuthors">Cohen, Stanley; Fleischmann, Roy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">330-335</span>CODEN:
                <span class="NLM_cas:coden">CORHES</span>;
        ISSN:<span class="NLM_cas:issn">1040-8711</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Purpose of review: Due to the cost and parenteral mode of administration of biologics, efforts to develop oral small mol. inhibitors to protein kinases involved in cellular signaling that impact inflammatory cytokine prodn. have been ongoing.  This article will review the recent publications on these efforts.  Recent findings: On preclin. work, p38 mitogen-activated kinases were considered attractive targets to suppress cytokine prodn.  Three different mols. (SCIO469, Pamapimod, VX-702) that target the p38α isoform have been evaluated in phase 2 trials.  Unfortunately, clin. efficacy was not obsd., and dose-related toxicity was seen.  The future of this approach is unclear.  Targeting more upstream protein tyrosine kinases such as spleen tyrosine kinase (SyK) and the JAK family of kinases has been assocd. with greater success in clin. trials, with efficacy demonstrated.  Adverse events occurred in a dose-dependent fashion with the SyK inhibitor, such as diarrhea and hypertension.  Neutropenia, elevated liver-function tests, serum creatinine elevations and lipid elevations have occurred with JAK-kinase inhibition.  Dose modifications have been made based on the phase 2 trial results; phase 3 clin. trials are ongoing.  Summary: Inhibiting downstream proteins involved in cellular signaling, such as p38, has not been successful to date.  Inhibitors of more upstream protein-tyrosine kinases involved in cellular signaling appear to be viable mol. candidates for rheumatoid arthritis.  If the results seen in phase 2 studies are confirmed in larger phase 3 studies, we may soon have new, oral DMARD therapies available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPHTV_zDWSYLVg90H21EOLACvtfcHk0lhPYtzwx8GnPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFClurg%253D&md5=e698be5034c9d7cf330959936b21da16</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1097%2FBOR.0b013e3283378e6f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FBOR.0b013e3283378e6f%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DFleischmann%26aufirst%3DR.%26atitle%3DKinase%2520inhibitors%253A%2520a%2520new%2520approach%2520to%2520rheumatoid%2520arthritis%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Rheumatol.%26date%3D2010%26volume%3D22%26spage%3D330%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111a"><span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dell, J. R.</span><span> </span><span class="NLM_article-title">State-of-the-art: rheumatoid arthritis</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1898</span><span class="NLM_x">–</span> <span class="NLM_lpage">1906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111a&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1136%2Fard.2010.134684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111a&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20959326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111a&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=1898-1906&author=I.+B.+McInnesauthor=J.+R.+O%E2%80%99Dell&title=State-of-the-art%3A+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111aR"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">State-of-the-art: rheumatoid arthritis</span></div><div class="casAuthors">McInnes, Iain B.; O'Dell, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1898-1906</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review.  The understanding of the pathogenesis and optimal therapeutics for rheumatoid arthritis (RA) has advanced remarkably over the last decade.  This review highlights these key advances, particularly the outcomes of genome-wide scans which have provided an increasingly robust appraisal of the complex genetics that underpin RA.  Such observations are placed in pathogenetic context, particularly concerning the breach of tolerance that presages synovitis and the mechanisms that subserve chronicity.  The key therapeutic strategies and treatment agents, both conventional and biol., now available to effectively manage the disease are described.  Throughout the review, emphasis is placed on unanswered questions and challenges in this exciting field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy_fwi51knDLVg90H21EOLACvtfcHk0li0CZ9lfJ__7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakur3K&md5=0380db3ca2f3ea43890325bb1f97e418</span></div><a href="/servlet/linkout?suffix=cit111a&amp;dbid=16384&amp;doi=10.1136%2Fard.2010.134684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2010.134684%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DJ.%2BR.%26atitle%3DState-of-the-art%253A%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2010%26volume%3D69%26spage%3D1898%26epage%3D1906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit111a1"><span>Correction appears in Ann. Rheum. Dis.<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span>. </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111a1&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1136%2Fard.2010.134684corr1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Correction+appears+in+Ann.+Rheum.+Dis.+2011%2C+70%2C+399.+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111a1&amp;dbid=16384&amp;doi=10.1136%2Fard.2010.134684corr1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1136%252Fard.2010.134684corr1%26sid%3Dliteratum%253Aachs%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2011%26volume%3D70%26spage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Hueber, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Is spleen tyrosine kinase inhibition an effective therapy for patients with RA?</span> <span class="citation_source-journal">Nat. Clin. Pract. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fncprheum1025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19252517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=130-131&author=A.+J.+Hueberauthor=I.+B.+McInnes&title=Is+spleen+tyrosine+kinase+inhibition+an+effective+therapy+for+patients+with+RA%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Is spleen tyrosine kinase inhibition an effective therapy for patients with RA?</span></div><div class="casAuthors">Hueber, Axel J.; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Rheumatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-131</span>CODEN:
                <span class="NLM_cas:coden">NCPRCF</span>;
        ISSN:<span class="NLM_cas:issn">1745-8382</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the success of biol. therapeutic agents that target cytokines and lymphocytes, clin. needs remain unmet in the treatment of rheumatoid arthritis (RA).  The development of small-mol. inhibitors that can block crit. immune signal-transduction pathways are of particular interest as novel therapies for RA.  Spleen tyrosine kinase (SYK) subserves the function of Fc receptors and the B-cell receptor; as such, it is attractive as a potential therapeutic target.  Weinblatt and colleagues recently performed a proof-of-concept study, which demonstrated that inhibition of SYK reduced RA disease activity and levels of disease-relevant biomarkers.  Dose-limiting adverse effects include diarrhea, neutropenia and hypertension, which result from both target-dependent and off-target effects.  This novel study provides the first evidence that SYK could be a useful therapeutic target in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfO85VWMx__LVg90H21EOLACvtfcHk0li0CZ9lfJ__7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVOlsL4%253D&md5=c4bcee63a3811034033e3134c0a40fde</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fncprheum1025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncprheum1025%26sid%3Dliteratum%253Aachs%26aulast%3DHueber%26aufirst%3DA.%2BJ.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DIs%2520spleen%2520tyrosine%2520kinase%2520inhibition%2520an%2520effective%2520therapy%2520for%2520patients%2520with%2520RA%253F%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Rheumatol.%26date%3D2009%26volume%3D5%26spage%3D130%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Edwards, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambridge, G.</span><span> </span><span class="NLM_article-title">B-cell targeting in rheumatoid arthritis and other autoimmune diseases</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri1838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16622478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=394-403&author=J.+C.+Edwardsauthor=G.+Cambridge&title=B-cell+targeting+in+rheumatoid+arthritis+and+other+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">B-cell targeting in rheumatoid arthritis and other autoimmune diseases</span></div><div class="casAuthors">Edwards, Jonathan C. W.; Cambridge, Geraldine</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">394-403</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  B-cell-targeted therapy for autoimmune disease emerged from theor. proposition to practical reality between 1997 and 1998, with the availability of the B-cell-depleting monoclonal antibody rituximab.  Since then, a score of autoantibody-assocd. disorders have been treated, with most convincing evidence of efficacy seen in subjects with rheumatoid arthritis.  Several classes of B-cell-targeted agent are now under investigation.  From the outset, a major goal of B-cell targeting has been the re-establishment of some form of immunol. tolerance.  In some subjects, the obsd. improvement of disease for years following therapy fuels hope that this goal might ultimately be achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe1G7uLySu5bVg90H21EOLACvtfcHk0li0CZ9lfJ__7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOhu7g%253D&md5=2c5e0e12629dc50a1d12b01321645c1d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnri1838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1838%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DJ.%2BC.%26aulast%3DCambridge%26aufirst%3DG.%26atitle%3DB-cell%2520targeting%2520in%2520rheumatoid%2520arthritis%2520and%2520other%2520autoimmune%2520diseases%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2006%26volume%3D6%26spage%3D394%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Gómez-Puerta, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, X.</span><span> </span><span class="NLM_article-title">Therapy: spleen tyrosine kinase inhibitors-novel therapies for RA?</span> <span class="citation_source-journal">Nat. Rev. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnrrheum.2011.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21304505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislOktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=134-136&author=J.+A.+G%C3%B3mez-Puertaauthor=X.+Bosch&title=Therapy%3A+spleen+tyrosine+kinase+inhibitors-novel+therapies+for+RA%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Spleen tyrosine kinase inhibitors-novel therapies for RA?</span></div><div class="casAuthors">Gomez-Puerta, Jose A.; Bosch, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">134-136</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In patients with active rheumatoid arthritis despite therapy with DMARDs, treatment with a spleen tyrosine kinase inhibitor has achieved similar response rates to those achieved in clin. trials of other drugs, including biol. agents.  Where might these agents fit in the current armamentarium against this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNIfsSlfCofrVg90H21EOLACvtfcHk0li0CZ9lfJ__7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislOktLY%253D&md5=318bf1fc5c710874911d1aa1ff234a36</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2011.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2011.8%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B3mez-Puerta%26aufirst%3DJ.%2BA.%26aulast%3DBosch%26aufirst%3DX.%26atitle%3DTherapy%253A%2520spleen%2520tyrosine%2520kinase%2520inhibitors-novel%2520therapies%2520for%2520RA%253F%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2011%26volume%3D7%26spage%3D134%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">Evolving concepts of rheumatoid arthritis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnature01661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12748655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ynu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2003&pages=356-361&author=G.+S.+Firestein&title=Evolving+concepts+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving concepts of rheumatoid arthritis</span></div><div class="casAuthors">Firestein, Gary S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">423</span>
        (<span class="NLM_cas:issue">6937</span>),
    <span class="NLM_cas:pages">356-361</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis is the most common inflammatory arthritis and is a major cause of disability.  It existed in early Native American populations several thousand years ago but might not have appeared in Europe until the 17th century.  Early theories on the pathogenesis of rheumatoid arthritis focused on autoantibodies and immune complexes.  T-cell-mediated antigen-specific responses, T-cell-independent cytokine networks, and aggressive tumor-like behavior of rheumatoid synovium have also been implicated.  More recently, the contribution of autoantibodies has returned to the forefront.  Based on the pathogenic mechanisms, specific therapeutic interventions can be designed to suppress synovial inflammation and joint destruction in rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0a0dB-eD7krVg90H21EOLACvtfcHk0lgV4y-kn3dHag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ynu7c%253D&md5=36a642276886ccc8d0106a0c41ef57b1</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnature01661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01661%26sid%3Dliteratum%253Aachs%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DEvolving%2520concepts%2520of%2520rheumatoid%2520arthritis%26jtitle%3DNature%26date%3D2003%26volume%3D423%26spage%3D356%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Galli, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piliponsky, A. M.</span><span> </span><span class="NLM_article-title">The development of allergic inflammation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">454</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=2008&pages=445-454&author=S.+J.+Galliauthor=M.+Tsaiauthor=A.+M.+Piliponsky&title=The+development+of+allergic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DTsai%26aufirst%3DM.%26aulast%3DPiliponsky%26aufirst%3DA.%2BM.%26atitle%3DThe%2520development%2520of%2520allergic%2520inflammation%26jtitle%3DNature%26date%3D2008%26volume%3D454%26spage%3D445%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Holgate, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosa, R.</span><span> </span><span class="NLM_article-title">Treatment strategies for allergy and asthma</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18274559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVKjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=218-230&author=S.+T.+Holgateauthor=R.+Polosa&title=Treatment+strategies+for+allergy+and+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment strategies for allergy and asthma</span></div><div class="casAuthors">Holgate, Stephen T.; Polosa, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">218-230</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Allergic diseases have reached epidemic proportions worldwide.  An understanding of the cellular and sol. mediators that are involved in allergic inflammatory responses not only helps in understanding the mechanisms of current treatments, but is also important for the identification of new targets that are amenable to both small-mol. and biol. interventions.  There is now considerable optimism with regards to tackling the allergy epidemic in light of improvements in systemic and mucosal allergen-specific immunotherapy, the identification of key cytokines and their receptors that drive T-helper-2-cell polarization, a clearer understanding of the pathways of leukocyte recruitment and the signalling pathways that are involved in cell activation and mediator secretion, and new approaches to vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4BOKmEiCJ5LVg90H21EOLACvtfcHk0lgV4y-kn3dHag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVKjsrY%253D&md5=66f8a45e4a64002fc265a0892ea2a110</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fnri2262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2262%26sid%3Dliteratum%253Aachs%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DPolosa%26aufirst%3DR.%26atitle%3DTreatment%2520strategies%2520for%2520allergy%2520and%2520asthma%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D218%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Holgate, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broide, D.</span><span> </span><span class="NLM_article-title">New targets for allergic rhinitis: a disease of civilization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=903-915&author=S.+T.+Holgateauthor=D.+Broide&title=New+targets+for+allergic+rhinitis%3A+a+disease+of+civilization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DBroide%26aufirst%3DD.%26atitle%3DNew%2520targets%2520for%2520allergic%2520rhinitis%253A%2520a%2520disease%2520of%2520civilization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D903%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Boguniewicz, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D. Y.</span><span> </span><span class="NLM_article-title">10. Atopic dermatitis</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">2, Suppl. Mini-Primer</span><span class="NLM_x">) </span> <span class="NLM_fpage">S475</span><span class="NLM_x">–</span> <span class="NLM_lpage">S480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2006&pages=S475-S480&issue=2%2C+Suppl.+Mini-Primer&author=M+Boguniewiczauthor=D.+Y.+Leung&title=10.+Atopic+dermatitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoguniewicz%26aufirst%3DM%26aulast%3DLeung%26aufirst%3DD.%2BY.%26atitle%3D10.%2520Atopic%2520dermatitis%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2006%26volume%3D117%26issue%3D2%252C%2520Suppl.%2520Mini-Primer%26spage%3DS475%26epage%3DS480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Enyedy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambiar, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liossis, S. N, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Fcε receptor type I γ chain replaces the deficient T cell receptor ζ chain in T cells of patients with systemic lupus erythematosus</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2F1529-0131%28200105%2944%3A5%3C1114%3A%3AAID-ANR192%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11352243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlE%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1114-1121&author=E.+J.+Enyedyauthor=M.+P.+Nambiarauthor=S.+N%2C+C.+Liossisauthor=G.+Dennisauthor=G.+M.+Kammerauthor=G.+C.+Tsokos&title=Fc%CE%B5+receptor+type+I+%CE%B3+chain+replaces+the+deficient+T+cell+receptor+%CE%B6+chain+in+T+cells+of+patients+with+systemic+lupus+erythematosus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Fcε receptor type I γ chain replaces the deficient T cell receptor ζ chain in T cells of patients with systemic lupus erythematosus</span></div><div class="casAuthors">Enyedy, Edith J.; Nambiar, Madhusoodana P.; Liossis, Stamatis-Nick C.; Dennis, Gregory; Kammer, Gary M.; Tsokos, George C.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1114-1121</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">T cells from the majority of patients with systemic lupus erythematosus (SLE) express significantly lower levels of T cell receptor chain, a crit. signaling mol.  However, TCR/CD3 triggering of SLE T cells shows increased phosphorylation of downstream signaling intermediates and increased [Ca2+]i response, suggesting the presence of alternative signaling mechanisms.  We investigated whether Fcε receptor type I γ chain (FcεRIγ) could substitute for TCR chain and contribute to T cell signaling in SLE.  T cells were purified from the peripheral blood of 21 patients with SLE and 5 healthy volunteers.  The expression of FcεRIγ was investigated using immunoblotting, reverse transcriptase-polymerase chain reaction, and flow cytometry methods.  Involvement of the FcεRIγ in T cell signaling was studied by immunopptn. and/or immunoblotting after TCR/CD3 stimulation.  Western blotting and densitometric anal. showed that the expression of FcεRIγ in SLE T cells was 4.3-fold higher than in normal T cells (P < 0.001).  Flow cytometric analyses of T lymphocyte subsets revealed that the proportions of FcεRIγ+,CD3+,FcεRIγ+,CD4+, and FcεRIγ+, CD8+ cells were significantly greater in SLE patients than in healthy controls (P < 0.001).  Immunopptn. of SLE T cell lysates with an anti-FcεRIγ antibody showed that FcεRIγ assocs. with the tyrosine kinase Syk and the CD3ε chain, suggesting that FcεRIγ is functionally involved in TCR signaling.  These results demonstrate that the FcεRI γ chain is expressed at high levels in a large proportion of SLE T cells.  The increased expression of FcεRI γ chain in SLE T cells may account in part for the aberrant antigen receptor-initiated signaling and contribute to the diverse cellular abnormalities found in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzrYakwhlwQ7Vg90H21EOLACvtfcHk0lgAbQaFfZwXMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlE%253D&md5=55222fbf6205e33c829c878eb1fd2344</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28200105%2944%3A5%3C1114%3A%3AAID-ANR192%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528200105%252944%253A5%253C1114%253A%253AAID-ANR192%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DEnyedy%26aufirst%3DE.%2BJ.%26aulast%3DNambiar%26aufirst%3DM.%2BP.%26aulast%3DLiossis%26aufirst%3DS.%2BN%252C%2BC.%26aulast%3DDennis%26aufirst%3DG.%26aulast%3DKammer%26aufirst%3DG.%2BM.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DFc%25CE%25B5%2520receptor%2520type%2520I%2520%25CE%25B3%2520chain%2520replaces%2520the%2520deficient%2520T%2520cell%2520receptor%2520%25CE%25B6%2520chain%2520in%2520T%2520cells%2520of%2520patients%2520with%2520systemic%2520lupus%2520erythematosus%26jtitle%3DArthritis%2520Rheum.%26date%3D2001%26volume%3D44%26spage%3D1114%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Cines, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchette, V. S.</span><span> </span><span class="NLM_article-title">Immune thrombocytopenic purpura</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1056%2FNEJMra010501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11919310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD387ovFOntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2002&pages=995-1008&author=D.+B.+Cinesauthor=V.+S.+Blanchette&title=Immune+thrombocytopenic+purpura"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Immune thrombocytopenic purpura</span></div><div class="casAuthors">Cines Douglas B; Blanchette Victor S</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">995-1008</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJVeKVHwuSNzEwO064Z95rfW6udTcc2eb1p0dQorTblLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ovFOntw%253D%253D&md5=c47bb4799a595d73d19b21756354e9f1</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1056%2FNEJMra010501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra010501%26sid%3Dliteratum%253Aachs%26aulast%3DCines%26aufirst%3DD.%2BB.%26aulast%3DBlanchette%26aufirst%3DV.%2BS.%26atitle%3DImmune%2520thrombocytopenic%2520purpura%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D346%26spage%3D995%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Rosse, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, A. D.</span><span> </span><span class="NLM_article-title">Immune-mediated hemolytic anemia</span> <span class="citation_source-journal">Hematology: Am. Soc. Hematol., Educ. Program</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1182%2Fasheducation-2004.1.48" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15561676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD2crovVamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=48-62&author=W.+F.+Rosseauthor=P.+Hillmenauthor=A.+D.+Schreiber&title=Immune-mediated+hemolytic+anemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Immune-mediated hemolytic anemia</span></div><div class="casAuthors">Rosse Wendell F; Hillmen Peter; Schreiber Alan D</div><div class="citationInfo"><span class="NLM_cas:title">Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-62</span>
        ISSN:<span class="NLM_cas:issn">1520-4391</span>.
    </div><div class="casAbstract">Hemolytic anemia due to immune function is one of the major causes of acquired hemolytic anemia.  In recent years, as more is known about the immune system, these entities have become better understood and their treatment improved.  In this section, we will discuss three areas in which this progress has been apparent.  In Section I, Dr.  Peter Hillmen outlines the recent findings in the pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH), relating the biochemical defect (the lack of glycosylphosphatidylinositol [GPI]-linked proteins on the cell surface) to the clinical manifestations, particularly hemolysis (and its effects) and thrombosis.  He discusses the pathogenesis of the disorder in the face of marrow dysfunction insofar as it is known.  His major emphasis is on innovative therapies that are designed to decrease the effectiveness of complement activation, since the lack of cellular modulation of this system is the primary cause of the pathology of the disease.  He recounts his considerable experience with a humanized monoclonal antibody against C5, which has a remarkable effect in controlling the manifestations of the disease.  Other means of controlling the action of complement include replacing the missing modulatory proteins on the cell surface; these studies are not as developed as the former agent.  In Section II, Dr.  Alan Schreiber describes the biochemistry, genetics, and function of the Fc gamma receptors and their role in the pathobiology of autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura due to IgG antibodies.  He outlines the complex varieties of these molecules, showing how they vary in genetic origin and in function.  These variations can be related to three-dimensional topography, which is known in some detail.  Liganding IgG results in the transduction of a signal through the tyrosine-based activation motif and Syk signaling.  The role of these receptors in the pathogenesis of hematological diseases due to IgG antibodies is outlined and the potential of therapy of these diseases by regulation of these receptors is discussed.  In Section III, Dr.  Wendell Rosse discusses the forms of autoimmune hemolytic anemia characterized by antibodies that react preferentially in the cold-cold agglutinin disease and paroxysmal cold hemoglobinuria (PCH).  The former is due to IgM antibodies with a common but particular structure that reacts primarily with carbohydrate or carbohydrate-containing antigens, an interaction that is diminished at body temperature.  PCH is a less common but probably underdiagnosed illness due to an IgG antibody reacting with a carbohydrate antigen; improved techniques for the diagnosis of PCH are described.  Therapy for the two disorders differs somewhat because of the differences in isotype of the antibody.  Since the hemolysis in both is primarily due to complement activation, the potential role of its control, as by the monoclonal antibody described by Dr.  Hillmen, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlZ_ReN1VA_denUz0lpNqnfW6udTcc2eb1p0dQorTblLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crovVamsQ%253D%253D&md5=015844adf996f9d00e3c469cdd066df4</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1182%2Fasheducation-2004.1.48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fasheducation-2004.1.48%26sid%3Dliteratum%253Aachs%26aulast%3DRosse%26aufirst%3DW.%2BF.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DSchreiber%26aufirst%3DA.%2BD.%26atitle%3DImmune-mediated%2520hemolytic%2520anemia%26jtitle%3DHematology%253A%2520Am.%2520Soc.%2520Hematol.%252C%2520Educ.%2520Program%26date%3D2004%26spage%3D48%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Robbie-Ryan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span> </span><span class="NLM_article-title">The role of mast cells in allergy and autoimmunity</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">733</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0952-7915%2802%2900394-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12413522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1agt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=728-733&author=M.+Robbie-Ryanauthor=M.+A.+Brown&title=The+role+of+mast+cells+in+allergy+and+autoimmunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mast cells in allergy and autoimmunity</span></div><div class="casAuthors">Robbie-Ryan, Michaela; Brown, Melissa A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">728-733</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Two potential outcomes of dysregulated immunity are allergy and autoimmunity.  Both are characterized by localized inflammation that leads to the injury and/or destruction of target tissues.  Until recently, it was generally accepted that the mechanisms that govern these disease processes are quite disparate; however, new discoveries suggest that the mast cell may underlie much of the pathol. in both these disease syndromes.  Amongst these discoveries is the observation that mast cell-deficient mice exhibit significantly reduced disease severity compared to wild-type littermates in a murine model of multiple sclerosis (MS) and drugs that block mast cell function can improve clin. symptoms in this model.  In addn., gene microarray anal. has revealed that the expression of several mast cell-specific genes is increased in the central nervous system plaques of MS patients.  Although well established as effector cells in allergic inflammation, the location of mast cells and the wealth of inflammatory mediators they express make it likely that they have profound effects on many other autoimmune processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovTpIJaeIXCLVg90H21EOLACvtfcHk0lgAbQaFfZwXMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1agt7Y%253D&md5=de9d7f85e09a5636a52dc69b068b6f41</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2802%2900394-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252802%252900394-1%26sid%3Dliteratum%253Aachs%26aulast%3DRobbie-Ryan%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26atitle%3DThe%2520role%2520of%2520mast%2520cells%2520in%2520allergy%2520and%2520autoimmunity%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2002%26volume%3D14%26spage%3D728%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Robbie-Ryan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzola, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secor, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span> </span><span class="NLM_article-title">Cutting edge: both activating and inhibitory fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=1630-1634&author=M.+Robbie-Ryanauthor=M.+B.+Tanzolaauthor=V.+H.+Secorauthor=M.+A.+Brown&title=Cutting+edge%3A+both+activating+and+inhibitory+fc+receptors+expressed+on+mast+cells+regulate+experimental+allergic+encephalomyelitis+disease+severity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobbie-Ryan%26aufirst%3DM.%26aulast%3DTanzola%26aufirst%3DM.%2BB.%26aulast%3DSecor%26aufirst%3DV.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26atitle%3DCutting%2520edge%253A%2520both%2520activating%2520and%2520inhibitory%2520fc%2520receptors%2520expressed%2520on%2520mast%2520cells%2520regulate%2520experimental%2520allergic%2520encephalomyelitis%2520disease%2520severity%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D1630%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Pedotti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Voss, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, S. J.</span><span> </span><span class="NLM_article-title">Involvement of both “allergic” and “autoimmune” mechanisms in EAE, MS and other autoimmune diseases</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS1471-4906%2803%2900233-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12967671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=479-484&author=R.+Pedottiauthor=J.+J.+De+Vossauthor=L.+Steinmanauthor=S.+J.+Galli&title=Involvement+of+both+%E2%80%9Callergic%E2%80%9D+and+%E2%80%9Cautoimmune%E2%80%9D+mechanisms+in+EAE%2C+MS+and+other+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases</span></div><div class="casAuthors">Pedotti, Rosetta; De Voss, Jason J.; Steinman, Lawrence; Galli, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">479-484</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Allergic and autoimmune diseases have been considered to be at the opposite sides of the spectrum of the immune response.  Autoimmune diseases, such as multiple sclerosis (MS), rheumatoid arthritis and type 1 insulin-dependent diabetes mellitus, are considered T helper 1 (Th1)-mediated diseases, and allergic disorders, such as asthma, food allergy or rhinitis, are considered to be Th2-mediated.  In this Opinion, we present evidence for the hypothesis that, elements of the immune response classically assocd. with allergy, importantly contribute to the pathogenesis of autoimmune demyelinating diseases of the central nervous system (CNS), in both the human disease, MS, and its animal model, exptl. autoimmune (formerly allergic') encephalomyelitis.  Autoimmune demyelinating diseases of the CNS, and other autoimmune diseases, can reflect the interplay of both Th1- and Th2-assocd. mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqW7qFIeCQrVg90H21EOLACvtfcHk0livZ0PEueWAkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGhs7s%253D&md5=1b9675aa483aea8bc0afdb0393bbd8c1</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2FS1471-4906%2803%2900233-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4906%252803%252900233-3%26sid%3Dliteratum%253Aachs%26aulast%3DPedotti%26aufirst%3DR.%26aulast%3DDe%2BVoss%26aufirst%3DJ.%2BJ.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26atitle%3DInvolvement%2520of%2520both%2520%25E2%2580%259Callergic%25E2%2580%259D%2520and%2520%25E2%2580%259Cautoimmune%25E2%2580%259D%2520mechanisms%2520in%2520EAE%252C%2520MS%2520and%2520other%2520autoimmune%2520diseases%26jtitle%3DTrends%2520Immunol.%26date%3D2003%26volume%3D24%26spage%3D479%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Secor, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secor, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutekunst, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span> </span><span class="NLM_article-title">Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2000&pages=813-822&author=V.+H.+Secorauthor=W.+E.+Secorauthor=C.+A.+Gutekunstauthor=M.+A.+Brown&title=Mast+cells+are+essential+for+early+onset+and+severe+disease+in+a+murine+model+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSecor%26aufirst%3DV.%2BH.%26aulast%3DSecor%26aufirst%3DW.%2BE.%26aulast%3DGutekunst%26aufirst%3DC.%2BA.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26atitle%3DMast%2520cells%2520are%2520essential%2520for%2520early%2520onset%2520and%2520severe%2520disease%2520in%2520a%2520murine%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D191%26spage%3D813%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Wong, W. S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, K. P.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: a new approach for asthma</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1697</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1697&publication_year=2004&pages=53-69&author=W.+S.+F.+Wongauthor=K.+P.+Leong&title=Tyrosine+kinase+inhibitors%3A+a+new+approach+for+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DW.%2BS.%2BF.%26aulast%3DLeong%26aufirst%3DK.%2BP.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520a%2520new%2520approach%2520for%2520asthma%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1697%26spage%3D53%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Wong, W. S. F.</span><span> </span><span class="NLM_article-title">Inhibitors of the tyrosine kinase signaling cascade for asthma</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.coph.2005.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15907913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlejtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=264-271&author=W.+S.+F.+Wong&title=Inhibitors+of+the+tyrosine+kinase+signaling+cascade+for+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the tyrosine kinase signaling cascade for asthma</span></div><div class="casAuthors">Wong, Ws fred</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">264-271</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathogenesis of allergic asthma involves the interplay of inflammatory cells and resident airway cells, and of their secreted mediators including cytokines, chemokines, growth factors and inflammatory mediators.  Tyrosine kinase signaling cascades play a crit. role in the pathogenesis of allergic airway inflammation.  Receptor tyrosine kinases (e.g. epidermal growth factor receptor [EGFR] and platelet-derived growth factor receptor) are important for the pathogenesis of airway remodeling.  Stimulation of non-receptor tyrosine kinases (e.g. Lyn, Lck, Syk, ZAP-70, Btk, Itk and JAK) is the earliest detectable signaling response upon activation of immune receptors (T cell receptor, B cell receptor and FCεR1), cytokine receptors and chemokine receptors in inflammatory cells.  Activation of tyrosine kinases invokes multiple downstream signaling pathways, including phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB), leading to cell differentiation, survival, proliferation, degranulation and chemotaxis.  Inhibitors targeted at different enzyme mols. of the tyrosine kinase signaling cascade might afford therapeutic potential for asthma.  Anti-inflammatory effects of pharmacol. agents targeted at tyrosine kinases, Syk, Itk, signal transducer and activator of transcription-1, NF-κB, GATA3, EGFR, PI3K, MEK1/2, p38 MAPK and JNK have been reported in animal models of allergic airway inflammation.  Therefore, development of inhibitors targeted at the tyrosine kinase signaling cascade is an attractive strategy for the treatment of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu78VGFIAiJrVg90H21EOLACvtfcHk0livZ0PEueWAkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlejtbw%253D&md5=7b9daf7ec944ef95db7a495ccece3329</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DW.%2BS.%2BF.%26atitle%3DInhibitors%2520of%2520the%2520tyrosine%2520kinase%2520signaling%2520cascade%2520for%2520asthma%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D264%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Oliver, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepley, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, B. S.</span><span> </span><span class="NLM_article-title">Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcεR1 signaling pathway</span> <span class="citation_source-journal">Immunopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0162-3109%2800%2900224-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10960668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvV2nur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=269-281&author=J.+M.+Oliverauthor=C.+L.+Kepleyauthor=E.+Ortegaauthor=B.+S.+Wilson&title=Immunologically+mediated+signaling+in+basophils+and+mast+cells%3A+finding+therapeutic+targets+for+allergic+diseases+in+the+human+Fc%CE%B5R1+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcεR1 signaling pathway</span></div><div class="casAuthors">Oliver, J. M.; Kepley, C. L.; Ortega, E.; Wilson, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Immunopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-281</span>CODEN:
                <span class="NLM_cas:coden">IMMUDP</span>;
        ISSN:<span class="NLM_cas:issn">0162-3109</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 34 refs.  The high affinity IgE receptor, FcεRI, plays key roles in an array of acute and chronic human allergic reactions including asthma, allergic rhinitis, atopic dermatitis, urticaria and anaphylaxis.  In humans and rodents, this receptor is found at high levels on basophils and mast cells where its activation by IgE and multivalent antigen produces mediators and cytokines responsible for FcεRI-dependent acute inflammation.  Mast cells can addnl. contribute to sustained inflammatory responses by internalizing antigen bound to IgE-FcεRI complexes for processing to peptides and presentation to T cells.  In humans, the FcεRI is also expressed, at lower d., on monocytes, macrophages and dendritic cells (DC) where its likely functions again include both signaling to mediator and cytokine prodn. and antigen presentation.  Our labs. have focused on defining the earliest steps in the FcεRI signaling cascade in basophils and mast cells and on developing new routes to control allergic inflammation based on inhibiting these events.  Here, the authors describe novel strategies to limit antigen-stimulated FcεRI signaling by: (1) sequestering the FcεRI-assocd. protein-tyrosine kinase, Lyn, that initiates FcεRI signaling; (2) eliminating; or (3) inactivating the protein-tyrosine kinase, Syk, that propagates FcεRI signaling; and (4) establishing inhibitory crosstalk between FcεRI and a co-expressed receptor, FcγRII, that again limits FcεRI-mediated Syk activation.  These strategies may form the basis for new therapies for allergic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr72QJZNtYFg7Vg90H21EOLACvtfcHk0limin3XsGnt1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvV2nur8%253D&md5=0e964778b93ec34aa97a655d82f2edbb</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2FS0162-3109%2800%2900224-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-3109%252800%252900224-1%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DJ.%2BM.%26aulast%3DKepley%26aufirst%3DC.%2BL.%26aulast%3DOrtega%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DB.%2BS.%26atitle%3DImmunologically%2520mediated%2520signaling%2520in%2520basophils%2520and%2520mast%2520cells%253A%2520finding%2520therapeutic%2520targets%2520for%2520allergic%2520diseases%2520in%2520the%2520human%2520Fc%25CE%25B5R1%2520signaling%2520pathway%26jtitle%3DImmunopharmacology%26date%3D2000%26volume%3D48%26spage%3D269%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Galli, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M.</span><span> </span><span class="NLM_article-title">Mast cells in the development of adaptive immune responses</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fni1158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15662442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FjsV2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=135-142&author=S.+J.+Galliauthor=S.+Nakaeauthor=M.+Tsai&title=Mast+cells+in+the+development+of+adaptive+immune+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cells in the development of adaptive immune responses</span></div><div class="casAuthors">Galli Stephen J; Nakae Susumu; Tsai Mindy</div><div class="citationInfo"><span class="NLM_cas:title">Nature immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-42</span>
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    </div><div class="casAbstract">Mast cells are so widely recognized as critical effector cells in allergic disorders and other immunoglobulin E-associated acquired immune responses that it can be difficult to think of them in any other context.  However, mast cells also can be important as initiators and effectors of innate immunity.  In addition, mast cells that are activated during innate immune responses to pathogens, or in other contexts, can secrete products and have cellular functions with the potential to facilitate the development, amplify the magnitude or regulate the kinetics of adaptive immune responses.  Thus, mast cells may influence the development, intensity and duration of adaptive immune responses that contribute to host defense, allergy and autoimmunity, rather than simply functioning as effector cells in these settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkdMLHjD84DBJ5E29YNGvQfW6udTcc2eZAuUotOTLPJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FjsV2mtQ%253D%253D&md5=57758be92aa3f47f3134bf7a57a8a531</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1038%2Fni1158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1158%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DNakae%26aufirst%3DS.%26aulast%3DTsai%26aufirst%3DM.%26atitle%3DMast%2520cells%2520in%2520the%2520development%2520of%2520adaptive%2520immune%2520responses%26jtitle%3DNat.%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D135%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Holgate, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haitchi, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span> </span><span class="NLM_article-title">Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.jaci.2006.01.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16522446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1aqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2006&pages=496-506&author=S.+T.+Holgateauthor=J.+Hollowayauthor=S.+Wilsonauthor=P.+H.+Howarthauthor=H.+M.+Haitchiauthor=S.+Babuauthor=D.+E.+Davies&title=Understanding+the+pathophysiology+of+severe+asthma+to+generate+new+therapeutic+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities</span></div><div class="casAuthors">Holgate, Stephen T.; Holloway, John; Wilson, Susan; Howarth, Peter H.; Haitchi, Hans Michael; Babu, Suresh; Davies, Donna E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">496-506</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Although asthma is defined in terms of reversibility of airflow obstruction, as the disease becomes more severe and chronic, it adopts different characteristics, including a degree of fixed airflow obstruction and corticosteroid refractoriness.  Underlying these phenotypes is evidence of airway wall remodeling, which should be distinguished from the increase in smooth muscle linked to airways hyperresponsiveness.  Aberrant epithelial-mesenchymal communication leads to a chronic wound scenario, which is characterized by activation of the epithelial-mesenchymal trophic unit, epithelial damage, the laying down of new matrix, and greater involvement of neutrophils in the inflammatory response.  In allergic asthmatic patients who remain symptomatic despite high-dose corticosteroid therapy, blockade of IgE with omalizumab confers appreciable clin. benefit.  Chronic severe asthma is also accompanied by a marked increase in TNF-α prodn. that might contribute to corticosteroid refractoriness.  Based on this, TNF blockade with the sol. fusion protein entanercept produces improvement in asthma symptoms, lung function, and quality of life paralleled by a marked redn. in airways hyperresponsiveness.  Identification of novel susceptibility genes, such as a disintegrin and metalloprotease 33 (ADAM33), will provide further targets against which to direct novel therapies for asthma, esp. at the more severe end of the disease spectrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpapU5eHB23ZbVg90H21EOLACvtfcHk0limin3XsGnt1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1aqt7o%253D&md5=b93058f0b3f852ddc287efd169edbc4a</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2006.01.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2006.01.039%26sid%3Dliteratum%253Aachs%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DHolloway%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DHowarth%26aufirst%3DP.%2BH.%26aulast%3DHaitchi%26aufirst%3DH.%2BM.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26atitle%3DUnderstanding%2520the%2520pathophysiology%2520of%2520severe%2520asthma%2520to%2520generate%2520new%2520therapeutic%2520opportunities%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2006%26volume%3D117%26spage%3D496%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Galli, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimbaldeston, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M.</span><span> </span><span class="NLM_article-title">Immunomodulatory mast cells: negative, as well as positive, regulators of immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18483499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=478-486&author=S.+J.+Galliauthor=M.+Grimbaldestonauthor=M.+Tsai&title=Immunomodulatory+mast+cells%3A+negative%2C+as+well+as+positive%2C+regulators+of+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory mast cells: negative, as well as positive, regulators of immunity</span></div><div class="casAuthors">Galli, Stephen J.; Grimbaldeston, Michele; Tsai, Mindy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">478-486</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Opinion article, Stephen Galli and colleagues discuss the recent evidence that mast cells can have neg., as well as pos., immunomodulatory functions, and suggest that mast cells might have distinct roles at different phases of an immune response.  Mast cells can promote inflammation and other tissue changes in IgE-assocd. allergic disorders, as well as in certain innate and adaptive immune responses that are thought to be independent of IgE.  However, mast cells can also have anti-inflammatory and immunosuppressive functions.  Here, we review the evidence that mast cells can have neg., as well as pos., immunomodulatory roles in vivo, and we propose that mast cells can both enhance and later suppress certain features of an immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-1oHz1hfDorVg90H21EOLACvtfcHk0limin3XsGnt1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojt78%253D&md5=ab7ef0dec97e712222860a4096d694c9</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fnri2327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2327%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DGrimbaldeston%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DM.%26atitle%3DImmunomodulatory%2520mast%2520cells%253A%2520negative%252C%2520as%2520well%2520as%2520positive%252C%2520regulators%2520of%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D478%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Kalesnikoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, S. J.</span><span> </span><span class="NLM_article-title">New developments in mast cell biology</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fni.f.216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18936782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KrtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1215-1223&author=J.+Kalesnikoffauthor=S.+J.+Galli&title=New+developments+in+mast+cell+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in mast cell biology</span></div><div class="casAuthors">Kalesnikoff, Janet; Galli, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1215-1223</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mast cells can function as effector and immunoregulatory cells in IgE-assocd. allergic disorders, as well as in certain innate and adaptive immune responses.  This review focuses on exciting new developments in the field of mast cell biol. published in the past year.  The authors highlight advances in the understanding of FcεRI-mediated signaling and mast cell-activation events, as well as in the use of genetic models to study mast cell function in vivo.  Finally, the authors discuss newly identified functions for mast cells or individual mast cell products, such as proteases and interleukin 10, in host defense, cardiovascular disease and tumor biol. and in settings in which mast cells have anti-inflammatory or immunosuppressive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokEORX7NAwYrVg90H21EOLACvtfcHk0ljWxNrdvrwZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KrtbrI&md5=e765c0d24b6d89c46d7e1521b2508960</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fni.f.216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.f.216%26sid%3Dliteratum%253Aachs%26aulast%3DKalesnikoff%26aufirst%3DJ.%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26atitle%3DNew%2520developments%2520in%2520mast%2520cell%2520biology%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1215%26epage%3D1223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Rivera, J.</span><span> </span><span class="NLM_article-title">Molecular adapters in FcεR1 signaling and the allergic response</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0952-7915%2802%2900396-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12413516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1agt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=688-693&author=J.+Rivera&title=Molecular+adapters+in+Fc%CE%B5R1+signaling+and+the+allergic+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular adapters in Fc.vepsiln.RI signaling and the allergic response</span></div><div class="casAuthors">Rivera, Juan</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">688-693</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  IgE-dependent activation of mast cells is central to the allergic response.  The engagement of IgE-occupied receptors initiates a series of mol. events that cause the release of preformed, and de novo synthesis of, allergic mediators.  Recent investigations demonstrate a crit. role for non-enzymic proteins that facilitate the activation and coordination of biochem. signals required for mast cell activation.  Among these LAT, SLP-76 and Gab2 are critically important as adapters that facilitate events initiated by IgE receptor-dependent activation of Src family protein tyrosine kinases, Lyn and Fyn.  An evaluation of the role of these adapters points to complementary but independent steps in early signaling and the possibility that preference for one or another adaptor complex may result in selective mast cell responses.  Recent investigations show that mol. adapters play a major role in IgE-mediated allergic responses because of their ability to coordinate intracellular signaling and their essential nature in mast cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbMUY9icWSFbVg90H21EOLACvtfcHk0ljWxNrdvrwZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1agt7w%253D&md5=9c63226b7ad10e4667c2c49292189b4d</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2802%2900396-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252802%252900396-5%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DJ.%26atitle%3DMolecular%2520adapters%2520in%2520Fc%25CE%25B5R1%2520signaling%2520and%2520the%2520allergic%2520response%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2002%26volume%3D14%26spage%3D688%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Fahy, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fick, R. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boushey, H. A.</span><span> </span><span class="NLM_article-title">The effect of an anti-IgE monoclonal antibody on the early and late-phase responses to allergen inhalation in asthmatic subjects</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">1828</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1164%2Fajrccm.155.6.9196082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9196082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADyaK2szjvFCrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1997&pages=1828-1834&author=J.+V.+Fahyauthor=H.+E.+Flemingauthor=H.+H.+Wongauthor=J.+T.+Liuauthor=J.+Q.+Suauthor=J.+Reimannauthor=R.+B.+Fickauthor=H.+A.+Boushey&title=The+effect+of+an+anti-IgE+monoclonal+antibody+on+the+early+and+late-phase+responses+to+allergen+inhalation+in+asthmatic+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects</span></div><div class="casAuthors">Fahy J V; Fleming H E; Wong H H; Liu J T; Su J Q; Reimann J; Fick R B Jr; Boushey H A</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1828-34</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">A humanized murine monoclonal antibody directed to the Fc epsilonR1-binding domain of human IgE (rhuMAb-E25) has been shown to inhibit the binding of IgE to mast cells without provoking mast cell activation.  To examine the effects of neutralizing IgE on allergic airway responses, we assessed the effects of 9 wk of treatment with rhuMAb-E25 in a parallel group, randomized, double-blind, placebo-controlled study of 19 allergic asthmatic subjects.  We found that treatment with rhuMAb-E25 reduced serum IgE, increased the dose of allergen needed to provoke an early asthmatic response, reduced the mean maximal fall in FEV1 during the early response (30 +/- 10% at baseline to 18.8 +/- 8%, versus 33 +/- 8% at baseline to 34 +/- 4% after placebo; p = 0.01), and reduced the mean maximal fall in FEV1 during the late response (24 +/- 20% at baseline to 9 +/- 10% versus 20 +/- 17% at baseline to 18 +/- 17% after placebo; p = 0.047).  We conclude that an anti-IgE monoclonal antibody, which inhibits binding of IgE to its receptor, suppresses the early- and late-phase responses to inhaled allergen in allergic asthmatic subjects.  Targeting IgE with rhuMAb-E25 might be a useful treatment for allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7uWM2JdA5uVf1XRtfYM0dfW6udTcc2ea-RrkRI8dfobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szjvFCrsQ%253D%253D&md5=5c87ce5aab05a1877d81fa704d82e5d2</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.155.6.9196082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.155.6.9196082%26sid%3Dliteratum%253Aachs%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26aulast%3DFleming%26aufirst%3DH.%2BE.%26aulast%3DWong%26aufirst%3DH.%2BH.%26aulast%3DLiu%26aufirst%3DJ.%2BT.%26aulast%3DSu%26aufirst%3DJ.%2BQ.%26aulast%3DReimann%26aufirst%3DJ.%26aulast%3DFick%26aufirst%3DR.%2BB.%26aulast%3DBoushey%26aufirst%3DH.%2BA.%26atitle%3DThe%2520effect%2520of%2520an%2520anti-IgE%2520monoclonal%2520antibody%2520on%2520the%2520early%2520and%2520late-phase%2520responses%2520to%2520allergen%2520inhalation%2520in%2520asthmatic%2520subjects%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1997%26volume%3D155%26spage%3D1828%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Fahy, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulet, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschesnes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelman, D. C.</span><span> </span><span class="NLM_article-title">Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1164%2Fajrccm.160.3.9810012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10471635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADyaK1MvgtlamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1999&pages=1023-1027&author=J.+V.+Fahyauthor=D.+W.+Cockcroftauthor=L.+P.+Bouletauthor=H.+H.+Wongauthor=F.+Deschesnesauthor=E.+E.+Davisauthor=J.+Ruppelauthor=J.+Q.+Suauthor=D.+C.+Adelman&title=Effect+of+aerosolized+anti-IgE+%28E25%29+on+airway+responses+to+inhaled+allergen+in+asthmatic+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects</span></div><div class="casAuthors">Fahy J V; Cockcroft D W; Boulet L P; Wong H H; Deschesnes F; Davis E E; Ruppel J; Su J Q; Adelman D C</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1023-7</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Intravenous administration of a humanized monoclonal antibody of IgE (E25) attenuates the early and late phase response to inhaled allergen in allergic asthmatic subjects.  To test whether direct delivery of E25 to the airway might have the same effect, we conducted a randomized, double-blind, three group study in 33 subjects with mild allergic asthma (20 to 46 yr of age, 21 men, FEV(1) > 70% predicted).  The airway responses to aerosolized allergen were determined at baseline, after 2 and 8 wk of once daily treatment with aerosolized placebo (n = 11), aerosolized E25 1 mg (n = 12), or aerosolized E25 10 mg (n = 10), and after 4 wk of treatment withdrawal.  We found that E25 was detectable in the serum during aerosol treatment, although serum IgE did not change significantly in any of the three groups during treatment.  In addition, both doses of E25 were no more effective than placebo in attenuating the early phase responses to allergen at both times during treatment.  Although aerosolized E25 was generally well tolerated, one subject receiving aerosolized E25 10 mg daily was found to have serum IgG and IgA antibodies to E25.  We conclude that aerosol administration of an anti-IgE monoclonal antibody does not inhibit the airway responses to inhaled allergen in allergic asthmatic subjects.  We speculate that the observed lack of efficacy may be due to the inability of aerosol route of delivery to result in high enough concentrations of E25 in the tissue compartments surrounding IgE effector cells to neutralize IgE arising from local airway and pulmonary sources and IgE arising from the vascular space.  Additionally, the aerosol route of delivery of monoclonal antibodies may be more immunogenic than the parenteral route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRZex4-GzQCR0LsK7uFuY7fW6udTcc2eZ4NhEiwy7K_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MvgtlamsQ%253D%253D&md5=3945dd12aeabd36544894dc033117d4c</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.160.3.9810012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.160.3.9810012%26sid%3Dliteratum%253Aachs%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26aulast%3DCockcroft%26aufirst%3DD.%2BW.%26aulast%3DBoulet%26aufirst%3DL.%2BP.%26aulast%3DWong%26aufirst%3DH.%2BH.%26aulast%3DDeschesnes%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DE.%2BE.%26aulast%3DRuppel%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DJ.%2BQ.%26aulast%3DAdelman%26aufirst%3DD.%2BC.%26atitle%3DEffect%2520of%2520aerosolized%2520anti-IgE%2520%2528E25%2529%2520on%2520airway%2520responses%2520to%2520inhaled%2520allergen%2520in%2520asthmatic%2520subjects%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1999%26volume%3D160%26spage%3D1023%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Podolanczuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crow, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussel, J. B.</span><span> </span><span class="NLM_article-title">Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=3154-3160&author=A.+Podolanczukauthor=A.+H.+Lazarusauthor=A.+R.+Crowauthor=E.+B.+Grossbardauthor=J.+B.+Bussel&title=Of+mice+and+men%3A+an+open-label+pilot+study+for+treatment+of+immune+thrombocytopenic+purpura+by+an+inhibitor+of+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPodolanczuk%26aufirst%3DA.%26aulast%3DLazarus%26aufirst%3DA.%2BH.%26aulast%3DCrow%26aufirst%3DA.%2BR.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DBussel%26aufirst%3DJ.%2BB.%26atitle%3DOf%2520mice%2520and%2520men%253A%2520an%2520open-label%2520pilot%2520study%2520for%2520treatment%2520of%2520immune%2520thrombocytopenic%2520purpura%2520by%2520an%2520inhibitor%2520of%2520Syk%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D3154%26epage%3D3160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Pine, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoettler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banquerigo, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahn, E.</span><span> </span><span class="NLM_article-title">Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor</span> <span class="citation_source-journal">Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.clim.2007.03.543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17537677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1eltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2007&pages=244-257&author=P.+R.+Pineauthor=B.+Changauthor=N.+Schoettlerauthor=M.+L.+Banquerigoauthor=S.+Wangauthor=A.+Lauauthor=F.+Zhaoauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+Brahn&title=Inflammation+and+bone+erosion+are+suppressed+in+models+of+rheumatoid+arthritis+following+treatment+with+a+novel+Syk+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor</span></div><div class="casAuthors">Pine, Polly R.; Chang, Betty; Schoettler, Nathan; Banquerigo, Mona L.; Wang, Su; Lau, Angela; Zhao, Feifei; Grossbard, Elliott B.; Payan, Donald G.; Brahn, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-257</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk), a key mediator of immunoreceptor signaling in inflammatory cells, is essential for immune complex-mediated signal transduction initiated by activated receptors for IgG.  In collagen-induced arthritis, R788/R406, a novel and potent small mol. Syk inhibitor suppressed clin. arthritis, bone erosions, pannus formation, and synovitis.  Serum anti-collagen type II antibody levels were unaltered, while the half-life of exogenous antibody was extended when co-administered with R406.  Expression of the targeted kinase (Syk) in synovial tissue correlated with the joint level of inflammatory cell infiltrates and was virtually undetectable in treated rats.  Syk inhibition suppressed synovial cytokines and cartilage oligomeric matrix protein (COMP) in serum, suggesting a sensitive and reliable biomarker for R406 activity.  These results highlight the role of activating Fcgamma receptors in inflammatory synovitis and suggest that interruption of the signaling cascade with a novel Syk inhibitor may be a useful addn. to immunosuppressive disease-modifying anti-rheumatic drugs currently used in the treatment of human autoimmune diseases such as rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Nm2XObIb37Vg90H21EOLACvtfcHk0lgJtGCG8whykA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1eltb0%253D&md5=98b5020fb23cc209e5b7c322024748fb</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2007.03.543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2007.03.543%26sid%3Dliteratum%253Aachs%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DSchoettler%26aufirst%3DN.%26aulast%3DBanquerigo%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DBrahn%26aufirst%3DE.%26atitle%3DInflammation%2520and%2520bone%2520erosion%2520are%2520suppressed%2520in%2520models%2520of%2520rheumatoid%2520arthritis%2520following%2520treatment%2520with%2520a%2520novel%2520Syk%2520inhibitor%26jtitle%3DClin.%2520Immunol.%26date%3D2007%26volume%3D124%26spage%3D244%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Takayanagi, H.</span><span> </span><span class="NLM_article-title">Osteoimmunology: shared mechanisms and crosstalk between the immune and bone system</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17380158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlyhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=292-304&author=H.+Takayanagi&title=Osteoimmunology%3A+shared+mechanisms+and+crosstalk+between+the+immune+and+bone+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems</span></div><div class="casAuthors">Takayanagi, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-304</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Osteoimmunol. is an interdisciplinary research field focused on the mol. understanding of the interplay between the immune and skeletal systems.  Although osteoimmunol. started with the study of the immune regulation of osteoclasts, its scope has been extended to encompass a wide range of mol. and cellular interactions, including those between osteoblasts and osteoclasts, lymphocytes and osteoclasts, and osteoblasts and hematopoietic cells.  Therefore, the two systems should be understood to be integrated and operating in the context of the 'osteoimmune' system, a heuristic concept that provides not only a framework for obtaining new insights by basic research, but also a scientific basis for the discovery of novel treatments for diseases related to both systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZxVDBwUkq3rVg90H21EOLACvtfcHk0lgJtGCG8whykA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlyhurc%253D&md5=61d02a7dac0ac2a0abddeda9ca6eab42</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fnri2062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2062%26sid%3Dliteratum%253Aachs%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DOsteoimmunology%253A%2520shared%2520mechanisms%2520and%2520crosstalk%2520between%2520the%2520immune%2520and%2520bone%2520system%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26spage%3D292%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Nakashima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, H.</span><span> </span><span class="NLM_article-title">Osteoimmunology: crosstalk between the immune and bone systems</span> <span class="citation_source-journal">J. Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1007%2Fs10875-009-9316-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19585227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD1MrmsFaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=555-567&author=T.+Nakashimaauthor=H.+Takayanagi&title=Osteoimmunology%3A+crosstalk+between+the+immune+and+bone+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoimmunology: crosstalk between the immune and bone systems</span></div><div class="casAuthors">Nakashima Tomoki; Takayanagi Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION: The interaction between the immune and skeletal systems has long been acknowledged, but investigation into rheumatoid arthritis (RA) as well as the various bone phenotypes found in immunocompromised gene-deficient mice has highlighted the importance of the dynamic interplay between the two systems.  This has led to the recent emergence and subsequent rapid evolution of the field of osteoimmunology.  BONE DESTRUCTION WITH ARTHRITIS AS A RANKL DISEASE: In the bone destruction associated with RA, IL-17-producing helper T cells (T(H)17) play a major role by inducing receptor activator of nuclear factor-kappaB ligand (RANKL).  RANKL stimulates osteoclastogenesis through nuclear factor of activated T cells cytoplasmic 1 (NFATc1), which is well known as a crucial regulator of immunity.  NEW PLAYERS IN OSTEOIMMUNOLOGY: In addition to cellular interactions via cytokines, the immune and skeletal systems share various molecules, including transcription factors, signaling molecules, and membrane receptors.  CONCLUSION: The scope of osteoimmunology has grown to encompass a wide range of molecular and cellular interactions, the elucidation of which will provide a scientific basis for future therapeutic approaches to diseases of both the immune and skeletal systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVaWkgxT62xczK395ZObgVfW6udTcc2ea5xxr0tX5pq7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrmsFaiug%253D%253D&md5=522e206b1c1bfd0467098e9d1d7d673d</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1007%2Fs10875-009-9316-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10875-009-9316-6%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima%26aufirst%3DT.%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DOsteoimmunology%253A%2520crosstalk%2520between%2520the%2520immune%2520and%2520bone%2520systems%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D2009%26volume%3D29%26spage%3D555%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Takayanagi, H.</span><span> </span><span class="NLM_article-title">New immune connections in osteoclast formation</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1192</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1192&publication_year=2010&pages=117-123&author=H.+Takayanagi&title=New+immune+connections+in+osteoclast+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DNew%2520immune%2520connections%2520in%2520osteoclast%2520formation%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1192%26spage%3D117%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Mócsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ziffle, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spusta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumdar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M. C.</span><span> </span><span class="NLM_article-title">The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">6158</span><span class="NLM_x">–</span> <span class="NLM_lpage">6163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=6158-6163&author=A.+M%C3%B3csaiauthor=M.+B.+Humphreyauthor=J.+A.+Van+Ziffleauthor=Y.+Huauthor=A.+Burghardtauthor=S.+C.+Spustaauthor=S.+Majumdarauthor=L.+L.+Lanierauthor=C.+A.+Lowellauthor=M.+C.+Nakamura&title=The+immunomodulatory+adapter+proteins+DAP12+and+Fc+receptor+%CE%B3-chain+%28FcR%CE%B3%29+regulate+development+of+functional+osteoclasts+through+the+Syk+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26aulast%3DHumphrey%26aufirst%3DM.%2BB.%26aulast%3DVan%2BZiffle%26aufirst%3DJ.%2BA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBurghardt%26aufirst%3DA.%26aulast%3DSpusta%26aufirst%3DS.%2BC.%26aulast%3DMajumdar%26aufirst%3DS.%26aulast%3DLanier%26aufirst%3DL.%2BL.%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DNakamura%26aufirst%3DM.%2BC.%26atitle%3DThe%2520immunomodulatory%2520adapter%2520proteins%2520DAP12%2520and%2520Fc%2520receptor%2520%25CE%25B3-chain%2520%2528FcR%25CE%25B3%2529%2520regulate%2520development%2520of%2520functional%2520osteoclasts%2520through%2520the%2520Syk%2520tyrosine%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D6158%26epage%3D6163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Koga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suematsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matozaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, T.</span><span> </span><span class="NLM_article-title">Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnature02444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15085135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtV2mt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=758-763&author=T.+Kogaauthor=M.+Inuiauthor=K.+Inoueauthor=S.+Kimauthor=A.+Suematsuauthor=E.+Kobayashiauthor=T.+Iwataauthor=H.+Ohnishiauthor=T.+Matozakiauthor=T.+Kodamaauthor=T.+Taniguchiauthor=H.+Takayanagiauthor=T.+Takai&title=Costimulatory+signals+mediated+by+the+ITAM+motif+cooperate+with+RANKL+for+bone+homeostasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis</span></div><div class="casAuthors">Koga, Takako; Inui, Masanori; Inoue, Kazuya; Kim, Sunhwa; Suematsu, Ayako; Kobayashi, Eiji; Iwata, Toshio; Ohnishi, Hiroshi; Matozaki, Takashi; Kodama, Tatsuhiko; Taniguchi, Tadatsugu; Takayanagi, Hiroshi; Takai, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6984</span>),
    <span class="NLM_cas:pages">758-763</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Costimulatory signals are required for activation of immune cells, but it is not known whether they contribute to other biol. systems.  The development and homeostasis of the skeletal system depend on the balance between bone formation and resorption.  Receptor activator of NF-κB ligand (RANKL) regulates the differentiation of bone-resorbing cells, osteoclasts, in the presence of macrophage-colony stimulating factor (M-CSF).  But it remains unclear how RANKL activates the calcium signals that lead to induction of nuclear factor of activated T cells c1, a key transcription factor for osteoclastogenesis.  Here the authors show that mice lacking immunoreceptor tyrosine-based activation motif (ITAM)-harboring adaptors, Fc receptor common γ subunit (FcRγ) and DNAX-activating protein (DAP)12, exhibit severe osteopetrosis owing to impaired osteoclast differentiation.  In osteoclast precursor cells, FcRγ and DAP12 assoc. with multiple immunoreceptors and activate calcium signaling through phospholipase Cγ.  Thus, ITAM-dependent costimulatory signals activated by multiple immunoreceptors are essential for the maintenance of bone homeostasis.  These results reveal that RANKL and M-CSF are not sufficient to activate the signals required for osteoclastogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvHiH4e8xvSLVg90H21EOLACvtfcHk0liS8C_LTvlOMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtV2mt78%253D&md5=cc70a7455fe1d9932271758c2791eac5</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1038%2Fnature02444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02444%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSuematsu%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DE.%26aulast%3DIwata%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DH.%26aulast%3DMatozaki%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DTakayanagi%26aufirst%3DH.%26aulast%3DTakai%26aufirst%3DT.%26atitle%3DCostimulatory%2520signals%2520mediated%2520by%2520the%2520ITAM%2520motif%2520cooperate%2520with%2520RANKL%2520for%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D758%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Jakus, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frommhold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperandio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mócsai, A.</span><span> </span><span class="NLM_article-title">Critical role of phospholipase Cγ2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=577-593&author=Z.+Jakusauthor=E.+Simonauthor=D.+Frommholdauthor=M.+Sperandioauthor=A.+M%C3%B3csai&title=Critical+role+of+phospholipase+C%CE%B32+in+integrin+and+Fc+receptor-mediated+neutrophil+functions+and+the+effector+phase+of+autoimmune+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakus%26aufirst%3DZ.%26aulast%3DSimon%26aufirst%3DE.%26aulast%3DFrommhold%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DM.%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26atitle%3DCritical%2520role%2520of%2520phospholipase%2520C%25CE%25B32%2520in%2520integrin%2520and%2520Fc%2520receptor-mediated%2520neutrophil%2520functions%2520and%2520the%2520effector%2520phase%2520of%2520autoimmune%2520arthritis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2009%26volume%3D206%26spage%3D577%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Zou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shattil, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginsberg, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, S. L.</span><span> </span><span class="NLM_article-title">Syk, c-Src, the ανβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2007&pages=877-888&author=W.+Zouauthor=H.+Kitauraauthor=J.+Reeveauthor=F.+Longauthor=V.+L.+J+Tybulewiczauthor=S.+J.+Shattilauthor=M.+H.+Ginsbergauthor=F.+P.+Rossauthor=S.+L.+Teitelbaum&title=Syk%2C+c-Src%2C+the+%CE%B1%CE%BD%CE%B23+integrin%2C+and+ITAM+immunoreceptors%2C+in+concert%2C+regulate+osteoclastic+bone+resorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DW.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DReeve%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ%26aulast%3DShattil%26aufirst%3DS.%2BJ.%26aulast%3DGinsberg%26aufirst%3DM.%2BH.%26aulast%3DRoss%26aufirst%3DF.%2BP.%26aulast%3DTeitelbaum%26aufirst%3DS.%2BL.%26atitle%3DSyk%252C%2520c-Src%252C%2520the%2520%25CE%25B1%25CE%25BD%25CE%25B23%2520integrin%252C%2520and%2520ITAM%2520immunoreceptors%252C%2520in%2520concert%252C%2520regulate%2520osteoclastic%2520bone%2520resorption%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D176%26spage%3D877%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Yoshitomi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakihama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaguchi, S.</span><span> </span><span class="NLM_article-title">A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2005&pages=949-960&author=H.+Yoshitomiauthor=N.+Sakaguchiauthor=K.+Kobayashiauthor=G.+D.+Brownauthor=T.+Tagamiauthor=T.+Sakihamaauthor=K.+Hirotaauthor=S.+Tanakaauthor=T.+Nomuraauthor=I.+Mikiauthor=S.+Gordonauthor=S.+Akiraauthor=T.+Nakamuraauthor=S.+Sakaguchi&title=A+role+for+fungal+%CE%B2-glucans+and+their+receptor+Dectin-1+in+the+induction+of+autoimmune+arthritis+in+genetically+susceptible+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshitomi%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DG.%2BD.%26aulast%3DTagami%26aufirst%3DT.%26aulast%3DSakihama%26aufirst%3DT.%26aulast%3DHirota%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DMiki%26aufirst%3DI.%26aulast%3DGordon%26aufirst%3DS.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DSakaguchi%26aufirst%3DS.%26atitle%3DA%2520role%2520for%2520fungal%2520%25CE%25B2-glucans%2520and%2520their%2520receptor%2520Dectin-1%2520in%2520the%2520induction%2520of%2520autoimmune%2520arthritis%2520in%2520genetically%2520susceptible%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2005%26volume%3D201%26spage%3D949%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Goodridge, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsumoto, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilakos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underhill, D. M.</span><span> </span><span class="NLM_article-title">Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse”</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">472</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2011&pages=471-475&author=H.+S.+Goodridgeauthor=C.+N.+Reyesauthor=C.+A.+Beckerauthor=T.+R.+Katsumotoauthor=J.+Maauthor=A.+J.+Wolfauthor=N.+Boseauthor=A.+S.+H.+Chanauthor=A.+S.+Mageeauthor=M.+E.+Danielsonauthor=A.+Weissauthor=J.+P.+Vasilakosauthor=D.+M.+Underhill&title=Activation+of+the+innate+immune+receptor+Dectin-1+upon+formation+of+a+%E2%80%9Cphagocytic+synapse%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoodridge%26aufirst%3DH.%2BS.%26aulast%3DReyes%26aufirst%3DC.%2BN.%26aulast%3DBecker%26aufirst%3DC.%2BA.%26aulast%3DKatsumoto%26aufirst%3DT.%2BR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DA.%2BJ.%26aulast%3DBose%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DA.%2BS.%2BH.%26aulast%3DMagee%26aufirst%3DA.%2BS.%26aulast%3DDanielson%26aufirst%3DM.%2BE.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DVasilakos%26aufirst%3DJ.%2BP.%26aulast%3DUnderhill%26aufirst%3DD.%2BM.%26atitle%3DActivation%2520of%2520the%2520innate%2520immune%2520receptor%2520Dectin-1%2520upon%2520formation%2520of%2520a%2520%25E2%2580%259Cphagocytic%2520synapse%25E2%2580%259D%26jtitle%3DNature%26date%3D2011%26volume%3D472%26spage%3D471%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Tsokos, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambiar, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juang, Y. T.</span><span> </span><span class="NLM_article-title">Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS1471-4906%2803%2900100-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12738420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVarur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=259-263&author=G.+C.+Tsokosauthor=M.+P.+Nambiarauthor=K.+Tenbrockauthor=Y.+T.+Juang&title=Rewiring+the+T-cell%3A+signaling+defects+and+novel+prospects+for+the+treatment+of+SLE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE</span></div><div class="casAuthors">Tsokos, George C.; Nambiar, Madhusoodana P.; Tenbrock, Klaus; Juang, Yuang-Taung</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">259-263</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Activation of T cells from patients with systemic lupus erythematosus (SLE) leads to increased signaling responses, detected by increased calcium and protein tyrosine phosphorylation patterns.  This over-excitability occurs in spite of decreased levels of T-cell receptor ζ chain.  The replacement of the ζ chain by the Fc receptor (FcR) γ chain and the formation of signaling mol. aggregates on the surface of T cells are considered to be responsible for the obsd. signaling phenotype.  Decreased prodn. of the ζ-chain promoter binding form of the transcription factor Elf-1 is responsible for the decreased transcription of the ζ chain gene.  In addn., transcription of the interleukin-2 (IL-2) gene is decreased because of the presence of the transcriptional repressor cyclic adenine mono-phosphate (cAMP) response element modulator.  Replenishment of the ζ chain and elimination of the repressor by antisense approaches leads to increased expression of IL-2, suggesting that gene therapy approaches might represent tangible modalities in the treatment of human SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVIl0naG-8sbVg90H21EOLACvtfcHk0lh223nbAEyhjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVarur4%253D&md5=56fccb8525ea59e0d45b753a84e0e9f0</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2FS1471-4906%2803%2900100-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4906%252803%252900100-5%26sid%3Dliteratum%253Aachs%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26aulast%3DNambiar%26aufirst%3DM.%2BP.%26aulast%3DTenbrock%26aufirst%3DK.%26aulast%3DJuang%26aufirst%3DY.%2BT.%26atitle%3DRewiring%2520the%2520T-cell%253A%2520signaling%2520defects%2520and%2520novel%2520prospects%2520for%2520the%2520treatment%2520of%2520SLE%26jtitle%3DTrends%2520Immunol.%26date%3D2003%26volume%3D24%26spage%3D259%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Liossis, S. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1457</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1998&pages=1448-1457&author=S.+N.+C.+Liossisauthor=X.+Z.+Dingauthor=G.+J.+Dennisauthor=G.+C.+Tsokos&title=Altered+pattern+of+TCR%2FCD3-mediated+protein-tyrosyl+phosphorylation+in+T+cells+from+patients+with+systemic+lupus+erythematosus.+Deficient+expression+of+the+T+cell+receptor+zeta+chain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiossis%26aufirst%3DS.%2BN.%2BC.%26aulast%3DDing%26aufirst%3DX.%2BZ.%26aulast%3DDennis%26aufirst%3DG.%2BJ.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DAltered%2520pattern%2520of%2520TCR%252FCD3-mediated%2520protein-tyrosyl%2520phosphorylation%2520in%2520T%2520cells%2520from%2520patients%2520with%2520systemic%2520lupus%2520erythematosus.%2520Deficient%2520expression%2520of%2520the%2520T%2520cell%2520receptor%2520zeta%2520chain%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1998%26volume%3D101%26spage%3D1448%26epage%3D1457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Bahjat, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitsma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassafer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daikh, D. I.</span><span> </span><span class="NLM_article-title">An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1433</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fart.23428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18438845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1egsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=1433-1444&author=F.+R.+Bahjatauthor=P.+R.+Pineauthor=A.+Reitsmaauthor=G.+Cassaferauthor=M.+Baluomauthor=S.+Grilloauthor=B.+Changauthor=F.+F.+Zhaoauthor=D.+G.+Payanauthor=E.+B.+Grossbardauthor=D.+I.+Daikh&title=An+orally+bioavailable+spleen+tyrosine+kinase+inhibitor+delays+disease+progression+and+prolongs+survival+in+murine+lupus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus</span></div><div class="casAuthors">Bahjat, Frances Rena; Pine, Polly R.; Reitsma, Andrea; Cassafer, Gail; Baluom, Muhammad; Grillo, Sunny; Chang, Betty; Zhao, Fei Fei; Payan, Donald G.; Grossbard, Elliott B.; Daikh, David I.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1433-1444</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective;. To assess whether R788, an orally bioavailable small mol. inhibitor of spleen tyrosine kinase (Syk)-dependent signaling, could modulate disease in lupus-prone (NZB × NZW)F1 (NZB/NZW) mice via inhibition of Fc receptor (FcR) and B cell receptor signaling.  Methods: R788 was administered to NZB/NZW mice before and after disease onset.  Proteinuria, blood urea nitrogen levels, and autoantibody titers were examd. periodically, and overall survival and renal pathol. features were assessed following long-term treatment (24-34 wk).  The distribution and immunophenotype of various splenic T cell and B cell subpopulations were evaluated at the time of study termination.  Arthus responses in NZB/NZW mice pretreated with R788 or Fc-blocking antibody (anti-CD16/32) were also examd.  Results: When R788 was administered prior to or after disease onset, it delayed the onset of proteinuria and azotemia, reduced renal pathol. and kidney infiltrates, and significantly prolonged survival of lupus-prone NZB/NZW mice; autoantibody titers were minimally affected throughout the study.  Dose-dependent redns. in the nos. of CD4+ activated T cells expressing high levels of CD44 or CD69 were apparent in spleens from R788-treated mice.  Minimal effects on the nos. of naive T cells expressing CD62 ligand and total CD8+ T cells per spleen were obsd. following long-term drug treatment.  R788 pretreatment resulted in reduced Arthus responses in NZB/NZW mice, similar to results obtained in mice pretreated with FcR-blocking antibody.  Conclusion: We demonstrate that a novel Syk-selective inhibitor prevents the development of renal disease and treats established murine lupus nephritis.  These data suggest that Syk inhibitors may be of therapeutic benefit in human lupus and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv3W8z7XnMUrVg90H21EOLACvtfcHk0lhc7zkuMvwpOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1egsro%253D&md5=19928c22718e8199af4d427446f53c42</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2Fart.23428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23428%26sid%3Dliteratum%253Aachs%26aulast%3DBahjat%26aufirst%3DF.%2BR.%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DReitsma%26aufirst%3DA.%26aulast%3DCassafer%26aufirst%3DG.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrillo%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DF.%2BF.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DDaikh%26aufirst%3DD.%2BI.%26atitle%3DAn%2520orally%2520bioavailable%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520delays%2520disease%2520progression%2520and%2520prolongs%2520survival%2520in%2520murine%2520lupus%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D1433%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaid, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chawanasuntorapoj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pusey, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, F. W.</span><span> </span><span class="NLM_article-title">A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1681%2FASN.2009030263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19959716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislSqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=231-236&author=J.+Smithauthor=J.+P.+McDaidauthor=G.+Bhangalauthor=R.+Chawanasuntorapojauthor=E.+S.+Masudaauthor=H.+T.+Cookauthor=C.+D.+Puseyauthor=F.+W.+Tam&title=A+spleen+tyrosine+kinase+inhibitor+reduces+the+severity+of+established+glomerulonephritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis</span></div><div class="casAuthors">Smith, Jennifer; McDaid, John P.; Bhangal, Gurjeet; Chawanasuntorapoj, Ratana; Masuda, Esteban S.; Cook, H. Terence; Pusey, Charles D.; Tam, Frederick W. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-236</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Antibody-mediated glomerulonephritis, including that resulting from immune complexes, is an important cause of renal failure and is in need of more specific and effective treatment.  Binding of antibody or immune complexes to Fc receptors activates intracellular signal transduction pathways, including spleen tyrosine kinase (Syk), leading to the prodn. of inflammatory cytokines.  We examd. the effect of R788 (fostamatinib disodium), an oral prodrug of the selective Syk inhibitor R406, in nephrotoxic nephritis in Wistar-Kyoto rats.  Treatment with R788 reduced proteinuria, tissue injury, glomerular macrophage and CD8+ cell nos., and renal monocyte chemoattractant protein-1 (MCP-1) and IL-1β, even when we started treatment after the onset of glomerulonephritis.  When we administered R788 from days 4 to 10, glomerular crescents reduced by 100% (P < 0.01) compared with the vehicle group.  When we administered R788 treatment from days 7 to 14, established glomerular crescents reversed (reduced by 21%, P < 0.001), and renal function was better than the vehicle group (P < 0.001).  In vitro, R406 downregulated MCP-1 prodn. from mesangial cells and macrophages stimulated with aggregated IgG.  These results suggest that Syk is an important therapeutic target for the treatment of glomerulonephritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyYk0j2Vk5j7Vg90H21EOLACvtfcHk0lhc7zkuMvwpOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislSqtL0%253D&md5=47c98549849565302a6c0027d89bc7a7</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1681%2FASN.2009030263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2009030263%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DMcDaid%26aufirst%3DJ.%2BP.%26aulast%3DBhangal%26aufirst%3DG.%26aulast%3DChawanasuntorapoj%26aufirst%3DR.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DCook%26aufirst%3DH.%2BT.%26aulast%3DPusey%26aufirst%3DC.%2BD.%26aulast%3DTam%26aufirst%3DF.%2BW.%26atitle%3DA%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520reduces%2520the%2520severity%2520of%2520established%2520glomerulonephritis%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2010%26volume%3D21%26spage%3D231%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Colonna, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agati, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reizis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clynes, R.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Syk in autoimmune diabetes</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=1532-1543&author=L.+Colonnaauthor=G.+Catalanoauthor=C.+Chewauthor=V.+D%E2%80%99Agatiauthor=J.+W.+Thomasauthor=F.+S.+Wongauthor=J.+Schmitzauthor=E.+S.+Masudaauthor=B.+Reizisauthor=A.+Tarakhovskyauthor=R.+Clynes&title=Therapeutic+targeting+of+Syk+in+autoimmune+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColonna%26aufirst%3DL.%26aulast%3DCatalano%26aufirst%3DG.%26aulast%3DChew%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Agati%26aufirst%3DV.%26aulast%3DThomas%26aufirst%3DJ.%2BW.%26aulast%3DWong%26aufirst%3DF.%2BS.%26aulast%3DSchmitz%26aufirst%3DJ.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DReizis%26aufirst%3DB.%26aulast%3DTarakhovsky%26aufirst%3DA.%26aulast%3DClynes%26aufirst%3DR.%26atitle%3DTherapeutic%2520targeting%2520of%2520Syk%2520in%2520autoimmune%2520diabetes%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D185%26spage%3D1532%26epage%3D1543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Spalton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollitt, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eble, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1538-7836.2009.03451.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19422460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvV2itL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=1192-1199&author=J.+C.+Spaltonauthor=J.+Moriauthor=A.+Y.+Pollittauthor=C.+E.+Hughesauthor=J.+A.+Ebleauthor=S.+P.+Watson&title=The+novel+Syk+inhibitor+R406+reveals+mechanistic+differences+in+the+initiation+of+GPVI+and+CLEC-2+signaling+in+platelets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets</span></div><div class="casAuthors">Spalton, J. C.; Mori, J.; Pollitt, A. Y.; Hughes, C. E.; Eble, J. A.; Watson, S. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1192-1199</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Syk is a key mediator of signaling pathways downstream of several platelet surface receptors including GPVI/FcRγ collagen receptor, the C-type lectin receptor CLEC-2, and integrin αIIbβ3.  A recent study identified the novel small mol. R406 as a selective inhibitor of Syk.  The present study evaluates the role of Syk in human platelets using the novel inhibitor R406.  Agonist-induced GPVI and CLEC-2 signaling were assessed using aggregometry, immunopptn. and western blotting to det. the effects of R406 on platelet activation.  We demonstrate R406 to be a powerful inhibitor of Syk in human platelets.  R406 abrogated shape change and aggregation induced by activation of GPVI and CLEC-2, and reduced platelet spreading on fibrinogen.  The inhibitory effect of R406 was assocd. with inhibition of tyrosine phosphorylation of signaling proteins that lay downstream of Syk for all three receptors, including PLCγ2.  Strikingly, R406 markedly inhibited tyrosine phosphorylation of CLEC-2 and Syk downstream of CLEC-2 activation, whereas phosphorylation of Syk downstream of GPVI and integrin αIIbβ3 was unaffected.  The inhibitory effect of R406 provides direct evidence of a role for Syk in GPVI, CLEC-2 and integrin αIIbβ3 signaling in human platelets.  Further, the results demonstrate a crit. role for Syk in mediating tyrosine phosphorylation of CLEC-2, suggesting a novel model in which both Src and Syk kinases regulate tyrosine phosphorylation of the C-type lectin receptor leading to platelet activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRxU2oWcCyLVg90H21EOLACvtfcHk0lhc7zkuMvwpOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvV2itL8%253D&md5=2daca5334b33d3170ef7c11f4548bd81</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2009.03451.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2009.03451.x%26sid%3Dliteratum%253Aachs%26aulast%3DSpalton%26aufirst%3DJ.%2BC.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DPollitt%26aufirst%3DA.%2BY.%26aulast%3DHughes%26aufirst%3DC.%2BE.%26aulast%3DEble%26aufirst%3DJ.%2BA.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520novel%2520Syk%2520inhibitor%2520R406%2520reveals%2520mechanistic%2520differences%2520in%2520the%2520initiation%2520of%2520GPVI%2520and%2520CLEC-2%2520signaling%2520in%2520platelets%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2009%26volume%3D7%26spage%3D1192%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Pamuk, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapchak, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalle Lucca, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase inhibition prevents tissue damage after ischemia–reperfusion</span> <span class="citation_source-journal">Am. J. Physiol.: Gastrointest. Liver Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">G391</span><span class="NLM_x">–</span> <span class="NLM_lpage">G399</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=G391-G399&author=O.+N.+Pamukauthor=P.+H.+Lapchakauthor=P.+Raniauthor=P.+Pineauthor=J.+J.+Dalle+Luccaauthor=G.+C.+Tsokos&title=Spleen+tyrosine+kinase+inhibition+prevents+tissue+damage+after+ischemia%E2%80%93reperfusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPamuk%26aufirst%3DO.%2BN.%26aulast%3DLapchak%26aufirst%3DP.%2BH.%26aulast%3DRani%26aufirst%3DP.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DDalle%2BLucca%26aufirst%3DJ.%2BJ.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DSpleen%2520tyrosine%2520kinase%2520inhibition%2520prevents%2520tissue%2520damage%2520after%2520ischemia%25E2%2580%2593reperfusion%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2010%26volume%3D299%26spage%3DG391%26epage%3DG399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Hilgendorf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeschky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willecke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirlik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozhkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Zur Muehlen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zur Hausen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirlik, A.</span><span> </span><span class="NLM_article-title">The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1161%2FATVBAHA.111.230847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21700926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaktr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=1991-1999&author=I.+Hilgendorfauthor=S.+Eiseleauthor=I.+Remerauthor=J.+Schmitzauthor=K.+Zeschkyauthor=C.+Colbergauthor=P.+Stachonauthor=D.+Wolfauthor=F.+Willeckeauthor=M.+Buchnerauthor=K.+Zirlikauthor=A.+Ortiz-Rodriguezauthor=A.+Lozhkinauthor=N.+Hoppeauthor=C.+von+Zur+Muehlenauthor=A.+Zur+Hausenauthor=C.+Bodeauthor=A.+Zirlik&title=The+oral+spleen+tyrosine+kinase+inhibitor+fostamatinib+attenuates+inflammation+and+atherogenesis+in+low-density+lipoprotein+receptor-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice</span></div><div class="casAuthors">Hilgendorf, Ingo; Eisele, Sara; Remer, Imke; Schmitz, Jochen; Zeschky, Katharina; Colberg, Christian; Stachon, Peter; Wolf, Dennis; Willecke, Florian; Buchner, Maike; Zirlik, Katja; Ortiz-Rodriguez, Alexandra; Lozhkin, Andrey; Hoppe, Natalie; von zur Muhlen, Constantin; zur Hausen, Axel; Bode, Christoph; Zirlik, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1991-1999</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: Spleen tyrosine kinase (SYK) has come into focus as a potential therapeutic target in chronic inflammatory diseases, such as rheumatoid arthritis and asthma, as well as in B-cell lymphomas.  SYK has also been involved in the signaling of immunoreceptors, cytokine receptors, and integrins.  We therefore hypothesized that inhibition of SYK attenuates the inflammatory process underlying atherosclerosis and reduces plaque development.  Methods and Results: Low-d. lipoprotein receptor-deficient mice consuming a high-cholesterol diet supplemented with 2 doses of the orally available SYK inhibitor fostamatinib for 16 wk showed a dose-dependent redn. in atherosclerotic lesion size by up to 59±6% compared with the resp. controls.  Lesions of fostamatinib-treated animals contained fewer macrophages but more smooth muscle cells and collagen-characteristics assocd. with more stable plaques in humans.  Mechanistically, fostamatinib attenuated adhesion and migration of inflammatory cells and limited macrophage survival.  Furthermore, fostamatinib normalized high-cholesterol diet -induced monocytosis and inflammatory gene expression.  Conclusion: We present the novel finding that the SYK inhibitor fostamatinib attenuates atherogenesis in mice.  Our data identify SYK inhibition as a potentially fruitful antiinflammatory therapeutic strategy in atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBEf6qXu7jB7Vg90H21EOLACvtfcHk0lgOXuo0jeGqSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaktr3M&md5=6d706cb01a8fc2c762cc688e29871df5</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.111.230847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.111.230847%26sid%3Dliteratum%253Aachs%26aulast%3DHilgendorf%26aufirst%3DI.%26aulast%3DEisele%26aufirst%3DS.%26aulast%3DRemer%26aufirst%3DI.%26aulast%3DSchmitz%26aufirst%3DJ.%26aulast%3DZeschky%26aufirst%3DK.%26aulast%3DColberg%26aufirst%3DC.%26aulast%3DStachon%26aufirst%3DP.%26aulast%3DWolf%26aufirst%3DD.%26aulast%3DWillecke%26aufirst%3DF.%26aulast%3DBuchner%26aufirst%3DM.%26aulast%3DZirlik%26aufirst%3DK.%26aulast%3DOrtiz-Rodriguez%26aufirst%3DA.%26aulast%3DLozhkin%26aufirst%3DA.%26aulast%3DHoppe%26aufirst%3DN.%26aulast%3Dvon%2BZur%2BMuehlen%26aufirst%3DC.%26aulast%3DZur%2BHausen%26aufirst%3DA.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DZirlik%26aufirst%3DA.%26atitle%3DThe%2520oral%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520fostamatinib%2520attenuates%2520inflammation%2520and%2520atherogenesis%2520in%2520low-density%2520lipoprotein%2520receptor-deficient%2520mice%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D1991%26epage%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Winer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadia, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yantha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paltser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caimol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenkel, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedder, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miklos, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dosch, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engleman, E. G.</span><span> </span><span class="NLM_article-title">B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnm.2353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21499269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=610-617&author=D.+A.+Winerauthor=S.+Winerauthor=L.+Shenauthor=P.+P.+Wadiaauthor=J.+Yanthaauthor=G.+Paltserauthor=H.+Tsuiauthor=P.+Wuauthor=M.+G.+Davidsonauthor=M.+N.+Alonsoauthor=H.+X.+Leongauthor=A.+Glassfordauthor=M.+Caimolauthor=J.+A.+Kenkelauthor=T.+F.+Tedderauthor=T.+McLaughlinauthor=D.+B.+Miklosauthor=H.+M.+Doschauthor=E.+G.+Engleman&title=B+cells+promote+insulin+resistance+through+modulation+of+T+cells+and+production+of+pathogenic+IgG+antibodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies</span></div><div class="casAuthors">Winer, Daniel A.; Winer, Shawn; Shen, Lei; Wadia, Persis P.; Yantha, Jason; Paltser, Geoffrey; Tsui, Hubert; Wu, Ping; Davidson, Matthew G.; Alonso, Michael N.; Leong, Hwei X.; Glassford, Alec; Caimol, Maria; Kenkel, Justin A.; Tedder, Thomas F.; McLaughlin, Tracey; Miklos, David B.; Dosch, H-Michael; Engleman, Edgar G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">610-617</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chronic inflammation characterized by T cell and macrophage infiltration of visceral adipose tissue (VAT) is a hallmark of obesity-assocd. insulin resistance and glucose intolerance.  Here we show a fundamental pathogenic role for B cells in the development of these metabolic abnormalities.  B cells accumulate in VAT in diet-induced obese (DIO) mice, and DIO mice lacking B cells are protected from disease despite wt. gain.  B cell effects on glucose metab. are mechanistically linked to the activation of proinflammatory macrophages and T cells and to the prodn. of pathogenic IgG antibodies.  Treatment with a B cell-depleting CD20 antibody attenuates disease, whereas transfer of IgG from DIO mice rapidly induces insulin resistance and glucose intolerance.  Moreover, insulin resistance in obese humans is assocd. with a unique profile of IgG autoantibodies.  These results establish the importance of B cells and adaptive immunity in insulin resistance and suggest new diagnostic and therapeutic modalities for managing the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon3x-1-REfArVg90H21EOLACvtfcHk0lgOXuo0jeGqSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCmtrg%253D&md5=3c030bb72c6e842ca66fe0adffa11282</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fnm.2353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2353%26sid%3Dliteratum%253Aachs%26aulast%3DWiner%26aufirst%3DD.%2BA.%26aulast%3DWiner%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DWadia%26aufirst%3DP.%2BP.%26aulast%3DYantha%26aufirst%3DJ.%26aulast%3DPaltser%26aufirst%3DG.%26aulast%3DTsui%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DDavidson%26aufirst%3DM.%2BG.%26aulast%3DAlonso%26aufirst%3DM.%2BN.%26aulast%3DLeong%26aufirst%3DH.%2BX.%26aulast%3DGlassford%26aufirst%3DA.%26aulast%3DCaimol%26aufirst%3DM.%26aulast%3DKenkel%26aufirst%3DJ.%2BA.%26aulast%3DTedder%26aufirst%3DT.%2BF.%26aulast%3DMcLaughlin%26aufirst%3DT.%26aulast%3DMiklos%26aufirst%3DD.%2BB.%26aulast%3DDosch%26aufirst%3DH.%2BM.%26aulast%3DEngleman%26aufirst%3DE.%2BG.%26atitle%3DB%2520cells%2520promote%2520insulin%2520resistance%2520through%2520modulation%2520of%2520T%2520cells%2520and%2520production%2520of%2520pathogenic%2520IgG%2520antibodies%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D610%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Andreu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affara, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korets, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawfik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNardo, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Visser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Palma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coussens, L. M.</span><span> </span><span class="NLM_article-title">FcRγ activation regulates inflammation-associated squamous carcinogenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=121-134&author=P.+Andreuauthor=M.+Johanssonauthor=N.+I.+Affaraauthor=F.+Pucciauthor=T.+Tanauthor=S.+Junankarauthor=L.+Koretsauthor=J.+Lamauthor=D.+Tawfikauthor=D.+G.+DeNardoauthor=L.+Naldiniauthor=K.+E.+de+Visserauthor=M.+De+Palmaauthor=L.+M.+Coussens&title=FcR%CE%B3+activation+regulates+inflammation-associated+squamous+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreu%26aufirst%3DP.%26aulast%3DJohansson%26aufirst%3DM.%26aulast%3DAffara%26aufirst%3DN.%2BI.%26aulast%3DPucci%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DJunankar%26aufirst%3DS.%26aulast%3DKorets%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DJ.%26aulast%3DTawfik%26aufirst%3DD.%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3Dde%2BVisser%26aufirst%3DK.%2BE.%26aulast%3DDe%2BPalma%26aufirst%3DM.%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26atitle%3DFcR%25CE%25B3%2520activation%2520regulates%2520inflammation-associated%2520squamous%2520carcinogenesis%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D121%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Lam, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kühn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajewsky, K.</span><span> </span><span class="NLM_article-title">In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1073</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=1073-1083&author=K.+P.+Lamauthor=R.+K%C3%BChnauthor=K.+Rajewsky&title=In+vivo+ablation+of+surface+immunoglobulin+on+mature+B+cells+by+inducible+gene+targeting+results+in+rapid+cell+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DK.%2BP.%26aulast%3DK%25C3%25BChn%26aufirst%3DR.%26aulast%3DRajewsky%26aufirst%3DK.%26atitle%3DIn%2520vivo%2520ablation%2520of%2520surface%2520immunoglobulin%2520on%2520mature%2520B%2520cells%2520by%2520inducible%2520gene%2520targeting%2520results%2520in%2520rapid%2520cell%2520death%26jtitle%3DCell%26date%3D1997%26volume%3D90%26spage%3D1073%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Kraus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canono, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussenzweig, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajewsky, K.</span><span> </span><span class="NLM_article-title">Interference with immunoglobulin (Ig)α immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B-cell development, depending on the availability of an Igβ cytoplasmic tail</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2001&pages=455-469&author=M.+Krausauthor=L.+I.+Paoauthor=A.+Reichlinauthor=Y.+Huauthor=B.+Canonoauthor=J.+C.+Cambierauthor=M.+C.+Nussenzweigauthor=K.+Rajewsky&title=Interference+with+immunoglobulin+%28Ig%29%CE%B1+immunoreceptor+tyrosine-based+activation+motif+%28ITAM%29+phosphorylation+modulates+or+blocks+B-cell+development%2C+depending+on+the+availability+of+an+Ig%CE%B2+cytoplasmic+tail"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DPao%26aufirst%3DL.%2BI.%26aulast%3DReichlin%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCanono%26aufirst%3DB.%26aulast%3DCambier%26aufirst%3DJ.%2BC.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DRajewsky%26aufirst%3DK.%26atitle%3DInterference%2520with%2520immunoglobulin%2520%2528Ig%2529%25CE%25B1%2520immunoreceptor%2520tyrosine-based%2520activation%2520motif%2520%2528ITAM%2529%2520phosphorylation%2520modulates%2520or%2520blocks%2520B-cell%2520development%252C%2520depending%2520on%2520the%2520availability%2520of%2520an%2520Ig%25CE%25B2%2520cytoplasmic%2520tail%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2001%26volume%3D194%26spage%3D455%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Young, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refaeli, Y.</span><span> </span><span class="NLM_article-title">Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2508</span><span class="NLM_x">–</span> <span class="NLM_lpage">2516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=2508-2516&author=R.+M.+Youngauthor=I.+R.+Hardyauthor=R.+L.+Clarkeauthor=N.+Lundyauthor=P.+Pineauthor=B.+C.+Turnerauthor=T.+A.+Potterauthor=Y.+Refaeli&title=Mouse+models+of+non-Hodgkin+lymphoma+reveal+Syk+as+an+important+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BM.%26aulast%3DHardy%26aufirst%3DI.%2BR.%26aulast%3DClarke%26aufirst%3DR.%2BL.%26aulast%3DLundy%26aufirst%3DN.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DTurner%26aufirst%3DB.%2BC.%26aulast%3DPotter%26aufirst%3DT.%2BA.%26aulast%3DRefaeli%26aufirst%3DY.%26atitle%3DMouse%2520models%2520of%2520non-Hodgkin%2520lymphoma%2520reveal%2520Syk%2520as%2520an%2520important%2520therapeutic%2520target%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D2508%26epage%3D2516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Wossning, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzog, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Köhler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meixlsperger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulathu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borkhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jumaa, H.</span><span> </span><span class="NLM_article-title">Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">2829</span><span class="NLM_x">–</span> <span class="NLM_lpage">2840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2829-2840&author=T.+Wossningauthor=S.+Herzogauthor=F.+K%C3%B6hlerauthor=S.+Meixlspergerauthor=Y.+Kulathuauthor=G.+Mittlerauthor=A.+Abeauthor=U.+Fuchsauthor=A.+Borkhardtauthor=H.+Jumaa&title=Deregulated+Syk+inhibits+differentiation+and+induces+growth+factor-independent+proliferation+of+pre-B+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWossning%26aufirst%3DT.%26aulast%3DHerzog%26aufirst%3DS.%26aulast%3DK%25C3%25B6hler%26aufirst%3DF.%26aulast%3DMeixlsperger%26aufirst%3DS.%26aulast%3DKulathu%26aufirst%3DY.%26aulast%3DMittler%26aufirst%3DG.%26aulast%3DAbe%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DU.%26aulast%3DBorkhardt%26aufirst%3DA.%26aulast%3DJumaa%26aufirst%3DH.%26atitle%3DDeregulated%2520Syk%2520inhibits%2520differentiation%2520and%2520induces%2520growth%2520factor-independent%2520proliferation%2520of%2520pre-B%2520cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2829%26epage%3D2840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Suljagic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurenti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, D. G.</span><span> </span><span class="NLM_article-title">The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ-TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">4894</span><span class="NLM_x">–</span> <span class="NLM_lpage">4905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=4894-4905&author=M.+Suljagicauthor=P.+G.+Longoauthor=S.+Bennardoauthor=E.+Perlasauthor=G.+Leoneauthor=L.+Laurentiauthor=D.+G.+Efremov&title=The+Syk+inhibitor+fostamatinib+disodium+%28R788%29+inhibits+tumor+growth+in+the+E%CE%BC-TCL1+transgenic+mouse+model+of+CLL+by+blocking+antigen-dependent+B-cell+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuljagic%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DP.%2BG.%26aulast%3DBennardo%26aufirst%3DS.%26aulast%3DPerlas%26aufirst%3DE.%26aulast%3DLeone%26aufirst%3DG.%26aulast%3DLaurenti%26aufirst%3DL.%26aulast%3DEfremov%26aufirst%3DD.%2BG.%26atitle%3DThe%2520Syk%2520inhibitor%2520fostamatinib%2520disodium%2520%2528R788%2529%2520inhibits%2520tumor%2520growth%2520in%2520the%2520E%25CE%25BC-TCL1%2520transgenic%2520mouse%2520model%2520of%2520CLL%2520by%2520blocking%2520antigen-dependent%2520B-cell%2520receptor%2520signaling%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D4894%26epage%3D4905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Friedberg, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetenham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vose, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCasce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer-Cutillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cripe, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterba, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipp, M. A.</span><span> </span><span class="NLM_article-title">Inhibition of SYK with fostamatinib disodium has significant clinical activity in non Hodgkin’s lymphoma and chronic lymphocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2578</span><span class="NLM_x">–</span> <span class="NLM_lpage">2585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2578-2585&author=J.+W.+Friedbergauthor=J.+Sharmanauthor=J.+Sweetenhamauthor=P.+B.+Johnstonauthor=J.+M.+Voseauthor=A.+LaCasceauthor=J.+Schaefer-Cutilloauthor=S.+De+Vosauthor=R.+Sinhaauthor=J.+P.+Leonardauthor=L.+D.+Cripeauthor=S.+A.+Gregoryauthor=M.+P.+Sterbaauthor=A.+M.+Loweauthor=R.+Levyauthor=M.+A.+Shipp&title=Inhibition+of+SYK+with+fostamatinib+disodium+has+significant+clinical+activity+in+non+Hodgkin%E2%80%99s+lymphoma+and+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedberg%26aufirst%3DJ.%2BW.%26aulast%3DSharman%26aufirst%3DJ.%26aulast%3DSweetenham%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DP.%2BB.%26aulast%3DVose%26aufirst%3DJ.%2BM.%26aulast%3DLaCasce%26aufirst%3DA.%26aulast%3DSchaefer-Cutillo%26aufirst%3DJ.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DJ.%2BP.%26aulast%3DCripe%26aufirst%3DL.%2BD.%26aulast%3DGregory%26aufirst%3DS.%2BA.%26aulast%3DSterba%26aufirst%3DM.%2BP.%26aulast%3DLowe%26aufirst%3DA.%2BM.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DShipp%26aufirst%3DM.%2BA.%26atitle%3DInhibition%2520of%2520SYK%2520with%2520fostamatinib%2520disodium%2520has%2520significant%2520clinical%2520activity%2520in%2520non%2520Hodgkin%25E2%2580%2599s%2520lymphoma%2520and%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D2578%26epage%3D2585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Oliver, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burg, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Inhibition of mast cell FcεR1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">29697</span><span class="NLM_x">–</span> <span class="NLM_lpage">29703</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=29697-29703&author=J.+M.+Oliverauthor=D.+L.+Burgauthor=B.+S.+Wilsonauthor=J.+L.+McLaughlinauthor=R.+L.+Geahlen&title=Inhibition+of+mast+cell+Fc%CE%B5R1-mediated+signaling+and+effector+function+by+the+Syk-selective+inhibitor%2C+piceatannol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DJ.%2BM.%26aulast%3DBurg%26aufirst%3DD.%2BL.%26aulast%3DWilson%26aufirst%3DB.%2BS.%26aulast%3DMcLaughlin%26aufirst%3DJ.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DInhibition%2520of%2520mast%2520cell%2520Fc%25CE%25B5R1-mediated%2520signaling%2520and%2520effector%2520function%2520by%2520the%2520Syk-selective%2520inhibitor%252C%2520piceatannol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D29697%26epage%3D29703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Lavens-Phillips, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mockford, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, J. A.</span><span> </span><span class="NLM_article-title">The effect of tyrosine kinase inhibitors on IgE-mediated histamine release from human lung mast cells and basophils</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1007%2Fs000110050303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9562339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1cXit1Whtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=137-143&author=S.+E.+Lavens-Phillipsauthor=E.+H.+Mockfordauthor=J.+A.+Warner&title=The+effect+of+tyrosine+kinase+inhibitors+on+IgE-mediated+histamine+release+from+human+lung+mast+cells+and+basophils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of tyrosine kinase inhibitors on IgE-mediated histamine release from human lung mast cells and basophils</span></div><div class="casAuthors">Lavens-Phillips, S. E.; Mockford, E. H.; Warner, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-143</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">The role of Tyr kinases (TK) in IgE-mediated signal transduction in human lung mast cells (HLMC) and peripheral blood basophils was investigated.  Cells were preincubated with TK inhibitor for 15 min at 37°, before the addn. of anti-IgE.  Histamine release was assayed using a fluorimetry.  Piceatannol and ST638 inhibited anti-IgE induced histamine release from HLMCs and basophils while lavendustin C had no effect in either cell type.  Herbimycin A also inhibited anti-IgE induced histamine release from both cell types, an effect which was dose dependent but did require a l6 h preincubation with drug.  In summary, HLMCs and basophils exhibit distinct inhibitory profiles in the presence of various inhibitors of TK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3g2ytSiCGqrVg90H21EOLACvtfcHk0liKUMaAf678OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1Whtrg%253D&md5=dfd7c48c10643c634ee138996352be1d</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1007%2Fs000110050303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000110050303%26sid%3Dliteratum%253Aachs%26aulast%3DLavens-Phillips%26aufirst%3DS.%2BE.%26aulast%3DMockford%26aufirst%3DE.%2BH.%26aulast%3DWarner%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520effect%2520of%2520tyrosine%2520kinase%2520inhibitors%2520on%2520IgE-mediated%2520histamine%2520release%2520from%2520human%2520lung%2520mast%2520cells%2520and%2520basophils%26jtitle%3DInflammation%2520Res.%26date%3D1998%26volume%3D47%26spage%3D137%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Lusková, P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dráber, P.</span><span> </span><span class="NLM_article-title">Modulation of the Fcε receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1727</span><span class="NLM_x">–</span> <span class="NLM_lpage">1737</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.2174%2F1381612043384538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15180535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktV2gsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1727-1737&author=P+Luskov%C3%A1author=P.+Dr%C3%A1ber&title=Modulation+of+the+Fc%CE%B5+receptor+I+signaling+by+tyrosine+kinase+inhibitors%3A+search+for+therapeutic+targets+of+inflammatory+and+allergy+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the Fcε receptor I signaling by tyrosine kinase inhibitors: Search for therapeutic targets of inflammatory and allergy diseases</span></div><div class="casAuthors">Luskova, Petra; Draber, Petr</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1727-1737</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mast cells and basophils are major effector cells in the IgE (IgE)-dependent allergic reactions as well as in the innate immunity.  They are distributed throughout the body and, upon allergen exposure, are stimulated via the high affinity IgE receptor (FcεRI) to release several pro-inflammatory mediators such as leukotrienes, immunoregulatory cytokines and histamine.  FcεRI-mediated signaling is initiated by tyrosine phosphorylation of FcεRI subunits by Src family kinase Lyn, which is followed by an activation of Syk/Zap family kinase Syk.  The activated kinases then in turn phosphorylate and activate other enzymes [phospholipase Cγ (PLCγ) isoforms, phosphatidylinositol-3 kinase (PI3K) isoforms, protein kinase C (PKC) isoforms, Bruton's tyrosine kinase (Btk) and others], adaptors [linker for activation of T cells (LAT), Cbl, Grb2 and others] and GTP exchange factors/GTPases (Vav, Ras, Rho, and others), and subsequently induce the mobilization of stored and extracellular Ca2+.  These and other biochem. events lead within seconds and minutes to the secretory response and later to the prodn. of chemokines.  This review is focused on the use of tyrosine kinase inhibitors specific for Src family kinases (PP1/PP2, SU6656 and CT5269), Syk kinase (piceatannol, ER-27319 and BAY 61-3606) and Btk (terreic acid and LFM-A13) for a modulation of FcεRI-mediated signaling in mast cells.  Potential use of the inhibitors in the treatment of inflammatory and allergy diseases as well as future directions in the development of highly specific tyrosine kinases inhibitors of new generations and their use in an intended modulation of mast cell signaling are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7T-_Nc0u6P7Vg90H21EOLACvtfcHk0liKUMaAf678OA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktV2gsbo%253D&md5=173584a1b2a56bf040b3ce8015e4b235</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.2174%2F1381612043384538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043384538%26sid%3Dliteratum%253Aachs%26aulast%3DLuskov%25C3%25A1%26aufirst%3DP%26aulast%3DDr%25C3%25A1ber%26aufirst%3DP.%26atitle%3DModulation%2520of%2520the%2520Fc%25CE%25B5%2520receptor%2520I%2520signaling%2520by%2520tyrosine%2520kinase%2520inhibitors%253A%2520search%2520for%2520therapeutic%2520targets%2520of%2520inflammatory%2520and%2520allergy%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D1727%26epage%3D1737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Moriya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muramato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span> </span><span class="NLM_article-title">ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of Fcε receptor I-mediated activation of Syk</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">12539</span><span class="NLM_x">–</span> <span class="NLM_lpage">12544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=12539-12544&author=K.+Moriyaauthor=J.+Riveraauthor=S.+Odomauthor=Y.+Sakumaauthor=K.+Muramatoauthor=T.+Yoshiuchiauthor=M.+Miyamotoauthor=K.+Yamada&title=ER-27319%2C+an+acridone-related+compound%2C+inhibits+release+of+antigen-induced+allergic+mediators+from+mast+cells+by+selective+inhibition+of+Fc%CE%B5+receptor+I-mediated+activation+of+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoriya%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DJ.%26aulast%3DOdom%26aufirst%3DS.%26aulast%3DSakuma%26aufirst%3DY.%26aulast%3DMuramato%26aufirst%3DK.%26aulast%3DYoshiuchi%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DER-27319%252C%2520an%2520acridone-related%2520compound%252C%2520inhibits%2520release%2520of%2520antigen-induced%2520allergic%2520mediators%2520from%2520mast%2520cells%2520by%2520selective%2520inhibition%2520of%2520Fc%25CE%25B5%2520receptor%2520I-mediated%2520activation%2520of%2520Syk%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D12539%26epage%3D12544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzumaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahata, T.</span><span> </span><span class="NLM_article-title">Characterization of cord-blood-derived human mast cells cultured in the presence of steel factor and interleukin-6</span> <span class="citation_source-journal">Int. Arch. Allergy Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1159%2F000236932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=7542104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK2MXnsVWktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1995&pages=63-65&author=H.+Saitoauthor=M.+Ebisawaauthor=N.+Sakaguchiauthor=T.+Ondaauthor=Y.+Iikuraauthor=M.+Yanagidaauthor=H.+Uzumakiauthor=T.+Nakahata&title=Characterization+of+cord-blood-derived+human+mast+cells+cultured+in+the+presence+of+steel+factor+and+interleukin-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of cord-blood-derived human mast cells cultured in the presence of steel factor and interleukin-6</span></div><div class="casAuthors">Saito, Hirohisa; Ebisawa, Motohiro; Sakaguchi, Naoya; Onda, Takebumi; Iikura, Yoji; Yanagida, Makoto; Uzumaki, Hiroya; Nakahata, Tatsutoshi</div><div class="citationInfo"><span class="NLM_cas:title">International Archives of Allergy and Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-5</span>CODEN:
                <span class="NLM_cas:coden">IAAIEG</span>;
        ISSN:<span class="NLM_cas:issn">1018-2438</span>.
    
            (<span class="NLM_cas:orgname">Karger</span>)
        </div><div class="casAbstract">The authors generated >107 mast cells by culturing 107 cord blood mononuclear cells for >10 wks in the presence of Steel factor, interleukin-6, and prostaglandin E2.  99% Of the cultured cells had tryptase-pos. granules, while 18% had chymase-pos. granules.  Cultured mast cells contained 3.6 μg histamine and 3.5 μg tryptase per 106 cells.  Cells sensitized with 1 μg/mL human IgE released 58.5% histamine and 1.55 ng tumor necrosis factor (TNF)-α per 106 cells when challenged with 1 μg/mL antihuman IgE, whereas the control cells spontaneously released 3.7% histamine and 0.18 ng TNF-α.  Anal. for surface antigens revealed that cultured mast cells expressed the following CD mols.: 9, 13, 14, 29, 33, 38, 43, 44, 45RA, 45RB, 46, 47, 48, 49d, 50, 51, 53, 54, 55, 58, 59, 60, 61, and 117 (c-Kit).  Taken together, these cultured cells seem to be functionally mature mast cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA6dVcLAKAprVg90H21EOLACvtfcHk0lhEanQiwISRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsVWktb0%253D&md5=627615b8b0899fe6ffdf5cae3fe204d8</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1159%2F000236932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000236932%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DEbisawa%26aufirst%3DM.%26aulast%3DSakaguchi%26aufirst%3DN.%26aulast%3DOnda%26aufirst%3DT.%26aulast%3DIikura%26aufirst%3DY.%26aulast%3DYanagida%26aufirst%3DM.%26aulast%3DUzumaki%26aufirst%3DH.%26aulast%3DNakahata%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520cord-blood-derived%2520human%2520mast%2520cells%2520cultured%2520in%2520the%2520presence%2520of%2520steel%2520factor%2520and%2520interleukin-6%26jtitle%3DInt.%2520Arch.%2520Allergy%2520Immunol.%26date%3D1995%26volume%3D107%26spage%3D63%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujishita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, T.</span><span> </span><span class="NLM_article-title">Inhibition of Syk activity and degranulation of human mast cells by flavonoids</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1248%2Fbpb.26.1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=14646171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFaksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=1685-1690&author=M.+Shichijoauthor=N.+Yamamotoauthor=H.+Tsujishitaauthor=M.+Kimataauthor=H.+Nagaiauthor=T.+Kokubo&title=Inhibition+of+Syk+activity+and+degranulation+of+human+mast+cells+by+flavonoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Syk activity and degranulation of human mast cells by flavonoids</span></div><div class="casAuthors">Shichijo, Michitaka; Yamamoto, Noriyuki; Tsujishita, Hideki; Kimata, Masahiro; Nagai, Hiroichi; Kokubo, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1685-1690</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">To investigate the effect of flavonoids on the activation of p72syk (Syk) protein tyrosine kinase which plays a pivotal role in the high affinity IgE receptor-mediated degranulation of mast cells, we picked out 10 flavonoids, classified them into 4 series, and examd. their effects on the activation of Syk and on the degranulation of human mast cells.  Flavones and flavonols showed clear inhibition, whereas flavanones and isoflavones had either weak or no effect on Syk enzymic activity induced by amino acid peptide corresponding to the activation loop domain and on IgE-dependent degranulation of human cultured mast cells (HCMC).  On the basis of calcd. logP (ClogP) values as a prediction of compd. lipophilicity, some flavonoids were speculated to have low lipophilicity, the reason for poor cell permeability.  A significant relation was obsd. between the inhibition of Syk activity and HCMC degranulation attributable to flavonoids when the ClogP values of the compds. were taken into account (r2=0.89).  These results suggested that the impairment of mast cell degranulation by several flavonoids classified into flavones and flavonols might be mediated via inhibition of the intracellular activation of Syk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBSmyTkf8rzbVg90H21EOLACvtfcHk0lhEanQiwISRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFaksrw%253D&md5=de1f624ba1ad33ea994a1049af88f25e</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1248%2Fbpb.26.1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.26.1685%26sid%3Dliteratum%253Aachs%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DTsujishita%26aufirst%3DH.%26aulast%3DKimata%26aufirst%3DM.%26aulast%3DNagai%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520Syk%2520activity%2520and%2520degranulation%2520of%2520human%2520mast%2520cells%2520by%2520flavonoids%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2003%26volume%3D26%26spage%3D1685%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Lai, J. Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadiq, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurairatnam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagpal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parveen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T. K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span> </span><span class="NLM_article-title">Potent small molecule inhibitors of spleen tyrosine kinase (Syk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3111</span><span class="NLM_x">–</span> <span class="NLM_lpage">3114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0960-894X%2803%2900658-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12941345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3111-3114&author=J.+Y.+Q.+Laiauthor=P.+J.+Coxauthor=R.+Patelauthor=S.+Sadiqauthor=D.+J.+Aldousauthor=S.+Thurairatnamauthor=K.+Smithauthor=D.+Wheelerauthor=S.+Jagpalauthor=S.+Parveenauthor=G.+Fentonauthor=T.+K.+P.+Harrisonauthor=C.+McCarthyauthor=P.+Bamborough&title=Potent+small+molecule+inhibitors+of+spleen+tyrosine+kinase+%28Syk%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Potent small molecule inhibitors of spleen tyrosine kinase (Syk)</span></div><div class="casAuthors">Lai, Justine Y. Q.; Cox, Paul J.; Patel, Rajesh; Sadiq, Shazia; Aldous, David J.; Thurairatnam, Sukanthini; Smith, Keith; Wheeler, Darren; Jagpal, Savita; Parveen, Sofia; Fenton, Gary; Harrison, Trevor K. P.; McCarthy, Clive; Bamborough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3111-3114</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A series of oxindoles demonstrating inhibition of the phosphorylation of biotinylated substrates of Syk and IgE/FcεERI triggered basophil cell degranulation has been identified.  A study of the SAR around sulfonamide I (R = SO2NH2) (IC50=5 nM, EC50=1400 nM) is discussed.  The modest cellular activity representative of the sulfonamide series was overcome when the Polar Surface Area was lowered to <110 A2, leading to the identification of amide II (R = CONHMe) (IC50=145 nM, EC50=100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYSraIANrufbVg90H21EOLACvtfcHk0lhEanQiwISRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7k%253D&md5=4188cf03867c4ecfd958cf7582daf30b</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900658-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900658-9%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DJ.%2BY.%2BQ.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DSadiq%26aufirst%3DS.%26aulast%3DAldous%26aufirst%3DD.%2BJ.%26aulast%3DThurairatnam%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DWheeler%26aufirst%3DD.%26aulast%3DJagpal%26aufirst%3DS.%26aulast%3DParveen%26aufirst%3DS.%26aulast%3DFenton%26aufirst%3DG.%26aulast%3DHarrison%26aufirst%3DT.%2BK.%2BP.%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DBamborough%26aufirst%3DP.%26atitle%3DPotent%2520small%2520molecule%2520inhibitors%2520of%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3111%26epage%3D3114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lgMZBomrOWYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Xie, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. Y.</span><span> </span><span class="NLM_article-title">Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1944</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1944-1949&author=H.+Z.+Xieauthor=L.+L.+Liauthor=J.+X.+Renauthor=J.+Zouauthor=L.+Yangauthor=Y.+Q.+Weiauthor=S.+Y.+Yang&title=Pharmacophore+modeling+study+based+on+known+spleen+tyrosine+kinase+inhibitors+together+with+virtual+screening+for+identifying+novel+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DH.%2BZ.%26aulast%3DLi%26aufirst%3DL.%2BL.%26aulast%3DRen%26aufirst%3DJ.%2BX.%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DY.%2BQ.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DPharmacophore%2520modeling%2520study%2520based%2520on%2520known%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520together%2520with%2520virtual%2520screening%2520for%2520identifying%2520novel%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1944%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, K. B.</span><span> </span><span class="NLM_article-title">The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-<i>c</i>]pyrimidin-5-ylamino]-nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">1174</span><span class="NLM_x">–</span> <span class="NLM_lpage">1181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1124%2Fjpet.103.052316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12766258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=1174-1181&author=N.+Yamamotoauthor=K.+Takeshitaauthor=M.+Shichijoauthor=T.+Kokuboauthor=M.+Satoauthor=K.+Nakashimaauthor=M.+Ishimoriauthor=H.+Nagaiauthor=Y.+F.+Liauthor=T.+Yuraauthor=K.+B.+Bacon&title=The+orally+available+spleen+tyrosine+kinase+inhibitor+2-%5B7-%283%2C4-dimethoxyphenyl%29-imidazo%5B1%2C2-c%5Dpyrimidin-5-ylamino%5D-nicotinamide+dihydrochloride+%28BAY+61-3606%29+blocks+antigen-induced+airway+inflammation+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]-nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents</span></div><div class="casAuthors">Yamamoto, Noriyuki; Takeshita, Keisuke; Shichijo, Michitaka; Kokubo, Toshio; Sato, Masako; Nakashima, Kosuke; Ishimori, Mina; Nagai, Hiroichi; Li, Ying-Fu; Yura, Takeshi; Bacon, Kevin B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1174-1181</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) tyrosine kinase plays essential roles in receptors for Fc portion of Igs and B cell receptor complex signaling in various inflammatory cells; therefore, inhibitors of Syk kinase may show potential as antiasthmatic/allergic therapeutics.  We identified 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]-nicotinamide dihydrochloride (BAY 61-3606), a potent (Ki = 7.5 nM) and selective inhibitor of Syk kinase.  BAY 61-3606 inhibited not only degranulation (IC50 values between 5 and 46 nM) but also lipid mediator and cytokine synthesis in mast cells.  BAY 61-3606 was highly efficacious in basophils obtained from healthy human subjects (IC50 = 10 nM) and seems to be at least as potent in basophils obtained from atopic (high serum IgE) subjects (IC50 = 8.1 nM).  B cell receptor activation and receptors for Fc portion of IgG signaling in eosinophils and monocytes were also potently suppressed by BAY 61-3606.  Oral administration of BAY 61-3606 to rats significantly suppressed antigen-induced passive cutaneous anaphylactic reaction, bronchoconstriction, and bronchial edema at 3 mg/kg.  Furthermore, BAY 61-3606 attenuated antigen-induced airway inflammation in rats.  Based on these anti-inflammatory effects of BAY 61-3606 both in vitro and in vivo, it was demonstrated that Syk may play a very crit. role in the pathogenesis of allergic reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqPCG2zkryKbVg90H21EOLACvtfcHk0lgMZBomrOWYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehtbo%253D&md5=0fec9d94565bd2993e38dd22a3953f2b</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.052316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.052316%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DTakeshita%26aufirst%3DK.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DKokubo%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DIshimori%26aufirst%3DM.%26aulast%3DNagai%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DBacon%26aufirst%3DK.%2BB.%26atitle%3DThe%2520orally%2520available%2520spleen%2520tyrosine%2520kinase%2520inhibitor%25202-%255B7-%25283%252C4-dimethoxyphenyl%2529-imidazo%255B1%252C2-c%255Dpyrimidin-5-ylamino%255D-nicotinamide%2520dihydrochloride%2520%2528BAY%252061-3606%2529%2520blocks%2520antigen-induced%2520airway%2520inflammation%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D1174%26epage%3D1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Kiefer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Alawi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span> </span><span class="NLM_article-title">The Syk protein tyrosine kinase is essential for Fcγ receptor signaling in macrophages and neutrophils</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4209</span><span class="NLM_x">–</span> <span class="NLM_lpage">4220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1128%2FMCB.18.7.4209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9632805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1Wjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=4209-4220&author=F.+Kieferauthor=J.+Brumellauthor=N.+Al-Alawiauthor=S.+Latourauthor=A.+Chengauthor=A.+Veilletteauthor=S.+Grinsteinauthor=T.+Pawson&title=The+Syk+protein+tyrosine+kinase+is+essential+for+Fc%CE%B3+receptor+signaling+in+macrophages+and+neutrophils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The Syk protein tyrosine kinase is essential for Fcγ receptor signaling in macrophages and neutrophils</span></div><div class="casAuthors">Kiefer, Friedemann; Brumell, John; Al-Alawi, Nadia; Latour, Sylvain; Cheng, Alec; Veillette, Andre; Grinstein, Sergio; Pawson, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4209-4220</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The cytoplasmic protein tyrosine kinase Syk has 2 N-terminal SH2 domains that engage phosphorylated immunoreceptor tyrosine-based activation motifs in the signaling subunits of immunoreceptors.  Syk, in conjunction with Src family kinases, has been implicated in immunoreceptor signaling in both lymphoid and myeloid cells.  The authors investigated the role of Syk in Fcγ receptor (FcγR)-dependent and -independent responses in bone marrow-derived macrophages and neutrophils by using mouse radiation chimeras reconstituted with fetal liver cells from Syk-/- embryos.  Chimeric mice developed an abdominal hemorrhage starting 2-3 mo after transplantation that was ultimately lethal.  Syk-deficient neutrophils derived from the bone marrow were incapable of generating reactive oxygen intermediates in response to FcγR engagement but responded normally to tetradecanoyl phorbol acetate stimulation.  Syk-deficient macrophages were defective in phagocytosis induced by FcγR but showed normal phagocytosis in response to complement.  The tyrosine phosphorylation of multiple cellular polypeptides, including the FcγR γ chain, as well as Erk2 activation, was compromised in Syk-/- macrophages after FcγR stimulation.  In contrast, the induction of nitric oxide synthase in macrophages stimulated with lipopolysaccharide and γ interferon was not dependent on Syk.  Surprisingly, Syk-deficient macrophages were impaired in the ability to survive or proliferate on plastic petri dishes.  Taken together, these results suggest that Syk has specific physiol. roles in signaling from FcγRs in neutrophils and macrophages and raise the possibility that in vivo, Syk is involved in signaling events other than those mediated by immunoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHazcdScFvi7Vg90H21EOLACvtfcHk0lhFl1Zpuh7O7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1Wjtro%253D&md5=2c4f53529d331f8ba50f02486ed37a90</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1128%2FMCB.18.7.4209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.18.7.4209%26sid%3Dliteratum%253Aachs%26aulast%3DKiefer%26aufirst%3DF.%26aulast%3DBrumell%26aufirst%3DJ.%26aulast%3DAl-Alawi%26aufirst%3DN.%26aulast%3DLatour%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DVeillette%26aufirst%3DA.%26aulast%3DGrinstein%26aufirst%3DS.%26aulast%3DPawson%26aufirst%3DT.%26atitle%3DThe%2520Syk%2520protein%2520tyrosine%2520kinase%2520is%2520essential%2520for%2520Fc%25CE%25B3%2520receptor%2520signaling%2520in%2520macrophages%2520and%2520neutrophils%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1998%26volume%3D18%26spage%3D4209%26epage%3D4220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Poole, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Vugt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Winkel, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The Fc receptor γ-chain and the tyrosine kinase SYK are essential for activation of mouse platelets by collagen</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2333</span><span class="NLM_x">–</span> <span class="NLM_lpage">2341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=2333-2341&author=A.+Pooleauthor=J.+M.+Gibbinsauthor=M.+Turnerauthor=M.+J.+van+Vugtauthor=J.+G.+van+de+Winkelauthor=T.+Saitoauthor=V.+L.+Tybulewiczauthor=S.+P.+Watson&title=The+Fc+receptor+%CE%B3-chain+and+the+tyrosine+kinase+SYK+are+essential+for+activation+of+mouse+platelets+by+collagen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoole%26aufirst%3DA.%26aulast%3DGibbins%26aufirst%3DJ.%2BM.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3Dvan%2BVugt%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2Bde%2BWinkel%26aufirst%3DJ.%2BG.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520Fc%2520receptor%2520%25CE%25B3-chain%2520and%2520the%2520tyrosine%2520kinase%2520SYK%2520are%2520essential%2520for%2520activation%2520of%2520mouse%2520platelets%2520by%2520collagen%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D2333%26epage%3D2341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Ruggeri, Z. M.</span><span> </span><span class="NLM_article-title">Platelets in atherothrombosis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1227</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnm1102-1227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12411949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlWmu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1227-1234&author=Z.+M.+Ruggeri&title=Platelets+in+atherothrombosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Platelets in atherothrombosis</span></div><div class="casAuthors">Ruggeri, Zaverio M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1227-1234</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The participation of platelets in atherogenesis and the subsequent formation of occlusive thrombi depend on platelets' adhesive properties and the inability to respond to stimuli with rapid activation.  By understanding the multifaceted mechanisms involved in platelet interactions with vascular surfaces and aggregation, new approaches can be tailored to selectively inhibit the pathways most relevant to the pathol. aspects of atherothrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3d0EIagloKLVg90H21EOLACvtfcHk0lhFl1Zpuh7O7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlWmu78%253D&md5=020994f0837100ace4695ddd5bcc6417</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1038%2Fnm1102-1227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1102-1227%26sid%3Dliteratum%253Aachs%26aulast%3DRuggeri%26aufirst%3DZ.%2BM.%26atitle%3DPlatelets%2520in%2520atherothrombosis%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D1227%26epage%3D1234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Obergfell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mócsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buensuceso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moores, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shattil, S. J.</span><span> </span><span class="NLM_article-title">Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1083%2Fjcb.200112113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11940607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFKktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2002&pages=265-275&author=A.+Obergfellauthor=K.+Etoauthor=A.+M%C3%B3csaiauthor=C.+Buensucesoauthor=S.+L.+Mooresauthor=J.+S.+Bruggeauthor=C.+A.+Lowellauthor=S.+J.+Shattil&title=Coordinate+interactions+of+Csk%2C+Src%2C+and+Syk+kinases+with+%CE%B1IIb%CE%B23+initiate+integrin+signaling+to+the+cytoskeleton"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton</span></div><div class="casAuthors">Obergfell, Achim; Eto, Koji; Mocsai, Attila; Buensuceso, Charito; Moores, Sheri L.; Brugge, Joan S.; Lowell, Clifford A.; Shattil, Sanford J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">265-275</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Integrins regulate cell adhesion and motility through tyrosine kinases, but initiation of this process is poorly understood.  We find here that Src assocs. constitutively with integrin αIIbβ3 in platelets.  Platelet adhesion to fibrinogen caused a rapid increase in αIIbβ3-assocd. Src activity, and active Src localized to filopodia and cell edges.  Csk, which neg. regulates Src by phosphorylating Tyr-529, was also constitutively assocd. with αIIbβ3.  However, fibrinogen binding caused Csk to dissoc. from αIIbβ3, concomitant with dephosphorylation of Src Tyr-529 and phosphorylation of Src activation loop Tyr-418.  In contrast to the behavior of Src and Csk, Syk was assocd. with αIIbβ3 only after fibrinogen binding.  Platelets multiply deficient in Src, Hck, Fgr, and Lyn, or normal platelets treated with Src kinase inhibitors failed to spread on fibrinogen.  Inhibition of Src kinases blocked Syk activation and inhibited phosphorylation of Syk substrates (Vav1, Vav3, SLP-76) implicated in cytoskeletal regulation.  Syk-deficient platelets exhibited Src activation upon adhesion to fibrinogen, but no spreading or phosphorylation of Vav1, Vav3, and SLP-76.  These studies establish that platelet spreading on fibrinogen requires sequential activation of Src and Syk in proximity to αIIbβ3, thus providing a paradigm for initiation of integrin signaling to the actin cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpObO8A1tVgibVg90H21EOLACvtfcHk0lhFl1Zpuh7O7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFKktLo%253D&md5=e4556e7e2687f8aaa49f5de8276dd744</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200112113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200112113%26sid%3Dliteratum%253Aachs%26aulast%3DObergfell%26aufirst%3DA.%26aulast%3DEto%26aufirst%3DK.%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26aulast%3DBuensuceso%26aufirst%3DC.%26aulast%3DMoores%26aufirst%3DS.%2BL.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DShattil%26aufirst%3DS.%2BJ.%26atitle%3DCoordinate%2520interactions%2520of%2520Csk%252C%2520Src%252C%2520and%2520Syk%2520kinases%2520with%2520%25CE%25B1IIb%25CE%25B23%2520initiate%2520integrin%2520signaling%2520to%2520the%2520cytoskeleton%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D157%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span> </span><span class="NLM_article-title">A novel SYK kinase-selective inhibitor blocks antigen presentation of immune complexes in dendritic cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">505</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.ejphar.2004.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15556156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWjsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2004&pages=223-228&author=K.+Nakashimaauthor=T.+Kokuboauthor=M.+Shichijoauthor=Y.+F.+Liauthor=T.+Yuraauthor=N.+Yamamoto&title=A+novel+SYK+kinase-selective+inhibitor+blocks+antigen+presentation+of+immune+complexes+in+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Syk kinase-selective inhibitor blocks antigen presentation of immune complexes in dendritic cells</span></div><div class="casAuthors">Nakashima, Kosuke; Kokubo, Toshio; Shichijo, Michitaka; Li, Ying-Fu; Yura, Takeshi; Yamamoto, Noriyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">223-228</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The initiation of antigen presentation by dendritic cells requires proper internalization of antigens through various mechanisms.  Internalization of immune complexes via Fc receptors has been shown to be around 100 times more efficient than the internalization of non-complexed antigens.  Spleen tyrosine kinase (Syk) plays an essential role in the signaling cascade initiated by Ig receptors.  We used a selective Syk inhibitor, 7-(3,4-dimethoxyphenyl)-N-1H-indazol-6-ylimidazo[1,2-c]pyrimidin-5-aminedihydrochloride (compd.-D), to evaluate the role of Syk in antigen presentation by mouse bone marrow-derived dendritic cells.  In line with our expectation, compd.-D concn.-dependently inhibited the internalization of immune complexes but not that of antigen itself.  Furthermore, when dendritic cells were pretreated with compd.-D, the ability of dendritic cells to present immune complex antigens to Th2 cells was attenuated, parallel by a reduced release of interleukin-4 prodn. in Th2 cells.  Therefore, Syk kinase activity is a crit. component in the process of Fcγ receptor-mediated internalization of immune complex antigens in dendritic cells, and Syk kinase inhibitors may be beneficial in selectively suppressing antibody-mediated antigen presentation in allergic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1CSm41ANgsbVg90H21EOLACvtfcHk0liDE3vmMg2ktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWjsb7O&md5=cf2123be0cd4673d8b3e398530ccc53f</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKokubo%26aufirst%3DT.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26atitle%3DA%2520novel%2520SYK%2520kinase-selective%2520inhibitor%2520blocks%2520antigen%2520presentation%2520of%2520immune%2520complexes%2520in%2520dendritic%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D505%26spage%3D223%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrapchak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Player, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. P.</span><span> </span><span class="NLM_article-title">Discovery and SAR of novel [l,6]naphthyridines as potent inhibitors of spleen tyrosine kinase (Syk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1415-1418&author=C.+L.+Cywinauthor=B.+P.+Zhaoauthor=D.+W.+McNeilauthor=M.+Hrapchakauthor=A.+S.+Prokopowiczauthor=D.+R.+Goldbergauthor=T.+M.+Morwickauthor=A.+Gaoauthor=S.+Jakesauthor=M.+Kashemauthor=R.+L.+Magoldaauthor=R.+M.+Sollauthor=M.+R.+Playerauthor=M.+A.+Bobkoauthor=J.+Rinkerauthor=R.+L.+DesJarlaisauthor=M.+P.+Winters&title=Discovery+and+SAR+of+novel+%5Bl%2C6%5Dnaphthyridines+as+potent+inhibitors+of+spleen+tyrosine+kinase+%28Syk%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DZhao%26aufirst%3DB.%2BP.%26aulast%3DMcNeil%26aufirst%3DD.%2BW.%26aulast%3DHrapchak%26aufirst%3DM.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKashem%26aufirst%3DM.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26aulast%3DBobko%26aufirst%3DM.%2BA.%26aulast%3DRinker%26aufirst%3DJ.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520novel%2520%255Bl%252C6%255Dnaphthyridines%2520as%2520potent%2520inhibitors%2520of%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1415%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Bouyssou, T.; Dahmann, G.; Engelhardt, H.; Fiegen, D.; Handschuh, S.; Hobbie, S.; Hoffmann, M.; Kono, T.; Reiser, U.; Sato, Y.; Schnapp, A.; Schuler-Metz, A.</span><span> </span><span class="NLM_article-title">Preparation of Naphthyridines as SYK Kinase Inhibitors</span>. WO2010015520,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Bouyssou&author=G.+Dahmann&author=H.+Engelhardt&author=D.+Fiegen&author=S.+Handschuh&author=S.+Hobbie&author=M.+Hoffmann&author=T.+Kono&author=U.+Reiser&author=Y.+Sato&author=A.+Schnapp&author=A.+Schuler-Metz&title=Preparation+of+Naphthyridines+as+SYK+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBouyssou%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Naphthyridines%2520as%2520SYK%2520Kinase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Fiegen, D.; Handschuh, S.; Hobbie, S.; Hoffmann, M.; Kono, T.; Sato, Y.; Schnapp, A.; Schuler-Metz, A.</span><span> </span><span class="NLM_article-title">Preparation of 7-Phenylnaphthyridines as SYK Kinase Inhibitors</span>. WO2010015518,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+Fiegen&author=S.+Handschuh&author=S.+Hobbie&author=M.+Hoffmann&author=T.+Kono&author=Y.+Sato&author=A.+Schnapp&author=A.+Schuler-Metz&title=Preparation+of+7-Phenylnaphthyridines+as+SYK+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFiegen%26aufirst%3DD.%26atitle%3DPreparation%2520of%25207-Phenylnaphthyridines%2520as%2520SYK%2520Kinase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Hisamichi, H.; Naito, R.; Kawazoe, S.; Toyoshima, A.; Tanabe, K.; Nakai, E.; Ichikawa, A.; Orita, A.; Takeuchi, M.</span><span> </span><span class="NLM_article-title">Pyrimidine-5-carboxamide Derivatives</span>. U.S. Patent 6,432,963, August 13,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=H.+Hisamichi&author=R.+Naito&author=S.+Kawazoe&author=A.+Toyoshima&author=K.+Tanabe&author=E.+Nakai&author=A.+Ichikawa&author=A.+Orita&author=M.+Takeuchi&title=Pyrimidine-5-carboxamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHisamichi%26aufirst%3DH.%26atitle%3DPyrimidine-5-carboxamide%2520Derivatives%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Hisamichi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span> </span><span class="NLM_article-title">Synthetic studies on novel SYK inhibitors. Part 1: Synthesis and structure–activity relationship of pyrimidine-5-carboxamide derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4936</span><span class="NLM_x">–</span> <span class="NLM_lpage">4951</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4936-4951&author=H.+Hisamichiauthor=R.+Naitoauthor=A.+Toyoshimaauthor=N.+Kawanoauthor=A.+Ichikawaauthor=A.+Oritaauthor=M.+Oritaauthor=N.+Hamadaauthor=M.+Takeuchiauthor=M.+Ohtaauthor=S.+Tsukamoto&title=Synthetic+studies+on+novel+SYK+inhibitors.+Part+1%3A+Synthesis+and+structure%E2%80%93activity+relationship+of+pyrimidine-5-carboxamide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHisamichi%26aufirst%3DH.%26aulast%3DNaito%26aufirst%3DR.%26aulast%3DToyoshima%26aufirst%3DA.%26aulast%3DKawano%26aufirst%3DN.%26aulast%3DIchikawa%26aufirst%3DA.%26aulast%3DOrita%26aufirst%3DA.%26aulast%3DOrita%26aufirst%3DM.%26aulast%3DHamada%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26atitle%3DSynthetic%2520studies%2520on%2520novel%2520SYK%2520inhibitors.%2520Part%25201%253A%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520pyrimidine-5-carboxamide%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D4936%26epage%3D4951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Hirabayashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnota, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">A novel Syk family kinase inhibitor: design, synthesis, and structure–activity relationship of 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine and 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7347</span><span class="NLM_x">–</span> <span class="NLM_lpage">7357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=7347-7357&author=A.+Hirabayashiauthor=H.+Mukaiyamaauthor=H.+Kobayashiauthor=H.+Shioharaauthor=S.+Nakayamaauthor=M.+Ozawaauthor=K.+Miyazawaauthor=K.+Misawaauthor=H.+Ohnotaauthor=M.+Isaji&title=A+novel+Syk+family+kinase+inhibitor%3A+design%2C+synthesis%2C+and+structure%E2%80%93activity+relationship+of+1%2C2%2C4-triazolo%5B4%2C3-c%5Dpyrimidine+and+1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirabayashi%26aufirst%3DA.%26aulast%3DMukaiyama%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DShiohara%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DM.%26aulast%3DMiyazawa%26aufirst%3DK.%26aulast%3DMisawa%26aufirst%3DK.%26aulast%3DOhnota%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DA%2520novel%2520Syk%2520family%2520kinase%2520inhibitor%253A%2520design%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%25201%252C2%252C4-triazolo%255B4%252C3-c%255Dpyrimidine%2520and%25201%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D7347%26epage%3D7357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Hirabayashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnota, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of imidazo[1,2-<i>c</i>]pyrimidine derivatives as potent and orally effective Syk family kinases inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">9247</span><span class="NLM_x">–</span> <span class="NLM_lpage">9260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=9247-9260&author=A.+Hirabayashiauthor=H.+Mukaiyamaauthor=H.+Kobayashiauthor=H.+Shioharaauthor=S.+Nakayamaauthor=M.+Ozawaauthor=E.+Tsujiauthor=K.+Miyazawaauthor=K.+Misawaauthor=H.+Ohnotaauthor=M.+Isaji&title=Structure%E2%80%93activity+relationship+studies+of+imidazo%5B1%2C2-c%5Dpyrimidine+derivatives+as+potent+and+orally+effective+Syk+family+kinases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirabayashi%26aufirst%3DA.%26aulast%3DMukaiyama%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DShiohara%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DM.%26aulast%3DTsuji%26aufirst%3DE.%26aulast%3DMiyazawa%26aufirst%3DK.%26aulast%3DMisawa%26aufirst%3DK.%26aulast%3DOhnota%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520imidazo%255B1%252C2-c%255Dpyrimidine%2520derivatives%2520as%2520potent%2520and%2520orally%2520effective%2520Syk%2520family%2520kinases%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D9247%26epage%3D9260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Hirabayashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnota, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of 5-benzylaminoimidazo[1,2-<i>c</i>]pyrimidine-8-carboxamide derivatives as potent, highly selective ZAP-70 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=284-294&author=A.+Hirabayashiauthor=H.+Mukaiyamaauthor=H.+Kobayashiauthor=H.+Shioharaauthor=S.+Nakayamaauthor=M.+Ozawaauthor=K.+Miyazawaauthor=K.+Misawaauthor=H.+Ohnotaauthor=M.+Isaji&title=Structure%E2%80%93activity+relationship+studies+of+5-benzylaminoimidazo%5B1%2C2-c%5Dpyrimidine-8-carboxamide+derivatives+as+potent%2C+highly+selective+ZAP-70+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirabayashi%26aufirst%3DA.%26aulast%3DMukaiyama%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DShiohara%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DM.%26aulast%3DMiyazawa%26aufirst%3DK.%26aulast%3DMisawa%26aufirst%3DK.%26aulast%3DOhnota%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%25205-benzylaminoimidazo%255B1%252C2-c%255Dpyrimidine-8-carboxamide%2520derivatives%2520as%2520potent%252C%2520highly%2520selective%2520ZAP-70%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D284%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Reilly, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">André, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGuzman, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, S. E.</span><span> </span><span class="NLM_article-title">PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2241</span><span class="NLM_x">–</span> <span class="NLM_lpage">2246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=2241-2246&author=M.+P.+Reillyauthor=U.+Sinhaauthor=P.+Andr%C3%A9author=S.+M.+Taylorauthor=Y.+Pakauthor=F.+R.+DeGuzmanauthor=N.+Nandaauthor=A.+Pandeyauthor=M.+Stollaauthor=W.+Bergmeierauthor=S.+E.+McKenzie&title=PRT-060318%2C+a+novel+Syk+inhibitor%2C+prevents+heparin-induced+thrombocytopenia+and+thrombosis+in+a+transgenic+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DM.%2BP.%26aulast%3DSinha%26aufirst%3DU.%26aulast%3DAndr%25C3%25A9%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DS.%2BM.%26aulast%3DPak%26aufirst%3DY.%26aulast%3DDeGuzman%26aufirst%3DF.%2BR.%26aulast%3DNanda%26aufirst%3DN.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DStolla%26aufirst%3DM.%26aulast%3DBergmeier%26aufirst%3DW.%26aulast%3DMcKenzie%26aufirst%3DS.%2BE.%26atitle%3DPRT-060318%252C%2520a%2520novel%2520Syk%2520inhibitor%252C%2520prevents%2520heparin-induced%2520thrombocytopenia%2520and%2520thrombosis%2520in%2520a%2520transgenic%2520mouse%2520model%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D2241%26epage%3D2246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Rossi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braselmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frances, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issakani, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">Identification of the Syk kinase inhibitor R112 by a human mast cell screen</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.jaci.2006.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16950297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2006&pages=749-755&author=A.+B.+Rossiauthor=E.+Herlaarauthor=S.+Braselmannauthor=S.+Huynhauthor=V.+Taylorauthor=R.+Francesauthor=S.+D.+Issakaniauthor=A.+Argadeauthor=R.+Singhauthor=D.+G.+Payanauthor=E.+S.+Masuda&title=Identification+of+the+Syk+kinase+inhibitor+R112+by+a+human+mast+cell+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the Syk kinase inhibitor R112 by a human mast cell screen</span></div><div class="casAuthors">Rossi, Alexander B.; Herlaar, Ellen; Braselmann, Sylvia; Huynh, Stacey; Taylor, Vanessa; Frances, Roy; Issakani, Sarkiz D.; Argade, Ankush; Singh, Rajinder; Payan, Donald G.; Masuda, Esteban S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Activation of the IgE receptor, Fc.vepsiln.RI, in mast cells is the key mechanism initiating and propagating pathophysiol. responses in allergic rhinitis.  Objective: Identify and characterize a small mol. inhibitor of IgE-dependent mast cell activation for the treatment of allergic diseases.  Methods: A cell-based high-throughput screen for small mols. that block IgE signaling was performed in cultured human mast cells.  A potent inhibitor, referred to as R112, was selected and characterized by using biochem. and cell-based assays.  R112 effects on IgE-dependent degranulation and cytokine prodn. was measured in mast cells and basophils and compared with other mast cell inhibitors.  Results: R112 inhibited degranulation induced by anti-IgE crosslinking in mast cells (tryptase release, effective concn. for 50% inhibition [EC50] = 353 nmol/L) or basophils (histamine release, EC50 = 280 nmol/L), and by allergen (dust mite) in basophils (histamine release, EC50 = 490 nmol/L).  R112 also blocked leukotriene C4 prodn. and all proinflammatory cytokines tested.  Subsequent mol. characterization indicated that R112 is an ATP-competitive spleen tyrosine kinase (Syk) inhibitor (inhibitory const. [Ki] = 96 nmol/L).  Its onset of action was immediate, and the inhibition was reversible.  Incubation of mast cells with R112 showed that cytokine prodn. in mast cells was dependent on sustained activation of the Fc.vepsiln.RI-Lyn-spleen tyrosine kinase pathway.  Unlike other mast cell inhibitors, R112 was able to completely inhibit all three IgE-induced mast cell functions: degranulation, lipid mediator prodn., and cytokine prodn.  Conclusion: R112 potently, completely, and rapidly abrogated all mast cell activation cascades triggered by IgE receptor crosslinking.  Clin. implications: R112 and its analogs offer a new modality in the treatment of allergic rhinitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBFncpEISRNrVg90H21EOLACvtfcHk0ljn0jmB_3G9pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWmtLo%253D&md5=4411bbd8d39931e089126fdc803805df</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2006.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2006.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DA.%2BB.%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DBraselmann%26aufirst%3DS.%26aulast%3DHuynh%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DFrances%26aufirst%3DR.%26aulast%3DIssakani%26aufirst%3DS.%2BD.%26aulast%3DArgade%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DIdentification%2520of%2520the%2520Syk%2520kinase%2520inhibitor%2520R112%2520by%2520a%2520human%2520mast%2520cell%2520screen%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2006%26volume%3D118%26spage%3D749%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, J.</span><span> </span><span class="NLM_article-title">Syk inhibitors as treatment for allergic rhinitis</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.pupt.2007.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17669674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=461-467&author=E.+S.+Masudaauthor=J.+Schmitz&title=Syk+inhibitors+as+treatment+for+allergic+rhinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Syk inhibitors as treatment for allergic rhinitis</span></div><div class="casAuthors">Masuda, Esteban S.; Schmitz, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-467</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Allergic rhinitis is characterized by a hypersensitive immune response in the upper airways to seasonal or perennial allergens leading to episodes of sneezing, itching, runny nose and nasal congestion.  These symptoms are mainly the manifestations of a large no. of mediators released by mast cells and basophils localized in the nasal mucosa, following their activation via allergen-specific immunoglubulin E (IgE) receptors.  Current medications antagonize the action of distinct mediators such as histamine and leukotrienes for symptom relief, or block the prodn. of pro-inflammatory cytokines to suppress allergic inflammation.  Notably, rather than neutralizing individual mediators, Syk kinase inhibitors can block the allergen-induced release of all mast cell mediators and the prodn. of most eicosanoids and cytokines.  Thus, Syk kinase represents an attractive therapeutic target for acute and chronic allergic inflammation.  Syk kinase inhibitors are now entering clin. trials.  Using cell-based structure-activity relationships with primary human mast cells, a series of 2,4-diaminopyrimidine Syk kinase inhibitors was developed.  One of these compds., referred to as R112, exhibited suitable characteristics for intranasal delivery and was tested for safety and efficacy in allergic rhinitis patients.  In a park environment, R112 showed remarkable amelioration of acute allergic rhinitis symptoms with rapid onset of action.  These results demonstrate the clin. significance of inhibiting Syk in allergic upper airway disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY3bfhViMJUrVg90H21EOLACvtfcHk0libcjzO9_aQCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSgt78%253D&md5=fadb261de75f443b3dd3fc9fd1f8edb9</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2007.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2007.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DSchmitz%26aufirst%3DJ.%26atitle%3DSyk%2520inhibitors%2520as%2520treatment%2520for%2520allergic%2520rhinitis%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D21%26spage%3D461%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Matsubara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joetham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swasey, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, E. W.</span><span> </span><span class="NLM_article-title">Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1165%2Frcmb.2005-0298OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16339999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=426-433&author=S.+Matsubaraauthor=T.+Koyaauthor=K.+Takedaauthor=A.+Joethamauthor=N.+Miyaharaauthor=P.+Pineauthor=E.+S.+Masudaauthor=C.+H.+Swaseyauthor=E.+W.+Gelfand&title=Syk+activation+in+dendritic+cells+is+essential+for+airway+hyperresponsiveness+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation</span></div><div class="casAuthors">Matsubara, Shigeki; Koya, Toshiyuki; Takeda, Katsuyuki; Joetham, Anthony; Miyahara, Nobuaki; Pine, Polly; Masuda, Esteban S.; Swasey, Christina H.; Gelfand, Erwin W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">426-433</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">We evaluated the role of Syk, using an inhibitor, on allergen-induced airway hyperresponsiveness (AHR) and airway inflammation in a system shown to be B cell- and mast cell-independent.  Sensitization of BALB/c mice with ovalbumin (OVA) and alum after three consecutive OVA challenges resulted in AHR to inhaled methacholine and airway inflammation.  The Syk inhibitor R406 (30 mg/kg, administered orally, twice daily) prevented the development of AHR, increases in eosinophils and lymphocytes and IL-13 levels in bronchoalveolar lavage (BAL) fluid, and goblet cell metaplasia when administered after sensitization and before challenge with OVA.  Levels of IL-4, IL-5, and IFN-γ in BAL fluid and allergen-specific antibody levels in serum were not affected by treatment.  Because many of these responses may be influenced by dendritic cell function, we investigated the effect of R406 on bone marrow-derived dendritic cell (BMDC) function.  Co-culture of BMDC with immune complexes of OVA and IgG anti-OVA together with OVA-sensitized spleen mononuclear cells resulted in increases in IL-13 prodn.  IL-13 prodn. was inhibited if the BMDCs were pretreated with the Syk inhibitor.  Intratracheal transfer of immune complex-pulsed BMDCs (but not nonpulsed BMDCs) to naive mice before airway allergen challenge induced the development of AHR and increases in BAL eosinophils and lymphocytes.  All of these responses were inhibited if the transferred BMDCs were pretreated with R406.  These results demonstrate that Syk inhibition prevents allergen-induced AHR and airway inflammation after systemic sensitization, and challenge, at least in part through alteration of DC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2yCPr3feg7Vg90H21EOLACvtfcHk0libcjzO9_aQCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCqurc%253D&md5=0c09f0ae29fb851f61febfa6e6a44ab1</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2005-0298OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2005-0298OC%26sid%3Dliteratum%253Aachs%26aulast%3DMatsubara%26aufirst%3DS.%26aulast%3DKoya%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DJoetham%26aufirst%3DA.%26aulast%3DMiyahara%26aufirst%3DN.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DSwasey%26aufirst%3DC.%2BH.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DSyk%2520activation%2520in%2520dendritic%2520cells%2520is%2520essential%2520for%2520airway%2520hyperresponsiveness%2520and%2520inflammation%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2006%26volume%3D34%26spage%3D426%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Matsubara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loader, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakhama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, E. W.</span><span> </span><span class="NLM_article-title">Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1164%2Frccm.200503-361OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16192454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSktr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2006&pages=56-63&author=S.+Matsubaraauthor=G.+Liauthor=K.+Takedaauthor=J.+E.+Loaderauthor=P.+Pineauthor=E.+S.+Masudaauthor=N.+Miyaharaauthor=S.+Miyaharaauthor=J.+J.+Lucasauthor=A.+Dakhamaauthor=E.+W.+Gelfand&title=Inhibition+of+spleen+tyrosine+kinase+prevents+mast+cell+activation+and+airway+hyperresponsiveness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness</span></div><div class="casAuthors">Matsubara, Shigeki; Li, Guiming; Takeda, Katsuyuki; Loader, Joan E.; Pine, Polly; Masuda, Esteban S.; Miyahara, Nobuaki; Miyahara, Satoko; Lucas, Joseph J.; Dakhama, Azzeddine; Gelfand, Erwin W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Spleen tyrosine kinase (Syk) is important for Fc and B-cell receptor-mediated signaling.  Objective: To det. the activity of a specific Syk inhibitor (R406) on mast cell activation in vitro and on the development of allergen-induced airway hyperresponsiveness (AHR) and inflammation in vivo.  Methods: AHR and inflammation were induced after 10 d of allergen (ovalbumin [OVA]) exposure exclusively via the airways and in the absence of adjuvant.  This approach was previously established to be IgE, FcεRI, and mast cell dependent.  Alternatively, mice were passively sensitized with OVA-specific IgE, followed by limited airway challenge.  In vitro, the inhibitor was added to cultures of IgE-sensitized bone marrow-derived mast cells (BMMCs) before crosslinking with allergen.  Results: The inhibitor prevented OVA-induced degranulation of passively IgE-sensitized murine BMMCs and inhibited the prodn. of interleukin (IL)-13, tumor necrosis factor α, IL-2, and IL-6 in these sensitized BMMCs.  When administered in vivo, R406 inhibited AHR, which developed in BALB/c mice exposed to aerosolized 1% OVA for 10 consecutive d (20 min/d), as well as pulmonary eosinophilia and goblet cell metaplasia.  A similar inhibition of AHR was demonstrated in mice passively sensitized with OVA-specific IgE and exposed to limited airway challenge.  Conclusion: This study delineates a functional role for Syk in the development of mast cell- and IgE-mediated AHR and airway inflammation, and these results indicate that inhibition of Syk may be a target in the treatment of allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNpn-O8jXJ6rVg90H21EOLACvtfcHk0libcjzO9_aQCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSktr4%253D&md5=ee54cff81d9100544d10091d96aa1f66</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1164%2Frccm.200503-361OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200503-361OC%26sid%3Dliteratum%253Aachs%26aulast%3DMatsubara%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DLoader%26aufirst%3DJ.%2BE.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DMiyahara%26aufirst%3DN.%26aulast%3DMiyahara%26aufirst%3DS.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DDakhama%26aufirst%3DA.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DInhibition%2520of%2520spleen%2520tyrosine%2520kinase%2520prevents%2520mast%2520cell%2520activation%2520and%2520airway%2520hyperresponsiveness%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2006%26volume%3D173%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burleson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, G. R.</span><span> </span><span class="NLM_article-title">Immunotoxicity assessment for the novel spleen tyrosine kinase inhibitor R406</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.taap.2007.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17490694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlSmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2007&pages=268-277&author=Y.+Zhuauthor=E.+Herlaarauthor=E.+S.+Masudaauthor=G.+R.+Burlesonauthor=A.+J.+Nelsonauthor=E.+B.+Grossbardauthor=G.+R.+Clemens&title=Immunotoxicity+assessment+for+the+novel+spleen+tyrosine+kinase+inhibitor+R406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotoxicity assessment for the novel spleen tyrosine kinase inhibitor R406</span></div><div class="casAuthors">Zhu, Yanhong; Herlaar, Ellen; Masuda, Esteban S.; Burleson, Gary R.; Nelson, Andrew J.; Grossbard, Elliott B.; Clemens, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">268-277</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a novel pharmaceutical target for treatment of allergic, autoimmune, and neoplastic disorders.  Previous studies have indicated that Syk signaling plays crit. roles in regulating the lymphohematopoietic system.  These observations prompted us to investigate whether inhibition of Syk would promote immunotoxicity.  In a series of studies, rats were treated orally with R406, at dose levels up to and including 100 mg/kg/day (or its prodrug R788 at dose levels up to and including 100 mg/kg/day, reduced to 50 mg/kg/day for females as MTD was exceeded), a potent Syk inhibitor, twice daily for 28 days.  In addn. to std. toxicol. assessments, immunophenotyping by flow cytometric anal., and a study of humoral immune response measuring anti-KLH IgM and IgG levels, were undertaken.  Other immunotoxicity studies included 3 host resistance models in female Balb/c mice to further ascertain effects of R406 on innate and acquired immunity.  Following R406 treatment, expected immunomodulating effects (e.g., decreased thymic and spleen wt., hypocellularity of bone marrow, and reduced lymphocyte counts, including T and B cells) were obsd. in the rat studies.  These changes essentially resolved during a 14-day treatment-free recovery period.  A KLH challenge in rats demonstrated no adverse effects on IgG or IgM response.  R788/406, administered orally at dose levels up to and including 80 mg/kg/day for 28 days, did not affect bacterial or viral clearance in the Listeria, Streptococcal, or Influenza host resistance mouse models, resp.  This correlated with previous in vitro macrophage and neutrophil function assays (assessing migration, phagocytosis, oxidative burst, and microbicidal activity), which revealed that R406 did not adversely affect macrophage or neutrophil function in innate immune responses.  Collectively, these results demonstrate that R406 has minimal functional immunotoxicity notwithstanding its lymphocytopenic effect, suggesting that inhibition of Syk might not lead to unacceptable mechanism-based adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGswVQ_gofd7Vg90H21EOLACvtfcHk0li4-Z23z6XXpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlSmt7o%253D&md5=11f4b6f9ee77bad470761ddd24d14094</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2007.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2007.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DBurleson%26aufirst%3DG.%2BR.%26aulast%3DNelson%26aufirst%3DA.%2BJ.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DClemens%26aufirst%3DG.%2BR.%26atitle%3DImmunotoxicity%2520assessment%2520for%2520the%2520novel%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520R406%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2007%26volume%3D221%26spage%3D268%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Cha, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoot, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tak, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1124%2Fjpet.105.097436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16452391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=571-578&author=H.+S.+Chaauthor=D.+L.+Boyleauthor=T.+Inoueauthor=R.+Schootauthor=P.+P.+Takauthor=P.+Pineauthor=G.+S.+Firestein&title=A+novel+spleen+tyrosine+kinase+inhibitor+blocks+c-Jun+N-terminal+kinase-mediated+gene+expression+in+synoviocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes</span></div><div class="casAuthors">Cha, Hoon-Suk; Boyle, David L.; Inoue, Tomoyuki; Schoot, Reineke; Tak, Paul P.; Pine, Polly; Firestein, Gary S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">571-578</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a key regulator of cell signaling induced by cytokines or Fc receptor engagement.  However, the role of Syk in rheumatoid arthritis (RA) is not known yet.  We investigated the pathways activated by Syk in tumor necrosis factor-α (TNFα)-stimulated fibroblast-like synoviocytes (FLS) using the novel Syk inhibitor N4-(2,2-dimethyl-3-oxo-4H-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine (R406).  Using immunohistochem., Syk was detected in RA synovial tissue (ST), primarily in the synovial intimal lining.  Western blot anal. demonstrated significantly greater amts. of phospho-Syk expression in RA ST compared with osteoarthritis ST.  The kinase was expressed and functionally activated by TNFα in FLS and was blocked by R406.  Western blot anal. demonstrated that Syk inhibition by R406 markedly suppressed TNFα-induced c-Jun N-terminal kinase (JNK) phosphorylation in FLS, with a modest decrease in extracellular signal-regulated kinase phosphorylation.  Surprisingly, p38 activation was not affected by R406.  The Syk inhibitor also decreased TNFα-induced mitogen-activated protein kinase kinase (MKK) 4 phosphorylation but not MKK3 and MKK6 phosphorylation, which is consistent with its selective sparing of p38.  The connection between Syk and JNK was confirmed by demonstrating decreased phospho-c-Jun protein expression and complete inhibition of JNK function in R406-treated cells.  R406 also suppressed downstream actions of JNK, as detd. by activator protein 1 binding, as well as matrix metalloproteinase 3 gene expression.  These data demonstrate that Syk activation plays an essential role in TNFα-induced cytokine and matrix metalloproteinase prodn. in RA FLS, esp. by suppressing activation of the JNK pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowy40JTv0l77Vg90H21EOLACvtfcHk0li4-Z23z6XXpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamtb8%253D&md5=561af856df90dc0d9c39b00ef7bff860</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097436%26sid%3Dliteratum%253Aachs%26aulast%3DCha%26aufirst%3DH.%2BS.%26aulast%3DBoyle%26aufirst%3DD.%2BL.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DSchoot%26aufirst%3DR.%26aulast%3DTak%26aufirst%3DP.%2BP.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DA%2520novel%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520c-Jun%2520N-terminal%2520kinase-mediated%2520gene%2520expression%2520in%2520synoviocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D571%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Sweeny, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clough, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamidipati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D. T.-W.</span><span> </span><span class="NLM_article-title">Metabolism of fostamatinib, the oral methylene phosphate prodrug of the spleen tyrosine kinase inhibitor R406 in humans: contribution of hepatic and gut bacterial processes to the overall biotransformation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1166-1176&author=D.+J.+Sweenyauthor=W.+Liauthor=J.+Cloughauthor=S.+Bhamidipatiauthor=R.+Singhauthor=G.+Parkauthor=M.+Baluomauthor=E.+B.+Grossbardauthor=D.+T.-W.+Lau&title=Metabolism+of+fostamatinib%2C+the+oral+methylene+phosphate+prodrug+of+the+spleen+tyrosine+kinase+inhibitor+R406+in+humans%3A+contribution+of+hepatic+and+gut+bacterial+processes+to+the+overall+biotransformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSweeny%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DClough%26aufirst%3DJ.%26aulast%3DBhamidipati%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DLau%26aufirst%3DD.%2BT.-W.%26atitle%3DMetabolism%2520of%2520fostamatinib%252C%2520the%2520oral%2520methylene%2520phosphate%2520prodrug%2520of%2520the%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520R406%2520in%2520humans%253A%2520contribution%2520of%2520hepatic%2520and%2520gut%2520bacterial%2520processes%2520to%2520the%2520overall%2520biotransformation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1166%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Sweeny, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D. T.</span><span> </span><span class="NLM_article-title">Contribution of gut bacteria to the metabolism of the spleen tyrosine kinase (Syk) inhibitor R406 in cynomolgus monkey</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=415-423&author=D.+J.+Sweenyauthor=W.+Liauthor=E.+B.+Grossbardauthor=D.+T.+Lau&title=Contribution+of+gut+bacteria+to+the+metabolism+of+the+spleen+tyrosine+kinase+%28Syk%29+inhibitor+R406+in+cynomolgus+monkey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSweeny%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DLau%26aufirst%3DD.%2BT.%26atitle%3DContribution%2520of%2520gut%2520bacteria%2520to%2520the%2520metabolism%2520of%2520the%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%2520inhibitor%2520R406%2520in%2520cynomolgus%2520monkey%26jtitle%3DXenobiotica%26date%3D2010%26volume%3D40%26spage%3D415%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Meltzer, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span> </span><span class="NLM_article-title">An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.jaci.2005.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15806000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2isrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=791-796&author=E.+O.+Meltzerauthor=R.+B.+Berkowitzauthor=E.+B.+Grossbard&title=An+intranasal+Syk-kinase+inhibitor+%28R112%29+improves+the+symptoms+of+seasonal+allergic+rhinitis+in+a+park+environment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment</span></div><div class="casAuthors">Meltzer, Eli O.; Berkowitz, Robert B.; Grossbard, Elliott B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">791-796</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: R112 inhibits Syk kinase, a transducer of signaling through the Fcε receptor of mast cells, blocking mast cell responses to allergic stimuli.  Objective: Examine the efficacy and safety of intranasal R112 in volunteers with symptomatic seasonal allergic rhinitis compared with a placebo in a park setting.  Methods: In this double-blind, placebo-controlled study of 319 volunteers with seasonal allergic rhinitis, 160 were randomized to intranasal R112 and 159 to a vehicle control during 2 days at 2 sep. locations in spring 2004.  Subjects were evaluated for symptoms of allergic rhinitis (ie, sneezes, runny nose/sniffles, itchy nose, stuffy nose) on the basis of a possible max. score of 32 for the Global Symptom Complex (GSC) scale.  The primary outcome evaluated was the difference in the redn. in GSC (area under the curve over a period of 8 h) from baseline between R112 and vehicle placebo.  Results: At baseline, the combined GSC was ∼18/32 and equal between treatment groups.  After 8 h (dosing 3 mg/nostril every 4 h × 2), R112 significantly reduced the GSC compared with placebo (7 vs 5.4 units, resp.; P = .0005).  Each individual symptom combined to form the GSC was also significantly improved in the R112 group compared with control (P < .05).  As early as 45 min after dosing, R112 showed a significant improvement in symptoms over placebo, and the duration of action exceeded 4 h.  Adverse effects were indistinguishable between the groups and clin. insignificant.  Conclusion: Intranasal R112 was effective in this park study and is a promising new treatment for seasonal allergic rhinitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrit-WK5KqSZbVg90H21EOLACvtfcHk0lgWrzST_yqdqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2isrk%253D&md5=ca5277558c0e72640465916b3a252964</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2005.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2005.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DE.%2BO.%26aulast%3DBerkowitz%26aufirst%3DR.%2BB.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26atitle%3DAn%2520intranasal%2520Syk-kinase%2520inhibitor%2520%2528R112%2529%2520improves%2520the%2520symptoms%2520of%2520seasonal%2520allergic%2520rhinitis%2520in%2520a%2520park%2520environment%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2005%26volume%3D115%26spage%3D791%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikranian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrano-Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-Torres, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straniero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-Gonzales, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span> </span><span class="NLM_article-title">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fart.23992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18975322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3309-3318&author=M.+E.+Weinblattauthor=A.+Kavanaughauthor=R.+Burgos-Vargasauthor=A.+H.+Dikranianauthor=G.+Medrano-Ramirezauthor=J.+L.+Morales-Torresauthor=F.+T.+Murphyauthor=T.+K.+Musserauthor=N.+Stranieroauthor=A.+V.+Vicente-Gonzalesauthor=E.+B.+Grossbard&title=Treatment+of+rheumatoid+arthritis+with+a+Syk+kinase+inhibitor%3A+a+twelve-week%2C+randomized%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span></div><div class="casAuthors">Weinblatt, Michael E.; Kavanaugh, Arthur; Burgos-Vargas, Ruben; Dikranian, Ara H.; Medrano-Ramirez, Gabriel; Morales-Torres, Jorge L.; Murphy, Frederick T.; Musser, Theresa Kane; Straniero, Nicholas; Vicente-Gonzales, Angela V.; Grossbard, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3309-3318</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Spleen tyrosine kinase (Syk) has been identified as an important modulator of immune signaling in B cells and cells bearing Fcγ-activating receptors.  R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinase, active in a variety of in vitro and in vivo models, suggesting potential activity in the treatment of rheumatoid arthritis (RA).  Methods: We enrolled 189 patients with active RA despite methotrexate therapy in a 3-mo, multicenter, ascending-dose, double-blind, placebo-controlled trial.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at week 12.  Results: Twice-daily oral doses of 100 mg and 150 mg of R788 were significantly superior to placebo or twice-daily oral doses of 50 mg at week 12 (ACR20 achieved in 65% and 72% vs. 38% and 32% of patients, resp. [P < 0.01]).  ACR50 (achieved in 49% and 57% vs. 19% and 17% of patients, resp.) and ACR70 (achieved in 33% and 40% vs. 4% and 2% of patients, resp.) scores showed a similar pattern.  Clin. effect was noted as early as 1 wk after initiation of therapy.  Redns. in serum interleukin-6 and matrix metalloproteinase 3 levels also occurred as early as week 1 in the groups receiving 100 mg and 150 mg R788.  The major adverse effects were gastrointestinal side effects (predominantly diarrhea) and neutropenia (<1,500/mm3), both of which were dose related.  Conclusion: These results indicate that an inhibitor of Syk kinase produces significant clin. benefits at 12 wk in a population of patients with active RA receiving methotrexate therapy.  Syk kinase may be an important new therapeutic target in RA and related autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqomUu-KV6uvbVg90H21EOLACvtfcHk0lgWrzST_yqdqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF&md5=a49db998eb1a011d8ae59580f4c868c6</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1002%2Fart.23992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23992%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DDikranian%26aufirst%3DA.%2BH.%26aulast%3DMedrano-Ramirez%26aufirst%3DG.%26aulast%3DMorales-Torres%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DF.%2BT.%26aulast%3DMusser%26aufirst%3DT.%2BK.%26aulast%3DStraniero%26aufirst%3DN.%26aulast%3DVicente-Gonzales%26aufirst%3DA.%2BV.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26atitle%3DTreatment%2520of%2520rheumatoid%2520arthritis%2520with%2520a%2520Syk%2520kinase%2520inhibitor%253A%2520a%2520twelve-week%252C%2520randomized%252C%2520placebo-controlled%2520trial%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3309%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magilavy, D. B.</span><span> </span><span class="NLM_article-title">An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1056%2FNEJMoa1000500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20879879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WqsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1303-1312&author=M.+E.+Weinblattauthor=A.+Kavanaughauthor=M.+C.+Genoveseauthor=T.+K.+Musserauthor=E.+B.+Grossbardauthor=D.+B.+Magilavy&title=An+oral+spleen+tyrosine+kinase+%28Syk%29+inhibitor+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">An oral spleen tyrosine kinase (SyK) inhibitor for rheumatoid arthritis</span></div><div class="casAuthors">Weinblatt, Michael E.; Kavanaugh, Arthur; Genovese, Mark C.; Musser, Theresa K.; Grossbard, Elliott B.; Magilavy, Daniel B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1303-1312</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND  Spleen tyrosine kinase (Syk) is an important modulator of immune signaling.  The objective of this phase 2 study was to evaluate the efficacy and safety of R788, an oral inhibitor of Syk, in patients with active rheumatoid arthritis despite methotrexate therapy.  METHODS  We enrolled 457 patients who had active rheumatoid arthritis despite long-term methotrexate therapy in a 6-mo, double-blind, placebo-controlled trial.  The primary outcome was the American College of Rheumatol. (ACR) 20 response (which indicates at least a 20% redn. in the no. of both tender and swollen joints and improvement in at least three of five other criteria) at month 6.  RESULTS  R788, at a dose of 100 mg twice daily and at a dose of 150 mg once daily, was significantly superior to placebo at month 6 (ACR 20 response rates of 67% and 57%, resp., vs. 35%; P < 0.001 for the comparison of both doses with placebo).  It was also significantly superior with respect to ACR 50, which indicates at least a 50% improvement (43% and 32% vs. 19%; P < 0.001 for the comparison of the 100-mg dose with placebo, P = 0.007 for the comparison of the 150-mg dose with placebo) and ACR70 (28% and 14% vs. 10%; P < 0.001 for the comparison of the 100-mg dose with placebo, P = 0.34 for the comparison of the 150-mg dose with placebo).  A clin. significant effect was noted by the end of the first week of treatment.  Adverse effects included diarrhea (in 19% of subjects taking the 100-mg dose of R788 vs. 3% of those taking placebo), upper respiratory infections (14% vs. 7%), and neutropenia (60/% vs. 1%0/).  R788 was assocd. with an increase in systolic blood pressure of approx. 3 mm Hg between baseline and month 1, as compared with a decrease of 2 mm Hg with placebo; 23% of the patients taking R788 vs. 7% of the patients receiving placebo required the initiation of or a change in antihypertensive therapy.  CONCLUSIONS  In this phase 2 study, a Syk inhibitor reduced disease activity in patients with rheumatoid arthritis; adverse events included diarrhea, hypertension, and neutropenia.  Addnl. studies will be needed to further assess the safety and efficacy of Syk-inhibition therapy in patients with rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv0QGXE3rZiLVg90H21EOLACvtfcHk0lgWrzST_yqdqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WqsLfI&md5=f6da21edb34b0fe9858b6d7bbfd6f0b4</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1000500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1000500%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DMusser%26aufirst%3DT.%2BK.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DMagilavy%26aufirst%3DD.%2BB.%26atitle%3DAn%2520oral%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%2520inhibitor%2520for%2520rheumatoid%2520arthritis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1303%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterfy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicarlo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magilavy, D. B.</span><span> </span><span class="NLM_article-title">An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fart.30114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21279990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVOlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=337-345&author=M.+C.+Genoveseauthor=A.+Kavanaughauthor=M.+E.+Weinblattauthor=C.+Peterfyauthor=J.+Dicarloauthor=M.+L.+Whiteauthor=M.+O%E2%80%99Brienauthor=E.+B.+Grossbardauthor=D.+B.+Magilavy&title=An+oral+Syk+kinase+inhibitor+in+the+treatment+of+rheumatoid+arthritis%3A+a+three-month+randomized%2C+placebo-controlled%2C+phase+II+study+in+patients+with+active+rheumatoid+arthritis+that+did+not+respond+to+biologic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents</span></div><div class="casAuthors">Genovese, Mark C.; Kavanaugh, Arthur; Weinblatt, Michael E.; Peterfy, Charles; DiCarlo, Julie; White, Michael L.; O'Brien, Maryann; Grossbard, Elliott B.; Magilavy, Daniel B.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-345</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To assess the efficacy and safety of R788 (fostamatinib disodium), an inhibitor of spleen tyrosine kinase (Syk), in patients with active rheumatoid arthritis (RA) that did not respond to biol. therapies.  Methods: A total of 219 patients with active RA in whom treatment with biol. agents had failed were enrolled in a 3-mo multicenter, randomized, double-blind, placebo-controlled trial of R788.  The primary end point was the percentage of patients who met the American College of Rheumatol. 20% improvement criteria (achieved an ACR20 response) at month 3.  Secondary end points included changes in inflammation and damage, as assessed by magnetic resonance imaging (MRI), and changes in the Disease Activity Score.  Results: The ACR20 response in the R788 100 mg twice daily group was 38%, vs. 37% in the placebo group, at month 3.  No significant differences were achieved in the ACR20, ACR50, or ACR70 response levels at 3 mo.  There were differences between the groups from baseline to month 3 in the secondary end points C-reactive protein (CRP) level and synovitis score on MRI.  There were baseline differences in steroid use, prior biol. use, and synovitis score on MRI between the R788 group and the placebo group that may have affected the outcomes.  A high placebo response rate was seen in this trial, and exploratory anal. suggested that this may in part have been driven by patients who entered the trial with an elevated erythrocyte sedimentation rate but normal CRP level.  Conclusion: Our findings indicate that there were no differences in the primary end point between the R788 and placebo groups.  Differences were obsd. between the R788 and placebo groups in secondary end points, particularly in those patients who entered the study with an elevated CRP level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSENODg4S987Vg90H21EOLACvtfcHk0lgYb80DnCcCvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVOlu7k%253D&md5=52391a831a7be49f13bdf2014ce2ee56</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1002%2Fart.30114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.30114%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DPeterfy%26aufirst%3DC.%26aulast%3DDicarlo%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DM.%2BL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DMagilavy%26aufirst%3DD.%2BB.%26atitle%3DAn%2520oral%2520Syk%2520kinase%2520inhibitor%2520in%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%253A%2520a%2520three-month%2520randomized%252C%2520placebo-controlled%252C%2520phase%2520II%2520study%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%2520that%2520did%2520not%2520respond%2520to%2520biologic%2520agents%26jtitle%3DArthritis%2520Rheum.%26date%3D2011%26volume%3D63%26spage%3D337%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Crow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siragam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, A. H.</span><span> </span><span class="NLM_article-title">Inhibition of immune thrombocytopenic purpura (ITP) by an orally bioavailable inhibitor of Syk kinase activity</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">612a</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=612a&author=A.+Crowauthor=V.+Siragamauthor=J.+Freedmanauthor=E.+B.+Grossbardauthor=E.+S.+Masudaauthor=P.+Pineauthor=A.+H.+Lazarus&title=Inhibition+of+immune+thrombocytopenic+purpura+%28ITP%29+by+an+orally+bioavailable+inhibitor+of+Syk+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrow%26aufirst%3DA.%26aulast%3DSiragam%26aufirst%3DV.%26aulast%3DFreedman%26aufirst%3DJ.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DLazarus%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520immune%2520thrombocytopenic%2520purpura%2520%2528ITP%2529%2520by%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520Syk%2520kinase%2520activity%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D612a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Singh, R.; Argade, A.; Payan, D. G.; Molineaux, S.; Holland, S. J.; Clough, J.; Keim, H.; Bhamidipati, S.; Sylvain, C.; Li, H.; Rossi, A. B.</span><span> </span><span class="NLM_article-title">2,4-Pyrimidinediamine Compounds and Their Uses</span>. WO2003063794,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=R.+Singh&author=A.+Argade&author=D.+G.+Payan&author=S.+Molineaux&author=S.+J.+Holland&author=J.+Clough&author=H.+Keim&author=S.+Bhamidipati&author=C.+Sylvain&author=H.+Li&author=A.+B.+Rossi&title=2%2C4-Pyrimidinediamine+Compounds+and+Their+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26atitle%3D2%252C4-Pyrimidinediamine%2520Compounds%2520and%2520Their%2520Uses%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Metcalfe, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baram, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekori, Y. A.</span><span> </span><span class="NLM_article-title">Mast cells</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1997&pages=1033-1079&author=D.+D.+Metcalfeauthor=D.+Baramauthor=Y.+A.+Mekori&title=Mast+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetcalfe%26aufirst%3DD.%2BD.%26aulast%3DBaram%26aufirst%3DD.%26aulast%3DMekori%26aufirst%3DY.%2BA.%26atitle%3DMast%2520cells%26jtitle%3DPhysiol.%2520Rev.%26date%3D1997%26volume%3D77%26spage%3D1033%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Clemens, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magness, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lech, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span> </span><span class="NLM_article-title">Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing</span> <span class="citation_source-journal">Birth Defects Res., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fbdra.20505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19107952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFegtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=130-136&author=G.+R.+Clemensauthor=R.+E.+Schroederauthor=S.+H.+Magnessauthor=E.+V.+Weaverauthor=J.+W.+Lechauthor=V.+C.+Taylorauthor=E.+S.+Masudaauthor=M.+Baluomauthor=E.+B.+Grossbard&title=Developmental+toxicity+associated+with+receptor+tyrosine+kinase+Ret+inhibition+in+reproductive+toxicity+testing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing</span></div><div class="casAuthors">Clemens, George R.; Schroeder, Raymond E.; Magness, Steven H.; Weaver, Elizabeth V.; Lech, Joseph W.; Taylor, Vanessa C.; Masuda, Esteban S.; Baluom, Muhammad; Grossbard, Elliott B.</div><div class="citationInfo"><span class="NLM_cas:title">Birth Defects Research, Part A: Clinical and Molecular Teratology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-136</span>CODEN:
                <span class="NLM_cas:coden">BDRPBT</span>;
        ISSN:<span class="NLM_cas:issn">1542-0752</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Urogenital abnormalities are among the most common of all human birth defects.  In developmental toxicity studies with the Syk kinase inhibitor R788, a spectrum of findings, including renal agenesis, were obsd.  R788 was also found to inhibit the receptor tyrosine kinase Ret.  Ret kinase is known to be an essential component in the signaling pathway required for renal organogenesis and ureteric duct formation.  Previously known is that mutant mice without the c-ret gene, develop urogenital malformations including renal agenesis.  In GLP developmental toxicity studies, gravid rabbits were treated orally with R788 at doses of 0, 10, 22, and 50 mg/kg/day (gestation days 7-19) and gravid rats received 0, 5, 12.5, and 25 mg/kg/day (gestation days 6-17) by the same route.  The activity of R406 against Ret kinase was assessed in biochem. and cell-based assays.  A dose-dependent increase in malformations, including renal and ureteric agenesis and a specific major vessel anomaly, retro-esophageal right subclavian artery, was obsd. in both the rat and rabbit.  R788 proved to be a potent inhibitor of Ret kinase.  R788 promoted a spectrum of developmental toxicity, including renal and ureteric agenesis and a specific major vessel abnormality, retro-esophageal right subclavian artery, in 2 different species.  These effects are likely the result of inhibition of Ret kinase given its importance in the normal ontogeny of the urogenital and cardiovascular systems across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkk1lYWlmwebVg90H21EOLACvtfcHk0ljwnT804e9UFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFegtrg%253D&md5=9cd3909537d2d22ce666d1e0e426ec7c</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1002%2Fbdra.20505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdra.20505%26sid%3Dliteratum%253Aachs%26aulast%3DClemens%26aufirst%3DG.%2BR.%26aulast%3DSchroeder%26aufirst%3DR.%2BE.%26aulast%3DMagness%26aufirst%3DS.%2BH.%26aulast%3DWeaver%26aufirst%3DE.%2BV.%26aulast%3DLech%26aufirst%3DJ.%2BW.%26aulast%3DTaylor%26aufirst%3DV.%2BC.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26atitle%3DDevelopmental%2520toxicity%2520associated%2520with%2520receptor%2520tyrosine%2520kinase%2520Ret%2520inhibition%2520in%2520reproductive%2520toxicity%2520testing%26jtitle%3DBirth%2520Defects%2520Res.%252C%2520Part%2520A%26date%3D2009%26volume%3D85%26spage%3D130%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group">Tohyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Complement-mediated phagocytosis: the role of Syk</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=304-308&author=Y.+Tohyamaauthor=H.+Yamamura&title=Complement-mediated+phagocytosis%3A+the+role+of+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTohyama%26aufirst%3DY.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DComplement-mediated%2520phagocytosis%253A%2520the%2520role%2520of%2520Syk%26jtitle%3DIUBMB%2520Life%26date%3D2006%26volume%3D58%26spage%3D304%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group">Tohyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Protein tyrosine kinase, Syk: a key player in phagocytic cells</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1093%2Fjb%2Fmvp001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19124456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFSnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2009&pages=267-273&author=Y.+Tohyamaauthor=H.+Yamamura&title=Protein+tyrosine+kinase%2C+Syk%3A+a+key+player+in+phagocytic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Tyrosine Kinase, Syk: A Key Player in Phagocytic Cells</span></div><div class="casAuthors">Tohyama, Yumi; Yamamura, Hirohei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (Syk) is a non-receptor protein tyrosine kinase expressed in a wide range of hematopoietic cells.  At the initial stage of investigation, main exploring was toward its functions in platelets and in classical immunoreceptor signaling.  However, Syk has now been recognized as a key player in both innate and adaptive immunity.  Esp., in phagocytosis, Syk plays essential roles in signaling evoked by various types of receptors such as FcγR, CR3, Dectin-1 and apoptotic cell-recognizing receptor.  A variety of upstream immunoreceptor tyrosine-based activation motif-like mols. have been found and are still in the course of new studies.  On the contrary, downstream effectors to explain diverse function of Syk are still under exploration.  As its novel function, the authors propose the role of Syk in the regulation of α-tubulin acetylation.  Further investigation on the effectors of Syk would give the authors more information in relation to therapeutic mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wYLlMmR1aLVg90H21EOLACvtfcHk0ljYBFG5ZE6JIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFSnt7w%253D&md5=80a02acd1d395b3fa5ce797db6277d4c</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvp001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvp001%26sid%3Dliteratum%253Aachs%26aulast%3DTohyama%26aufirst%3DY.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DProtein%2520tyrosine%2520kinase%252C%2520Syk%253A%2520a%2520key%2520player%2520in%2520phagocytic%2520cells%26jtitle%3DJ.%2520Biochem.%26date%3D2009%26volume%3D145%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group">Qu, K.</span><span> </span><span class="NLM_article-title">Identification of Pharmacophores from Co-Crystals of Spleen Tyrosine Kinase (SYK) and SYK Ligands</span>. U.S. Patent 7,962,290, June 14,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Qu&title=Identification+of+Pharmacophores+from+Co-Crystals+of+Spleen+Tyrosine+Kinase+%28SYK%29+and+SYK+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520Pharmacophores%2520from%2520Co-Crystals%2520of%2520Spleen%2520Tyrosine%2520Kinase%2520%2528SYK%2529%2520and%2520SYK%2520Ligands%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group">Bhagwat, S. S.</span><span> </span><span class="NLM_article-title">Kinase inhibitor selectivity</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1266</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1266-1268&author=S.+S.+Bhagwat&title=Kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhagwat%26aufirst%3DS.%2BS.%26atitle%3DKinase%2520inhibitor%2520selectivity%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D1266%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Selectivity and therapeutic inhibition of kinases: to be or not to be?</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fni.1701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19295632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlyms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=356-360&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Selectivity+and+therapeutic+inhibition+of+kinases%3A+to+be+or+not+to+be%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity and therapeutic inhibition of kinases: to be or not to be?</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-360</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases, which serve crit. functions in signaling pathways in all cells, are popular therapeutic targets.  At present, eight kinase inhibitors have been approved in the United States, each of which shows nanomolar potency.  Although the initial goal was to generate inhibitors with a high degree of selectivity, recent experience has revealed that many of these approved compds. target more than one kinase.  Surprisingly, this promiscuity is less problematic than one would have imagined; indeed, it opens new therapeutic opportunities.  In this Perspective, we discuss the present status of Janus kinase inhibitors-a new class of immunosuppressive drugs-and the advantages and disadvantages of selectively inhibiting this class of kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU0w6t4jgqirVg90H21EOLACvtfcHk0ljYBFG5ZE6JIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlyms78%253D&md5=64dd47e897181d00e5dce6be3bc5db6e</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1038%2Fni.1701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1701%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DSelectivity%2520and%2520therapeutic%2520inhibition%2520of%2520kinases%253A%2520to%2520be%2520or%2520not%2520to%2520be%253F%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D10%26spage%3D356%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, J.</span><span> </span><span class="NLM_article-title">How were new medicines discovered?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111a','cit111a1'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 55 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Adam G. Schwaid, <span class="NLM_string-name hlFld-ContribAuthor">Kerrie B. Spencer</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for Targeting the NLRP3 Inflammasome in the Clinical and Preclinical Space. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 101-122. <a href="https://doi.org/10.1021/acs.jmedchem.0c01307" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01307%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStrategies%252Bfor%252BTargeting%252Bthe%252BNLRP3%252BInflammasome%252Bin%252Bthe%252BClinical%252Band%252BPreclinical%252BSpace%26aulast%3DSchwaid%26aufirst%3DAdam%2BG.%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D27072020%26date%3D22122020%26volume%3D64%26issue%3D1%26spage%3D101%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Holly Foster, Clare Wilson, Helen Philippou, <span class="NLM_string-name hlFld-ContribAuthor">Richard Foster</span>. </span><span class="cited-content_cbyCitation_article-title">Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12213-12242. <a href="https://doi.org/10.1021/acs.jmedchem.0c00262" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Btoward%252Ba%252BGlycoprotein%252BVI%252BModulator%252Bfor%252Bthe%252BTreatment%252Bof%252BThrombosis%26aulast%3DFoster%26aufirst%3DHolly%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D12022020%26date%3D30062020%26date%3D28052020%26volume%3D63%26issue%3D21%26spage%3D12213%26epage%3D12242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma McInturff, Sarah J. Fink, Christopher J. Helal, Jacob C. DeForest, Peter D. Morse, Subham Mahapatra, <span class="NLM_string-name hlFld-ContribAuthor">Christopher J. O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Approaches to New Drugs Approved during 2018. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10652-10704. <a href="https://doi.org/10.1021/acs.jmedchem.0c00345" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00345</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00345%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252BApproaches%252Bto%252BNew%252BDrugs%252BApproved%252Bduring%252B2018%26aulast%3DFlick%26aufirst%3DAndrew%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D26022020%26date%3D22052020%26date%3D27042020%26volume%3D63%26issue%3D19%26spage%3D10652%26epage%3D10704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marian C. Bryan, <span class="NLM_string-name hlFld-ContribAuthor">Naomi S. Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9030-9058. <a href="https://doi.org/10.1021/acs.jmedchem.8b00667" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00667%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BImmunological%252BDisorders%25253A%252BRecent%252BAdvances%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26042018%26date%3D15062018%26date%3D05062018%26volume%3D61%26issue%3D20%26spage%3D9030%26epage%3D9058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kai Yuan, Lina Liu, Jiayi Chen, Songjin Guo, Hequan Yao, <span class="NLM_string-name hlFld-ContribAuthor">Aijun Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Cascade Heck Cyclization To Access Bisindoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (12)
                                     , 3477-3481. <a href="https://doi.org/10.1021/acs.orglett.8b01235" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01235%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPalladium-Catalyzed%252BCascade%252BHeck%252BCyclization%252BTo%252BAccess%252BBisindoles%26aulast%3DYuan%26aufirst%3DKai%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18042018%26date%3D04062018%26volume%3D20%26issue%3D12%26spage%3D3477%26epage%3D3481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gebhard  Thoma</span>, <span class="hlFld-ContribAuthor ">Alexander B.  Smith</span>, <span class="hlFld-ContribAuthor ">Maurice J.  van Eis</span>, <span class="hlFld-ContribAuthor ">Eric  Vangrevelinghe</span>, <span class="hlFld-ContribAuthor ">Joachim  Blanz</span>, <span class="hlFld-ContribAuthor ">Reiner  Aichholz</span>, <span class="hlFld-ContribAuthor ">Amanda  Littlewood-Evans</span>, <span class="hlFld-ContribAuthor ">Christian C.  Lee</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, and <span class="hlFld-ContribAuthor ">Hans-Günter  Zerwes</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Profiling of a Selective and Efficacious Syk Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (4)
                                     , 1950-1963. <a href="https://doi.org/10.1021/jm5018863" title="DOI URL">https://doi.org/10.1021/jm5018863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5018863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5018863%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BProfiling%252Bof%252Ba%252BSelective%252Band%252BEfficacious%252BSyk%252BInhibitor%26aulast%3DThoma%26aufirst%3DGebhard%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D09022015%26date%3D26022015%26date%3D29012015%26volume%3D58%26issue%3D4%26spage%3D1950%26epage%3D1963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Lou</span>, <span class="hlFld-ContribAuthor ">Xiaochun  Han</span>, <span class="hlFld-ContribAuthor ">Andreas  Kuglstatter</span>, <span class="hlFld-ContribAuthor ">Rama K.  Kondru</span>, <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>, <span class="hlFld-ContribAuthor ">Michael  Soth</span>, <span class="hlFld-ContribAuthor ">Joel  McIntosh</span>, <span class="hlFld-ContribAuthor ">Renee  Litman</span>, <span class="hlFld-ContribAuthor ">Judy  Suh</span>, <span class="hlFld-ContribAuthor ">Buelent  Kocer</span>, <span class="hlFld-ContribAuthor ">Dana  Davis</span>, <span class="hlFld-ContribAuthor ">Jaehyeon  Park</span>, <span class="hlFld-ContribAuthor ">Sandra  Frauchiger</span>, <span class="hlFld-ContribAuthor ">Nolan  Dewdney</span>, <span class="hlFld-ContribAuthor ">Hasim  Zecic</span>, <span class="hlFld-ContribAuthor ">Joshua P.  Taygerly</span>, <span class="hlFld-ContribAuthor ">Keshab  Sarma</span>, <span class="hlFld-ContribAuthor ">Junbae  Hong</span>, <span class="hlFld-ContribAuthor ">Ronald J.  Hill</span>, <span class="hlFld-ContribAuthor ">Tobias  Gabriel</span>, <span class="hlFld-ContribAuthor ">David M.  Goldstein</span>, and <span class="hlFld-ContribAuthor ">Timothy D.  Owens</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Drug Design of RN486, a Potent and Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor, for the Treatment of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (1)
                                     , 512-516. <a href="https://doi.org/10.1021/jm500305p" title="DOI URL">https://doi.org/10.1021/jm500305p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500305p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500305p%26sid%3Dliteratum%253Aachs%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D90%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDrug%252BDesign%252Bof%252BRN486%25252C%252Ba%252BPotent%252Band%252BSelective%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252B%252528BTK%252529%252BInhibitor%25252C%252Bfor%252Bthe%252BTreatment%252Bof%252BRheumatoid%252BArthritis%26aulast%3DLou%26aufirst%3DYan%26date%3D2015%26date%3D2014%26date%3D2014%26date%3D03032014%26date%3D16042014%26date%3D08012015%26date%3D08042014%26volume%3D58%26issue%3D1%26spage%3D512%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin S.  Currie</span>, <span class="hlFld-ContribAuthor ">Jeffrey E.  Kropf</span>, <span class="hlFld-ContribAuthor ">Tony  Lee</span>, <span class="hlFld-ContribAuthor ">Peter  Blomgren</span>, <span class="hlFld-ContribAuthor ">Jianjun  Xu</span>, <span class="hlFld-ContribAuthor ">Zhongdong  Zhao</span>, <span class="hlFld-ContribAuthor ">Steve  Gallion</span>, <span class="hlFld-ContribAuthor ">J. Andrew  Whitney</span>, <span class="hlFld-ContribAuthor ">Deborah  Maclin</span>, <span class="hlFld-ContribAuthor ">Eric B.  Lansdon</span>, <span class="hlFld-ContribAuthor ">Patricia  Maciejewski</span>, <span class="hlFld-ContribAuthor ">Ann Marie  Rossi</span>, <span class="hlFld-ContribAuthor ">Hong  Rong</span>, <span class="hlFld-ContribAuthor ">Jennifer  Macaluso</span>, <span class="hlFld-ContribAuthor ">James  Barbosa</span>, <span class="hlFld-ContribAuthor ">Julie A.  Di Paolo</span>, and <span class="hlFld-ContribAuthor ">Scott A.  Mitchell</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (9)
                                     , 3856-3873. <a href="https://doi.org/10.1021/jm500228a" title="DOI URL">https://doi.org/10.1021/jm500228a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500228a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500228a%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BGS-9973%25252C%252Ba%252BSelective%252Band%252BOrally%252BEfficacious%252BInhibitor%252Bof%252BSpleen%252BTyrosine%252BKinase%26aulast%3DCurrie%26aufirst%3DKevin%2BS.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18022014%26date%3D29042014%26date%3D08052014%26date%3D06042014%26volume%3D57%26issue%3D9%26spage%3D3856%26epage%3D3873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min-Che  Tung</span>, <span class="hlFld-ContribAuthor ">Keng-Chang  Tsai</span>, <span class="hlFld-ContribAuthor ">Kit-Man  Fung</span>, <span class="hlFld-ContribAuthor ">Ming-Jaw  Don</span>, <span class="hlFld-ContribAuthor ">Tien-Sheng  Tseng</span>. </span><span class="cited-content_cbyCitation_article-title">Characterizing the structure–activity relationships of natural products, tanshinones, reveals their mode of action in inhibiting spleen tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (4)
                                     , 2453-2461. <a href="https://doi.org/10.1039/D0RA08769F" title="DOI URL">https://doi.org/10.1039/D0RA08769F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA08769F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA08769F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCharacterizing%252Bthe%252Bstructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bnatural%252Bproducts%25252C%252Btanshinones%25252C%252Breveals%252Btheir%252Bmode%252Bof%252Baction%252Bin%252Binhibiting%252Bspleen%252Btyrosine%252Bkinase%26aulast%3DTung%26aufirst%3DMin-Che%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D4%26spage%3D2453%26epage%3D2461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan-nan  Zhang</span>, <span class="hlFld-ContribAuthor ">Jin-sen  Kang</span>, <span class="hlFld-ContribAuthor ">Shuai-Shuai  Liu</span>, <span class="hlFld-ContribAuthor ">Si-Meng  Gu</span>, <span class="hlFld-ContribAuthor ">Zhi-peng  Song</span>, <span class="hlFld-ContribAuthor ">Feng-xiang  Li</span>, <span class="hlFld-ContribAuthor ">Li-feng  Wang</span>, <span class="hlFld-ContribAuthor ">Lan  Yao</span>, <span class="hlFld-ContribAuthor ">Tian  Li</span>, <span class="hlFld-ContribAuthor ">Lin-lin  Li</span>, <span class="hlFld-ContribAuthor ">Ye  Wang</span>, <span class="hlFld-ContribAuthor ">Xue-jun  Li</span>, <span class="hlFld-ContribAuthor ">Xin-min  Mao</span>. </span><span class="cited-content_cbyCitation_article-title">Flavanomarein inhibits high glucose-stimulated epithelial-mesenchymal transition in HK-2 cells via targeting spleen tyrosine kinase. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-57360-4" title="DOI URL">https://doi.org/10.1038/s41598-019-57360-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-57360-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-57360-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DFlavanomarein%252Binhibits%252Bhigh%252Bglucose-stimulated%252Bepithelial-mesenchymal%252Btransition%252Bin%252BHK-2%252Bcells%252Bvia%252Btargeting%252Bspleen%252Btyrosine%252Bkinase%26aulast%3DZhang%26aufirst%3DNan-nan%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria  Kost-Alimova</span>, <span class="hlFld-ContribAuthor ">Eriene-Heidi  Sidhom</span>, <span class="hlFld-ContribAuthor ">Abhigyan  Satyam</span>, <span class="hlFld-ContribAuthor ">Brian T.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Moran  Dvela-Levitt</span>, <span class="hlFld-ContribAuthor ">Michelle  Melanson</span>, <span class="hlFld-ContribAuthor ">Seth L.  Alper</span>, <span class="hlFld-ContribAuthor ">Jean  Santos</span>, <span class="hlFld-ContribAuthor ">Juan  Gutierrez</span>, <span class="hlFld-ContribAuthor ">Ayshwarya  Subramanian</span>, <span class="hlFld-ContribAuthor ">Patrick J.  Byrne</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Grinkevich</span>, <span class="hlFld-ContribAuthor ">Estefanía  Reyes-Bricio</span>, <span class="hlFld-ContribAuthor ">Choah  Kim</span>, <span class="hlFld-ContribAuthor ">Abbe R.  Clark</span>, <span class="hlFld-ContribAuthor ">Andrew J.B.  Watts</span>, <span class="hlFld-ContribAuthor ">Rebecca  Thompson</span>, <span class="hlFld-ContribAuthor ">Jamie  Marshall</span>, <span class="hlFld-ContribAuthor ">Juan Lorenzo  Pablo</span>, <span class="hlFld-ContribAuthor ">Juliana  Coraor</span>, <span class="hlFld-ContribAuthor ">Julie  Roignot</span>, <span class="hlFld-ContribAuthor ">Katherine A.  Vernon</span>, <span class="hlFld-ContribAuthor ">Keith  Keller</span>, <span class="hlFld-ContribAuthor ">Alissa  Campbell</span>, <span class="hlFld-ContribAuthor ">Maheswarareddy  Emani</span>, <span class="hlFld-ContribAuthor ">Matthew  Racette</span>, <span class="hlFld-ContribAuthor ">Silvana  Bazua-Valenti</span>, <span class="hlFld-ContribAuthor ">Valeria  Padovano</span>, <span class="hlFld-ContribAuthor ">Astrid  Weins</span>, <span class="hlFld-ContribAuthor ">Stephen P.  McAdoo</span>, <span class="hlFld-ContribAuthor ">Frederick W.K.  Tam</span>, <span class="hlFld-ContribAuthor ">Luciene  Ronco</span>, <span class="hlFld-ContribAuthor ">Florence  Wagner</span>, <span class="hlFld-ContribAuthor ">George C.  Tsokos</span>, <span class="hlFld-ContribAuthor ">Jillian L.  Shaw</span>, <span class="hlFld-ContribAuthor ">Anna  Greka</span>. </span><span class="cited-content_cbyCitation_article-title">A High-Content Screen for Mucin-1-Reducing Compounds Identifies Fostamatinib as a Candidate for Rapid Repurposing for Acute Lung Injury. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports Medicine</span><span> <strong>2020,</strong> <em>1 </em>
                                    (8)
                                     , 100137. <a href="https://doi.org/10.1016/j.xcrm.2020.100137" title="DOI URL">https://doi.org/10.1016/j.xcrm.2020.100137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.xcrm.2020.100137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.xcrm.2020.100137%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%2520Medicine%26atitle%3DA%252BHigh-Content%252BScreen%252Bfor%252BMucin-1-Reducing%252BCompounds%252BIdentifies%252BFostamatinib%252Bas%252Ba%252BCandidate%252Bfor%252BRapid%252BRepurposing%252Bfor%252BAcute%252BLung%252BInjury%26aulast%3DKost-Alimova%26aufirst%3DMaria%26date%3D2020%26volume%3D1%26issue%3D8%26spage%3D100137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kelly  Regan-Fendt</span>, <span class="hlFld-ContribAuthor ">Ding  Li</span>, <span class="hlFld-ContribAuthor ">Ryan  Reyes</span>, <span class="hlFld-ContribAuthor ">Lianbo  Yu</span>, <span class="hlFld-ContribAuthor ">Nissar A.  Wani</span>, <span class="hlFld-ContribAuthor ">Peng  Hu</span>, <span class="hlFld-ContribAuthor ">Samson T.  Jacob</span>, <span class="hlFld-ContribAuthor ">Kalpana  Ghoshal</span>, <span class="hlFld-ContribAuthor ">Philip R.O.  Payne</span>, <span class="hlFld-ContribAuthor ">Tasneem  Motiwala</span>. </span><span class="cited-content_cbyCitation_article-title">Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (10)
                                     , 2730. <a href="https://doi.org/10.3390/cancers12102730" title="DOI URL">https://doi.org/10.3390/cancers12102730</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12102730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12102730%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTranscriptomics-Based%252BDrug%252BRepurposing%252BApproach%252BIdentifies%252BNovel%252BDrugs%252Bagainst%252BSorafenib-Resistant%252BHepatocellular%252BCarcinoma%26aulast%3DRegan-Fendt%26aufirst%3DKelly%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D10%26spage%3D2730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giuseppe  Marchetti</span>, <span class="hlFld-ContribAuthor ">Alessandro  Dessì</span>, <span class="hlFld-ContribAuthor ">Roberto  Dallocchio</span>, <span class="hlFld-ContribAuthor ">Ioannis  Tsamesidis</span>, <span class="hlFld-ContribAuthor ">Maria Carmina  Pau</span>, <span class="hlFld-ContribAuthor ">Francesco Michelangelo  Turrini</span>, <span class="hlFld-ContribAuthor ">Antonella  Pantaleo</span>. </span><span class="cited-content_cbyCitation_article-title">Syk Inhibitors: New Computational Insights into Their Intraerythrocytic Action in Plasmodium falciparum Malaria. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (19)
                                     , 7009. <a href="https://doi.org/10.3390/ijms21197009" title="DOI URL">https://doi.org/10.3390/ijms21197009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21197009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21197009%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSyk%252BInhibitors%25253A%252BNew%252BComputational%252BInsights%252Binto%252BTheir%252BIntraerythrocytic%252BAction%252Bin%252BPlasmodium%252Bfalciparum%252BMalaria%26aulast%3DMarchetti%26aufirst%3DGiuseppe%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D19%26spage%3D7009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dhadhang Wahyu  Kurniawan</span>, <span class="hlFld-ContribAuthor ">Gert  Storm</span>, <span class="hlFld-ContribAuthor ">Jai  Prakash</span>, <span class="hlFld-ContribAuthor ">Ruchi  Bansal</span>. </span><span class="cited-content_cbyCitation_article-title">Role of spleen tyrosine kinase in liver diseases. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Gastroenterology</span><span> <strong>2020,</strong> <em>26 </em>
                                    (10)
                                     , 1005-1019. <a href="https://doi.org/10.3748/wjg.v26.i10.1005" title="DOI URL">https://doi.org/10.3748/wjg.v26.i10.1005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3748/wjg.v26.i10.1005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3748%2Fwjg.v26.i10.1005%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Gastroenterology%26atitle%3DRole%252Bof%252Bspleen%252Btyrosine%252Bkinase%252Bin%252Bliver%252Bdiseases%26aulast%3DKurniawan%26aufirst%3DDhadhang%2BWahyu%26date%3D2020%26volume%3D26%26issue%3D10%26spage%3D1005%26epage%3D1019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haibo  Mei</span>, <span class="hlFld-ContribAuthor ">Jianlin  Han</span>, <span class="hlFld-ContribAuthor ">Santos  Fustero</span>, <span class="hlFld-ContribAuthor ">Mercedes  Medio‐Simon</span>, <span class="hlFld-ContribAuthor ">Daniel M.  Sedgwick</span>, <span class="hlFld-ContribAuthor ">Claudio  Santi</span>, <span class="hlFld-ContribAuthor ">Renzo  Ruzziconi</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>. </span><span class="cited-content_cbyCitation_article-title">Fluorine‐Containing Drugs Approved by the FDA in 2018. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (51)
                                     , 11797-11819. <a href="https://doi.org/10.1002/chem.201901840" title="DOI URL">https://doi.org/10.1002/chem.201901840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201901840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201901840%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DFluorine%2525E2%252580%252590Containing%252BDrugs%252BApproved%252Bby%252Bthe%252BFDA%252Bin%252B2018%26aulast%3DMei%26aufirst%3DHaibo%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D51%26spage%3D11797%26epage%3D11819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhixin  Wang</span>, <span class="hlFld-ContribAuthor ">Jingyu  Liu</span>, <span class="hlFld-ContribAuthor ">Xiangjian  Zhong</span>, <span class="hlFld-ContribAuthor ">Jinjie  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Linlin  Ji</span>, <span class="hlFld-ContribAuthor ">Xiaoya  Shang</span>. </span><span class="cited-content_cbyCitation_article-title">Rapid Characterization of Chemical Components in Edible Mushroom Sparassis crispa by UPLC-Orbitrap MS Analysis and Potential Inhibitory Effects on Allergic Rhinitis. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (16)
                                     , 3014. <a href="https://doi.org/10.3390/molecules24163014" title="DOI URL">https://doi.org/10.3390/molecules24163014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24163014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24163014%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRapid%252BCharacterization%252Bof%252BChemical%252BComponents%252Bin%252BEdible%252BMushroom%252BSparassis%252Bcrispa%252Bby%252BUPLC-Orbitrap%252BMS%252BAnalysis%252Band%252BPotential%252BInhibitory%252BEffects%252Bon%252BAllergic%252BRhinitis%26aulast%3DWang%26aufirst%3DZhixin%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D16%26spage%3D3014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yazhou  Wang</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Minhang  Xin</span>, <span class="hlFld-ContribAuthor ">Pan  Chen</span>, <span class="hlFld-ContribAuthor ">Li  Gui</span>, <span class="hlFld-ContribAuthor ">Xinxin  Zhao</span>, <span class="hlFld-ContribAuthor ">Xinrong  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongpeng  Luo</span>, <span class="hlFld-ContribAuthor ">Xin  Cong</span>, <span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Fei  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potent anti-inflammatory 4-(4,5,6,7-tetrahydrofuro[3,2-c]pyridin-2-yl) pyrimidin-2-amines for use as Janus kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (12)
                                     , 2592-2597. <a href="https://doi.org/10.1016/j.bmc.2019.03.048" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.03.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.03.048%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpotent%252Banti-inflammatory%252B4-%2525284%25252C5%25252C6%25252C7-tetrahydrofuro%25255B3%25252C2-c%25255Dpyridin-2-yl%252529%252Bpyrimidin-2-amines%252Bfor%252Buse%252Bas%252BJanus%252Bkinase%252Binhibitors%26aulast%3DWang%26aufirst%3DYazhou%26date%3D2019%26volume%3D27%26issue%3D12%26spage%3D2592%26epage%3D2597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Page  Clemons Bankston</span>, <span class="hlFld-ContribAuthor ">Rami A.  Al-Horani</span>. </span><span class="cited-content_cbyCitation_article-title">New Small Molecule Drugs for Thrombocytopenia: Chemical, Pharmacological, and Therapeutic Use Considerations. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (12)
                                     , 3013. <a href="https://doi.org/10.3390/ijms20123013" title="DOI URL">https://doi.org/10.3390/ijms20123013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20123013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20123013%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DNew%252BSmall%252BMolecule%252BDrugs%252Bfor%252BThrombocytopenia%25253A%252BChemical%25252C%252BPharmacological%25252C%252Band%252BTherapeutic%252BUse%252BConsiderations%26aulast%3DClemons%2BBankston%26aufirst%3DPage%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D12%26spage%3D3013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Suha  Deen</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Storr</span>, <span class="hlFld-ContribAuthor ">Anqi  Yao</span>, <span class="hlFld-ContribAuthor ">Stewart G.  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of Syk and MAP4 proteins in ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Research and Clinical Oncology</span><span> <strong>2019,</strong> <em>145 </em>
                                    (4)
                                     , 909-919. <a href="https://doi.org/10.1007/s00432-019-02856-9" title="DOI URL">https://doi.org/10.1007/s00432-019-02856-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00432-019-02856-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00432-019-02856-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Research%2520and%2520Clinical%2520Oncology%26atitle%3DExpression%252Bof%252BSyk%252Band%252BMAP4%252Bproteins%252Bin%252Bovarian%252Bcancer%26aulast%3DZhang%26aufirst%3DSiwei%26date%3D2019%26date%3D2019%26volume%3D145%26issue%3D4%26spage%3D909%26epage%3D919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjie  Hu</span>, <span class="hlFld-ContribAuthor ">Lin  Wen</span>, <span class="hlFld-ContribAuthor ">Fang  Cao</span>, <span class="hlFld-ContribAuthor ">Yexin  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Down-Regulation of Mir-107 Worsen Spatial Memory by Suppressing SYK Expression and Inactivating NF-ΚB Signaling Pathway. </span><span class="cited-content_cbyCitation_journal-name">Current Alzheimer Research</span><span> <strong>2019,</strong> <em>16 </em>
                                    (2)
                                     , 135-145. <a href="https://doi.org/10.2174/1567205016666181212154347" title="DOI URL">https://doi.org/10.2174/1567205016666181212154347</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1567205016666181212154347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1567205016666181212154347%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Alzheimer%2520Research%26atitle%3DDown-Regulation%252Bof%252BMir-107%252BWorsen%252BSpatial%252BMemory%252Bby%252BSuppressing%252BSYK%252BExpression%252Band%252BInactivating%252BNF-%2525CE%25259AB%252BSignaling%252BPathway%26aulast%3DHu%26aufirst%3DWenjie%26date%3D2019%26volume%3D16%26issue%3D2%26spage%3D135%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel M.  Sedgwick</span>, <span class="hlFld-ContribAuthor ">Raquel  Román</span>, <span class="hlFld-ContribAuthor ">Pablo  Barrio</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Santos  Fustero</span>. </span><span class="cited-content_cbyCitation_article-title">Biorelevant fluorine-containing N-heterocycles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 575-606. <a href="https://doi.org/10.1016/B978-0-12-812733-9.00016-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-812733-9.00016-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-812733-9.00016-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-812733-9.00016-7%26sid%3Dliteratum%253Aachs%26atitle%3DBiorelevant%252Bfluorine-containing%252BN-heterocycles%26aulast%3DSedgwick%26aufirst%3DDaniel%2BM.%26date%3D2019%26spage%3D575%26epage%3D606%26pub%3DElsevier%26atitle%3DFluorine%252Bin%252BLife%252BSciences%25253A%252BPharmaceuticals%25252C%252BMedicinal%252BDiagnostics%25252C%252Band%252BAgrochemicals%26date%3D2019%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiyong  Zhang</span>, <span class="hlFld-ContribAuthor ">Ya  Gao</span>, <span class="hlFld-ContribAuthor ">Ximin  Qiao</span>. </span><span class="cited-content_cbyCitation_article-title">WITHDRAWN: Spleen tyrosine kinase (SYK) protects renal tubular epithelial cell against hypoxia injury in children with acute kidney injury. </span><span class="cited-content_cbyCitation_journal-name">Gene</span><span> <strong>2018,</strong> <em> </em><a href="https://doi.org/10.1016/j.gene.2018.11.013" title="DOI URL">https://doi.org/10.1016/j.gene.2018.11.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gene.2018.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gene.2018.11.013%26sid%3Dliteratum%253Aachs%26jtitle%3DGene%26atitle%3DWITHDRAWN%25253A%252BSpleen%252Btyrosine%252Bkinase%252B%252528SYK%252529%252Bprotects%252Brenal%252Btubular%252Bepithelial%252Bcell%252Bagainst%252Bhypoxia%252Binjury%252Bin%252Bchildren%252Bwith%252Bacute%252Bkidney%252Binjury%26aulast%3DZhang%26aufirst%3DZhiyong%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaokang  Li</span>, <span class="hlFld-ContribAuthor ">Yahui  Huang</span>, <span class="hlFld-ContribAuthor ">Junfei  Cheng</span>, <span class="hlFld-ContribAuthor ">Lingling  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel Syk/PDGFR-α/c-Kit inhibitors as multi-targeting drugs to treat rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (15)
                                     , 4375-4381. <a href="https://doi.org/10.1016/j.bmc.2018.06.029" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.06.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.06.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.06.029%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BSyk%25252FPDGFR-%2525CE%2525B1%25252Fc-Kit%252Binhibitors%252Bas%252Bmulti-targeting%252Bdrugs%252Bto%252Btreat%252Brheumatoid%252Barthritis%26aulast%3DLi%26aufirst%3DXiaokang%26date%3D2018%26volume%3D26%26issue%3D15%26spage%3D4375%26epage%3D4381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dylan E.  Lee</span>, <span class="hlFld-ContribAuthor ">Ashley K.  Clark</span>, <span class="hlFld-ContribAuthor ">Khiem A.  Tran</span>, <span class="hlFld-ContribAuthor ">Vivian Y.  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">New and emerging targeted systemic therapies: a new era for atopic dermatitis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Dermatological Treatment</span><span> <strong>2018,</strong> <em>29 </em>
                                    (4)
                                     , 364-374. <a href="https://doi.org/10.1080/09546634.2017.1373736" title="DOI URL">https://doi.org/10.1080/09546634.2017.1373736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/09546634.2017.1373736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F09546634.2017.1373736%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Dermatological%2520Treatment%26atitle%3DNew%252Band%252Bemerging%252Btargeted%252Bsystemic%252Btherapies%25253A%252Ba%252Bnew%252Bera%252Bfor%252Batopic%252Bdermatitis%26aulast%3DLee%26aufirst%3DDylan%2BE.%26date%3D2018%26date%3D2017%26volume%3D29%26issue%3D4%26spage%3D364%26epage%3D374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Byron B.  Au-Yeung</span>, <span class="hlFld-ContribAuthor ">Neel H.  Shah</span>, <span class="hlFld-ContribAuthor ">Lin  Shen</span>, <span class="hlFld-ContribAuthor ">Arthur  Weiss</span>. </span><span class="cited-content_cbyCitation_article-title">ZAP-70 in Signaling, Biology, and Disease. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Immunology</span><span> <strong>2018,</strong> <em>36 </em>
                                    (1)
                                     , 127-156. <a href="https://doi.org/10.1146/annurev-immunol-042617-053335" title="DOI URL">https://doi.org/10.1146/annurev-immunol-042617-053335</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-immunol-042617-053335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-immunol-042617-053335%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Immunology%26atitle%3DZAP-70%252Bin%252BSignaling%25252C%252BBiology%25252C%252Band%252BDisease%26aulast%3DAu-Yeung%26aufirst%3DByron%2BB.%26date%3D2018%26volume%3D36%26issue%3D1%26spage%3D127%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Drug-target interactions that involve the replacement or displacement of magnesium ions. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (24)
                                     , 5355-5372. <a href="https://doi.org/10.1016/j.bmcl.2017.11.002" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDrug-target%252Binteractions%252Bthat%252Binvolve%252Bthe%252Breplacement%252Bor%252Bdisplacement%252Bof%252Bmagnesium%252Bions%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2017%26volume%3D27%26issue%3D24%26spage%3D5355%26epage%3D5372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Delong  Liu</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Mamorska-Dyga</span>. </span><span class="cited-content_cbyCitation_article-title">Syk inhibitors in clinical development for hematological malignancies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2017,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-017-0512-1" title="DOI URL">https://doi.org/10.1186/s13045-017-0512-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-017-0512-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-017-0512-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DSyk%252Binhibitors%252Bin%252Bclinical%252Bdevelopment%252Bfor%252Bhematological%252Bmalignancies%26aulast%3DLiu%26aufirst%3DDelong%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachit  Badolia</span>, <span class="hlFld-ContribAuthor ">John  Kostyak</span>, <span class="hlFld-ContribAuthor ">Carol  Dangelmaier</span>, <span class="hlFld-ContribAuthor ">Satya  Kunapuli</span>. </span><span class="cited-content_cbyCitation_article-title">Syk Activity Is Dispensable for Platelet GP1b-IX-V Signaling. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2017,</strong> <em>18 </em>
                                    (6)
                                     , 1238. <a href="https://doi.org/10.3390/ijms18061238" title="DOI URL">https://doi.org/10.3390/ijms18061238</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms18061238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms18061238%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DSyk%252BActivity%252BIs%252BDispensable%252Bfor%252BPlatelet%252BGP1b-IX-V%252BSignaling%26aulast%3DBadolia%26aufirst%3DRachit%26date%3D2017%26date%3D2017%26volume%3D18%26issue%3D6%26spage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahui  Huang</span>, <span class="hlFld-ContribAuthor ">Youjun  Zhang</span>, <span class="hlFld-ContribAuthor ">Kexin  Fan</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Bohua  Li</span>, <span class="hlFld-ContribAuthor ">Wannian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new Syk inhibitors through structure-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (8)
                                     , 1776-1779. <a href="https://doi.org/10.1016/j.bmcl.2017.02.060" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnew%252BSyk%252Binhibitors%252Bthrough%252Bstructure-based%252Bvirtual%252Bscreening%26aulast%3DHuang%26aufirst%3DYahui%26date%3D2017%26volume%3D27%26issue%3D8%26spage%3D1776%26epage%3D1779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiayi  Shen</span>, <span class="hlFld-ContribAuthor ">Xiaokai  Li</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jingfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Huoyou  Long</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhou</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">3-aminopyrazolopyrazine derivatives as spleen tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2016,</strong> <em>88 </em>
                                    (5)
                                     , 690-698. <a href="https://doi.org/10.1111/cbdd.12798" title="DOI URL">https://doi.org/10.1111/cbdd.12798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12798%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3D3-aminopyrazolopyrazine%252Bderivatives%252Bas%252Bspleen%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DShen%26aufirst%3DJiayi%26date%3D2016%26date%3D2016%26volume%3D88%26issue%3D5%26spage%3D690%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sang Jae  Lee</span>, <span class="hlFld-ContribAuthor ">Jang-Sik  Choi</span>, <span class="hlFld-ContribAuthor ">Byeong-Gu  Han</span>, <span class="hlFld-ContribAuthor ">Hyoun Sook  Kim</span>, <span class="hlFld-ContribAuthor ">Ho-Juhn  Song</span>, <span class="hlFld-ContribAuthor ">Jaekyoo  Lee</span>, <span class="hlFld-ContribAuthor ">Seungyoon  Nam</span>, <span class="hlFld-ContribAuthor ">Sung-Ho  Goh</span>, <span class="hlFld-ContribAuthor ">Jung-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Jong Sung  Koh</span>, <span class="hlFld-ContribAuthor ">Byung Il  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal structures of spleen tyrosine kinase in complex with novel inhibitors: structural insights for design of anticancer drugs. </span><span class="cited-content_cbyCitation_journal-name">The FEBS Journal</span><span> <strong>2016,</strong> <em>283 </em>
                                    (19)
                                     , 3613-3625. <a href="https://doi.org/10.1111/febs.13831" title="DOI URL">https://doi.org/10.1111/febs.13831</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/febs.13831&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Ffebs.13831%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520FEBS%2520Journal%26atitle%3DCrystal%252Bstructures%252Bof%252Bspleen%252Btyrosine%252Bkinase%252Bin%252Bcomplex%252Bwith%252Bnovel%252Binhibitors%25253A%252Bstructural%252Binsights%252Bfor%252Bdesign%252Bof%252Banticancer%252Bdrugs%26aulast%3DLee%26aufirst%3DSang%2BJae%26date%3D2016%26date%3D2016%26volume%3D283%26issue%3D19%26spage%3D3613%26epage%3D3625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. J.  Lamb</span>, <span class="hlFld-ContribAuthor ">S. L.  Wollin</span>, <span class="hlFld-ContribAuthor ">A.  Schnapp</span>, <span class="hlFld-ContribAuthor ">D.  Bischoff</span>, <span class="hlFld-ContribAuthor ">K. J.  Erb</span>, <span class="hlFld-ContribAuthor ">T.  Bouyssou</span>, <span class="hlFld-ContribAuthor ">B.  Guilliard</span>, <span class="hlFld-ContribAuthor ">C.  Strasser</span>, <span class="hlFld-ContribAuthor ">E.  Wex</span>, <span class="hlFld-ContribAuthor ">S.  Blum</span>, <span class="hlFld-ContribAuthor ">E.  Thaler</span>, <span class="hlFld-ContribAuthor ">H.  Nickel</span>, <span class="hlFld-ContribAuthor ">O.  Radmacher</span>, <span class="hlFld-ContribAuthor ">H.  Haas</span>, <span class="hlFld-ContribAuthor ">J. L.  Swantek</span>, <span class="hlFld-ContribAuthor ">D.  Souza</span>, <span class="hlFld-ContribAuthor ">M.  Canfield</span>, <span class="hlFld-ContribAuthor ">D.  White</span>, <span class="hlFld-ContribAuthor ">M.  Panzenbeck</span>, <span class="hlFld-ContribAuthor ">M. A.  Kashem</span>, <span class="hlFld-ContribAuthor ">M.  Sanville-Ross</span>, <span class="hlFld-ContribAuthor ">T.  Kono</span>, <span class="hlFld-ContribAuthor ">K.  Sewald</span>, <span class="hlFld-ContribAuthor ">A.  Braun</span>, <span class="hlFld-ContribAuthor ">H.  Obernolte</span>, <span class="hlFld-ContribAuthor ">O.  Danov</span>, <span class="hlFld-ContribAuthor ">G.  Schaenzle</span>, <span class="hlFld-ContribAuthor ">G.  Rast</span>, <span class="hlFld-ContribAuthor ">G.-M.  Maier</span>, <span class="hlFld-ContribAuthor ">M.  Hoffmann</span>. </span><span class="cited-content_cbyCitation_article-title">BI 1002494, a Novel Potent and Selective Oral Spleen Tyrosine Kinase Inhibitor, Displays Differential Potency in Human Basophils and B Cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacology and Experimental Therapeutics</span><span> <strong>2016,</strong> <em>357 </em>
                                    (3)
                                     , 554-561. <a href="https://doi.org/10.1124/jpet.116.233155" title="DOI URL">https://doi.org/10.1124/jpet.116.233155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/jpet.116.233155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fjpet.116.233155%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacology%2520and%2520Experimental%2520Therapeutics%26atitle%3DBI%252B1002494%25252C%252Ba%252BNovel%252BPotent%252Band%252BSelective%252BOral%252BSpleen%252BTyrosine%252BKinase%252BInhibitor%25252C%252BDisplays%252BDifferential%252BPotency%252Bin%252BHuman%252BBasophils%252Band%252BB%252BCells%26aulast%3DLamb%26aufirst%3DD.%2BJ.%26date%3D2016%26date%3D2016%26volume%3D357%26issue%3D3%26spage%3D554%26epage%3D561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory D.  Ferguson</span>, <span class="hlFld-ContribAuthor ">Mercedes  Delgado</span>, <span class="hlFld-ContribAuthor ">Veronique  Plantevin-Krenitsky</span>, <span class="hlFld-ContribAuthor ">Kristen  Jensen-Pergakes</span>, <span class="hlFld-ContribAuthor ">R. J.  Bates</span>, <span class="hlFld-ContribAuthor ">Sanaa  Torres</span>, <span class="hlFld-ContribAuthor ">Maria  Celeridad</span>, <span class="hlFld-ContribAuthor ">Heather  Brown</span>, <span class="hlFld-ContribAuthor ">Kelven  Burnett</span>, <span class="hlFld-ContribAuthor ">Lisa  Nadolny</span>, <span class="hlFld-ContribAuthor ">Lida  Tehrani</span>, <span class="hlFld-ContribAuthor ">Garrick  Packard</span>, <span class="hlFld-ContribAuthor ">Barbra  Pagarigan</span>, <span class="hlFld-ContribAuthor ">Jason  Haelewyn</span>, <span class="hlFld-ContribAuthor ">Trish  Nguyen</span>, <span class="hlFld-ContribAuthor ">Li  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Tang</span>, <span class="hlFld-ContribAuthor ">Matthew  Hickman</span>, <span class="hlFld-ContribAuthor ">Frans  Baculi</span>, <span class="hlFld-ContribAuthor ">Steven  Pierce</span>, <span class="hlFld-ContribAuthor ">Keiji  Miyazawa</span>, <span class="hlFld-ContribAuthor ">Pilgrim  Jackson</span>, <span class="hlFld-ContribAuthor ">Philip  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Laurie  LeBrun</span>, <span class="hlFld-ContribAuthor ">Weilin  Xie</span>, <span class="hlFld-ContribAuthor ">Brydon  Bennett</span>, <span class="hlFld-ContribAuthor ">Kate  Blease</span>, . </span><span class="cited-content_cbyCitation_article-title">A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (1)
                                     , e0145705. <a href="https://doi.org/10.1371/journal.pone.0145705" title="DOI URL">https://doi.org/10.1371/journal.pone.0145705</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0145705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0145705%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DA%252BNovel%252BTriazolopyridine-Based%252BSpleen%252BTyrosine%252BKinase%252BInhibitor%252BThat%252BArrests%252BJoint%252BInflammation%26aulast%3DFerguson%26aufirst%3DGregory%2BD.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D1%26spage%3De0145705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael G.  Rolf</span>, <span class="hlFld-ContribAuthor ">Jon O.  Curwen</span>, <span class="hlFld-ContribAuthor ">Margaret  Veldman‐Jones</span>, <span class="hlFld-ContribAuthor ">Cath  Eberlein</span>, <span class="hlFld-ContribAuthor ">Jianyan  Wang</span>, <span class="hlFld-ContribAuthor ">Alex  Harmer</span>, <span class="hlFld-ContribAuthor ">Caroline J.  Hellawell</span>, <span class="hlFld-ContribAuthor ">Martin  Braddock</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2015,</strong> <em>3 </em>
                                    (5)
                                     <a href="https://doi.org/10.1002/prp2.175" title="DOI URL">https://doi.org/10.1002/prp2.175</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.175&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.175%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DIn%252Bvitro%252Bpharmacological%252Bprofiling%252Bof%252BR406%252Bidentifies%252Bmolecular%252Btargets%252Bunderlying%252Bthe%252Bclinical%252Beffects%252Bof%252Bfostamatinib%26aulast%3DRolf%26aufirst%3DMichael%2BG.%26date%3D2015%26date%3D2015%26volume%3D3%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jang-Sik  Choi</span>, <span class="hlFld-ContribAuthor ">Hae-jun  Hwang</span>, <span class="hlFld-ContribAuthor ">Se-Won  Kim</span>, <span class="hlFld-ContribAuthor ">Byung Il  Lee</span>, <span class="hlFld-ContribAuthor ">Jaekyoo  Lee</span>, <span class="hlFld-ContribAuthor ">Ho-Juhn  Song</span>, <span class="hlFld-ContribAuthor ">Jong Sung  Koh</span>, <span class="hlFld-ContribAuthor ">Jung-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Phil Ho  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Highly potent and selective pyrazolylpyrimidines as Syk kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4441-4446. <a href="https://doi.org/10.1016/j.bmcl.2015.09.011" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHighly%252Bpotent%252Band%252Bselective%252Bpyrazolylpyrimidines%252Bas%252BSyk%252Bkinase%252Binhibitors%26aulast%3DChoi%26aufirst%3DJang-Sik%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4441%26epage%3D4446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gebhard  Thoma</span>, <span class="hlFld-ContribAuthor ">Siem  Veenstra</span>, <span class="hlFld-ContribAuthor ">Ross  Strang</span>, <span class="hlFld-ContribAuthor ">Joachim  Blanz</span>, <span class="hlFld-ContribAuthor ">Eric  Vangrevelinghe</span>, <span class="hlFld-ContribAuthor ">Jörg  Berghausen</span>, <span class="hlFld-ContribAuthor ">Christian C.  Lee</span>, <span class="hlFld-ContribAuthor ">Hans-Günter  Zerwes</span>. </span><span class="cited-content_cbyCitation_article-title">Orally bioavailable Syk inhibitors with activity in a rat PK/PD model. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4642-4647. <a href="https://doi.org/10.1016/j.bmcl.2015.08.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.08.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.08.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOrally%252Bbioavailable%252BSyk%252Binhibitors%252Bwith%252Bactivity%252Bin%252Ba%252Brat%252BPK%25252FPD%252Bmodel%26aulast%3DThoma%26aufirst%3DGebhard%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4642%26epage%3D4647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Isabel  Ramis</span>, <span class="hlFld-ContribAuthor ">Raquel  Otal</span>, <span class="hlFld-ContribAuthor ">Cristina  Carreño</span>, <span class="hlFld-ContribAuthor ">Anna  Domènech</span>, <span class="hlFld-ContribAuthor ">Peter  Eichhorn</span>, <span class="hlFld-ContribAuthor ">Adelina  Orellana</span>, <span class="hlFld-ContribAuthor ">Mónica  Maldonado</span>, <span class="hlFld-ContribAuthor ">Jorge  De Alba</span>, <span class="hlFld-ContribAuthor ">Neus  Prats</span>, <span class="hlFld-ContribAuthor ">Joan-Carles  Fernández</span>, <span class="hlFld-ContribAuthor ">Bernat  Vidal</span>, <span class="hlFld-ContribAuthor ">Montserrat  Miralpeix</span>. </span><span class="cited-content_cbyCitation_article-title">A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2015,</strong> <em>99 </em>, 116-124. <a href="https://doi.org/10.1016/j.phrs.2015.05.011" title="DOI URL">https://doi.org/10.1016/j.phrs.2015.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2015.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2015.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DA%252Bnovel%252Binhaled%252BSyk%252Binhibitor%252Bblocks%252Bmast%252Bcell%252Bdegranulation%252Band%252Bearly%252Basthmatic%252Bresponse%26aulast%3DRamis%26aufirst%3DIsabel%26date%3D2015%26volume%3D99%26spage%3D116%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Glossop</span>, <span class="hlFld-ContribAuthor ">Gavin  Whitlock</span>, <span class="hlFld-ContribAuthor ">Karl  Gibson</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule anti-inflammatory drug compositions for the treatment of asthma: a patent review (2013 – 2014). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (7)
                                     , 743-754. <a href="https://doi.org/10.1517/13543776.2015.1041923" title="DOI URL">https://doi.org/10.1517/13543776.2015.1041923</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1041923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1041923%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252Banti-inflammatory%252Bdrug%252Bcompositions%252Bfor%252Bthe%252Btreatment%252Bof%252Basthma%25253A%252Ba%252Bpatent%252Breview%252B%2525282013%252B%2525E2%252580%252593%252B2014%252529%26aulast%3DGlossop%26aufirst%3DPaul%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D743%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingling  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Fei  Mao</span>, <span class="hlFld-ContribAuthor ">Jin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guoqiang  Dong</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Chunquan  Sheng</span>, <span class="hlFld-ContribAuthor ">Liyan  Miao</span>, <span class="hlFld-ContribAuthor ">Lixin  Huang</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Benzylidene Derivatives as Potent Syk Inhibitors: Synthesis, SAR Analysis, and Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2015,</strong> <em>348 </em>
                                    (7)
                                     , 463-474. <a href="https://doi.org/10.1002/ardp.201500096" title="DOI URL">https://doi.org/10.1002/ardp.201500096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201500096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201500096%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDiscovery%252Bof%252BBenzylidene%252BDerivatives%252Bas%252BPotent%252BSyk%252BInhibitors%25253A%252BSynthesis%25252C%252BSAR%252BAnalysis%25252C%252Band%252BBiological%252BEvaluation%26aulast%3DZhang%26aufirst%3DLingling%26date%3D2015%26date%3D2015%26volume%3D348%26issue%3D7%26spage%3D463%26epage%3D474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankush  Argade</span>, <span class="hlFld-ContribAuthor ">Somasekhar  Bhamidipati</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">Catherine  Sylvain</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Clough</span>, <span class="hlFld-ContribAuthor ">David  Carroll</span>, <span class="hlFld-ContribAuthor ">Holger  Keim</span>, <span class="hlFld-ContribAuthor ">Sylvia  Braselmann</span>, <span class="hlFld-ContribAuthor ">Vanessa  Taylor</span>, <span class="hlFld-ContribAuthor ">Haoran  Zhao</span>, <span class="hlFld-ContribAuthor ">Ellen  Herlaar</span>, <span class="hlFld-ContribAuthor ">Sarkiz D.  Issakani</span>, <span class="hlFld-ContribAuthor ">Brian R.  Wong</span>, <span class="hlFld-ContribAuthor ">Esteban S.  Masuda</span>, <span class="hlFld-ContribAuthor ">Donald G.  Payan</span>, <span class="hlFld-ContribAuthor ">Rajinder  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis of diaminopyrimidine inhibitors targeting IgE- and IgG-mediated activation of Fc receptor signaling. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (10)
                                     , 2122-2128. <a href="https://doi.org/10.1016/j.bmcl.2015.03.072" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.072%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Bof%252Bdiaminopyrimidine%252Binhibitors%252Btargeting%252BIgE-%252Band%252BIgG-mediated%252Bactivation%252Bof%252BFc%252Breceptor%252Bsignaling%26aulast%3DArgade%26aufirst%3DAnkush%26date%3D2015%26volume%3D25%26issue%3D10%26spage%3D2122%26epage%3D2128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ankush  Argade</span>, <span class="hlFld-ContribAuthor ">Somasekhar  Bhamidipati</span>, <span class="hlFld-ContribAuthor ">Hui  Li</span>, <span class="hlFld-ContribAuthor ">David  Carroll</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Clough</span>, <span class="hlFld-ContribAuthor ">Holger  Keim</span>, <span class="hlFld-ContribAuthor ">Catherine  Sylvain</span>, <span class="hlFld-ContribAuthor ">Alexander B.  Rossi</span>, <span class="hlFld-ContribAuthor ">Christina  Coquilla</span>, <span class="hlFld-ContribAuthor ">Sarkiz D.  Issakani</span>, <span class="hlFld-ContribAuthor ">Esteban S.  Masuda</span>, <span class="hlFld-ContribAuthor ">Donald G.  Payan</span>, <span class="hlFld-ContribAuthor ">Rajinder  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Application of cultured human mast cells (CHMC) for the design and structure–activity relationship of IgE-mediated mast cell activation inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (10)
                                     , 2117-2121. <a href="https://doi.org/10.1016/j.bmcl.2015.03.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.03.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.03.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.03.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DApplication%252Bof%252Bcultured%252Bhuman%252Bmast%252Bcells%252B%252528CHMC%252529%252Bfor%252Bthe%252Bdesign%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252BIgE-mediated%252Bmast%252Bcell%252Bactivation%252Binhibitors%26aulast%3DArgade%26aufirst%3DAnkush%26date%3D2015%26volume%3D25%26issue%3D10%26spage%3D2117%26epage%3D2121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leonid I.  Belen'kii</span>, <span class="hlFld-ContribAuthor ">Yu B.  Evdokimenkova</span>. </span><span class="cited-content_cbyCitation_article-title">The Literature of Heterocyclic Chemistry, Part XIII, 2012–2013. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 193-363. <a href="https://doi.org/10.1016/bs.aihch.2015.04.002" title="DOI URL">https://doi.org/10.1016/bs.aihch.2015.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2015.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2015.04.002%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BLiterature%252Bof%252BHeterocyclic%252BChemistry%25252C%252BPart%252BXIII%25252C%252B2012%2525E2%252580%2525932013%26aulast%3DBelen%2527kii%26aufirst%3DLeonid%2BI.%26date%3D2015%26spage%3D193%26epage%3D363%26pub%3DElsevier%26date%3D2015%26volume%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleanor M.  Pritchard</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Stewart</span>, <span class="hlFld-ContribAuthor ">Fangyi  Zhu</span>, <span class="hlFld-ContribAuthor ">Cori  Bradley</span>, <span class="hlFld-ContribAuthor ">Lyra  Griffiths</span>, <span class="hlFld-ContribAuthor ">Lei  Yang</span>, <span class="hlFld-ContribAuthor ">Praveen Kumar  Suryadevara</span>, <span class="hlFld-ContribAuthor ">Jiakun  Zhang</span>, <span class="hlFld-ContribAuthor ">Burgess B.  Freeman</span>, <span class="hlFld-ContribAuthor ">R. Kiplin  Guy</span>, <span class="hlFld-ContribAuthor ">Michael A.  Dyer</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetics and Efficacy of the Spleen Tyrosine Kinase Inhibitor R406 after Ocular Delivery for Retinoblastoma. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Research</span><span> <strong>2014,</strong> <em>31 </em>
                                    (11)
                                     , 3060-3072. <a href="https://doi.org/10.1007/s11095-014-1399-y" title="DOI URL">https://doi.org/10.1007/s11095-014-1399-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11095-014-1399-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11095-014-1399-y%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Research%26atitle%3DPharmacokinetics%252Band%252BEfficacy%252Bof%252Bthe%252BSpleen%252BTyrosine%252BKinase%252BInhibitor%252BR406%252Bafter%252BOcular%252BDelivery%252Bfor%252BRetinoblastoma%26aulast%3DPritchard%26aufirst%3DEleanor%2BM.%26date%3D2014%26date%3D2014%26volume%3D31%26issue%3D11%26spage%3D3060%26epage%3D3072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew C  Lucas</span>, <span class="hlFld-ContribAuthor ">Seng-Lai  Tan</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (16)
                                     , 1811-1827. <a href="https://doi.org/10.4155/fmc.14.126" title="DOI URL">https://doi.org/10.4155/fmc.14.126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.126%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSmall-molecule%252Binhibitors%252Bof%252Bspleen%252Btyrosine%252Bkinase%252Bas%252Btherapeutic%252Bagents%252Bfor%252Bimmune%252Bdisorders%25253A%252Bwill%252Bpromise%252Bmeet%252Bexpectations%25253F%26aulast%3DLucas%26aufirst%3DMatthew%2BC%26date%3D2014%26volume%3D6%26issue%3D16%26spage%3D1811%26epage%3D1827" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Jiang</span>, <span class="hlFld-ContribAuthor ">Renping  Liu</span>, <span class="hlFld-ContribAuthor ">Ying  Chen</span>, <span class="hlFld-ContribAuthor ">Qisheng  Zheng</span>, <span class="hlFld-ContribAuthor ">Saijun  Fan</span>, <span class="hlFld-ContribAuthor ">Peixun  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A Combined Experimental and Computational Study of Vam3, a Derivative of Resveratrol, and Syk Interaction. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2014,</strong> <em>15 </em>
                                    (9)
                                     , 17188-17203. <a href="https://doi.org/10.3390/ijms150917188" title="DOI URL">https://doi.org/10.3390/ijms150917188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms150917188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms150917188%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DA%252BCombined%252BExperimental%252Band%252BComputational%252BStudy%252Bof%252BVam3%25252C%252Ba%252BDerivative%252Bof%252BResveratrol%25252C%252Band%252BSyk%252BInteraction%26aulast%3DJiang%26aufirst%3DMing%26date%3D2014%26date%3D2014%26volume%3D15%26issue%3D9%26spage%3D17188%26epage%3D17203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gebhard  Thoma</span>, <span class="hlFld-ContribAuthor ">Joachim  Blanz</span>, <span class="hlFld-ContribAuthor ">Peter  Bühlmayer</span>, <span class="hlFld-ContribAuthor ">Peter  Drückes</span>, <span class="hlFld-ContribAuthor ">Matthias  Kittelmann</span>, <span class="hlFld-ContribAuthor ">Alexander B.  Smith</span>, <span class="hlFld-ContribAuthor ">Maurice  van Eis</span>, <span class="hlFld-ContribAuthor ">Eric  Vangrevelinghe</span>, <span class="hlFld-ContribAuthor ">Hans-Günter  Zerwes</span>, <span class="hlFld-ContribAuthor ">Jianwei (John)  Che</span>, <span class="hlFld-ContribAuthor ">Xiaohui  He</span>, <span class="hlFld-ContribAuthor ">Yunho  Jin</span>, <span class="hlFld-ContribAuthor ">Christian C.  Lee</span>, <span class="hlFld-ContribAuthor ">Pierre-Yves  Michellys</span>, <span class="hlFld-ContribAuthor ">Tetsuo  Uno</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Syk inhibitors with high potency in presence of blood. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (10)
                                     , 2278-2282. <a href="https://doi.org/10.1016/j.bmcl.2014.03.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.03.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.03.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.03.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSyk%252Binhibitors%252Bwith%252Bhigh%252Bpotency%252Bin%252Bpresence%252Bof%252Bblood%26aulast%3DThoma%26aufirst%3DGebhard%26date%3D2014%26volume%3D24%26issue%3D10%26spage%3D2278%26epage%3D2282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen  L. Berg</span>, <span class="hlFld-ContribAuthor ">Yu-Chih  Hsu</span>, <span class="hlFld-ContribAuthor ">Jonathan A.  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Consideration of the cellular microenvironment: Physiologically relevant co-culture systems in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2014,</strong> <em>69-70 </em>, 190-204. <a href="https://doi.org/10.1016/j.addr.2014.01.013" title="DOI URL">https://doi.org/10.1016/j.addr.2014.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2014.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2014.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DConsideration%252Bof%252Bthe%252Bcellular%252Bmicroenvironment%25253A%252BPhysiologically%252Brelevant%252Bco-culture%252Bsystems%252Bin%252Bdrug%252Bdiscovery%26aulast%3DL.%2BBerg%26aufirst%3DEllen%26date%3D2014%26volume%3D69-70%26spage%3D190%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongtao  Zhao</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of dual ZAP70 and Syk kinases inhibitors by docking into a rare C-helix-out conformation of Syk. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (6)
                                     , 1523-1527. <a href="https://doi.org/10.1016/j.bmcl.2014.01.083" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.01.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.01.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.01.083%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bdual%252BZAP70%252Band%252BSyk%252Bkinases%252Binhibitors%252Bby%252Bdocking%252Binto%252Ba%252Brare%252BC-helix-out%252Bconformation%252Bof%252BSyk%26aulast%3DZhao%26aufirst%3DHongtao%26date%3D2014%26volume%3D24%26issue%3D6%26spage%3D1523%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Mortlock</span>, <span class="hlFld-ContribAuthor ">K.  Foote</span>, <span class="hlFld-ContribAuthor ">J.  Kettle</span>, <span class="hlFld-ContribAuthor ">B.  Aquila</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors in Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11033-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11033-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11033-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11033-9%26sid%3Dliteratum%253Aachs%26atitle%3DKinase%252BInhibitors%252Bin%252BCancer%26aulast%3DMortlock%26aufirst%3DA.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014%26volume%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chuan-Li  Ren</span>, <span class="hlFld-ContribAuthor ">Tao  Zhang</span>, <span class="hlFld-ContribAuthor ">Xing-Yong  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Wu</span>, <span class="hlFld-ContribAuthor ">Jing  Ma</span>, <span class="hlFld-ContribAuthor ">Qing-Qing  Xuan</span>, <span class="hlFld-ContribAuthor ">Feng  Wei</span>, <span class="hlFld-ContribAuthor ">Hong-Yan  Huang</span>, <span class="hlFld-ContribAuthor ">Dong  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Highly enantioselective reaction of 2-oxindoles with (3-indolyl)methanols by cooperative Catalysis of a Lewis acid and organocatalyst. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2014,</strong> <em>12 </em>
                                    (48)
                                     , 9881-9886. <a href="https://doi.org/10.1039/C4OB02035A" title="DOI URL">https://doi.org/10.1039/C4OB02035A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4OB02035A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4OB02035A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DHighly%252Benantioselective%252Breaction%252Bof%252B2-oxindoles%252Bwith%252B%2525283-indolyl%252529methanols%252Bby%252Bcooperative%252BCatalysis%252Bof%252Ba%252BLewis%252Bacid%252Band%252Borganocatalyst%26aulast%3DRen%26aufirst%3DChuan-Li%26date%3D2014%26date%3D2014%26volume%3D12%26issue%3D48%26spage%3D9881%26epage%3D9886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongtao  Zhao</span>, <span class="hlFld-ContribAuthor ">Amedeo  Caflisch</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of ZAP70 inhibitors by high-throughput docking into a conformation of its kinase domain generated by molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (20)
                                     , 5721-5726. <a href="https://doi.org/10.1016/j.bmcl.2013.08.009" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BZAP70%252Binhibitors%252Bby%252Bhigh-throughput%252Bdocking%252Binto%252Ba%252Bconformation%252Bof%252Bits%252Bkinase%252Bdomain%252Bgenerated%252Bby%252Bmolecular%252Bdynamics%26aulast%3DZhao%26aufirst%3DHongtao%26date%3D2013%26volume%3D23%26issue%3D20%26spage%3D5721%26epage%3D5726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yinghong  Gao</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Davies</span>, <span class="hlFld-ContribAuthor ">Martin  Augustin</span>, <span class="hlFld-ContribAuthor ">Anna  Woodward</span>, <span class="hlFld-ContribAuthor ">Umesh A.  Patel</span>, <span class="hlFld-ContribAuthor ">Robert  Kovelman</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Harvey</span>. </span><span class="cited-content_cbyCitation_article-title">A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2013,</strong> <em>451 </em>
                                    (2)
                                     , 313-328. <a href="https://doi.org/10.1042/BJ20121418" title="DOI URL">https://doi.org/10.1042/BJ20121418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BJ20121418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBJ20121418%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DA%252Bbroad%252Bactivity%252Bscreen%252Bin%252Bsupport%252Bof%252Ba%252Bchemogenomic%252Bmap%252Bfor%252Bkinase%252Bsignalling%252Bresearch%252Band%252Bdrug%252Bdiscovery%26aulast%3DGao%26aufirst%3DYinghong%26date%3D2013%26date%3D2013%26volume%3D451%26issue%3D2%26spage%3D313%26epage%3D328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulrich  Grädler</span>, <span class="hlFld-ContribAuthor ">Daniel  Schwarz</span>, <span class="hlFld-ContribAuthor ">Verena  Dresing</span>, <span class="hlFld-ContribAuthor ">Djordje  Musil</span>, <span class="hlFld-ContribAuthor ">Jörg  Bomke</span>, <span class="hlFld-ContribAuthor ">Matthias  Frech</span>, <span class="hlFld-ContribAuthor ">Hartmut  Greiner</span>, <span class="hlFld-ContribAuthor ">Stefan  Jäkel</span>, <span class="hlFld-ContribAuthor ">Thomas  Rysiok</span>, <span class="hlFld-ContribAuthor ">Dirk  Müller-Pompalla</span>, <span class="hlFld-ContribAuthor ">Ansgar  Wegener</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and Biophysical Characterization of the Syk Activation Switch. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2013,</strong> <em>425 </em>
                                    (2)
                                     , 309-333. <a href="https://doi.org/10.1016/j.jmb.2012.11.007" title="DOI URL">https://doi.org/10.1016/j.jmb.2012.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2012.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2012.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DStructural%252Band%252BBiophysical%252BCharacterization%252Bof%252Bthe%252BSyk%252BActivation%252BSwitch%26aulast%3DGr%25C3%25A4dler%26aufirst%3DUlrich%26date%3D2013%26volume%3D425%26issue%3D2%26spage%3D309%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Bamborough</span>. </span><span class="cited-content_cbyCitation_article-title">System-based drug discovery within the human kinome. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2012,</strong> <em>7 </em>
                                    (11)
                                     , 1053-1070. <a href="https://doi.org/10.1517/17460441.2012.724056" title="DOI URL">https://doi.org/10.1517/17460441.2012.724056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2012.724056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2012.724056%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DSystem-based%252Bdrug%252Bdiscovery%252Bwithin%252Bthe%252Bhuman%252Bkinome%26aulast%3DBamborough%26aufirst%3DPaul%26date%3D2012%26date%3D2012%26volume%3D7%26issue%3D11%26spage%3D1053%26epage%3D1070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcos  Castillo</span>, <span class="hlFld-ContribAuthor ">Pilar  Forns</span>, <span class="hlFld-ContribAuthor ">Montse  Erra</span>, <span class="hlFld-ContribAuthor ">Marta  Mir</span>, <span class="hlFld-ContribAuthor ">Manel  López</span>, <span class="hlFld-ContribAuthor ">Mónica  Maldonado</span>, <span class="hlFld-ContribAuthor ">Adelina  Orellana</span>, <span class="hlFld-ContribAuthor ">Cristina  Carreño</span>, <span class="hlFld-ContribAuthor ">Isabel  Ramis</span>, <span class="hlFld-ContribAuthor ">Montserrat  Miralpeix</span>, <span class="hlFld-ContribAuthor ">Bernat  Vidal</span>. </span><span class="cited-content_cbyCitation_article-title">Highly potent aminopyridines as Syk kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (17)
                                     , 5419-5423. <a href="https://doi.org/10.1016/j.bmcl.2012.07.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.07.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.07.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.07.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHighly%252Bpotent%252Baminopyridines%252Bas%252BSyk%252Bkinase%252Binhibitors%26aulast%3DCastillo%26aufirst%3DMarcos%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5419%26epage%3D5423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structural sequence of SYK kinase. SYK is composed of tandem N-SH2 and C-SH2 domains, separated by interdomain-A and interdomain-B (activation loop) leads to kinase catalytic domain. The sites on SYK involved in phosphorylation through trans- and autophosphorylation, leading to activation and substrate docking and regulation of kinase activity, are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. SYK in ITAM receptor signaling in multiple hematopoietic cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) SYK kinase is maintained in an inactive conformation, which entails the N-SH2 and C-SH2, along with C-terminus blocking access to the kinase ATP pocket. (b) Activation can be initiated through ITAM binding to the dual SH2 domains of SYK, resulting in conformational change and access to the kinase ATP pocket opening. Release from ITAM following phosphorylation of tyrosine residues (not shown) on SYK leaves the kinase in fully activated form.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of SYK kinase inhibitors <b>2</b>–<b>10</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Cocrystal image of compounds <b>3</b> (green), <b>4</b> (orange), and <b>5</b> (purple). (b) Cocrystal image of compound <b>3</b>. (c) Cocrystal image of compounds <b>6</b> (orange) and <b>7</b> (green) and overlap with docked compound <b>8</b> (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cocrystal image of compound <b>9</b> (green) and overlap with docked compound <b>10</b> (purple).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Conversion of methylene phosphate prodrug <b>11</b> to biologically active parent compound <b>3</b>. The conversion is catalyzed by the action of alkaline phosphatases present on the apical brush-border of the membranes of the intestinal enterocytes.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Structures of SYK inhibitors <b>12</b>, <b>28</b>, <b>83</b> and compound <b>13</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Cocrystal image of compound <b>9</b> (green) and docked compound <b>70</b> (purple) in SYK. In contrast to enantiomer <b>9</b>, hydroxyl group on enantiomer <b>70</b> is facing away from ASP512.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of SYK inhibitors <b>84</b> and <b>85</b> and HTS hit <b>86</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/medium/jm-2011-01271b_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cocrystal image of compounds <b>3</b> (green), <b>84</b> (purple), and <b>85</b> (yellow). Compound <b>84</b> shows hydrogen bonds with hinge residues ALA451 and GLU452 but no hydrogen bonds with ASP512 and LYS458. In contrast to compound <b>84</b>, compound <b>3</b> has hydrogen bonds with hinge ALA451, GLU452 and ASP512, LYS458 residues. Compound <b>85</b> forms hydrogen bonds with hinge ALA451, GLU452. Difluorobenzoxazinone ring also forms a hydrogen bond with ASP512, and the carbonyl moiety from the phenoxyacetamide side chain interacts with LYS458.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-8/jm201271b/production/images/large/jm-2011-01271b_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201271b&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i30">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 209 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Zioncheck, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Purification and characterization of a protein-tyrosine kinase from bovine thymus</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">261</span><span class="NLM_x">, </span> <span class="NLM_fpage">15637</span><span class="NLM_x">–</span> <span class="NLM_lpage">15643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=261&publication_year=1986&pages=15637-15643&author=T.+F.+Zioncheckauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Purification+and+characterization+of+a+protein-tyrosine+kinase+from+bovine+thymus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZioncheck%26aufirst%3DT.%2BF.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DPurification%2520and%2520characterization%2520of%2520a%2520protein-tyrosine%2520kinase%2520from%2520bovine%2520thymus%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1986%26volume%3D261%26spage%3D15637%26epage%3D15643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Zioncheck, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Generation of an active protein-tyrosine kinase from lymphocytes by proteolysis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">19195</span><span class="NLM_x">–</span> <span class="NLM_lpage">19202</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1988&pages=19195-19202&author=T.+F.+Zioncheckauthor=M.+L.+Harrisonauthor=C.+C.+Isaacsonauthor=R.+L.+Geahlen&title=Generation+of+an+active+protein-tyrosine+kinase+from+lymphocytes+by+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZioncheck%26aufirst%3DT.%2BF.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DIsaacson%26aufirst%3DC.%2BC.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DGeneration%2520of%2520an%2520active%2520protein-tyrosine%2520kinase%2520from%2520lymphocytes%2520by%2520proteolysis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1988%26volume%3D263%26spage%3D19195%26epage%3D19202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Sakai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Characterization of partially purified cytosolic protein-tyrosine kinase from porcine spleen</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">1123</span><span class="NLM_x">–</span> <span class="NLM_lpage">1130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1988&pages=1123-1130&author=K.+Sakaiauthor=S.+Nakamuraauthor=K.+Sadaauthor=T.+Kobayashiauthor=H.+Unoauthor=H.+Yamamura&title=Characterization+of+partially+purified+cytosolic+protein-tyrosine+kinase+from+porcine+spleen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DSada%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DUno%26aufirst%3DH.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520partially%2520purified%2520cytosolic%2520protein-tyrosine%2520kinase%2520from%2520porcine%2520spleen%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1988%26volume%3D152%26spage%3D1123%26epage%3D1130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Purification and characterization of a cytosolic protein-tyrosine kinase from porcine spleen</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">188</span><span class="NLM_x">, </span> <span class="NLM_fpage">535</span><span class="NLM_x">–</span> <span class="NLM_lpage">540</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1432-1033.1990.tb15433.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=2331984" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK3cXhslCmsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=1990&pages=535-540&author=T.+Kobayashiauthor=S.+Nakamuraauthor=T.+Taniguchiauthor=H.+Yamamura&title=Purification+and+characterization+of+a+cytosolic+protein-tyrosine+kinase+from+porcine+spleen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of a cytosolic protein-tyrosine kinase from porcine spleen</span></div><div class="casAuthors">Kobayashi, Tomoko; Nakamura, Shunichi; Taniguchi, Takanobu; Yamamura, Hirohei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">535-40</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">A cytosolic protein-tyrosine kinase was highly purified from porcine spleen using [Val5]angiotensin II as a substrate.  The purifn. procedure involves sequential column chromatogs. on phosphocellulose, Sephacryl S-200, casein-Sepharose 4B, heparin-Sepharose CL-6B, and anti-(4-aminobenzyl phosphonic acid)-Sepharose 4B.  Anal. of the most highly purified prepn. by SDS/PAGE revealed a major Ag-stained band of mol. mass 40 kDa.  The 40-kDa cytosolic protein-tyrosine kinase was purified ∼10,000-fold with an overall yield of ∼7%.  It had autophosphorylation activity which was carried out by intramol. catalysis.  The stoichiometry of phosphate incorporation was ∼1 mol phosphate/mol enzyme.  In the autophosphorylation reaction, the apparent Km for ATP was relatively low, 0.35 μM; Mn2+ was slightly preferred to Mg2+ as divalent cation.  [Val5]angiotensin II phosphorylation activity of the 40-kDa kinase increased with the amt. of phosphate incorporated into the enzyme.  A phosphate exchange reaction was obsd. during the autophosphorylation.  Apparently, the 40-kDa kinase described here is a different type of protein-tyrosine kinase than the enzymes so far reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLxkMWu0JEy7Vg90H21EOLACvtfcHk0lgfLtJX4sXIeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhslCmsbg%253D&md5=d469bff4aea3dbe07f6c29d7a3ecc4b4</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1990.tb15433.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1990.tb15433.x%26sid%3Dliteratum%253Aachs%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DPurification%2520and%2520characterization%2520of%2520a%2520cytosolic%2520protein-tyrosine%2520kinase%2520from%2520porcine%2520spleen%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1990%26volume%3D188%26spage%3D535%26epage%3D540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Molecular cloning of a porcine gene <i>SYK</i> that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">266</span><span class="NLM_x">, </span> <span class="NLM_fpage">15790</span><span class="NLM_x">–</span> <span class="NLM_lpage">15796</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=266&publication_year=1991&pages=15790-15796&author=T.+Taniguchiauthor=T.+Kobayashiauthor=J.+Kondoauthor=K.+Takahashiauthor=H.+Nakamuraauthor=J.+Suzukiauthor=K+Nagaiauthor=T.+Yamadaauthor=S.+Nakamuraauthor=H.+Yamamura&title=Molecular+cloning+of+a+porcine+gene+SYK+that+encodes+a+72-kDa+protein-tyrosine+kinase+showing+high+susceptibility+to+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DKondo%26aufirst%3DJ.%26aulast%3DTakahashi%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DJ.%26aulast%3DNagai%26aufirst%3DK%26aulast%3DYamada%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520porcine%2520gene%2520SYK%2520that%2520encodes%2520a%252072-kDa%2520protein-tyrosine%2520kinase%2520showing%2520high%2520susceptibility%2520to%2520proteolysis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1991%26volume%3D266%26spage%3D15790%26epage%3D15796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Geahlen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burg, D. L.</span><span> </span><span class="NLM_article-title">The role of SYK in cell signaling</span> <span class="citation_source-journal">Adv. Exp. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">365</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=365&publication_year=1994&pages=103-109&author=R.+L.+Geahlenauthor=D.+L.+Burg&title=The+role+of+SYK+in+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26aulast%3DBurg%26aufirst%3DD.%2BL.%26atitle%3DThe%2520role%2520of%2520SYK%2520in%2520cell%2520signaling%26jtitle%3DAdv.%2520Exp.%2520Med.%2520Biol.%26date%3D1994%26volume%3D365%26spage%3D103%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Brunati, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donella-Deana, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruzzene, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, L. A.</span><span> </span><span class="NLM_article-title">Site specificity of p72<sup><i>syk</i></sup> protein tyrosine kinase: efficient phosphorylation of motifs recognized by Src homology 2 domains of the Src family</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">367</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=367&publication_year=1995&pages=149-152&author=A.+M.+Brunatiauthor=A.+Donella-Deanaauthor=M.+Ruzzeneauthor=O.+Marinauthor=L.+A.+Pinna&title=Site+specificity+of+p72syk+protein+tyrosine+kinase%3A+efficient+phosphorylation+of+motifs+recognized+by+Src+homology+2+domains+of+the+Src+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrunati%26aufirst%3DA.%2BM.%26aulast%3DDonella-Deana%26aufirst%3DA.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DSite%2520specificity%2520of%2520p72syk%2520protein%2520tyrosine%2520kinase%253A%2520efficient%2520phosphorylation%2520of%2520motifs%2520recognized%2520by%2520Src%2520homology%25202%2520domains%2520of%2520the%2520Src%2520family%26jtitle%3DFEBS%2520Lett.%26date%3D1995%26volume%3D367%26spage%3D149%26epage%3D152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Purification and characterization of a protein-tyrosine kinase p72<sup><i>syk</i></sup> from porcine spleen</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1432-1033.1994.tb18813.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=8181480" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK2cXkt12lurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=1994&pages=973-978&author=C.+Yangauthor=S.+Yanagiauthor=X.+Wangauthor=K.+Sakaiauthor=T.+Taniguchiauthor=H.+Yamamura&title=Purification+and+characterization+of+a+protein-tyrosine+kinase+p72syk+from+porcine+spleen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Purification and characterization of a protein-tyrosine kinase p72syk from porcine spleen</span></div><div class="casAuthors">Yang, Cheng; Yanagi, Shigeru; Wang, Xiaoying; Sakai, Keiko; Taniguchi, Takanobu; Yamamura, Hirohei</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">973-8</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">The authors have succeeded in purifying p72syk, a non-receptor-type protein-tyrosine kinase carrying high susceptibility to proteolysis [Taniguchi, T., Kobayashi, T., Kondo, J., Takahashi, K., Nakamura, H., Suzuki, J., Nagai, K., Yamada, T., Nakamura, S. and Yamamura, H. (1991) J. Biol. Chem. 266, 15790-15796] from porcine spleen.  The purifn. procedure involves a sequential column chromatog., following extn. with 0.5 M NaCl from spleen homogenate, on phosphocellulose, Sephacryl S-200, heparin-Sepharose CL-6B, Mono Q and Mono S.  SDS/PAGE of the final purified sample revealed a 72-Da protein band with about 95% purity and immunodepletion anal. showed immunol. cross-reactivity with anti-p72syk antibody which does not recognize ZAP-70.  It was purified approx. 3000-fold with an overall yield of 0.54% according to [Val5]angiotensin II phosphorylation activity and the specific activity of the final sample (30nmol phosphate min-1·mg protein-1) was relatively lower than that of the 40-kDa kinase, catalytic fragment f p72syk which lacks two src homol. regions 2 domains.  The p72syk had an autophosphorylation activity that was performed by intramol. catalysis accompanied by a phosphate exchange reaction, and could efficiently phosphorylate tubulin, myelin basic protein and H2B histone.  Employing [Val5]angiotensin II as a substrate, the apparent Km value for the peptide was 0.91 mM and that for ATP was 0.48 μM.  Mn2+, Mg2+ and Co2+ were effective divalent cations and optimum pH was around 8.0-8.5 for the expression of the activity.  These results suggest that the purified p 72syk may exist as a less active form compared with the 40-kDa kinase and that the part of p72syk contg. two src homol. region 2 domains may participate in the regulation of its activity through the enzyme character is quite similar to that of the 40-kDa kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjL-MWyEbC7rVg90H21EOLACvtfcHk0ljhu5Ntc22lFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt12lurg%253D&md5=9fb487a7a11c3a43eeab24541141dd7d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1994.tb18813.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1994.tb18813.x%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%26aulast%3DYanagi%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSakai%26aufirst%3DK.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DPurification%2520and%2520characterization%2520of%2520a%2520protein-tyrosine%2520kinase%2520p72syk%2520from%2520porcine%2520spleen%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1994%26volume%3D221%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L.</span><span> </span><span class="NLM_article-title">Tyrosine kinase SYK: essential functions for immunoreceptor signalling</span> <span class="citation_source-journal">Immunol. Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0167-5699%2899%2901574-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10689303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFOju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=148-154&author=M.+Turnerauthor=E.+Schweighofferauthor=F.+Colucciauthor=J.+P.+Di+Santoauthor=V.+L.+Tybulewicz&title=Tyrosine+kinase+SYK%3A+essential+functions+for+immunoreceptor+signalling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinase SYK: essential functions for immunoreceptor signaling</span></div><div class="casAuthors">Turner, M.; Schweighoffer, E.; Colucci, F.; Di Santo, J. P.; Tybulewicz, V. L.</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Today</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">148-154</span>CODEN:
                <span class="NLM_cas:coden">IMTOD8</span>;
        ISSN:<span class="NLM_cas:issn">0167-4919</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 54 refs.  The tyrosine kinase SYK plays crit. roles in signaling through immune receptors.  Gene-targeting studies have identified the cell types that require SYK for development and function, and the receptors that use SYK as well as their downstream signaling effectors.  There is also evidence of a role for SYK in non-immune cells and in the maintenance of vascular integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZlinILlIox7Vg90H21EOLACvtfcHk0ljhu5Ntc22lFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFOju7g%253D&md5=8eebc20afd9de9e2bae1894f9c90b40f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2FS0167-5699%2899%2901574-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0167-5699%252899%252901574-1%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DSchweighoffer%26aufirst%3DE.%26aulast%3DColucci%26aufirst%3DF.%26aulast%3DDi%2BSanto%26aufirst%3DJ.%2BP.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%26atitle%3DTyrosine%2520kinase%2520SYK%253A%2520essential%2520functions%2520for%2520immunoreceptor%2520signalling%26jtitle%3DImmunol.%2520Today%26date%3D2000%26volume%3D21%26spage%3D148%26epage%3D154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Wong, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">Targeting Syk as a treatment for allergic and autoimmune disorders</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">743</span><span class="NLM_x">–</span> <span class="NLM_lpage">762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2004&pages=743-762&author=B.+R.+Wongauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+S.+Masuda&title=Targeting+Syk+as+a+treatment+for+allergic+and+autoimmune+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DB.%2BR.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DTargeting%2520Syk%2520as%2520a%2520treatment%2520for%2520allergic%2520and%2520autoimmune%2520disorders%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D13%26spage%3D743%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Mócsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruland, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J.</span><span> </span><span class="NLM_article-title">The SYK tyrosine kinase: a crucial player in diverse biological functions</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">402</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20467426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvFOkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=387-402&author=A.+M%C3%B3csaiauthor=J.+Rulandauthor=V.+L.+J.+Tybulewicz&title=The+SYK+tyrosine+kinase%3A+a+crucial+player+in+diverse+biological+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The SYK tyrosine kinase: a crucial player in diverse biological functions</span></div><div class="casAuthors">Mocsai, Attila; Ruland, Jurgen; Tybulewicz, Victor L. J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">387-402</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (SYK) is known to have a crucial role in adaptive immune receptor signalling.  However, recent reports indicate that SYK also mediates other, unexpectedly diverse biol. functions, including cellular adhesion, innate immune recognition, osteoclast maturation, platelet activation and vascular development.  SYK is activated by C-type lectins and integrins, and activates new targets, including the CARD9-BCL-10-MALT1 pathway and the NLRP3 inflammasome.  Studies using Drosophila melanogaster suggest that there is an evolutionarily ancient origin of SYK-mediated signalling.  Moreover, SYK has a crucial role in autoimmune diseases and haematol. malignancies.  This Review summarizes our current understanding of the diverse functions of SYK and how this is being translated for therapeutic purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3YO5BcMqrf7Vg90H21EOLACvtfcHk0lhdxnXQUjGNVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvFOkurk%253D&md5=85857a2b9beb84e0fe74263a90fa8a53</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnri2765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2765%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ.%26atitle%3DThe%2520SYK%2520tyrosine%2520kinase%253A%2520a%2520crucial%2520player%2520in%2520diverse%2520biological%2520functions%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2010%26volume%3D10%26spage%3D387%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase (Syk) biology, inhibitors and therapeutic applications</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">379</span><span class="NLM_x">–</span> <span class="NLM_lpage">391</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=379-391&author=R.+Singhauthor=E.+S.+Masuda&title=Spleen+tyrosine+kinase+%28Syk%29+biology%2C+inhibitors+and+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DSpleen%2520tyrosine%2520kinase%2520%2528Syk%2529%2520biology%252C%2520inhibitors%2520and%2520therapeutic%2520applications%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D379%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Riccaboni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrillo, P.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinases: biology, therapeutic targets and drugs</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">530</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.drudis.2010.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20553955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXosVKjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=517-530&author=M.+Riccaboniauthor=I.+Bianchiauthor=P.+Petrillo&title=Spleen+tyrosine+kinases%3A+biology%2C+therapeutic+targets+and+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Spleen tyrosine kinases: biology, therapeutic targets and drugs</span></div><div class="casAuthors">Riccaboni, Mauro; Bianchi, Ivana; Petrillo, Paola</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">13/14</span>),
    <span class="NLM_cas:pages">517-530</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (Syk) is an intriguing protein tyrosine kinase involved in signal transduction in a variety of cell types, and its aberrant regulation is assocd. with different allergic disorders and antibody-mediated autoimmune diseases such as rheumatoid arthritis, asthma and allergic rhinitis.  Syk also plays an important part in the uncontrolled growth of tumor cells, particularly B cells.  For these reasons, Syk is considered one of the most interesting biol. targets of the last decade, as proved by the great no. of papers and patents published, and the possibility of treating these pathologies by means of Syk kinase inhibitors has led to a great interest from the pharmaceutical and biotech industry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqimmbpqDWfbVg90H21EOLACvtfcHk0lhh0v_7rbhkxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXosVKjurg%253D&md5=77def570415a150b4ea728ec12144710</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DRiccaboni%26aufirst%3DM.%26aulast%3DBianchi%26aufirst%3DI.%26aulast%3DPetrillo%26aufirst%3DP.%26atitle%3DSpleen%2520tyrosine%2520kinases%253A%2520biology%252C%2520therapeutic%2520targets%2520and%2520drugs%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D517%26epage%3D530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Ruzza, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biondi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderan, A.</span><span> </span><span class="NLM_article-title">Therapeutic prospect of Syk inhibitors</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1376</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1517%2F13543770903207039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19670961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFyhtLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1361-1376&author=P.+Ruzzaauthor=B.+Biondiauthor=A.+Calderan&title=Therapeutic+prospect+of+Syk+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic prospect of Syk inhibitors</span></div><div class="casAuthors">Ruzza, Paolo; Biondi, Barbara; Calderan, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1361-1376</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: The non-receptor spleen tyrosine kinase (Syk; EC 2.7.10.2) is involved in signal transduction in a variety of cell types.  In particular, it is a key mediator of immune receptors signaling in host inflammatory cells (B cells, mast cells, macrophages and neutrophils), important for both allergic and antibody-mediated autoimmune diseases.  Deregulated Syk kinase activity also allows growth factor-independent proliferation and transforms bone marrow-derived pre-B cells that are able to induce leukemia.  Consequently, the development of Syk kinase inhibitors could conceivably treat these disorders and so they have became a major focus in the pharmaceutical and biotech industry.  Objective: In this review, we analyze the structure and role of Syk kinase, the use of small mols., interacting with ATP-binding site, as inhibitors of kinase activity and finally the potential of using inhibitors of Syk kinase expression to attenuate pathol. conditions.  Conclusion: Syk kinase inhibition is suggested as a powerful tool for the therapy of different pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq5SKC7HVACbVg90H21EOLACvtfcHk0lhh0v_7rbhkxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFyhtLfJ&md5=19295f5d8164e52ccfe8d79bd10175d9</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1517%2F13543770903207039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903207039%26sid%3Dliteratum%253Aachs%26aulast%3DRuzza%26aufirst%3DP.%26aulast%3DBiondi%26aufirst%3DB.%26aulast%3DCalderan%26aufirst%3DA.%26atitle%3DTherapeutic%2520prospect%2520of%2520Syk%2520inhibitors%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D1361%26epage%3D1376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Denyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V.</span><span> </span><span class="NLM_article-title">Syk kinase inhibitors in allergic diseases</span> <span class="citation_source-journal">Drug News Perspect.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">146</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1358%2Fdnp.2009.22.3.1354124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19440557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnvVOmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=146-150&author=J.+Denyerauthor=V.+Patel&title=Syk+kinase+inhibitors+in+allergic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Sky kinase inhibitors in allergic diseases</span></div><div class="casAuthors">Denyer, Jane; Patel, Vipul</div><div class="citationInfo"><span class="NLM_cas:title">Drug News & Perspectives</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">146-150</span>CODEN:
                <span class="NLM_cas:coden">DNPEED</span>;
        ISSN:<span class="NLM_cas:issn">0214-0934</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Recent advances in the understanding of allergic mechanisms have highlighted the role of IgE signaling in the mast cell.  One of the most important kinases in the IgE signaling pathway is spleen tyrosine kinase (Syk) which has a crit. function early in the signaling cascade following binding of allergen to receptor bound IgE on the mast cell.  A no. of Syk inhibitors have now been developed which have been shown to effectively inhibit IgE-driven mast cell degranulation and release of inflammatory cytokines in vitro and inhibit allergic responses in a variety of in vivo models.  In humans, allergen-driven symptoms were reduced in allergic rhinitis patients exposed to tree pollen in an outdoor environment following intranasal dosing of the Syk inhibitor R-112.  Syk therefore represents a promising target for therapeutic intervention in allergic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4432yAMdRCbVg90H21EOLACvtfcHk0lhh0v_7rbhkxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnvVOmt7k%253D&md5=dd088a5051c3b3db64eee4ce8d963541</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1358%2Fdnp.2009.22.3.1354124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdnp.2009.22.3.1354124%26sid%3Dliteratum%253Aachs%26aulast%3DDenyer%26aufirst%3DJ.%26aulast%3DPatel%26aufirst%3DV.%26atitle%3DSyk%2520kinase%2520inhibitors%2520in%2520allergic%2520diseases%26jtitle%3DDrug%2520News%2520Perspect.%26date%3D2009%26volume%3D22%26spage%3D146%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bajpai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dastidar, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, A.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase: a novel target for therapeutic intervention of rheumatoid arthritis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">659</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=641-659&author=M.+Bajpaiauthor=P.+Chopraauthor=S.+G.+Dastidarauthor=A.+Ray&title=Spleen+tyrosine+kinase%3A+a+novel+target+for+therapeutic+intervention+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBajpai%26aufirst%3DM.%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DDastidar%26aufirst%3DS.%2BG.%26aulast%3DRay%26aufirst%3DA.%26atitle%3DSpleen%2520tyrosine%2520kinase%253A%2520a%2520novel%2520target%2520for%2520therapeutic%2520intervention%2520of%2520rheumatoid%2520arthritis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D641%26epage%3D659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Moore, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorarensen, A.</span><span> </span><span class="NLM_article-title">An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1703</span><span class="NLM_x">–</span> <span class="NLM_lpage">1722</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1517%2F13543776.2010.534459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21073366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1703-1722&author=W.+J.+Mooreauthor=D.+Richardauthor=A.+Thorarensen&title=An+analysis+of+the+diaminopyrimidine+patent+estates+describing+spleen+tyrosine+kinase+inhibitors+by+Rigel+and+Portola"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">An analysis of the diaminopyrimidine patent estates describing spleen tyrosine kinase inhibitors by Rigel and Portola</span></div><div class="casAuthors">Moore, William J.; Richard, David; Thorarensen, Atli</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1703-1722</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Discovery of small mol. inhibitors for treatment of rheumatoid arthritis is a major ongoing effort within the pharmaceutical industry.  Spleen tyrosine kinase (SYK) is one of the leading small mol. targets with regard to clin. developments due to the efforts of Rigel and Portola.Areas covered in this review: Diaminopyrimidines are one of the most prominent structural elements incorporated into the design of kinase inhibitors.  This review provides an extensive overview of the patent estates for the leading discovery programs at Portola and Rigel on diaminopyrimidines and how their patent estates are in relationship with the competition and prior art.What the reader will gain: An overview of the patent landscape for diaminopyrimidines.  In addn., the reader will be updated on what modifications in these scaffolds lead to very potent SYK inhibitors as judged by the applications.  Finally, the authors will provide their best guess on what the structure is of Portola's recently announced clin. candidate.Take home message: The Rigel and the Portola research organizations have filed a series of patent applications on diaminopyrimidines as inhibitors of SYK.  The scope of these applications is broad in a crowded chem. space.  These applications contain very broad claims and the future will tell how much of the generic space claimed will be allowed in granted patents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7wp-QGiNYmrVg90H21EOLACvtfcHk0lhOrf6FyPvmww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bJ&md5=a594fee4a53660d83042531aaf569eaf</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.534459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.534459%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DRichard%26aufirst%3DD.%26aulast%3DThorarensen%26aufirst%3DA.%26atitle%3DAn%2520analysis%2520of%2520the%2520diaminopyrimidine%2520patent%2520estates%2520describing%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520by%2520Rigel%2520and%2520Portola%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1703%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Duta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulanova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puttagunta, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musat-Marcu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrod, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhoff, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Befus, A. D.</span><span> </span><span class="NLM_article-title">Differential expression of spleen tyrosine kinase Syk isoforms in tissues: effects of the microbial flora</span> <span class="citation_source-journal">Histochem. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">495</span><span class="NLM_x">–</span> <span class="NLM_lpage">505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1007%2Fs00418-006-0188-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16708245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVart78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2006&pages=495-505&author=F.+Dutaauthor=M.+Ulanovaauthor=D.+Seidelauthor=L.+Puttaguntaauthor=S.+Musat-Marcuauthor=K.+S.+Harrodauthor=A.+D.+Schreiberauthor=U.+Steinhoffauthor=A.+D.+Befus&title=Differential+expression+of+spleen+tyrosine+kinase+Syk+isoforms+in+tissues%3A+effects+of+the+microbial+flora"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora</span></div><div class="casAuthors">Duta, Florentina; Ulanova, Marina; Seidel, Daniel; Puttagunta, Lakshmi; Musat-Marcu, Sorin; Harrod, Kevin S.; Schreiber, Alan D.; Steinhoff, Ulrich; Befus, A. Dean</div><div class="citationInfo"><span class="NLM_cas:title">Histochemistry and Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">495-505</span>CODEN:
                <span class="NLM_cas:coden">HCBIFP</span>;
        ISSN:<span class="NLM_cas:issn">0948-6143</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is expressed widely in hematopoietic and non-hematopoietic cells.  The widespread distribution of Syk and its involvement in host defense and allergic reactions, prompted us analyze the influence of microbial exposure on Syk expression.  We compared the distribution of Syk in various tissues of germ-free and conventional mice using immunohistochem., Western blot anal. and real time RT-PCR.  Total Syk expression was similar between germ-free and conventional mice.  Since it was claimed that Syk isoforms are differentially expressed, we studied the distribution and abundance of Syk (L) and Syk (S) isoforms in tissues from these mice.  In contrast to previous reports, we found broad tissue expression of Syk (S).  Interestingly, in germ-free mice the amt. of Syk (S) but not Syk L protein was selectively increased in lung and spleen.  In summary, our study reveals new and broad tissue expression of both Syk isoforms and demonstrates that lack of microbial flora results in selectively increased expression of Syk (S) isoform in lung and spleen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8ojD6rYkMlrVg90H21EOLACvtfcHk0lhOrf6FyPvmww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVart78%253D&md5=f9d0539d1cc1aed5f9456b42c47a42c4</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00418-006-0188-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00418-006-0188-z%26sid%3Dliteratum%253Aachs%26aulast%3DDuta%26aufirst%3DF.%26aulast%3DUlanova%26aufirst%3DM.%26aulast%3DSeidel%26aufirst%3DD.%26aulast%3DPuttagunta%26aufirst%3DL.%26aulast%3DMusat-Marcu%26aufirst%3DS.%26aulast%3DHarrod%26aufirst%3DK.%2BS.%26aulast%3DSchreiber%26aufirst%3DA.%2BD.%26aulast%3DSteinhoff%26aufirst%3DU.%26aulast%3DBefus%26aufirst%3DA.%2BD.%26atitle%3DDifferential%2520expression%2520of%2520spleen%2520tyrosine%2520kinase%2520Syk%2520isoforms%2520in%2520tissues%253A%2520effects%2520of%2520the%2520microbial%2520flora%26jtitle%3DHistochem.%2520Cell%2520Biol.%26date%3D2006%26volume%3D126%26spage%3D495%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Latour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chow, L. M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span> </span><span class="NLM_article-title">Differential intrinsic enzymatic activity of Syk and ZAP-70 protein-tyrosine kinases</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">22782</span><span class="NLM_x">–</span> <span class="NLM_lpage">22790</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=22782-22790&author=S.+Latourauthor=L.+M.+L.+Chowauthor=A.+Veillette&title=Differential+intrinsic+enzymatic+activity+of+Syk+and+ZAP-70+protein-tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLatour%26aufirst%3DS.%26aulast%3DChow%26aufirst%3DL.%2BM.%2BL.%26aulast%3DVeillette%26aufirst%3DA.%26atitle%3DDifferential%2520intrinsic%2520enzymatic%2520activity%2520of%2520Syk%2520and%2520ZAP-70%2520protein-tyrosine%2520kinases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D22782%26epage%3D22790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Latour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siraganian, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span> </span><span class="NLM_article-title">A unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signaling</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2584</span><span class="NLM_x">–</span> <span class="NLM_lpage">2595</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=2584-2595&author=S.+Latourauthor=J.+Zhangauthor=R.+P.+Siraganianauthor=A.+Veillette&title=A+unique+insert+in+the+linker+domain+of+Syk+is+necessary+for+its+function+in+immunoreceptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLatour%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26aulast%3DVeillette%26aufirst%3DA.%26atitle%3DA%2520unique%2520insert%2520in%2520the%2520linker%2520domain%2520of%2520Syk%2520is%2520necessary%2520for%2520its%2520function%2520in%2520immunoreceptor%2520signaling%26jtitle%3DEMBO%2520J.%26date%3D1998%26volume%3D17%26spage%3D2584%26epage%3D2595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burg, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P. S.</span><span> </span><span class="NLM_article-title">Phosphorylation of human erythrocyte band 3 by endogenous p72<sup><i>syk</i></sup></span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">955</span><span class="NLM_x">–</span> <span class="NLM_lpage">959</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=955-959&author=M.+L.+Harrisonauthor=C.+C.+Isaacsonauthor=D.+L.+Burgauthor=R.+L.+Geahlenauthor=P.+S.+Low&title=Phosphorylation+of+human+erythrocyte+band+3+by+endogenous+p72syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DIsaacson%26aufirst%3DC.%2BC.%26aulast%3DBurg%26aufirst%3DD.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26aulast%3DLow%26aufirst%3DP.%2BS.%26atitle%3DPhosphorylation%2520of%2520human%2520erythrocyte%2520band%25203%2520by%2520endogenous%2520p72syk%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D955%26epage%3D959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Chan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turck, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCRζ chain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">649</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1992&pages=649-662&author=A.+C.+Chanauthor=M.+Iwashimaauthor=C.+W.+Turckauthor=A.+Weiss&title=ZAP-70%3A+a+70+kd+protein-tyrosine+kinase+that+associates+with+the+TCR%CE%B6+chain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DA.%2BC.%26aulast%3DIwashima%26aufirst%3DM.%26aulast%3DTurck%26aufirst%3DC.%2BW.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DZAP-70%253A%2520a%252070%2520kd%2520protein-tyrosine%2520kinase%2520that%2520associates%2520with%2520the%2520TCR%25CE%25B6%2520chain%26jtitle%3DCell%26date%3D1992%26volume%3D71%26spage%3D649%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">van Oers, N. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signalling processes</span> <span class="citation_source-journal">Semin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1006%2Fsmim.1995.0027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=8520027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK2MXotFegsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=227-236&author=N.+S.+C.+van+Oersauthor=A.+Weiss&title=The+Syk%2FZAP-70+protein+tyrosine+kinase+connection+to+antigen+receptor+signalling+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The Syk/ZAP-70 protein tyrosine kinase connection to antigen receptor signaling processes</span></div><div class="casAuthors">van Oers, Nicolai S.C.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">227-36</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">A review, with 71 refs.  The T- and B-cell receptor (TCR and BCR) signal transduction processes involve a coordinated interplay between two classes of non-receptor protein tyrosine kinases (PTKs), the Src-family and the Syk/ZAP-70 family of PTKs.  Following antigen-receptor stimulation, the Src-family of PTKs mediate the phosphorylation of tyrosine residues contained in a signaling motif localized in the TCR and BCR subunits.  The phosphorylation of this signaling motif recruits the Syk/ZAP-70 family of PTKs into the antigen receptor complex.  This mechanism requires the tandem SH2 domains in ZAP-70 complexing to two critically spaced phosphotyrosine residues within the signaling motif.  The clustering of Syk/ZAP-70 and cross-talk between this family and the Src-PTKs regulates subsequent signaling events that lead to a variety of cellular responses, such as antibody secretion, lymphokine prodn., cytolytic activity, proliferation, differentiation and cell survival.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowHEeGg6TFm7Vg90H21EOLACvtfcHk0lhSTvZep47pag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotFegsbs%253D&md5=90b0d29f8cc03e7aaf489025fbe2709f</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1006%2Fsmim.1995.0027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fsmim.1995.0027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BOers%26aufirst%3DN.%2BS.%2BC.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DThe%2520Syk%252FZAP-70%2520protein%2520tyrosine%2520kinase%2520connection%2520to%2520antigen%2520receptor%2520signalling%2520processes%26jtitle%3DSemin.%2520Immunol.%26date%3D1995%26volume%3D7%26spage%3D227%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Au-Yeung, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deindl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palacios, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levin, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">The structure, regulation, and function of ZAP-70</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.2008.00753.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19290920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=41-57&author=B.+B.+Au-Yeungauthor=S.+Deindlauthor=L.+Y.+Hsuauthor=E.+H.+Palaciosauthor=S.+E.+Levinauthor=J.+Kuriyanauthor=A.+Weiss&title=The+structure%2C+regulation%2C+and+function+of+ZAP-70"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The structure, regulation, and function of ZAP-70</span></div><div class="casAuthors">Au-Yeung, Byron B.; Deindl, Sebastian; Hsu, Lih-Yun; Palacios, Emil H.; Levin, Susan E.; Kuriyan, John; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-57</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The tyrosine ZAP-70 (ζ-assocd. protein of 70 kDa) kinase plays a crit. role in activating many downstream signal transduction pathways in T cells following T-cell receptor (TCR) engagement.  The importance of ZAP-70 is evidenced by the severe combined immunodeficiency that occurs in ZAP-70-deficient mice and humans.  In this review, we describe recent analyses of the ZAP-70 crystal structure, revealing a complex regulatory mechanism of ZAP-70 activity, the differential requirements for ZAP-70 and spleen tyrosine kinase (SyK) in early T-cell development, as well as the role of ZAP-70 in chronic lymphocytic leukemia and autoimmunity.  Thus, the crit. importance of ZAP-70 in TCR signaling and its predominantly T-cell-restricted expression pattern make.  ZAP-70 an attractive drug target for the inhibition of pathol. T-cell responses in disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpELG5-oWT4XbVg90H21EOLACvtfcHk0lgdLXdddkmSTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7rN&md5=84d19a10fcda9dc5dd7305679b11cc22</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00753.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00753.x%26sid%3Dliteratum%253Aachs%26aulast%3DAu-Yeung%26aufirst%3DB.%2BB.%26aulast%3DDeindl%26aufirst%3DS.%26aulast%3DHsu%26aufirst%3DL.%2BY.%26aulast%3DPalacios%26aufirst%3DE.%2BH.%26aulast%3DLevin%26aufirst%3DS.%2BE.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DThe%2520structure%252C%2520regulation%252C%2520and%2520function%2520of%2520ZAP-70%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D41%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Chu, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morita, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">The Syk family protein tyrosine kinases in T-cell activation and development</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">180</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.1998.tb01238.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9850860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1cXotVKhtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=1998&pages=167-180&author=D.+H.+Chuauthor=C.+T.+Moritaauthor=A.+Weiss&title=The+Syk+family+protein+tyrosine+kinases+in+T-cell+activation+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The Syk family of protein tyrosine kinases in T-cell activation and development</span></div><div class="casAuthors">Chu, David H.; Morita, Craig T.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">167-180</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard International Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 79 refs.  The processes of T-cell development and activation employ similar immature and mature receptors as well as similar signal transduction pathways to achieve different outcomes.  Many signaling mols. are shared between the receptor signaling pathways, including two families of cytoplasmic protein tyrosine kinases, the Src family and the Syk family.  The two Syk family members expressed in T cells, Syk and ZAP-70, are structurally similar but are expressed at different times during thymic development and during T-cell activation.  These two kinases, although they share many phys. features, differ in terms of biochem. activity and regulation.  We discuss the overlapping and distinct characteristics of Syk and ZAP-70 in T-cell signaling and the potential biol. importance of their differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojpRLoUNBms7Vg90H21EOLACvtfcHk0lgdLXdddkmSTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXotVKhtL4%253D&md5=bd8970d0540dc33a5197e5283f31e2ca</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.1998.tb01238.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.1998.tb01238.x%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DD.%2BH.%26aulast%3DMorita%26aufirst%3DC.%2BT.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DThe%2520Syk%2520family%2520protein%2520tyrosine%2520kinases%2520in%2520T-cell%2520activation%2520and%2520development%26jtitle%3DImmunol.%2520Rev.%26date%3D1998%26volume%3D165%26spage%3D167%26epage%3D180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Bolen, J. B.</span><span> </span><span class="NLM_article-title">Protein tyrosine kinases in the initiation of antigen receptor signaling</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2F0952-7915%2895%2980103-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=7546393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK2MXntFalt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1995&pages=306-311&author=J.+B.+Bolen&title=Protein+tyrosine+kinases+in+the+initiation+of+antigen+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine kinases in the initiation of antigen receptor signaling</span></div><div class="casAuthors">Bolen, Joseph B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-11</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review, with 54 refs.  Intracellular responses to antigen receptor engagement involve the activation of protein tyrosine kinases and the tyrosine phosphorylation of cellular proteins, including components of the antigen receptor.  Phosphorylation of two tyrosine residues within an 18 amino acid segment of the cytoplasmic domain of antigen receptor subunits, and the subsequent assocn. of either the Syk or Zap protein tyrosine kinase, has recently been shown to be required for successful antigen receptor signal propagation.  The recent finding that distinct primary human immunodeficiencies result from mutations in genes encoding two non-transmembrane protein tyrosine kinases underscores the importance of this class of enzyme in antigen receptor signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa2fXgX99g67Vg90H21EOLACvtfcHk0lgdLXdddkmSTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXntFalt7w%253D&md5=b76e01e636e09bbc538e8a87b25c3985</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0952-7915%2895%2980103-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0952-7915%252895%252980103-0%26sid%3Dliteratum%253Aachs%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26atitle%3DProtein%2520tyrosine%2520kinases%2520in%2520the%2520initiation%2520of%2520antigen%2520receptor%2520signaling%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1995%26volume%3D7%26spage%3D306%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Sada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Structure and function of Syk protein-tyrosine kinase</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1093%2Foxfordjournals.jbchem.a002970" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11481033" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvFCrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2001&pages=177-186&author=K.+Sadaauthor=T.+Takanoauthor=S.+Yanagiauthor=H.+Yamamura&title=Structure+and+function+of+Syk+protein-tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of Syk protein-tyrosine kinase</span></div><div class="casAuthors">Sada, Kiyonao; Takano, Tomoko; Yanagi, Shigeru; Yamamura, Hirohei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-186</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review with refs.  Non-receptor type of protein-tyrosine kinase Syk contains 2 Src homol. 2 (SH2) domains in tandem and multiple autophosphorylation sites.  Syk is activated upon binding of tandem SH2 domains to immunoreceptor tyrosine-based activating motif (ITAM) and plays an essential role in lymphocyte development and activation of immune cells.  Syk is crit. for tyrosine phosphorylation of multiple proteins which regulate important pathways leading from the receptor, such as Ca2+ mobilization and mitogen-activated protein kinase (MAPK) cascades.  Recent findings reveal that expression of Syk appears to be involved in a wide variety of cellular functions and pathogenesis of malignant cancer.  These observations have demonstrated that Syk is a key mol. that controls multiple physiol. functions in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEMQjZtBs-1LVg90H21EOLACvtfcHk0lgyg-RiH5lwiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvFCrtbk%253D&md5=3c25c4b262ce61fd8d45fd137b2c7e97</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.jbchem.a002970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.jbchem.a002970%26sid%3Dliteratum%253Aachs%26aulast%3DSada%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DT.%26aulast%3DYanagi%26aufirst%3DS.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DStructure%2520and%2520function%2520of%2520Syk%2520protein-tyrosine%2520kinase%26jtitle%3DJ.%2520Biochem.%26date%3D2001%26volume%3D130%26spage%3D177%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Furlong, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahrenholz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashendel, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Identification of the major sites of autophosphorylation of the murine protein-tyrosine kinase Syk</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">1355</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">190</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1355&publication_year=1997&pages=177-190&author=M.+T.+Furlongauthor=A.+M.+Mahrenholzauthor=K.+H.+Kimauthor=C.+L.+Ashendelauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Identification+of+the+major+sites+of+autophosphorylation+of+the+murine+protein-tyrosine+kinase+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFurlong%26aufirst%3DM.%2BT.%26aulast%3DMahrenholz%26aufirst%3DA.%2BM.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DAshendel%26aufirst%3DC.%2BL.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DIdentification%2520of%2520the%2520major%2520sites%2520of%2520autophosphorylation%2520of%2520the%2520murine%2520protein-tyrosine%2520kinase%2520Syk%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D1997%26volume%3D1355%26spage%3D177%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Chan, A. C.</span><span> </span><span class="NLM_article-title">Syk Family of Protein Tyrosine Kinases</span>. In  <span class="citation_source-book">Encyclopedia of Biological Chemistry</span>; <span class="NLM_contrib-group">Lennarz, W. J.; Lane, M. D.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">Boston, MA</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">4</span>, pp  <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FB0-12-443710-9%2F00650-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=139-145&author=A.+C.+Chanauthor=W.+J.+Lennarz&author=M.+D.+Lane&title=Encyclopedia+of+Biological+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2FB0-12-443710-9%2F00650-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB0-12-443710-9%252F00650-5%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DA.%2BC.%26atitle%3DSyk%2520Family%2520of%2520Protein%2520Tyrosine%2520Kinases%26btitle%3DEncyclopedia%2520of%2520Biological%2520Chemistry%26aulast%3DLennarz%26aufirst%3DW.%2BJ.%26pub%3DAcademic%2520Press%26date%3D2004%26volume%3D4%26spage%3D139%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Reth, M.</span><span> </span><span class="NLM_article-title">Antigen receptor tail clue</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">384</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1989&pages=383-384&author=M.+Reth&title=Antigen+receptor+tail+clue"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReth%26aufirst%3DM.%26atitle%3DAntigen%2520receptor%2520tail%2520clue%26jtitle%3DNature%26date%3D1989%26volume%3D338%26spage%3D383%26epage%3D384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Cambier, J. C.</span><span> </span><span class="NLM_article-title">Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM)</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">3281</span><span class="NLM_x">–</span> <span class="NLM_lpage">3285</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1995&pages=3281-3285&author=J.+C.+Cambier&title=Antigen+and+Fc+receptor+signaling.+The+awesome+power+of+the+immunoreceptor+tyrosine-based+activation+motif+%28ITAM%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCambier%26aufirst%3DJ.%2BC.%26atitle%3DAntigen%2520and%2520Fc%2520receptor%2520signaling.%2520The%2520awesome%2520power%2520of%2520the%2520immunoreceptor%2520tyrosine-based%2520activation%2520motif%2520%2528ITAM%2529%26jtitle%3DJ.%2520Immunol.%26date%3D1995%26volume%3D155%26spage%3D3281%26epage%3D3285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Johnson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleiman, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneringer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hippen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambier, J. C.</span><span> </span><span class="NLM_article-title">Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">4596</span><span class="NLM_x">–</span> <span class="NLM_lpage">4603</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1995&pages=4596-4603&author=S.+A.+Johnsonauthor=C.+M.+Pleimanauthor=L.+Paoauthor=J.+Schneringerauthor=K.+Hippenauthor=J.+C.+Cambier&title=Phosphorylated+immunoreceptor+signaling+motifs+%28ITAMs%29+exhibit+unique+abilities+to+bind+and+activate+Lyn+and+Syk+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DS.%2BA.%26aulast%3DPleiman%26aufirst%3DC.%2BM.%26aulast%3DPao%26aufirst%3DL.%26aulast%3DSchneringer%26aufirst%3DJ.%26aulast%3DHippen%26aufirst%3DK.%26aulast%3DCambier%26aufirst%3DJ.%2BC.%26atitle%3DPhosphorylated%2520immunoreceptor%2520signaling%2520motifs%2520%2528ITAMs%2529%2520exhibit%2520unique%2520abilities%2520to%2520bind%2520and%2520activate%2520Lyn%2520and%2520Syk%2520tyrosine%2520kinases%26jtitle%3DJ.%2520Immunol.%26date%3D1995%26volume%3D155%26spage%3D4596%26epage%3D4603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Underhill, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodridge, H. S.</span><span> </span><span class="NLM_article-title">The many faces of ITAMs</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">66</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.it.2006.12.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17197236" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlSgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=66-73&author=D.+M.+Underhillauthor=H.+S.+Goodridge&title=The+many+faces+of+ITAMs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">The many faces of ITAMs</span></div><div class="casAuthors">Underhill, David M.; Goodridge, Helen S.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">66-73</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Innate and adaptive immune responses are regulated by receptors that signal through immunoreceptor tyrosine-based activation motifs (ITAMs).  The mol. basis of ITAM signaling has been extensively characterized and serves as a model for receptor-mediated signal transduction.  Src family kinases typically phosphorylate ITAMs on dual tyrosines, which enable recruitment and activation of Syk family kinases through binding to dual SH2 domains on these kinases.  Examples of ITAM-based signaling that do not conform precisely to the std. model are becoming increasingly common.  ITAMs that suppress signaling under specific conditions and activate under others have been described, as have ITAM-like signaling mechanisms using nonstandard sequence motifs.  Elucidating the diversity of ITAM-based signaling mechanisms will clarify how activating signals generated by ITAMs are tightly regulated and will open opportunities for specific therapeutic manipulation of ITAM-based signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEtzsSmJyxRrVg90H21EOLACvtfcHk0lgyg-RiH5lwiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlSgurw%253D&md5=d246311b91627915e89601206be35e7f</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2006.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2006.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DUnderhill%26aufirst%3DD.%2BM.%26aulast%3DGoodridge%26aufirst%3DH.%2BS.%26atitle%3DThe%2520many%2520faces%2520of%2520ITAMs%26jtitle%3DTrends%2520Immunol.%26date%3D2007%26volume%3D28%26spage%3D66%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Abram, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C. A.</span><span> </span><span class="NLM_article-title">The expanding role for ITAM-based signaling pathways in immune cells</span> <span class="citation_source-journal">Sci. STKE</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span><span class="NLM_issue">377</span><span class="NLM_x">) </span> <span class="NLM_fpage">re2</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1126%2Fstke.3772007re2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17356173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD2s7ls1WrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=re2&issue=377&author=C.+L.+Abramauthor=C.+A.+Lowell&title=The+expanding+role+for+ITAM-based+signaling+pathways+in+immune+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The expanding role for ITAM-based signaling pathways in immune cells</span></div><div class="casAuthors">Abram Clare L; Lowell Clifford A</div><div class="citationInfo"><span class="NLM_cas:title">Science's STKE : signal transduction knowledge environment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2007</span>
        (<span class="NLM_cas:issue">377</span>),
    <span class="NLM_cas:pages">re2</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The immunoreceptor tyrosine-based activation motif (ITAM) is the primary signaling domain used by classical immunoreceptors, such as the antigen receptors on B and T lymphocytes and the Fc receptors (FcRs) on myeloid cells.  The ITAM is contained in the intracellular region of subunits associated with these receptors, often in pairs, or is part of the cytoplasmic domain of the receptors themselves.  Data from many investigators have demonstrated that ITAMs are both necessary and sufficient for initiation of signaling downstream of all immunoreceptors.  More recent reports indicate that ITAM signaling is used by additional receptors beyond the classical immunoreceptors: Cell adhesion molecules (integrins and PSGL-1), chemokine receptors (CXCR4), plexins, and lectin receptors all mediate immune cell function through ITAM-like signaling pathways.  This convergence of intracellular signaling pathways in leukocytes illuminates the importance of tyrosine-based activation motifs in the immune system and suggests that inhibitors of ITAM signaling may have broader effects than originally envisioned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT-n2lEL3UQYuRS7coPn-RtfW6udTcc2ebvlJOQ1VTtj7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7ls1WrsA%253D%253D&md5=b9dbc541e2de9ba313c84245281c3e48</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1126%2Fstke.3772007re2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fstke.3772007re2%26sid%3Dliteratum%253Aachs%26aulast%3DAbram%26aufirst%3DC.%2BL.%26aulast%3DLowell%26aufirst%3DC.%2BA.%26atitle%3DThe%2520expanding%2520role%2520for%2520ITAM-based%2520signaling%2520pathways%2520in%2520immune%2520cells%26jtitle%3DSci.%2520STKE%26date%3D2007%26issue%3D377%26spage%3Dre2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Cheng, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowley, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayday, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span> </span><span class="NLM_article-title">Syk tyrosine kinase required for mouse viability and B-cell development</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">303</span><span class="NLM_x">–</span> <span class="NLM_lpage">306</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=303-306&author=A.+M.+Chengauthor=B.+Rowleyauthor=W.+Paoauthor=A.+Haydayauthor=J.+B.+Bolenauthor=T.+Pawson&title=Syk+tyrosine+kinase+required+for+mouse+viability+and+B-cell+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DA.%2BM.%26aulast%3DRowley%26aufirst%3DB.%26aulast%3DPao%26aufirst%3DW.%26aulast%3DHayday%26aufirst%3DA.%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DPawson%26aufirst%3DT.%26atitle%3DSyk%2520tyrosine%2520kinase%2520required%2520for%2520mouse%2520viability%2520and%2520B-cell%2520development%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D303%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mee, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duddy, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furlong, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J.</span><span> </span><span class="NLM_article-title">Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">378</span><span class="NLM_x">, </span> <span class="NLM_fpage">298</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=378&publication_year=1995&pages=298-302&author=M.+Turnerauthor=P.+J.+Meeauthor=P.+S.+Costelloauthor=O.+Williamsauthor=A.+A.+Priceauthor=L.+P.+Duddyauthor=M.+T.+Furlongauthor=R.+L.+Geahlenauthor=V.+L.+J.+Tybulewicz&title=Perinatal+lethality+and+blocked+B-cell+development+in+mice+lacking+the+tyrosine+kinase+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DMee%26aufirst%3DP.%2BJ.%26aulast%3DCostello%26aufirst%3DP.%2BS.%26aulast%3DWilliams%26aufirst%3DO.%26aulast%3DPrice%26aufirst%3DA.%2BA.%26aulast%3DDuddy%26aufirst%3DL.%2BP.%26aulast%3DFurlong%26aufirst%3DM.%2BT.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ.%26atitle%3DPerinatal%2520lethality%2520and%2520blocked%2520B-cell%2520development%2520in%2520mice%2520lacking%2520the%2520tyrosine%2520kinase%2520Syk%26jtitle%3DNature%26date%3D1995%26volume%3D378%26spage%3D298%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Abtahian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerriero, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebzda, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mócsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lepore, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koretzky, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, M. L.</span><span> </span><span class="NLM_article-title">Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2003&pages=247-251&author=F.+Abtahianauthor=A.+Guerrieroauthor=E.+Sebzdaauthor=M.+M.+Luauthor=R.+Zhouauthor=A.+M%C3%B3csaiauthor=E.+E.+Myersauthor=B.+Huangauthor=D.+G.+Jacksonauthor=V.+A.+Ferrariauthor=V.+Tybulewiczauthor=C.+A.+Lowellauthor=J.+J.+Leporeauthor=G.+A.+Koretzkyauthor=M.+L.+Kahn&title=Regulation+of+blood+and+lymphatic+vascular+separation+by+signaling+proteins+SLP-76+and+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbtahian%26aufirst%3DF.%26aulast%3DGuerriero%26aufirst%3DA.%26aulast%3DSebzda%26aufirst%3DE.%26aulast%3DLu%26aufirst%3DM.%2BM.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26aulast%3DMyers%26aufirst%3DE.%2BE.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DJackson%26aufirst%3DD.%2BG.%26aulast%3DFerrari%26aufirst%3DV.%2BA.%26aulast%3DTybulewicz%26aufirst%3DV.%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DLepore%26aufirst%3DJ.%2BJ.%26aulast%3DKoretzky%26aufirst%3DG.%2BA.%26aulast%3DKahn%26aufirst%3DM.%2BL.%26atitle%3DRegulation%2520of%2520blood%2520and%2520lymphatic%2520vascular%2520separation%2520by%2520signaling%2520proteins%2520SLP-76%2520and%2520Syk%26jtitle%3DScience%26date%3D2003%26volume%3D299%26spage%3D247%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Jakus, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balàzs, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mócsai, A.</span><span> </span><span class="NLM_article-title">Genetic deficiency of Syk protects mice from autoantibody-induced arthritis</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1899</span><span class="NLM_x">–</span> <span class="NLM_lpage">1910</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20201079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1aqsL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=1899-1910&author=Z.+Jakusauthor=E.+Simonauthor=B.+Bal%C3%A0zsauthor=A.+M%C3%B3csai&title=Genetic+deficiency+of+Syk+protects+mice+from+autoantibody-induced+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic deficiency of Syk protects mice from autoantibody-induced arthritis</span></div><div class="casAuthors">Jakus, Zoltan; Simon, Edina; Balazs, Balint; Mocsai, Attila</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1899-1910</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: The Syk tyrosine kinase plays an important role in diverse functions in hematopoietic lineage cells.  Although previous in vitro and pharmacol. analyses suggested Syk to be a possible player in the development of autoimmune arthritis, no in vivo genetic studies addressing that issue have yet been reported.  The aim of the present study was to test whether genetic deficiency of Syk affects autoantibody-induced exptl. arthritis in the K/BxN serumtransfer model.  Methods: Syk-/- bone marrow chimeras carrying a Syk-deficient hematopoietic system were generated by transplanting Syk-/- fetal liver cells into lethally irradiated wild-type recipients.  After complete repopulation of the hematopoietic compartment, autoantibody-mediated arthritis was induced by injection of arthritogenic K/BxN serum.  Arthritis development was monitored by macroscopic and microscopic observation of the ankle joints, micro-computed tomog. of bone morphol., as well as joint function assay.  Results: Genetic deficiency of Syk in the hematopoietic compartment completely blocked the development of all macroscopic and microscopic signs of arthritis.  The Syk-/- mutation also prevented the appearance of periarticular bone erosions.  Finally, Syk-/- bone marrow chimeras were completely protected from arthritis-induced loss of articular function.  Conclusion: Our results indicate that Syk is critically involved in the development of all clin. relevant aspects of autoantibody-mediated K/BxN serumtransfer arthritis in exptl. mice.  These results provide the first in vivo genetic evidence of the role of Syk in the development of autoimmune arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMg3hF7NyGgrVg90H21EOLACvtfcHk0lg7XctAi7DGUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1aqsL%252FO&md5=0dfab55caa648c3c556fcc8a63ba9a4f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakus%26aufirst%3DZ.%26aulast%3DSimon%26aufirst%3DE.%26aulast%3DBal%25C3%25A0zs%26aufirst%3DB.%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26atitle%3DGenetic%2520deficiency%2520of%2520Syk%2520protects%2520mice%2520from%2520autoantibody-induced%2520arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26spage%3D1899%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Sedlik, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orbach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamberale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioan-Facsinay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbeek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricciardi-Castagnoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnerot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Santo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amigorena, S.</span><span> </span><span class="NLM_article-title">A critical role for SYK protein tyrosine kinase in Fc receptor-mediated antigen presentation and induction of dendritic cell maturation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">846</span><span class="NLM_x">–</span> <span class="NLM_lpage">852</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=846-852&author=C.+Sedlikauthor=D.+Orbachauthor=P.+Veronauthor=E.+Schweighofferauthor=F.+Colucciauthor=R.+Gamberaleauthor=A.+Ioan-Facsinayauthor=S.+Verbeekauthor=P.+Ricciardi-Castagnoliauthor=C.+Bonnerotauthor=V.+L.+Tybulewiczauthor=J.+Di+Santoauthor=S.+Amigorena&title=A+critical+role+for+SYK+protein+tyrosine+kinase+in+Fc+receptor-mediated+antigen+presentation+and+induction+of+dendritic+cell+maturation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSedlik%26aufirst%3DC.%26aulast%3DOrbach%26aufirst%3DD.%26aulast%3DVeron%26aufirst%3DP.%26aulast%3DSchweighoffer%26aufirst%3DE.%26aulast%3DColucci%26aufirst%3DF.%26aulast%3DGamberale%26aufirst%3DR.%26aulast%3DIoan-Facsinay%26aufirst%3DA.%26aulast%3DVerbeek%26aufirst%3DS.%26aulast%3DRicciardi-Castagnoli%26aufirst%3DP.%26aulast%3DBonnerot%26aufirst%3DC.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%26aulast%3DDi%2BSanto%26aufirst%3DJ.%26aulast%3DAmigorena%26aufirst%3DS.%26atitle%3DA%2520critical%2520role%2520for%2520SYK%2520protein%2520tyrosine%2520kinase%2520in%2520Fc%2520receptor-mediated%2520antigen%2520presentation%2520and%2520induction%2520of%2520dendritic%2520cell%2520maturation%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D846%26epage%3D852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Crowley, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzer-Attas, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFranco, A. L.</span><span> </span><span class="NLM_article-title">A critical role for Syk in signal transduction and phagocytosis mediated by Fcγ receptors on macrophages</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">186</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1039</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=1997&pages=1027-1039&author=M.+T.+Crowleyauthor=P.+S.+Costelloauthor=C.+J.+Fitzer-Attasauthor=M.+Turnerauthor=F.+Mengauthor=C.+Lowellauthor=V.+L.+J.+Tybulewiczauthor=A.+L.+DeFranco&title=A+critical+role+for+Syk+in+signal+transduction+and+phagocytosis+mediated+by+Fc%CE%B3+receptors+on+macrophages"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowley%26aufirst%3DM.%2BT.%26aulast%3DCostello%26aufirst%3DP.%2BS.%26aulast%3DFitzer-Attas%26aufirst%3DC.%2BJ.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DLowell%26aufirst%3DC.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ.%26aulast%3DDeFranco%26aufirst%3DA.%2BL.%26atitle%3DA%2520critical%2520role%2520for%2520Syk%2520in%2520signal%2520transduction%2520and%2520phagocytosis%2520mediated%2520by%2520Fc%25CE%25B3%2520receptors%2520on%2520macrophages%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1997%26volume%3D186%26spage%3D1027%26epage%3D1039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Efremov, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurenti, L.</span><span> </span><span class="NLM_article-title">The Syk kinase as a therapeutic target in leukemia and lymphoma</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=623-636&author=D.+G.+Efremovauthor=L.+Laurenti&title=The+Syk+kinase+as+a+therapeutic+target+in+leukemia+and+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEfremov%26aufirst%3DD.%2BG.%26aulast%3DLaurenti%26aufirst%3DL.%26atitle%3DThe%2520Syk%2520kinase%2520as%2520a%2520therapeutic%2520target%2520in%2520leukemia%2520and%2520lymphoma%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26spage%3D623%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Coopman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowden, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basyuk, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blancato, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezza, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLeskey, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangeat, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S. C.</span><span> </span><span class="NLM_article-title">The SYK tyrosine kinase suppresses malignant growth of human breast cancer cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">406</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">747</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=742-747&author=P.+J.+Coopmanauthor=M.+T.+Doauthor=M.+Barthauthor=E.+T.+Bowdenauthor=A.+J.+Hayesauthor=E.+Basyukauthor=J.+K.+Blancatoauthor=P.+R.+Vezzaauthor=S.+W.+McLeskeyauthor=P.+H.+Mangeatauthor=S.+C.+Mueller&title=The+SYK+tyrosine+kinase+suppresses+malignant+growth+of+human+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoopman%26aufirst%3DP.%2BJ.%26aulast%3DDo%26aufirst%3DM.%2BT.%26aulast%3DBarth%26aufirst%3DM.%26aulast%3DBowden%26aufirst%3DE.%2BT.%26aulast%3DHayes%26aufirst%3DA.%2BJ.%26aulast%3DBasyuk%26aufirst%3DE.%26aulast%3DBlancato%26aufirst%3DJ.%2BK.%26aulast%3DVezza%26aufirst%3DP.%2BR.%26aulast%3DMcLeskey%26aufirst%3DS.%2BW.%26aulast%3DMangeat%26aufirst%3DP.%2BH.%26aulast%3DMueller%26aufirst%3DS.%2BC.%26atitle%3DThe%2520SYK%2520tyrosine%2520kinase%2520suppresses%2520malignant%2520growth%2520of%2520human%2520breast%2520cancer%2520cells%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D742%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Coopman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S. C.</span><span> </span><span class="NLM_article-title">The SYK tyrosine kinase: a new negative regulator in tumor growth and progression</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.canlet.2005.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16442709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XotV2ms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=2006&pages=159-173&author=P.+J.+Coopmanauthor=S.+C.+Mueller&title=The+SYK+tyrosine+kinase%3A+a+new+negative+regulator+in+tumor+growth+and+progression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Syk tyrosine kinase: A new negative regulator in tumor growth and progression</span></div><div class="casAuthors">Coopman, Peter J.; Mueller, Susette C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-173</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The spleen tyrosine kinase Syk was long thought to be a hematopoietic cell-specific signaling mol.  Recent evidence demonstrated that it is also expressed by many non-hematopoietic cell types and that it plays a neg. role in cancer.  A significant drop in its expression was first obsd. during breast cancer progression, but an anomalous Syk expression has now also been evidenced in many other tumor types.  Mechanistic studies using Syk re-expression demonstrated its suppressive function in tumorigenesis and metastasis formation, which is surprising for a tyrosine kinase.  Loss of Syk expression is regulated, albeit not exclusively, by its promoter hypermethylation.  The mol. mechanism of its tumor-suppressive function remains largely unknown; the identification of its activators and effectors in non-hematopoietic cells will be a challenge for the years to come.  An increasing no. of clin. studies reveal a correlation between reduced Syk expression and an increased risk for metastasis formation, and assign Syk as a potential new prognostic marker in different tumor types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsb5arUIVnUbVg90H21EOLACvtfcHk0lg6vVGiS-ZhCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotV2ms7Y%253D&md5=8b02c95328d67f3b9fb2626c86f2dd64</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2005.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2005.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DCoopman%26aufirst%3DP.%2BJ.%26aulast%3DMueller%26aufirst%3DS.%2BC.%26atitle%3DThe%2520SYK%2520tyrosine%2520kinase%253A%2520a%2520new%2520negative%2520regulator%2520in%2520tumor%2520growth%2520and%2520progression%26jtitle%3DCancer%2520Lett.%26date%3D2006%26volume%3D241%26spage%3D159%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Ross, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherf, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Rijin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waltham, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergamenschikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lashkari, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botstein, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span> </span><span class="NLM_article-title">Systematic variation in gene expression patterns in human cancer cell lines</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2F73432" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10700174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2000&pages=227-235&author=D.+T.+Rossauthor=U.+Scherfauthor=M.+B.+Eisenauthor=C.+M.+Perouauthor=C.+Reesauthor=P.+Spellmanauthor=V.+Iyerauthor=S.+S.+Jeffreyauthor=M.+Van+de+Rijinauthor=M.+Walthamauthor=A.+Pergamenschikovauthor=J.+C.+F.+Leeauthor=D.+Lashkariauthor=D.+Shalonauthor=T.+G.+Myersauthor=J.+N.+Weinsteinauthor=D.+Botsteinauthor=P.+O.+Brown&title=Systematic+variation+in+gene+expression+patterns+in+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic variation in gene expression patterns in human cancer cell lines</span></div><div class="casAuthors">Ross, Douglas T.; Scherf, Uwe; Eisen, Michael B.; Perou, Charles M.; Rees, Christian; Spellman, Paul; Iyer, Vishwanath; Jeffrey, Stefanie S.; Van de Rijn, Matt; Waltham, Mark; Pergamenschikov, Alexander; Lee, Jeffrey C. F.; Lashkari, Deval; Shalon, Dari; Myers, Timothy G.; Weinstein, John N.; Botstein, David; Brown, Patrick O.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-235</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America</span>)
        </div><div class="casAbstract">We used cDNA microarrays to explore the variation in expression of approx. 8,000 unique genes among the 60 cell lines used in the National Cancer Institute's screen for anti-cancer drugs.  Classification of the cell lines based solely on the obsd. patterns of gene expression revealed a correspondence to the ostensible origins of the tumors from which the cell lines were derived.  The consistent relationship between the gene expression patterns and the tissue of origin allowed us to recognize outliers whose previous classification appeared incorrect.  Specific features of the gene expression patterns appeared to be related to physiol. properties of the cell lines, such as their doubling time in culture, drug metab. or the interferon response.  Comparison of gene expression patterns in the cell lines to those obsd. in normal breast tissue or in breast tumor specimens revealed features of the expression patterns in the tumors that had recognizable counterparts in specific cell lines, reflecting the tumor, stromal and inflammatory components of the tumor tissue.  These results provided a novel mol. characterization of this important group of human cell lines and their relationships to tumors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZhocezjCTNbVg90H21EOLACvtfcHk0lg6vVGiS-ZhCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFaqtrg%253D&md5=248ffa9428fa078fff0bdf45fddaecf4</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1038%2F73432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F73432%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DScherf%26aufirst%3DU.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DRees%26aufirst%3DC.%26aulast%3DSpellman%26aufirst%3DP.%26aulast%3DIyer%26aufirst%3DV.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DVan%2Bde%2BRijin%26aufirst%3DM.%26aulast%3DWaltham%26aufirst%3DM.%26aulast%3DPergamenschikov%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DJ.%2BC.%2BF.%26aulast%3DLashkari%26aufirst%3DD.%26aulast%3DShalon%26aufirst%3DD.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DWeinstein%26aufirst%3DJ.%2BN.%26aulast%3DBotstein%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26atitle%3DSystematic%2520variation%2520in%2520gene%2520expression%2520patterns%2520in%2520human%2520cancer%2520cell%2520lines%26jtitle%3DNat.%2520Genet.%26date%3D2000%26volume%3D24%26spage%3D227%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Neve, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridlyand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baehner, F. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fevr, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppe, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speed, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spellman, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vries, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilwell, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinkel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albertson, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldman, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazdar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, J. W.</span><span> </span><span class="NLM_article-title">A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.ccr.2006.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17157791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlCnsrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=515-527&author=R.+M.+Neveauthor=K.+Chinauthor=J.+Fridlyandauthor=J.+Yehauthor=F.+L.+Baehnerauthor=T.+Fevrauthor=L.+Clarkauthor=N.+Bayaniauthor=J.-P.+Coppeauthor=F.+Tongauthor=T.+Speedauthor=P.+T.+Spellmanauthor=S.+De+Vriesauthor=A.+Lapukauthor=N.+J.+Wangauthor=W.-L.+Kuoauthor=J.+L.+Stilwellauthor=D.+Pinkelauthor=D.+G.+Albertsonauthor=F.+M.+Waldmanauthor=F.+McCormickauthor=R.+B.+Dicksonauthor=M.+D.+Johnsonauthor=M.+Lippmanauthor=S.+Ethierauthor=A.+Gazdarauthor=J.+W.+Gray&title=A+collection+of+breast+cancer+cell+lines+for+the+study+of+functionally+distinct+cancer+subtypes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes</span></div><div class="casAuthors">Neve, Richard M.; Chin, Koei; Fridlyand, Jane; Yeh, Jennifer; Baehner, Frederick L.; Fevr, Tea; Clark, Laura; Bayani, Nora; Coppe, Jean-Philippe; Tong, Frances; Speed, Terry; Spellman, Paul T.; DeVries, Sandy; Lapuk, Anna; Wang, Nick J.; Kuo, Wen-Lin; Stilwell, Jackie L.; Pinkel, Daniel; Albertson, Donna G.; Waldman, Frederic M.; McCormick, Frank; Dickson, Robert B.; Johnson, Michael D.; Lippman, Marc; Ethier, Stephen; Gazdar, Adi; Gray, Joe W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">515-527</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Recent studies suggest that thousands of genes may contribute to breast cancer pathophysiologies when deregulated by genomic or epigenomic events.  Here, we describe a model "system" to appraise the functional contributions of these genes to breast cancer subsets.  In general, the recurrent genomic and transcriptional characteristics of 51 breast cancer cell lines mirror those of 145 primary breast tumors, although some significant differences are documented.  The cell lines that comprise the system also exhibit the substantial genomic, transcriptional, and biol. heterogeneity found in primary tumors.  We show, using Trastuzumab (Herceptin) monotherapy as an example, that the system can be used to identify mol. features that predict or indicate response to targeted therapies or other physiol. perturbations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprHlT0rEcwBrVg90H21EOLACvtfcHk0lixhjJqWlnU5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlCnsrbE&md5=218682c6f7ffebff329208d476ab35ad</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DNeve%26aufirst%3DR.%2BM.%26aulast%3DChin%26aufirst%3DK.%26aulast%3DFridlyand%26aufirst%3DJ.%26aulast%3DYeh%26aufirst%3DJ.%26aulast%3DBaehner%26aufirst%3DF.%2BL.%26aulast%3DFevr%26aufirst%3DT.%26aulast%3DClark%26aufirst%3DL.%26aulast%3DBayani%26aufirst%3DN.%26aulast%3DCoppe%26aufirst%3DJ.-P.%26aulast%3DTong%26aufirst%3DF.%26aulast%3DSpeed%26aufirst%3DT.%26aulast%3DSpellman%26aufirst%3DP.%2BT.%26aulast%3DDe%2BVries%26aufirst%3DS.%26aulast%3DLapuk%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DN.%2BJ.%26aulast%3DKuo%26aufirst%3DW.-L.%26aulast%3DStilwell%26aufirst%3DJ.%2BL.%26aulast%3DPinkel%26aufirst%3DD.%26aulast%3DAlbertson%26aufirst%3DD.%2BG.%26aulast%3DWaldman%26aufirst%3DF.%2BM.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DDickson%26aufirst%3DR.%2BB.%26aulast%3DJohnson%26aufirst%3DM.%2BD.%26aulast%3DLippman%26aufirst%3DM.%26aulast%3DEthier%26aufirst%3DS.%26aulast%3DGazdar%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DJ.%2BW.%26atitle%3DA%2520collection%2520of%2520breast%2520cancer%2520cell%2520lines%2520for%2520the%2520study%2520of%2520functionally%2520distinct%2520cancer%2520subtypes%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D515%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span> </span><span class="NLM_article-title">Reply</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.jaci.2006.12.667" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17321574" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2007&pages=1277-1279&author=E.+S.+Masudaauthor=E.+B.+Grossbardauthor=D.+G.+Payan&title=Reply"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2006.12.667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2006.12.667%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26atitle%3DReply%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2007%26volume%3D119%26spage%3D1277%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Perou, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sørlie, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisen, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Rijn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rees, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akslen, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fluge, Ø.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pergamenschikov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lønning, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Børresen-Dale, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botstein, D.</span><span> </span><span class="NLM_article-title">Molecular portraits of human breast tumours</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">406</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2F35021093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10963602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmt1CnsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=747-752&author=C.+M.+Perouauthor=T.+S%C3%B8rlieauthor=M.+B.+Eisenauthor=M.+van+de+Rijnauthor=S.+S.+Jeffreyauthor=C.+A.+Reesauthor=J.+R.+Pollackauthor=D.+T.+Rossauthor=H.+Johnsenauthor=L.+A.+Akslenauthor=%C3%98.+Flugeauthor=A.+Pergamenschikovauthor=C.+Williamsauthor=S.+X.+Zhuauthor=P.+E.+L%C3%B8nningauthor=A.-L.+B%C3%B8rresen-Daleauthor=P.+O.+Brownauthor=D.+Botstein&title=Molecular+portraits+of+human+breast+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular portraits of human breast tumors</span></div><div class="casAuthors">Perou, Charles M.; Serlie, Therese; Eisen, Michael B.; Van De Rijn, Matt; Jeffrey, Stefanie S.; Rees, Christian A.; Pollack, Jonathan R.; Rossi, Douglas T.; Johnsen, Hilde; Akslen, Lars A.; Fluge, Oystein; Pergamenschikov, Alexander; Williams, Cheryl; Zhu, Shirley X.; Lenning, Per E.; Berresen-Dale, Anne-Use; Brown, Patrick O.; Botstein, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6797</span>),
    <span class="NLM_cas:pages">747-752</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Human breast tumors are diverse in their natural history and in their responsiveness to treatments.  Variation in transcriptional programs accounts for much of the biol. diversity of human cells and tumors.  In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome.  Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumors from 42 different individuals, using cDNA microarrays representing 8102 human genes.  These patterns provided a distinctive mol. portrait of each tumor.  Twenty of the tumors were sampled twice, before and after a 16-wk course of doxorubicin chemotherapy, and two tumors were paired with a lymph node metastasis from the same patient.  Gene expression patterns in two tumor samples from the same individual were almost always more similar to each other than either was to any other sample.  Sets of co-expressed genes were identified for which variation in mRNA levels could be related to specific features of physiol. variation.  The tumors could be classified into subtypes distinguished by pervasive differences in their gene expression patterns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorYsVvqq_EyLVg90H21EOLACvtfcHk0lixhjJqWlnU5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmt1CnsLw%253D&md5=f81e9b3e3d5e339ea463428b1c973f8d</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1038%2F35021093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35021093%26sid%3Dliteratum%253Aachs%26aulast%3DPerou%26aufirst%3DC.%2BM.%26aulast%3DS%25C3%25B8rlie%26aufirst%3DT.%26aulast%3DEisen%26aufirst%3DM.%2BB.%26aulast%3Dvan%2Bde%2BRijn%26aufirst%3DM.%26aulast%3DJeffrey%26aufirst%3DS.%2BS.%26aulast%3DRees%26aufirst%3DC.%2BA.%26aulast%3DPollack%26aufirst%3DJ.%2BR.%26aulast%3DRoss%26aufirst%3DD.%2BT.%26aulast%3DJohnsen%26aufirst%3DH.%26aulast%3DAkslen%26aufirst%3DL.%2BA.%26aulast%3DFluge%26aufirst%3D%25C3%2598.%26aulast%3DPergamenschikov%26aufirst%3DA.%26aulast%3DWilliams%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DS.%2BX.%26aulast%3DL%25C3%25B8nning%26aufirst%3DP.%2BE.%26aulast%3DB%25C3%25B8rresen-Dale%26aufirst%3DA.-L.%26aulast%3DBrown%26aufirst%3DP.%2BO.%26aulast%3DBotstein%26aufirst%3DD.%26atitle%3DMolecular%2520portraits%2520of%2520human%2520breast%2520tumours%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D747%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">van’t Veer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Vijver, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterse, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Kooy, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witteveen, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerkhoven, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linsley, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friend, S. H.</span><span> </span><span class="NLM_article-title">Gene expression profiling predicts clinical outcome of breast cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">530</span><span class="NLM_x">–</span> <span class="NLM_lpage">536</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=530-536&author=L.+J.+van%E2%80%99t+Veerauthor=H.+Daiauthor=M.+J.+van+de+Vijverauthor=Y.+D.+Heauthor=A.+A.+M.+Hartauthor=M.+Maoauthor=H.+L.+Peterseauthor=K.+van+der+Kooyauthor=M.+J.+Martonauthor=A.+T.+Witteveenauthor=G.+J.+Schreiberauthor=R.+M.+Kerkhovenauthor=C.+Robertsauthor=P.+S.+Linsleyauthor=R.+Bernardsauthor=S.+H.+Friend&title=Gene+expression+profiling+predicts+clinical+outcome+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%25E2%2580%2599t%2BVeer%26aufirst%3DL.%2BJ.%26aulast%3DDai%26aufirst%3DH.%26aulast%3Dvan%2Bde%2BVijver%26aufirst%3DM.%2BJ.%26aulast%3DHe%26aufirst%3DY.%2BD.%26aulast%3DHart%26aufirst%3DA.%2BA.%2BM.%26aulast%3DMao%26aufirst%3DM.%26aulast%3DPeterse%26aufirst%3DH.%2BL.%26aulast%3Dvan%2Bder%2BKooy%26aufirst%3DK.%26aulast%3DMarton%26aufirst%3DM.%2BJ.%26aulast%3DWitteveen%26aufirst%3DA.%2BT.%26aulast%3DSchreiber%26aufirst%3DG.%2BJ.%26aulast%3DKerkhoven%26aufirst%3DR.%2BM.%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DLinsley%26aufirst%3DP.%2BS.%26aulast%3DBernards%26aufirst%3DR.%26aulast%3DFriend%26aufirst%3DS.%2BH.%26atitle%3DGene%2520expression%2520profiling%2520predicts%2520clinical%2520outcome%2520of%2520breast%2520cancer%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D530%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Fan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigelt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuyten, D. S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobel, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van’t Veer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perou, C. M.</span><span> </span><span class="NLM_article-title">Concordance among gene-expression-based predictors for breast cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">569</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1056%2FNEJMoa052933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16899776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XotVKnur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=560-569&author=C.+Fanauthor=D.+S.+Ohauthor=L.+Wesselsauthor=B.+Weigeltauthor=D.+S.+A.+Nuytenauthor=A.+B.+Nobelauthor=L.+J.+van%E2%80%99t+Veerauthor=C.+M.+Perou&title=Concordance+among+gene-expression-based+predictors+for+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Concordance among gene-expression-based predictors for breast cancer</span></div><div class="casAuthors">Fan, Cheng; Oh, Daniel S.; Wessels, Lodewyk; Weigelt, Britta; Nuyten, Dimitry S. A.; Nobel, Andrew B.; van't Veer, Laura J.; Perou, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">560-569</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND: Gene-expression-profiling studies of primary breast tumors performed by different labs. have resulted in the identification of a no. of distinct prognostic profiles, or gene sets, with little overlap in terms of gene identity.  METHODS: To compare the predictions derived from these gene sets for individual samples, we obtained a single data set of 295 samples and applied five gene-expression-based models: intrinsic subtypes, 70-gene profile, wound response, recurrence score, and the two-gene ratio (for patients who had been treated with tamoxifen).  RESULTS: We found that most models had high rates of concordance in their outcome predictions for the individual samples.  In particular, almost all tumors identified as having an intrinsic subtype of basal-like, HER2-pos. and estrogen-receptor-neg., or luminal B (assocd. with a poor prognosis) were also classified as having a poor 70-gene profile, activated wound response, and high recurrence score.  The 70-gene and recurrence-score models, which are beginning to be used in the clin. setting, showed 77 to 81 % agreement in outcome classification.  CONCLUSIONS: Even though different gene sets were used for prognostication in patients with breast cancer, four of the five tested showed significant agreement in the outcome predictions for individual patients and are probably tracking a common set of biol. phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ2DPq9UVqQ7Vg90H21EOLACvtfcHk0liCSh_x8ZqEQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotVKnur4%253D&md5=8ed145dc04309fda37bfa779927a87cb</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa052933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa052933%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DC.%26aulast%3DOh%26aufirst%3DD.%2BS.%26aulast%3DWessels%26aufirst%3DL.%26aulast%3DWeigelt%26aufirst%3DB.%26aulast%3DNuyten%26aufirst%3DD.%2BS.%2BA.%26aulast%3DNobel%26aufirst%3DA.%2BB.%26aulast%3Dvan%25E2%2580%2599t%2BVeer%26aufirst%3DL.%2BJ.%26aulast%3DPerou%26aufirst%3DC.%2BM.%26atitle%3DConcordance%2520among%2520gene-expression-based%2520predictors%2520for%2520breast%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D560%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Chin, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teschendorff, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marioni, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbosa-Morais, N. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorne, N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinder, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Wiel, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, I. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavaré, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ylstra, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldas, C.</span><span> </span><span class="NLM_article-title">High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer</span> <span class="citation_source-journal">Genome Biol. [Online]</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">R215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2007&pages=R215&author=S.+F.+Chinauthor=A.+E.+Teschendorffauthor=J.+C.+Marioniauthor=Y.+Wangauthor=N.+L.+Barbosa-Moraisauthor=N.+P.+Thorneauthor=J.+L.+Costaauthor=S.+E.+Pinderauthor=M.+A.+van+de+Wielauthor=A.+R.+Greenauthor=I.+O.+Ellisauthor=P.+L.+Porterauthor=S.+Tavar%C3%A9author=J.+D.+Brentonauthor=B.+Ylstraauthor=C.+Caldas&title=High-resolution+aCGH+and+expression+profiling+identifies+a+novel+genomic+subtype+of+ER+negative+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChin%26aufirst%3DS.%2BF.%26aulast%3DTeschendorff%26aufirst%3DA.%2BE.%26aulast%3DMarioni%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBarbosa-Morais%26aufirst%3DN.%2BL.%26aulast%3DThorne%26aufirst%3DN.%2BP.%26aulast%3DCosta%26aufirst%3DJ.%2BL.%26aulast%3DPinder%26aufirst%3DS.%2BE.%26aulast%3Dvan%2Bde%2BWiel%26aufirst%3DM.%2BA.%26aulast%3DGreen%26aufirst%3DA.%2BR.%26aulast%3DEllis%26aufirst%3DI.%2BO.%26aulast%3DPorter%26aufirst%3DP.%2BL.%26aulast%3DTavar%25C3%25A9%26aufirst%3DS.%26aulast%3DBrenton%26aufirst%3DJ.%2BD.%26aulast%3DYlstra%26aufirst%3DB.%26aulast%3DCaldas%26aufirst%3DC.%26atitle%3DHigh-resolution%2520aCGH%2520and%2520expression%2520profiling%2520identifies%2520a%2520novel%2520genomic%2520subtype%2520of%2520ER%2520negative%2520breast%2520cancer%26jtitle%3DGenome%2520Biol.%2520%255BOnline%255D%26date%3D2007%26volume%3D8%26spage%3DR215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Bertucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rougemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charafe-Jauffret, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervera, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarpin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xerri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houlgatte, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacquemier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birnbaum, D.</span><span> </span><span class="NLM_article-title">Gene expression profiling identifies molecular subtypes of inflammatory breast cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">2170</span><span class="NLM_x">–</span> <span class="NLM_lpage">2178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=2170-2178&author=F.+Bertucciauthor=P.+Finettiauthor=J.+Rougemontauthor=E.+Charafe-Jauffretauthor=N.+Cerveraauthor=C.+Tarpinauthor=C.+Nguyenauthor=L.+Xerriauthor=R.+Houlgatteauthor=J.+Jacquemierauthor=P.+Viensauthor=D.+Birnbaum&title=Gene+expression+profiling+identifies+molecular+subtypes+of+inflammatory+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertucci%26aufirst%3DF.%26aulast%3DFinetti%26aufirst%3DP.%26aulast%3DRougemont%26aufirst%3DJ.%26aulast%3DCharafe-Jauffret%26aufirst%3DE.%26aulast%3DCervera%26aufirst%3DN.%26aulast%3DTarpin%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DXerri%26aufirst%3DL.%26aulast%3DHoulgatte%26aufirst%3DR.%26aulast%3DJacquemier%26aufirst%3DJ.%26aulast%3DViens%26aufirst%3DP.%26aulast%3DBirnbaum%26aufirst%3DD.%26atitle%3DGene%2520expression%2520profiling%2520identifies%2520molecular%2520subtypes%2520of%2520inflammatory%2520breast%2520cancer%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D2170%26epage%3D2178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, T.</span><span> </span><span class="NLM_article-title">Establishment of the superoxide production assay with human monocytic cell line, U937, for the evaluation of Syk kinase inhibitors</span> <span class="citation_source-journal">J. Immunol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">268</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0022-1759%2802%2900188-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12215380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1yitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2002&pages=123-130&author=N.+Yamamotoauthor=M.+Shichijoauthor=T.+Kokubo&title=Establishment+of+the+superoxide+production+assay+with+human+monocytic+cell+line%2C+U937%2C+for+the+evaluation+of+Syk+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Establishment of the superoxide production assay with human monocytic cell line, U937, for the evaluation of Syk kinase inhibitors</span></div><div class="casAuthors">Yamamoto, Noriyuki; Shichijo, Michitaka; Kokubo, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunological Methods</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-130</span>CODEN:
                <span class="NLM_cas:coden">JIMMBG</span>;
        ISSN:<span class="NLM_cas:issn">0022-1759</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Protein tyrosine kinase Syk is known to play crit. roles in the signal transduction from receptors for Fc portion of Igs (FcRs) and B cell receptor complex (BCR).  Its importance was well studied in FcεRI-induced activation of mast cells; therefore, Syk inhibitors are expected to have anti-allergic effects and to be novel therapy for allergic diseases, such as asthma, allergic rhinitis and atopic dermatitis.  We previously developed an enzyme assay of recombinant human Syk kinase for the high throughput screening.  In order to evaluate the Syk kinase inhibitors in a human cell system, we have developed an assay with human monocytic cell line, U937, to monitor FcγRI-mediated superoxide prodn.  We treated cells with IFN-γ to enhance the expression of FcγRI and to obtain enough prodn. of superoxide.  Engagement of FcγRI stimulated superoxide prodn., which was accompanied with Syk phosphorylation.  PMA, an activator of protein kinase C, also evoked superoxide prodn., but Syk was not phosphorylated.  Moreover, the treatment of cells with antisense oligonucleotide against syk attenuated Syk protein expression and suppressed superoxide prodn. induced by FcγRI-engagement, but not by PMA.  These results confirm that Syk is involved in the signal transduction from FcγRI upstream of PKC in U937 cells and we can evaluate the efficacy and the selectivity of Syk inhibitors with this assay system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRSzIv0lq517Vg90H21EOLACvtfcHk0liSfXKopD1O3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1yitrs%253D&md5=fa214d24c90f1d9d966ea30c3cc277d5</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0022-1759%2802%2900188-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-1759%252802%252900188-6%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DKokubo%26aufirst%3DT.%26atitle%3DEstablishment%2520of%2520the%2520superoxide%2520production%2520assay%2520with%2520human%2520monocytic%2520cell%2520line%252C%2520U937%252C%2520for%2520the%2520evaluation%2520of%2520Syk%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Immunol.%2520Methods%26date%3D2002%26volume%3D268%26spage%3D123%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegelbauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, T.</span><span> </span><span class="NLM_article-title">Development of a high-throughput fluoroimmunoasassy for Syk kinase and Syk kinase inhibitors</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">256</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2003&pages=256-261&author=N.+Yamamotoauthor=H.+Hasegawaauthor=H.+Sekiauthor=K.+Ziegelbauerauthor=T.+Yasuda&title=Development+of+a+high-throughput+fluoroimmunoasassy+for+Syk+kinase+and+Syk+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DHasegawa%26aufirst%3DH.%26aulast%3DSeki%26aufirst%3DH.%26aulast%3DZiegelbauer%26aufirst%3DK.%26aulast%3DYasuda%26aufirst%3DT.%26atitle%3DDevelopment%2520of%2520a%2520high-throughput%2520fluoroimmunoasassy%2520for%2520Syk%2520kinase%2520and%2520Syk%2520kinase%2520inhibitors%26jtitle%3DAnal.%2520Biochem.%26date%3D2003%26volume%3D315%26spage%3D256%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luraghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, X. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deakin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surby, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, E. M.</span><span> </span><span class="NLM_article-title">Kinetic assay for characterization of spleen tyrosine kinase activity and inhibition with recombinant kinase and crude cell lysates</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">384</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=384&publication_year=2009&pages=56-67&author=M.+Liauthor=P.+Luraghiauthor=A.+Amourauthor=X.+D.+Qianauthor=P.+S.+Carterauthor=C.+J.+Clarkauthor=A.+Deakinauthor=J.+Denyerauthor=C.+I.+Hobbsauthor=M.+Surbyauthor=V.+K.+Patelauthor=E.+M.+Schaefer&title=Kinetic+assay+for+characterization+of+spleen+tyrosine+kinase+activity+and+inhibition+with+recombinant+kinase+and+crude+cell+lysates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLuraghi%26aufirst%3DP.%26aulast%3DAmour%26aufirst%3DA.%26aulast%3DQian%26aufirst%3DX.%2BD.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DClark%26aufirst%3DC.%2BJ.%26aulast%3DDeakin%26aufirst%3DA.%26aulast%3DDenyer%26aufirst%3DJ.%26aulast%3DHobbs%26aufirst%3DC.%2BI.%26aulast%3DSurby%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSchaefer%26aufirst%3DE.%2BM.%26atitle%3DKinetic%2520assay%2520for%2520characterization%2520of%2520spleen%2520tyrosine%2520kinase%2520activity%2520and%2520inhibition%2520with%2520recombinant%2520kinase%2520and%2520crude%2520cell%2520lysates%26jtitle%3DAnal.%2520Biochem.%26date%3D2009%26volume%3D384%26spage%3D56%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Singh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grover, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saini, K. S.</span><span> </span><span class="NLM_article-title">Human spleen tyrosine kinase (Syk) recombinant expression systems for high-throughput assays</span> <span class="citation_source-journal">Biotechnol. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fbiot.200900139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20013945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitVaqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=201-212&author=D.+Singhauthor=R.+Raniauthor=R.+Rajendranauthor=N.+J.+Kaurauthor=A.+Pandeyauthor=P.+Chopraauthor=T.+Jainauthor=M.+K.+Jainauthor=S.+Groverauthor=R.+Aryaauthor=K.+S.+Saini&title=Human+spleen+tyrosine+kinase+%28Syk%29+recombinant+expression+systems+for+high-throughput+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Human spleen tyrosine kinase (Syk) recombinant expression systems for high-throughput assays</span></div><div class="casAuthors">Singh, Deepika; Rani, Reema; Rajendran, Resmi; Kaur, Namrata Jit; Pandey, Abhinav; Chopra, Puneet; Jain, Tarun; Jain, Manish Kumar; Grover, Sonam; Arya, Ranjana; Saini, Kulvinder Singh</div><div class="citationInfo"><span class="NLM_cas:title">Biotechnology Journal</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">201-212</span>CODEN:
                <span class="NLM_cas:coden">BJIOAM</span>;
        ISSN:<span class="NLM_cas:issn">1860-6768</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is an important non-receptor tyrosine kinase and its aberrant regulation is assocd. with a variety of allergic disorders and autoimmune diseases.  To identify small mol. inhibitors of Syk in high-throughput assays, recombinant Syk protein is needed in bulk quantity.  The expression of recombinant human Syk in was studied in three heterologous systems: Escherichia coli, baculovirus expression vector system (BEVS), and the cellular slime mold Dictyostelium discoideum (Dd).  Syk activity was higher in the BEVS as compared to the Dd expression host, whereas in E. coli, no activity was obsd. under the assay conditions.  Purified Syk kinase domain protein from BEVS showed concn. dependent inhibition with OXSI-2, a known Syk inhibitor.  Mol. modeling and docking studies were performed to understand the binding mode and crit. interactions of the inhibitor with catalytic domain of Syk.  The BEVS generated Syk kinase domain showed stability upon multiple freeze-thaw cycles and exhibited significantly higher levels of tyrosine phosphorylation at pTyr525/Tyr526 in the Syk activation loop.  Based on the data, it is concluded that BEVS is the ideal host to produce an active and stable enzyme, which can be successfully employed for screening of Syk inhibitors in a high-throughput system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptM6jBePXyW7Vg90H21EOLACvtfcHk0liSfXKopD1O3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitVaqtLs%253D&md5=a08a7142e2ce0126376c3322881d782f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fbiot.200900139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbiot.200900139%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DD.%26aulast%3DRani%26aufirst%3DR.%26aulast%3DRajendran%26aufirst%3DR.%26aulast%3DKaur%26aufirst%3DN.%2BJ.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DChopra%26aufirst%3DP.%26aulast%3DJain%26aufirst%3DT.%26aulast%3DJain%26aufirst%3DM.%2BK.%26aulast%3DGrover%26aufirst%3DS.%26aulast%3DArya%26aufirst%3DR.%26aulast%3DSaini%26aufirst%3DK.%2BS.%26atitle%3DHuman%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%2520recombinant%2520expression%2520systems%2520for%2520high-throughput%2520assays%26jtitle%3DBiotechnol.%2520J.%26date%3D2010%26volume%3D5%26spage%3D201%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Kinet, J. P.</span><span> </span><span class="NLM_article-title">The high-affinity IgE receptor (FcεRI): from physiology to pathology</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">931</span><span class="NLM_x">–</span> <span class="NLM_lpage">972</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1146%2Fannurev.immunol.17.1.931" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10358778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1MXjtVWls7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1999&pages=931-972&author=J.+P.+Kinet&title=The+high-affinity+IgE+receptor+%28Fc%CE%B5RI%29%3A+from+physiology+to+pathology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The high-affinity IgE receptor (FcεRI): From physiology to pathology</span></div><div class="casAuthors">Kinet, Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">931-972</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 249 refs.  The high affinity receptor for IgE (designated Fc.vepsiln.RI) is the member of the antigen (Ag) receptor superfamily responsible for linking pathogen-or allergen-specific IgEs with cellular immunol. effector functions.  This review provides background information on Fc.vepsiln.RI function combined with more detailed summaries of recent progress in understanding specific aspects of Fc.vepsiln.RI biol. and biochem.  Topics covered include the coordination and function of the large multiprotein signaling complexes that are assembled when Fc.vepsiln.RI and other Ag receptors are engaged, new information on human receptor structures and tissue distribution, and the role of the FcRβ chain in signaling and its potential contribution to atopic phenotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCuAC1T5JlBLVg90H21EOLACvtfcHk0liSfXKopD1O3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjtVWls7g%253D&md5=d37fa09083728c0f9edce06ae492741d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.17.1.931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.17.1.931%26sid%3Dliteratum%253Aachs%26aulast%3DKinet%26aufirst%3DJ.%2BP.%26atitle%3DThe%2520high-affinity%2520IgE%2520receptor%2520%2528Fc%25CE%25B5RI%2529%253A%2520from%2520physiology%2520to%2520pathology%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1999%26volume%3D17%26spage%3D931%26epage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Kurosaki, T.</span><span> </span><span class="NLM_article-title">Regulation of B cell fates by BCR signaling components</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">347</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0952-7915%2802%2900344-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11973132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtVeit7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=341-347&author=T.+Kurosaki&title=Regulation+of+B+cell+fates+by+BCR+signaling+components"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of B cell fates by BCR signaling components</span></div><div class="casAuthors">Kurosaki, Tomohiro</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">341-347</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent results obtained in mice harboring cytoplasmic mutations of Igα and/or Igβ have reinforced the concept that the strength of BCR signaling is important for ensuring appropriate developmental outcomes as well as antigen-specific responses.  To establish the optimal signaling intensity and duration, the BCR utilizes pos. and neg. regulatory mols.  Studies are beginning to reveal how these mols. maintain immunol. homeostasis and tolerance.  Each B cell developmental checkpoint requires the distinct signaling intensity through BCR and its surrogates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-895L9tokD7Vg90H21EOLACvtfcHk0lgd7Ck0Rreuiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtVeit7c%253D&md5=44fc24782a60417313c4319b03b42dd7</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2802%2900344-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252802%252900344-8%26sid%3Dliteratum%253Aachs%26aulast%3DKurosaki%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520B%2520cell%2520fates%2520by%2520BCR%2520signaling%2520components%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2002%26volume%3D14%26spage%3D341%26epage%3D347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Daëron, M.</span><span> </span><span class="NLM_article-title">Structural bases of FcγR functions</span> <span class="citation_source-journal">Int. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.3109%2F08830189709045701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9651784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1cXitFensb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=1-27&author=M.+Da%C3%ABron&title=Structural+bases+of+Fc%CE%B3R+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structural bases of FcγR functions</span></div><div class="casAuthors">Daeron, Marc</div><div class="citationInfo"><span class="NLM_cas:title">International Reviews of Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-27</span>CODEN:
                <span class="NLM_cas:coden">IRIMEH</span>;
        ISSN:<span class="NLM_cas:issn">0883-0185</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">A review with 158 refs.  This review describes structures which det. the biol. activities triggered by FcγR and account for the cell-mediated functions of IgG antibodies in physiol. and pathol.  The binding specificity and affinity of FcγR depend primarily on IgG-binding structures, in their Ig-like extracellular domains.  Binding is however also influenced by subunits that assoc. to multichain FcγR.  Effector and regulatory intracytoplasmic sequences that are unique to mols. of the FcγRIIB family det. the internalization properties of these receptors.  Immunoreceptor Tyrosine-based Activation Motifs (ITAMs) are intracytoplasmic effector sequences shared by FcγR and other receptors involved in the recognition of antigen, which trigger cell activation and internalization.  Immunoreceptor Tyrosine-based Inhibition Motifs (ITIMs) are intracytoplasmic sequences, shared by FcγRIIB and a growing no. of neg. coreceptors which neg. regulate cell activation via ITAM-bearing receptors.  Altogether, these structures enable IgG antibodies to exert a variety of finely tuned biol. effects during the immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO2A5g5vnVnbVg90H21EOLACvtfcHk0lgd7Ck0Rreuiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFensb4%253D&md5=b17717545468d24c6b0ef9de85dfb94d</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3109%2F08830189709045701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08830189709045701%26sid%3Dliteratum%253Aachs%26aulast%3DDa%25C3%25ABron%26aufirst%3DM.%26atitle%3DStructural%2520bases%2520of%2520Fc%25CE%25B3R%2520functions%26jtitle%3DInt.%2520Rev.%2520Immunol.%26date%3D1997%26volume%3D16%26spage%3D1%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Nimmerjahn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravetch, J. V.</span><span> </span><span class="NLM_article-title">Fcγ receptors as regulators of immune responses</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18064051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVKrsLnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=34-47&author=F.+Nimmerjahnauthor=J.+V.+Ravetch&title=Fc%CE%B3+receptors+as+regulators+of+immune+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Fcγ receptors as regulators of immune responses</span></div><div class="casAuthors">Nimmerjahn, Falk; Ravetch, Jeffrey V.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-47</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In addn. to their role in binding antigen, antibodies can regulate immune responses via interaction with Fc receptors (FcRs).  In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo.  Here, the authors discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcγRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBbBMzHXrMsrVg90H21EOLACvtfcHk0lgd7Ck0Rreuiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVKrsLnK&md5=dae5144e17b125fe8665944be2486783</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fnri2206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2206%26sid%3Dliteratum%253Aachs%26aulast%3DNimmerjahn%26aufirst%3DF.%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26atitle%3DFc%25CE%25B3%2520receptors%2520as%2520regulators%2520of%2520immune%2520responses%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D34%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Siraganian, R. P.</span><span> </span><span class="NLM_article-title">Mast cell signal transduction from the high-affinity IgE receptor</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">646</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.coi.2003.09.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=14630197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVeqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=639-646&author=R.+P.+Siraganian&title=Mast+cell+signal+transduction+from+the+high-affinity+IgE+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cell signal transduction from the high-affinity IgE receptor</span></div><div class="casAuthors">Siraganian, Reuben P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">639-646</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Antigen-mediated aggregation of IgE bound to its high-affinity receptor on mast cells or basophils initiates a complex series of biochem. events, resulting in the release of mediators that cause allergic inflammation and anaphylactic reactions.  Recent progress has defined the mol. pathways that are involved in stimulating these cells and has shown the importance of protein tyrosine kinases in the subsequent reactions.  The activation pathways are regulated both pos. and neg. by the interactions of numerous signaling mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnT2393blBILVg90H21EOLACvtfcHk0lgd7Ck0Rreuiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVeqsLk%253D&md5=0170c139fa1b8a003d87f939cbd260f5</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.coi.2003.09.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coi.2003.09.010%26sid%3Dliteratum%253Aachs%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DMast%2520cell%2520signal%2520transduction%2520from%2520the%2520high-affinity%2520IgE%2520receptor%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2003%26volume%3D15%26spage%3D639%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Metzger, H.</span><span> </span><span class="NLM_article-title">The receptor with high affinity for IgE</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.1992.tb00624.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=1532373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1CgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=1992&pages=37-48&author=H.+Metzger&title=The+receptor+with+high+affinity+for+IgE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">The receptor with high affinity for IgE</span></div><div class="casAuthors">Metzger, Henry</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-48</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    </div><div class="casAbstract">A review, with 60 refs., of the current knowledge on the function and structure of the high-affinity IgE receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCkUgLEHd20LVg90H21EOLACvtfcHk0lghNmALywcgTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1CgsLk%253D&md5=33735404aff1dce0b59153501a9e74d3</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.1992.tb00624.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.1992.tb00624.x%26sid%3Dliteratum%253Aachs%26aulast%3DMetzger%26aufirst%3DH.%26atitle%3DThe%2520receptor%2520with%2520high%2520affinity%2520for%2520IgE%26jtitle%3DImmunol.%2520Rev.%26date%3D1992%26volume%3D125%26spage%3D37%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Ravetch, J. V.</span><span> </span><span class="NLM_article-title">Fc Receptors</span>. In  <span class="citation_source-book">Fundamental Immunology</span>, <span class="NLM_edition">5</span>th ed.; <span class="NLM_contrib-group">Paul, W. E.</span>, Ed.; <span class="NLM_publisher-name">Lippincott Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=685-700&author=J.+V.+Ravetchauthor=W.+E.+Paul&title=Fundamental+Immunology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26atitle%3DFc%2520Receptors%26btitle%3DFundamental%2520Immunology%26aulast%3DPaul%26aufirst%3DW.%2BE.%26pub%3DLippincott%2520Williams%2520%2526%2520Wilkins%26date%3D2003%26spage%3D685%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Ravetch, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolland, S.</span><span> </span><span class="NLM_article-title">IgG Fc Receptors</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">290</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1146%2Fannurev.immunol.19.1.275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11244038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFKgur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2001&pages=275-290&author=J.+V.+Ravetchauthor=S.+Bolland&title=IgG+Fc+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">IgG Fc receptors</span></div><div class="casAuthors">Ravetch, Jeffrey V.; Bolland, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">275-290</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review with 98 refs.  Since the description of the first mouse knockout for an IgG Fc receptor seven years ago, considerable progress has been made in defining the in vivo functions of these receptors in diverse biol. systems.  The role of activating FcγRs in providing a crit. link between ligands and effector cells in type II and type III inflammation is now well established and has led to a fundamental revision of the significance of these receptors in initiating cellular responses in host defense, in detg. the efficacy of therapeutic antibodies, and in pathol. autoimmune conditions.  Considerable progress has been made in the last two years on the in vivo regulation of these responses, through the appreciation of the importance of balancing activation responses with inhibitory signaling.  The inhibitory FcR functions in the maintenance of peripheral tolerance, in regulating the threshold of activation responses, and ultimately in terminating IgG mediated effector stimulation.  The consequences of deleting the inhibitory arm of this system are thus manifested in both the afferent and efferent immune responses.  The hyperresponsive state that results leads to greatly magnified effector responses by cytotoxic antibodies and immune complexes and can culminate in autoimmunity and autoimmune disease when modified by environmental or genetic factors.  FcγRs offer a paradigm for the biol. significance of balancing activation and inhibitory signaling in the expanding family of activation/inhibitory receptor pairs found in the immune system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLaA63gbW8-LVg90H21EOLACvtfcHk0lghNmALywcgTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFKgur4%253D&md5=238ba74f178d0db9d1d16734153cfe8f</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.19.1.275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.19.1.275%26sid%3Dliteratum%253Aachs%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26aulast%3DBolland%26aufirst%3DS.%26atitle%3DIgG%2520Fc%2520Receptors%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2001%26volume%3D19%26spage%3D275%26epage%3D290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Siraganian, R. P.; Zhang, J.; Kimura, T.</span><span> </span><span class="NLM_article-title">Regulation and Function of Protein Tyrosine Kinase Syk in FcεR1-Mediated Signaling</span>. In  <span class="citation_source-book">Signal Transduction in Mast Cells and Basophils</span>; <span class="NLM_contrib-group">Razin, E.; Rivera, J.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1999</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">115</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1007%2F978-1-4612-2154-8_10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=115-133&author=R.+P.+Siraganian&author=J.+Zhang&author=T.+Kimuraauthor=E.+Razin&author=J.+Rivera&title=Signal+Transduction+in+Mast+Cells+and+Basophils"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1007%2F978-1-4612-2154-8_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4612-2154-8_10%26sid%3Dliteratum%253Aachs%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DRegulation%2520and%2520Function%2520of%2520Protein%2520Tyrosine%2520Kinase%2520Syk%2520in%2520Fc%25CE%25B5R1-Mediated%2520Signaling%26btitle%3DSignal%2520Transduction%2520in%2520Mast%2520Cells%2520and%2520Basophils%26aulast%3DRazin%26aufirst%3DE.%26pub%3DSpringer%26date%3D1999%26spage%3D115%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appella, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siraganian, R. P.</span><span> </span><span class="NLM_article-title">Conformational changes induced in the protein tyrosine kinase p72<sup><i>syk</i></sup> by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1478</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1128%2FMCB.16.4.1471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=8657120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK28XhvVahurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=1471-1478&author=T.+Kimuraauthor=H.+Sakamotoauthor=E.+Appellaauthor=R.+P.+Siraganian&title=Conformational+changes+induced+in+the+protein+tyrosine+kinase+p72syk+by+tyrosine+phosphorylation+or+by+binding+of+phosphorylated+immunoreceptor+tyrosine-based+activation+motif+peptides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides</span></div><div class="casAuthors">Kimura, Teruaki; Sakamoto, Hiroshi; Appella, Ettore; Siraganian, Reuben P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1471-8</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A crit. event in signaling in immune cells is the interaction of Syk or ZAP-70 protein tyrosine kinases with multisubunit receptors that contain an ∼18-amino-acid domain called the immunoreceptor tyrosine-based activation motif (ITAM).  Tyrosine-phosphorylated Syk from activated cells was in a conformation different from that in nonstimulated cells as demonstrated by changes in immunoreactivity.  The addn. of tyrosine-diphosphorylated ITAM peptides resulted in a similar conformational change in Syk from nonactivated cells.  The peptides based on FcεRIγ were more active than those based on FcεRIβ.  In vitro autophosphorylation of Syk was dramatically enhanced by the addn. of the diphosphorylated ITAM peptides.  The conformational change and the enhanced autophosphorylation required the presence of both phosphorylated tyrosines on the same mol.  These conformational changes in Syk by tyrosine phosphorylation or binding to diphosphorylated ITAM could be crit. for Syk activation and downstream propagation of intracellular signals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3gCIMEi8-HbVg90H21EOLACvtfcHk0lghNmALywcgTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhvVahurg%253D&md5=312f8e16881619d114c7810d562fce36</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.4.1471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.4.1471%26sid%3Dliteratum%253Aachs%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DSakamoto%26aufirst%3DH.%26aulast%3DAppella%26aufirst%3DE.%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DConformational%2520changes%2520induced%2520in%2520the%2520protein%2520tyrosine%2520kinase%2520p72syk%2520by%2520tyrosine%2520phosphorylation%2520or%2520by%2520binding%2520of%2520phosphorylated%2520immunoreceptor%2520tyrosine-based%2520activation%2520motif%2520peptides%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D1471%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Tsang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannetti, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, J. K. Y</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gandhi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span> </span><span class="NLM_article-title">Molecular mechanism of the Syk activation switch</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32650</span><span class="NLM_x">–</span> <span class="NLM_lpage">32659</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32650-32659&author=E.+Tsangauthor=A.+M.+Giannettiauthor=D.+Shawauthor=M.+Dinhauthor=J.+K.+Y+Tseauthor=S.+Gandhiauthor=H.+Hoauthor=S.+Wangauthor=E.+Pappauthor=J.+M.+Bradshaw&title=Molecular+mechanism+of+the+Syk+activation+switch"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTsang%26aufirst%3DE.%26aulast%3DGiannetti%26aufirst%3DA.%2BM.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DDinh%26aufirst%3DM.%26aulast%3DTse%26aufirst%3DJ.%2BK.%2BY%26aulast%3DGandhi%26aufirst%3DS.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26atitle%3DMolecular%2520mechanism%2520of%2520the%2520Syk%2520activation%2520switch%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32650%26epage%3D32659" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Bradshaw, J. M.</span><span> </span><span class="NLM_article-title">The Src, Syk, and Tec family kinases: distinct types of molecular switches</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1175</span><span class="NLM_x">–</span> <span class="NLM_lpage">1184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.cellsig.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20206686" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlyntbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=1175-1184&author=J.+M.+Bradshaw&title=The+Src%2C+Syk%2C+and+Tec+family+kinases%3A+distinct+types+of+molecular+switches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">The Src, Syk, and Tec family kinases: Distinct types of molecular switches</span></div><div class="casAuthors">Bradshaw, J. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1175-1184</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The Src, Syk, and Tec family kinases are three of the most well characterized tyrosine kinase families found in the human genome.  Members of these kinase families function downstream of antigen and Fc receptors in hematopoietic cells and transduce signals leading to calcium mobilization, altered gene expression, cytokine prodn., and cell proliferation.  Over the last several years, structural and biochem. studies have begun to uncover the mol. mechanisms regulating activation of these kinases.  It appears that each kinase family functions as a distinct type of mol. switch.  This review discusses the activation of the Src, Syk, and Tec kinases from the perspective of structure, phosphorylation, allosteric regulation, and kinetics.  The multiple factors that regulate the Src, Syk, and Tec families illustrate the important role played by each of these kinases in immune cell signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_PA9QDCCGPLVg90H21EOLACvtfcHk0ljJvbaxPoSETg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlyntbw%253D&md5=7f562f792a04682d05aa32dc09a7cb6e</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Src%252C%2520Syk%252C%2520and%2520Tec%2520family%2520kinases%253A%2520distinct%2520types%2520of%2520molecular%2520switches%26jtitle%3DCell.%2520Signalling%26date%3D2010%26volume%3D22%26spage%3D1175%26epage%3D1184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">El-Hillal, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinet, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scharenberg, A. M.</span><span> </span><span class="NLM_article-title">syk kinase activation by a src kinase-initiated activation loop phosphorylation chain reaction</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">1919</span><span class="NLM_x">–</span> <span class="NLM_lpage">1924</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=1919-1924&author=O.+El-Hillalauthor=T.+Kurosakiauthor=H.+Yamamuraauthor=J.+P.+Kinetauthor=A.+M.+Scharenberg&title=syk+kinase+activation+by+a+src+kinase-initiated+activation+loop+phosphorylation+chain+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Hillal%26aufirst%3DO.%26aulast%3DKurosaki%26aufirst%3DT.%26aulast%3DYamamura%26aufirst%3DH.%26aulast%3DKinet%26aufirst%3DJ.%2BP.%26aulast%3DScharenberg%26aufirst%3DA.%2BM.%26atitle%3Dsyk%2520kinase%2520activation%2520by%2520a%2520src%2520kinase-initiated%2520activation%2520loop%2520phosphorylation%2520chain%2520reaction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D1919%26epage%3D1924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Kulathu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grothe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reth, M.</span><span> </span><span class="NLM_article-title">Autoinhibition and adapter function of Syk</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">232</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.2009.00837.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19909371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGlsL3E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2009&pages=286-299&author=Y.+Kulathuauthor=G.+Grotheauthor=M.+Reth&title=Autoinhibition+and+adapter+function+of+Syk"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Autoinhibition and adapter function of Syk</span></div><div class="casAuthors">Kulathu, Yogesh; Grothe, Gesina; Reth, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">286-299</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Development, survival, and activation of B lymphocytes are controlled by signals emanating from the B-cell antigen receptor (BCR).  The BCR has an autonomous signaling function also known as tonic signaling that allows for long-term survival of B cells in the immune system.  Upon binding of antigen to the BCR, the tonic signal is amplified and diversified, leading to alteration in gene expression and B-cell activation.  The spleen tyrosine kinase (Syk) intimately cooperates with the signaling subunits of the BCR and plays a central role in the amplification and diversification of BCR signals.  In this review, we discuss the mol. mechanisms by which Syk activity is inhibited and activated at the BCR.  Importantly, Syk acts not only as a kinase that phosphorylates downstream substrates but also as an adapter that can bind to a diverse set of signaling proteins.  Depending on its interactions and localization, Syk can signal opposing cell fate decisions such as proliferation or differentiation of B cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr38HEBsyF34bVg90H21EOLACvtfcHk0ljJvbaxPoSETg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGlsL3E&md5=94fda0d96894c3ccbe0771b0ef438d72</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2009.00837.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2009.00837.x%26sid%3Dliteratum%253Aachs%26aulast%3DKulathu%26aufirst%3DY.%26aulast%3DGrothe%26aufirst%3DG.%26aulast%3DReth%26aufirst%3DM.%26atitle%3DAutoinhibition%2520and%2520adapter%2520function%2520of%2520Syk%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D232%26spage%3D286%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Syk and pTyr’d: signaling through the B cell antigen receptor</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1793</span><span class="NLM_x">, </span> <span class="NLM_fpage">1115</span><span class="NLM_x">–</span> <span class="NLM_lpage">1127</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1793&publication_year=2009&pages=1115-1127&author=R.+L.+Geahlen&title=Syk+and+pTyr%E2%80%99d%3A+signaling+through+the+B+cell+antigen+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DSyk%2520and%2520pTyr%25E2%2580%2599d%253A%2520signaling%2520through%2520the%2520B%2520cell%2520antigen%2520receptor%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D1793%26spage%3D1115%26epage%3D1127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Deindl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadlecek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brdicka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structural basis for the inhibition of tyrosine kinase activity of ZAP-70</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">735</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=735-746&author=S.+Deindlauthor=T.+A.+Kadlecekauthor=T.+Brdickaauthor=X.+Caoauthor=A.+Weissauthor=J.+Kuriyan&title=Structural+basis+for+the+inhibition+of+tyrosine+kinase+activity+of+ZAP-70"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeindl%26aufirst%3DS.%26aulast%3DKadlecek%26aufirst%3DT.%2BA.%26aulast%3DBrdicka%26aufirst%3DT.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520tyrosine%2520kinase%2520activity%2520of%2520ZAP-70%26jtitle%3DCell%26date%3D2007%26volume%3D129%26spage%3D735%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Kannan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neuwald, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Analogous regulatory sites within the αC-β4 loop regions of ZAP-70 tyrosine kinase and AGC kinases</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">1784</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1784&publication_year=2008&pages=27-32&author=N.+Kannanauthor=A.+F.+Neuwaldauthor=S.+S.+Taylor&title=Analogous+regulatory+sites+within+the+%CE%B1C-%CE%B24+loop+regions+of+ZAP-70+tyrosine+kinase+and+AGC+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKannan%26aufirst%3DN.%26aulast%3DNeuwald%26aufirst%3DA.%2BF.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DAnalogous%2520regulatory%2520sites%2520within%2520the%2520%25CE%25B1C-%25CE%25B24%2520loop%2520regions%2520of%2520ZAP-70%2520tyrosine%2520kinase%2520and%2520AGC%2520kinases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2008%26volume%3D1784%26spage%3D27%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Arias-Palomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recuero-Checa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustelo, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorca, O.</span><span> </span><span class="NLM_article-title">3D structure of Syk kinase determined by single particle electron microscopy</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1774</span><span class="NLM_x">, </span> <span class="NLM_fpage">1493</span><span class="NLM_x">–</span> <span class="NLM_lpage">1499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1774&publication_year=2007&pages=1493-1499&author=E.+Arias-Palomoauthor=M.+A.+Recuero-Checaauthor=X.+R.+Busteloauthor=O.+Llorca&title=3D+structure+of+Syk+kinase+determined+by+single+particle+electron+microscopy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArias-Palomo%26aufirst%3DE.%26aulast%3DRecuero-Checa%26aufirst%3DM.%2BA.%26aulast%3DBustelo%26aufirst%3DX.%2BR.%26aulast%3DLlorca%26aufirst%3DO.%26atitle%3D3D%2520structure%2520of%2520Syk%2520kinase%2520determined%2520by%2520single%2520particle%2520electron%2520microscopy%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2007%26volume%3D1774%26spage%3D1493%26epage%3D1499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Arias-Palomo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recuero-Checa, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bustelo, X. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llorca, O.</span><span> </span><span class="NLM_article-title">Conformational rearrangements upon Syk auto-phosphorylation</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">1794</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1794&publication_year=2009&pages=1211-1217&author=E.+Arias-Palomoauthor=M.+A.+Recuero-Checaauthor=X.+R.+Busteloauthor=O.+Llorca&title=Conformational+rearrangements+upon+Syk+auto-phosphorylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArias-Palomo%26aufirst%3DE.%26aulast%3DRecuero-Checa%26aufirst%3DM.%2BA.%26aulast%3DBustelo%26aufirst%3DX.%2BR.%26aulast%3DLlorca%26aufirst%3DO.%26atitle%3DConformational%2520rearrangements%2520upon%2520Syk%2520auto-phosphorylation%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2009%26volume%3D1794%26spage%3D1211%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Brdicka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadlecek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roose, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastuszak, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">4924</span><span class="NLM_x">–</span> <span class="NLM_lpage">4933</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1128%2FMCB.25.12.4924-4933.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15923611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt1OrtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=4924-4933&author=T.+Brdickaauthor=T.+A.+Kadlecekauthor=J.+P.+Rooseauthor=A.+W.+Pastuszakauthor=A.+Weiss&title=Intramolecular+regulatory+switch+in+ZAP-70%3A+analogy+with+receptor+tyrosine+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular regulatory switch in ZAP-70: Analogy with receptor tyrosine kinases</span></div><div class="casAuthors">Brdicka, Tomas; Kadlecek, Theresa A.; Roose, Jeroen P.; Pastuszak, Alexander W.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">4924-4933</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">ZAP-70, a Syk family cytoplasmic protein tyrosine kinase (PTK), is required to couple the activated T-cell antigen receptor (TCR) to downstream signaling pathways.  It contains two tandem SH2 domains that bind to phosphorylated TCR subunits and a C-terminal catalytic domain.  The region connecting the SH2 domains with the kinase domain, termed interdomain B, has previously been shown to have striking regulatory effects on ZAP-70 function, presumed to be due to the recruitment of key substrates.  Paradoxically, deletion of interdomain B preserves ZAP-70 function.  Recent structural studies of several receptor tyrosine kinases (RTKs) revealed that their juxtamembrane regions neg. regulate their catalytic activities.  In EphB2 and several other RTKs, this autoinhibition depends upon interaction between the kinase domain and tyrosine residues within the juxtamembrane region.  Autoinhibition is released when these tyrosines become phosphorylated following receptor stimulation.  Sequence homol. suggested analogous regulation for ZAP-70.  Based on mutagenesis anal. of ZAP-70 interdomain B, we find that this region downregulates ZAP-70 catalytic activity in a similar manner as the juxtamembrane region of EphB2.  Similar regulation was also noted for the related Syk kinase.  These findings suggest that a general autoinhibitory mechanism employed by RTKs is also used by some cytoplasmic tyrosine kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeROLSubXLtLVg90H21EOLACvtfcHk0lj88at2zUk9Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt1OrtLg%253D&md5=e45310dd79c4f16b4579d9d211b9f0f8</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1128%2FMCB.25.12.4924-4933.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.25.12.4924-4933.2005%26sid%3Dliteratum%253Aachs%26aulast%3DBrdicka%26aufirst%3DT.%26aulast%3DKadlecek%26aufirst%3DT.%2BA.%26aulast%3DRoose%26aufirst%3DJ.%2BP.%26aulast%3DPastuszak%26aufirst%3DA.%2BW.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DIntramolecular%2520regulatory%2520switch%2520in%2520ZAP-70%253A%2520analogy%2520with%2520receptor%2520tyrosine%2520kinases%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2005%26volume%3D25%26spage%3D4924%26epage%3D4933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berenstein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siraganian, R. P.</span><span> </span><span class="NLM_article-title">Phosphorylation of Tyr342 in the linker region of Syk is critical for FcεR1 signaling in mast cells</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">8144</span><span class="NLM_x">–</span> <span class="NLM_lpage">8154</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1128%2FMCB.22.23.8144-8154.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12417718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xos1yhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=8144-8154&author=J.+Zhangauthor=E.+Berensteinauthor=R.+P.+Siraganian&title=Phosphorylation+of+Tyr342+in+the+linker+region+of+Syk+is+critical+for+Fc%CE%B5R1+signaling+in+mast+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation of Tyr342 in the linker region of Syk is critical for FcεRI signaling in mast cells</span></div><div class="casAuthors">Zhang, Juan; Berenstein, Elsa; Siraganian, Reuben P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8144-8154</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The linker region of Syk and ZAP70 tyrosine kinases plays an important role in regulating their function.  There are three conserved tyrosines in this linker region; Tyr317 of Syk and its equiv. residue in ZAP70 were previously shown to neg. regulate the function of Syk and ZAP70.  Here we studied the roles of the other two tyrosines, Tyr342 and Tyr346 of Syk, in FcεRI-mediated signaling.  Antigen stimulation resulted in Tyr342 phosphorylation in mast cells.  Syk with Y342F mutation failed to reconstitute FcεRI-initiated histamine release.  In the Syk Y342F-expressing cells there was dramatically impaired receptor-induced phosphorylation of multiple signaling mols., including LAT, SLP-76, phospholipase C-γ2, but not Vav.  Compared to wild-type Syk, Y342F Syk had decreased binding to phosphorylated immunoreceptor tyrosine-based activation motifs and reduced kinase activity.  Surprisingly, mutation of Tyr346 had much less effect on FcεRI-dependent mast cell degranulation.  An anti-Syk-phospho-346 tyrosine antibody indicated that antigen stimulation induced only a very minor increase in the phosphorylation of this tyrosine.  Therefore, Tyr342, but not Tyr346, is crit. for regulating Syk in mast cells and the function of these tyrosines in immune receptor signaling appears to be different from what has been previously reported for the equiv. residues of ZAP70.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrymOpJkP_O-bVg90H21EOLACvtfcHk0lj88at2zUk9Uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xos1yhs7o%253D&md5=db0afe64aa9c959b72c28f6c50584742</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1128%2FMCB.22.23.8144-8154.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.22.23.8144-8154.2002%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DBerenstein%26aufirst%3DE.%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DPhosphorylation%2520of%2520Tyr342%2520in%2520the%2520linker%2520region%2520of%2520Syk%2520is%2520critical%2520for%2520Fc%25CE%25B5R1%2520signaling%2520in%2520mast%2520cells%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2002%26volume%3D22%26spage%3D8144%26epage%3D8154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Sanderson, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wex, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnapp, A.</span><span> </span><span class="NLM_article-title">Syk and Lyn mediate distinct Syk phosphorylation events in FcεRI-signal transduction: implications for regulation of IgE-mediated degranulation</span> <span class="citation_source-journal">Mol. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.molimm.2010.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20828828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOnsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=171-178&author=M.+P.+Sandersonauthor=E.+Wexauthor=T.+Konoauthor=K.+Utoauthor=A.+Schnapp&title=Syk+and+Lyn+mediate+distinct+Syk+phosphorylation+events+in+Fc%CE%B5RI-signal+transduction%3A+implications+for+regulation+of+IgE-mediated+degranulation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Syk and Lyn mediate distinct Syk phosphorylation events in FcεRI-signal transduction: Implications for regulation of IgE-mediated degranulation</span></div><div class="casAuthors">Sanderson, Michael P.; Wex, Eva; Kono, Takeshi; Uto, Katsuhiro; Schnapp, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Immunology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">171-178</span>CODEN:
                <span class="NLM_cas:coden">MOIMD5</span>;
        ISSN:<span class="NLM_cas:issn">0161-5890</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a key regulatory factor in the IgE-mediated allergic signal transduction pathway in mast cells and basophils.  Syk is phosphorylated on a no. of tyrosines following the binding of IgE/allergen complexes to FcεRI receptors leading to initiation of inflammatory signaling via downstream enzymes and scaffolding proteins.  We examd. the kinases responsible for the phosphorylation of key Syk tyrosines in rat RBL-2H3 basophilic cells and bone marrow-derived mast cells (BMMCs).  The phosphorylation of Syk tyrosine 346 was completely blocked by the novel Src family kinase inhibitor BIRA766, suggesting this tyrosine is a pure substrate for Src family kinases.  This was supported by the findings that kinase-dead (KD) Syk was efficiently phosphorylated on this tyrosine and that a specific Syk inhibitor BAY61-3606 was without effect.  The phosphorylation of other Syk tyrosines 317, 342, 519 and 520 was reduced by Syk and Src family inhibitors, suggesting a role for auto- and trans-phosphorylation.  Lyn was the predominant Src family kinase expressed and activated in RBL-2H3 cells, meanwhile Lyn knockdown with a specific siRNA interfered with the phosphorylation of all Syk tyrosines and the Syk substrates SLP-76 and LAT.  Pharmacol. inhibition of Syk completely blocked the degranulation of RBL-2H3 and BMMCs.  However, Lyn knockdown sensitized RBL-2H3 cells to FcεRI-induced degranulation.  We showed that while interference with Lyn expression disrupts FcεRI proximal signaling via Syk and its direct substrates including SLP-76 and LAT, distal activation of downstream proteins including Erk is enhanced.  This study identifies the responsible kinases for the phosphorylation of key Syk tyrosines and the propagation of FcεRI receptor mediated signal transduction in allergic responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogo10wbe3ZX7Vg90H21EOLACvtfcHk0ljE3vdI-6YxBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOnsr7I&md5=e5760b1776ab667759d7af5af7fbc6dd</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.molimm.2010.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molimm.2010.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DSanderson%26aufirst%3DM.%2BP.%26aulast%3DWex%26aufirst%3DE.%26aulast%3DKono%26aufirst%3DT.%26aulast%3DUto%26aufirst%3DK.%26aulast%3DSchnapp%26aufirst%3DA.%26atitle%3DSyk%2520and%2520Lyn%2520mediate%2520distinct%2520Syk%2520phosphorylation%2520events%2520in%2520Fc%25CE%25B5RI-signal%2520transduction%253A%2520implications%2520for%2520regulation%2520of%2520IgE-mediated%2520degranulation%26jtitle%3DMol.%2520Immunol.%26date%3D2010%26volume%3D48%26spage%3D171%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Braselmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvain, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, G</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurcevic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1124%2Fjpet.106.109058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16946104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1yltL7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=998-1008&author=S.+Braselmannauthor=V.+Taylorauthor=H.+Zhaoauthor=S.+Wangauthor=C.+Sylvainauthor=M.+Baluomauthor=K.+Quauthor=E.+Herlaarauthor=A.+Lauauthor=C.+Youngauthor=B.+R.+Wongauthor=S+Lovellauthor=T.+Sunauthor=G+Parkauthor=A.+Argadeauthor=S.+Jurcevicauthor=P.+Pineauthor=R.+Singhauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+S.+Masuda&title=R406%2C+an+orally+available+spleen+tyrosine+kinase+inhibitor+blocks+Fc+receptor+signaling+and+reduces+immune+complex-mediated+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation</span></div><div class="casAuthors">Braselmann, Sylvia; Taylor, Vanessa; Zhao, Haoran; Wang, Su; Sylvain, Catherine; Baluom, Muhammad; Qu, Kunbin; Herlaar, Ellen; Lau, Angela; Young, Chi; Wong, Brian R.; Lovell, Scott; Sun, Thomas; Park, Gary; Argade, Ankush; Jurcevic, Stipo; Pine, Polly; Singh, Rajinder; Grossbard, Elliott B.; Payan, Donald G.; Masuda, Esteban S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">998-1008</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Recent compelling evidence has lead to renewed interest in the role of antibodies and immune complexes in the pathogenesis of several autoimmune disorders, such as rheumatoid arthritis.  These immune complexes, consisting of autoantibodies to self-antigens, can mediate inflammatory responses largely through binding and activating the Ig Fc receptors (FcRs).  Using cell-based structure activity relationships with cultured human mast cells, we have identified the small mol. R406 [N4-(2,2-dimethyl-3-oxo-4H-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2- (3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine] as a potent inhibitor of IgE (IgE)- and IgG-mediated activation of Fc receptor signaling (EC50 for degranulation = 56-64 nM).  Here we show that the primary target for R406 is the spleen tyrosine kinase (Syk), which plays a key role in the signaling of activating Fc receptors and the B-cell receptor (BCR).  R406 inhibited phosphorylation of Syk substrate linker for activation of T cells in mast cells and B-cell linker protein/SLP65 in B cells.  R406 bound to the ATP binding pocket of Syk and inhibited its kinase activity as an ATP-competitive inhibitor (Ki = 30 nM).  Furthermore, R406 blocked Syk-dependent FcR-mediated activation of monocytes/macrophages and neutrophils and BCR-mediated activation of B lymphocytes.  R406 was selective as assessed using a large panel of Syk-independent cell-based assays representing both specific and general signaling pathways.  Consistent with Syk inhibition, oral administration of R406 to mice reduced immune complex-mediated inflammation in a reverse-passive Arthus reaction and two antibody-induced arthritis models.  Finally, we report a first-in-human study showing that R406 is orally bioavailable, achieving exposures capable of inhibiting Syk-dependent IgE-mediated basophil activation.  Collectively, the results show R406 potential for modulating Syk activity in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohoeT9BJQAyLVg90H21EOLACvtfcHk0ljE3vdI-6YxBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1yltL7P&md5=18fea516041ea075d2123158f321a186</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.109058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.109058%26sid%3Dliteratum%253Aachs%26aulast%3DBraselmann%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DSylvain%26aufirst%3DC.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DQu%26aufirst%3DK.%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DYoung%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DB.%2BR.%26aulast%3DLovell%26aufirst%3DS%26aulast%3DSun%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DG%26aulast%3DArgade%26aufirst%3DA.%26aulast%3DJurcevic%26aufirst%3DS.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DR406%252C%2520an%2520orally%2520available%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520Fc%2520receptor%2520signaling%2520and%2520reduces%2520immune%2520complex-mediated%2520inflammation%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D998%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">de Castro, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamur, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siraganian, R. P.</span><span> </span><span class="NLM_article-title">Tyrosines in the carboxyl terminus regulate Syk kinase activity and function</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">26674</span><span class="NLM_x">–</span> <span class="NLM_lpage">26684</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=26674-26684&author=R.+O.+de+Castroauthor=J.+Zhangauthor=M.+C.+Jamurauthor=C.+Oliverauthor=R.+P.+Siraganian&title=Tyrosines+in+the+carboxyl+terminus+regulate+Syk+kinase+activity+and+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCastro%26aufirst%3DR.%2BO.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJamur%26aufirst%3DM.%2BC.%26aulast%3DOliver%26aufirst%3DC.%26aulast%3DSiraganian%26aufirst%3DR.%2BP.%26atitle%3DTyrosines%2520in%2520the%2520carboxyl%2520terminus%2520regulate%2520Syk%2520kinase%2520activity%2520and%2520function%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D26674%26epage%3D26684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">de Castro, R. O.</span><span> </span><span class="NLM_article-title">Regulation and function of Syk tyrosine kinase in mast cell signaling and beyond</span> <span class="citation_source-journal">J. Signal Transduct.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_fpage">507291</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21776385" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BC3MnpvVKksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=507291&author=R.+O.+de+Castro&title=Regulation+and+function+of+Syk+tyrosine+kinase+in+mast+cell+signaling+and+beyond"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation and function of syk tyrosine kinase in mast cell signaling and beyond</span></div><div class="casAuthors">de Castro Rodrigo Orlandini</div><div class="citationInfo"><span class="NLM_cas:title">Journal of signal transduction</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">507291</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The protein tyrosine kinase Syk plays a critical role in FcεRI signaling in mast cells.  Binding of Syk to phosphorylated immunoreceptor tyrosine-based activation motifs (p-ITAM) of the receptor subunits results in conformational changes and tyrosine phosphorylation at multiple sites that leads to activation of Syk.  The phosphorylated tyrosines throughout the molecule play an important role in the regulation of Syk-mediated signaling.  Reconstitution of receptor-mediated signaling in Syk(-/-) cells by wild-type Syk or mutants which have substitution of these tyrosines with phenylalanine together with in vitro assays has been useful strategies to understand the regulation and function of Syk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCfOL0q4nTvJggzHGM8X5CfW6udTcc2eaOdlxEBTiZBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MnpvVKksg%253D%253D&md5=23b545f22faa5756e178e86dc180baaf</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BCastro%26aufirst%3DR.%2BO.%26atitle%3DRegulation%2520and%2520function%2520of%2520Syk%2520tyrosine%2520kinase%2520in%2520mast%2520cell%2520signaling%2520and%2520beyond%26jtitle%3DJ.%2520Signal%2520Transduct.%26date%3D2011%26spage%3D507291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Deindl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kadlecek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Stability of an autoinhibitory interface in the structure of the tyrosine kinase ZAP-70 impacts T cell receptor response</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">20699</span><span class="NLM_x">–</span> <span class="NLM_lpage">20704</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=20699-20704&author=S.+Deindlauthor=T.+A.+Kadlecekauthor=X.+Caoauthor=J.+Kuriyanauthor=A.+Weiss&title=Stability+of+an+autoinhibitory+interface+in+the+structure+of+the+tyrosine+kinase+ZAP-70+impacts+T+cell+receptor+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeindl%26aufirst%3DS.%26aulast%3DKadlecek%26aufirst%3DT.%2BA.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DKuriyan%26aufirst%3DJ.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DStability%2520of%2520an%2520autoinhibitory%2520interface%2520in%2520the%2520structure%2520of%2520the%2520tyrosine%2520kinase%2520ZAP-70%2520impacts%2520T%2520cell%2520receptor%2520response%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D20699%26epage%3D20704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Isakov, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wange, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samelson, L. E.</span><span> </span><span class="NLM_article-title">ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">181</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=181&publication_year=1995&pages=375-380&author=N.+Isakovauthor=R.+L.+Wangeauthor=W.+H.+Burgessauthor=J.+D.+Wattsauthor=R.+Aebersoldauthor=L.+E.+Samelson&title=ZAP-70+binding+specificity+to+T+cell+receptor+tyrosine-based+activation+motifs%3A+the+tandem+SH2+domains+of+ZAP-70+bind+distinct+tyrosine-based+activation+motifs+with+varying+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsakov%26aufirst%3DN.%26aulast%3DWange%26aufirst%3DR.%2BL.%26aulast%3DBurgess%26aufirst%3DW.%2BH.%26aulast%3DWatts%26aufirst%3DJ.%2BD.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26atitle%3DZAP-70%2520binding%2520specificity%2520to%2520T%2520cell%2520receptor%2520tyrosine-based%2520activation%2520motifs%253A%2520the%2520tandem%2520SH2%2520domains%2520of%2520ZAP-70%2520bind%2520distinct%2520tyrosine-based%2520activation%2520motifs%2520with%2520varying%2520affinity%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1995%26volume%3D181%26spage%3D375%26epage%3D380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Atwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feil, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froning, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller-Dieckmann, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nienaber, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noland, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajashankar, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burley, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, S. G.</span><span> </span><span class="NLM_article-title">A novel mode of gleevec binding is revealed by the structure of spleen tyrosine kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">55827</span><span class="NLM_x">–</span> <span class="NLM_lpage">55832</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1074%2Fjbc.M409792200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15507431" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFeisL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=55827-55832&author=S.+Atwellauthor=J.+M.+Adamsauthor=J.+Badgerauthor=M.+D.+Buchananauthor=I.+K.+Feilauthor=K.+J.+Froningauthor=X.+Gaoauthor=J.+Hendleauthor=K.+Keeganauthor=B.+C.+Leonauthor=H.+J.+M%C3%BCller-Dieckmannauthor=V.+L.+Nienaberauthor=B.+W.+Nolandauthor=K.+Postauthor=K.+R.+Rajashankarauthor=A.+Ramosauthor=M.+Russellauthor=S.+K.+Burleyauthor=S.+G.+Buchanan&title=A+novel+mode+of+gleevec+binding+is+revealed+by+the+structure+of+spleen+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase</span></div><div class="casAuthors">Atwell, Shane; Adams, Jason M.; Badger, John; Buchanan, Michelle D.; Feil, Ingeborg K.; Froning, Karen J.; Gao, Xia; Hendle, Joerg; Keegan, Kevin; Leon, Barbara C.; Mueller-Dieckmann, Hans J.; Nienaber, Vicki L.; Noland, Brian W.; Post, Kai; Rajashankar, K. R.; Ramos, Aurora; Russell, Marijane; Burley, Stephen K.; Buchanan, Sean G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">53</span>),
    <span class="NLM_cas:pages">55827-55832</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a non-receptor tyrosine kinase required for signaling from immunoreceptors in various hematopoietic cells.  Phosphorylation of two tyrosine residues in the activation loop of the Syk kinase catalytic domain is necessary for signaling, a phenomenon typical of tyrosine kinase family members.  Syk in vitro enzyme activity, however, does not depend on phosphorylation (activation loop tyrosine phenylalanine mutants retain catalytic activity).  We have detd. the x-ray structure of the unphosphorylated form of the kinase catalytic domain of Syk.  The enzyme adopts a conformation of the activation loop typically seen only in activated, phosphorylated tyrosine kinases, explaining why Syk does not require phosphorylation for activation.  We also demonstrate that Gleevec (STI-571, Imatinib) inhibits the isolated kinase domains of both unphosphorylated Syk and phosphorylated Abl with comparable potency.  Gleevec binds Syk in a novel, compact cis-conformation that differs dramatically from the binding mode obsd. with unphosphorylated Abl, the more Gleevec-sensitive form of Abl.  This finding suggests the existence of two distinct Gleevec binding modes: an extended, trans-conformation characteristic of tight binding to the inactive conformation of a protein kinase and a second compact, cis-conformation characteristic of weaker binding to the active conformation.  Finally, the Syk-bound cis-conformation of Gleevec bears a striking resemblance to the rigid structure of the nonspecific, natural product kinase inhibitor staurosporine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7D3dM-QQRHLVg90H21EOLACvtfcHk0ljd3g7wQbJDAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFeisL7N&md5=b55eefe8790607cb5c8ae7be8795a83b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M409792200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M409792200%26sid%3Dliteratum%253Aachs%26aulast%3DAtwell%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBadger%26aufirst%3DJ.%26aulast%3DBuchanan%26aufirst%3DM.%2BD.%26aulast%3DFeil%26aufirst%3DI.%2BK.%26aulast%3DFroning%26aufirst%3DK.%2BJ.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DHendle%26aufirst%3DJ.%26aulast%3DKeegan%26aufirst%3DK.%26aulast%3DLeon%26aufirst%3DB.%2BC.%26aulast%3DM%25C3%25BCller-Dieckmann%26aufirst%3DH.%2BJ.%26aulast%3DNienaber%26aufirst%3DV.%2BL.%26aulast%3DNoland%26aufirst%3DB.%2BW.%26aulast%3DPost%26aufirst%3DK.%26aulast%3DRajashankar%26aufirst%3DK.%2BR.%26aulast%3DRamos%26aufirst%3DA.%26aulast%3DRussell%26aufirst%3DM.%26aulast%3DBurley%26aufirst%3DS.%2BK.%26aulast%3DBuchanan%26aufirst%3DS.%2BG.%26atitle%3DA%2520novel%2520mode%2520of%2520gleevec%2520binding%2520is%2520revealed%2520by%2520the%2520structure%2520of%2520spleen%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D55827%26epage%3D55832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Fütterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grucza, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waksman, G.</span><span> </span><span class="NLM_article-title">Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1998&pages=523-537&author=K.+F%C3%BCttererauthor=J.+Wongauthor=R.+A.+Gruczaauthor=A.+C.+Chanauthor=G.+Waksman&title=Structural+basis+for+Syk+tyrosine+kinase+ubiquity+in+signal+transduction+pathways+revealed+by+the+crystal+structure+of+its+regulatory+SH2+domains+bound+to+a+dually+phosphorylated+ITAM+peptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DGrucza%26aufirst%3DR.%2BA.%26aulast%3DChan%26aufirst%3DA.%2BC.%26aulast%3DWaksman%26aufirst%3DG.%26atitle%3DStructural%2520basis%2520for%2520Syk%2520tyrosine%2520kinase%2520ubiquity%2520in%2520signal%2520transduction%2520pathways%2520revealed%2520by%2520the%2520crystal%2520structure%2520of%2520its%2520regulatory%2520SH2%2520domains%2520bound%2520to%2520a%2520dually%2520phosphorylated%2520ITAM%2520peptide%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1998%26volume%3D281%26spage%3D523%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Geijtenbeek, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gringhuis, S. I.</span><span> </span><span class="NLM_article-title">Signalling through C-type lectin receptors: shaping immune responses</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2569" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19521399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXntFCgurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=465-479&author=T.+B.+Geijtenbeekauthor=S.+I.+Gringhuis&title=Signalling+through+C-type+lectin+receptors%3A+shaping+immune+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Signalling through C-type lectin receptors: shaping immune responses</span></div><div class="casAuthors">Geijtenbeek, Teunis B. H.; Gringhuis, Sonja I.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">465-479</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  C-type lectin receptors (CLRs) expressed by dendritic cells are crucial for tailoring immune responses to pathogens.  Following pathogen binding, CLRs trigger distinct signalling pathways that induce the expression of specific cytokines which det. T cell polarization fates.  Some CLRs can induce signalling pathways that directly activate nuclear factor-κB, whereas other CLRs affect signalling by Toll-like receptors.  Dissecting these signalling pathways and their effects on host immune cells is essential to understand the mol. mechanisms involved in the induction of adaptive immune responses.  In this Review we describe the role of CLR signalling in regulating adaptive immunity and immunopathogenesis and discuss how this knowledge can be harnessed for the development of innovative vaccination approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHSCoghEUNSLVg90H21EOLACvtfcHk0ljd3g7wQbJDAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXntFCgurc%253D&md5=91f3810595e1bb4794efa63a97321ecf</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1038%2Fnri2569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2569%26sid%3Dliteratum%253Aachs%26aulast%3DGeijtenbeek%26aufirst%3DT.%2BB.%26aulast%3DGringhuis%26aufirst%3DS.%2BI.%26atitle%3DSignalling%2520through%2520C-type%2520lectin%2520receptors%253A%2520shaping%2520immune%2520responses%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26spage%3D465%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Lowell, C. A.</span><span> </span><span class="NLM_article-title">Src-family and SYK kinases in activating and inhibitory pathways in innate immune cells: signaling cross talk</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">a002352</span><div class="note"><p class="first last"> (DOI: 10.1101/cshperspect.a002352)</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2011&pages=a002352&author=C.+A.+Lowell&title=Src-family+and+SYK+kinases+in+activating+and+inhibitory+pathways+in+innate+immune+cells%3A+signaling+cross+talk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLowell%26aufirst%3DC.%2BA.%26atitle%3DSrc-family%2520and%2520SYK%2520kinases%2520in%2520activating%2520and%2520inhibitory%2520pathways%2520in%2520innate%2520immune%2520cells%253A%2520signaling%2520cross%2520talk%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2011%26volume%3D3%26spage%3Da002352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgner, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C. B.</span><span> </span><span class="NLM_article-title">Tyr130 phosphorylation triggers Syk release from antigen receptor by long-distance conformational uncoupling</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">11760</span><span class="NLM_x">–</span> <span class="NLM_lpage">11765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=11760-11765&author=Y.+Zhangauthor=H.+Ohauthor=R.+A.+Burtonauthor=J.+W.+Burgnerauthor=R.+L.+Geahlenauthor=C.+B.+Post&title=Tyr130+phosphorylation+triggers+Syk+release+from+antigen+receptor+by+long-distance+conformational+uncoupling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DOh%26aufirst%3DH.%26aulast%3DBurton%26aufirst%3DR.%2BA.%26aulast%3DBurgner%26aufirst%3DJ.%2BW.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26aulast%3DPost%26aufirst%3DC.%2BB.%26atitle%3DTyr130%2520phosphorylation%2520triggers%2520Syk%2520release%2520from%2520antigen%2520receptor%2520by%2520long-distance%2520conformational%2520uncoupling%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D11760%26epage%3D11765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Keshvara, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Syk activation and dissociation from the B-cell antigen receptor is mediated by phosphorylation of tyrosine 130</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x">, </span> <span class="NLM_fpage">10377</span><span class="NLM_x">–</span> <span class="NLM_lpage">10381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=10377-10381&author=L.+M.+Keshvaraauthor=C.+Isaacsonauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Syk+activation+and+dissociation+from+the+B-cell+antigen+receptor+is+mediated+by+phosphorylation+of+tyrosine+130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeshvara%26aufirst%3DL.%2BM.%26aulast%3DIsaacson%26aufirst%3DC.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DSyk%2520activation%2520and%2520dissociation%2520from%2520the%2520B-cell%2520antigen%2520receptor%2520is%2520mediated%2520by%2520phosphorylation%2520of%2520tyrosine%2520130%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26spage%3D10377%26epage%3D10381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Yankee, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keshvara, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawasdikosol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen., R. L.</span><span> </span><span class="NLM_article-title">Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tryrosine 317 and the c-Cbl phosphotyrosine-binding domain</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x">, </span> <span class="NLM_fpage">5827</span><span class="NLM_x">–</span> <span class="NLM_lpage">5835</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=1999&pages=5827-5835&author=T.+M.+Yankeeauthor=L.+M.+Keshvaraauthor=S.+Sawasdikosolauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen.&title=Inhibition+of+signaling+through+the+B+cell+antigen+receptor+by+the+protooncogene+product%2C+c-Cbl%2C+requires+Syk+tryrosine+317+and+the+c-Cbl+phosphotyrosine-binding+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYankee%26aufirst%3DT.%2BM.%26aulast%3DKeshvara%26aufirst%3DL.%2BM.%26aulast%3DSawasdikosol%26aufirst%3DS.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen.%26aufirst%3DR.%2BL.%26atitle%3DInhibition%2520of%2520signaling%2520through%2520the%2520B%2520cell%2520antigen%2520receptor%2520by%2520the%2520protooncogene%2520product%252C%2520c-Cbl%252C%2520requires%2520Syk%2520tryrosine%2520317%2520and%2520the%2520c-Cbl%2520phosphotyrosine-binding%2520domain%26jtitle%3DJ.%2520Immunol.%26date%3D1999%26volume%3D163%26spage%3D5827%26epage%3D5835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Ota, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samelson, L. E.</span><span> </span><span class="NLM_article-title">The product of the proto-oncogene c-cbl: a negative regulator of the Syk tyrosine kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">420</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=1997&pages=418-420&author=Y.+Otaauthor=L.+E.+Samelson&title=The+product+of+the+proto-oncogene+c-cbl%3A+a+negative+regulator+of+the+Syk+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOta%26aufirst%3DY.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26atitle%3DThe%2520product%2520of%2520the%2520proto-oncogene%2520c-cbl%253A%2520a%2520negative%2520regulator%2520of%2520the%2520Syk%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D1997%26volume%3D276%26spage%3D418%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Keshvara, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaacson, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yankee, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarac, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Syk- and Lyn-dependent phosphorylation of Syk on multiple tyrosines following B cell activation includes a site that negatively regulates signaling</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">5276</span><span class="NLM_x">–</span> <span class="NLM_lpage">5283</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=1998&pages=5276-5283&author=L.+M.+Keshvaraauthor=C.+C.+Isaacsonauthor=T.+M.+Yankeeauthor=R.+Saracauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Syk-+and+Lyn-dependent+phosphorylation+of+Syk+on+multiple+tyrosines+following+B+cell+activation+includes+a+site+that+negatively+regulates+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKeshvara%26aufirst%3DL.%2BM.%26aulast%3DIsaacson%26aufirst%3DC.%2BC.%26aulast%3DYankee%26aufirst%3DT.%2BM.%26aulast%3DSarac%26aufirst%3DR.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DSyk-%2520and%2520Lyn-dependent%2520phosphorylation%2520of%2520Syk%2520on%2520multiple%2520tyrosines%2520following%2520B%2520cell%2520activation%2520includes%2520a%2520site%2520that%2520negatively%2520regulates%2520signaling%26jtitle%3DJ.%2520Immunol.%26date%3D1998%26volume%3D161%26spage%3D5276%26epage%3D5283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Scharenberg, A. M.</span><span> </span><span class="NLM_article-title">The inhibitory receptor superfamily: potential relevance to atopy</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">621</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0952-7915%2899%2900027-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10631545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFKmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1999&pages=621-625&author=A.+M.+Scharenberg&title=The+inhibitory+receptor+superfamily%3A+potential+relevance+to+atopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">The inhibitory receptor superfamily: potential relevance to atopy</span></div><div class="casAuthors">Scharenberg, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">621-625</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">A review with 42 refs.  The role of inhibitory receptor superfamily (IRS) members in the pathophysiol. of atopy is still largely unexplored but the past year or so has brought at least three important advances in the understanding of IRS member function: first, several targets of an inositol-phosphatase-dependent inhibitory signaling pathway utilized by some IRS members were identified; second, there is accumulating evidence from murine models supporting the importance of inhibitory Fcγ receptors in modulating immune-complex-mediated inflammation; third, the inhibitory signaling capability of several previously identified candidate IRS members, including several expressed on cell types implicated in atopy and allergic reactions, has been demonstrated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpysnpvzXEECrVg90H21EOLACvtfcHk0lhXOtDE6uu28Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFKmtrg%253D&md5=83e956a143f9385cc5340a07dd382fda</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2899%2900027-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252899%252900027-8%26sid%3Dliteratum%253Aachs%26aulast%3DScharenberg%26aufirst%3DA.%2BM.%26atitle%3DThe%2520inhibitory%2520receptor%2520superfamily%253A%2520potential%2520relevance%2520to%2520atopy%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D1999%26volume%3D11%26spage%3D621%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Gergely, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pecht, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sármay, G.</span><span> </span><span class="NLM_article-title">Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells</span> <span class="citation_source-journal">Immunol. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1999&pages=3-15&author=J.+Gergelyauthor=I.+Pechtauthor=G.+S%C3%A1rmay&title=Immunoreceptor+tyrosine-based+inhibition+motif-bearing+receptors+regulate+the+immunoreceptor+tyrosine-based+activation+motif-induced+activation+of+immune+competent+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGergely%26aufirst%3DJ.%26aulast%3DPecht%26aufirst%3DI.%26aulast%3DS%25C3%25A1rmay%26aufirst%3DG.%26atitle%3DImmunoreceptor%2520tyrosine-based%2520inhibition%2520motif-bearing%2520receptors%2520regulate%2520the%2520immunoreceptor%2520tyrosine-based%2520activation%2520motif-induced%2520activation%2520of%2520immune%2520competent%2520cells%26jtitle%3DImmunol.%2520Lett.%26date%3D1999%26volume%3D68%26spage%3D3%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Ravetch, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, L. L.</span><span> </span><span class="NLM_article-title">Immune inhibitory receptors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">290</span><span class="NLM_x">, </span> <span class="NLM_fpage">84</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2000&pages=84-89&author=J.+V.+Ravetchauthor=L.+L.+Lanier&title=Immune+inhibitory+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavetch%26aufirst%3DJ.%2BV.%26aulast%3DLanier%26aufirst%3DL.%2BL.%26atitle%3DImmune%2520inhibitory%2520receptors%26jtitle%3DScience%26date%3D2000%26volume%3D290%26spage%3D84%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Galli, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalesnikoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimbaldeston, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piliponsky, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M.</span><span> </span><span class="NLM_article-title">Mast cells as “tunable” effector and immunoregulatory cells: recent advances</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1146%2Fannurev.immunol.21.120601.141025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15771585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFOju70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=749-786&author=S.+J.+Galliauthor=J.+Kalesnikoffauthor=M.+A.+Grimbaldestonauthor=A.+M.+Piliponskyauthor=C.+M.+M.+Williamsauthor=M.+Tsai&title=Mast+cells+as+%E2%80%9Ctunable%E2%80%9D+effector+and+immunoregulatory+cells%3A+recent+advances"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cells as "Tunable" effector and immunoregulatory cells: Recent advances</span></div><div class="casAuthors">Galli, Stephen J.; Kalesnikoff, Janet; Grimbaldeston, Michele A.; Piliponsky, Adrian M.; Williams, Cara M. M.; Tsai, Mindy</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">749-786</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">This review focuses on recent progress in our understanding of how mast cells can contribute to the initiation, development, expression, and regulation of acquired immune responses, both those assocd. with IgE and those that are apparently expressed independently of this class of Ig.  We emphasize findings derived from in vivo studies in mice, particularly those employing genetic approaches to influence mast cell nos. and/or to alter or delete components of pathways that can regulate mast cell development, signaling, or function.  We advance the hypothesis that mast cells not only can function as proinflammatory effector cells and drivers of tissue remodeling in established acquired immune responses, but also may contribute to the initiation and regulation of such responses.  That is, we propose that mast cells can also function as immunoregulatory cells.  Finally, we show that the notion that mast cells have primarily two functional configurations, off (or resting) or on (or activated for extensive mediator release), markedly oversimplifies reality.  Instead, we propose that mast cells are "tunable," by both genetic and environmental factors, such that, depending on the circumstances, the cell can be positioned phenotypically to express a wide spectrum of variation in the types, kinetics, and/or magnitude of its secretory functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSZ9BB0Ws8j7Vg90H21EOLACvtfcHk0ljylirIKya9sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFOju70%253D&md5=4b97d1fd03f2cb9a13db0cf69552b4a4</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.21.120601.141025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.21.120601.141025%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DKalesnikoff%26aufirst%3DJ.%26aulast%3DGrimbaldeston%26aufirst%3DM.%2BA.%26aulast%3DPiliponsky%26aufirst%3DA.%2BM.%26aulast%3DWilliams%26aufirst%3DC.%2BM.%2BM.%26aulast%3DTsai%26aufirst%3DM.%26atitle%3DMast%2520cells%2520as%2520%25E2%2580%259Ctunable%25E2%2580%259D%2520effector%2520and%2520immunoregulatory%2520cells%253A%2520recent%2520advances%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2005%26volume%3D23%26spage%3D749%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Liang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dale, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colonna, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweighoffer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vignali, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clynes, R.</span><span> </span><span class="NLM_article-title">Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">5916</span><span class="NLM_x">–</span> <span class="NLM_lpage">5926</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=5916-5926&author=B.+Liangauthor=C.+Workmanauthor=J.+Leeauthor=C.+Chewauthor=B.+M.+Daleauthor=L.+Colonnaauthor=M.+Floresauthor=N.+Liauthor=E.+Schweighofferauthor=S.+Greenbergauthor=V.+Tybulewiczauthor=D.+Vignaliauthor=R.+Clynes&title=Regulatory+T+cells+inhibit+dendritic+cells+by+lymphocyte+activation+gene-3+engagement+of+MHC+class+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DB.%26aulast%3DWorkman%26aufirst%3DC.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DChew%26aufirst%3DC.%26aulast%3DDale%26aufirst%3DB.%2BM.%26aulast%3DColonna%26aufirst%3DL.%26aulast%3DFlores%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DSchweighoffer%26aufirst%3DE.%26aulast%3DGreenberg%26aufirst%3DS.%26aulast%3DTybulewicz%26aufirst%3DV.%26aulast%3DVignali%26aufirst%3DD.%26aulast%3DClynes%26aufirst%3DR.%26atitle%3DRegulatory%2520T%2520cells%2520inhibit%2520dendritic%2520cells%2520by%2520lymphocyte%2520activation%2520gene-3%2520engagement%2520of%2520MHC%2520class%2520II%26jtitle%3DJ.%2520Immunol.%26date%3D2008%26volume%3D180%26spage%3D5916%26epage%3D5926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Paris, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Regulation of Syk by phosphorylation on serine in the linker insert</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">39844</span><span class="NLM_x">–</span> <span class="NLM_lpage">39854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=39844-39854&author=L.+L.+Parisauthor=J.+Huauthor=J.+Galanauthor=S.+S.+Ongauthor=V.+A.+Martinauthor=H.+Maauthor=W.+A.+Taoauthor=M.+L.+Harrisonauthor=R.+L.+Geahlen&title=Regulation+of+Syk+by+phosphorylation+on+serine+in+the+linker+insert"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParis%26aufirst%3DL.%2BL.%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DGalan%26aufirst%3DJ.%26aulast%3DOng%26aufirst%3DS.%2BS.%26aulast%3DMartin%26aufirst%3DV.%2BA.%26aulast%3DMa%26aufirst%3DH.%26aulast%3DTao%26aufirst%3DW.%2BA.%26aulast%3DHarrison%26aufirst%3DM.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DRegulation%2520of%2520Syk%2520by%2520phosphorylation%2520on%2520serine%2520in%2520the%2520linker%2520insert%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D39844%26epage%3D39854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Narula, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zydowsky, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botfield, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laird, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karas, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D. C.</span><span> </span><span class="NLM_article-title">Solution structure of the C-terminal SH2 domain of the human tyrosine kinase SYK complexed with a phosphotyrosine pentapeptide</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">1061</span><span class="NLM_x">–</span> <span class="NLM_lpage">1073</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=1061-1073&author=S.+S.+Narulaauthor=R.+W.+Yuanauthor=S.+E.+Adamsauthor=O.+M.+Greenauthor=J.+Greenauthor=T.+B.+Philipsauthor=L.+D.+Zydowskyauthor=M.+C.+Botfieldauthor=M.+Hatadaauthor=E.+R.+Lairdauthor=M.+J.+Zollerauthor=J.+L.+Karasauthor=D.+C.+Dalgarno&title=Solution+structure+of+the+C-terminal+SH2+domain+of+the+human+tyrosine+kinase+SYK+complexed+with+a+phosphotyrosine+pentapeptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNarula%26aufirst%3DS.%2BS.%26aulast%3DYuan%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DS.%2BE.%26aulast%3DGreen%26aufirst%3DO.%2BM.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DPhilips%26aufirst%3DT.%2BB.%26aulast%3DZydowsky%26aufirst%3DL.%2BD.%26aulast%3DBotfield%26aufirst%3DM.%2BC.%26aulast%3DHatada%26aufirst%3DM.%26aulast%3DLaird%26aufirst%3DE.%2BR.%26aulast%3DZoller%26aufirst%3DM.%2BJ.%26aulast%3DKaras%26aufirst%3DJ.%2BL.%26aulast%3DDalgarno%26aufirst%3DD.%2BC.%26atitle%3DSolution%2520structure%2520of%2520the%2520C-terminal%2520SH2%2520domain%2520of%2520the%2520human%2520tyrosine%2520kinase%2520SYK%2520complexed%2520with%2520a%2520phosphotyrosine%2520pentapeptide%26jtitle%3DStructure%26date%3D1995%26volume%3D3%26spage%3D1061%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Gilfillan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, J.</span><span> </span><span class="NLM_article-title">The tyrosine kinase network regulating mast cell activation</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x">, </span> <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1600-065X.2008.00742.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19290926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=149-169&author=A.+M.+Gilfillanauthor=J.+Rivera&title=The+tyrosine+kinase+network+regulating+mast+cell+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine kinase network regulating mast cell activation</span></div><div class="casAuthors">Gilfillan, Alasdair M.; Rivera, Juan</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">149-169</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Mast cell mediator release represents a pivotal event in the initiation of inflammatory reactions assocd. with allergic disorders.  These responses follow antigen-mediated aggregation of IgE-occupied high-affinity receptors for IgE (FcεRI) on the mast cell surface, a response which can be further enhanced following stem cell factor-induced ligation of the mast cell growth factor receptor KIT (CD117).  Activation of tyrosine kinases is central to the ability of both FcεRI and KIT to transmit downstream signaling events required for the regulation of mast cell activation.  Whereas KIT possesses inherent tyrosine kinase activity, FcεRI requires the recruitment of Src family tyrosine kinases and Syk to control the early receptor-proximal signaling events.  The signaling pathways propagated by these tyrosine kinases can be further upregulated by the Tec kinase Bruton's tyrosine kinase and downregulated by the actions of the tyrosine Src homol. 1 domain-contg. phosphatase 1 (SHP-1) and SHP-2.  In this review, we discuss the regulation and role of specific members of this tyrosine kinase network in KIT and FcεRI-mediated mast cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoy56joV_npvbVg90H21EOLACvtfcHk0lgggLyC_d7YHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7rL&md5=64230109d9dc900672ae0e605bee57db</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00742.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00742.x%26sid%3Dliteratum%253Aachs%26aulast%3DGilfillan%26aufirst%3DA.%2BM.%26aulast%3DRivera%26aufirst%3DJ.%26atitle%3DThe%2520tyrosine%2520kinase%2520network%2520regulating%2520mast%2520cell%2520activation%26jtitle%3DImmunol.%2520Rev.%26date%3D2009%26volume%3D228%26spage%3D149%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Williams, D. H.; Lamers, M. B. A. C.; Smith, S.; Cherry, M.</span><span> </span><span class="NLM_article-title">Spleen Tyrosine Kinase Catalytic Domain: Crystal Structure and Binding Pockets Thereof</span>. WO2004035604,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=D.+H.+Williams&author=M.+B.+A.+C.+Lamers&author=S.+Smith&author=M.+Cherry&title=Spleen+Tyrosine+Kinase+Catalytic+Domain%3A+Crystal+Structure+and+Binding+Pockets+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DSpleen%2520Tyrosine%2520Kinase%2520Catalytic%2520Domain%253A%2520Crystal%2520Structure%2520and%2520Binding%2520Pockets%2520Thereof%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Villaseñor, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondru, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papp, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Browner, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span> </span><span class="NLM_article-title">Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">–</span> <span class="NLM_lpage">470</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1747-0285.2009.00785.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19220318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVWhsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2009&pages=466-470&author=A.+G.+Villase%C3%B1orauthor=R.+Kondruauthor=H.+Hoauthor=S.+Wangauthor=E.+Pappauthor=D.+Shawauthor=J.+W.+Barnettauthor=M.+F.+Brownerauthor=A.+Kuglstatter&title=Structural+insights+for+design+of+potent+spleen+tyrosine+kinase+inhibitors+from+crystallographic+analysis+of+three+inhibitor+complexes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes</span></div><div class="casAuthors">Villasenor, Armando G.; Kondru, Rama; Ho, Hoangdung; Wang, Sandra; Papp, Eva; Shaw, David; Barnett, Jim W.; Browner, Michelle F.; Kuglstatter, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466-470</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase is considered an attractive drug target for the treatment of allergic and anti-body mediated autoimmune diseases.  We have detd. the co-crystal structures of spleen tyrosine kinase complexed with three known inhibitors: YM193306, a 7-azaindole deriv. and R406.  The cis-cyclohexyldiamino moiety of YM193306 is forming four hydrophobically shielded polar interactions with the spleen tyrosine kinase protein and is therefore crucial for the high potency of this inhibitor.  Its primary amino group is inducing a conformational change of the spleen tyrosine kinase DFG Asp side chain.  The crystal structure of the 7-azaindole deriv. bound to spleen tyrosine kinase is the first demonstration of a 2-substituted 7-azaindole bound to a protein kinase.  Its indole-amide substituent is tightly packed between the N- and C-terminal kinase lobes.  The co-crystal structure of the spleen tyrosine kinase-R406 complex shows two main differences to the previously reported structure of spleen tyrosine kinase soaked with R406: (i) the side chain of the highly conserved Lys is disordered and not forming a hydrogen bond to R406 and (ii) the DFG Asp side chain is pointing away from and not towards R406.  The novel protein-ligand interactions and protein conformational changes revealed in these structures guide the rational design and structure-based optimization of second-generation spleen tyrosine kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4ofv25cSrSbVg90H21EOLACvtfcHk0lgGFa7MEPzyyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVWhsrY%253D&md5=1646c908ca57dc3b1d612769f9a53c02</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2009.00785.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2009.00785.x%26sid%3Dliteratum%253Aachs%26aulast%3DVillase%25C3%25B1or%26aufirst%3DA.%2BG.%26aulast%3DKondru%26aufirst%3DR.%26aulast%3DHo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPapp%26aufirst%3DE.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DBarnett%26aufirst%3DJ.%2BW.%26aulast%3DBrowner%26aufirst%3DM.%2BF.%26aulast%3DKuglstatter%26aufirst%3DA.%26atitle%3DStructural%2520insights%2520for%2520design%2520of%2520potent%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520from%2520crystallographic%2520analysis%2520of%2520three%2520inhibitor%2520complexes%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2009%26volume%3D73%26spage%3D466%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Hisamichi, H.; Naito, R.; Kawazoe, S.; Toyoshima, A.; Tanabe, K.; Nakai, E.; Ichikawa, A.; Orita, A.; Takeuchi, M.</span><span> </span><span class="NLM_article-title">Preparation of Novel Pyrimidine-5-carboxamide Derivatives as Tyrosinase Inhibitors</span>. WO199931073,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=H.+Hisamichi&author=R.+Naito&author=S.+Kawazoe&author=A.+Toyoshima&author=K.+Tanabe&author=E.+Nakai&author=A.+Ichikawa&author=A.+Orita&author=M.+Takeuchi&title=Preparation+of+Novel+Pyrimidine-5-carboxamide+Derivatives+as+Tyrosinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHisamichi%26aufirst%3DH.%26atitle%3DPreparation%2520of%2520Novel%2520Pyrimidine-5-carboxamide%2520Derivatives%2520as%2520Tyrosinase%2520Inhibitors%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Cox, P. J.; Majid, T. N.; Lai, J. Y. Q.; Morley, A. D.; Amendola, S.; Deprets, S.; Edlin, C.</span><span> </span><span class="NLM_article-title">Preparation of Azaindoles as Protein Kinase Inhibitors</span>. WO200147922,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=P.+J.+Cox&author=T.+N.+Majid&author=J.+Y.+Q.+Lai&author=A.+D.+Morley&author=S.+Amendola&author=S.+Deprets&author=C.+Edlin&title=Preparation+of+Azaindoles+as+Protein+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DP.%2BJ.%26atitle%3DPreparation%2520of%2520Azaindoles%2520as%2520Protein%2520Kinase%2520Inhibitors%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Farmer, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britt, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cochran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connors, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrington, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markland, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanthakumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taslimi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhaveri, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, F. G.</span><span> </span><span class="NLM_article-title">Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">6231</span><span class="NLM_x">–</span> <span class="NLM_lpage">6235</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=6231-6235&author=L.+J.+Farmerauthor=G.+Bemisauthor=S.+D.+Brittauthor=J.+Cochranauthor=M.+Connorsauthor=E.+M.+Harringtonauthor=T.+Hoockauthor=W.+Marklandauthor=S.+Nanthakumarauthor=P.+Taslimiauthor=E.+Ter+Haarauthor=J.+Wangauthor=D.+Zhaveriauthor=F.+G.+Salituro&title=Discovery+and+SAR+of+novel+4-thiazolyl-2-phenylaminopyrimidines+as+potent+inhibitors+of+spleen+tyrosine+kinase+%28SYK%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarmer%26aufirst%3DL.%2BJ.%26aulast%3DBemis%26aufirst%3DG.%26aulast%3DBritt%26aufirst%3DS.%2BD.%26aulast%3DCochran%26aufirst%3DJ.%26aulast%3DConnors%26aufirst%3DM.%26aulast%3DHarrington%26aufirst%3DE.%2BM.%26aulast%3DHoock%26aufirst%3DT.%26aulast%3DMarkland%26aufirst%3DW.%26aulast%3DNanthakumar%26aufirst%3DS.%26aulast%3DTaslimi%26aufirst%3DP.%26aulast%3DTer%2BHaar%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhaveri%26aufirst%3DD.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520novel%25204-thiazolyl-2-phenylaminopyrimidines%2520as%2520potent%2520inhibitors%2520of%2520spleen%2520tyrosine%2520kinase%2520%2528SYK%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D6231%26epage%3D6235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Hammaker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">“Go upstream, young man”: lessons learned from the p38 saga</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">i77</span><span class="NLM_x">–</span> <span class="NLM_lpage">i82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=i77-i82&issue=Suppl.+1&author=D.+Hammakerauthor=G.+S.+Firestein&title=%E2%80%9CGo+upstream%2C+young+man%E2%80%9D%3A+lessons+learned+from+the+p38+saga"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHammaker%26aufirst%3DD.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3D%25E2%2580%259CGo%2520upstream%252C%2520young%2520man%25E2%2580%259D%253A%2520lessons%2520learned%2520from%2520the%2520p38%2520saga%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2010%26volume%3D69%26issue%3DSuppl.%25201%26spage%3Di77%26epage%3Di82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Smolen, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, G.</span><span> </span><span class="NLM_article-title">Therapeutic strategies for rheumatoid arthritis</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=473-488&author=J.+S.+Smolenauthor=G.+Steiner&title=Therapeutic+strategies+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmolen%26aufirst%3DJ.%2BS.%26aulast%3DSteiner%26aufirst%3DG.%26atitle%3DTherapeutic%2520strategies%2520for%2520rheumatoid%2520arthritis%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D473%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Pamuk, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases</span> <span class="citation_source-journal">Arthritis Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1186%2Far3198" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21211067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVSjtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=222&author=O.+N.+Pamukauthor=G.+C.+Tsokos&title=Spleen+tyrosine+kinase+inhibition+in+the+treatment+of+autoimmune%2C+allergic+and+autoinflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases</span></div><div class="casAuthors">Pamuk, Omer N.; Tsokos, George C.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis Research & Therapy</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">222</span>CODEN:
                <span class="NLM_cas:coden">ARTRCV</span>;
        ISSN:<span class="NLM_cas:issn">1478-6362</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (Syk) is involved in the development of the adaptive immune system and has been recognized as being important in the function of addnl. cell types, including platelets, phagocytes, fibroblasts, and osteoclasts, and in the generation of the inflammasome.  Preclin. studies presented compelling evidence that Syk inhibition may have therapeutic value in the treatment of rheumatoid arthritis and other forms of arthritis, systemic lupus erythematosus, autoimmune cytopenias, and allergic and autoinflammatory diseases.  In addn., Syk inhibition may have a place in limiting tissue injury assocd. with organ transplant and revascularization procedures.  Clin. trials have documented exciting success in the treatment of patients with rheumatoid arthritis, autoimmune cytopenias, and allergic rhinitis.  While the extent and severity of side effects appear to be limited so far, larger studies will unravel the risk involved with the clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjha8mMit0ELVg90H21EOLACvtfcHk0lhJuNgNBgf_aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVSjtLk%253D&md5=2dd62b67d775892137304f8e8514620e</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1186%2Far3198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Far3198%26sid%3Dliteratum%253Aachs%26aulast%3DPamuk%26aufirst%3DO.%2BN.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DSpleen%2520tyrosine%2520kinase%2520inhibition%2520in%2520the%2520treatment%2520of%2520autoimmune%252C%2520allergic%2520and%2520autoinflammatory%2520diseases%26jtitle%3DArthritis%2520Res.%2520Ther.%26date%3D2010%26volume%3D12%26spage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Ghosh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases</span> <span class="citation_source-journal">Autoimmunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2010&pages=48-55&author=D.+Ghoshauthor=G.+C.+Tsokos&title=Spleen+tyrosine+kinase%3A+an+Src+family+of+non-receptor+kinase+has+multiple+functions+and+represents+a+valuable+therapeutic+target+in+the+treatment+of+autoimmune+and+inflammatory+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DD.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DSpleen%2520tyrosine%2520kinase%253A%2520an%2520Src%2520family%2520of%2520non-receptor%2520kinase%2520has%2520multiple%2520functions%2520and%2520represents%2520a%2520valuable%2520therapeutic%2520target%2520in%2520the%2520treatment%2520of%2520autoimmune%2520and%2520inflammatory%2520diseases%26jtitle%3DAutoimmunity%26date%3D2010%26volume%3D43%26spage%3D48%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Šenolt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vencovský, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavelka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ospelt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gay, S.</span><span> </span><span class="NLM_article-title">Prospective new biological therapies for rheumatoid arthritis</span> <span class="citation_source-journal">Autoimmun. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">107</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.autrev.2009.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19328245" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1SjtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=102-107&author=L.+%C5%A0enoltauthor=J.+Vencovsk%C3%BDauthor=K.+Pavelkaauthor=C.+Ospeltauthor=S.+Gay&title=Prospective+new+biological+therapies+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective new biological therapies for rheumatoid arthritis</span></div><div class="casAuthors">Senolt, Ladislav; Vencovsky, Jiri; Pavelka, Karel; Ospelt, Caroline; Gay, Steffen</div><div class="citationInfo"><span class="NLM_cas:title">Autoimmunity Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">102-107</span>CODEN:
                <span class="NLM_cas:coden">ARUEBU</span>;
        ISSN:<span class="NLM_cas:issn">1568-9972</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Advances in the current knowledge of pathogenetic mechanisms of rheumatoid arthritis have contributed to the development of biol. therapy, and translated research findings into clin. practice.  TNF-α (infliximab, etanercept, adalimumab), IL-1 (anakinra) and IL-6 (tocilizumab) inhibitors, a B-cell depleting agent (rituximab) and a drug blocking T-cell costimulation (abatacept) have been approved for rheumatoid arthritis.  The progress in manufg. biotechnol. has contributed to the development of several other prospective agents that may form the basis for the therapy of rheumatoid arthritis in the near future.  New or modified TNF-α inhibitors (golimumab, certolizumab pegol), new monoclonal antibodies against other cytokines (e.g. IL-1, IL-6, IL-12, IL-15, 1L-17, IL-23), and other agents targeting B-cell depletion (e.g. ocrelizumab, ofatumumab) are in various stages of development.  Many pharmaceutical companies have focused on developing small mol. inhibitors with possible peroral administration, which are considered promising drugs for rheumatoid arthritis.  In most cases, these small mols. inhibit cellular kinases (e.g. p38, JAK or Syk) that mediate the signaling and transcription of proinflammatory genes.  In this review, we describe the cytokine inhibitors and modulators of the immune response currently in ongoing clin. trials, the results of which may further expand the spectrum of efficient therapies for chronic autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpssxuz675AqbVg90H21EOLACvtfcHk0lhIMrnxOEDknQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1SjtL7M&md5=2a6638a933c1b6be91b2a4c5eb068a07</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.autrev.2009.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autrev.2009.03.010%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0enolt%26aufirst%3DL.%26aulast%3DVencovsk%25C3%25BD%26aufirst%3DJ.%26aulast%3DPavelka%26aufirst%3DK.%26aulast%3DOspelt%26aufirst%3DC.%26aulast%3DGay%26aufirst%3DS.%26atitle%3DProspective%2520new%2520biological%2520therapies%2520for%2520rheumatoid%2520arthritis%26jtitle%3DAutoimmun.%2520Rev.%26date%3D2009%26volume%3D9%26spage%3D102%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Cohen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleischmann, R.</span><span> </span><span class="NLM_article-title">Kinase inhibitors: a new approach to rheumatoid arthritis treatment</span> <span class="citation_source-journal">Curr. Opin. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">330</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1097%2FBOR.0b013e3283378e6f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20164774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvFClurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2010&pages=330-335&author=S.+Cohenauthor=R.+Fleischmann&title=Kinase+inhibitors%3A+a+new+approach+to+rheumatoid+arthritis+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Kinase inhibitors: a new approach to rheumatoid arthritis treatment</span></div><div class="casAuthors">Cohen, Stanley; Fleischmann, Roy</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Rheumatology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">330-335</span>CODEN:
                <span class="NLM_cas:coden">CORHES</span>;
        ISSN:<span class="NLM_cas:issn">1040-8711</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Purpose of review: Due to the cost and parenteral mode of administration of biologics, efforts to develop oral small mol. inhibitors to protein kinases involved in cellular signaling that impact inflammatory cytokine prodn. have been ongoing.  This article will review the recent publications on these efforts.  Recent findings: On preclin. work, p38 mitogen-activated kinases were considered attractive targets to suppress cytokine prodn.  Three different mols. (SCIO469, Pamapimod, VX-702) that target the p38α isoform have been evaluated in phase 2 trials.  Unfortunately, clin. efficacy was not obsd., and dose-related toxicity was seen.  The future of this approach is unclear.  Targeting more upstream protein tyrosine kinases such as spleen tyrosine kinase (SyK) and the JAK family of kinases has been assocd. with greater success in clin. trials, with efficacy demonstrated.  Adverse events occurred in a dose-dependent fashion with the SyK inhibitor, such as diarrhea and hypertension.  Neutropenia, elevated liver-function tests, serum creatinine elevations and lipid elevations have occurred with JAK-kinase inhibition.  Dose modifications have been made based on the phase 2 trial results; phase 3 clin. trials are ongoing.  Summary: Inhibiting downstream proteins involved in cellular signaling, such as p38, has not been successful to date.  Inhibitors of more upstream protein-tyrosine kinases involved in cellular signaling appear to be viable mol. candidates for rheumatoid arthritis.  If the results seen in phase 2 studies are confirmed in larger phase 3 studies, we may soon have new, oral DMARD therapies available.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPHTV_zDWSYLVg90H21EOLACvtfcHk0lhIMrnxOEDknQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvFClurg%253D&md5=e698be5034c9d7cf330959936b21da16</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1097%2FBOR.0b013e3283378e6f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FBOR.0b013e3283378e6f%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%26aulast%3DFleischmann%26aufirst%3DR.%26atitle%3DKinase%2520inhibitors%253A%2520a%2520new%2520approach%2520to%2520rheumatoid%2520arthritis%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Rheumatol.%26date%3D2010%26volume%3D22%26spage%3D330%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111a"><span><span class="NLM_contrib-group">McInnes, I. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dell, J. R.</span><span> </span><span class="NLM_article-title">State-of-the-art: rheumatoid arthritis</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1898</span><span class="NLM_x">–</span> <span class="NLM_lpage">1906</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111a&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1136%2Fard.2010.134684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111a&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20959326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111a&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2010&pages=1898-1906&author=I.+B.+McInnesauthor=J.+R.+O%E2%80%99Dell&title=State-of-the-art%3A+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111aR"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">State-of-the-art: rheumatoid arthritis</span></div><div class="casAuthors">McInnes, Iain B.; O'Dell, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1898-1906</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review.  The understanding of the pathogenesis and optimal therapeutics for rheumatoid arthritis (RA) has advanced remarkably over the last decade.  This review highlights these key advances, particularly the outcomes of genome-wide scans which have provided an increasingly robust appraisal of the complex genetics that underpin RA.  Such observations are placed in pathogenetic context, particularly concerning the breach of tolerance that presages synovitis and the mechanisms that subserve chronicity.  The key therapeutic strategies and treatment agents, both conventional and biol., now available to effectively manage the disease are described.  Throughout the review, emphasis is placed on unanswered questions and challenges in this exciting field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy_fwi51knDLVg90H21EOLACvtfcHk0lhIMrnxOEDknQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakur3K&md5=0380db3ca2f3ea43890325bb1f97e418</span></div><a href="/servlet/linkout?suffix=cit111a&amp;dbid=16384&amp;doi=10.1136%2Fard.2010.134684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fard.2010.134684%26sid%3Dliteratum%253Aachs%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DJ.%2BR.%26atitle%3DState-of-the-art%253A%2520rheumatoid%2520arthritis%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2010%26volume%3D69%26spage%3D1898%26epage%3D1906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit111a1"><span>Correction appears in Ann. Rheum. Dis.<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">399</span>. </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111a1&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1136%2Fard.2010.134684corr1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Correction+appears+in+Ann.+Rheum.+Dis.+2011%2C+70%2C+399.+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111a1&amp;dbid=16384&amp;doi=10.1136%2Fard.2010.134684corr1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1136%252Fard.2010.134684corr1%26sid%3Dliteratum%253Aachs%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2011%26volume%3D70%26spage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Hueber, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Is spleen tyrosine kinase inhibition an effective therapy for patients with RA?</span> <span class="citation_source-journal">Nat. Clin. Pract. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fncprheum1025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19252517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVOlsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=130-131&author=A.+J.+Hueberauthor=I.+B.+McInnes&title=Is+spleen+tyrosine+kinase+inhibition+an+effective+therapy+for+patients+with+RA%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Is spleen tyrosine kinase inhibition an effective therapy for patients with RA?</span></div><div class="casAuthors">Hueber, Axel J.; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Rheumatology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">130-131</span>CODEN:
                <span class="NLM_cas:coden">NCPRCF</span>;
        ISSN:<span class="NLM_cas:issn">1745-8382</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the success of biol. therapeutic agents that target cytokines and lymphocytes, clin. needs remain unmet in the treatment of rheumatoid arthritis (RA).  The development of small-mol. inhibitors that can block crit. immune signal-transduction pathways are of particular interest as novel therapies for RA.  Spleen tyrosine kinase (SYK) subserves the function of Fc receptors and the B-cell receptor; as such, it is attractive as a potential therapeutic target.  Weinblatt and colleagues recently performed a proof-of-concept study, which demonstrated that inhibition of SYK reduced RA disease activity and levels of disease-relevant biomarkers.  Dose-limiting adverse effects include diarrhea, neutropenia and hypertension, which result from both target-dependent and off-target effects.  This novel study provides the first evidence that SYK could be a useful therapeutic target in RA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfO85VWMx__LVg90H21EOLACvtfcHk0ljUz5dLxKoWbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVOlsL4%253D&md5=c4bcee63a3811034033e3134c0a40fde</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fncprheum1025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncprheum1025%26sid%3Dliteratum%253Aachs%26aulast%3DHueber%26aufirst%3DA.%2BJ.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DIs%2520spleen%2520tyrosine%2520kinase%2520inhibition%2520an%2520effective%2520therapy%2520for%2520patients%2520with%2520RA%253F%26jtitle%3DNat.%2520Clin.%2520Pract.%2520Rheumatol.%26date%3D2009%26volume%3D5%26spage%3D130%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Edwards, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambridge, G.</span><span> </span><span class="NLM_article-title">B-cell targeting in rheumatoid arthritis and other autoimmune diseases</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">394</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri1838" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16622478" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslOhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=394-403&author=J.+C.+Edwardsauthor=G.+Cambridge&title=B-cell+targeting+in+rheumatoid+arthritis+and+other+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">B-cell targeting in rheumatoid arthritis and other autoimmune diseases</span></div><div class="casAuthors">Edwards, Jonathan C. W.; Cambridge, Geraldine</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">394-403</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  B-cell-targeted therapy for autoimmune disease emerged from theor. proposition to practical reality between 1997 and 1998, with the availability of the B-cell-depleting monoclonal antibody rituximab.  Since then, a score of autoantibody-assocd. disorders have been treated, with most convincing evidence of efficacy seen in subjects with rheumatoid arthritis.  Several classes of B-cell-targeted agent are now under investigation.  From the outset, a major goal of B-cell targeting has been the re-establishment of some form of immunol. tolerance.  In some subjects, the obsd. improvement of disease for years following therapy fuels hope that this goal might ultimately be achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe1G7uLySu5bVg90H21EOLACvtfcHk0ljUz5dLxKoWbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslOhu7g%253D&md5=2c5e0e12629dc50a1d12b01321645c1d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnri1838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri1838%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DJ.%2BC.%26aulast%3DCambridge%26aufirst%3DG.%26atitle%3DB-cell%2520targeting%2520in%2520rheumatoid%2520arthritis%2520and%2520other%2520autoimmune%2520diseases%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2006%26volume%3D6%26spage%3D394%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Gómez-Puerta, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosch, X.</span><span> </span><span class="NLM_article-title">Therapy: spleen tyrosine kinase inhibitors-novel therapies for RA?</span> <span class="citation_source-journal">Nat. Rev. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">134</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnrrheum.2011.8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21304505" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislOktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=134-136&author=J.+A.+G%C3%B3mez-Puertaauthor=X.+Bosch&title=Therapy%3A+spleen+tyrosine+kinase+inhibitors-novel+therapies+for+RA%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Spleen tyrosine kinase inhibitors-novel therapies for RA?</span></div><div class="casAuthors">Gomez-Puerta, Jose A.; Bosch, Xavier</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Rheumatology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">134-136</span>CODEN:
                <span class="NLM_cas:coden">NRRACB</span>;
        ISSN:<span class="NLM_cas:issn">1759-4790</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">In patients with active rheumatoid arthritis despite therapy with DMARDs, treatment with a spleen tyrosine kinase inhibitor has achieved similar response rates to those achieved in clin. trials of other drugs, including biol. agents.  Where might these agents fit in the current armamentarium against this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNIfsSlfCofrVg90H21EOLACvtfcHk0lhwmFrZ5yM3CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislOktLY%253D&md5=318bf1fc5c710874911d1aa1ff234a36</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fnrrheum.2011.8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrrheum.2011.8%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B3mez-Puerta%26aufirst%3DJ.%2BA.%26aulast%3DBosch%26aufirst%3DX.%26atitle%3DTherapy%253A%2520spleen%2520tyrosine%2520kinase%2520inhibitors-novel%2520therapies%2520for%2520RA%253F%26jtitle%3DNat.%2520Rev.%2520Rheumatol.%26date%3D2011%26volume%3D7%26spage%3D134%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">Evolving concepts of rheumatoid arthritis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnature01661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12748655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ynu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2003&pages=356-361&author=G.+S.+Firestein&title=Evolving+concepts+of+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Evolving concepts of rheumatoid arthritis</span></div><div class="casAuthors">Firestein, Gary S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">423</span>
        (<span class="NLM_cas:issue">6937</span>),
    <span class="NLM_cas:pages">356-361</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rheumatoid arthritis is the most common inflammatory arthritis and is a major cause of disability.  It existed in early Native American populations several thousand years ago but might not have appeared in Europe until the 17th century.  Early theories on the pathogenesis of rheumatoid arthritis focused on autoantibodies and immune complexes.  T-cell-mediated antigen-specific responses, T-cell-independent cytokine networks, and aggressive tumor-like behavior of rheumatoid synovium have also been implicated.  More recently, the contribution of autoantibodies has returned to the forefront.  Based on the pathogenic mechanisms, specific therapeutic interventions can be designed to suppress synovial inflammation and joint destruction in rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0a0dB-eD7krVg90H21EOLACvtfcHk0lhwmFrZ5yM3CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ynu7c%253D&md5=36a642276886ccc8d0106a0c41ef57b1</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1038%2Fnature01661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01661%26sid%3Dliteratum%253Aachs%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DEvolving%2520concepts%2520of%2520rheumatoid%2520arthritis%26jtitle%3DNature%26date%3D2003%26volume%3D423%26spage%3D356%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Galli, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piliponsky, A. M.</span><span> </span><span class="NLM_article-title">The development of allergic inflammation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">454</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">454</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=454&publication_year=2008&pages=445-454&author=S.+J.+Galliauthor=M.+Tsaiauthor=A.+M.+Piliponsky&title=The+development+of+allergic+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DTsai%26aufirst%3DM.%26aulast%3DPiliponsky%26aufirst%3DA.%2BM.%26atitle%3DThe%2520development%2520of%2520allergic%2520inflammation%26jtitle%3DNature%26date%3D2008%26volume%3D454%26spage%3D445%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Holgate, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosa, R.</span><span> </span><span class="NLM_article-title">Treatment strategies for allergy and asthma</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">218</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18274559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVKjsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=218-230&author=S.+T.+Holgateauthor=R.+Polosa&title=Treatment+strategies+for+allergy+and+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment strategies for allergy and asthma</span></div><div class="casAuthors">Holgate, Stephen T.; Polosa, Riccardo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">218-230</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Allergic diseases have reached epidemic proportions worldwide.  An understanding of the cellular and sol. mediators that are involved in allergic inflammatory responses not only helps in understanding the mechanisms of current treatments, but is also important for the identification of new targets that are amenable to both small-mol. and biol. interventions.  There is now considerable optimism with regards to tackling the allergy epidemic in light of improvements in systemic and mucosal allergen-specific immunotherapy, the identification of key cytokines and their receptors that drive T-helper-2-cell polarization, a clearer understanding of the pathways of leukocyte recruitment and the signalling pathways that are involved in cell activation and mediator secretion, and new approaches to vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4BOKmEiCJ5LVg90H21EOLACvtfcHk0lh1ArW5GBYGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVKjsrY%253D&md5=66f8a45e4a64002fc265a0892ea2a110</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1038%2Fnri2262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2262%26sid%3Dliteratum%253Aachs%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DPolosa%26aufirst%3DR.%26atitle%3DTreatment%2520strategies%2520for%2520allergy%2520and%2520asthma%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D218%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Holgate, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broide, D.</span><span> </span><span class="NLM_article-title">New targets for allergic rhinitis: a disease of civilization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">903</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=903-915&author=S.+T.+Holgateauthor=D.+Broide&title=New+targets+for+allergic+rhinitis%3A+a+disease+of+civilization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DBroide%26aufirst%3DD.%26atitle%3DNew%2520targets%2520for%2520allergic%2520rhinitis%253A%2520a%2520disease%2520of%2520civilization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2003%26volume%3D2%26spage%3D903%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Boguniewicz, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, D. Y.</span><span> </span><span class="NLM_article-title">10. Atopic dermatitis</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x"> (</span><span class="NLM_issue">2, Suppl. Mini-Primer</span><span class="NLM_x">) </span> <span class="NLM_fpage">S475</span><span class="NLM_x">–</span> <span class="NLM_lpage">S480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2006&pages=S475-S480&issue=2%2C+Suppl.+Mini-Primer&author=M+Boguniewiczauthor=D.+Y.+Leung&title=10.+Atopic+dermatitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoguniewicz%26aufirst%3DM%26aulast%3DLeung%26aufirst%3DD.%2BY.%26atitle%3D10.%2520Atopic%2520dermatitis%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2006%26volume%3D117%26issue%3D2%252C%2520Suppl.%2520Mini-Primer%26spage%3DS475%26epage%3DS480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Enyedy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambiar, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liossis, S. N, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kammer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Fcε receptor type I γ chain replaces the deficient T cell receptor ζ chain in T cells of patients with systemic lupus erythematosus</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1114</span><span class="NLM_x">–</span> <span class="NLM_lpage">1121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2F1529-0131%28200105%2944%3A5%3C1114%3A%3AAID-ANR192%3E3.0.CO%3B2-B" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11352243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38XptlE%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1114-1121&author=E.+J.+Enyedyauthor=M.+P.+Nambiarauthor=S.+N%2C+C.+Liossisauthor=G.+Dennisauthor=G.+M.+Kammerauthor=G.+C.+Tsokos&title=Fc%CE%B5+receptor+type+I+%CE%B3+chain+replaces+the+deficient+T+cell+receptor+%CE%B6+chain+in+T+cells+of+patients+with+systemic+lupus+erythematosus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Fcε receptor type I γ chain replaces the deficient T cell receptor ζ chain in T cells of patients with systemic lupus erythematosus</span></div><div class="casAuthors">Enyedy, Edith J.; Nambiar, Madhusoodana P.; Liossis, Stamatis-Nick C.; Dennis, Gregory; Kammer, Gary M.; Tsokos, George C.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1114-1121</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">T cells from the majority of patients with systemic lupus erythematosus (SLE) express significantly lower levels of T cell receptor chain, a crit. signaling mol.  However, TCR/CD3 triggering of SLE T cells shows increased phosphorylation of downstream signaling intermediates and increased [Ca2+]i response, suggesting the presence of alternative signaling mechanisms.  We investigated whether Fcε receptor type I γ chain (FcεRIγ) could substitute for TCR chain and contribute to T cell signaling in SLE.  T cells were purified from the peripheral blood of 21 patients with SLE and 5 healthy volunteers.  The expression of FcεRIγ was investigated using immunoblotting, reverse transcriptase-polymerase chain reaction, and flow cytometry methods.  Involvement of the FcεRIγ in T cell signaling was studied by immunopptn. and/or immunoblotting after TCR/CD3 stimulation.  Western blotting and densitometric anal. showed that the expression of FcεRIγ in SLE T cells was 4.3-fold higher than in normal T cells (P < 0.001).  Flow cytometric analyses of T lymphocyte subsets revealed that the proportions of FcεRIγ+,CD3+,FcεRIγ+,CD4+, and FcεRIγ+, CD8+ cells were significantly greater in SLE patients than in healthy controls (P < 0.001).  Immunopptn. of SLE T cell lysates with an anti-FcεRIγ antibody showed that FcεRIγ assocs. with the tyrosine kinase Syk and the CD3ε chain, suggesting that FcεRIγ is functionally involved in TCR signaling.  These results demonstrate that the FcεRI γ chain is expressed at high levels in a large proportion of SLE T cells.  The increased expression of FcεRI γ chain in SLE T cells may account in part for the aberrant antigen receptor-initiated signaling and contribute to the diverse cellular abnormalities found in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzrYakwhlwQ7Vg90H21EOLACvtfcHk0lh1ArW5GBYGNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptlE%253D&md5=55222fbf6205e33c829c878eb1fd2344</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1002%2F1529-0131%28200105%2944%3A5%3C1114%3A%3AAID-ANR192%3E3.0.CO%3B2-B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1529-0131%2528200105%252944%253A5%253C1114%253A%253AAID-ANR192%253E3.0.CO%253B2-B%26sid%3Dliteratum%253Aachs%26aulast%3DEnyedy%26aufirst%3DE.%2BJ.%26aulast%3DNambiar%26aufirst%3DM.%2BP.%26aulast%3DLiossis%26aufirst%3DS.%2BN%252C%2BC.%26aulast%3DDennis%26aufirst%3DG.%26aulast%3DKammer%26aufirst%3DG.%2BM.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DFc%25CE%25B5%2520receptor%2520type%2520I%2520%25CE%25B3%2520chain%2520replaces%2520the%2520deficient%2520T%2520cell%2520receptor%2520%25CE%25B6%2520chain%2520in%2520T%2520cells%2520of%2520patients%2520with%2520systemic%2520lupus%2520erythematosus%26jtitle%3DArthritis%2520Rheum.%26date%3D2001%26volume%3D44%26spage%3D1114%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Cines, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchette, V. S.</span><span> </span><span class="NLM_article-title">Immune thrombocytopenic purpura</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">346</span><span class="NLM_x">, </span> <span class="NLM_fpage">995</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1056%2FNEJMra010501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11919310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD387ovFOntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2002&pages=995-1008&author=D.+B.+Cinesauthor=V.+S.+Blanchette&title=Immune+thrombocytopenic+purpura"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Immune thrombocytopenic purpura</span></div><div class="casAuthors">Cines Douglas B; Blanchette Victor S</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">995-1008</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJVeKVHwuSNzEwO064Z95rfW6udTcc2eZzM9DNwnubbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD387ovFOntw%253D%253D&md5=c47bb4799a595d73d19b21756354e9f1</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1056%2FNEJMra010501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra010501%26sid%3Dliteratum%253Aachs%26aulast%3DCines%26aufirst%3DD.%2BB.%26aulast%3DBlanchette%26aufirst%3DV.%2BS.%26atitle%3DImmune%2520thrombocytopenic%2520purpura%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2002%26volume%3D346%26spage%3D995%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Rosse, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillmen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, A. D.</span><span> </span><span class="NLM_article-title">Immune-mediated hemolytic anemia</span> <span class="citation_source-journal">Hematology: Am. Soc. Hematol., Educ. Program</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">48</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1182%2Fasheducation-2004.1.48" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15561676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD2crovVamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=48-62&author=W.+F.+Rosseauthor=P.+Hillmenauthor=A.+D.+Schreiber&title=Immune-mediated+hemolytic+anemia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Immune-mediated hemolytic anemia</span></div><div class="casAuthors">Rosse Wendell F; Hillmen Peter; Schreiber Alan D</div><div class="citationInfo"><span class="NLM_cas:title">Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-62</span>
        ISSN:<span class="NLM_cas:issn">1520-4391</span>.
    </div><div class="casAbstract">Hemolytic anemia due to immune function is one of the major causes of acquired hemolytic anemia.  In recent years, as more is known about the immune system, these entities have become better understood and their treatment improved.  In this section, we will discuss three areas in which this progress has been apparent.  In Section I, Dr.  Peter Hillmen outlines the recent findings in the pathogenesis of paroxysmal nocturnal hemoglobinuria (PNH), relating the biochemical defect (the lack of glycosylphosphatidylinositol [GPI]-linked proteins on the cell surface) to the clinical manifestations, particularly hemolysis (and its effects) and thrombosis.  He discusses the pathogenesis of the disorder in the face of marrow dysfunction insofar as it is known.  His major emphasis is on innovative therapies that are designed to decrease the effectiveness of complement activation, since the lack of cellular modulation of this system is the primary cause of the pathology of the disease.  He recounts his considerable experience with a humanized monoclonal antibody against C5, which has a remarkable effect in controlling the manifestations of the disease.  Other means of controlling the action of complement include replacing the missing modulatory proteins on the cell surface; these studies are not as developed as the former agent.  In Section II, Dr.  Alan Schreiber describes the biochemistry, genetics, and function of the Fc gamma receptors and their role in the pathobiology of autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura due to IgG antibodies.  He outlines the complex varieties of these molecules, showing how they vary in genetic origin and in function.  These variations can be related to three-dimensional topography, which is known in some detail.  Liganding IgG results in the transduction of a signal through the tyrosine-based activation motif and Syk signaling.  The role of these receptors in the pathogenesis of hematological diseases due to IgG antibodies is outlined and the potential of therapy of these diseases by regulation of these receptors is discussed.  In Section III, Dr.  Wendell Rosse discusses the forms of autoimmune hemolytic anemia characterized by antibodies that react preferentially in the cold-cold agglutinin disease and paroxysmal cold hemoglobinuria (PCH).  The former is due to IgM antibodies with a common but particular structure that reacts primarily with carbohydrate or carbohydrate-containing antigens, an interaction that is diminished at body temperature.  PCH is a less common but probably underdiagnosed illness due to an IgG antibody reacting with a carbohydrate antigen; improved techniques for the diagnosis of PCH are described.  Therapy for the two disorders differs somewhat because of the differences in isotype of the antibody.  Since the hemolysis in both is primarily due to complement activation, the potential role of its control, as by the monoclonal antibody described by Dr.  Hillmen, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQlZ_ReN1VA_denUz0lpNqnfW6udTcc2eZzM9DNwnubbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2crovVamsQ%253D%253D&md5=015844adf996f9d00e3c469cdd066df4</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1182%2Fasheducation-2004.1.48&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fasheducation-2004.1.48%26sid%3Dliteratum%253Aachs%26aulast%3DRosse%26aufirst%3DW.%2BF.%26aulast%3DHillmen%26aufirst%3DP.%26aulast%3DSchreiber%26aufirst%3DA.%2BD.%26atitle%3DImmune-mediated%2520hemolytic%2520anemia%26jtitle%3DHematology%253A%2520Am.%2520Soc.%2520Hematol.%252C%2520Educ.%2520Program%26date%3D2004%26spage%3D48%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Robbie-Ryan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span> </span><span class="NLM_article-title">The role of mast cells in allergy and autoimmunity</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">728</span><span class="NLM_x">–</span> <span class="NLM_lpage">733</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0952-7915%2802%2900394-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12413522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1agt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=728-733&author=M.+Robbie-Ryanauthor=M.+A.+Brown&title=The+role+of+mast+cells+in+allergy+and+autoimmunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mast cells in allergy and autoimmunity</span></div><div class="casAuthors">Robbie-Ryan, Michaela; Brown, Melissa A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">728-733</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Two potential outcomes of dysregulated immunity are allergy and autoimmunity.  Both are characterized by localized inflammation that leads to the injury and/or destruction of target tissues.  Until recently, it was generally accepted that the mechanisms that govern these disease processes are quite disparate; however, new discoveries suggest that the mast cell may underlie much of the pathol. in both these disease syndromes.  Amongst these discoveries is the observation that mast cell-deficient mice exhibit significantly reduced disease severity compared to wild-type littermates in a murine model of multiple sclerosis (MS) and drugs that block mast cell function can improve clin. symptoms in this model.  In addn., gene microarray anal. has revealed that the expression of several mast cell-specific genes is increased in the central nervous system plaques of MS patients.  Although well established as effector cells in allergic inflammation, the location of mast cells and the wealth of inflammatory mediators they express make it likely that they have profound effects on many other autoimmune processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovTpIJaeIXCLVg90H21EOLACvtfcHk0ljqdAW_mc-IFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1agt7Y%253D&md5=de9d7f85e09a5636a52dc69b068b6f41</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2802%2900394-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252802%252900394-1%26sid%3Dliteratum%253Aachs%26aulast%3DRobbie-Ryan%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26atitle%3DThe%2520role%2520of%2520mast%2520cells%2520in%2520allergy%2520and%2520autoimmunity%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2002%26volume%3D14%26spage%3D728%26epage%3D733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Robbie-Ryan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanzola, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secor, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span> </span><span class="NLM_article-title">Cutting edge: both activating and inhibitory fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x">, </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2003&pages=1630-1634&author=M.+Robbie-Ryanauthor=M.+B.+Tanzolaauthor=V.+H.+Secorauthor=M.+A.+Brown&title=Cutting+edge%3A+both+activating+and+inhibitory+fc+receptors+expressed+on+mast+cells+regulate+experimental+allergic+encephalomyelitis+disease+severity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobbie-Ryan%26aufirst%3DM.%26aulast%3DTanzola%26aufirst%3DM.%2BB.%26aulast%3DSecor%26aufirst%3DV.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26atitle%3DCutting%2520edge%253A%2520both%2520activating%2520and%2520inhibitory%2520fc%2520receptors%2520expressed%2520on%2520mast%2520cells%2520regulate%2520experimental%2520allergic%2520encephalomyelitis%2520disease%2520severity%26jtitle%3DJ.%2520Immunol.%26date%3D2003%26volume%3D170%26spage%3D1630%26epage%3D1634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Pedotti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Voss, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, S. J.</span><span> </span><span class="NLM_article-title">Involvement of both “allergic” and “autoimmune” mechanisms in EAE, MS and other autoimmune diseases</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">479</span><span class="NLM_x">–</span> <span class="NLM_lpage">484</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS1471-4906%2803%2900233-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12967671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=479-484&author=R.+Pedottiauthor=J.+J.+De+Vossauthor=L.+Steinmanauthor=S.+J.+Galli&title=Involvement+of+both+%E2%80%9Callergic%E2%80%9D+and+%E2%80%9Cautoimmune%E2%80%9D+mechanisms+in+EAE%2C+MS+and+other+autoimmune+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases</span></div><div class="casAuthors">Pedotti, Rosetta; De Voss, Jason J.; Steinman, Lawrence; Galli, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">479-484</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Allergic and autoimmune diseases have been considered to be at the opposite sides of the spectrum of the immune response.  Autoimmune diseases, such as multiple sclerosis (MS), rheumatoid arthritis and type 1 insulin-dependent diabetes mellitus, are considered T helper 1 (Th1)-mediated diseases, and allergic disorders, such as asthma, food allergy or rhinitis, are considered to be Th2-mediated.  In this Opinion, we present evidence for the hypothesis that, elements of the immune response classically assocd. with allergy, importantly contribute to the pathogenesis of autoimmune demyelinating diseases of the central nervous system (CNS), in both the human disease, MS, and its animal model, exptl. autoimmune (formerly allergic') encephalomyelitis.  Autoimmune demyelinating diseases of the CNS, and other autoimmune diseases, can reflect the interplay of both Th1- and Th2-assocd. mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVqW7qFIeCQrVg90H21EOLACvtfcHk0ljqdAW_mc-IFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGhs7s%253D&md5=1b9675aa483aea8bc0afdb0393bbd8c1</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1016%2FS1471-4906%2803%2900233-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4906%252803%252900233-3%26sid%3Dliteratum%253Aachs%26aulast%3DPedotti%26aufirst%3DR.%26aulast%3DDe%2BVoss%26aufirst%3DJ.%2BJ.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26atitle%3DInvolvement%2520of%2520both%2520%25E2%2580%259Callergic%25E2%2580%259D%2520and%2520%25E2%2580%259Cautoimmune%25E2%2580%259D%2520mechanisms%2520in%2520EAE%252C%2520MS%2520and%2520other%2520autoimmune%2520diseases%26jtitle%3DTrends%2520Immunol.%26date%3D2003%26volume%3D24%26spage%3D479%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Secor, V. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secor, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutekunst, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. A.</span><span> </span><span class="NLM_article-title">Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">191</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">822</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2000&pages=813-822&author=V.+H.+Secorauthor=W.+E.+Secorauthor=C.+A.+Gutekunstauthor=M.+A.+Brown&title=Mast+cells+are+essential+for+early+onset+and+severe+disease+in+a+murine+model+of+multiple+sclerosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSecor%26aufirst%3DV.%2BH.%26aulast%3DSecor%26aufirst%3DW.%2BE.%26aulast%3DGutekunst%26aufirst%3DC.%2BA.%26aulast%3DBrown%26aufirst%3DM.%2BA.%26atitle%3DMast%2520cells%2520are%2520essential%2520for%2520early%2520onset%2520and%2520severe%2520disease%2520in%2520a%2520murine%2520model%2520of%2520multiple%2520sclerosis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2000%26volume%3D191%26spage%3D813%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Wong, W. S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, K. P.</span><span> </span><span class="NLM_article-title">Tyrosine kinase inhibitors: a new approach for asthma</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1697</span><span class="NLM_x">, </span> <span class="NLM_fpage">53</span><span class="NLM_x">–</span> <span class="NLM_lpage">69</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1697&publication_year=2004&pages=53-69&author=W.+S.+F.+Wongauthor=K.+P.+Leong&title=Tyrosine+kinase+inhibitors%3A+a+new+approach+for+asthma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DW.%2BS.%2BF.%26aulast%3DLeong%26aufirst%3DK.%2BP.%26atitle%3DTyrosine%2520kinase%2520inhibitors%253A%2520a%2520new%2520approach%2520for%2520asthma%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1697%26spage%3D53%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Wong, W. S. F.</span><span> </span><span class="NLM_article-title">Inhibitors of the tyrosine kinase signaling cascade for asthma</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">–</span> <span class="NLM_lpage">271</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.coph.2005.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15907913" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktlejtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=264-271&author=W.+S.+F.+Wong&title=Inhibitors+of+the+tyrosine+kinase+signaling+cascade+for+asthma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of the tyrosine kinase signaling cascade for asthma</span></div><div class="casAuthors">Wong, Ws fred</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">264-271</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathogenesis of allergic asthma involves the interplay of inflammatory cells and resident airway cells, and of their secreted mediators including cytokines, chemokines, growth factors and inflammatory mediators.  Tyrosine kinase signaling cascades play a crit. role in the pathogenesis of allergic airway inflammation.  Receptor tyrosine kinases (e.g. epidermal growth factor receptor [EGFR] and platelet-derived growth factor receptor) are important for the pathogenesis of airway remodeling.  Stimulation of non-receptor tyrosine kinases (e.g. Lyn, Lck, Syk, ZAP-70, Btk, Itk and JAK) is the earliest detectable signaling response upon activation of immune receptors (T cell receptor, B cell receptor and FCεR1), cytokine receptors and chemokine receptors in inflammatory cells.  Activation of tyrosine kinases invokes multiple downstream signaling pathways, including phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB), leading to cell differentiation, survival, proliferation, degranulation and chemotaxis.  Inhibitors targeted at different enzyme mols. of the tyrosine kinase signaling cascade might afford therapeutic potential for asthma.  Anti-inflammatory effects of pharmacol. agents targeted at tyrosine kinases, Syk, Itk, signal transducer and activator of transcription-1, NF-κB, GATA3, EGFR, PI3K, MEK1/2, p38 MAPK and JNK have been reported in animal models of allergic airway inflammation.  Therefore, development of inhibitors targeted at the tyrosine kinase signaling cascade is an attractive strategy for the treatment of asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu78VGFIAiJrVg90H21EOLACvtfcHk0lhpYiVQluND2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktlejtbw%253D&md5=7b9daf7ec944ef95db7a495ccece3329</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DW.%2BS.%2BF.%26atitle%3DInhibitors%2520of%2520the%2520tyrosine%2520kinase%2520signaling%2520cascade%2520for%2520asthma%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D264%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Oliver, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepley, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortega, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, B. S.</span><span> </span><span class="NLM_article-title">Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcεR1 signaling pathway</span> <span class="citation_source-journal">Immunopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">281</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0162-3109%2800%2900224-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10960668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlvV2nur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2000&pages=269-281&author=J.+M.+Oliverauthor=C.+L.+Kepleyauthor=E.+Ortegaauthor=B.+S.+Wilson&title=Immunologically+mediated+signaling+in+basophils+and+mast+cells%3A+finding+therapeutic+targets+for+allergic+diseases+in+the+human+Fc%CE%B5R1+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcεR1 signaling pathway</span></div><div class="casAuthors">Oliver, J. M.; Kepley, C. L.; Ortega, E.; Wilson, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Immunopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">269-281</span>CODEN:
                <span class="NLM_cas:coden">IMMUDP</span>;
        ISSN:<span class="NLM_cas:issn">0162-3109</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review with 34 refs.  The high affinity IgE receptor, FcεRI, plays key roles in an array of acute and chronic human allergic reactions including asthma, allergic rhinitis, atopic dermatitis, urticaria and anaphylaxis.  In humans and rodents, this receptor is found at high levels on basophils and mast cells where its activation by IgE and multivalent antigen produces mediators and cytokines responsible for FcεRI-dependent acute inflammation.  Mast cells can addnl. contribute to sustained inflammatory responses by internalizing antigen bound to IgE-FcεRI complexes for processing to peptides and presentation to T cells.  In humans, the FcεRI is also expressed, at lower d., on monocytes, macrophages and dendritic cells (DC) where its likely functions again include both signaling to mediator and cytokine prodn. and antigen presentation.  Our labs. have focused on defining the earliest steps in the FcεRI signaling cascade in basophils and mast cells and on developing new routes to control allergic inflammation based on inhibiting these events.  Here, the authors describe novel strategies to limit antigen-stimulated FcεRI signaling by: (1) sequestering the FcεRI-assocd. protein-tyrosine kinase, Lyn, that initiates FcεRI signaling; (2) eliminating; or (3) inactivating the protein-tyrosine kinase, Syk, that propagates FcεRI signaling; and (4) establishing inhibitory crosstalk between FcεRI and a co-expressed receptor, FcγRII, that again limits FcεRI-mediated Syk activation.  These strategies may form the basis for new therapies for allergic inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr72QJZNtYFg7Vg90H21EOLACvtfcHk0lhpYiVQluND2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlvV2nur8%253D&md5=0e964778b93ec34aa97a655d82f2edbb</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2FS0162-3109%2800%2900224-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0162-3109%252800%252900224-1%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DJ.%2BM.%26aulast%3DKepley%26aufirst%3DC.%2BL.%26aulast%3DOrtega%26aufirst%3DE.%26aulast%3DWilson%26aufirst%3DB.%2BS.%26atitle%3DImmunologically%2520mediated%2520signaling%2520in%2520basophils%2520and%2520mast%2520cells%253A%2520finding%2520therapeutic%2520targets%2520for%2520allergic%2520diseases%2520in%2520the%2520human%2520Fc%25CE%25B5R1%2520signaling%2520pathway%26jtitle%3DImmunopharmacology%26date%3D2000%26volume%3D48%26spage%3D269%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Galli, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M.</span><span> </span><span class="NLM_article-title">Mast cells in the development of adaptive immune responses</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fni1158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15662442" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD2M%252FjsV2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=135-142&author=S.+J.+Galliauthor=S.+Nakaeauthor=M.+Tsai&title=Mast+cells+in+the+development+of+adaptive+immune+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Mast cells in the development of adaptive immune responses</span></div><div class="casAuthors">Galli Stephen J; Nakae Susumu; Tsai Mindy</div><div class="citationInfo"><span class="NLM_cas:title">Nature immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-42</span>
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    </div><div class="casAbstract">Mast cells are so widely recognized as critical effector cells in allergic disorders and other immunoglobulin E-associated acquired immune responses that it can be difficult to think of them in any other context.  However, mast cells also can be important as initiators and effectors of innate immunity.  In addition, mast cells that are activated during innate immune responses to pathogens, or in other contexts, can secrete products and have cellular functions with the potential to facilitate the development, amplify the magnitude or regulate the kinetics of adaptive immune responses.  Thus, mast cells may influence the development, intensity and duration of adaptive immune responses that contribute to host defense, allergy and autoimmunity, rather than simply functioning as effector cells in these settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkdMLHjD84DBJ5E29YNGvQfW6udTcc2eb_iZM_EQsxQ7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M%252FjsV2mtQ%253D%253D&md5=57758be92aa3f47f3134bf7a57a8a531</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1038%2Fni1158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni1158%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DNakae%26aufirst%3DS.%26aulast%3DTsai%26aufirst%3DM.%26atitle%3DMast%2520cells%2520in%2520the%2520development%2520of%2520adaptive%2520immune%2520responses%26jtitle%3DNat.%2520Immunol.%26date%3D2005%26volume%3D6%26spage%3D135%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Holgate, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howarth, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haitchi, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, D. E.</span><span> </span><span class="NLM_article-title">Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">496</span><span class="NLM_x">–</span> <span class="NLM_lpage">506</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.jaci.2006.01.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16522446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28Xit1aqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2006&pages=496-506&author=S.+T.+Holgateauthor=J.+Hollowayauthor=S.+Wilsonauthor=P.+H.+Howarthauthor=H.+M.+Haitchiauthor=S.+Babuauthor=D.+E.+Davies&title=Understanding+the+pathophysiology+of+severe+asthma+to+generate+new+therapeutic+opportunities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities</span></div><div class="casAuthors">Holgate, Stephen T.; Holloway, John; Wilson, Susan; Howarth, Peter H.; Haitchi, Hans Michael; Babu, Suresh; Davies, Donna E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">496-506</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Although asthma is defined in terms of reversibility of airflow obstruction, as the disease becomes more severe and chronic, it adopts different characteristics, including a degree of fixed airflow obstruction and corticosteroid refractoriness.  Underlying these phenotypes is evidence of airway wall remodeling, which should be distinguished from the increase in smooth muscle linked to airways hyperresponsiveness.  Aberrant epithelial-mesenchymal communication leads to a chronic wound scenario, which is characterized by activation of the epithelial-mesenchymal trophic unit, epithelial damage, the laying down of new matrix, and greater involvement of neutrophils in the inflammatory response.  In allergic asthmatic patients who remain symptomatic despite high-dose corticosteroid therapy, blockade of IgE with omalizumab confers appreciable clin. benefit.  Chronic severe asthma is also accompanied by a marked increase in TNF-α prodn. that might contribute to corticosteroid refractoriness.  Based on this, TNF blockade with the sol. fusion protein entanercept produces improvement in asthma symptoms, lung function, and quality of life paralleled by a marked redn. in airways hyperresponsiveness.  Identification of novel susceptibility genes, such as a disintegrin and metalloprotease 33 (ADAM33), will provide further targets against which to direct novel therapies for asthma, esp. at the more severe end of the disease spectrum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpapU5eHB23ZbVg90H21EOLACvtfcHk0liE13dqv73b-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xit1aqt7o%253D&md5=b93058f0b3f852ddc287efd169edbc4a</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2006.01.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2006.01.039%26sid%3Dliteratum%253Aachs%26aulast%3DHolgate%26aufirst%3DS.%2BT.%26aulast%3DHolloway%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DHowarth%26aufirst%3DP.%2BH.%26aulast%3DHaitchi%26aufirst%3DH.%2BM.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DDavies%26aufirst%3DD.%2BE.%26atitle%3DUnderstanding%2520the%2520pathophysiology%2520of%2520severe%2520asthma%2520to%2520generate%2520new%2520therapeutic%2520opportunities%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2006%26volume%3D117%26spage%3D496%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Galli, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimbaldeston, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, M.</span><span> </span><span class="NLM_article-title">Immunomodulatory mast cells: negative, as well as positive, regulators of immunity</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2327" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18483499" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=478-486&author=S.+J.+Galliauthor=M.+Grimbaldestonauthor=M.+Tsai&title=Immunomodulatory+mast+cells%3A+negative%2C+as+well+as+positive%2C+regulators+of+immunity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Immunomodulatory mast cells: negative, as well as positive, regulators of immunity</span></div><div class="casAuthors">Galli, Stephen J.; Grimbaldeston, Michele; Tsai, Mindy</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">478-486</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In this Opinion article, Stephen Galli and colleagues discuss the recent evidence that mast cells can have neg., as well as pos., immunomodulatory functions, and suggest that mast cells might have distinct roles at different phases of an immune response.  Mast cells can promote inflammation and other tissue changes in IgE-assocd. allergic disorders, as well as in certain innate and adaptive immune responses that are thought to be independent of IgE.  However, mast cells can also have anti-inflammatory and immunosuppressive functions.  Here, we review the evidence that mast cells can have neg., as well as pos., immunomodulatory roles in vivo, and we propose that mast cells can both enhance and later suppress certain features of an immune response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-1oHz1hfDorVg90H21EOLACvtfcHk0lhjFGQUmu085g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmt1Ojt78%253D&md5=ab7ef0dec97e712222860a4096d694c9</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1038%2Fnri2327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2327%26sid%3Dliteratum%253Aachs%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26aulast%3DGrimbaldeston%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DM.%26atitle%3DImmunomodulatory%2520mast%2520cells%253A%2520negative%252C%2520as%2520well%2520as%2520positive%252C%2520regulators%2520of%2520immunity%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2008%26volume%3D8%26spage%3D478%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Kalesnikoff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galli, S. J.</span><span> </span><span class="NLM_article-title">New developments in mast cell biology</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1215</span><span class="NLM_x">–</span> <span class="NLM_lpage">1223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fni.f.216" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18936782" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KrtbrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=1215-1223&author=J.+Kalesnikoffauthor=S.+J.+Galli&title=New+developments+in+mast+cell+biology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in mast cell biology</span></div><div class="casAuthors">Kalesnikoff, Janet; Galli, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1215-1223</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Mast cells can function as effector and immunoregulatory cells in IgE-assocd. allergic disorders, as well as in certain innate and adaptive immune responses.  This review focuses on exciting new developments in the field of mast cell biol. published in the past year.  The authors highlight advances in the understanding of FcεRI-mediated signaling and mast cell-activation events, as well as in the use of genetic models to study mast cell function in vivo.  Finally, the authors discuss newly identified functions for mast cells or individual mast cell products, such as proteases and interleukin 10, in host defense, cardiovascular disease and tumor biol. and in settings in which mast cells have anti-inflammatory or immunosuppressive functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokEORX7NAwYrVg90H21EOLACvtfcHk0lhjFGQUmu085g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KrtbrI&md5=e765c0d24b6d89c46d7e1521b2508960</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fni.f.216&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.f.216%26sid%3Dliteratum%253Aachs%26aulast%3DKalesnikoff%26aufirst%3DJ.%26aulast%3DGalli%26aufirst%3DS.%2BJ.%26atitle%3DNew%2520developments%2520in%2520mast%2520cell%2520biology%26jtitle%3DNat.%2520Immunol.%26date%3D2008%26volume%3D9%26spage%3D1215%26epage%3D1223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Rivera, J.</span><span> </span><span class="NLM_article-title">Molecular adapters in FcεR1 signaling and the allergic response</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0952-7915%2802%2900396-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12413516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1agt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=688-693&author=J.+Rivera&title=Molecular+adapters+in+Fc%CE%B5R1+signaling+and+the+allergic+response"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular adapters in Fc.vepsiln.RI signaling and the allergic response</span></div><div class="casAuthors">Rivera, Juan</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">688-693</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  IgE-dependent activation of mast cells is central to the allergic response.  The engagement of IgE-occupied receptors initiates a series of mol. events that cause the release of preformed, and de novo synthesis of, allergic mediators.  Recent investigations demonstrate a crit. role for non-enzymic proteins that facilitate the activation and coordination of biochem. signals required for mast cell activation.  Among these LAT, SLP-76 and Gab2 are critically important as adapters that facilitate events initiated by IgE receptor-dependent activation of Src family protein tyrosine kinases, Lyn and Fyn.  An evaluation of the role of these adapters points to complementary but independent steps in early signaling and the possibility that preference for one or another adaptor complex may result in selective mast cell responses.  Recent investigations show that mol. adapters play a major role in IgE-mediated allergic responses because of their ability to coordinate intracellular signaling and their essential nature in mast cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbMUY9icWSFbVg90H21EOLACvtfcHk0lhjFGQUmu085g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1agt7w%253D&md5=9c63226b7ad10e4667c2c49292189b4d</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2802%2900396-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252802%252900396-5%26sid%3Dliteratum%253Aachs%26aulast%3DRivera%26aufirst%3DJ.%26atitle%3DMolecular%2520adapters%2520in%2520Fc%25CE%25B5R1%2520signaling%2520and%2520the%2520allergic%2520response%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2002%26volume%3D14%26spage%3D688%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Fahy, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fick, R. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boushey, H. A.</span><span> </span><span class="NLM_article-title">The effect of an anti-IgE monoclonal antibody on the early and late-phase responses to allergen inhalation in asthmatic subjects</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">1828</span><span class="NLM_x">–</span> <span class="NLM_lpage">1834</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1164%2Fajrccm.155.6.9196082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9196082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADyaK2szjvFCrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1997&pages=1828-1834&author=J.+V.+Fahyauthor=H.+E.+Flemingauthor=H.+H.+Wongauthor=J.+T.+Liuauthor=J.+Q.+Suauthor=J.+Reimannauthor=R.+B.+Fickauthor=H.+A.+Boushey&title=The+effect+of+an+anti-IgE+monoclonal+antibody+on+the+early+and+late-phase+responses+to+allergen+inhalation+in+asthmatic+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects</span></div><div class="casAuthors">Fahy J V; Fleming H E; Wong H H; Liu J T; Su J Q; Reimann J; Fick R B Jr; Boushey H A</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1828-34</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">A humanized murine monoclonal antibody directed to the Fc epsilonR1-binding domain of human IgE (rhuMAb-E25) has been shown to inhibit the binding of IgE to mast cells without provoking mast cell activation.  To examine the effects of neutralizing IgE on allergic airway responses, we assessed the effects of 9 wk of treatment with rhuMAb-E25 in a parallel group, randomized, double-blind, placebo-controlled study of 19 allergic asthmatic subjects.  We found that treatment with rhuMAb-E25 reduced serum IgE, increased the dose of allergen needed to provoke an early asthmatic response, reduced the mean maximal fall in FEV1 during the early response (30 +/- 10% at baseline to 18.8 +/- 8%, versus 33 +/- 8% at baseline to 34 +/- 4% after placebo; p = 0.01), and reduced the mean maximal fall in FEV1 during the late response (24 +/- 20% at baseline to 9 +/- 10% versus 20 +/- 17% at baseline to 18 +/- 17% after placebo; p = 0.047).  We conclude that an anti-IgE monoclonal antibody, which inhibits binding of IgE to its receptor, suppresses the early- and late-phase responses to inhaled allergen in allergic asthmatic subjects.  Targeting IgE with rhuMAb-E25 might be a useful treatment for allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7uWM2JdA5uVf1XRtfYM0dfW6udTcc2ebpe-RF-PxT0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szjvFCrsQ%253D%253D&md5=5c87ce5aab05a1877d81fa704d82e5d2</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.155.6.9196082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.155.6.9196082%26sid%3Dliteratum%253Aachs%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26aulast%3DFleming%26aufirst%3DH.%2BE.%26aulast%3DWong%26aufirst%3DH.%2BH.%26aulast%3DLiu%26aufirst%3DJ.%2BT.%26aulast%3DSu%26aufirst%3DJ.%2BQ.%26aulast%3DReimann%26aufirst%3DJ.%26aulast%3DFick%26aufirst%3DR.%2BB.%26aulast%3DBoushey%26aufirst%3DH.%2BA.%26atitle%3DThe%2520effect%2520of%2520an%2520anti-IgE%2520monoclonal%2520antibody%2520on%2520the%2520early%2520and%2520late-phase%2520responses%2520to%2520allergen%2520inhalation%2520in%2520asthmatic%2520subjects%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1997%26volume%3D155%26spage%3D1828%26epage%3D1834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Fahy, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cockcroft, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulet, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschesnes, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruppel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelman, D. C.</span><span> </span><span class="NLM_article-title">Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">1023</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1164%2Fajrccm.160.3.9810012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=10471635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADyaK1MvgtlamsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=1999&pages=1023-1027&author=J.+V.+Fahyauthor=D.+W.+Cockcroftauthor=L.+P.+Bouletauthor=H.+H.+Wongauthor=F.+Deschesnesauthor=E.+E.+Davisauthor=J.+Ruppelauthor=J.+Q.+Suauthor=D.+C.+Adelman&title=Effect+of+aerosolized+anti-IgE+%28E25%29+on+airway+responses+to+inhaled+allergen+in+asthmatic+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects</span></div><div class="casAuthors">Fahy J V; Cockcroft D W; Boulet L P; Wong H H; Deschesnes F; Davis E E; Ruppel J; Su J Q; Adelman D C</div><div class="citationInfo"><span class="NLM_cas:title">American journal of respiratory and critical care medicine</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1023-7</span>
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    </div><div class="casAbstract">Intravenous administration of a humanized monoclonal antibody of IgE (E25) attenuates the early and late phase response to inhaled allergen in allergic asthmatic subjects.  To test whether direct delivery of E25 to the airway might have the same effect, we conducted a randomized, double-blind, three group study in 33 subjects with mild allergic asthma (20 to 46 yr of age, 21 men, FEV(1) > 70% predicted).  The airway responses to aerosolized allergen were determined at baseline, after 2 and 8 wk of once daily treatment with aerosolized placebo (n = 11), aerosolized E25 1 mg (n = 12), or aerosolized E25 10 mg (n = 10), and after 4 wk of treatment withdrawal.  We found that E25 was detectable in the serum during aerosol treatment, although serum IgE did not change significantly in any of the three groups during treatment.  In addition, both doses of E25 were no more effective than placebo in attenuating the early phase responses to allergen at both times during treatment.  Although aerosolized E25 was generally well tolerated, one subject receiving aerosolized E25 10 mg daily was found to have serum IgG and IgA antibodies to E25.  We conclude that aerosol administration of an anti-IgE monoclonal antibody does not inhibit the airway responses to inhaled allergen in allergic asthmatic subjects.  We speculate that the observed lack of efficacy may be due to the inability of aerosol route of delivery to result in high enough concentrations of E25 in the tissue compartments surrounding IgE effector cells to neutralize IgE arising from local airway and pulmonary sources and IgE arising from the vascular space.  Additionally, the aerosol route of delivery of monoclonal antibodies may be more immunogenic than the parenteral route.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQRZex4-GzQCR0LsK7uFuY7fW6udTcc2ebpe-RF-PxT0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1MvgtlamsQ%253D%253D&md5=3945dd12aeabd36544894dc033117d4c</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1164%2Fajrccm.160.3.9810012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm.160.3.9810012%26sid%3Dliteratum%253Aachs%26aulast%3DFahy%26aufirst%3DJ.%2BV.%26aulast%3DCockcroft%26aufirst%3DD.%2BW.%26aulast%3DBoulet%26aufirst%3DL.%2BP.%26aulast%3DWong%26aufirst%3DH.%2BH.%26aulast%3DDeschesnes%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DE.%2BE.%26aulast%3DRuppel%26aufirst%3DJ.%26aulast%3DSu%26aufirst%3DJ.%2BQ.%26aulast%3DAdelman%26aufirst%3DD.%2BC.%26atitle%3DEffect%2520of%2520aerosolized%2520anti-IgE%2520%2528E25%2529%2520on%2520airway%2520responses%2520to%2520inhaled%2520allergen%2520in%2520asthmatic%2520subjects%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D1999%26volume%3D160%26spage%3D1023%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Podolanczuk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crow, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussel, J. B.</span><span> </span><span class="NLM_article-title">Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">3154</span><span class="NLM_x">–</span> <span class="NLM_lpage">3160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=3154-3160&author=A.+Podolanczukauthor=A.+H.+Lazarusauthor=A.+R.+Crowauthor=E.+B.+Grossbardauthor=J.+B.+Bussel&title=Of+mice+and+men%3A+an+open-label+pilot+study+for+treatment+of+immune+thrombocytopenic+purpura+by+an+inhibitor+of+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPodolanczuk%26aufirst%3DA.%26aulast%3DLazarus%26aufirst%3DA.%2BH.%26aulast%3DCrow%26aufirst%3DA.%2BR.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DBussel%26aufirst%3DJ.%2BB.%26atitle%3DOf%2520mice%2520and%2520men%253A%2520an%2520open-label%2520pilot%2520study%2520for%2520treatment%2520of%2520immune%2520thrombocytopenic%2520purpura%2520by%2520an%2520inhibitor%2520of%2520Syk%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D3154%26epage%3D3160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Pine, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoettler, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banquerigo, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahn, E.</span><span> </span><span class="NLM_article-title">Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor</span> <span class="citation_source-journal">Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">244</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.clim.2007.03.543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17537677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpt1eltb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2007&pages=244-257&author=P.+R.+Pineauthor=B.+Changauthor=N.+Schoettlerauthor=M.+L.+Banquerigoauthor=S.+Wangauthor=A.+Lauauthor=F.+Zhaoauthor=E.+B.+Grossbardauthor=D.+G.+Payanauthor=E.+Brahn&title=Inflammation+and+bone+erosion+are+suppressed+in+models+of+rheumatoid+arthritis+following+treatment+with+a+novel+Syk+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor</span></div><div class="casAuthors">Pine, Polly R.; Chang, Betty; Schoettler, Nathan; Banquerigo, Mona L.; Wang, Su; Lau, Angela; Zhao, Feifei; Grossbard, Elliott B.; Payan, Donald G.; Brahn, Ernest</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Immunology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">244-257</span>CODEN:
                <span class="NLM_cas:coden">CLIIFY</span>;
        ISSN:<span class="NLM_cas:issn">1521-6616</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk), a key mediator of immunoreceptor signaling in inflammatory cells, is essential for immune complex-mediated signal transduction initiated by activated receptors for IgG.  In collagen-induced arthritis, R788/R406, a novel and potent small mol. Syk inhibitor suppressed clin. arthritis, bone erosions, pannus formation, and synovitis.  Serum anti-collagen type II antibody levels were unaltered, while the half-life of exogenous antibody was extended when co-administered with R406.  Expression of the targeted kinase (Syk) in synovial tissue correlated with the joint level of inflammatory cell infiltrates and was virtually undetectable in treated rats.  Syk inhibition suppressed synovial cytokines and cartilage oligomeric matrix protein (COMP) in serum, suggesting a sensitive and reliable biomarker for R406 activity.  These results highlight the role of activating Fcgamma receptors in inflammatory synovitis and suggest that interruption of the signaling cascade with a novel Syk inhibitor may be a useful addn. to immunosuppressive disease-modifying anti-rheumatic drugs currently used in the treatment of human autoimmune diseases such as rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Nm2XObIb37Vg90H21EOLACvtfcHk0lguj_uSxEXl8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpt1eltb0%253D&md5=98b5020fb23cc209e5b7c322024748fb</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.clim.2007.03.543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.clim.2007.03.543%26sid%3Dliteratum%253Aachs%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DSchoettler%26aufirst%3DN.%26aulast%3DBanquerigo%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLau%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DBrahn%26aufirst%3DE.%26atitle%3DInflammation%2520and%2520bone%2520erosion%2520are%2520suppressed%2520in%2520models%2520of%2520rheumatoid%2520arthritis%2520following%2520treatment%2520with%2520a%2520novel%2520Syk%2520inhibitor%26jtitle%3DClin.%2520Immunol.%26date%3D2007%26volume%3D124%26spage%3D244%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Takayanagi, H.</span><span> </span><span class="NLM_article-title">Osteoimmunology: shared mechanisms and crosstalk between the immune and bone system</span> <span class="citation_source-journal">Nat. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">292</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnri2062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17380158" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtlyhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=292-304&author=H.+Takayanagi&title=Osteoimmunology%3A+shared+mechanisms+and+crosstalk+between+the+immune+and+bone+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems</span></div><div class="casAuthors">Takayanagi, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">292-304</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Osteoimmunol. is an interdisciplinary research field focused on the mol. understanding of the interplay between the immune and skeletal systems.  Although osteoimmunol. started with the study of the immune regulation of osteoclasts, its scope has been extended to encompass a wide range of mol. and cellular interactions, including those between osteoblasts and osteoclasts, lymphocytes and osteoclasts, and osteoblasts and hematopoietic cells.  Therefore, the two systems should be understood to be integrated and operating in the context of the 'osteoimmune' system, a heuristic concept that provides not only a framework for obtaining new insights by basic research, but also a scientific basis for the discovery of novel treatments for diseases related to both systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZxVDBwUkq3rVg90H21EOLACvtfcHk0lg3hwbJQLOImA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtlyhurc%253D&md5=61d02a7dac0ac2a0abddeda9ca6eab42</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fnri2062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2062%26sid%3Dliteratum%253Aachs%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DOsteoimmunology%253A%2520shared%2520mechanisms%2520and%2520crosstalk%2520between%2520the%2520immune%2520and%2520bone%2520system%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2007%26volume%3D7%26spage%3D292%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Nakashima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, H.</span><span> </span><span class="NLM_article-title">Osteoimmunology: crosstalk between the immune and bone systems</span> <span class="citation_source-journal">J. Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1007%2Fs10875-009-9316-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19585227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A280%3ADC%252BD1MrmsFaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=555-567&author=T.+Nakashimaauthor=H.+Takayanagi&title=Osteoimmunology%3A+crosstalk+between+the+immune+and+bone+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoimmunology: crosstalk between the immune and bone systems</span></div><div class="casAuthors">Nakashima Tomoki; Takayanagi Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">555-67</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION: The interaction between the immune and skeletal systems has long been acknowledged, but investigation into rheumatoid arthritis (RA) as well as the various bone phenotypes found in immunocompromised gene-deficient mice has highlighted the importance of the dynamic interplay between the two systems.  This has led to the recent emergence and subsequent rapid evolution of the field of osteoimmunology.  BONE DESTRUCTION WITH ARTHRITIS AS A RANKL DISEASE: In the bone destruction associated with RA, IL-17-producing helper T cells (T(H)17) play a major role by inducing receptor activator of nuclear factor-kappaB ligand (RANKL).  RANKL stimulates osteoclastogenesis through nuclear factor of activated T cells cytoplasmic 1 (NFATc1), which is well known as a crucial regulator of immunity.  NEW PLAYERS IN OSTEOIMMUNOLOGY: In addition to cellular interactions via cytokines, the immune and skeletal systems share various molecules, including transcription factors, signaling molecules, and membrane receptors.  CONCLUSION: The scope of osteoimmunology has grown to encompass a wide range of molecular and cellular interactions, the elucidation of which will provide a scientific basis for future therapeutic approaches to diseases of both the immune and skeletal systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTVaWkgxT62xczK395ZObgVfW6udTcc2eZzXokuo605Fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MrmsFaiug%253D%253D&md5=522e206b1c1bfd0467098e9d1d7d673d</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1007%2Fs10875-009-9316-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10875-009-9316-6%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima%26aufirst%3DT.%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DOsteoimmunology%253A%2520crosstalk%2520between%2520the%2520immune%2520and%2520bone%2520systems%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D2009%26volume%3D29%26spage%3D555%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Takayanagi, H.</span><span> </span><span class="NLM_article-title">New immune connections in osteoclast formation</span> <span class="citation_source-journal">Ann. N.Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1192</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">123</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1192&publication_year=2010&pages=117-123&author=H.+Takayanagi&title=New+immune+connections+in+osteoclast+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DNew%2520immune%2520connections%2520in%2520osteoclast%2520formation%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2010%26volume%3D1192%26spage%3D117%26epage%3D123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Mócsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Ziffle, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burghardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spusta, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majumdar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M. C.</span><span> </span><span class="NLM_article-title">The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">6158</span><span class="NLM_x">–</span> <span class="NLM_lpage">6163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=6158-6163&author=A.+M%C3%B3csaiauthor=M.+B.+Humphreyauthor=J.+A.+Van+Ziffleauthor=Y.+Huauthor=A.+Burghardtauthor=S.+C.+Spustaauthor=S.+Majumdarauthor=L.+L.+Lanierauthor=C.+A.+Lowellauthor=M.+C.+Nakamura&title=The+immunomodulatory+adapter+proteins+DAP12+and+Fc+receptor+%CE%B3-chain+%28FcR%CE%B3%29+regulate+development+of+functional+osteoclasts+through+the+Syk+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26aulast%3DHumphrey%26aufirst%3DM.%2BB.%26aulast%3DVan%2BZiffle%26aufirst%3DJ.%2BA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DBurghardt%26aufirst%3DA.%26aulast%3DSpusta%26aufirst%3DS.%2BC.%26aulast%3DMajumdar%26aufirst%3DS.%26aulast%3DLanier%26aufirst%3DL.%2BL.%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DNakamura%26aufirst%3DM.%2BC.%26atitle%3DThe%2520immunomodulatory%2520adapter%2520proteins%2520DAP12%2520and%2520Fc%2520receptor%2520%25CE%25B3-chain%2520%2528FcR%25CE%25B3%2529%2520regulate%2520development%2520of%2520functional%2520osteoclasts%2520through%2520the%2520Syk%2520tyrosine%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2004%26volume%3D101%26spage%3D6158%26epage%3D6163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Koga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inui, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suematsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matozaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniguchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takai, T.</span><span> </span><span class="NLM_article-title">Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">428</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnature02444" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15085135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtV2mt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=428&publication_year=2004&pages=758-763&author=T.+Kogaauthor=M.+Inuiauthor=K.+Inoueauthor=S.+Kimauthor=A.+Suematsuauthor=E.+Kobayashiauthor=T.+Iwataauthor=H.+Ohnishiauthor=T.+Matozakiauthor=T.+Kodamaauthor=T.+Taniguchiauthor=H.+Takayanagiauthor=T.+Takai&title=Costimulatory+signals+mediated+by+the+ITAM+motif+cooperate+with+RANKL+for+bone+homeostasis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis</span></div><div class="casAuthors">Koga, Takako; Inui, Masanori; Inoue, Kazuya; Kim, Sunhwa; Suematsu, Ayako; Kobayashi, Eiji; Iwata, Toshio; Ohnishi, Hiroshi; Matozaki, Takashi; Kodama, Tatsuhiko; Taniguchi, Tadatsugu; Takayanagi, Hiroshi; Takai, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">428</span>
        (<span class="NLM_cas:issue">6984</span>),
    <span class="NLM_cas:pages">758-763</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Costimulatory signals are required for activation of immune cells, but it is not known whether they contribute to other biol. systems.  The development and homeostasis of the skeletal system depend on the balance between bone formation and resorption.  Receptor activator of NF-κB ligand (RANKL) regulates the differentiation of bone-resorbing cells, osteoclasts, in the presence of macrophage-colony stimulating factor (M-CSF).  But it remains unclear how RANKL activates the calcium signals that lead to induction of nuclear factor of activated T cells c1, a key transcription factor for osteoclastogenesis.  Here the authors show that mice lacking immunoreceptor tyrosine-based activation motif (ITAM)-harboring adaptors, Fc receptor common γ subunit (FcRγ) and DNAX-activating protein (DAP)12, exhibit severe osteopetrosis owing to impaired osteoclast differentiation.  In osteoclast precursor cells, FcRγ and DAP12 assoc. with multiple immunoreceptors and activate calcium signaling through phospholipase Cγ.  Thus, ITAM-dependent costimulatory signals activated by multiple immunoreceptors are essential for the maintenance of bone homeostasis.  These results reveal that RANKL and M-CSF are not sufficient to activate the signals required for osteoclastogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvHiH4e8xvSLVg90H21EOLACvtfcHk0lhHf3D_RnBDwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtV2mt78%253D&md5=cc70a7455fe1d9932271758c2791eac5</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1038%2Fnature02444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02444%26sid%3Dliteratum%253Aachs%26aulast%3DKoga%26aufirst%3DT.%26aulast%3DInui%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DSuematsu%26aufirst%3DA.%26aulast%3DKobayashi%26aufirst%3DE.%26aulast%3DIwata%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DH.%26aulast%3DMatozaki%26aufirst%3DT.%26aulast%3DKodama%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DTakayanagi%26aufirst%3DH.%26aulast%3DTakai%26aufirst%3DT.%26atitle%3DCostimulatory%2520signals%2520mediated%2520by%2520the%2520ITAM%2520motif%2520cooperate%2520with%2520RANKL%2520for%2520bone%2520homeostasis%26jtitle%3DNature%26date%3D2004%26volume%3D428%26spage%3D758%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Jakus, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frommhold, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperandio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mócsai, A.</span><span> </span><span class="NLM_article-title">Critical role of phospholipase Cγ2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">206</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=206&publication_year=2009&pages=577-593&author=Z.+Jakusauthor=E.+Simonauthor=D.+Frommholdauthor=M.+Sperandioauthor=A.+M%C3%B3csai&title=Critical+role+of+phospholipase+C%CE%B32+in+integrin+and+Fc+receptor-mediated+neutrophil+functions+and+the+effector+phase+of+autoimmune+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJakus%26aufirst%3DZ.%26aulast%3DSimon%26aufirst%3DE.%26aulast%3DFrommhold%26aufirst%3DD.%26aulast%3DSperandio%26aufirst%3DM.%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26atitle%3DCritical%2520role%2520of%2520phospholipase%2520C%25CE%25B32%2520in%2520integrin%2520and%2520Fc%2520receptor-mediated%2520neutrophil%2520functions%2520and%2520the%2520effector%2520phase%2520of%2520autoimmune%2520arthritis%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2009%26volume%3D206%26spage%3D577%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Zou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitaura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeve, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L. J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shattil, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginsberg, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teitelbaum, S. L.</span><span> </span><span class="NLM_article-title">Syk, c-Src, the ανβ3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">176</span><span class="NLM_x">, </span> <span class="NLM_fpage">877</span><span class="NLM_x">–</span> <span class="NLM_lpage">888</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2007&pages=877-888&author=W.+Zouauthor=H.+Kitauraauthor=J.+Reeveauthor=F.+Longauthor=V.+L.+J+Tybulewiczauthor=S.+J.+Shattilauthor=M.+H.+Ginsbergauthor=F.+P.+Rossauthor=S.+L.+Teitelbaum&title=Syk%2C+c-Src%2C+the+%CE%B1%CE%BD%CE%B23+integrin%2C+and+ITAM+immunoreceptors%2C+in+concert%2C+regulate+osteoclastic+bone+resorption"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DW.%26aulast%3DKitaura%26aufirst%3DH.%26aulast%3DReeve%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%2BJ%26aulast%3DShattil%26aufirst%3DS.%2BJ.%26aulast%3DGinsberg%26aufirst%3DM.%2BH.%26aulast%3DRoss%26aufirst%3DF.%2BP.%26aulast%3DTeitelbaum%26aufirst%3DS.%2BL.%26atitle%3DSyk%252C%2520c-Src%252C%2520the%2520%25CE%25B1%25CE%25BD%25CE%25B23%2520integrin%252C%2520and%2520ITAM%2520immunoreceptors%252C%2520in%2520concert%252C%2520regulate%2520osteoclastic%2520bone%2520resorption%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D176%26spage%3D877%26epage%3D888" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Yoshitomi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakihama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirota, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaguchi, S.</span><span> </span><span class="NLM_article-title">A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">201</span><span class="NLM_x">, </span> <span class="NLM_fpage">949</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=201&publication_year=2005&pages=949-960&author=H.+Yoshitomiauthor=N.+Sakaguchiauthor=K.+Kobayashiauthor=G.+D.+Brownauthor=T.+Tagamiauthor=T.+Sakihamaauthor=K.+Hirotaauthor=S.+Tanakaauthor=T.+Nomuraauthor=I.+Mikiauthor=S.+Gordonauthor=S.+Akiraauthor=T.+Nakamuraauthor=S.+Sakaguchi&title=A+role+for+fungal+%CE%B2-glucans+and+their+receptor+Dectin-1+in+the+induction+of+autoimmune+arthritis+in+genetically+susceptible+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshitomi%26aufirst%3DH.%26aulast%3DSakaguchi%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DK.%26aulast%3DBrown%26aufirst%3DG.%2BD.%26aulast%3DTagami%26aufirst%3DT.%26aulast%3DSakihama%26aufirst%3DT.%26aulast%3DHirota%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DMiki%26aufirst%3DI.%26aulast%3DGordon%26aufirst%3DS.%26aulast%3DAkira%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DSakaguchi%26aufirst%3DS.%26atitle%3DA%2520role%2520for%2520fungal%2520%25CE%25B2-glucans%2520and%2520their%2520receptor%2520Dectin-1%2520in%2520the%2520induction%2520of%2520autoimmune%2520arthritis%2520in%2520genetically%2520susceptible%2520mice%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2005%26volume%3D201%26spage%3D949%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Goodridge, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katsumoto, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bose, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A. S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magee, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danielson, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasilakos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underhill, D. M.</span><span> </span><span class="NLM_article-title">Activation of the innate immune receptor Dectin-1 upon formation of a “phagocytic synapse”</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">472</span><span class="NLM_x">, </span> <span class="NLM_fpage">471</span><span class="NLM_x">–</span> <span class="NLM_lpage">475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=472&publication_year=2011&pages=471-475&author=H.+S.+Goodridgeauthor=C.+N.+Reyesauthor=C.+A.+Beckerauthor=T.+R.+Katsumotoauthor=J.+Maauthor=A.+J.+Wolfauthor=N.+Boseauthor=A.+S.+H.+Chanauthor=A.+S.+Mageeauthor=M.+E.+Danielsonauthor=A.+Weissauthor=J.+P.+Vasilakosauthor=D.+M.+Underhill&title=Activation+of+the+innate+immune+receptor+Dectin-1+upon+formation+of+a+%E2%80%9Cphagocytic+synapse%E2%80%9D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoodridge%26aufirst%3DH.%2BS.%26aulast%3DReyes%26aufirst%3DC.%2BN.%26aulast%3DBecker%26aufirst%3DC.%2BA.%26aulast%3DKatsumoto%26aufirst%3DT.%2BR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWolf%26aufirst%3DA.%2BJ.%26aulast%3DBose%26aufirst%3DN.%26aulast%3DChan%26aufirst%3DA.%2BS.%2BH.%26aulast%3DMagee%26aufirst%3DA.%2BS.%26aulast%3DDanielson%26aufirst%3DM.%2BE.%26aulast%3DWeiss%26aufirst%3DA.%26aulast%3DVasilakos%26aufirst%3DJ.%2BP.%26aulast%3DUnderhill%26aufirst%3DD.%2BM.%26atitle%3DActivation%2520of%2520the%2520innate%2520immune%2520receptor%2520Dectin-1%2520upon%2520formation%2520of%2520a%2520%25E2%2580%259Cphagocytic%2520synapse%25E2%2580%259D%26jtitle%3DNature%26date%3D2011%26volume%3D472%26spage%3D471%26epage%3D475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Tsokos, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambiar, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrock, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Juang, Y. T.</span><span> </span><span class="NLM_article-title">Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">259</span><span class="NLM_x">–</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS1471-4906%2803%2900100-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12738420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsVarur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=259-263&author=G.+C.+Tsokosauthor=M.+P.+Nambiarauthor=K.+Tenbrockauthor=Y.+T.+Juang&title=Rewiring+the+T-cell%3A+signaling+defects+and+novel+prospects+for+the+treatment+of+SLE"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Rewiring the T-cell: signaling defects and novel prospects for the treatment of SLE</span></div><div class="casAuthors">Tsokos, George C.; Nambiar, Madhusoodana P.; Tenbrock, Klaus; Juang, Yuang-Taung</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">259-263</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Activation of T cells from patients with systemic lupus erythematosus (SLE) leads to increased signaling responses, detected by increased calcium and protein tyrosine phosphorylation patterns.  This over-excitability occurs in spite of decreased levels of T-cell receptor ζ chain.  The replacement of the ζ chain by the Fc receptor (FcR) γ chain and the formation of signaling mol. aggregates on the surface of T cells are considered to be responsible for the obsd. signaling phenotype.  Decreased prodn. of the ζ-chain promoter binding form of the transcription factor Elf-1 is responsible for the decreased transcription of the ζ chain gene.  In addn., transcription of the interleukin-2 (IL-2) gene is decreased because of the presence of the transcriptional repressor cyclic adenine mono-phosphate (cAMP) response element modulator.  Replenishment of the ζ chain and elimination of the repressor by antisense approaches leads to increased expression of IL-2, suggesting that gene therapy approaches might represent tangible modalities in the treatment of human SLE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVIl0naG-8sbVg90H21EOLACvtfcHk0lgDhgjB3SQvUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsVarur4%253D&md5=56fccb8525ea59e0d45b753a84e0e9f0</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1016%2FS1471-4906%2803%2900100-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1471-4906%252803%252900100-5%26sid%3Dliteratum%253Aachs%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26aulast%3DNambiar%26aufirst%3DM.%2BP.%26aulast%3DTenbrock%26aufirst%3DK.%26aulast%3DJuang%26aufirst%3DY.%2BT.%26atitle%3DRewiring%2520the%2520T-cell%253A%2520signaling%2520defects%2520and%2520novel%2520prospects%2520for%2520the%2520treatment%2520of%2520SLE%26jtitle%3DTrends%2520Immunol.%26date%3D2003%26volume%3D24%26spage%3D259%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Liossis, S. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">1448</span><span class="NLM_x">–</span> <span class="NLM_lpage">1457</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1998&pages=1448-1457&author=S.+N.+C.+Liossisauthor=X.+Z.+Dingauthor=G.+J.+Dennisauthor=G.+C.+Tsokos&title=Altered+pattern+of+TCR%2FCD3-mediated+protein-tyrosyl+phosphorylation+in+T+cells+from+patients+with+systemic+lupus+erythematosus.+Deficient+expression+of+the+T+cell+receptor+zeta+chain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiossis%26aufirst%3DS.%2BN.%2BC.%26aulast%3DDing%26aufirst%3DX.%2BZ.%26aulast%3DDennis%26aufirst%3DG.%2BJ.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DAltered%2520pattern%2520of%2520TCR%252FCD3-mediated%2520protein-tyrosyl%2520phosphorylation%2520in%2520T%2520cells%2520from%2520patients%2520with%2520systemic%2520lupus%2520erythematosus.%2520Deficient%2520expression%2520of%2520the%2520T%2520cell%2520receptor%2520zeta%2520chain%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1998%26volume%3D101%26spage%3D1448%26epage%3D1457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Bahjat, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitsma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassafer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grillo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daikh, D. I.</span><span> </span><span class="NLM_article-title">An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1433</span><span class="NLM_x">–</span> <span class="NLM_lpage">1444</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fart.23428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18438845" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXms1egsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=1433-1444&author=F.+R.+Bahjatauthor=P.+R.+Pineauthor=A.+Reitsmaauthor=G.+Cassaferauthor=M.+Baluomauthor=S.+Grilloauthor=B.+Changauthor=F.+F.+Zhaoauthor=D.+G.+Payanauthor=E.+B.+Grossbardauthor=D.+I.+Daikh&title=An+orally+bioavailable+spleen+tyrosine+kinase+inhibitor+delays+disease+progression+and+prolongs+survival+in+murine+lupus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus</span></div><div class="casAuthors">Bahjat, Frances Rena; Pine, Polly R.; Reitsma, Andrea; Cassafer, Gail; Baluom, Muhammad; Grillo, Sunny; Chang, Betty; Zhao, Fei Fei; Payan, Donald G.; Grossbard, Elliott B.; Daikh, David I.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1433-1444</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective;. To assess whether R788, an orally bioavailable small mol. inhibitor of spleen tyrosine kinase (Syk)-dependent signaling, could modulate disease in lupus-prone (NZB × NZW)F1 (NZB/NZW) mice via inhibition of Fc receptor (FcR) and B cell receptor signaling.  Methods: R788 was administered to NZB/NZW mice before and after disease onset.  Proteinuria, blood urea nitrogen levels, and autoantibody titers were examd. periodically, and overall survival and renal pathol. features were assessed following long-term treatment (24-34 wk).  The distribution and immunophenotype of various splenic T cell and B cell subpopulations were evaluated at the time of study termination.  Arthus responses in NZB/NZW mice pretreated with R788 or Fc-blocking antibody (anti-CD16/32) were also examd.  Results: When R788 was administered prior to or after disease onset, it delayed the onset of proteinuria and azotemia, reduced renal pathol. and kidney infiltrates, and significantly prolonged survival of lupus-prone NZB/NZW mice; autoantibody titers were minimally affected throughout the study.  Dose-dependent redns. in the nos. of CD4+ activated T cells expressing high levels of CD44 or CD69 were apparent in spleens from R788-treated mice.  Minimal effects on the nos. of naive T cells expressing CD62 ligand and total CD8+ T cells per spleen were obsd. following long-term drug treatment.  R788 pretreatment resulted in reduced Arthus responses in NZB/NZW mice, similar to results obtained in mice pretreated with FcR-blocking antibody.  Conclusion: We demonstrate that a novel Syk-selective inhibitor prevents the development of renal disease and treats established murine lupus nephritis.  These data suggest that Syk inhibitors may be of therapeutic benefit in human lupus and related disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv3W8z7XnMUrVg90H21EOLACvtfcHk0liId4ggSGOxMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXms1egsro%253D&md5=19928c22718e8199af4d427446f53c42</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1002%2Fart.23428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23428%26sid%3Dliteratum%253Aachs%26aulast%3DBahjat%26aufirst%3DF.%2BR.%26aulast%3DPine%26aufirst%3DP.%2BR.%26aulast%3DReitsma%26aufirst%3DA.%26aulast%3DCassafer%26aufirst%3DG.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrillo%26aufirst%3DS.%26aulast%3DChang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DF.%2BF.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DDaikh%26aufirst%3DD.%2BI.%26atitle%3DAn%2520orally%2520bioavailable%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520delays%2520disease%2520progression%2520and%2520prolongs%2520survival%2520in%2520murine%2520lupus%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D1433%26epage%3D1444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Smith, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDaid, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chawanasuntorapoj, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pusey, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, F. W.</span><span> </span><span class="NLM_article-title">A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1681%2FASN.2009030263" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19959716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXislSqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2010&pages=231-236&author=J.+Smithauthor=J.+P.+McDaidauthor=G.+Bhangalauthor=R.+Chawanasuntorapojauthor=E.+S.+Masudaauthor=H.+T.+Cookauthor=C.+D.+Puseyauthor=F.+W.+Tam&title=A+spleen+tyrosine+kinase+inhibitor+reduces+the+severity+of+established+glomerulonephritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis</span></div><div class="casAuthors">Smith, Jennifer; McDaid, John P.; Bhangal, Gurjeet; Chawanasuntorapoj, Ratana; Masuda, Esteban S.; Cook, H. Terence; Pusey, Charles D.; Tam, Frederick W. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">231-236</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Antibody-mediated glomerulonephritis, including that resulting from immune complexes, is an important cause of renal failure and is in need of more specific and effective treatment.  Binding of antibody or immune complexes to Fc receptors activates intracellular signal transduction pathways, including spleen tyrosine kinase (Syk), leading to the prodn. of inflammatory cytokines.  We examd. the effect of R788 (fostamatinib disodium), an oral prodrug of the selective Syk inhibitor R406, in nephrotoxic nephritis in Wistar-Kyoto rats.  Treatment with R788 reduced proteinuria, tissue injury, glomerular macrophage and CD8+ cell nos., and renal monocyte chemoattractant protein-1 (MCP-1) and IL-1β, even when we started treatment after the onset of glomerulonephritis.  When we administered R788 from days 4 to 10, glomerular crescents reduced by 100% (P < 0.01) compared with the vehicle group.  When we administered R788 treatment from days 7 to 14, established glomerular crescents reversed (reduced by 21%, P < 0.001), and renal function was better than the vehicle group (P < 0.001).  In vitro, R406 downregulated MCP-1 prodn. from mesangial cells and macrophages stimulated with aggregated IgG.  These results suggest that Syk is an important therapeutic target for the treatment of glomerulonephritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyYk0j2Vk5j7Vg90H21EOLACvtfcHk0lgA_jtXUHj4UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXislSqtL0%253D&md5=47c98549849565302a6c0027d89bc7a7</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1681%2FASN.2009030263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2009030263%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DJ.%26aulast%3DMcDaid%26aufirst%3DJ.%2BP.%26aulast%3DBhangal%26aufirst%3DG.%26aulast%3DChawanasuntorapoj%26aufirst%3DR.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DCook%26aufirst%3DH.%2BT.%26aulast%3DPusey%26aufirst%3DC.%2BD.%26aulast%3DTam%26aufirst%3DF.%2BW.%26atitle%3DA%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520reduces%2520the%2520severity%2520of%2520established%2520glomerulonephritis%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2010%26volume%3D21%26spage%3D231%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Colonna, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Agati, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reizis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clynes, R.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Syk in autoimmune diabetes</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=2010&pages=1532-1543&author=L.+Colonnaauthor=G.+Catalanoauthor=C.+Chewauthor=V.+D%E2%80%99Agatiauthor=J.+W.+Thomasauthor=F.+S.+Wongauthor=J.+Schmitzauthor=E.+S.+Masudaauthor=B.+Reizisauthor=A.+Tarakhovskyauthor=R.+Clynes&title=Therapeutic+targeting+of+Syk+in+autoimmune+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColonna%26aufirst%3DL.%26aulast%3DCatalano%26aufirst%3DG.%26aulast%3DChew%26aufirst%3DC.%26aulast%3DD%25E2%2580%2599Agati%26aufirst%3DV.%26aulast%3DThomas%26aufirst%3DJ.%2BW.%26aulast%3DWong%26aufirst%3DF.%2BS.%26aulast%3DSchmitz%26aufirst%3DJ.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DReizis%26aufirst%3DB.%26aulast%3DTarakhovsky%26aufirst%3DA.%26aulast%3DClynes%26aufirst%3DR.%26atitle%3DTherapeutic%2520targeting%2520of%2520Syk%2520in%2520autoimmune%2520diabetes%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D185%26spage%3D1532%26epage%3D1543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Spalton, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollitt, A. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eble, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets</span> <span class="citation_source-journal">J. Thromb. Haemostasis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1192</span><span class="NLM_x">–</span> <span class="NLM_lpage">1199</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1111%2Fj.1538-7836.2009.03451.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19422460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpvV2itL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=1192-1199&author=J.+C.+Spaltonauthor=J.+Moriauthor=A.+Y.+Pollittauthor=C.+E.+Hughesauthor=J.+A.+Ebleauthor=S.+P.+Watson&title=The+novel+Syk+inhibitor+R406+reveals+mechanistic+differences+in+the+initiation+of+GPVI+and+CLEC-2+signaling+in+platelets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets</span></div><div class="casAuthors">Spalton, J. C.; Mori, J.; Pollitt, A. Y.; Hughes, C. E.; Eble, J. A.; Watson, S. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Thrombosis and Haemostasis</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1192-1199</span>CODEN:
                <span class="NLM_cas:coden">JTHOA5</span>;
        ISSN:<span class="NLM_cas:issn">1538-7933</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Syk is a key mediator of signaling pathways downstream of several platelet surface receptors including GPVI/FcRγ collagen receptor, the C-type lectin receptor CLEC-2, and integrin αIIbβ3.  A recent study identified the novel small mol. R406 as a selective inhibitor of Syk.  The present study evaluates the role of Syk in human platelets using the novel inhibitor R406.  Agonist-induced GPVI and CLEC-2 signaling were assessed using aggregometry, immunopptn. and western blotting to det. the effects of R406 on platelet activation.  We demonstrate R406 to be a powerful inhibitor of Syk in human platelets.  R406 abrogated shape change and aggregation induced by activation of GPVI and CLEC-2, and reduced platelet spreading on fibrinogen.  The inhibitory effect of R406 was assocd. with inhibition of tyrosine phosphorylation of signaling proteins that lay downstream of Syk for all three receptors, including PLCγ2.  Strikingly, R406 markedly inhibited tyrosine phosphorylation of CLEC-2 and Syk downstream of CLEC-2 activation, whereas phosphorylation of Syk downstream of GPVI and integrin αIIbβ3 was unaffected.  The inhibitory effect of R406 provides direct evidence of a role for Syk in GPVI, CLEC-2 and integrin αIIbβ3 signaling in human platelets.  Further, the results demonstrate a crit. role for Syk in mediating tyrosine phosphorylation of CLEC-2, suggesting a novel model in which both Src and Syk kinases regulate tyrosine phosphorylation of the C-type lectin receptor leading to platelet activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryRxU2oWcCyLVg90H21EOLACvtfcHk0lgA_jtXUHj4UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpvV2itL8%253D&md5=2daca5334b33d3170ef7c11f4548bd81</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1111%2Fj.1538-7836.2009.03451.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1538-7836.2009.03451.x%26sid%3Dliteratum%253Aachs%26aulast%3DSpalton%26aufirst%3DJ.%2BC.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DPollitt%26aufirst%3DA.%2BY.%26aulast%3DHughes%26aufirst%3DC.%2BE.%26aulast%3DEble%26aufirst%3DJ.%2BA.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520novel%2520Syk%2520inhibitor%2520R406%2520reveals%2520mechanistic%2520differences%2520in%2520the%2520initiation%2520of%2520GPVI%2520and%2520CLEC-2%2520signaling%2520in%2520platelets%26jtitle%3DJ.%2520Thromb.%2520Haemostasis%26date%3D2009%26volume%3D7%26spage%3D1192%26epage%3D1199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Pamuk, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapchak, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalle Lucca, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsokos, G. C.</span><span> </span><span class="NLM_article-title">Spleen tyrosine kinase inhibition prevents tissue damage after ischemia–reperfusion</span> <span class="citation_source-journal">Am. J. Physiol.: Gastrointest. Liver Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">G391</span><span class="NLM_x">–</span> <span class="NLM_lpage">G399</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2010&pages=G391-G399&author=O.+N.+Pamukauthor=P.+H.+Lapchakauthor=P.+Raniauthor=P.+Pineauthor=J.+J.+Dalle+Luccaauthor=G.+C.+Tsokos&title=Spleen+tyrosine+kinase+inhibition+prevents+tissue+damage+after+ischemia%E2%80%93reperfusion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPamuk%26aufirst%3DO.%2BN.%26aulast%3DLapchak%26aufirst%3DP.%2BH.%26aulast%3DRani%26aufirst%3DP.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DDalle%2BLucca%26aufirst%3DJ.%2BJ.%26aulast%3DTsokos%26aufirst%3DG.%2BC.%26atitle%3DSpleen%2520tyrosine%2520kinase%2520inhibition%2520prevents%2520tissue%2520damage%2520after%2520ischemia%25E2%2580%2593reperfusion%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Gastrointest.%2520Liver%2520Physiol.%26date%3D2010%26volume%3D299%26spage%3DG391%26epage%3DG399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Hilgendorf, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisele, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeschky, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachon, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willecke, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirlik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortiz-Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozhkin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Zur Muehlen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zur Hausen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bode, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zirlik, A.</span><span> </span><span class="NLM_article-title">The oral spleen tyrosine kinase inhibitor fostamatinib attenuates inflammation and atherogenesis in low-density lipoprotein receptor-deficient mice</span> <span class="citation_source-journal">Arterioscler., Thromb., Vasc. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1991</span><span class="NLM_x">–</span> <span class="NLM_lpage">1999</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1161%2FATVBAHA.111.230847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21700926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVaktr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=1991-1999&author=I.+Hilgendorfauthor=S.+Eiseleauthor=I.+Remerauthor=J.+Schmitzauthor=K.+Zeschkyauthor=C.+Colbergauthor=P.+Stachonauthor=D.+Wolfauthor=F.+Willeckeauthor=M.+Buchnerauthor=K.+Zirlikauthor=A.+Ortiz-Rodriguezauthor=A.+Lozhkinauthor=N.+Hoppeauthor=C.+von+Zur+Muehlenauthor=A.+Zur+Hausenauthor=C.+Bodeauthor=A.+Zirlik&title=The+oral+spleen+tyrosine+kinase+inhibitor+fostamatinib+attenuates+inflammation+and+atherogenesis+in+low-density+lipoprotein+receptor-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">The Oral Spleen Tyrosine Kinase Inhibitor Fostamatinib Attenuates Inflammation and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice</span></div><div class="casAuthors">Hilgendorf, Ingo; Eisele, Sara; Remer, Imke; Schmitz, Jochen; Zeschky, Katharina; Colberg, Christian; Stachon, Peter; Wolf, Dennis; Willecke, Florian; Buchner, Maike; Zirlik, Katja; Ortiz-Rodriguez, Alexandra; Lozhkin, Andrey; Hoppe, Natalie; von zur Muhlen, Constantin; zur Hausen, Axel; Bode, Christoph; Zirlik, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1991-1999</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: Spleen tyrosine kinase (SYK) has come into focus as a potential therapeutic target in chronic inflammatory diseases, such as rheumatoid arthritis and asthma, as well as in B-cell lymphomas.  SYK has also been involved in the signaling of immunoreceptors, cytokine receptors, and integrins.  We therefore hypothesized that inhibition of SYK attenuates the inflammatory process underlying atherosclerosis and reduces plaque development.  Methods and Results: Low-d. lipoprotein receptor-deficient mice consuming a high-cholesterol diet supplemented with 2 doses of the orally available SYK inhibitor fostamatinib for 16 wk showed a dose-dependent redn. in atherosclerotic lesion size by up to 59±6% compared with the resp. controls.  Lesions of fostamatinib-treated animals contained fewer macrophages but more smooth muscle cells and collagen-characteristics assocd. with more stable plaques in humans.  Mechanistically, fostamatinib attenuated adhesion and migration of inflammatory cells and limited macrophage survival.  Furthermore, fostamatinib normalized high-cholesterol diet -induced monocytosis and inflammatory gene expression.  Conclusion: We present the novel finding that the SYK inhibitor fostamatinib attenuates atherogenesis in mice.  Our data identify SYK inhibition as a potentially fruitful antiinflammatory therapeutic strategy in atherosclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBEf6qXu7jB7Vg90H21EOLACvtfcHk0lh-2CcXGi7HBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVaktr3M&md5=6d706cb01a8fc2c762cc688e29871df5</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.111.230847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.111.230847%26sid%3Dliteratum%253Aachs%26aulast%3DHilgendorf%26aufirst%3DI.%26aulast%3DEisele%26aufirst%3DS.%26aulast%3DRemer%26aufirst%3DI.%26aulast%3DSchmitz%26aufirst%3DJ.%26aulast%3DZeschky%26aufirst%3DK.%26aulast%3DColberg%26aufirst%3DC.%26aulast%3DStachon%26aufirst%3DP.%26aulast%3DWolf%26aufirst%3DD.%26aulast%3DWillecke%26aufirst%3DF.%26aulast%3DBuchner%26aufirst%3DM.%26aulast%3DZirlik%26aufirst%3DK.%26aulast%3DOrtiz-Rodriguez%26aufirst%3DA.%26aulast%3DLozhkin%26aufirst%3DA.%26aulast%3DHoppe%26aufirst%3DN.%26aulast%3Dvon%2BZur%2BMuehlen%26aufirst%3DC.%26aulast%3DZur%2BHausen%26aufirst%3DA.%26aulast%3DBode%26aufirst%3DC.%26aulast%3DZirlik%26aufirst%3DA.%26atitle%3DThe%2520oral%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520fostamatinib%2520attenuates%2520inflammation%2520and%2520atherogenesis%2520in%2520low-density%2520lipoprotein%2520receptor-deficient%2520mice%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2011%26volume%3D31%26spage%3D1991%26epage%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Winer, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wadia, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yantha, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paltser, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leong, H. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glassford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caimol, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenkel, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedder, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miklos, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dosch, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engleman, E. G.</span><span> </span><span class="NLM_article-title">B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnm.2353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21499269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslCmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=610-617&author=D.+A.+Winerauthor=S.+Winerauthor=L.+Shenauthor=P.+P.+Wadiaauthor=J.+Yanthaauthor=G.+Paltserauthor=H.+Tsuiauthor=P.+Wuauthor=M.+G.+Davidsonauthor=M.+N.+Alonsoauthor=H.+X.+Leongauthor=A.+Glassfordauthor=M.+Caimolauthor=J.+A.+Kenkelauthor=T.+F.+Tedderauthor=T.+McLaughlinauthor=D.+B.+Miklosauthor=H.+M.+Doschauthor=E.+G.+Engleman&title=B+cells+promote+insulin+resistance+through+modulation+of+T+cells+and+production+of+pathogenic+IgG+antibodies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies</span></div><div class="casAuthors">Winer, Daniel A.; Winer, Shawn; Shen, Lei; Wadia, Persis P.; Yantha, Jason; Paltser, Geoffrey; Tsui, Hubert; Wu, Ping; Davidson, Matthew G.; Alonso, Michael N.; Leong, Hwei X.; Glassford, Alec; Caimol, Maria; Kenkel, Justin A.; Tedder, Thomas F.; McLaughlin, Tracey; Miklos, David B.; Dosch, H-Michael; Engleman, Edgar G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">610-617</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chronic inflammation characterized by T cell and macrophage infiltration of visceral adipose tissue (VAT) is a hallmark of obesity-assocd. insulin resistance and glucose intolerance.  Here we show a fundamental pathogenic role for B cells in the development of these metabolic abnormalities.  B cells accumulate in VAT in diet-induced obese (DIO) mice, and DIO mice lacking B cells are protected from disease despite wt. gain.  B cell effects on glucose metab. are mechanistically linked to the activation of proinflammatory macrophages and T cells and to the prodn. of pathogenic IgG antibodies.  Treatment with a B cell-depleting CD20 antibody attenuates disease, whereas transfer of IgG from DIO mice rapidly induces insulin resistance and glucose intolerance.  Moreover, insulin resistance in obese humans is assocd. with a unique profile of IgG autoantibodies.  These results establish the importance of B cells and adaptive immunity in insulin resistance and suggest new diagnostic and therapeutic modalities for managing the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon3x-1-REfArVg90H21EOLACvtfcHk0lgdFKAAijsvQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslCmtrg%253D&md5=3c030bb72c6e842ca66fe0adffa11282</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1038%2Fnm.2353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2353%26sid%3Dliteratum%253Aachs%26aulast%3DWiner%26aufirst%3DD.%2BA.%26aulast%3DWiner%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DWadia%26aufirst%3DP.%2BP.%26aulast%3DYantha%26aufirst%3DJ.%26aulast%3DPaltser%26aufirst%3DG.%26aulast%3DTsui%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DDavidson%26aufirst%3DM.%2BG.%26aulast%3DAlonso%26aufirst%3DM.%2BN.%26aulast%3DLeong%26aufirst%3DH.%2BX.%26aulast%3DGlassford%26aufirst%3DA.%26aulast%3DCaimol%26aufirst%3DM.%26aulast%3DKenkel%26aufirst%3DJ.%2BA.%26aulast%3DTedder%26aufirst%3DT.%2BF.%26aulast%3DMcLaughlin%26aufirst%3DT.%26aulast%3DMiklos%26aufirst%3DD.%2BB.%26aulast%3DDosch%26aufirst%3DH.%2BM.%26aulast%3DEngleman%26aufirst%3DE.%2BG.%26atitle%3DB%2520cells%2520promote%2520insulin%2520resistance%2520through%2520modulation%2520of%2520T%2520cells%2520and%2520production%2520of%2520pathogenic%2520IgG%2520antibodies%26jtitle%3DNat.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D610%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Andreu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Affara, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pucci, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Junankar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korets, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawfik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNardo, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naldini, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Visser, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Palma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coussens, L. M.</span><span> </span><span class="NLM_article-title">FcRγ activation regulates inflammation-associated squamous carcinogenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=121-134&author=P.+Andreuauthor=M.+Johanssonauthor=N.+I.+Affaraauthor=F.+Pucciauthor=T.+Tanauthor=S.+Junankarauthor=L.+Koretsauthor=J.+Lamauthor=D.+Tawfikauthor=D.+G.+DeNardoauthor=L.+Naldiniauthor=K.+E.+de+Visserauthor=M.+De+Palmaauthor=L.+M.+Coussens&title=FcR%CE%B3+activation+regulates+inflammation-associated+squamous+carcinogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreu%26aufirst%3DP.%26aulast%3DJohansson%26aufirst%3DM.%26aulast%3DAffara%26aufirst%3DN.%2BI.%26aulast%3DPucci%26aufirst%3DF.%26aulast%3DTan%26aufirst%3DT.%26aulast%3DJunankar%26aufirst%3DS.%26aulast%3DKorets%26aufirst%3DL.%26aulast%3DLam%26aufirst%3DJ.%26aulast%3DTawfik%26aufirst%3DD.%26aulast%3DDeNardo%26aufirst%3DD.%2BG.%26aulast%3DNaldini%26aufirst%3DL.%26aulast%3Dde%2BVisser%26aufirst%3DK.%2BE.%26aulast%3DDe%2BPalma%26aufirst%3DM.%26aulast%3DCoussens%26aufirst%3DL.%2BM.%26atitle%3DFcR%25CE%25B3%2520activation%2520regulates%2520inflammation-associated%2520squamous%2520carcinogenesis%26jtitle%3DCancer%2520Cell%26date%3D2010%26volume%3D17%26spage%3D121%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Lam, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kühn, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajewsky, K.</span><span> </span><span class="NLM_article-title">In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1073</span><span class="NLM_x">–</span> <span class="NLM_lpage">1083</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1997&pages=1073-1083&author=K.+P.+Lamauthor=R.+K%C3%BChnauthor=K.+Rajewsky&title=In+vivo+ablation+of+surface+immunoglobulin+on+mature+B+cells+by+inducible+gene+targeting+results+in+rapid+cell+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLam%26aufirst%3DK.%2BP.%26aulast%3DK%25C3%25BChn%26aufirst%3DR.%26aulast%3DRajewsky%26aufirst%3DK.%26atitle%3DIn%2520vivo%2520ablation%2520of%2520surface%2520immunoglobulin%2520on%2520mature%2520B%2520cells%2520by%2520inducible%2520gene%2520targeting%2520results%2520in%2520rapid%2520cell%2520death%26jtitle%3DCell%26date%3D1997%26volume%3D90%26spage%3D1073%26epage%3D1083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Kraus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichlin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canono, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussenzweig, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajewsky, K.</span><span> </span><span class="NLM_article-title">Interference with immunoglobulin (Ig)α immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B-cell development, depending on the availability of an Igβ cytoplasmic tail</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2001&pages=455-469&author=M.+Krausauthor=L.+I.+Paoauthor=A.+Reichlinauthor=Y.+Huauthor=B.+Canonoauthor=J.+C.+Cambierauthor=M.+C.+Nussenzweigauthor=K.+Rajewsky&title=Interference+with+immunoglobulin+%28Ig%29%CE%B1+immunoreceptor+tyrosine-based+activation+motif+%28ITAM%29+phosphorylation+modulates+or+blocks+B-cell+development%2C+depending+on+the+availability+of+an+Ig%CE%B2+cytoplasmic+tail"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DPao%26aufirst%3DL.%2BI.%26aulast%3DReichlin%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DCanono%26aufirst%3DB.%26aulast%3DCambier%26aufirst%3DJ.%2BC.%26aulast%3DNussenzweig%26aufirst%3DM.%2BC.%26aulast%3DRajewsky%26aufirst%3DK.%26atitle%3DInterference%2520with%2520immunoglobulin%2520%2528Ig%2529%25CE%25B1%2520immunoreceptor%2520tyrosine-based%2520activation%2520motif%2520%2528ITAM%2529%2520phosphorylation%2520modulates%2520or%2520blocks%2520B-cell%2520development%252C%2520depending%2520on%2520the%2520availability%2520of%2520an%2520Ig%25CE%25B2%2520cytoplasmic%2520tail%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2001%26volume%3D194%26spage%3D455%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Young, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Refaeli, Y.</span><span> </span><span class="NLM_article-title">Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">2508</span><span class="NLM_x">–</span> <span class="NLM_lpage">2516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=2508-2516&author=R.+M.+Youngauthor=I.+R.+Hardyauthor=R.+L.+Clarkeauthor=N.+Lundyauthor=P.+Pineauthor=B.+C.+Turnerauthor=T.+A.+Potterauthor=Y.+Refaeli&title=Mouse+models+of+non-Hodgkin+lymphoma+reveal+Syk+as+an+important+therapeutic+target"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BM.%26aulast%3DHardy%26aufirst%3DI.%2BR.%26aulast%3DClarke%26aufirst%3DR.%2BL.%26aulast%3DLundy%26aufirst%3DN.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DTurner%26aufirst%3DB.%2BC.%26aulast%3DPotter%26aufirst%3DT.%2BA.%26aulast%3DRefaeli%26aufirst%3DY.%26atitle%3DMouse%2520models%2520of%2520non-Hodgkin%2520lymphoma%2520reveal%2520Syk%2520as%2520an%2520important%2520therapeutic%2520target%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D2508%26epage%3D2516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Wossning, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzog, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Köhler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meixlsperger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulathu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mittler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuchs, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borkhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jumaa, H.</span><span> </span><span class="NLM_article-title">Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">203</span><span class="NLM_x">, </span> <span class="NLM_fpage">2829</span><span class="NLM_x">–</span> <span class="NLM_lpage">2840</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=203&publication_year=2006&pages=2829-2840&author=T.+Wossningauthor=S.+Herzogauthor=F.+K%C3%B6hlerauthor=S.+Meixlspergerauthor=Y.+Kulathuauthor=G.+Mittlerauthor=A.+Abeauthor=U.+Fuchsauthor=A.+Borkhardtauthor=H.+Jumaa&title=Deregulated+Syk+inhibits+differentiation+and+induces+growth+factor-independent+proliferation+of+pre-B+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWossning%26aufirst%3DT.%26aulast%3DHerzog%26aufirst%3DS.%26aulast%3DK%25C3%25B6hler%26aufirst%3DF.%26aulast%3DMeixlsperger%26aufirst%3DS.%26aulast%3DKulathu%26aufirst%3DY.%26aulast%3DMittler%26aufirst%3DG.%26aulast%3DAbe%26aufirst%3DA.%26aulast%3DFuchs%26aufirst%3DU.%26aulast%3DBorkhardt%26aufirst%3DA.%26aulast%3DJumaa%26aufirst%3DH.%26atitle%3DDeregulated%2520Syk%2520inhibits%2520differentiation%2520and%2520induces%2520growth%2520factor-independent%2520proliferation%2520of%2520pre-B%2520cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2006%26volume%3D203%26spage%3D2829%26epage%3D2840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Suljagic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longo, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennardo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurenti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, D. G.</span><span> </span><span class="NLM_article-title">The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ-TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">4894</span><span class="NLM_x">–</span> <span class="NLM_lpage">4905</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2010&pages=4894-4905&author=M.+Suljagicauthor=P.+G.+Longoauthor=S.+Bennardoauthor=E.+Perlasauthor=G.+Leoneauthor=L.+Laurentiauthor=D.+G.+Efremov&title=The+Syk+inhibitor+fostamatinib+disodium+%28R788%29+inhibits+tumor+growth+in+the+E%CE%BC-TCL1+transgenic+mouse+model+of+CLL+by+blocking+antigen-dependent+B-cell+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuljagic%26aufirst%3DM.%26aulast%3DLongo%26aufirst%3DP.%2BG.%26aulast%3DBennardo%26aufirst%3DS.%26aulast%3DPerlas%26aufirst%3DE.%26aulast%3DLeone%26aufirst%3DG.%26aulast%3DLaurenti%26aufirst%3DL.%26aulast%3DEfremov%26aufirst%3DD.%2BG.%26atitle%3DThe%2520Syk%2520inhibitor%2520fostamatinib%2520disodium%2520%2528R788%2529%2520inhibits%2520tumor%2520growth%2520in%2520the%2520E%25CE%25BC-TCL1%2520transgenic%2520mouse%2520model%2520of%2520CLL%2520by%2520blocking%2520antigen-dependent%2520B-cell%2520receptor%2520signaling%26jtitle%3DBlood%26date%3D2010%26volume%3D116%26spage%3D4894%26epage%3D4905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Friedberg, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetenham, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vose, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCasce, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer-Cutillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Vos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cripe, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregory, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterba, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipp, M. A.</span><span> </span><span class="NLM_article-title">Inhibition of SYK with fostamatinib disodium has significant clinical activity in non Hodgkin’s lymphoma and chronic lymphocytic leukemia</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2578</span><span class="NLM_x">–</span> <span class="NLM_lpage">2585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2010&pages=2578-2585&author=J.+W.+Friedbergauthor=J.+Sharmanauthor=J.+Sweetenhamauthor=P.+B.+Johnstonauthor=J.+M.+Voseauthor=A.+LaCasceauthor=J.+Schaefer-Cutilloauthor=S.+De+Vosauthor=R.+Sinhaauthor=J.+P.+Leonardauthor=L.+D.+Cripeauthor=S.+A.+Gregoryauthor=M.+P.+Sterbaauthor=A.+M.+Loweauthor=R.+Levyauthor=M.+A.+Shipp&title=Inhibition+of+SYK+with+fostamatinib+disodium+has+significant+clinical+activity+in+non+Hodgkin%E2%80%99s+lymphoma+and+chronic+lymphocytic+leukemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFriedberg%26aufirst%3DJ.%2BW.%26aulast%3DSharman%26aufirst%3DJ.%26aulast%3DSweetenham%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DP.%2BB.%26aulast%3DVose%26aufirst%3DJ.%2BM.%26aulast%3DLaCasce%26aufirst%3DA.%26aulast%3DSchaefer-Cutillo%26aufirst%3DJ.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DSinha%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DJ.%2BP.%26aulast%3DCripe%26aufirst%3DL.%2BD.%26aulast%3DGregory%26aufirst%3DS.%2BA.%26aulast%3DSterba%26aufirst%3DM.%2BP.%26aulast%3DLowe%26aufirst%3DA.%2BM.%26aulast%3DLevy%26aufirst%3DR.%26aulast%3DShipp%26aufirst%3DM.%2BA.%26atitle%3DInhibition%2520of%2520SYK%2520with%2520fostamatinib%2520disodium%2520has%2520significant%2520clinical%2520activity%2520in%2520non%2520Hodgkin%25E2%2580%2599s%2520lymphoma%2520and%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DBlood%26date%3D2010%26volume%3D115%26spage%3D2578%26epage%3D2585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Oliver, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burg, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geahlen, R. L.</span><span> </span><span class="NLM_article-title">Inhibition of mast cell FcεR1-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x">, </span> <span class="NLM_fpage">29697</span><span class="NLM_x">–</span> <span class="NLM_lpage">29703</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=29697-29703&author=J.+M.+Oliverauthor=D.+L.+Burgauthor=B.+S.+Wilsonauthor=J.+L.+McLaughlinauthor=R.+L.+Geahlen&title=Inhibition+of+mast+cell+Fc%CE%B5R1-mediated+signaling+and+effector+function+by+the+Syk-selective+inhibitor%2C+piceatannol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOliver%26aufirst%3DJ.%2BM.%26aulast%3DBurg%26aufirst%3DD.%2BL.%26aulast%3DWilson%26aufirst%3DB.%2BS.%26aulast%3DMcLaughlin%26aufirst%3DJ.%2BL.%26aulast%3DGeahlen%26aufirst%3DR.%2BL.%26atitle%3DInhibition%2520of%2520mast%2520cell%2520Fc%25CE%25B5R1-mediated%2520signaling%2520and%2520effector%2520function%2520by%2520the%2520Syk-selective%2520inhibitor%252C%2520piceatannol%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26spage%3D29697%26epage%3D29703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Lavens-Phillips, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mockford, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, J. A.</span><span> </span><span class="NLM_article-title">The effect of tyrosine kinase inhibitors on IgE-mediated histamine release from human lung mast cells and basophils</span> <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">143</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1007%2Fs000110050303" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9562339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1cXit1Whtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=137-143&author=S.+E.+Lavens-Phillipsauthor=E.+H.+Mockfordauthor=J.+A.+Warner&title=The+effect+of+tyrosine+kinase+inhibitors+on+IgE-mediated+histamine+release+from+human+lung+mast+cells+and+basophils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of tyrosine kinase inhibitors on IgE-mediated histamine release from human lung mast cells and basophils</span></div><div class="casAuthors">Lavens-Phillips, S. E.; Mockford, E. H.; Warner, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Inflammation Research</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">137-143</span>CODEN:
                <span class="NLM_cas:coden">INREFB</span>;
        ISSN:<span class="NLM_cas:issn">1023-3830</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Verlag</span>)
        </div><div class="casAbstract">The role of Tyr kinases (TK) in IgE-mediated signal transduction in human lung mast cells (HLMC) and peripheral blood basophils was investigated.  Cells were preincubated with TK inhibitor for 15 min at 37°, before the addn. of anti-IgE.  Histamine release was assayed using a fluorimetry.  Piceatannol and ST638 inhibited anti-IgE induced histamine release from HLMCs and basophils while lavendustin C had no effect in either cell type.  Herbimycin A also inhibited anti-IgE induced histamine release from both cell types, an effect which was dose dependent but did require a l6 h preincubation with drug.  In summary, HLMCs and basophils exhibit distinct inhibitory profiles in the presence of various inhibitors of TK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3g2ytSiCGqrVg90H21EOLACvtfcHk0ljMiPoVTgzqsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXit1Whtrg%253D&md5=dfd7c48c10643c634ee138996352be1d</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1007%2Fs000110050303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs000110050303%26sid%3Dliteratum%253Aachs%26aulast%3DLavens-Phillips%26aufirst%3DS.%2BE.%26aulast%3DMockford%26aufirst%3DE.%2BH.%26aulast%3DWarner%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520effect%2520of%2520tyrosine%2520kinase%2520inhibitors%2520on%2520IgE-mediated%2520histamine%2520release%2520from%2520human%2520lung%2520mast%2520cells%2520and%2520basophils%26jtitle%3DInflammation%2520Res.%26date%3D1998%26volume%3D47%26spage%3D137%26epage%3D143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Lusková, P</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dráber, P.</span><span> </span><span class="NLM_article-title">Modulation of the Fcε receptor I signaling by tyrosine kinase inhibitors: search for therapeutic targets of inflammatory and allergy diseases</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1727</span><span class="NLM_x">–</span> <span class="NLM_lpage">1737</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.2174%2F1381612043384538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15180535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXktV2gsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1727-1737&author=P+Luskov%C3%A1author=P.+Dr%C3%A1ber&title=Modulation+of+the+Fc%CE%B5+receptor+I+signaling+by+tyrosine+kinase+inhibitors%3A+search+for+therapeutic+targets+of+inflammatory+and+allergy+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the Fcε receptor I signaling by tyrosine kinase inhibitors: Search for therapeutic targets of inflammatory and allergy diseases</span></div><div class="casAuthors">Luskova, Petra; Draber, Petr</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1727-1737</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Mast cells and basophils are major effector cells in the IgE (IgE)-dependent allergic reactions as well as in the innate immunity.  They are distributed throughout the body and, upon allergen exposure, are stimulated via the high affinity IgE receptor (FcεRI) to release several pro-inflammatory mediators such as leukotrienes, immunoregulatory cytokines and histamine.  FcεRI-mediated signaling is initiated by tyrosine phosphorylation of FcεRI subunits by Src family kinase Lyn, which is followed by an activation of Syk/Zap family kinase Syk.  The activated kinases then in turn phosphorylate and activate other enzymes [phospholipase Cγ (PLCγ) isoforms, phosphatidylinositol-3 kinase (PI3K) isoforms, protein kinase C (PKC) isoforms, Bruton's tyrosine kinase (Btk) and others], adaptors [linker for activation of T cells (LAT), Cbl, Grb2 and others] and GTP exchange factors/GTPases (Vav, Ras, Rho, and others), and subsequently induce the mobilization of stored and extracellular Ca2+.  These and other biochem. events lead within seconds and minutes to the secretory response and later to the prodn. of chemokines.  This review is focused on the use of tyrosine kinase inhibitors specific for Src family kinases (PP1/PP2, SU6656 and CT5269), Syk kinase (piceatannol, ER-27319 and BAY 61-3606) and Btk (terreic acid and LFM-A13) for a modulation of FcεRI-mediated signaling in mast cells.  Potential use of the inhibitors in the treatment of inflammatory and allergy diseases as well as future directions in the development of highly specific tyrosine kinases inhibitors of new generations and their use in an intended modulation of mast cell signaling are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7T-_Nc0u6P7Vg90H21EOLACvtfcHk0liYzn_Ciq0WIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXktV2gsbo%253D&md5=173584a1b2a56bf040b3ce8015e4b235</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.2174%2F1381612043384538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043384538%26sid%3Dliteratum%253Aachs%26aulast%3DLuskov%25C3%25A1%26aufirst%3DP%26aulast%3DDr%25C3%25A1ber%26aufirst%3DP.%26atitle%3DModulation%2520of%2520the%2520Fc%25CE%25B5%2520receptor%2520I%2520signaling%2520by%2520tyrosine%2520kinase%2520inhibitors%253A%2520search%2520for%2520therapeutic%2520targets%2520of%2520inflammatory%2520and%2520allergy%2520diseases%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26spage%3D1727%26epage%3D1737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Moriya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odom, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakuma, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muramato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshiuchi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, K.</span><span> </span><span class="NLM_article-title">ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of Fcε receptor I-mediated activation of Syk</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">12539</span><span class="NLM_x">–</span> <span class="NLM_lpage">12544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=12539-12544&author=K.+Moriyaauthor=J.+Riveraauthor=S.+Odomauthor=Y.+Sakumaauthor=K.+Muramatoauthor=T.+Yoshiuchiauthor=M.+Miyamotoauthor=K.+Yamada&title=ER-27319%2C+an+acridone-related+compound%2C+inhibits+release+of+antigen-induced+allergic+mediators+from+mast+cells+by+selective+inhibition+of+Fc%CE%B5+receptor+I-mediated+activation+of+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMoriya%26aufirst%3DK.%26aulast%3DRivera%26aufirst%3DJ.%26aulast%3DOdom%26aufirst%3DS.%26aulast%3DSakuma%26aufirst%3DY.%26aulast%3DMuramato%26aufirst%3DK.%26aulast%3DYoshiuchi%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DER-27319%252C%2520an%2520acridone-related%2520compound%252C%2520inhibits%2520release%2520of%2520antigen-induced%2520allergic%2520mediators%2520from%2520mast%2520cells%2520by%2520selective%2520inhibition%2520of%2520Fc%25CE%25B5%2520receptor%2520I-mediated%2520activation%2520of%2520Syk%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1997%26volume%3D94%26spage%3D12539%26epage%3D12544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Saito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaguchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iikura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uzumaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakahata, T.</span><span> </span><span class="NLM_article-title">Characterization of cord-blood-derived human mast cells cultured in the presence of steel factor and interleukin-6</span> <span class="citation_source-journal">Int. Arch. Allergy Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">–</span> <span class="NLM_lpage">65</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1159%2F000236932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=7542104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK2MXnsVWktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1995&pages=63-65&author=H.+Saitoauthor=M.+Ebisawaauthor=N.+Sakaguchiauthor=T.+Ondaauthor=Y.+Iikuraauthor=M.+Yanagidaauthor=H.+Uzumakiauthor=T.+Nakahata&title=Characterization+of+cord-blood-derived+human+mast+cells+cultured+in+the+presence+of+steel+factor+and+interleukin-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of cord-blood-derived human mast cells cultured in the presence of steel factor and interleukin-6</span></div><div class="casAuthors">Saito, Hirohisa; Ebisawa, Motohiro; Sakaguchi, Naoya; Onda, Takebumi; Iikura, Yoji; Yanagida, Makoto; Uzumaki, Hiroya; Nakahata, Tatsutoshi</div><div class="citationInfo"><span class="NLM_cas:title">International Archives of Allergy and Immunology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">63-5</span>CODEN:
                <span class="NLM_cas:coden">IAAIEG</span>;
        ISSN:<span class="NLM_cas:issn">1018-2438</span>.
    
            (<span class="NLM_cas:orgname">Karger</span>)
        </div><div class="casAbstract">The authors generated >107 mast cells by culturing 107 cord blood mononuclear cells for >10 wks in the presence of Steel factor, interleukin-6, and prostaglandin E2.  99% Of the cultured cells had tryptase-pos. granules, while 18% had chymase-pos. granules.  Cultured mast cells contained 3.6 μg histamine and 3.5 μg tryptase per 106 cells.  Cells sensitized with 1 μg/mL human IgE released 58.5% histamine and 1.55 ng tumor necrosis factor (TNF)-α per 106 cells when challenged with 1 μg/mL antihuman IgE, whereas the control cells spontaneously released 3.7% histamine and 0.18 ng TNF-α.  Anal. for surface antigens revealed that cultured mast cells expressed the following CD mols.: 9, 13, 14, 29, 33, 38, 43, 44, 45RA, 45RB, 46, 47, 48, 49d, 50, 51, 53, 54, 55, 58, 59, 60, 61, and 117 (c-Kit).  Taken together, these cultured cells seem to be functionally mature mast cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA6dVcLAKAprVg90H21EOLACvtfcHk0liYzn_Ciq0WIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXnsVWktb0%253D&md5=627615b8b0899fe6ffdf5cae3fe204d8</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1159%2F000236932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000236932%26sid%3Dliteratum%253Aachs%26aulast%3DSaito%26aufirst%3DH.%26aulast%3DEbisawa%26aufirst%3DM.%26aulast%3DSakaguchi%26aufirst%3DN.%26aulast%3DOnda%26aufirst%3DT.%26aulast%3DIikura%26aufirst%3DY.%26aulast%3DYanagida%26aufirst%3DM.%26aulast%3DUzumaki%26aufirst%3DH.%26aulast%3DNakahata%26aufirst%3DT.%26atitle%3DCharacterization%2520of%2520cord-blood-derived%2520human%2520mast%2520cells%2520cultured%2520in%2520the%2520presence%2520of%2520steel%2520factor%2520and%2520interleukin-6%26jtitle%3DInt.%2520Arch.%2520Allergy%2520Immunol.%26date%3D1995%26volume%3D107%26spage%3D63%26epage%3D65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujishita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, T.</span><span> </span><span class="NLM_article-title">Inhibition of Syk activity and degranulation of human mast cells by flavonoids</span> <span class="citation_source-journal">Biol. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1685</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1248%2Fbpb.26.1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=14646171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvFaksrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=1685-1690&author=M.+Shichijoauthor=N.+Yamamotoauthor=H.+Tsujishitaauthor=M.+Kimataauthor=H.+Nagaiauthor=T.+Kokubo&title=Inhibition+of+Syk+activity+and+degranulation+of+human+mast+cells+by+flavonoids"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Syk activity and degranulation of human mast cells by flavonoids</span></div><div class="casAuthors">Shichijo, Michitaka; Yamamoto, Noriyuki; Tsujishita, Hideki; Kimata, Masahiro; Nagai, Hiroichi; Kokubo, Toshio</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1685-1690</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">To investigate the effect of flavonoids on the activation of p72syk (Syk) protein tyrosine kinase which plays a pivotal role in the high affinity IgE receptor-mediated degranulation of mast cells, we picked out 10 flavonoids, classified them into 4 series, and examd. their effects on the activation of Syk and on the degranulation of human mast cells.  Flavones and flavonols showed clear inhibition, whereas flavanones and isoflavones had either weak or no effect on Syk enzymic activity induced by amino acid peptide corresponding to the activation loop domain and on IgE-dependent degranulation of human cultured mast cells (HCMC).  On the basis of calcd. logP (ClogP) values as a prediction of compd. lipophilicity, some flavonoids were speculated to have low lipophilicity, the reason for poor cell permeability.  A significant relation was obsd. between the inhibition of Syk activity and HCMC degranulation attributable to flavonoids when the ClogP values of the compds. were taken into account (r2=0.89).  These results suggested that the impairment of mast cell degranulation by several flavonoids classified into flavones and flavonols might be mediated via inhibition of the intracellular activation of Syk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBSmyTkf8rzbVg90H21EOLACvtfcHk0liYzn_Ciq0WIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvFaksrw%253D&md5=de1f624ba1ad33ea994a1049af88f25e</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1248%2Fbpb.26.1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.26.1685%26sid%3Dliteratum%253Aachs%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DTsujishita%26aufirst%3DH.%26aulast%3DKimata%26aufirst%3DM.%26aulast%3DNagai%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DT.%26atitle%3DInhibition%2520of%2520Syk%2520activity%2520and%2520degranulation%2520of%2520human%2520mast%2520cells%2520by%2520flavonoids%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2003%26volume%3D26%26spage%3D1685%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Lai, J. Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadiq, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldous, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurairatnam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wheeler, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagpal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parveen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T. K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span> </span><span class="NLM_article-title">Potent small molecule inhibitors of spleen tyrosine kinase (Syk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3111</span><span class="NLM_x">–</span> <span class="NLM_lpage">3114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2FS0960-894X%2803%2900658-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12941345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3111-3114&author=J.+Y.+Q.+Laiauthor=P.+J.+Coxauthor=R.+Patelauthor=S.+Sadiqauthor=D.+J.+Aldousauthor=S.+Thurairatnamauthor=K.+Smithauthor=D.+Wheelerauthor=S.+Jagpalauthor=S.+Parveenauthor=G.+Fentonauthor=T.+K.+P.+Harrisonauthor=C.+McCarthyauthor=P.+Bamborough&title=Potent+small+molecule+inhibitors+of+spleen+tyrosine+kinase+%28Syk%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Potent small molecule inhibitors of spleen tyrosine kinase (Syk)</span></div><div class="casAuthors">Lai, Justine Y. Q.; Cox, Paul J.; Patel, Rajesh; Sadiq, Shazia; Aldous, David J.; Thurairatnam, Sukanthini; Smith, Keith; Wheeler, Darren; Jagpal, Savita; Parveen, Sofia; Fenton, Gary; Harrison, Trevor K. P.; McCarthy, Clive; Bamborough, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3111-3114</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A series of oxindoles demonstrating inhibition of the phosphorylation of biotinylated substrates of Syk and IgE/FcεERI triggered basophil cell degranulation has been identified.  A study of the SAR around sulfonamide I (R = SO2NH2) (IC50=5 nM, EC50=1400 nM) is discussed.  The modest cellular activity representative of the sulfonamide series was overcome when the Polar Surface Area was lowered to <110 A2, leading to the identification of amide II (R = CONHMe) (IC50=145 nM, EC50=100 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYSraIANrufbVg90H21EOLACvtfcHk0ljjn_KSbGPYFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7k%253D&md5=4188cf03867c4ecfd958cf7582daf30b</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900658-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900658-9%26sid%3Dliteratum%253Aachs%26aulast%3DLai%26aufirst%3DJ.%2BY.%2BQ.%26aulast%3DCox%26aufirst%3DP.%2BJ.%26aulast%3DPatel%26aufirst%3DR.%26aulast%3DSadiq%26aufirst%3DS.%26aulast%3DAldous%26aufirst%3DD.%2BJ.%26aulast%3DThurairatnam%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DWheeler%26aufirst%3DD.%26aulast%3DJagpal%26aufirst%3DS.%26aulast%3DParveen%26aufirst%3DS.%26aulast%3DFenton%26aufirst%3DG.%26aulast%3DHarrison%26aufirst%3DT.%2BK.%2BP.%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DBamborough%26aufirst%3DP.%26atitle%3DPotent%2520small%2520molecule%2520inhibitors%2520of%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3111%26epage%3D3114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0ljjn_KSbGPYFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Xie, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, J. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S. Y.</span><span> </span><span class="NLM_article-title">Pharmacophore modeling study based on known spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1944</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1944-1949&author=H.+Z.+Xieauthor=L.+L.+Liauthor=J.+X.+Renauthor=J.+Zouauthor=L.+Yangauthor=Y.+Q.+Weiauthor=S.+Y.+Yang&title=Pharmacophore+modeling+study+based+on+known+spleen+tyrosine+kinase+inhibitors+together+with+virtual+screening+for+identifying+novel+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DH.%2BZ.%26aulast%3DLi%26aufirst%3DL.%2BL.%26aulast%3DRen%26aufirst%3DJ.%2BX.%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DY.%2BQ.%26aulast%3DYang%26aufirst%3DS.%2BY.%26atitle%3DPharmacophore%2520modeling%2520study%2520based%2520on%2520known%2520spleen%2520tyrosine%2520kinase%2520inhibitors%2520together%2520with%2520virtual%2520screening%2520for%2520identifying%2520novel%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1944%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Yamamoto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishimori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacon, K. B.</span><span> </span><span class="NLM_article-title">The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-<i>c</i>]pyrimidin-5-ylamino]-nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">306</span><span class="NLM_x">, </span> <span class="NLM_fpage">1174</span><span class="NLM_x">–</span> <span class="NLM_lpage">1181</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1124%2Fjpet.103.052316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12766258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVehtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=1174-1181&author=N.+Yamamotoauthor=K.+Takeshitaauthor=M.+Shichijoauthor=T.+Kokuboauthor=M.+Satoauthor=K.+Nakashimaauthor=M.+Ishimoriauthor=H.+Nagaiauthor=Y.+F.+Liauthor=T.+Yuraauthor=K.+B.+Bacon&title=The+orally+available+spleen+tyrosine+kinase+inhibitor+2-%5B7-%283%2C4-dimethoxyphenyl%29-imidazo%5B1%2C2-c%5Dpyrimidin-5-ylamino%5D-nicotinamide+dihydrochloride+%28BAY+61-3606%29+blocks+antigen-induced+airway+inflammation+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]-nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents</span></div><div class="casAuthors">Yamamoto, Noriyuki; Takeshita, Keisuke; Shichijo, Michitaka; Kokubo, Toshio; Sato, Masako; Nakashima, Kosuke; Ishimori, Mina; Nagai, Hiroichi; Li, Ying-Fu; Yura, Takeshi; Bacon, Kevin B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1174-1181</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) tyrosine kinase plays essential roles in receptors for Fc portion of Igs and B cell receptor complex signaling in various inflammatory cells; therefore, inhibitors of Syk kinase may show potential as antiasthmatic/allergic therapeutics.  We identified 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]-nicotinamide dihydrochloride (BAY 61-3606), a potent (Ki = 7.5 nM) and selective inhibitor of Syk kinase.  BAY 61-3606 inhibited not only degranulation (IC50 values between 5 and 46 nM) but also lipid mediator and cytokine synthesis in mast cells.  BAY 61-3606 was highly efficacious in basophils obtained from healthy human subjects (IC50 = 10 nM) and seems to be at least as potent in basophils obtained from atopic (high serum IgE) subjects (IC50 = 8.1 nM).  B cell receptor activation and receptors for Fc portion of IgG signaling in eosinophils and monocytes were also potently suppressed by BAY 61-3606.  Oral administration of BAY 61-3606 to rats significantly suppressed antigen-induced passive cutaneous anaphylactic reaction, bronchoconstriction, and bronchial edema at 3 mg/kg.  Furthermore, BAY 61-3606 attenuated antigen-induced airway inflammation in rats.  Based on these anti-inflammatory effects of BAY 61-3606 both in vitro and in vivo, it was demonstrated that Syk may play a very crit. role in the pathogenesis of allergic reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqPCG2zkryKbVg90H21EOLACvtfcHk0ljjn_KSbGPYFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVehtbo%253D&md5=0fec9d94565bd2993e38dd22a3953f2b</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1124%2Fjpet.103.052316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.103.052316%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DTakeshita%26aufirst%3DK.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DKokubo%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DIshimori%26aufirst%3DM.%26aulast%3DNagai%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DBacon%26aufirst%3DK.%2BB.%26atitle%3DThe%2520orally%2520available%2520spleen%2520tyrosine%2520kinase%2520inhibitor%25202-%255B7-%25283%252C4-dimethoxyphenyl%2529-imidazo%255B1%252C2-c%255Dpyrimidin-5-ylamino%255D-nicotinamide%2520dihydrochloride%2520%2528BAY%252061-3606%2529%2520blocks%2520antigen-induced%2520airway%2520inflammation%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D1174%26epage%3D1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Kiefer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brumell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Alawi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latour, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawson, T.</span><span> </span><span class="NLM_article-title">The Syk protein tyrosine kinase is essential for Fcγ receptor signaling in macrophages and neutrophils</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4209</span><span class="NLM_x">–</span> <span class="NLM_lpage">4220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1128%2FMCB.18.7.4209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=9632805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADyaK1cXkt1Wjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1998&pages=4209-4220&author=F.+Kieferauthor=J.+Brumellauthor=N.+Al-Alawiauthor=S.+Latourauthor=A.+Chengauthor=A.+Veilletteauthor=S.+Grinsteinauthor=T.+Pawson&title=The+Syk+protein+tyrosine+kinase+is+essential+for+Fc%CE%B3+receptor+signaling+in+macrophages+and+neutrophils"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The Syk protein tyrosine kinase is essential for Fcγ receptor signaling in macrophages and neutrophils</span></div><div class="casAuthors">Kiefer, Friedemann; Brumell, John; Al-Alawi, Nadia; Latour, Sylvain; Cheng, Alec; Veillette, Andre; Grinstein, Sergio; Pawson, Tony</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4209-4220</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The cytoplasmic protein tyrosine kinase Syk has 2 N-terminal SH2 domains that engage phosphorylated immunoreceptor tyrosine-based activation motifs in the signaling subunits of immunoreceptors.  Syk, in conjunction with Src family kinases, has been implicated in immunoreceptor signaling in both lymphoid and myeloid cells.  The authors investigated the role of Syk in Fcγ receptor (FcγR)-dependent and -independent responses in bone marrow-derived macrophages and neutrophils by using mouse radiation chimeras reconstituted with fetal liver cells from Syk-/- embryos.  Chimeric mice developed an abdominal hemorrhage starting 2-3 mo after transplantation that was ultimately lethal.  Syk-deficient neutrophils derived from the bone marrow were incapable of generating reactive oxygen intermediates in response to FcγR engagement but responded normally to tetradecanoyl phorbol acetate stimulation.  Syk-deficient macrophages were defective in phagocytosis induced by FcγR but showed normal phagocytosis in response to complement.  The tyrosine phosphorylation of multiple cellular polypeptides, including the FcγR γ chain, as well as Erk2 activation, was compromised in Syk-/- macrophages after FcγR stimulation.  In contrast, the induction of nitric oxide synthase in macrophages stimulated with lipopolysaccharide and γ interferon was not dependent on Syk.  Surprisingly, Syk-deficient macrophages were impaired in the ability to survive or proliferate on plastic petri dishes.  Taken together, these results suggest that Syk has specific physiol. roles in signaling from FcγRs in neutrophils and macrophages and raise the possibility that in vivo, Syk is involved in signaling events other than those mediated by immunoreceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHazcdScFvi7Vg90H21EOLACvtfcHk0lhdnnpF5hhg9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt1Wjtro%253D&md5=2c4f53529d331f8ba50f02486ed37a90</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1128%2FMCB.18.7.4209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.18.7.4209%26sid%3Dliteratum%253Aachs%26aulast%3DKiefer%26aufirst%3DF.%26aulast%3DBrumell%26aufirst%3DJ.%26aulast%3DAl-Alawi%26aufirst%3DN.%26aulast%3DLatour%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DVeillette%26aufirst%3DA.%26aulast%3DGrinstein%26aufirst%3DS.%26aulast%3DPawson%26aufirst%3DT.%26atitle%3DThe%2520Syk%2520protein%2520tyrosine%2520kinase%2520is%2520essential%2520for%2520Fc%25CE%25B3%2520receptor%2520signaling%2520in%2520macrophages%2520and%2520neutrophils%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1998%26volume%3D18%26spage%3D4209%26epage%3D4220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Poole, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbins, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Vugt, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Winkel, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tybulewicz, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. P.</span><span> </span><span class="NLM_article-title">The Fc receptor γ-chain and the tyrosine kinase SYK are essential for activation of mouse platelets by collagen</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2333</span><span class="NLM_x">–</span> <span class="NLM_lpage">2341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1997&pages=2333-2341&author=A.+Pooleauthor=J.+M.+Gibbinsauthor=M.+Turnerauthor=M.+J.+van+Vugtauthor=J.+G.+van+de+Winkelauthor=T.+Saitoauthor=V.+L.+Tybulewiczauthor=S.+P.+Watson&title=The+Fc+receptor+%CE%B3-chain+and+the+tyrosine+kinase+SYK+are+essential+for+activation+of+mouse+platelets+by+collagen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPoole%26aufirst%3DA.%26aulast%3DGibbins%26aufirst%3DJ.%2BM.%26aulast%3DTurner%26aufirst%3DM.%26aulast%3Dvan%2BVugt%26aufirst%3DM.%2BJ.%26aulast%3Dvan%2Bde%2BWinkel%26aufirst%3DJ.%2BG.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DTybulewicz%26aufirst%3DV.%2BL.%26aulast%3DWatson%26aufirst%3DS.%2BP.%26atitle%3DThe%2520Fc%2520receptor%2520%25CE%25B3-chain%2520and%2520the%2520tyrosine%2520kinase%2520SYK%2520are%2520essential%2520for%2520activation%2520of%2520mouse%2520platelets%2520by%2520collagen%26jtitle%3DEMBO%2520J.%26date%3D1997%26volume%3D16%26spage%3D2333%26epage%3D2341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Ruggeri, Z. M.</span><span> </span><span class="NLM_article-title">Platelets in atherothrombosis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1227</span><span class="NLM_x">–</span> <span class="NLM_lpage">1234</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fnm1102-1227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=12411949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38XotlWmu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=1227-1234&author=Z.+M.+Ruggeri&title=Platelets+in+atherothrombosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Platelets in atherothrombosis</span></div><div class="casAuthors">Ruggeri, Zaverio M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1227-1234</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The participation of platelets in atherogenesis and the subsequent formation of occlusive thrombi depend on platelets' adhesive properties and the inability to respond to stimuli with rapid activation.  By understanding the multifaceted mechanisms involved in platelet interactions with vascular surfaces and aggregation, new approaches can be tailored to selectively inhibit the pathways most relevant to the pathol. aspects of atherothrombosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3d0EIagloKLVg90H21EOLACvtfcHk0lhdnnpF5hhg9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XotlWmu78%253D&md5=020994f0837100ace4695ddd5bcc6417</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1038%2Fnm1102-1227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1102-1227%26sid%3Dliteratum%253Aachs%26aulast%3DRuggeri%26aufirst%3DZ.%2BM.%26atitle%3DPlatelets%2520in%2520atherothrombosis%26jtitle%3DNat.%2520Med.%26date%3D2002%26volume%3D8%26spage%3D1227%26epage%3D1234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Obergfell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mócsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buensuceso, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moores, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shattil, S. J.</span><span> </span><span class="NLM_article-title">Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">157</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1083%2Fjcb.200112113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=11940607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD38XivFKktLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2002&pages=265-275&author=A.+Obergfellauthor=K.+Etoauthor=A.+M%C3%B3csaiauthor=C.+Buensucesoauthor=S.+L.+Mooresauthor=J.+S.+Bruggeauthor=C.+A.+Lowellauthor=S.+J.+Shattil&title=Coordinate+interactions+of+Csk%2C+Src%2C+and+Syk+kinases+with+%CE%B1IIb%CE%B23+initiate+integrin+signaling+to+the+cytoskeleton"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Coordinate interactions of Csk, Src, and Syk kinases with αIIbβ3 initiate integrin signaling to the cytoskeleton</span></div><div class="casAuthors">Obergfell, Achim; Eto, Koji; Mocsai, Attila; Buensuceso, Charito; Moores, Sheri L.; Brugge, Joan S.; Lowell, Clifford A.; Shattil, Sanford J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">265-275</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Integrins regulate cell adhesion and motility through tyrosine kinases, but initiation of this process is poorly understood.  We find here that Src assocs. constitutively with integrin αIIbβ3 in platelets.  Platelet adhesion to fibrinogen caused a rapid increase in αIIbβ3-assocd. Src activity, and active Src localized to filopodia and cell edges.  Csk, which neg. regulates Src by phosphorylating Tyr-529, was also constitutively assocd. with αIIbβ3.  However, fibrinogen binding caused Csk to dissoc. from αIIbβ3, concomitant with dephosphorylation of Src Tyr-529 and phosphorylation of Src activation loop Tyr-418.  In contrast to the behavior of Src and Csk, Syk was assocd. with αIIbβ3 only after fibrinogen binding.  Platelets multiply deficient in Src, Hck, Fgr, and Lyn, or normal platelets treated with Src kinase inhibitors failed to spread on fibrinogen.  Inhibition of Src kinases blocked Syk activation and inhibited phosphorylation of Syk substrates (Vav1, Vav3, SLP-76) implicated in cytoskeletal regulation.  Syk-deficient platelets exhibited Src activation upon adhesion to fibrinogen, but no spreading or phosphorylation of Vav1, Vav3, and SLP-76.  These studies establish that platelet spreading on fibrinogen requires sequential activation of Src and Syk in proximity to αIIbβ3, thus providing a paradigm for initiation of integrin signaling to the actin cytoskeleton.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpObO8A1tVgibVg90H21EOLACvtfcHk0liN2BQe6hTqPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivFKktLo%253D&md5=e4556e7e2687f8aaa49f5de8276dd744</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1083%2Fjcb.200112113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.200112113%26sid%3Dliteratum%253Aachs%26aulast%3DObergfell%26aufirst%3DA.%26aulast%3DEto%26aufirst%3DK.%26aulast%3DM%25C3%25B3csai%26aufirst%3DA.%26aulast%3DBuensuceso%26aufirst%3DC.%26aulast%3DMoores%26aufirst%3DS.%2BL.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DShattil%26aufirst%3DS.%2BJ.%26atitle%3DCoordinate%2520interactions%2520of%2520Csk%252C%2520Src%252C%2520and%2520Syk%2520kinases%2520with%2520%25CE%25B1IIb%25CE%25B23%2520initiate%2520integrin%2520signaling%2520to%2520the%2520cytoskeleton%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2002%26volume%3D157%26spage%3D265%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Nakashima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kokubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shichijo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, N.</span><span> </span><span class="NLM_article-title">A novel SYK kinase-selective inhibitor blocks antigen presentation of immune complexes in dendritic cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">505</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.ejphar.2004.10.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15556156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVWjsb7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2004&pages=223-228&author=K.+Nakashimaauthor=T.+Kokuboauthor=M.+Shichijoauthor=Y.+F.+Liauthor=T.+Yuraauthor=N.+Yamamoto&title=A+novel+SYK+kinase-selective+inhibitor+blocks+antigen+presentation+of+immune+complexes+in+dendritic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">A novel Syk kinase-selective inhibitor blocks antigen presentation of immune complexes in dendritic cells</span></div><div class="casAuthors">Nakashima, Kosuke; Kokubo, Toshio; Shichijo, Michitaka; Li, Ying-Fu; Yura, Takeshi; Yamamoto, Noriyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">223-228</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The initiation of antigen presentation by dendritic cells requires proper internalization of antigens through various mechanisms.  Internalization of immune complexes via Fc receptors has been shown to be around 100 times more efficient than the internalization of non-complexed antigens.  Spleen tyrosine kinase (Syk) plays an essential role in the signaling cascade initiated by Ig receptors.  We used a selective Syk inhibitor, 7-(3,4-dimethoxyphenyl)-N-1H-indazol-6-ylimidazo[1,2-c]pyrimidin-5-aminedihydrochloride (compd.-D), to evaluate the role of Syk in antigen presentation by mouse bone marrow-derived dendritic cells.  In line with our expectation, compd.-D concn.-dependently inhibited the internalization of immune complexes but not that of antigen itself.  Furthermore, when dendritic cells were pretreated with compd.-D, the ability of dendritic cells to present immune complex antigens to Th2 cells was attenuated, parallel by a reduced release of interleukin-4 prodn. in Th2 cells.  Therefore, Syk kinase activity is a crit. component in the process of Fcγ receptor-mediated internalization of immune complex antigens in dendritic cells, and Syk kinase inhibitors may be beneficial in selectively suppressing antibody-mediated antigen presentation in allergic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1CSm41ANgsbVg90H21EOLACvtfcHk0liN2BQe6hTqPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVWjsb7O&md5=cf2123be0cd4673d8b3e398530ccc53f</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.10.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.10.024%26sid%3Dliteratum%253Aachs%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKokubo%26aufirst%3DT.%26aulast%3DShichijo%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%2BF.%26aulast%3DYura%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26atitle%3DA%2520novel%2520SYK%2520kinase-selective%2520inhibitor%2520blocks%2520antigen%2520presentation%2520of%2520immune%2520complexes%2520in%2520dendritic%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D505%26spage%3D223%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Cywin, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNeil, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrapchak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Player, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bobko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, M. P.</span><span> </span><span class="NLM_article-title">Discovery and SAR of novel [l,6]naphthyridines as potent inhibitors of spleen tyrosine kinase (Syk)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1418</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1415-1418&author=C.+L.+Cywinauthor=B.+P.+Zhaoauthor=D.+W.+McNeilauthor=M.+Hrapchakauthor=A.+S.+Prokopowiczauthor=D.+R.+Goldbergauthor=T.+M.+Morwickauthor=A.+Gaoauthor=S.+Jakesauthor=M.+Kashemauthor=R.+L.+Magoldaauthor=R.+M.+Sollauthor=M.+R.+Playerauthor=M.+A.+Bobkoauthor=J.+Rinkerauthor=R.+L.+DesJarlaisauthor=M.+P.+Winters&title=Discovery+and+SAR+of+novel+%5Bl%2C6%5Dnaphthyridines+as+potent+inhibitors+of+spleen+tyrosine+kinase+%28Syk%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCywin%26aufirst%3DC.%2BL.%26aulast%3DZhao%26aufirst%3DB.%2BP.%26aulast%3DMcNeil%26aufirst%3DD.%2BW.%26aulast%3DHrapchak%26aufirst%3DM.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKashem%26aufirst%3DM.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DPlayer%26aufirst%3DM.%2BR.%26aulast%3DBobko%26aufirst%3DM.%2BA.%26aulast%3DRinker%26aufirst%3DJ.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DWinters%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520and%2520SAR%2520of%2520novel%2520%255Bl%252C6%255Dnaphthyridines%2520as%2520potent%2520inhibitors%2520of%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1415%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Bouyssou, T.; Dahmann, G.; Engelhardt, H.; Fiegen, D.; Handschuh, S.; Hobbie, S.; Hoffmann, M.; Kono, T.; Reiser, U.; Sato, Y.; Schnapp, A.; Schuler-Metz, A.</span><span> </span><span class="NLM_article-title">Preparation of Naphthyridines as SYK Kinase Inhibitors</span>. WO2010015520,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Bouyssou&author=G.+Dahmann&author=H.+Engelhardt&author=D.+Fiegen&author=S.+Handschuh&author=S.+Hobbie&author=M.+Hoffmann&author=T.+Kono&author=U.+Reiser&author=Y.+Sato&author=A.+Schnapp&author=A.+Schuler-Metz&title=Preparation+of+Naphthyridines+as+SYK+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBouyssou%26aufirst%3DT.%26atitle%3DPreparation%2520of%2520Naphthyridines%2520as%2520SYK%2520Kinase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Fiegen, D.; Handschuh, S.; Hobbie, S.; Hoffmann, M.; Kono, T.; Sato, Y.; Schnapp, A.; Schuler-Metz, A.</span><span> </span><span class="NLM_article-title">Preparation of 7-Phenylnaphthyridines as SYK Kinase Inhibitors</span>. WO2010015518,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+Fiegen&author=S.+Handschuh&author=S.+Hobbie&author=M.+Hoffmann&author=T.+Kono&author=Y.+Sato&author=A.+Schnapp&author=A.+Schuler-Metz&title=Preparation+of+7-Phenylnaphthyridines+as+SYK+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFiegen%26aufirst%3DD.%26atitle%3DPreparation%2520of%25207-Phenylnaphthyridines%2520as%2520SYK%2520Kinase%2520Inhibitors%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Hisamichi, H.; Naito, R.; Kawazoe, S.; Toyoshima, A.; Tanabe, K.; Nakai, E.; Ichikawa, A.; Orita, A.; Takeuchi, M.</span><span> </span><span class="NLM_article-title">Pyrimidine-5-carboxamide Derivatives</span>. U.S. Patent 6,432,963, August 13,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=H.+Hisamichi&author=R.+Naito&author=S.+Kawazoe&author=A.+Toyoshima&author=K.+Tanabe&author=E.+Nakai&author=A.+Ichikawa&author=A.+Orita&author=M.+Takeuchi&title=Pyrimidine-5-carboxamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHisamichi%26aufirst%3DH.%26atitle%3DPyrimidine-5-carboxamide%2520Derivatives%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Hisamichi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, S.</span><span> </span><span class="NLM_article-title">Synthetic studies on novel SYK inhibitors. Part 1: Synthesis and structure–activity relationship of pyrimidine-5-carboxamide derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">4936</span><span class="NLM_x">–</span> <span class="NLM_lpage">4951</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=4936-4951&author=H.+Hisamichiauthor=R.+Naitoauthor=A.+Toyoshimaauthor=N.+Kawanoauthor=A.+Ichikawaauthor=A.+Oritaauthor=M.+Oritaauthor=N.+Hamadaauthor=M.+Takeuchiauthor=M.+Ohtaauthor=S.+Tsukamoto&title=Synthetic+studies+on+novel+SYK+inhibitors.+Part+1%3A+Synthesis+and+structure%E2%80%93activity+relationship+of+pyrimidine-5-carboxamide+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHisamichi%26aufirst%3DH.%26aulast%3DNaito%26aufirst%3DR.%26aulast%3DToyoshima%26aufirst%3DA.%26aulast%3DKawano%26aufirst%3DN.%26aulast%3DIchikawa%26aufirst%3DA.%26aulast%3DOrita%26aufirst%3DA.%26aulast%3DOrita%26aufirst%3DM.%26aulast%3DHamada%26aufirst%3DN.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DOhta%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DS.%26atitle%3DSynthetic%2520studies%2520on%2520novel%2520SYK%2520inhibitors.%2520Part%25201%253A%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520pyrimidine-5-carboxamide%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D4936%26epage%3D4951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Hirabayashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnota, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">A novel Syk family kinase inhibitor: design, synthesis, and structure–activity relationship of 1,2,4-triazolo[4,3-<i>c</i>]pyrimidine and 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">7347</span><span class="NLM_x">–</span> <span class="NLM_lpage">7357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=7347-7357&author=A.+Hirabayashiauthor=H.+Mukaiyamaauthor=H.+Kobayashiauthor=H.+Shioharaauthor=S.+Nakayamaauthor=M.+Ozawaauthor=K.+Miyazawaauthor=K.+Misawaauthor=H.+Ohnotaauthor=M.+Isaji&title=A+novel+Syk+family+kinase+inhibitor%3A+design%2C+synthesis%2C+and+structure%E2%80%93activity+relationship+of+1%2C2%2C4-triazolo%5B4%2C3-c%5Dpyrimidine+and+1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirabayashi%26aufirst%3DA.%26aulast%3DMukaiyama%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DShiohara%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DM.%26aulast%3DMiyazawa%26aufirst%3DK.%26aulast%3DMisawa%26aufirst%3DK.%26aulast%3DOhnota%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DA%2520novel%2520Syk%2520family%2520kinase%2520inhibitor%253A%2520design%252C%2520synthesis%252C%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%25201%252C2%252C4-triazolo%255B4%252C3-c%255Dpyrimidine%2520and%25201%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidine%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D7347%26epage%3D7357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Hirabayashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuji, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnota, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of imidazo[1,2-<i>c</i>]pyrimidine derivatives as potent and orally effective Syk family kinases inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">9247</span><span class="NLM_x">–</span> <span class="NLM_lpage">9260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=9247-9260&author=A.+Hirabayashiauthor=H.+Mukaiyamaauthor=H.+Kobayashiauthor=H.+Shioharaauthor=S.+Nakayamaauthor=M.+Ozawaauthor=E.+Tsujiauthor=K.+Miyazawaauthor=K.+Misawaauthor=H.+Ohnotaauthor=M.+Isaji&title=Structure%E2%80%93activity+relationship+studies+of+imidazo%5B1%2C2-c%5Dpyrimidine+derivatives+as+potent+and+orally+effective+Syk+family+kinases+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirabayashi%26aufirst%3DA.%26aulast%3DMukaiyama%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DShiohara%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DM.%26aulast%3DTsuji%26aufirst%3DE.%26aulast%3DMiyazawa%26aufirst%3DK.%26aulast%3DMisawa%26aufirst%3DK.%26aulast%3DOhnota%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%2520imidazo%255B1%252C2-c%255Dpyrimidine%2520derivatives%2520as%2520potent%2520and%2520orally%2520effective%2520Syk%2520family%2520kinases%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D9247%26epage%3D9260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Hirabayashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukaiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiohara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnota, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isaji, M.</span><span> </span><span class="NLM_article-title">Structure–activity relationship studies of 5-benzylaminoimidazo[1,2-<i>c</i>]pyrimidine-8-carboxamide derivatives as potent, highly selective ZAP-70 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=284-294&author=A.+Hirabayashiauthor=H.+Mukaiyamaauthor=H.+Kobayashiauthor=H.+Shioharaauthor=S.+Nakayamaauthor=M.+Ozawaauthor=K.+Miyazawaauthor=K.+Misawaauthor=H.+Ohnotaauthor=M.+Isaji&title=Structure%E2%80%93activity+relationship+studies+of+5-benzylaminoimidazo%5B1%2C2-c%5Dpyrimidine-8-carboxamide+derivatives+as+potent%2C+highly+selective+ZAP-70+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirabayashi%26aufirst%3DA.%26aulast%3DMukaiyama%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DShiohara%26aufirst%3DH.%26aulast%3DNakayama%26aufirst%3DS.%26aulast%3DOzawa%26aufirst%3DM.%26aulast%3DMiyazawa%26aufirst%3DK.%26aulast%3DMisawa%26aufirst%3DK.%26aulast%3DOhnota%26aufirst%3DH.%26aulast%3DIsaji%26aufirst%3DM.%26atitle%3DStructure%25E2%2580%2593activity%2520relationship%2520studies%2520of%25205-benzylaminoimidazo%255B1%252C2-c%255Dpyrimidine-8-carboxamide%2520derivatives%2520as%2520potent%252C%2520highly%2520selective%2520ZAP-70%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D284%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Reilly, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">André, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pak, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeGuzman, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandey, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergmeier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenzie, S. E.</span><span> </span><span class="NLM_article-title">PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">2241</span><span class="NLM_x">–</span> <span class="NLM_lpage">2246</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2011&pages=2241-2246&author=M.+P.+Reillyauthor=U.+Sinhaauthor=P.+Andr%C3%A9author=S.+M.+Taylorauthor=Y.+Pakauthor=F.+R.+DeGuzmanauthor=N.+Nandaauthor=A.+Pandeyauthor=M.+Stollaauthor=W.+Bergmeierauthor=S.+E.+McKenzie&title=PRT-060318%2C+a+novel+Syk+inhibitor%2C+prevents+heparin-induced+thrombocytopenia+and+thrombosis+in+a+transgenic+mouse+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReilly%26aufirst%3DM.%2BP.%26aulast%3DSinha%26aufirst%3DU.%26aulast%3DAndr%25C3%25A9%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DS.%2BM.%26aulast%3DPak%26aufirst%3DY.%26aulast%3DDeGuzman%26aufirst%3DF.%2BR.%26aulast%3DNanda%26aufirst%3DN.%26aulast%3DPandey%26aufirst%3DA.%26aulast%3DStolla%26aufirst%3DM.%26aulast%3DBergmeier%26aufirst%3DW.%26aulast%3DMcKenzie%26aufirst%3DS.%2BE.%26atitle%3DPRT-060318%252C%2520a%2520novel%2520Syk%2520inhibitor%252C%2520prevents%2520heparin-induced%2520thrombocytopenia%2520and%2520thrombosis%2520in%2520a%2520transgenic%2520mouse%2520model%26jtitle%3DBlood%26date%3D2011%26volume%3D117%26spage%3D2241%26epage%3D2246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Rossi, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braselmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frances, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Issakani, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argade, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payan, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span> </span><span class="NLM_article-title">Identification of the Syk kinase inhibitor R112 by a human mast cell screen</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.jaci.2006.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16950297" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2006&pages=749-755&author=A.+B.+Rossiauthor=E.+Herlaarauthor=S.+Braselmannauthor=S.+Huynhauthor=V.+Taylorauthor=R.+Francesauthor=S.+D.+Issakaniauthor=A.+Argadeauthor=R.+Singhauthor=D.+G.+Payanauthor=E.+S.+Masuda&title=Identification+of+the+Syk+kinase+inhibitor+R112+by+a+human+mast+cell+screen"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the Syk kinase inhibitor R112 by a human mast cell screen</span></div><div class="casAuthors">Rossi, Alexander B.; Herlaar, Ellen; Braselmann, Sylvia; Huynh, Stacey; Taylor, Vanessa; Frances, Roy; Issakani, Sarkiz D.; Argade, Ankush; Singh, Rajinder; Payan, Donald G.; Masuda, Esteban S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">749-755</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Activation of the IgE receptor, Fc.vepsiln.RI, in mast cells is the key mechanism initiating and propagating pathophysiol. responses in allergic rhinitis.  Objective: Identify and characterize a small mol. inhibitor of IgE-dependent mast cell activation for the treatment of allergic diseases.  Methods: A cell-based high-throughput screen for small mols. that block IgE signaling was performed in cultured human mast cells.  A potent inhibitor, referred to as R112, was selected and characterized by using biochem. and cell-based assays.  R112 effects on IgE-dependent degranulation and cytokine prodn. was measured in mast cells and basophils and compared with other mast cell inhibitors.  Results: R112 inhibited degranulation induced by anti-IgE crosslinking in mast cells (tryptase release, effective concn. for 50% inhibition [EC50] = 353 nmol/L) or basophils (histamine release, EC50 = 280 nmol/L), and by allergen (dust mite) in basophils (histamine release, EC50 = 490 nmol/L).  R112 also blocked leukotriene C4 prodn. and all proinflammatory cytokines tested.  Subsequent mol. characterization indicated that R112 is an ATP-competitive spleen tyrosine kinase (Syk) inhibitor (inhibitory const. [Ki] = 96 nmol/L).  Its onset of action was immediate, and the inhibition was reversible.  Incubation of mast cells with R112 showed that cytokine prodn. in mast cells was dependent on sustained activation of the Fc.vepsiln.RI-Lyn-spleen tyrosine kinase pathway.  Unlike other mast cell inhibitors, R112 was able to completely inhibit all three IgE-induced mast cell functions: degranulation, lipid mediator prodn., and cytokine prodn.  Conclusion: R112 potently, completely, and rapidly abrogated all mast cell activation cascades triggered by IgE receptor crosslinking.  Clin. implications: R112 and its analogs offer a new modality in the treatment of allergic rhinitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBFncpEISRNrVg90H21EOLACvtfcHk0ljaEjgMhTzeHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWmtLo%253D&md5=4411bbd8d39931e089126fdc803805df</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2006.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2006.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DRossi%26aufirst%3DA.%2BB.%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DBraselmann%26aufirst%3DS.%26aulast%3DHuynh%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DV.%26aulast%3DFrances%26aufirst%3DR.%26aulast%3DIssakani%26aufirst%3DS.%2BD.%26aulast%3DArgade%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPayan%26aufirst%3DD.%2BG.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26atitle%3DIdentification%2520of%2520the%2520Syk%2520kinase%2520inhibitor%2520R112%2520by%2520a%2520human%2520mast%2520cell%2520screen%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2006%26volume%3D118%26spage%3D749%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitz, J.</span><span> </span><span class="NLM_article-title">Syk inhibitors as treatment for allergic rhinitis</span> <span class="citation_source-journal">Pulm. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">461</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.pupt.2007.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17669674" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=461-467&author=E.+S.+Masudaauthor=J.+Schmitz&title=Syk+inhibitors+as+treatment+for+allergic+rhinitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Syk inhibitors as treatment for allergic rhinitis</span></div><div class="casAuthors">Masuda, Esteban S.; Schmitz, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Pulmonary Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">461-467</span>CODEN:
                <span class="NLM_cas:coden">PPTHFJ</span>;
        ISSN:<span class="NLM_cas:issn">1094-5539</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Allergic rhinitis is characterized by a hypersensitive immune response in the upper airways to seasonal or perennial allergens leading to episodes of sneezing, itching, runny nose and nasal congestion.  These symptoms are mainly the manifestations of a large no. of mediators released by mast cells and basophils localized in the nasal mucosa, following their activation via allergen-specific immunoglubulin E (IgE) receptors.  Current medications antagonize the action of distinct mediators such as histamine and leukotrienes for symptom relief, or block the prodn. of pro-inflammatory cytokines to suppress allergic inflammation.  Notably, rather than neutralizing individual mediators, Syk kinase inhibitors can block the allergen-induced release of all mast cell mediators and the prodn. of most eicosanoids and cytokines.  Thus, Syk kinase represents an attractive therapeutic target for acute and chronic allergic inflammation.  Syk kinase inhibitors are now entering clin. trials.  Using cell-based structure-activity relationships with primary human mast cells, a series of 2,4-diaminopyrimidine Syk kinase inhibitors was developed.  One of these compds., referred to as R112, exhibited suitable characteristics for intranasal delivery and was tested for safety and efficacy in allergic rhinitis patients.  In a park environment, R112 showed remarkable amelioration of acute allergic rhinitis symptoms with rapid onset of action.  These results demonstrate the clin. significance of inhibiting Syk in allergic upper airway disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY3bfhViMJUrVg90H21EOLACvtfcHk0ljaEjgMhTzeHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVSgt78%253D&md5=fadb261de75f443b3dd3fc9fd1f8edb9</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1016%2Fj.pupt.2007.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pupt.2007.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DSchmitz%26aufirst%3DJ.%26atitle%3DSyk%2520inhibitors%2520as%2520treatment%2520for%2520allergic%2520rhinitis%26jtitle%3DPulm.%2520Pharmacol.%2520Ther.%26date%3D2008%26volume%3D21%26spage%3D461%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Matsubara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joetham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swasey, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, E. W.</span><span> </span><span class="NLM_article-title">Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">426</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1165%2Frcmb.2005-0298OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16339999" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFCqurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=426-433&author=S.+Matsubaraauthor=T.+Koyaauthor=K.+Takedaauthor=A.+Joethamauthor=N.+Miyaharaauthor=P.+Pineauthor=E.+S.+Masudaauthor=C.+H.+Swaseyauthor=E.+W.+Gelfand&title=Syk+activation+in+dendritic+cells+is+essential+for+airway+hyperresponsiveness+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation</span></div><div class="casAuthors">Matsubara, Shigeki; Koya, Toshiyuki; Takeda, Katsuyuki; Joetham, Anthony; Miyahara, Nobuaki; Pine, Polly; Masuda, Esteban S.; Swasey, Christina H.; Gelfand, Erwin W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">426-433</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">We evaluated the role of Syk, using an inhibitor, on allergen-induced airway hyperresponsiveness (AHR) and airway inflammation in a system shown to be B cell- and mast cell-independent.  Sensitization of BALB/c mice with ovalbumin (OVA) and alum after three consecutive OVA challenges resulted in AHR to inhaled methacholine and airway inflammation.  The Syk inhibitor R406 (30 mg/kg, administered orally, twice daily) prevented the development of AHR, increases in eosinophils and lymphocytes and IL-13 levels in bronchoalveolar lavage (BAL) fluid, and goblet cell metaplasia when administered after sensitization and before challenge with OVA.  Levels of IL-4, IL-5, and IFN-γ in BAL fluid and allergen-specific antibody levels in serum were not affected by treatment.  Because many of these responses may be influenced by dendritic cell function, we investigated the effect of R406 on bone marrow-derived dendritic cell (BMDC) function.  Co-culture of BMDC with immune complexes of OVA and IgG anti-OVA together with OVA-sensitized spleen mononuclear cells resulted in increases in IL-13 prodn.  IL-13 prodn. was inhibited if the BMDCs were pretreated with the Syk inhibitor.  Intratracheal transfer of immune complex-pulsed BMDCs (but not nonpulsed BMDCs) to naive mice before airway allergen challenge induced the development of AHR and increases in BAL eosinophils and lymphocytes.  All of these responses were inhibited if the transferred BMDCs were pretreated with R406.  These results demonstrate that Syk inhibition prevents allergen-induced AHR and airway inflammation after systemic sensitization, and challenge, at least in part through alteration of DC function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE2yCPr3feg7Vg90H21EOLACvtfcHk0lijEmqA9lMGgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFCqurc%253D&md5=0c09f0ae29fb851f61febfa6e6a44ab1</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2005-0298OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2005-0298OC%26sid%3Dliteratum%253Aachs%26aulast%3DMatsubara%26aufirst%3DS.%26aulast%3DKoya%26aufirst%3DT.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DJoetham%26aufirst%3DA.%26aulast%3DMiyahara%26aufirst%3DN.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DSwasey%26aufirst%3DC.%2BH.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DSyk%2520activation%2520in%2520dendritic%2520cells%2520is%2520essential%2520for%2520airway%2520hyperresponsiveness%2520and%2520inflammation%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2006%26volume%3D34%26spage%3D426%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Matsubara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loader, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyahara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dakhama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelfand, E. W.</span><span> </span><span class="NLM_article-title">Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness</span> <span class="citation_source-journal">Am. J. Respir. Crit. Care Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1164%2Frccm.200503-361OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16192454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XmslSktr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2006&pages=56-63&author=S.+Matsubaraauthor=G.+Liauthor=K.+Takedaauthor=J.+E.+Loaderauthor=P.+Pineauthor=E.+S.+Masudaauthor=N.+Miyaharaauthor=S.+Miyaharaauthor=J.+J.+Lucasauthor=A.+Dakhamaauthor=E.+W.+Gelfand&title=Inhibition+of+spleen+tyrosine+kinase+prevents+mast+cell+activation+and+airway+hyperresponsiveness"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness</span></div><div class="casAuthors">Matsubara, Shigeki; Li, Guiming; Takeda, Katsuyuki; Loader, Joan E.; Pine, Polly; Masuda, Esteban S.; Miyahara, Nobuaki; Miyahara, Satoko; Lucas, Joseph J.; Dakhama, Azzeddine; Gelfand, Erwin W.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory and Critical Care Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">AJCMED</span>;
        ISSN:<span class="NLM_cas:issn">1073-449X</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Rationale: Spleen tyrosine kinase (Syk) is important for Fc and B-cell receptor-mediated signaling.  Objective: To det. the activity of a specific Syk inhibitor (R406) on mast cell activation in vitro and on the development of allergen-induced airway hyperresponsiveness (AHR) and inflammation in vivo.  Methods: AHR and inflammation were induced after 10 d of allergen (ovalbumin [OVA]) exposure exclusively via the airways and in the absence of adjuvant.  This approach was previously established to be IgE, FcεRI, and mast cell dependent.  Alternatively, mice were passively sensitized with OVA-specific IgE, followed by limited airway challenge.  In vitro, the inhibitor was added to cultures of IgE-sensitized bone marrow-derived mast cells (BMMCs) before crosslinking with allergen.  Results: The inhibitor prevented OVA-induced degranulation of passively IgE-sensitized murine BMMCs and inhibited the prodn. of interleukin (IL)-13, tumor necrosis factor α, IL-2, and IL-6 in these sensitized BMMCs.  When administered in vivo, R406 inhibited AHR, which developed in BALB/c mice exposed to aerosolized 1% OVA for 10 consecutive d (20 min/d), as well as pulmonary eosinophilia and goblet cell metaplasia.  A similar inhibition of AHR was demonstrated in mice passively sensitized with OVA-specific IgE and exposed to limited airway challenge.  Conclusion: This study delineates a functional role for Syk in the development of mast cell- and IgE-mediated AHR and airway inflammation, and these results indicate that inhibition of Syk may be a target in the treatment of allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNpn-O8jXJ6rVg90H21EOLACvtfcHk0lijEmqA9lMGgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmslSktr4%253D&md5=ee54cff81d9100544d10091d96aa1f66</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1164%2Frccm.200503-361OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Frccm.200503-361OC%26sid%3Dliteratum%253Aachs%26aulast%3DMatsubara%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DLoader%26aufirst%3DJ.%2BE.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DMiyahara%26aufirst%3DN.%26aulast%3DMiyahara%26aufirst%3DS.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DDakhama%26aufirst%3DA.%26aulast%3DGelfand%26aufirst%3DE.%2BW.%26atitle%3DInhibition%2520of%2520spleen%2520tyrosine%2520kinase%2520prevents%2520mast%2520cell%2520activation%2520and%2520airway%2520hyperresponsiveness%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2006%26volume%3D173%26spage%3D56%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herlaar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burleson, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clemens, G. R.</span><span> </span><span class="NLM_article-title">Immunotoxicity assessment for the novel spleen tyrosine kinase inhibitor R406</span> <span class="citation_source-journal">Toxicol. Appl. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">221</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.taap.2007.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=17490694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlSmt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=221&publication_year=2007&pages=268-277&author=Y.+Zhuauthor=E.+Herlaarauthor=E.+S.+Masudaauthor=G.+R.+Burlesonauthor=A.+J.+Nelsonauthor=E.+B.+Grossbardauthor=G.+R.+Clemens&title=Immunotoxicity+assessment+for+the+novel+spleen+tyrosine+kinase+inhibitor+R406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Immunotoxicity assessment for the novel spleen tyrosine kinase inhibitor R406</span></div><div class="casAuthors">Zhu, Yanhong; Herlaar, Ellen; Masuda, Esteban S.; Burleson, Gary R.; Nelson, Andrew J.; Grossbard, Elliott B.; Clemens, George R.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">221</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">268-277</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a novel pharmaceutical target for treatment of allergic, autoimmune, and neoplastic disorders.  Previous studies have indicated that Syk signaling plays crit. roles in regulating the lymphohematopoietic system.  These observations prompted us to investigate whether inhibition of Syk would promote immunotoxicity.  In a series of studies, rats were treated orally with R406, at dose levels up to and including 100 mg/kg/day (or its prodrug R788 at dose levels up to and including 100 mg/kg/day, reduced to 50 mg/kg/day for females as MTD was exceeded), a potent Syk inhibitor, twice daily for 28 days.  In addn. to std. toxicol. assessments, immunophenotyping by flow cytometric anal., and a study of humoral immune response measuring anti-KLH IgM and IgG levels, were undertaken.  Other immunotoxicity studies included 3 host resistance models in female Balb/c mice to further ascertain effects of R406 on innate and acquired immunity.  Following R406 treatment, expected immunomodulating effects (e.g., decreased thymic and spleen wt., hypocellularity of bone marrow, and reduced lymphocyte counts, including T and B cells) were obsd. in the rat studies.  These changes essentially resolved during a 14-day treatment-free recovery period.  A KLH challenge in rats demonstrated no adverse effects on IgG or IgM response.  R788/406, administered orally at dose levels up to and including 80 mg/kg/day for 28 days, did not affect bacterial or viral clearance in the Listeria, Streptococcal, or Influenza host resistance mouse models, resp.  This correlated with previous in vitro macrophage and neutrophil function assays (assessing migration, phagocytosis, oxidative burst, and microbicidal activity), which revealed that R406 did not adversely affect macrophage or neutrophil function in innate immune responses.  Collectively, these results demonstrate that R406 has minimal functional immunotoxicity notwithstanding its lymphocytopenic effect, suggesting that inhibition of Syk might not lead to unacceptable mechanism-based adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGswVQ_gofd7Vg90H21EOLACvtfcHk0lijEmqA9lMGgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlSmt7o%253D&md5=11f4b6f9ee77bad470761ddd24d14094</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2007.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2007.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DHerlaar%26aufirst%3DE.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DBurleson%26aufirst%3DG.%2BR.%26aulast%3DNelson%26aufirst%3DA.%2BJ.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DClemens%26aufirst%3DG.%2BR.%26atitle%3DImmunotoxicity%2520assessment%2520for%2520the%2520novel%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520R406%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2007%26volume%3D221%26spage%3D268%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Cha, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoot, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tak, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestein, G. S.</span><span> </span><span class="NLM_article-title">A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">571</span><span class="NLM_x">–</span> <span class="NLM_lpage">578</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1124%2Fjpet.105.097436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=16452391" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD28XktFamtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2006&pages=571-578&author=H.+S.+Chaauthor=D.+L.+Boyleauthor=T.+Inoueauthor=R.+Schootauthor=P.+P.+Takauthor=P.+Pineauthor=G.+S.+Firestein&title=A+novel+spleen+tyrosine+kinase+inhibitor+blocks+c-Jun+N-terminal+kinase-mediated+gene+expression+in+synoviocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">A novel spleen tyrosine kinase inhibitor blocks c-Jun N-terminal kinase-mediated gene expression in synoviocytes</span></div><div class="casAuthors">Cha, Hoon-Suk; Boyle, David L.; Inoue, Tomoyuki; Schoot, Reineke; Tak, Paul P.; Pine, Polly; Firestein, Gary S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">571-578</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Spleen tyrosine kinase (Syk) is a key regulator of cell signaling induced by cytokines or Fc receptor engagement.  However, the role of Syk in rheumatoid arthritis (RA) is not known yet.  We investigated the pathways activated by Syk in tumor necrosis factor-α (TNFα)-stimulated fibroblast-like synoviocytes (FLS) using the novel Syk inhibitor N4-(2,2-dimethyl-3-oxo-4H-pyrid[1,4]oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine (R406).  Using immunohistochem., Syk was detected in RA synovial tissue (ST), primarily in the synovial intimal lining.  Western blot anal. demonstrated significantly greater amts. of phospho-Syk expression in RA ST compared with osteoarthritis ST.  The kinase was expressed and functionally activated by TNFα in FLS and was blocked by R406.  Western blot anal. demonstrated that Syk inhibition by R406 markedly suppressed TNFα-induced c-Jun N-terminal kinase (JNK) phosphorylation in FLS, with a modest decrease in extracellular signal-regulated kinase phosphorylation.  Surprisingly, p38 activation was not affected by R406.  The Syk inhibitor also decreased TNFα-induced mitogen-activated protein kinase kinase (MKK) 4 phosphorylation but not MKK3 and MKK6 phosphorylation, which is consistent with its selective sparing of p38.  The connection between Syk and JNK was confirmed by demonstrating decreased phospho-c-Jun protein expression and complete inhibition of JNK function in R406-treated cells.  R406 also suppressed downstream actions of JNK, as detd. by activator protein 1 binding, as well as matrix metalloproteinase 3 gene expression.  These data demonstrate that Syk activation plays an essential role in TNFα-induced cytokine and matrix metalloproteinase prodn. in RA FLS, esp. by suppressing activation of the JNK pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowy40JTv0l77Vg90H21EOLACvtfcHk0lioRuv59g9uUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktFamtb8%253D&md5=561af856df90dc0d9c39b00ef7bff860</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.097436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.097436%26sid%3Dliteratum%253Aachs%26aulast%3DCha%26aufirst%3DH.%2BS.%26aulast%3DBoyle%26aufirst%3DD.%2BL.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DSchoot%26aufirst%3DR.%26aulast%3DTak%26aufirst%3DP.%2BP.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DFirestein%26aufirst%3DG.%2BS.%26atitle%3DA%2520novel%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520blocks%2520c-Jun%2520N-terminal%2520kinase-mediated%2520gene%2520expression%2520in%2520synoviocytes%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D317%26spage%3D571%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Sweeny, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clough, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamidipati, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D. T.-W.</span><span> </span><span class="NLM_article-title">Metabolism of fostamatinib, the oral methylene phosphate prodrug of the spleen tyrosine kinase inhibitor R406 in humans: contribution of hepatic and gut bacterial processes to the overall biotransformation</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1166</span><span class="NLM_x">–</span> <span class="NLM_lpage">1176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=1166-1176&author=D.+J.+Sweenyauthor=W.+Liauthor=J.+Cloughauthor=S.+Bhamidipatiauthor=R.+Singhauthor=G.+Parkauthor=M.+Baluomauthor=E.+B.+Grossbardauthor=D.+T.-W.+Lau&title=Metabolism+of+fostamatinib%2C+the+oral+methylene+phosphate+prodrug+of+the+spleen+tyrosine+kinase+inhibitor+R406+in+humans%3A+contribution+of+hepatic+and+gut+bacterial+processes+to+the+overall+biotransformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSweeny%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DClough%26aufirst%3DJ.%26aulast%3DBhamidipati%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DG.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DLau%26aufirst%3DD.%2BT.-W.%26atitle%3DMetabolism%2520of%2520fostamatinib%252C%2520the%2520oral%2520methylene%2520phosphate%2520prodrug%2520of%2520the%2520spleen%2520tyrosine%2520kinase%2520inhibitor%2520R406%2520in%2520humans%253A%2520contribution%2520of%2520hepatic%2520and%2520gut%2520bacterial%2520processes%2520to%2520the%2520overall%2520biotransformation%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D1166%26epage%3D1176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Sweeny, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, D. T.</span><span> </span><span class="NLM_article-title">Contribution of gut bacteria to the metabolism of the spleen tyrosine kinase (Syk) inhibitor R406 in cynomolgus monkey</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2010&pages=415-423&author=D.+J.+Sweenyauthor=W.+Liauthor=E.+B.+Grossbardauthor=D.+T.+Lau&title=Contribution+of+gut+bacteria+to+the+metabolism+of+the+spleen+tyrosine+kinase+%28Syk%29+inhibitor+R406+in+cynomolgus+monkey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSweeny%26aufirst%3DD.%2BJ.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DLau%26aufirst%3DD.%2BT.%26atitle%3DContribution%2520of%2520gut%2520bacteria%2520to%2520the%2520metabolism%2520of%2520the%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%2520inhibitor%2520R406%2520in%2520cynomolgus%2520monkey%26jtitle%3DXenobiotica%26date%3D2010%26volume%3D40%26spage%3D415%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Meltzer, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span> </span><span class="NLM_article-title">An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1016%2Fj.jaci.2005.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=15806000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivV2isrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=791-796&author=E.+O.+Meltzerauthor=R.+B.+Berkowitzauthor=E.+B.+Grossbard&title=An+intranasal+Syk-kinase+inhibitor+%28R112%29+improves+the+symptoms+of+seasonal+allergic+rhinitis+in+a+park+environment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment</span></div><div class="casAuthors">Meltzer, Eli O.; Berkowitz, Robert B.; Grossbard, Elliott B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">791-796</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Background: R112 inhibits Syk kinase, a transducer of signaling through the Fcε receptor of mast cells, blocking mast cell responses to allergic stimuli.  Objective: Examine the efficacy and safety of intranasal R112 in volunteers with symptomatic seasonal allergic rhinitis compared with a placebo in a park setting.  Methods: In this double-blind, placebo-controlled study of 319 volunteers with seasonal allergic rhinitis, 160 were randomized to intranasal R112 and 159 to a vehicle control during 2 days at 2 sep. locations in spring 2004.  Subjects were evaluated for symptoms of allergic rhinitis (ie, sneezes, runny nose/sniffles, itchy nose, stuffy nose) on the basis of a possible max. score of 32 for the Global Symptom Complex (GSC) scale.  The primary outcome evaluated was the difference in the redn. in GSC (area under the curve over a period of 8 h) from baseline between R112 and vehicle placebo.  Results: At baseline, the combined GSC was ∼18/32 and equal between treatment groups.  After 8 h (dosing 3 mg/nostril every 4 h × 2), R112 significantly reduced the GSC compared with placebo (7 vs 5.4 units, resp.; P = .0005).  Each individual symptom combined to form the GSC was also significantly improved in the R112 group compared with control (P < .05).  As early as 45 min after dosing, R112 showed a significant improvement in symptoms over placebo, and the duration of action exceeded 4 h.  Adverse effects were indistinguishable between the groups and clin. insignificant.  Conclusion: Intranasal R112 was effective in this park study and is a promising new treatment for seasonal allergic rhinitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrit-WK5KqSZbVg90H21EOLACvtfcHk0lioRuv59g9uUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivV2isrk%253D&md5=ca5277558c0e72640465916b3a252964</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.jaci.2005.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaci.2005.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DE.%2BO.%26aulast%3DBerkowitz%26aufirst%3DR.%2BB.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26atitle%3DAn%2520intranasal%2520Syk-kinase%2520inhibitor%2520%2528R112%2529%2520improves%2520the%2520symptoms%2520of%2520seasonal%2520allergic%2520rhinitis%2520in%2520a%2520park%2520environment%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2005%26volume%3D115%26spage%3D791%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikranian, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medrano-Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales-Torres, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straniero, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vicente-Gonzales, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span> </span><span class="NLM_article-title">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">3309</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fart.23992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=18975322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2008&pages=3309-3318&author=M.+E.+Weinblattauthor=A.+Kavanaughauthor=R.+Burgos-Vargasauthor=A.+H.+Dikranianauthor=G.+Medrano-Ramirezauthor=J.+L.+Morales-Torresauthor=F.+T.+Murphyauthor=T.+K.+Musserauthor=N.+Stranieroauthor=A.+V.+Vicente-Gonzalesauthor=E.+B.+Grossbard&title=Treatment+of+rheumatoid+arthritis+with+a+Syk+kinase+inhibitor%3A+a+twelve-week%2C+randomized%2C+placebo-controlled+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial</span></div><div class="casAuthors">Weinblatt, Michael E.; Kavanaugh, Arthur; Burgos-Vargas, Ruben; Dikranian, Ara H.; Medrano-Ramirez, Gabriel; Morales-Torres, Jorge L.; Murphy, Frederick T.; Musser, Theresa Kane; Straniero, Nicholas; Vicente-Gonzales, Angela V.; Grossbard, Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3309-3318</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: Spleen tyrosine kinase (Syk) has been identified as an important modulator of immune signaling in B cells and cells bearing Fcγ-activating receptors.  R788, a prodrug of active metabolite R406, has been shown to be an inhibitor of Syk kinase, active in a variety of in vitro and in vivo models, suggesting potential activity in the treatment of rheumatoid arthritis (RA).  Methods: We enrolled 189 patients with active RA despite methotrexate therapy in a 3-mo, multicenter, ascending-dose, double-blind, placebo-controlled trial.  The primary end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at week 12.  Results: Twice-daily oral doses of 100 mg and 150 mg of R788 were significantly superior to placebo or twice-daily oral doses of 50 mg at week 12 (ACR20 achieved in 65% and 72% vs. 38% and 32% of patients, resp. [P < 0.01]).  ACR50 (achieved in 49% and 57% vs. 19% and 17% of patients, resp.) and ACR70 (achieved in 33% and 40% vs. 4% and 2% of patients, resp.) scores showed a similar pattern.  Clin. effect was noted as early as 1 wk after initiation of therapy.  Redns. in serum interleukin-6 and matrix metalloproteinase 3 levels also occurred as early as week 1 in the groups receiving 100 mg and 150 mg R788.  The major adverse effects were gastrointestinal side effects (predominantly diarrhea) and neutropenia (<1,500/mm3), both of which were dose related.  Conclusion: These results indicate that an inhibitor of Syk kinase produces significant clin. benefits at 12 wk in a population of patients with active RA receiving methotrexate therapy.  Syk kinase may be an important new therapeutic target in RA and related autoimmune conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqomUu-KV6uvbVg90H21EOLACvtfcHk0lioRuv59g9uUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsV2hs7jF&md5=a49db998eb1a011d8ae59580f4c868c6</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1002%2Fart.23992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.23992%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DDikranian%26aufirst%3DA.%2BH.%26aulast%3DMedrano-Ramirez%26aufirst%3DG.%26aulast%3DMorales-Torres%26aufirst%3DJ.%2BL.%26aulast%3DMurphy%26aufirst%3DF.%2BT.%26aulast%3DMusser%26aufirst%3DT.%2BK.%26aulast%3DStraniero%26aufirst%3DN.%26aulast%3DVicente-Gonzales%26aufirst%3DA.%2BV.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26atitle%3DTreatment%2520of%2520rheumatoid%2520arthritis%2520with%2520a%2520Syk%2520kinase%2520inhibitor%253A%2520a%2520twelve-week%252C%2520randomized%252C%2520placebo-controlled%2520trial%26jtitle%3DArthritis%2520Rheum.%26date%3D2008%26volume%3D58%26spage%3D3309%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musser, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magilavy, D. B.</span><span> </span><span class="NLM_article-title">An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1303</span><span class="NLM_x">–</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1056%2FNEJMoa1000500" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=20879879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1WqsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1303-1312&author=M.+E.+Weinblattauthor=A.+Kavanaughauthor=M.+C.+Genoveseauthor=T.+K.+Musserauthor=E.+B.+Grossbardauthor=D.+B.+Magilavy&title=An+oral+spleen+tyrosine+kinase+%28Syk%29+inhibitor+for+rheumatoid+arthritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">An oral spleen tyrosine kinase (SyK) inhibitor for rheumatoid arthritis</span></div><div class="casAuthors">Weinblatt, Michael E.; Kavanaugh, Arthur; Genovese, Mark C.; Musser, Theresa K.; Grossbard, Elliott B.; Magilavy, Daniel B.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">1303-1312</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND  Spleen tyrosine kinase (Syk) is an important modulator of immune signaling.  The objective of this phase 2 study was to evaluate the efficacy and safety of R788, an oral inhibitor of Syk, in patients with active rheumatoid arthritis despite methotrexate therapy.  METHODS  We enrolled 457 patients who had active rheumatoid arthritis despite long-term methotrexate therapy in a 6-mo, double-blind, placebo-controlled trial.  The primary outcome was the American College of Rheumatol. (ACR) 20 response (which indicates at least a 20% redn. in the no. of both tender and swollen joints and improvement in at least three of five other criteria) at month 6.  RESULTS  R788, at a dose of 100 mg twice daily and at a dose of 150 mg once daily, was significantly superior to placebo at month 6 (ACR 20 response rates of 67% and 57%, resp., vs. 35%; P < 0.001 for the comparison of both doses with placebo).  It was also significantly superior with respect to ACR 50, which indicates at least a 50% improvement (43% and 32% vs. 19%; P < 0.001 for the comparison of the 100-mg dose with placebo, P = 0.007 for the comparison of the 150-mg dose with placebo) and ACR70 (28% and 14% vs. 10%; P < 0.001 for the comparison of the 100-mg dose with placebo, P = 0.34 for the comparison of the 150-mg dose with placebo).  A clin. significant effect was noted by the end of the first week of treatment.  Adverse effects included diarrhea (in 19% of subjects taking the 100-mg dose of R788 vs. 3% of those taking placebo), upper respiratory infections (14% vs. 7%), and neutropenia (60/% vs. 1%0/).  R788 was assocd. with an increase in systolic blood pressure of approx. 3 mm Hg between baseline and month 1, as compared with a decrease of 2 mm Hg with placebo; 23% of the patients taking R788 vs. 7% of the patients receiving placebo required the initiation of or a change in antihypertensive therapy.  CONCLUSIONS  In this phase 2 study, a Syk inhibitor reduced disease activity in patients with rheumatoid arthritis; adverse events included diarrhea, hypertension, and neutropenia.  Addnl. studies will be needed to further assess the safety and efficacy of Syk-inhibition therapy in patients with rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv0QGXE3rZiLVg90H21EOLACvtfcHk0lgr9xCv3eIiog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1WqsLfI&md5=f6da21edb34b0fe9858b6d7bbfd6f0b4</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1000500&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1000500%26sid%3Dliteratum%253Aachs%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DMusser%26aufirst%3DT.%2BK.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DMagilavy%26aufirst%3DD.%2BB.%26atitle%3DAn%2520oral%2520spleen%2520tyrosine%2520kinase%2520%2528Syk%2529%2520inhibitor%2520for%2520rheumatoid%2520arthritis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1303%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kavanaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinblatt, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterfy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dicarlo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magilavy, D. B.</span><span> </span><span class="NLM_article-title">An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fart.30114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=21279990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVOlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=337-345&author=M.+C.+Genoveseauthor=A.+Kavanaughauthor=M.+E.+Weinblattauthor=C.+Peterfyauthor=J.+Dicarloauthor=M.+L.+Whiteauthor=M.+O%E2%80%99Brienauthor=E.+B.+Grossbardauthor=D.+B.+Magilavy&title=An+oral+Syk+kinase+inhibitor+in+the+treatment+of+rheumatoid+arthritis%3A+a+three-month+randomized%2C+placebo-controlled%2C+phase+II+study+in+patients+with+active+rheumatoid+arthritis+that+did+not+respond+to+biologic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">An oral Syk kinase inhibitor in the treatment of rheumatoid arthritis: a three-month randomized, placebo-controlled, phase II study in patients with active rheumatoid arthritis that did not respond to biologic agents</span></div><div class="casAuthors">Genovese, Mark C.; Kavanaugh, Arthur; Weinblatt, Michael E.; Peterfy, Charles; DiCarlo, Julie; White, Michael L.; O'Brien, Maryann; Grossbard, Elliott B.; Magilavy, Daniel B.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-345</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective: To assess the efficacy and safety of R788 (fostamatinib disodium), an inhibitor of spleen tyrosine kinase (Syk), in patients with active rheumatoid arthritis (RA) that did not respond to biol. therapies.  Methods: A total of 219 patients with active RA in whom treatment with biol. agents had failed were enrolled in a 3-mo multicenter, randomized, double-blind, placebo-controlled trial of R788.  The primary end point was the percentage of patients who met the American College of Rheumatol. 20% improvement criteria (achieved an ACR20 response) at month 3.  Secondary end points included changes in inflammation and damage, as assessed by magnetic resonance imaging (MRI), and changes in the Disease Activity Score.  Results: The ACR20 response in the R788 100 mg twice daily group was 38%, vs. 37% in the placebo group, at month 3.  No significant differences were achieved in the ACR20, ACR50, or ACR70 response levels at 3 mo.  There were differences between the groups from baseline to month 3 in the secondary end points C-reactive protein (CRP) level and synovitis score on MRI.  There were baseline differences in steroid use, prior biol. use, and synovitis score on MRI between the R788 group and the placebo group that may have affected the outcomes.  A high placebo response rate was seen in this trial, and exploratory anal. suggested that this may in part have been driven by patients who entered the trial with an elevated erythrocyte sedimentation rate but normal CRP level.  Conclusion: Our findings indicate that there were no differences in the primary end point between the R788 and placebo groups.  Differences were obsd. between the R788 and placebo groups in secondary end points, particularly in those patients who entered the study with an elevated CRP level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSENODg4S987Vg90H21EOLACvtfcHk0lgr9xCv3eIiog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVOlu7k%253D&md5=52391a831a7be49f13bdf2014ce2ee56</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1002%2Fart.30114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.30114%26sid%3Dliteratum%253Aachs%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DKavanaugh%26aufirst%3DA.%26aulast%3DWeinblatt%26aufirst%3DM.%2BE.%26aulast%3DPeterfy%26aufirst%3DC.%26aulast%3DDicarlo%26aufirst%3DJ.%26aulast%3DWhite%26aufirst%3DM.%2BL.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DMagilavy%26aufirst%3DD.%2BB.%26atitle%3DAn%2520oral%2520Syk%2520kinase%2520inhibitor%2520in%2520the%2520treatment%2520of%2520rheumatoid%2520arthritis%253A%2520a%2520three-month%2520randomized%252C%2520placebo-controlled%252C%2520phase%2520II%2520study%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%2520that%2520did%2520not%2520respond%2520to%2520biologic%2520agents%26jtitle%3DArthritis%2520Rheum.%26date%3D2011%26volume%3D63%26spage%3D337%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Crow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siragam, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarus, A. H.</span><span> </span><span class="NLM_article-title">Inhibition of immune thrombocytopenic purpura (ITP) by an orally bioavailable inhibitor of Syk kinase activity</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">612a</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2005&pages=612a&author=A.+Crowauthor=V.+Siragamauthor=J.+Freedmanauthor=E.+B.+Grossbardauthor=E.+S.+Masudaauthor=P.+Pineauthor=A.+H.+Lazarus&title=Inhibition+of+immune+thrombocytopenic+purpura+%28ITP%29+by+an+orally+bioavailable+inhibitor+of+Syk+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrow%26aufirst%3DA.%26aulast%3DSiragam%26aufirst%3DV.%26aulast%3DFreedman%26aufirst%3DJ.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DPine%26aufirst%3DP.%26aulast%3DLazarus%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520immune%2520thrombocytopenic%2520purpura%2520%2528ITP%2529%2520by%2520an%2520orally%2520bioavailable%2520inhibitor%2520of%2520Syk%2520kinase%2520activity%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D612a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Singh, R.; Argade, A.; Payan, D. G.; Molineaux, S.; Holland, S. J.; Clough, J.; Keim, H.; Bhamidipati, S.; Sylvain, C.; Li, H.; Rossi, A. B.</span><span> </span><span class="NLM_article-title">2,4-Pyrimidinediamine Compounds and Their Uses</span>. WO2003063794,<span class="NLM_x"> </span><span class="NLM_year">2003</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&author=R.+Singh&author=A.+Argade&author=D.+G.+Payan&author=S.+Molineaux&author=S.+J.+Holland&author=J.+Clough&author=H.+Keim&author=S.+Bhamidipati&author=C.+Sylvain&author=H.+Li&author=A.+B.+Rossi&title=2%2C4-Pyrimidinediamine+Compounds+and+Their+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSingh%26aufirst%3DR.%26atitle%3D2%252C4-Pyrimidinediamine%2520Compounds%2520and%2520Their%2520Uses%26date%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Metcalfe, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baram, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mekori, Y. A.</span><span> </span><span class="NLM_article-title">Mast cells</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1997&pages=1033-1079&author=D.+D.+Metcalfeauthor=D.+Baramauthor=Y.+A.+Mekori&title=Mast+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetcalfe%26aufirst%3DD.%2BD.%26aulast%3DBaram%26aufirst%3DD.%26aulast%3DMekori%26aufirst%3DY.%2BA.%26atitle%3DMast%2520cells%26jtitle%3DPhysiol.%2520Rev.%26date%3D1997%26volume%3D77%26spage%3D1033%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Clemens, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magness, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, E. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lech, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuda, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baluom, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossbard, E. B.</span><span> </span><span class="NLM_article-title">Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing</span> <span class="citation_source-journal">Birth Defects Res., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1002%2Fbdra.20505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19107952" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFegtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=130-136&author=G.+R.+Clemensauthor=R.+E.+Schroederauthor=S.+H.+Magnessauthor=E.+V.+Weaverauthor=J.+W.+Lechauthor=V.+C.+Taylorauthor=E.+S.+Masudaauthor=M.+Baluomauthor=E.+B.+Grossbard&title=Developmental+toxicity+associated+with+receptor+tyrosine+kinase+Ret+inhibition+in+reproductive+toxicity+testing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Developmental toxicity associated with receptor tyrosine kinase Ret inhibition in reproductive toxicity testing</span></div><div class="casAuthors">Clemens, George R.; Schroeder, Raymond E.; Magness, Steven H.; Weaver, Elizabeth V.; Lech, Joseph W.; Taylor, Vanessa C.; Masuda, Esteban S.; Baluom, Muhammad; Grossbard, Elliott B.</div><div class="citationInfo"><span class="NLM_cas:title">Birth Defects Research, Part A: Clinical and Molecular Teratology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-136</span>CODEN:
                <span class="NLM_cas:coden">BDRPBT</span>;
        ISSN:<span class="NLM_cas:issn">1542-0752</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Urogenital abnormalities are among the most common of all human birth defects.  In developmental toxicity studies with the Syk kinase inhibitor R788, a spectrum of findings, including renal agenesis, were obsd.  R788 was also found to inhibit the receptor tyrosine kinase Ret.  Ret kinase is known to be an essential component in the signaling pathway required for renal organogenesis and ureteric duct formation.  Previously known is that mutant mice without the c-ret gene, develop urogenital malformations including renal agenesis.  In GLP developmental toxicity studies, gravid rabbits were treated orally with R788 at doses of 0, 10, 22, and 50 mg/kg/day (gestation days 7-19) and gravid rats received 0, 5, 12.5, and 25 mg/kg/day (gestation days 6-17) by the same route.  The activity of R406 against Ret kinase was assessed in biochem. and cell-based assays.  A dose-dependent increase in malformations, including renal and ureteric agenesis and a specific major vessel anomaly, retro-esophageal right subclavian artery, was obsd. in both the rat and rabbit.  R788 proved to be a potent inhibitor of Ret kinase.  R788 promoted a spectrum of developmental toxicity, including renal and ureteric agenesis and a specific major vessel abnormality, retro-esophageal right subclavian artery, in 2 different species.  These effects are likely the result of inhibition of Ret kinase given its importance in the normal ontogeny of the urogenital and cardiovascular systems across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkk1lYWlmwebVg90H21EOLACvtfcHk0lgYkwVRXoWjdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFegtrg%253D&md5=9cd3909537d2d22ce666d1e0e426ec7c</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1002%2Fbdra.20505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdra.20505%26sid%3Dliteratum%253Aachs%26aulast%3DClemens%26aufirst%3DG.%2BR.%26aulast%3DSchroeder%26aufirst%3DR.%2BE.%26aulast%3DMagness%26aufirst%3DS.%2BH.%26aulast%3DWeaver%26aufirst%3DE.%2BV.%26aulast%3DLech%26aufirst%3DJ.%2BW.%26aulast%3DTaylor%26aufirst%3DV.%2BC.%26aulast%3DMasuda%26aufirst%3DE.%2BS.%26aulast%3DBaluom%26aufirst%3DM.%26aulast%3DGrossbard%26aufirst%3DE.%2BB.%26atitle%3DDevelopmental%2520toxicity%2520associated%2520with%2520receptor%2520tyrosine%2520kinase%2520Ret%2520inhibition%2520in%2520reproductive%2520toxicity%2520testing%26jtitle%3DBirth%2520Defects%2520Res.%252C%2520Part%2520A%26date%3D2009%26volume%3D85%26spage%3D130%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group">Tohyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Complement-mediated phagocytosis: the role of Syk</span> <span class="citation_source-journal">IUBMB Life</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">–</span> <span class="NLM_lpage">308</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2006&pages=304-308&author=Y.+Tohyamaauthor=H.+Yamamura&title=Complement-mediated+phagocytosis%3A+the+role+of+Syk"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTohyama%26aufirst%3DY.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DComplement-mediated%2520phagocytosis%253A%2520the%2520role%2520of%2520Syk%26jtitle%3DIUBMB%2520Life%26date%3D2006%26volume%3D58%26spage%3D304%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group">Tohyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, H.</span><span> </span><span class="NLM_article-title">Protein tyrosine kinase, Syk: a key player in phagocytic cells</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">267</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1093%2Fjb%2Fmvp001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19124456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivFSnt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2009&pages=267-273&author=Y.+Tohyamaauthor=H.+Yamamura&title=Protein+tyrosine+kinase%2C+Syk%3A+a+key+player+in+phagocytic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Protein Tyrosine Kinase, Syk: A Key Player in Phagocytic Cells</span></div><div class="casAuthors">Tohyama, Yumi; Yamamura, Hirohei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">267-273</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  Spleen tyrosine kinase (Syk) is a non-receptor protein tyrosine kinase expressed in a wide range of hematopoietic cells.  At the initial stage of investigation, main exploring was toward its functions in platelets and in classical immunoreceptor signaling.  However, Syk has now been recognized as a key player in both innate and adaptive immunity.  Esp., in phagocytosis, Syk plays essential roles in signaling evoked by various types of receptors such as FcγR, CR3, Dectin-1 and apoptotic cell-recognizing receptor.  A variety of upstream immunoreceptor tyrosine-based activation motif-like mols. have been found and are still in the course of new studies.  On the contrary, downstream effectors to explain diverse function of Syk are still under exploration.  As its novel function, the authors propose the role of Syk in the regulation of α-tubulin acetylation.  Further investigation on the effectors of Syk would give the authors more information in relation to therapeutic mol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4wYLlMmR1aLVg90H21EOLACvtfcHk0lgYkwVRXoWjdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivFSnt7w%253D&md5=80a02acd1d395b3fa5ce797db6277d4c</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvp001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvp001%26sid%3Dliteratum%253Aachs%26aulast%3DTohyama%26aufirst%3DY.%26aulast%3DYamamura%26aufirst%3DH.%26atitle%3DProtein%2520tyrosine%2520kinase%252C%2520Syk%253A%2520a%2520key%2520player%2520in%2520phagocytic%2520cells%26jtitle%3DJ.%2520Biochem.%26date%3D2009%26volume%3D145%26spage%3D267%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group">Qu, K.</span><span> </span><span class="NLM_article-title">Identification of Pharmacophores from Co-Crystals of Spleen Tyrosine Kinase (SYK) and SYK Ligands</span>. U.S. Patent 7,962,290, June 14,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.+Qu&title=Identification+of+Pharmacophores+from+Co-Crystals+of+Spleen+Tyrosine+Kinase+%28SYK%29+and+SYK+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DQu%26aufirst%3DK.%26atitle%3DIdentification%2520of%2520Pharmacophores%2520from%2520Co-Crystals%2520of%2520Spleen%2520Tyrosine%2520Kinase%2520%2528SYK%2529%2520and%2520SYK%2520Ligands%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group">Bhagwat, S. S.</span><span> </span><span class="NLM_article-title">Kinase inhibitor selectivity</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1266</span><span class="NLM_x">–</span> <span class="NLM_lpage">1268</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=1266-1268&author=S.+S.+Bhagwat&title=Kinase+inhibitor+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhagwat%26aufirst%3DS.%2BS.%26atitle%3DKinase%2520inhibitor%2520selectivity%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D1266%26epage%3D1268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Selectivity and therapeutic inhibition of kinases: to be or not to be?</span> <span class="citation_source-journal">Nat. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">356</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Fjm201271b&amp;key=10.1038%2Fni.1701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Fjm201271b&amp;key=19295632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Fjm201271b&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtlyms78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=356-360&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Selectivity+and+therapeutic+inhibition+of+kinases%3A+to+be+or+not+to+be%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity and therapeutic inhibition of kinases: to be or not to be?</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-360</span>CODEN:
                <span class="NLM_cas:coden">NIAMCZ</span>;
        ISSN:<span class="NLM_cas:issn">1529-2908</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases, which serve crit. functions in signaling pathways in all cells, are popular therapeutic targets.  At present, eight kinase inhibitors have been approved in the United States, each of which shows nanomolar potency.  Although the initial goal was to generate inhibitors with a high degree of selectivity, recent experience has revealed that many of these approved compds. target more than one kinase.  Surprisingly, this promiscuity is less problematic than one would have imagined; indeed, it opens new therapeutic opportunities.  In this Perspective, we discuss the present status of Janus kinase inhibitors-a new class of immunosuppressive drugs-and the advantages and disadvantages of selectively inhibiting this class of kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrU0w6t4jgqirVg90H21EOLACvtfcHk0lgfpSzdhW6iUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtlyms78%253D&md5=64dd47e897181d00e5dce6be3bc5db6e</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1038%2Fni.1701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fni.1701%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DSelectivity%2520and%2520therapeutic%2520inhibition%2520of%2520kinases%253A%2520to%2520be%2520or%2520not%2520to%2520be%253F%26jtitle%3DNat.%2520Immunol.%26date%3D2009%26volume%3D10%26spage%3D356%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group">Swinney, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anthony, J.</span><span> </span><span class="NLM_article-title">How were new medicines discovered?</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=507-519&author=D.+C.+Swinneyauthor=J.+Anthony&title=How+were+new+medicines+discovered%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwinney%26aufirst%3DD.%2BC.%26aulast%3DAnthony%26aufirst%3DJ.%26atitle%3DHow%2520were%2520new%2520medicines%2520discovered%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D507%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OZO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2OZO','PDB','2OZO'); return false;">PDB: 2OZO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XBC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XBC','PDB','1XBC'); return false;">PDB: 1XBC</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201271b&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-8%3Barticle%3Aarticle%3A10.1021%2Fjm201271b%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201271b" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b758ffddcd942","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
